data_6gq9_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6gq9 _Structure_validation_residue.Date_analyzed 2019-06-14 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.508 HG22 ' ND1' ' A' ' 123' ' ' HIS . 43.5 t -128.46 131.92 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -1.204 . . . . 0.0 109.666 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.528 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 99.3 m-85 -89.21 129.33 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.883 . . . . 0.0 109.122 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 120' ' ' SER . 93.4 m -116.09 121.72 43.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.528 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 97.8 m-85 -121.19 147.72 45.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 85.1 tt0 -124.08 134.44 53.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.42 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 92.4 m-20 -104.75 148.6 26.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.276 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -116.57 138.09 51.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.69 123.28 13.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.5 m -110.7 127.33 55.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.996 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 p -160.57 147.37 15.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 p -83.82 91.15 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 94.0 mt -139.02 144.78 42.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 45.5 Cg_endo -67.91 121.48 8.52 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 111.235 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.76 -31.85 38.52 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.848 2.365 . . . . 0.0 112.451 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.87 -54.23 8.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 109.654 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.408 ' O ' ' OG ' ' A' ' 22' ' ' SER . 33.8 mtp-105 -72.25 -39.19 68.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 109.762 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 60.4 tp -61.26 -45.15 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 77' ' ' HIS . 58.4 t80 -67.4 -46.94 71.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.861 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.504 ' HA ' ' CG ' ' A' ' 25' ' ' LEU . 15.9 tttp -72.72 -22.23 60.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.833 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.459 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 83.8 p -97.72 -29.19 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.072 -1.017 . . . . 0.0 109.826 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.528 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 14.2 t80 -100.27 -46.46 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.493 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.8 t -84.34 -52.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.504 ' CG ' ' HA ' ' A' ' 21' ' ' LYS . 42.5 mt -71.86 -41.89 67.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.024 -1.047 . . . . 0.0 109.681 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.9 m-20 -97.43 26.35 4.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.546 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.55 -44.51 70.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.512 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' N ' ' OD2' ' A' ' 28' ' ' ASP . 37.2 p-10 -74.19 -18.4 60.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.01 -38.81 14.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.621 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.459 ' CD1' ' O ' ' A' ' 22' ' ' SER . 48.5 mt -71.88 -30.89 65.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.624 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 34.4 mt . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.805 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -141.19 138.91 33.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 47' ' ' GLY . 37.4 t30 -87.89 115.42 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.53 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 54' ' ' ILE . 20.8 tp -73.35 -32.91 64.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.396 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 81.6 tt0 -166.98 160.18 13.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.505 ' O ' ' ND2' ' A' ' 44' ' ' ASN . . . 92.76 161.45 36.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -98.91 10.48 41.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.99 20.93 9.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 75' ' ' ILE . . . -118.75 -146.02 7.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.2 Cg_endo -68.82 125.08 12.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.826 2.351 . . . . 0.0 111.777 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.14 3.44 75.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 99.6 m -72.91 140.21 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -1.185 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.504 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 18.5 mm -110.91 118.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 70' ' ' HIS . 46.8 mttt -120.52 143.26 48.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HD2' ' HG2' ' A' ' 69' ' ' LYS . 16.4 mtmt -127.51 135.41 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.454 HG12 ' HB2' ' A' ' 42' ' ' ALA . 71.4 mt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.376 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 85.8 mtp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 87.2 mttt -132.38 141.11 48.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 55' ' ' LYS . 97.9 m-70 -121.86 135.55 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.504 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 61.5 tttt -131.51 131.73 43.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.423 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.56 HG22 ' CE1' ' A' ' 84' ' ' TYR . 21.9 t -89.07 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 86.2 tt0 -71.79 -43.51 65.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.96 . . . . 0.0 109.61 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.4 tt0 -178.36 146.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.525 ' CD1' ' HA2' ' A' ' 50' ' ' GLY . 30.0 mt -126.31 120.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 20.6 t70 -128.74 93.29 3.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 55.7 p-80 -69.75 -26.46 64.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.0 -43.13 99.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 23.4 m120 -91.25 3.56 54.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.93 . . . . 0.0 109.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 59.29 27.17 16.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 79' ' ' ASN . 36.6 mttt -116.14 141.45 48.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.482 ' CE2' HD11 ' A' ' 75' ' ' ILE . 17.8 t80 -130.23 137.28 49.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 13.2 m -117.32 122.49 44.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.56 ' CE1' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -120.7 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.468 ' HB3' ' HE2' ' A' ' 98' ' ' LYS . 73.3 m -127.74 149.25 50.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.533 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 99' ' ' ILE . 26.9 mm -116.96 129.69 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.415 ' C ' ' HG3' ' A' ' 88' ' ' GLU . 84.9 mt -87.0 -49.75 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.256 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 87' ' ' ILE . 97.5 mt-10 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 55.73 17.71 2.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.383 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 130' ' ' ILE . 42.8 mt -97.98 91.01 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.152 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' HIS . 91.4 mt-10 -51.37 -43.01 61.74 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.276 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.506 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 16.7 tttt -155.96 158.18 37.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 0.0 110.315 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 101' ' ' TYR . 35.6 mt -134.41 117.11 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 84' ' ' TYR . 32.5 t -120.87 150.89 40.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.003 -1.061 . . . . 0.0 110.237 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 99' ' ' ILE . 93.4 m-85 -131.38 133.49 45.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 93.5 mt-10 -121.22 139.65 53.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.25 125.86 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 109.392 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -125.04 146.94 49.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.1 mtt -122.82 150.44 42.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.43 153.48 40.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.37 39.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.5 t -112.78 143.99 43.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -1.166 . . . . 0.0 109.55 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 70.1 mt -115.48 135.81 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.6 mp -105.91 138.35 42.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.59 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.406 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 70.7 mttt -127.56 139.66 52.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 76.0 mt -123.31 138.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.618 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 29.7 m -120.33 142.4 49.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.342 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 54.1 m -125.44 148.81 48.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.615 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -134.94 122.5 22.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.888 . . . . 0.0 109.256 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.565 ' CE1' HG22 ' A' ' 99' ' ' ILE . 50.9 m-85 -119.2 119.75 35.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 97' ' ' GLU . 0.9 OUTLIER -84.7 114.01 21.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 108.722 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' THR . 9.6 t -103.38 144.38 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.022 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 124' ' ' THR . 16.0 tttt -43.84 -45.44 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 149.68 -54.06 0.5 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -85.93 8.94 18.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -107.0 145.33 32.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 m -124.16 145.61 49.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.519 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 52.6 mt -101.82 134.07 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -86.14 142.48 28.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.433 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.3 mt-10 -58.88 -35.89 73.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -63.31 -46.26 87.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.843 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -57.22 -44.3 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.351 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.476 ' CG2' HG21 ' A' ' 130' ' ' ILE . 39.7 pt -75.37 -30.64 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.282 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -56.09 -40.55 73.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.19 -47.18 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.9 . . . . 0.0 109.31 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.66 67.87 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.98 -42.6 99.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -1.08 . . . . 0.0 109.214 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -54.95 -45.48 74.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.173 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -59.44 -45.12 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.95 93.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.72 95.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.168 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.69 -46.98 88.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.9 -38.76 76.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.238 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.479 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.6 t80 -62.83 -41.04 99.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -0.895 . . . . 0.0 109.277 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -59.21 -40.99 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.75 -51.94 65.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 146' ' ' PHE . 4.3 p -61.83 -41.2 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 149' ' ' VAL . 84.3 tt0 -63.54 -38.47 91.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.348 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.41 91.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -61.15 -48.28 82.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.26 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.31 -35.82 78.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.329 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' A' ' 154' ' ' LEU . 2.0 tm? -63.06 -39.87 96.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.853 . . . . 0.0 109.293 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.78 64.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.57 HG23 ' CG ' ' A' ' 123' ' ' HIS . 29.1 t -129.39 133.63 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -1.115 . . . . 0.0 109.313 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.48 ' CD1' ' CD1' ' A' ' 130' ' ' ILE . 97.2 m-85 -92.86 132.09 37.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 109.302 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 120' ' ' SER . 28.5 p -117.89 121.33 40.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 119' ' ' THR . 33.5 m-85 -115.27 143.69 44.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.75 152.51 37.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -135.14 137.66 42.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.37 137.77 45.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.626 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.6 123.31 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.6 m -107.52 127.25 53.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.774 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.4 p -160.39 140.2 11.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.312 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' CG1' ' HA3' ' A' ' 113' ' ' GLY . 3.1 t -88.24 91.61 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 31.3 mm -138.5 144.49 42.67 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.1 Cg_endo -67.94 123.56 10.81 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.44 2.093 . . . . 0.0 111.463 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 43.7 Cg_endo -66.87 -40.01 13.3 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.75 2.3 . . . . 0.0 112.1 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.94 -53.82 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 0.0 109.433 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -72.14 -46.66 55.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.517 ' HB2' ' CG2' ' A' ' 14' ' ' ILE . 27.8 tp -61.11 -41.02 95.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 24' ' ' VAL . 44.1 t80 -68.19 -55.8 10.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 92.9 mttt -65.58 -13.67 59.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 109.888 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 52.9 p -109.16 -17.58 13.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.953 -1.092 . . . . 0.0 110.231 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 85.5 t80 -100.37 -51.57 3.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 110.109 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.583 HG23 ' CE2' ' A' ' 20' ' ' PHE . 6.6 m -85.67 -39.4 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.984 . . . . 0.0 110.092 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -81.63 -53.95 5.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.161 -0.962 . . . . 0.0 110.13 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' SER . 84.7 m-20 -76.81 4.87 8.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -65.61 -38.93 90.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.788 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -58.43 -26.66 63.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -106.04 -39.42 5.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.6 mt -69.25 -31.75 70.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 31' ' ' ILE . 52.2 mt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -124.15 145.43 49.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 82.3 m-20 -82.36 114.99 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.41 ' HB3' HG22 ' A' ' 54' ' ' ILE . 19.2 tp -56.63 -49.07 76.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -152.02 -171.35 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 70.74 163.33 4.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -98.37 7.97 45.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.167 . . . . 0.0 109.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 107.68 8.33 30.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' HD12 ' A' ' 75' ' ' ILE . . . -105.31 -145.08 13.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.69 122.71 9.4 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.654 2.236 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.521 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . 95.63 -1.12 63.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.459 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 92.6 m -72.96 141.25 47.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -1.191 . . . . 0.0 109.481 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.557 ' N ' ' CD1' ' A' ' 54' ' ' ILE . 1.6 mp -111.45 131.35 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 27.0 mttm -109.7 140.16 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 109.337 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -129.23 136.3 49.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.585 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 64.8 mt . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.39 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.287 0.565 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -111.12 144.81 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.925 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 77.9 m80 -127.04 134.64 50.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HB2' HD11 ' A' ' 87' ' ' ILE . 28.9 tttp -133.5 143.96 49.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG22 ' CG1' ' A' ' 75' ' ' ILE . 9.8 p -108.57 135.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.44 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 97.0 mt-10 -81.72 -43.49 18.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 92.5 mt-10 -158.84 142.37 15.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.606 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.555 HG12 ' CE2' ' A' ' 82' ' ' TYR . 77.5 mt -125.4 123.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 79' ' ' ASN . 25.9 t0 -125.69 91.72 3.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.623 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.437 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 87.8 m-70 -65.2 -41.09 94.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.504 ' O ' ' CE2' ' A' ' 80' ' ' PHE . . . -65.26 -40.43 93.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.436 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 56.3 t30 -79.33 -10.69 59.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' A' ' 78' ' ' ALA . 66.3 m-85 62.16 35.77 15.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.512 ' NZ ' ' OE1' ' A' ' 102' ' ' GLU . 73.0 tttt -128.87 122.53 30.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.294 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.555 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.4 t80 -117.66 116.7 27.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.441 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 51.1 t -117.64 123.66 46.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.209 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.499 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.2 p90 -140.31 167.35 22.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 47.3 t -137.06 169.84 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 86' ' ' ILE . 10.6 mt -112.28 122.73 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 71' ' ' LYS . 73.9 mt -79.2 -38.39 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.301 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.337 0.589 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 59.47 22.99 11.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.699 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.416 HD23 ' CD1' ' A' ' 130' ' ' ILE . 49.0 mt -110.65 95.95 5.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.949 . . . . 0.0 109.296 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 123' ' ' HIS . 90.0 mt-10 -48.02 -49.71 30.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.619 -0.675 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 23.9 mttp -156.47 169.77 23.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.634 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 55.9 mt -144.66 115.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 42.7 t -116.33 153.33 32.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 110.058 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -125.22 133.49 52.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 108.994 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' OE1' ' NZ ' ' A' ' 81' ' ' LYS . 80.2 tt0 -111.94 136.9 50.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.813 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.01 127.87 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -126.27 130.92 51.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.3 mtt -115.18 130.77 57.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.884 . . . . 0.0 109.162 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.63 154.26 42.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.71 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.97 139.51 33.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 0.0 109.345 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.53 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.523 ' HA3' ' CG1' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 55.8 m -143.05 165.16 28.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -1.117 . . . . 0.0 109.418 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.443 HG13 ' HB2' ' A' ' 108' ' ' ALA . 76.7 mt -128.61 133.43 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.56 135.52 53.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -129.75 141.57 50.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.07 133.37 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 24.7 m -125.3 141.76 51.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 22.4 m -128.31 151.8 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.3 mttp -139.17 126.42 21.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE1' ' CG2' ' A' ' 99' ' ' ILE . 3.2 m-85 -121.21 112.74 19.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.388 -0.82 . . . . 0.0 109.536 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.57 ' CG ' HG23 ' A' ' 3' ' ' VAL . 50.1 m-70 -84.64 121.3 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.467 ' OG1' ' CA ' ' A' ' 127' ' ' ASN . 1.0 OUTLIER -100.93 151.74 21.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.028 -1.045 . . . . 0.0 109.986 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -56.91 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.9 57.97 0.6 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.467 ' CA ' ' OG1' ' A' ' 124' ' ' THR . 67.6 m-20 51.5 45.58 27.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.438 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -72.52 135.02 45.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.4 m -67.32 146.51 54.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.654 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.48 ' CD1' ' CD1' ' A' ' 4' ' ' PHE . 30.8 mt -111.28 130.37 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.69 139.76 55.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.191 -0.943 . . . . 0.0 109.609 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.0 mt-10 -67.8 -31.57 71.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.58 -41.89 95.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.97 -43.16 99.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 136' ' ' LYS . 42.4 pt -82.81 -31.87 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.345 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 58.6 tttm -56.24 -41.15 75.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.38 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.72 -45.42 74.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.392 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.69 -39.26 86.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -62.05 -42.15 98.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -1.139 . . . . 0.0 109.38 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -58.32 -43.71 88.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 109.325 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 145' ' ' LEU . . . -62.06 -40.19 94.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.7 84.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.463 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.65 -37.94 95.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 142' ' ' ALA . 3.6 mt -61.97 -40.9 97.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -1.133 . . . . 0.0 109.414 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.525 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.2 m-85 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.239 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.75 -37.73 87.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.94 -47.43 52.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.385 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.525 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 8.1 p -63.31 -47.18 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.494 ' N ' HG11 ' A' ' 149' ' ' VAL . 96.2 mt-10 -61.13 -42.69 98.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.28 76.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -61.15 -53.4 57.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.45 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 64.0 mt -57.62 -38.87 75.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 154' ' ' LEU . 7.1 mp -66.11 -47.14 75.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.18 -0.95 . . . . 0.0 109.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -55.06 -29.24 57.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.963 . . . . 0.0 109.277 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.595 HG23 ' CG ' ' A' ' 123' ' ' HIS . 17.9 t -123.25 134.98 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.166 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.643 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 96.5 m-85 -95.75 135.48 37.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -121.9 129.38 52.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 0.0 109.572 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.539 ' CZ ' ' CD1' ' A' ' 135' ' ' ILE . 97.9 m-85 -125.97 146.82 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.41 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.4 tt0 -116.78 137.38 52.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.585 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 67.7 t0 -115.25 130.38 56.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.342 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -105.06 131.16 52.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.728 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.02 125.56 22.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 109.069 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -112.77 135.09 53.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.814 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -160.25 152.3 20.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.156 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 13' ' ' VAL . 2.2 p -91.74 90.79 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -139.45 149.4 60.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 108.837 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 45.5 Cg_endo -67.81 126.41 14.6 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.266 1.977 . . . . 0.0 111.182 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.2 Cg_endo -66.44 -29.76 44.85 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.754 2.303 . . . . 0.0 112.333 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.01 7.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.552 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -72.26 -47.24 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.724 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 23' ' ' PHE . 15.0 tp -59.29 -46.96 87.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.761 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 77' ' ' HIS . 61.5 t80 -56.04 -48.04 76.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 0.0 109.668 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 30.8 mttm -69.15 -55.73 9.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -64.49 -19.1 65.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 109.983 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.525 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 78.1 t80 -100.2 -51.44 3.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.055 -1.028 . . . . 0.0 110.07 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 54.4 t -85.22 -52.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -62.26 -42.95 99.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.811 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.9 m-20 -97.67 18.61 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.71 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.78 -34.19 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -72.2 -27.22 62.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -105.76 -42.32 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.945 . . . . 0.0 109.752 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 15.8 tp -63.93 -32.15 73.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.746 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.487 ' CG1' ' O ' ' A' ' 27' ' ' ALA . 39.5 mt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.085 -1.01 . . . . 0.0 109.408 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.306 0.574 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -141.02 145.46 35.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.5 ' OD1' ' CD ' ' A' ' 55' ' ' LYS . 67.2 m-20 -82.33 112.55 19.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.3 tp -70.8 -35.48 72.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 85.9 tt0 -149.54 157.58 43.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.454 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.51 161.59 33.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -91.62 7.64 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.164 . . . . 0.0 109.479 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.431 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.03 18.75 11.69 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.463 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -115.24 -142.52 7.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.86 125.21 11.83 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.698 2.265 . . . . 0.0 111.74 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.37 -1.53 82.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 54' ' ' ILE . 67.5 m -72.64 141.11 48.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.517 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 24.8 mm -106.67 130.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.5 ' CD ' ' OD1' ' A' ' 44' ' ' ASN . 34.3 mmtp -102.35 147.86 26.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -123.9 137.62 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.517 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.561 HG12 ' CE1' ' A' ' 70' ' ' HIS . 22.7 mm . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.265 0.555 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.68 133.27 54.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CE1' HG12 ' A' ' 57' ' ' ILE . 76.2 m80 -118.45 139.24 51.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.517 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 34.7 tttt -135.72 137.06 41.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 11.8 p -104.73 130.09 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.49 -41.49 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 84.8 tt0 -176.36 139.79 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.452 HD11 ' HA2' ' A' ' 50' ' ' GLY . 68.5 mt -116.52 124.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -131.82 73.34 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 64.8 m170 -56.35 -37.48 70.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.48 70.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -92.32 8.3 38.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.492 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 74.7 m-85 51.74 28.32 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 0.0 109.477 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -123.92 136.81 54.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 71.4 t80 -133.78 133.6 41.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.448 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.6 m -135.58 120.04 18.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.493 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.2 p90 -135.97 166.25 23.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 92.8 p -148.07 164.11 34.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.2 mm -116.1 120.1 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.2 mt -77.65 -36.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.533 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 74.1 m80 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 57.57 16.14 3.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.643 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 99' ' ' ILE . 32.4 mt -96.25 90.78 5.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.007 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 123' ' ' HIS . 79.6 mt-10 -47.05 -36.87 8.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.644 . . . . 0.0 110.529 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.514 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 15.4 tttt -164.68 156.99 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.75 -1.219 . . . . 0.0 110.356 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.592 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 6.3 mm -134.43 113.22 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 17.5 m -115.77 152.88 32.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.061 . . . . 0.0 110.087 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 119' ' ' THR . 84.3 m-85 -132.24 128.93 38.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 84.5 tt0 -104.89 139.82 39.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.841 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.81 122.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.113 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -130.24 136.33 49.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.967 . . . . 0.0 109.724 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.513 ' HE1' ' CD1' ' A' ' 23' ' ' PHE . 64.0 mtt -117.75 143.84 45.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -140.83 152.35 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 109.566 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.21 135.19 47.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -151.61 154.23 36.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -1.153 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.5 mt -118.24 133.04 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.33 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.9 mp -111.15 135.78 51.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 18.6 mttt -122.61 135.76 54.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.271 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -119.75 136.8 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 109.627 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 26.2 m -117.98 142.56 47.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.31 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 73.4 m -120.65 151.73 39.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 28.2 mttp -139.78 129.1 24.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.05 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.592 ' CE1' ' CG2' ' A' ' 99' ' ' ILE . 15.4 m-85 -129.34 110.63 12.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.823 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.595 ' CG ' HG23 ' A' ' 3' ' ' VAL . 49.1 m-70 -81.06 113.38 19.21 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.0 OUTLIER -105.71 139.37 40.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.362 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.41 ' CD ' HG21 ' A' ' 95' ' ' THR . 31.3 mttt -42.2 -47.93 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.421 -0.799 . . . . 0.0 109.631 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.42 -64.83 0.27 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.43 -30.34 71.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.0 148.24 48.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.5 m -132.43 150.36 52.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.643 ' CG1' ' CD1' ' A' ' 4' ' ' PHE . 22.4 mm -102.54 122.63 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -92.53 136.24 33.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.494 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 136' ' ' LYS . 84.8 tt0 -55.62 -41.28 73.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.411 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.63 -40.39 95.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.38 -46.4 86.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.456 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.562 ' CG2' ' CG2' ' A' ' 130' ' ' ILE . 11.5 pt -80.1 -33.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 132' ' ' GLU . 46.7 tttm -56.8 -33.9 67.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.855 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.55 74.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.325 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.09 92.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -56.98 -46.79 81.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.213 -1.169 . . . . 0.0 109.371 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.38 -46.1 87.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 145' ' ' LEU . 39.6 ttpt -58.87 -45.98 88.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.327 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.72 77.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . -60.16 -41.92 93.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.97 89.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.473 ' CD1' ' O ' ' A' ' 141' ' ' LYS . 6.6 mp -64.22 -38.37 90.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -1.13 . . . . 0.0 109.369 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.502 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.8 t80 -63.8 -44.52 93.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.384 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 143' ' ' ALA . 20.3 mmtt -62.41 -38.26 89.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.419 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.39 76.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.337 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 146' ' ' PHE . 4.7 p -65.23 -40.37 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.32 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.7 tt0 -60.22 -40.89 91.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.365 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.43 98.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -62.28 -44.72 95.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.892 . . . . 0.0 109.343 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.8 tp -57.77 -38.76 76.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.4 mt -71.02 -43.17 68.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -56.72 -27.16 58.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.978 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.529 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.553 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 29.7 t -130.44 136.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -1.168 . . . . 0.0 109.417 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 93.6 m-85 -104.15 136.09 44.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.0 m -113.72 114.65 26.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 4' ' ' PHE . 33.1 m-85 -112.75 138.48 49.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 94.3 mt-10 -112.37 156.5 22.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.674 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -124.05 143.4 50.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.356 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -109.96 135.81 50.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.39 123.86 7.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.156 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.5 m -117.9 131.53 56.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -160.32 144.69 14.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.268 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.451 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 33.4 m -78.08 91.25 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.436 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.533 HG22 ' CD2' ' A' ' 19' ' ' LEU . 24.5 mt -139.0 144.29 40.58 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.443 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 45.4 Cg_endo -67.93 120.41 7.41 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.499 2.132 . . . . 0.0 111.368 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.0 -27.31 42.76 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.818 2.345 . . . . 0.0 112.263 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -54.34 6.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 22' ' ' SER . 62.8 mtt85 -72.15 -42.89 65.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.533 ' CD2' HG22 ' A' ' 14' ' ' ILE . 32.9 tp -59.98 -47.45 85.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.694 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 24' ' ' VAL . 47.1 t80 -59.23 -52.0 67.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' HA ' ' CB ' ' A' ' 25' ' ' LEU . 46.2 mttp -69.14 -29.36 67.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.773 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 83.5 p -84.16 -28.12 27.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.694 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' LEU . 84.7 t80 -100.76 -48.45 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.89 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 20' ' ' PHE . 54.7 t -84.42 -52.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.424 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.486 ' CB ' ' HA ' ' A' ' 21' ' ' LYS . 12.5 tp -74.95 -26.03 59.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 110.024 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' SER . 85.5 m-20 -113.74 27.11 9.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 109.585 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.68 -42.13 74.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HA ' HD12 ' A' ' 31' ' ' ILE . 56.0 t0 -62.63 -32.52 73.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -93.69 -31.38 14.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.857 . . . . 0.0 109.389 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 26' ' ' ASP . 15.9 tp -75.35 -25.8 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.459 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 12.3 mt . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -132.02 144.5 50.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.446 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 89.9 m-20 -88.29 112.1 22.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.519 HD12 ' CG2' ' A' ' 54' ' ' ILE . 2.0 mp -66.86 -37.79 85.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 82.4 tt0 -149.64 155.55 40.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.515 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 89.55 159.68 35.69 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -92.35 6.77 45.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.517 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.457 ' HA2' HG22 ' A' ' 53' ' ' THR . . . 107.25 18.44 10.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 75' ' ' ILE . . . -113.25 -145.97 9.49 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.4 Cg_endo -70.03 121.42 8.05 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.706 2.271 . . . . 0.0 111.725 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.69 67.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.457 HG22 ' HA2' ' A' ' 49' ' ' GLY . 52.4 m -79.47 135.07 36.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.18 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.519 ' CG2' HD12 ' A' ' 45' ' ' LEU . 19.4 mm -95.29 136.28 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.207 -0.933 . . . . 0.0 109.513 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 45.3 mttm -119.9 133.51 55.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . 30.5 tttm -107.36 142.1 37.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.503 HG12 ' ND1' ' A' ' 70' ' ' HIS . 26.3 mm . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.98 129.5 48.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.955 . . . . 0.0 109.677 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.503 ' ND1' HG12 ' A' ' 57' ' ' ILE . 80.8 m80 -128.32 126.67 41.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.359 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.466 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 18.0 tttm -123.6 145.42 48.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.45 HG13 ' CG1' ' A' ' 75' ' ' ILE . 46.9 t -90.39 129.58 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 83.9 tt0 -79.88 -37.46 34.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.492 ' N ' ' HB2' ' A' ' 83' ' ' CYS . 80.8 tt0 -179.12 144.31 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.534 HG12 ' CE1' ' A' ' 82' ' ' TYR . 27.5 mt -127.39 119.16 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 79' ' ' ASN . 29.4 t0 -127.11 86.88 2.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -66.88 -32.31 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.84 81.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.428 ' HB2' ' CG ' ' A' ' 76' ' ' ASP . 1.4 m120 -96.04 2.25 53.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 59.07 22.33 10.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 109.454 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.445 ' HG2' ' HB2' ' A' ' 104' ' ' LYS . 33.9 mttt -110.97 130.46 55.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.534 ' CE1' HG12 ' A' ' 75' ' ' ILE . 25.8 t80 -125.13 129.14 49.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.952 . . . . 0.0 109.673 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.499 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 35.9 m -109.39 131.92 54.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.228 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -120.89 139.53 53.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.668 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 20.2 t -127.2 142.81 51.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 99' ' ' ILE . 24.1 mt -117.97 127.45 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.68 -36.66 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.461 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 81.6 t60 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 124' ' ' THR . 1.4 m 64.08 11.25 6.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.488 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.463 HD21 ' CD1' ' A' ' 130' ' ' ILE . 93.9 mt -94.81 92.11 6.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.311 -0.868 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' HIS . 46.3 mt-10 -49.1 -40.27 31.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.751 -0.593 . . . . 0.0 110.963 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 95.0 mttt -158.12 156.57 31.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.585 HG21 ' CZ ' ' A' ' 122' ' ' TYR . 33.3 mm -133.18 113.0 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 29.7 t -113.68 150.08 33.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.575 ' CZ ' HG23 ' A' ' 99' ' ' ILE . 91.2 m-85 -129.08 130.69 46.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 85.1 tt0 -108.76 137.98 45.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.758 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.0 mt -124.12 124.54 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.299 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HE3' ' HD2' ' A' ' 117' ' ' LYS . 41.3 pttt -134.86 149.52 50.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.422 ' HG2' HD22 ' A' ' 116' ' ' LEU . 64.4 mtt -115.42 145.22 42.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.454 ' O ' ' OG ' ' A' ' 114' ' ' SER . . . -142.44 155.47 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.79 148.09 38.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' A' ' 115' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 106' ' ' ALA . 33.0 t -125.22 157.96 35.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.467 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.416 HG13 ' CB ' ' A' ' 108' ' ' ALA . 66.6 mt -117.03 136.99 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.422 HD22 ' HG2' ' A' ' 105' ' ' MET . 36.8 mt -106.24 136.2 46.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.649 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.457 ' HD2' ' HE3' ' A' ' 104' ' ' LYS . 77.1 mttt -130.66 144.58 51.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.122 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.5 mt -132.64 140.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 0.0 109.999 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 20.6 m -120.54 142.31 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' SER . 0.1 OUTLIER -118.98 146.62 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.499 ' CG ' HG13 ' A' ' 3' ' ' VAL . 37.3 ttpt -126.02 112.2 15.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 109.32 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.586 ' CB ' ' CD1' ' A' ' 130' ' ' ILE . 3.5 m-85 -109.74 108.51 18.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.553 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 4.9 t60 -83.79 121.79 27.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.3 p -113.08 143.93 43.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.991 -1.068 . . . . 0.0 109.765 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -70.19 153.33 43.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.59 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 47.59 -131.43 16.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -114.45 41.53 2.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.183 . . . . 0.0 109.385 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.05 150.08 48.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 96.6 p -114.65 155.48 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.586 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 58.3 mt -113.04 141.5 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -89.13 141.24 28.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.3 mt-10 -65.48 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 23.1 pt-20 -65.7 -41.74 92.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.457 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 133' ' ' GLU . 83.9 tt0 -61.3 -41.54 97.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 132' ' ' GLU . 47.8 pt -85.05 -29.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 34.0 tttt -55.76 -45.56 78.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.05 78.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.217 -0.927 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.99 -35.08 90.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.09 -44.16 95.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.29 -39.9 94.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.865 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -63.25 -41.05 99.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.939 . . . . 0.0 109.434 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.521 ' HB1' ' CE2' ' A' ' 146' ' ' PHE . . . -71.0 -36.67 72.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.446 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.61 95.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.42 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.45 -38.93 95.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 149' ' ' VAL . 25.1 tp -65.53 -41.2 93.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -1.154 . . . . 0.0 109.442 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.521 ' CE2' ' HB1' ' A' ' 142' ' ' ALA . 16.6 m-85 -65.13 -45.95 82.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -62.83 -37.57 87.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.67 -51.45 56.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.415 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -64.43 -47.53 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 154' ' ' LEU . 87.8 mt-10 -58.66 -38.84 79.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.4 -41.25 89.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.376 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -62.87 -38.59 91.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.09 -43.95 87.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.474 ' CD1' ' O ' ' A' ' 150' ' ' GLU . 6.6 mp -73.64 -40.83 63.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.23 -15.95 63.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.38 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.578 HG23 ' CD2' ' A' ' 123' ' ' HIS . 7.2 p -120.19 138.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -1.077 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.575 ' CE2' HG12 ' A' ' 130' ' ' ILE . 96.4 m-85 -98.6 146.03 26.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 5' ' ' CYS . 25.7 p -132.09 128.13 37.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -122.21 151.99 40.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.437 ' HG2' HG21 ' A' ' 119' ' ' THR . 95.9 mt-10 -118.48 145.61 45.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -123.01 145.82 48.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -121.81 137.34 54.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.59 122.97 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.092 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.427 HG23 HG12 ' A' ' 115' ' ' ILE . 59.4 p -123.82 143.21 50.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.534 ' OG ' ' CD1' ' A' ' 14' ' ' ILE . 98.9 p -160.28 149.36 17.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 108.933 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 33.6 m -66.2 90.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.021 . . . . 0.0 109.341 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 5.5 mt -139.36 142.29 31.88 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.32 -0.862 . . . . 0.0 109.341 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.3 Cg_endo -67.92 122.33 9.44 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 122.356 2.037 . . . . 0.0 111.197 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.79 -34.02 32.36 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.702 2.268 . . . . 0.0 112.209 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.64 11.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.994 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -72.15 -37.94 69.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 110.126 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.534 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 32.0 tp -67.0 -51.06 59.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.929 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 80' ' ' PHE . 67.7 t80 -56.25 -46.89 79.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 25.3 mttt -67.99 -49.56 60.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.139 -0.975 . . . . 0.0 109.879 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 88.7 p -71.49 -20.1 62.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.936 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 24.0 t80 -100.48 -51.12 3.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.16 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.562 HG23 ' CE2' ' A' ' 20' ' ' PHE . 54.9 t -85.11 -52.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -0.939 . . . . 0.0 110.128 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -67.08 -49.3 65.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.0 m-20 -89.52 20.23 4.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -68.18 -50.63 53.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.062 -1.024 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -63.43 -32.07 73.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.955 . . . . 0.0 109.798 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -88.91 -34.69 16.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.526 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.1 tp -74.89 -26.54 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.662 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 27' ' ' ALA . 12.9 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 56' ' ' LYS . 93.6 mt-10 -134.21 157.05 47.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 35.7 p-10 -87.96 112.11 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.466 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.64 -36.24 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 85.9 tt0 -143.1 154.96 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 91.12 159.26 35.47 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.9 8.26 38.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.49 20.39 13.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.446 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -117.67 -145.39 7.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.42 125.31 12.16 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.89 -1.51 80.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.461 HG21 ' HA2' ' A' ' 49' ' ' GLY . 96.2 m -73.59 139.98 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 109.471 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.485 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.8 mm -103.39 134.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 4.0 mtmp? -110.45 156.53 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' GLU . 52.5 tttt -130.91 128.66 40.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 109.353 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.459 HG13 ' CD2' ' A' ' 70' ' ' HIS . 70.5 mt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.527 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -134.65 129.01 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.459 ' CD2' HG13 ' A' ' 57' ' ' ILE . 93.9 m-70 -127.34 129.12 47.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.401 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.485 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 14.9 tttp -127.5 146.01 50.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 50' ' ' GLY . 14.8 p -108.43 138.72 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -75.71 -44.16 43.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -173.59 143.49 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 75' ' ' ILE . 70.4 mt -119.36 118.68 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.9 m-20 -125.04 78.36 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 98.1 m-70 -59.18 -34.62 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.63 66.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 80.7 m-20 -94.27 9.49 37.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.575 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 68.5 m-85 48.34 36.36 6.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -131.29 129.72 41.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.955 . . . . 0.0 109.346 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 61.3 t80 -126.12 122.81 36.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.989 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.6 117.77 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.487 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 35.1 p90 -134.84 167.25 21.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.6 p -145.99 175.23 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.337 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 mt -129.34 126.44 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.451 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.8 mt -78.81 -42.66 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 179.952 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 m80 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 58.17 16.65 4.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.535 ' CD2' HD13 ' A' ' 130' ' ' ILE . 28.0 mt -96.94 90.49 5.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.315 -0.865 . . . . 0.0 109.509 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 123' ' ' HIS . 89.8 mt-10 -43.59 -37.97 2.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.599 -0.688 . . . . 0.0 110.523 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.461 ' O ' HD11 ' A' ' 99' ' ' ILE . 68.2 mttm -145.67 158.06 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.818 -1.176 . . . . 0.0 110.466 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.561 HG21 ' CD1' ' A' ' 122' ' ' TYR . 20.5 mm -135.21 119.29 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -122.52 154.55 37.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 0.0 109.808 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.429 ' OH ' HG23 ' A' ' 99' ' ' ILE . 72.1 m-85 -132.99 137.46 46.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 119' ' ' THR . 80.0 tt0 -113.47 141.83 46.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 103' ' ' ILE . 61.3 mt -128.79 118.7 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.302 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -131.53 126.39 34.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.483 ' CE ' ' HA ' ' A' ' 20' ' ' PHE . 75.9 mtm -120.21 150.95 39.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.05 150.82 26.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 138.43 53.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 32.2 t -151.73 149.65 29.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -1.179 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.427 HG12 HG23 ' A' ' 11' ' ' THR . 64.5 mt -111.77 133.98 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 6.6 mp -106.37 130.9 54.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.731 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.6 tttm -124.62 135.71 53.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.115 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 69.4 mt -129.04 123.55 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.838 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 102' ' ' GLU . 46.8 m -122.52 131.24 53.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.375 -0.828 . . . . 0.0 109.032 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.469 ' CB ' ' OH ' ' A' ' 122' ' ' TYR . 1.8 m -114.34 160.76 18.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 109.969 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 44.8 mttp -143.08 123.9 14.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.561 ' CD1' HG21 ' A' ' 99' ' ' ILE . 5.6 m-85 -122.34 122.76 39.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.578 ' CD2' HG23 ' A' ' 3' ' ' VAL . 9.6 m-70 -85.31 113.9 21.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 108.82 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.509 HG21 ' CD1' ' A' ' 130' ' ' ILE . 1.3 p -94.42 148.39 22.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.679 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.444 ' HG2' ' OE2' ' A' ' 97' ' ' GLU . 32.8 mttm -67.27 145.3 55.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.02 -129.63 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -110.32 31.16 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.556 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.87 144.82 26.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 83.9 p -95.61 171.63 8.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.575 HG12 ' CE2' ' A' ' 4' ' ' PHE . 38.5 mm -118.72 121.89 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -59.18 119.69 7.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.477 ' HA ' HG13 ' A' ' 135' ' ' ILE . 97.0 mt-10 -54.27 -36.73 63.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.3 -35.95 82.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.215 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.44 -25.93 67.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.639 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.477 HG13 ' HA ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -87.9 -35.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.208 -0.932 . . . . 0.0 109.049 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -57.45 -44.27 84.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.688 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.83 -43.24 72.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.452 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.86 92.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -57.99 -47.11 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -1.087 . . . . 0.0 109.343 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.43 -40.11 93.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -58.56 -45.45 88.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -38.64 85.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.86 99.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.26 -45.98 92.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.01 -38.39 79.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -1.197 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.461 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 70.2 t80 -61.65 -41.57 97.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -60.42 -40.06 89.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.328 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.12 80.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 150' ' ' GLU . 5.7 p -67.32 -39.98 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.49 ' N ' HG11 ' A' ' 149' ' ' VAL . 85.2 tt0 -63.73 -38.61 91.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.73 97.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.351 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -59.55 -48.89 79.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.454 HD11 HD11 ' A' ' 19' ' ' LEU . 18.3 mt -61.68 -38.8 89.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 109.38 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.6 tp -63.76 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.67 68.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.7 t60 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.883 . . . . 0.0 109.415 179.93 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.442 ' O ' HG21 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.549 HG22 ' CE1' ' A' ' 123' ' ' HIS . 38.6 t -125.21 132.68 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.17 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 97.3 m-85 -95.44 130.52 42.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.181 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 t -110.59 125.04 52.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.474 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 93.7 m-85 -125.41 144.51 50.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.315 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 91.5 mt-10 -125.15 160.98 27.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.737 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 60.4 t0 -134.42 142.45 47.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.162 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.33 138.89 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.903 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.69 121.56 8.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.151 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.9 m -112.5 133.07 54.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.004 . . . . 0.0 109.971 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 14' ' ' ILE . 4.8 t -160.41 139.59 10.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.786 . . . . 0.0 109.026 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.511 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 28.2 m -68.59 91.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.04 . . . . 0.0 109.36 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.6 mt -138.89 143.84 39.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.216 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.3 Cg_endo -68.24 127.86 16.53 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.409 2.073 . . . . 0.0 111.259 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.88 -34.64 29.57 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.723 2.282 . . . . 0.0 112.199 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.12 -50.96 11.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.634 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HB2' ' HG2' ' A' ' 15' ' ' PRO . 42.0 mtt-85 -70.42 -45.98 64.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.853 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.528 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 40.5 tp -59.91 -48.44 81.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.538 ' CE2' ' HA ' ' A' ' 80' ' ' PHE . 65.9 t80 -52.41 -51.77 57.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.592 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 33.3 mttt -67.45 -57.57 6.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.881 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 46.6 m -62.03 -20.43 63.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CD1' ' CE ' ' A' ' 105' ' ' MET . 56.3 t80 -100.11 -51.27 3.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.993 -1.067 . . . . 0.0 110.095 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 51.7 t -84.93 -51.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 17.8 tp -66.42 -40.48 89.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.835 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.6 m-20 -99.8 20.44 14.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.722 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.63 -34.55 74.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.17 -32.38 72.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.857 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -101.6 -42.07 6.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.129 -0.982 . . . . 0.0 109.76 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 17.6 tp -56.3 -36.8 69.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.753 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.492 -179.71 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -125.81 165.26 19.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 109.38 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' ILE . 50.9 t30 -91.33 115.29 27.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.489 ' CD2' HG21 ' A' ' 54' ' ' ILE . 16.6 tp -63.87 -40.26 96.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.167 -0.958 . . . . 0.0 109.422 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 47' ' ' GLY . 53.1 tt0 -170.95 162.4 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.425 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' N ' ' CG ' ' A' ' 46' ' ' GLU . . . 94.74 162.54 34.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -95.03 6.16 49.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.573 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.6 19.28 11.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.52 ' HA2' ' CD1' ' A' ' 75' ' ' ILE . . . -117.4 -145.72 8.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.57 125.49 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.722 2.282 . . . . 0.0 111.826 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.55 -1.83 79.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 31.9 m -73.68 137.22 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -1.18 . . . . 0.0 109.452 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.492 HG22 HD11 ' A' ' 54' ' ' ILE . 4.7 mt -109.78 139.0 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.517 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' N ' HG23 ' A' ' 54' ' ' ILE . 68.6 mttm -112.01 149.07 32.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 45' ' ' LEU . 22.7 tttt -132.95 147.24 52.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.378 -0.827 . . . . 0.0 109.33 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.49 HG21 HD13 ' A' ' 57' ' ' ILE . 41.4 mt . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.46 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 81.0 mmm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.461 ' CB ' ' HB ' ' A' ' 87' ' ' ILE . 80.1 mttt -134.25 131.71 38.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.399 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 79.6 m80 -125.99 140.54 52.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.955 . . . . 0.0 109.612 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -138.24 140.75 39.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 109.362 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 50.1 t -100.77 138.57 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.5 tt0 -84.07 -56.85 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.384 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.4 mt-10 -158.78 141.64 14.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.454 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.561 HG22 ' CD2' ' A' ' 77' ' ' HIS . 74.0 mt -118.87 128.61 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 85.7 m-20 -128.79 81.25 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.561 ' CD2' HG22 ' A' ' 75' ' ' ILE . 81.8 m-70 -58.93 -36.5 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.93 74.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -85.53 6.96 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.538 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 92.0 m-85 49.44 33.0 5.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -127.82 139.72 52.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 67.1 t80 -126.46 131.4 51.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.45 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.7 m -128.39 117.05 20.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.439 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.6 p90 -139.84 157.47 45.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.483 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 83.9 p -137.71 174.17 10.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.6 mt -124.62 128.21 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.397 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.461 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 72.9 mt -74.86 -37.61 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.867 . . . . 0.0 109.593 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.555 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.8 m80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.447 HG22 ' CB ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 52.76 20.74 1.67 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' A' ' 122' ' ' TYR . 22.3 mt -94.7 90.49 6.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.3 mt-10 -46.24 -40.19 11.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.591 -0.693 . . . . 0.0 110.595 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 99' ' ' ILE . 55.7 tttp -155.88 154.39 31.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.634 -1.291 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.549 HG22 ' CE1' ' A' ' 122' ' ' TYR . 24.1 mm -129.41 118.51 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 120' ' ' SER . 44.8 m -119.52 148.13 43.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 109.945 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -125.55 140.82 52.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.162 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 119' ' ' THR . 84.5 tt0 -124.4 132.86 53.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.696 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.04 126.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.273 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -130.62 133.22 45.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.724 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.549 ' CE ' ' CD1' ' A' ' 23' ' ' PHE . 64.2 mtt -117.55 146.83 43.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.315 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.87 157.76 44.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.3 136.99 34.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 -179.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 22.5 t -155.13 145.38 21.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.475 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.9 mt -116.12 128.7 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 5.1 mp -108.44 135.67 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 68.1 mttm -126.6 135.34 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 77.0 mt -119.61 131.08 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 30.8 m -119.85 142.69 48.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 100' ' ' SER . 1.4 m -128.02 156.62 42.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.826 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -133.59 108.99 8.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.838 . . . . 0.0 108.973 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.549 ' CE1' HG22 ' A' ' 99' ' ' ILE . 8.4 m-30 -105.27 118.91 37.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.549 ' CE1' HG22 ' A' ' 3' ' ' VAL . 2.1 m-70 -84.94 134.13 34.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 108.912 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 128' ' ' ALA . 12.8 t -113.56 144.82 42.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 126' ' ' GLY . 22.9 mttp -72.09 139.77 48.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.51 -142.35 3.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' ALA . 73.0 m-20 -85.9 10.67 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.461 ' HB2' ' OG1' ' A' ' 124' ' ' THR . . . -44.12 146.96 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -115.88 161.89 18.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.571 ' CD1' ' CD2' ' A' ' 4' ' ' PHE . 55.8 mt -104.06 139.08 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.46 118.45 7.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.565 ' HA ' HG13 ' A' ' 135' ' ' ILE . 88.1 tt0 -57.72 -34.57 69.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.46 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -56.33 -42.39 77.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.91 -25.09 67.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.565 HG13 ' HA ' ' A' ' 132' ' ' GLU . 2.9 mt -69.49 -52.34 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 108.947 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -55.65 -41.34 73.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.43 86.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.238 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.2 -36.09 80.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.51 -40.27 95.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -1.177 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.39 -35.23 79.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -63.3 -39.72 95.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 109.567 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.6 76.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.909 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.84 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.595 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.31 -48.2 76.83 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 149' ' ' VAL . 64.7 mt -68.26 -37.92 81.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -1.188 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.434 ' O ' HG12 ' A' ' 149' ' ' VAL . 71.0 t80 -63.5 -45.72 89.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.569 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -63.05 -37.77 88.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.2 38.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.606 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 146' ' ' PHE . 7.5 p -66.13 -40.04 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.97 -39.16 91.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.554 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -65.89 -41.79 91.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.491 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.9 tp -61.53 -38.0 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.14 -0.975 . . . . 0.0 109.374 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 33.8 mt -77.98 -30.89 50.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.08 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 109.428 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.602 HG22 ' CG ' ' A' ' 123' ' ' HIS . 52.4 t -126.85 135.5 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.149 . . . . 0.0 109.471 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.584 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 97.9 m-85 -91.71 128.25 37.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.364 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.8 t -113.56 123.86 50.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.63 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 4' ' ' PHE . 92.4 m-85 -122.86 146.09 47.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 83.9 tt0 -121.94 131.39 53.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.947 . . . . 0.0 109.645 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.88 124.87 45.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -97.07 134.63 40.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.89 124.81 8.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.8 m -118.39 132.49 56.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -160.51 135.47 7.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.137 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.505 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 24.1 m -64.99 91.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.071 -1.018 . . . . 0.0 109.355 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.524 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 20.0 mt -138.86 144.65 42.39 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.48 119.54 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.563 2.176 . . . . 0.0 111.265 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.4 Cg_endo -66.78 -34.83 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.764 2.31 . . . . 0.0 112.264 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.74 14.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -72.2 -40.96 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 22.3 tp -66.39 -36.71 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.111 -0.993 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.565 ' CE1' ' HA ' ' A' ' 80' ' ' PHE . 56.3 t80 -63.79 -50.48 68.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASP . 29.6 mttt -69.26 -48.07 62.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.466 ' O ' HD22 ' A' ' 30' ' ' LEU . 19.2 m -65.62 -23.48 66.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.895 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.519 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 56.7 t80 -100.54 -51.08 3.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 110.139 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 20' ' ' PHE . 55.9 t -84.83 -52.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 22.2 tp -68.07 -29.44 68.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.864 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.8 m-20 -110.38 20.09 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.114 -0.991 . . . . 0.0 109.565 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -67.96 -34.79 77.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.583 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -66.68 -42.17 86.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.828 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -90.02 -34.07 16.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.718 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.528 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 23.2 tp -66.76 -32.82 74.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.461 ' CG1' ' O ' ' A' ' 27' ' ' ALA . 31.9 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.413 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 56' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 95.5 mt-10 -143.19 151.51 40.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.459 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.9 m-20 -89.04 111.5 22.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 54' ' ' ILE . 31.4 tp -77.3 -33.74 55.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 53' ' ' THR . 86.5 tt0 -150.9 155.55 39.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.432 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 76.04 157.8 7.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -81.81 -19.96 40.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -1.127 . . . . 0.0 109.449 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.525 ' HA2' ' CG2' ' A' ' 53' ' ' THR . . . 143.07 -12.6 2.34 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -78.55 -148.12 3.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.0 126.0 13.25 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.858 2.372 . . . . 0.0 111.847 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.09 -6.53 66.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.525 ' CG2' ' HA2' ' A' ' 49' ' ' GLY . 53.7 m -74.22 139.48 44.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.079 -1.248 . . . . 0.0 109.537 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.502 HG22 ' N ' ' A' ' 55' ' ' LYS . 7.3 mt -110.6 139.43 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' N ' HG22 ' A' ' 54' ' ' ILE . 64.9 mttt -130.27 138.44 50.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 109.519 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 17.4 mtmt -112.92 136.46 52.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.322 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -137.14 133.99 35.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 98.7 m-70 -122.4 131.43 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tttm -128.72 127.66 42.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.502 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.504 ' CG2' HD11 ' A' ' 75' ' ' ILE . 2.3 p -84.0 134.22 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 23.4 mt-10 -82.41 -44.76 15.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.857 . . . . 0.0 109.431 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.3 mt-10 -159.23 150.98 20.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.572 HG12 ' CE2' ' A' ' 82' ' ' TYR . 3.2 mt -135.54 107.12 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 79' ' ' ASN . 31.1 t0 -123.21 90.92 3.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.562 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.8 m170 -70.4 -32.78 70.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.58 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.59 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.447 ' OD1' ' OD1' ' A' ' 76' ' ' ASP . 12.4 m120 -84.34 8.25 16.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.565 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 75.6 m-85 54.72 25.36 6.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.378 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.451 ' HE2' ' OE2' ' A' ' 102' ' ' GLU . 63.6 tttt -108.78 122.21 46.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 109.232 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 84' ' ' TYR . 7.4 t80 -128.75 129.82 46.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 109.695 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 102' ' ' GLU . 1.8 t -109.55 123.63 49.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.013 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.608 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -121.14 138.62 54.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.121 -0.987 . . . . 0.0 109.966 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.476 ' HB3' ' NZ ' ' A' ' 98' ' ' LYS . 48.8 m -137.45 158.71 43.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.054 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 mt -127.65 128.1 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.653 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.472 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 89.1 mt -86.01 -39.16 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.4 ' C ' ' OG1' ' A' ' 95' ' ' THR . 81.8 t60 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.49 HG21 ' CB ' ' A' ' 128' ' ' ALA . 0.1 OUTLIER 61.36 13.34 4.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.61 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.529 HD22 ' CD1' ' A' ' 130' ' ' ILE . 32.3 mt -94.87 90.23 5.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' HIS . 86.7 mt-10 -47.19 -42.67 20.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.598 -0.689 . . . . 0.0 110.509 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 99' ' ' ILE . 19.7 tttm -158.96 162.49 36.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.713 -1.242 . . . . 0.0 110.522 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.573 HG22 ' CD1' ' A' ' 122' ' ' TYR . 7.2 mm -136.15 126.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.458 ' OG ' ' OG ' ' A' ' 85' ' ' SER . 23.3 t -132.79 155.8 48.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.112 -0.992 . . . . 0.0 109.996 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.57 ' CZ ' HG23 ' A' ' 99' ' ' ILE . 57.1 m-85 -137.86 129.72 28.56 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.451 ' OE2' ' HE2' ' A' ' 81' ' ' LYS . 83.6 tt0 -106.83 129.09 54.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.807 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -108.32 118.53 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -129.53 143.77 50.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.532 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.451 ' HE2' ' HA ' ' A' ' 20' ' ' PHE . 59.8 mtt -118.81 147.82 43.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.95 163.81 33.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.62 32.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.855 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.481 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 t -135.55 148.77 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -1.159 . . . . 0.0 109.479 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 108' ' ' ALA . 64.7 mt -113.86 134.25 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.1 mt -106.66 139.24 41.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 109.569 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -135.34 136.45 41.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.376 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.9 mt -125.02 135.23 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 25.3 m -116.16 141.9 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.912 . . . . 0.0 109.442 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 67.8 m -124.48 153.15 42.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -137.28 129.08 28.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.573 ' CD1' HG22 ' A' ' 99' ' ' ILE . 51.4 m-85 -125.77 108.72 11.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.745 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.602 ' CG ' HG22 ' A' ' 3' ' ' VAL . 52.6 m-70 -79.88 130.89 35.67 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' THR . 8.8 t -116.17 147.87 40.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.067 -1.02 . . . . 0.0 109.731 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 124' ' ' THR . 18.2 tttt -42.09 -40.96 2.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.646 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.85 0.52 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -86.41 10.72 14.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -1.171 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.49 ' CB ' HG21 ' A' ' 95' ' ' THR . . . -110.36 151.09 27.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -132.25 149.33 52.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.546 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 29.5 mt -98.56 121.39 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.527 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -54.69 138.86 40.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.481 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.2 mt-10 -66.3 -33.22 75.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 109.502 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -59.04 -33.58 70.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.304 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -65.73 -29.52 70.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.268 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.565 HG13 ' CZ ' ' A' ' 6' ' ' TYR . 1.8 mm -69.83 -48.51 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 108.749 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -55.59 -41.55 73.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.193 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.45 75.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.35 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.11 -34.81 58.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.3 -38.14 87.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.294 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.29 -43.74 96.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.282 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -60.2 -42.76 95.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.922 . . . . 0.0 109.428 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.49 82.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.75 89.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.46 -48.47 83.92 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 149' ' ' VAL . 25.2 tp -64.85 -38.85 92.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.16 . . . . 0.0 109.405 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.507 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 68.5 t80 -60.33 -41.31 93.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.291 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.29 66.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.404 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.507 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.9 p -64.2 -44.29 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.494 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.4 tt0 -54.33 -43.57 71.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.85 99.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -60.55 -47.29 86.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.467 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.42 ' HA ' HD11 ' A' ' 153' ' ' LEU . 30.1 tp -61.68 -36.99 82.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.434 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.24 -46.33 87.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.04 -32.08 70.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 m170 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.463 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.629 ' CG2' ' CD2' ' A' ' 123' ' ' HIS . 7.7 p -131.52 136.49 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.557 ' CE2' HG12 ' A' ' 130' ' ' ILE . 87.3 m-85 -95.92 144.38 26.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.409 ' SG ' ' HE3' ' A' ' 121' ' ' LYS . 4.0 m -125.26 119.75 29.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.637 ' CE1' ' CD1' ' A' ' 135' ' ' ILE . 29.3 m-85 -110.75 148.41 32.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.416 ' HG2' HG23 ' A' ' 119' ' ' THR . 96.9 mt-10 -121.53 151.97 39.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -131.8 138.94 48.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -108.98 132.47 54.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.645 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -148.89 125.63 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -114.38 135.56 53.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.84 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -160.36 141.33 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 13' ' ' VAL . 2.3 p -77.1 91.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 0.0 109.37 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.9 mt -138.77 142.62 34.59 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 48.4 Cg_endo -68.96 123.02 9.93 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.578 2.185 . . . . 0.0 111.47 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.78 -30.06 41.54 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.774 2.316 . . . . 0.0 112.278 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.38 6.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.597 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -72.55 -47.48 47.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.811 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 3.0 tm? -53.11 -37.17 61.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.84 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 24' ' ' VAL . 53.8 t80 -71.74 -54.93 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 0.0 109.784 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG3' ' CD1' ' A' ' 25' ' ' LEU . 17.5 tttm -67.67 -30.41 69.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.803 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 36.4 m -81.81 -30.53 32.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.945 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 88.0 t80 -100.84 -44.22 5.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 110.44 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.06 -52.98 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.964 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' CD1' ' HG3' ' A' ' 21' ' ' LYS . 45.0 mt -70.66 -28.68 64.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.937 -1.102 . . . . 0.0 110.037 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 22' ' ' SER . 87.5 m-20 -108.96 19.84 19.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.049 -1.032 . . . . 0.0 109.657 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.96 -52.24 26.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.992 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -62.54 -32.48 73.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.35 -41.62 18.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.001 . . . . 0.0 109.968 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 26' ' ' ASP . 45.2 mt -72.46 -34.15 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 27' ' ' ALA . 18.8 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.494 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.296 0.57 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -125.02 163.62 21.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -91.45 108.01 19.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 46.0 mt -61.72 -41.99 98.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -158.27 153.18 25.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.409 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.25 158.04 31.75 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -94.9 9.71 38.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -1.186 . . . . 0.0 109.536 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.77 21.82 8.42 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.524 ' HA2' ' CD1' ' A' ' 75' ' ' ILE . . . -118.46 -144.67 7.6 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.32 123.54 10.35 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.701 2.267 . . . . 0.0 111.874 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.23 1.46 72.25 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 93.4 m -73.38 134.64 44.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.553 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.517 HG12 ' CD ' ' A' ' 71' ' ' LYS . 3.9 mt -104.6 138.92 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 49.2 mttm -123.57 142.32 51.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.521 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . 49.3 tttt -134.15 142.46 47.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.422 HD11 ' HB1' ' A' ' 42' ' ' ALA . 6.1 tp . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.573 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 45.5 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -92.04 156.01 17.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.56 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 78.5 m80 -134.96 135.85 41.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.517 ' CD ' HG12 ' A' ' 54' ' ' ILE . 10.3 tptm -132.12 127.3 35.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.428 HG11 ' CG1' ' A' ' 75' ' ' ILE . 40.3 t -91.61 125.11 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.35 -42.67 58.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.382 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.2 tt0 -174.85 142.32 0.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.548 HG12 ' CE2' ' A' ' 82' ' ' TYR . 69.1 mt -119.12 132.4 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 80.8 m-20 -133.14 83.62 2.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -61.68 -37.57 84.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.76 71.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 75.2 m-20 -91.61 9.91 30.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASN . 86.1 m-85 43.71 45.64 6.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.451 ' HG3' ' HG2' ' A' ' 104' ' ' LYS . 10.3 ttpp -140.35 123.22 16.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.548 ' CE2' HG12 ' A' ' 75' ' ' ILE . 58.5 t80 -111.07 129.2 55.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 22.0 m -123.91 114.81 20.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 109.558 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.544 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 37.1 p90 -137.57 159.91 40.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.462 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 85.6 p -141.3 168.84 18.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.6 mm -114.29 121.45 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 81.2 mt -70.78 -41.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 109.531 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.297 0.57 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 59.51 14.79 4.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.565 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.534 ' CD1' HD12 ' A' ' 99' ' ' ILE . 36.5 mt -93.12 90.7 6.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 108.83 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 94.6 mt-10 -43.23 -44.59 5.34 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.795 -0.566 . . . . 0.0 110.125 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.455 ' O ' HD13 ' A' ' 99' ' ' ILE . 88.0 mttt -153.54 156.17 37.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.961 -1.087 . . . . 0.0 110.032 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.559 HD11 ' CD1' ' A' ' 122' ' ' TYR . 32.3 mm -130.51 112.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 36.8 m -115.76 152.5 33.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.769 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.467 ' OH ' HG21 ' A' ' 99' ' ' ILE . 91.2 m-85 -129.63 133.3 47.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.347 -0.846 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -117.4 139.27 51.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.682 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.6 mt -123.88 121.87 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.345 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.451 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 21.3 mtpt -117.54 127.5 54.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.463 ' HG2' HD22 ' A' ' 116' ' ' LEU . 70.1 mtm -124.48 138.6 54.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.34 37.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.96 135.53 43.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 t -115.05 154.48 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.44 127.37 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.332 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 105' ' ' MET . 55.9 mt -106.59 136.96 45.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 40.3 mttt -131.4 138.1 48.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.243 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.9 mt -125.68 122.71 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.731 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 94.3 m -128.66 138.3 52.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.1 m -123.24 166.56 15.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.409 ' HE3' ' SG ' ' A' ' 5' ' ' CYS . 10.6 mtpt -138.45 112.84 8.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.165 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.559 ' CD1' HD11 ' A' ' 99' ' ' ILE . 8.1 m-30 -108.29 115.13 29.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.629 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 12.7 m-70 -82.56 122.91 28.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 108.693 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.453 HG22 ' CE2' ' A' ' 4' ' ' PHE . 14.2 t -106.78 141.12 38.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.988 -1.07 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.411 ' HD2' HG21 ' A' ' 95' ' ' THR . 45.1 mttt -45.39 -40.58 8.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.635 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.22 -68.24 0.37 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -65.18 -27.73 68.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -1.141 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.74 149.52 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.497 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 92.3 p -126.63 159.86 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.581 ' CG2' ' CG2' ' A' ' 135' ' ' ILE . 35.1 mm -108.19 123.37 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.444 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 54.6 t30 -91.6 131.34 37.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 136' ' ' LYS . 75.0 mm-40 -53.96 -40.72 67.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.469 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.93 -42.04 90.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 73.6 mm-40 -63.14 -41.59 99.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 6' ' ' TYR . 20.9 pt -84.42 -30.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.511 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.1 tttp -55.72 -40.87 73.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.247 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.81 75.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.06 -39.4 69.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -60.95 -43.36 98.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -1.143 . . . . 0.0 109.225 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.53 -46.82 70.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -57.71 -45.97 85.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.66 -40.32 96.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.36 83.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.72 -46.79 88.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.95 -39.3 85.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -1.091 . . . . 0.0 109.091 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.514 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 68.9 t80 -60.97 -45.46 94.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 109.248 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -62.74 -34.49 77.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.237 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.83 -51.39 59.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 146' ' ' PHE . 3.5 p -59.57 -39.85 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.481 ' N ' HG11 ' A' ' 149' ' ' VAL . 85.9 tt0 -60.6 -39.89 89.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.38 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.13 90.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -59.91 -43.98 94.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.354 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 150' ' ' GLU . 14.7 mt -60.46 -40.45 91.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.299 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 156' ' ' HIS . 9.4 tt -60.58 -38.88 86.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.87 . . . . 0.0 109.403 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.574 ' O ' ' CG ' ' A' ' 156' ' ' HIS . . . -69.65 -25.44 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 155' ' ' ALA . 18.7 p80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.731 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.468 ' O ' HG21 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.567 HG22 ' CD2' ' A' ' 123' ' ' HIS . 7.3 p -119.96 143.39 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.539 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' N ' HG23 ' A' ' 3' ' ' VAL . 86.7 m-85 -104.42 137.29 42.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.0 t -117.44 125.67 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.536 ' CZ ' HD12 ' A' ' 135' ' ' ILE . 26.5 m-85 -118.14 147.96 42.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -119.94 149.8 41.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -130.32 139.46 50.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -115.69 139.13 50.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.95 122.42 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -113.19 133.11 55.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.767 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 t -160.26 137.98 9.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 109.2 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' ' CA ' ' A' ' 113' ' ' GLY . 2.7 p -73.02 91.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.541 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.521 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 16.6 mt -138.83 144.2 40.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.2 Cg_endo -68.62 118.13 5.45 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.384 2.056 . . . . 0.0 111.374 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 20' ' ' PHE . 45.1 Cg_endo -66.96 -43.13 7.12 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.769 2.313 . . . . 0.0 112.223 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -49.61 67.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.573 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.12 -43.98 63.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 7.1 tp -67.2 -41.01 86.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 109.72 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.561 ' CE1' HG23 ' A' ' 24' ' ' VAL . 52.3 t80 -65.42 -47.51 75.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.517 ' HA ' ' CG ' ' A' ' 25' ' ' LEU . 39.4 tttt -68.98 -36.57 78.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.81 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 35.3 t -80.81 -25.74 37.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 77.5 t80 -100.68 -50.11 3.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.356 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.561 HG23 ' CE1' ' A' ' 20' ' ' PHE . 54.7 t -84.46 -52.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.056 -1.028 . . . . 0.0 110.513 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.517 ' CG ' ' HA ' ' A' ' 21' ' ' LYS . 56.0 mt -72.48 -28.13 62.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.942 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 22' ' ' SER . 87.9 m-20 -113.79 28.38 8.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.461 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.52 -39.62 77.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.645 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 26.9 p-10 -69.81 -32.63 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 24.9 m120 -88.71 -32.32 18.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.86 -30.25 62.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.475 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 17.2 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.494 ' HB2' ' CE ' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.283 0.563 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.19 159.61 37.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.476 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -88.16 108.08 19.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.8 tp -67.88 -37.27 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 86.1 tt0 -139.94 155.71 47.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 87.09 160.82 35.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -91.9 8.88 35.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.554 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.453 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.97 13.36 25.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.509 ' O ' ' CG1' ' A' ' 72' ' ' VAL . . . -110.84 -143.85 9.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.5 Cg_endo -69.43 125.12 11.93 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -2.66 74.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 62.6 m -73.04 139.78 46.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -1.136 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.501 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.1 mm -101.41 128.48 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' CE ' ' HB2' ' A' ' 42' ' ' ALA . 63.1 tttt -105.95 133.86 49.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -122.7 143.32 49.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.408 HG12 ' HB1' ' A' ' 42' ' ' ALA . 73.0 mt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.443 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 23.6 mttm -118.31 136.82 53.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.618 ' NE2' ' CD2' ' A' ' 84' ' ' TYR . 11.1 t-80 -132.4 128.79 38.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.501 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 75.3 tttt -126.69 150.24 49.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.389 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 50' ' ' GLY . 7.4 p -108.34 134.61 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -82.49 -56.77 3.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 44.3 mt-10 -150.81 140.88 22.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.476 HG23 HD13 ' A' ' 75' ' ' ILE . 73.0 mt -125.59 126.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.482 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 84.3 m-20 -131.55 94.72 3.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.94 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -66.08 -37.88 86.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.47 66.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.482 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 18.7 m120 -85.0 2.48 42.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.606 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 49.78 34.36 7.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -130.83 128.49 40.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.447 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.7 t80 -122.74 130.17 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.5 m -132.48 118.56 19.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.618 ' CD2' ' NE2' ' A' ' 70' ' ' HIS . 36.3 p90 -132.94 162.14 32.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 39.7 t -138.42 150.24 46.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.452 ' CG2' ' O ' ' A' ' 69' ' ' LYS . 22.8 mt -104.04 133.08 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.429 HG21 ' HG3' ' A' ' 88' ' ' GLU . 85.2 mt -77.63 -41.45 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.52 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HG3' HG21 ' A' ' 87' ' ' ILE . 99.0 mt-10 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.224 0.535 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 45.69 24.31 0.2 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 122' ' ' TYR . 15.1 mt -95.24 90.69 5.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.278 -0.889 . . . . 0.0 109.31 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 123' ' ' HIS . 94.1 mt-10 -41.5 -41.15 2.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.528 -0.733 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 46.6 mttt -158.26 168.18 27.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.922 -1.111 . . . . 0.0 110.139 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.574 HG22 ' CE1' ' A' ' 101' ' ' TYR . 40.3 mt -146.61 117.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 24.1 t -127.41 150.03 49.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.574 ' CE1' HG22 ' A' ' 99' ' ' ILE . 98.6 m-85 -131.1 128.07 39.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.818 . . . . 0.0 109.042 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.7 mt-10 -106.25 141.74 37.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 109.722 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.03 124.18 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.285 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -130.73 129.22 42.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.656 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.509 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 69.0 mtm -126.61 141.0 52.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.82 30.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.53 137.13 52.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.436 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 t -152.03 152.12 32.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -1.117 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.81 130.14 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.923 . . . . 0.0 109.377 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.509 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 64.8 mt -109.02 132.51 54.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -130.27 135.62 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.37 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 118' ' ' ILE . 70.8 mt -124.58 133.09 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.586 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 30.4 m -125.58 141.45 52.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.343 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.2 m -126.44 151.95 47.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.66 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -138.32 126.49 22.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 109.221 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.558 ' CE1' HG21 ' A' ' 99' ' ' ILE . 38.0 m-85 -127.0 111.16 13.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.911 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.567 ' CD2' HG22 ' A' ' 3' ' ' VAL . 22.4 m-70 -85.04 135.53 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.526 ' OG1' ' CB ' ' A' ' 128' ' ' ALA . 11.3 t -115.82 141.27 48.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.029 . . . . 0.0 109.852 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.472 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 69.8 mttt -77.82 137.54 38.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.35 -153.76 50.69 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.43 13.81 7.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -1.2 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.526 ' CB ' ' OG1' ' A' ' 124' ' ' THR . . . -52.06 143.77 13.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.7 p -124.01 170.02 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 12.6 mt -115.95 126.82 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -60.78 134.84 57.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.545 ' HA ' HG13 ' A' ' 135' ' ' ILE . 86.6 tt0 -62.88 -29.87 71.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.33 -44.68 95.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 0.0 109.124 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -57.6 -24.92 58.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.842 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 132' ' ' GLU . 2.0 mt -71.69 -51.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.114 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -55.97 -38.29 70.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.93 78.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.364 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.11 -30.21 76.78 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.13 -36.24 72.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -1.214 . . . . 0.0 109.393 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.13 -42.35 93.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -63.05 -40.13 96.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.391 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.68 74.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.456 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.79 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.98 -39.33 97.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.7 tp -65.47 -40.25 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.457 ' O ' HG11 ' A' ' 149' ' ' VAL . 19.6 m-85 -60.97 -41.54 96.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.522 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -66.92 -34.8 78.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.99 -50.3 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.386 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 150' ' ' GLU . 3.8 p -57.53 -44.05 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.434 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.466 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.0 mt-10 -59.63 -44.36 93.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 155' ' ' ALA . . . -59.49 -35.61 74.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.9 -47.68 83.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -54.2 -46.98 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.323 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 154' ' ' LEU . 6.7 mp -80.1 -24.85 40.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 151' ' ' ALA . . . -78.81 -17.84 55.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.381 179.868 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.577 HG21 ' CG ' ' A' ' 123' ' ' HIS . 38.3 t -128.07 141.13 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -1.115 . . . . 0.0 109.511 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.453 ' N ' HG12 ' A' ' 3' ' ' VAL . 98.4 m-85 -99.11 135.2 40.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.338 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.1 p -119.02 125.3 49.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 119' ' ' THR . 77.6 m-85 -126.87 140.9 52.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.2 tt0 -115.95 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 59.9 t0 -101.62 124.7 47.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -99.16 131.48 45.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.963 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.1 124.98 10.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.9 m -105.11 131.96 51.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.786 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.401 ' OG ' HD11 ' A' ' 14' ' ' ILE . 52.8 p -160.34 140.47 11.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.26 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.456 ' O ' HG11 ' A' ' 13' ' ' VAL . 2.4 p -81.64 91.22 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 3.1 mt -138.69 142.52 34.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.231 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 45.3 Cg_endo -68.08 120.47 7.45 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.544 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.0 -28.47 41.7 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.847 2.365 . . . . 0.0 112.224 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.71 -56.5 5.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -72.57 -45.95 56.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.519 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 10.7 tp -56.45 -41.0 75.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.874 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 24' ' ' VAL . 67.6 t80 -64.5 -49.05 72.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.731 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HG2' ' CD1' ' A' ' 25' ' ' LEU . 41.7 mttm -69.08 -43.72 73.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 109.628 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 20.3 m -73.39 -22.25 60.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.764 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.527 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 69.7 t80 -100.88 -50.73 3.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.04 -52.83 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.918 . . . . 0.0 110.484 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.513 ' CD1' ' HG2' ' A' ' 21' ' ' LYS . 43.0 mt -71.77 -28.49 63.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 109.974 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 89.9 m-20 -108.4 18.67 20.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 109.555 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -68.29 -33.87 75.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.607 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.04 -37.55 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.703 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -92.29 -41.11 10.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.0 tp -56.98 -41.05 77.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.4 mt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.514 -179.774 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB1' ' HE3' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -144.56 142.45 30.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 84.8 m-20 -85.89 117.55 24.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.501 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 45.3 tp -69.54 -38.03 77.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.459 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 77.7 tt0 -159.22 157.35 30.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.483 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 91.96 158.02 34.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -93.57 11.37 28.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.163 . . . . 0.0 109.535 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.467 ' HA2' HG23 ' A' ' 53' ' ' THR . . . 101.64 31.08 5.6 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 75' ' ' ILE . . . -127.83 -144.14 5.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.62 125.51 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.701 2.268 . . . . 0.0 111.768 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.13 4.26 86.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.467 HG23 ' HA2' ' A' ' 49' ' ' GLY . 74.8 m -77.68 139.52 39.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.143 -1.21 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 16.8 mm -104.41 137.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 56.1 tttp -126.6 142.27 51.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -124.87 126.92 46.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.319 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.435 HG12 ' HB3' ' A' ' 42' ' ' ALA . 66.3 mt . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.607 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' HE3' ' CD1' ' A' ' 87' ' ' ILE . 39.2 tttp -129.26 130.7 46.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 90.0 m-70 -122.94 134.86 54.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.29 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -131.6 132.11 43.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 14.2 m -100.45 128.05 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -70.52 -41.62 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 84.9 tt0 -176.52 144.67 0.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.141 -0.974 . . . . 0.0 109.503 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.558 HG12 ' CE1' ' A' ' 82' ' ' TYR . 62.2 mt -118.79 129.91 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.5 m-20 -130.53 83.8 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.83 -41.24 90.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.11 79.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 22.4 m120 -86.8 5.91 34.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 47.67 33.43 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.945 . . . . 0.0 109.483 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -127.63 132.5 49.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.44 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.558 ' CE1' HG12 ' A' ' 75' ' ' ILE . 71.2 t80 -124.35 126.33 45.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.447 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 12.4 t -124.07 119.59 29.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.556 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 34.5 p90 -140.22 167.11 22.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.384 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 100' ' ' SER . 84.4 p -146.71 168.38 21.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.39 113.68 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.308 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.466 ' CD1' ' HE3' ' A' ' 69' ' ' LYS . 90.6 mt -68.09 -35.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.305 -0.872 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.413 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 84.7 t60 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.507 ' CG2' ' HB3' ' A' ' 128' ' ' ALA . 0.3 OUTLIER 64.08 15.21 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.338 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' A' ' 130' ' ' ILE . 71.5 mt -104.54 93.76 4.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 123' ' ' HIS . 85.5 mt-10 -45.97 -41.53 11.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.638 -0.664 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' O ' ' CD1' ' A' ' 99' ' ' ILE . 89.4 mttt -155.33 160.76 40.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.679 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 98' ' ' LYS . 12.5 mm -135.0 114.36 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.526 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 32.8 m -118.27 150.29 39.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.042 . . . . 0.0 110.405 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.95 132.57 43.64 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG3' ' SG ' ' A' ' 83' ' ' CYS . 87.1 tt0 -113.29 141.05 47.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.997 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 103' ' ' ILE . 70.0 mt -121.68 121.61 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -126.26 137.19 53.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.852 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.441 ' SD ' HD22 ' A' ' 19' ' ' LEU . 65.1 mtt -119.94 131.77 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.241 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.86 155.24 43.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 114' ' ' SER . . . -101.33 128.98 47.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 49.5 m -132.88 155.51 48.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 109.531 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.63 134.22 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 49.9 mt -105.86 135.89 46.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.468 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 50.6 mttp -133.46 137.41 45.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 68.8 mt -127.41 135.29 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.4 m -118.38 142.59 47.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.478 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 51.1 m -126.98 152.35 47.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -136.2 126.14 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.561 ' CB ' ' CD1' ' A' ' 130' ' ' ILE . 54.5 m-85 -122.26 116.27 23.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.975 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.577 ' CG ' HG21 ' A' ' 3' ' ' VAL . 72.2 m-70 -85.5 126.01 33.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.5 OUTLIER -109.85 152.65 25.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.106 . . . . 0.0 109.783 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -53.86 -40.86 66.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.01 -84.24 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -61.39 -26.26 67.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.137 . . . . 0.0 109.52 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.507 ' HB3' ' CG2' ' A' ' 95' ' ' THR . . . -62.44 146.25 51.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -137.69 151.15 47.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.561 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 36.4 mt -110.34 124.65 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.554 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -88.6 153.23 21.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.449 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 136' ' ' LYS . 98.2 mt-10 -61.02 -36.7 80.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.528 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.528 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 22.3 pt-20 -60.96 -46.08 92.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.939 . . . . 0.0 109.49 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 133' ' ' GLU . 85.4 tt0 -56.87 -47.61 80.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.489 ' CG2' HG21 ' A' ' 130' ' ' ILE . 41.8 pt -76.68 -29.27 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 132' ' ' GLU . 38.5 tttt -55.53 -41.47 73.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.229 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.36 76.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.072 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.83 -38.34 73.36 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -61.38 -43.74 98.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -1.097 . . . . 0.0 109.075 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.5 -47.68 69.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -57.8 -45.53 85.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.905 . . . . 0.0 109.081 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.53 88.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.302 -0.873 . . . . 0.0 109.127 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.8 66.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.48 -44.37 93.72 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 71.6 mt -55.64 -39.62 71.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.195 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.514 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.6 m-85 -65.91 -39.48 90.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.304 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.8 -38.69 89.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.311 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.01 -52.11 32.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.514 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.6 p -65.28 -41.53 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -58.83 -40.69 84.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.88 99.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 109.299 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.7 -49.37 78.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 109.352 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.6 -29.6 66.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.3 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.8 tt -65.29 -46.83 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.58 75.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.517 HG22 ' CD2' ' A' ' 123' ' ' HIS . 11.1 p -127.01 137.24 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.473 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.577 ' CE2' HG13 ' A' ' 130' ' ' ILE . 43.0 m-85 -101.99 152.55 20.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.82 111.73 11.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.917 . . . . 0.0 109.412 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 119' ' ' THR . 52.4 m-85 -108.4 151.18 26.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.471 ' HG2' ' CG2' ' A' ' 119' ' ' THR . 95.2 mt-10 -125.93 139.58 53.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.561 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 118' ' ' ILE . 91.6 m-20 -111.66 156.51 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.451 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -127.01 134.26 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.665 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.11 124.21 10.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.22 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.8 m -116.59 139.3 50.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.968 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' HG12 ' A' ' 14' ' ' ILE . 46.4 m -160.04 144.34 14.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.46 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 31.1 m -70.72 90.67 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.479 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.519 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -139.62 145.03 41.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.054 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 44.1 Cg_endo -67.26 129.92 21.46 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 122.367 2.045 . . . . 0.0 111.084 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.4 Cg_endo -66.62 -39.98 14.57 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.701 2.267 . . . . 0.0 112.502 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -46.52 20.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.062 -1.024 . . . . 0.0 109.794 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . 91.7 mtt-85 -71.99 -49.22 38.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.55 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 28.8 tp -59.51 -47.94 83.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.754 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CE1' ' C ' ' A' ' 80' ' ' PHE . 53.8 t80 -53.73 -55.02 29.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 83.0 tttt -65.84 -54.9 20.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.942 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 31.6 m -62.29 -27.41 69.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.406 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.501 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 86.3 t80 -93.92 -50.88 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.916 -1.115 . . . . 0.0 110.292 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 45.9 t -84.59 -50.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 110.028 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 4.1 tt -68.92 -49.14 60.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 22' ' ' SER . 66.3 m-20 -91.65 24.16 3.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.506 ' O ' ' CG1' ' A' ' 31' ' ' ILE . . . -69.44 -44.54 71.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.46 ' HA ' HD13 ' A' ' 31' ' ' ILE . 76.6 m-20 -64.14 -24.21 67.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -91.27 -38.47 12.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.849 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 22' ' ' SER . 22.1 mt -79.89 -36.64 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.587 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 27' ' ' ALA . 25.0 mt . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.62 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -133.97 159.11 41.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.5 m-20 -87.36 108.69 19.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.6 tp -68.59 -36.32 78.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 86.0 tt0 -140.05 155.29 47.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 85.33 163.81 37.89 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -90.22 8.84 31.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -1.183 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.442 ' HA2' HG23 ' A' ' 53' ' ' THR . . . 99.45 43.18 2.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -145.66 -137.34 3.08 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.1 Cg_endo -69.17 123.0 9.84 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.801 2.334 . . . . 0.0 112.049 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.56 8.73 84.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 54' ' ' ILE . 56.3 m -86.41 139.79 30.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -1.156 . . . . 0.0 109.542 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 54' ' ' ILE . 6.0 mt -101.46 139.18 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.526 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 54' ' ' ILE . 93.7 mttt -117.47 150.62 38.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -125.27 137.28 54.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.281 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.9 tt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.656 -179.865 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 37.6 mttm -130.69 140.66 50.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 97.4 m-70 -125.47 136.74 53.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.504 ' CD ' HG12 ' A' ' 54' ' ' ILE . 23.8 tptm -130.26 133.83 46.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 45.6 t -100.02 132.86 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.89 -56.48 4.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.662 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.8 tt0 -178.89 138.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.62 ' CG2' ' CD2' ' A' ' 82' ' ' TYR . 15.7 pt -136.29 145.36 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.567 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' OD1' ' A' ' 79' ' ' ASN . 60.7 t0 -132.84 109.14 9.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -60.22 -36.22 77.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.72 99.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.438 ' OD1' ' OD1' ' A' ' 76' ' ' ASP . 15.8 m120 -86.11 -5.74 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.222 -0.923 . . . . 0.0 109.587 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.524 ' C ' ' CE1' ' A' ' 20' ' ' PHE . 92.2 m-85 58.74 36.09 24.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.294 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -117.99 131.54 56.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.62 ' CD2' ' CG2' ' A' ' 75' ' ' ILE . 72.6 t80 -128.03 114.85 17.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.885 . . . . 0.0 109.683 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.71 118.17 30.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.217 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.576 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 32.5 p90 -129.33 154.62 46.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 51.1 m -128.9 159.14 36.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.27 129.57 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 69' ' ' LYS . 84.4 mt -77.6 -41.71 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 58.85 23.59 11.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 130' ' ' ILE . 96.5 mt -101.35 93.62 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.524 ' CG ' ' HG2' ' A' ' 125' ' ' LYS . 96.8 mt-10 -48.49 -32.72 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.764 -0.585 . . . . 0.0 111.287 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.449 ' O ' HD12 ' A' ' 99' ' ' ILE . 78.3 tttt -151.14 143.09 23.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 0.0 110.622 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.58 HD13 ' CD1' ' A' ' 122' ' ' TYR . 23.0 mm -124.81 113.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 28.5 t -116.97 148.68 41.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 120' ' ' SER . 3.7 m-85 -130.87 123.95 30.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.781 . . . . 0.0 109.057 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.457 ' HB2' ' OG1' ' A' ' 119' ' ' THR . 91.1 mt-10 -109.12 135.3 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.752 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.474 HG21 HD11 ' A' ' 103' ' ' ILE . 63.4 mt -131.52 119.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.98 155.11 47.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.698 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -117.35 147.85 42.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.277 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.79 147.18 46.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.23 138.5 38.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.1 p -144.37 165.48 27.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -1.055 . . . . 0.0 109.41 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.01 133.56 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.429 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.7 mp -106.98 138.91 42.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -124.69 135.49 53.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 8' ' ' ASP . 72.2 mt -123.82 128.79 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.471 ' CG2' ' HG2' ' A' ' 7' ' ' GLU . 8.4 p -126.39 142.69 51.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.468 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.497 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -121.65 152.88 38.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 109.676 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -132.34 115.04 15.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 108.931 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.58 ' CD1' HD13 ' A' ' 99' ' ' ILE . 9.6 m-30 -112.87 121.61 45.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.05 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 97' ' ' GLU . 4.5 m-70 -92.85 115.51 28.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.389 -0.819 . . . . 0.0 108.841 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.1 p -92.7 148.65 21.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.524 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 54.3 mttp -70.09 147.25 50.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 48.19 -143.59 7.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -92.88 15.97 13.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.126 . . . . 0.0 109.418 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 125' ' ' LYS . . . -49.12 146.31 3.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.6 p -113.9 161.75 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.577 HG13 ' CE2' ' A' ' 4' ' ' PHE . 49.4 mt -105.8 139.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.895 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -84.26 123.95 30.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.487 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 96.3 mt-10 -55.65 -35.59 66.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.08 -41.39 90.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -62.88 -45.63 91.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.464 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.519 ' CG2' HG21 ' A' ' 130' ' ' ILE . 38.2 pt -76.86 -31.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 26.4 tttm -55.76 -46.66 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.0 73.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.405 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.01 -39.56 92.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.91 -41.76 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -45.81 91.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -59.94 -45.79 91.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.16 90.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.28 97.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.12 88.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.442 ' O ' HG12 ' A' ' 149' ' ' VAL . 9.4 tt -62.88 -39.34 94.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.319 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.462 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 70.9 t80 -59.54 -46.35 89.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -60.73 -39.22 87.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.376 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.54 -48.74 68.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.507 HG11 ' N ' ' A' ' 150' ' ' GLU . 7.2 p -65.0 -43.65 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.0 109.355 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.507 ' N ' HG11 ' A' ' 149' ' ' VAL . 85.2 tt0 -60.63 -40.17 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.12 96.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.267 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -67.93 -42.34 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.459 ' CD1' ' C ' ' A' ' 153' ' ' LEU . 3.5 tm? -69.83 -31.49 69.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 154' ' ' LEU . 2.7 tm? -75.38 -40.09 58.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.926 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.48 74.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 109.583 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 122' ' ' TYR . 6.7 p -128.44 130.87 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -1.166 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -86.42 144.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.606 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.0 m -130.27 121.22 25.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 119' ' ' THR . 46.2 m-85 -116.72 139.84 50.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 119' ' ' THR . 93.6 mt-10 -114.82 146.66 40.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 118' ' ' ILE . 90.2 m-20 -122.37 154.83 37.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -115.82 143.1 45.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -154.29 121.73 5.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 0.0 109.182 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.8 m -110.15 133.78 52.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.833 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 m -160.3 146.5 15.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -0.881 . . . . 0.0 109.241 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.455 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.2 p -81.19 91.58 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.9 mt -138.65 142.93 35.95 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.301 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.4 Cg_endo -68.56 116.31 4.34 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.449 2.1 . . . . 0.0 111.244 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.45 -27.73 46.62 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.757 2.304 . . . . 0.0 112.36 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.99 6.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.552 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -72.5 -43.25 63.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 16.2 tp -61.04 -47.97 83.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.887 . . . . 0.0 109.747 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.577 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 70.2 t80 -57.3 -50.44 72.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.8 tttt -68.21 -48.38 65.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 87.0 p -71.79 -20.84 61.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 110.099 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.529 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 66.0 t80 -100.42 -50.51 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.286 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 54.7 t -84.62 -52.89 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.06 -1.025 . . . . 0.0 110.349 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 15.9 tp -70.24 -29.67 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 91.4 m-20 -110.42 22.14 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.488 ' OD2' ' NZ ' ' A' ' 55' ' ' LYS . 88.1 m-20 -69.27 -37.05 77.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -96.11 -38.04 10.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.685 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.6 tp -56.5 -42.32 78.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.704 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.333 -179.884 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.89 153.14 45.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 35.5 p-10 -89.03 108.6 19.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.411 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.64 -35.32 78.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.329 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 48.4 tp10 -137.91 154.28 49.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 85.48 159.33 31.51 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.52 10.62 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.483 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.83 6.58 43.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.518 ' O ' ' CG1' ' A' ' 72' ' ' VAL . . . -102.12 -147.99 20.36 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.7 Cg_endo -68.63 129.84 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.71 2.273 . . . . 0.0 111.756 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.46 -5.21 84.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -75.14 139.23 42.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.506 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.528 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.6 mm -104.05 135.14 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.488 ' NZ ' ' OD2' ' A' ' 28' ' ' ASP . 29.0 mttt -118.37 140.3 50.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.626 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -123.59 142.54 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.581 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.2 mtm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -131.08 144.13 51.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.485 ' CD2' HD12 ' A' ' 86' ' ' ILE . 65.5 m80 -126.56 133.9 50.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.528 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.4 tttm -124.45 144.28 50.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 50' ' ' GLY . 7.5 p -98.99 130.43 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -73.39 -46.83 46.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 50.6 tp10 -173.56 143.35 1.03 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.568 HG12 ' CE1' ' A' ' 82' ' ' TYR . 82.6 mt -126.95 125.23 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 8.3 t70 -128.14 105.44 8.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 109.511 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.577 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 70.2 m80 -70.24 -35.11 73.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.09 88.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.573 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 83.2 m-20 -85.14 5.33 30.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.551 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 45.11 42.31 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -130.44 137.39 49.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.568 ' CE1' HG12 ' A' ' 75' ' ' ILE . 62.0 t80 -126.32 125.03 41.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.467 ' CB ' ' HG3' ' A' ' 102' ' ' GLU . 8.1 t -127.57 115.56 19.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.376 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.484 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.5 p90 -129.42 159.57 35.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.501 ' CB ' ' HE3' ' A' ' 98' ' ' LYS . 60.0 p -141.42 167.58 21.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.485 HD12 ' CD2' ' A' ' 70' ' ' HIS . 17.9 mt -122.59 132.33 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.4 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.1 mt -80.16 -37.39 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.626 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.363 0.602 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 65.81 9.58 6.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.719 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 130' ' ' ILE . 83.7 mt -90.16 90.7 8.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 108.881 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 123' ' ' HIS . 33.3 mt-10 -48.59 -43.91 36.42 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.753 -0.592 . . . . 0.0 110.831 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.501 ' HE3' ' CB ' ' A' ' 85' ' ' SER . 54.9 tttp -150.65 155.17 38.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.616 -1.302 . . . . 0.0 110.464 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 34.1 mt -138.98 116.03 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 87.7 p -125.65 164.51 20.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.451 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 119' ' ' THR . 89.2 m-85 -137.89 120.48 16.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' HG3' ' CB ' ' A' ' 83' ' ' CYS . 83.1 tt0 -101.88 143.33 31.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.118 -0.989 . . . . 0.0 109.917 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.2 mt -128.51 118.36 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 0.0 108.912 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -120.38 139.61 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.615 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.495 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 63.8 mtm -122.35 137.49 54.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.262 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.95 40.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.555 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.85 135.72 40.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.504 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.0 t -134.69 150.69 50.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.409 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.23 132.02 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.495 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 49.5 mt -98.95 137.21 37.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.897 . . . . 0.0 109.357 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.03 131.44 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' ASP . 68.0 mt -118.47 137.57 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 80.8 m -133.1 137.29 46.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.4 m -113.88 154.71 27.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 32.4 mttm -142.12 122.05 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.524 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 34.7 m-85 -119.43 132.92 55.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.257 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLU . 2.9 m80 -100.31 121.25 41.18 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -112.09 137.89 49.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.341 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 124' ' ' THR . 71.7 mttt -40.96 -35.12 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.546 -0.722 . . . . 0.0 109.862 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.62 -79.55 0.21 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.98 -29.73 67.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -1.093 . . . . 0.0 109.316 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.5 143.26 57.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.1 m -126.4 154.38 43.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 48.6 mt -112.27 132.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 16.0 t-20 -87.04 138.08 31.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.413 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.427 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.2 mt-10 -62.7 -33.04 74.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.414 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 83.0 tt0 -65.62 -46.22 80.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.479 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.18 -45.14 88.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 109.349 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.436 ' CD1' ' CE1' ' A' ' 6' ' ' TYR . 35.8 pt -76.62 -29.19 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.1 tttt -55.63 -45.6 77.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.17 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 109.327 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.06 -38.39 75.86 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.88 -43.75 90.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -1.118 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.28 -43.25 82.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.259 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -57.92 -45.91 85.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.26 -38.6 85.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.127 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.75 96.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -48.21 79.95 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.488 ' C ' ' CD1' ' A' ' 145' ' ' LEU . 3.1 tm? -60.26 -38.44 83.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -1.131 . . . . 0.0 109.237 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.517 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 71.1 t80 -61.98 -41.39 97.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 0.0 109.298 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -61.0 -41.38 96.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.71 65.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.376 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.517 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.4 p -66.72 -41.94 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.49 -39.94 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.75 99.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.44 -47.18 87.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 24.7 mt -59.92 -34.18 72.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.72 -42.09 95.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -65.01 -31.29 72.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.446 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.576 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 25.0 t -126.39 142.43 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -1.119 . . . . 0.0 109.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.427 ' CE2' HG13 ' A' ' 130' ' ' ILE . 95.2 m-85 -105.73 129.64 53.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.472 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.0 t -107.76 129.74 55.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 119' ' ' THR . 21.9 m-85 -116.36 143.23 45.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -123.33 142.73 50.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -129.16 134.61 48.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.99 138.47 46.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.593 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -168.53 113.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -120.32 147.63 44.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -160.27 143.88 13.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.172 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 24.6 m -65.43 90.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.309 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 32.7 mm -138.87 144.18 40.47 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.464 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.6 Cg_endo -69.21 112.43 2.98 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.542 2.161 . . . . 0.0 111.287 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.9 Cg_endo -67.0 -29.55 40.4 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.761 2.308 . . . . 0.0 112.264 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 -56.13 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -72.58 -37.45 68.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.773 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 15.6 tp -67.07 -33.71 76.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.758 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 66.3 t80 -71.56 -47.87 52.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.139 -0.975 . . . . 0.0 109.954 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 20.0 mttt -71.56 -22.67 61.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.789 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 86.6 p -96.84 -23.64 16.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.09 -1.006 . . . . 0.0 109.458 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.517 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 79.9 t80 -100.46 -45.48 5.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.978 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.499 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 57.8 t -84.58 -52.7 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.98 . . . . 0.0 110.25 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 4.0 mm? -69.79 -45.71 67.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 109.618 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 22' ' ' SER . 80.5 m-20 -93.73 25.63 3.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 109.591 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.92 -42.18 73.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.983 . . . . 0.0 109.775 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.57 -20.52 58.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 0.0 109.965 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -94.88 -38.55 10.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.811 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 26' ' ' ASP . 18.1 mt -74.51 -30.03 61.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.564 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.478 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 21.9 mt . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.302 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -134.23 150.43 51.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -87.51 108.91 19.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.417 HD11 ' HD3' ' A' ' 56' ' ' LYS . 58.5 mt -66.48 -32.12 73.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 78.1 tt0 -147.92 162.7 38.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.516 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 73.88 156.49 4.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -91.42 9.31 32.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 108.29 30.21 3.95 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -126.95 -143.71 5.87 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.57 120.47 7.13 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.667 2.245 . . . . 0.0 111.809 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.95 -2.66 72.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 54' ' ' ILE . 52.2 m -76.83 138.16 39.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -1.216 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.479 ' CG2' ' O ' ' A' ' 70' ' ' HIS . 26.1 mm -102.94 134.28 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.898 . . . . 0.0 109.556 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 27.3 mttt -112.08 141.99 45.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.343 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.417 ' HD3' HD11 ' A' ' 45' ' ' LEU . 35.3 ttpt -125.32 125.29 43.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 109.516 -179.961 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.3 0.571 . . . . 0.0 109.629 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -98.45 144.7 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.479 ' O ' ' CG2' ' A' ' 54' ' ' ILE . 76.0 m80 -130.68 147.01 52.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 16.3 tttp -135.0 134.86 40.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.14 -0.975 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 75' ' ' ILE . 46.0 t -98.75 133.22 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -79.38 -43.01 24.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.1 tt0 -176.65 140.02 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.446 HD12 ' HA2' ' A' ' 50' ' ' GLY . 70.4 mt -119.31 126.52 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 75' ' ' ILE . 78.3 m-20 -134.7 76.76 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.7 m170 -55.86 -37.15 68.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.0 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.365 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 80' ' ' PHE . 58.7 m-20 -91.71 12.66 20.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ASN . 91.9 m-85 43.21 39.99 2.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.598 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.456 ' HE2' ' SG ' ' A' ' 83' ' ' CYS . 87.7 tttt -132.07 122.77 25.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.451 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 50.9 t80 -118.62 127.44 53.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.456 ' SG ' ' HE2' ' A' ' 81' ' ' LYS . 31.8 m -130.22 121.24 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -135.39 163.05 30.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.9 m -126.38 163.85 22.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 mt -119.97 133.63 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 88' ' ' GLU . 87.3 mt -111.91 -2.31 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.568 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 68' ' ' MET . 33.5 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.632 -0.668 . . . . 0.0 109.965 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.9 m80 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.281 0.563 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 67.85 6.25 4.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 109.779 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 97' ' ' GLU . 95.9 mt -108.34 94.37 5.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.152 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 123' ' ' HIS . 47.4 mt-10 -41.0 -42.45 1.89 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.7 -0.625 . . . . 0.0 109.888 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 31.4 ttpt -177.73 162.17 1.72 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 0.0 109.752 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.596 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 5.7 mm -129.6 118.05 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.505 -0.747 . . . . 0.0 109.154 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 120' ' ' SER . 46.9 t -112.08 141.02 46.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 119' ' ' THR . 97.3 m-85 -120.33 143.6 48.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.054 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.9 mt-10 -121.12 143.69 48.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.74 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 82' ' ' TYR . 75.7 mt -122.86 130.82 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.294 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -132.27 133.39 44.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.565 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -112.95 144.49 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.322 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.24 161.75 38.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.11 143.72 33.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 14' ' ' ILE . 74.6 m -135.29 139.75 44.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.14 . . . . 0.0 109.528 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 63.9 mt -107.75 137.67 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 10' ' ' ALA . 33.0 mt -117.21 130.29 56.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 0.0 109.628 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.37 141.38 51.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.52 138.22 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 0.0 109.738 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 28.7 m -126.78 142.57 51.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 100' ' ' SER . 8.9 m -126.58 158.87 35.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.95 . . . . 0.0 109.831 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 86.2 mttt -144.14 118.19 9.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.596 ' CE1' ' CG2' ' A' ' 99' ' ' ILE . 2.9 m-85 -113.18 113.22 25.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.576 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 54.9 m-70 -85.94 116.51 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 128' ' ' ALA . 1.4 p -107.33 146.14 31.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 109.98 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -80.82 140.69 35.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.46 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.54 67.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.446 ' OD1' ' HA2' ' A' ' 2' ' ' GLY . 30.1 t30 56.14 45.45 23.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 0.0 109.447 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -72.78 142.06 48.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.3 p -82.39 155.42 24.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 21.5 mt -111.57 131.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.83 141.56 58.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.48 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.6 mt-10 -67.65 -29.64 68.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -65.01 -37.56 88.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.94 -44.91 83.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 132' ' ' GLU . 46.4 pt -80.76 -31.85 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 135' ' ' ILE . 25.6 tttm -57.01 -39.87 75.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.87 73.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.913 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.3 -38.09 94.08 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -59.81 -43.61 94.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.69 -38.9 92.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -63.05 -40.91 99.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.79 -38.63 86.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.77 92.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.17 -42.88 97.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.3 tp -66.05 -39.53 90.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -1.108 . . . . 0.0 109.334 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.409 ' O ' HG13 ' A' ' 149' ' ' VAL . 65.9 t80 -64.38 -43.11 95.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.867 . . . . 0.0 109.354 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -66.21 -33.85 76.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.74 -49.25 32.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.361 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 146' ' ' PHE . 7.8 p -63.96 -41.51 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.402 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -56.31 -44.39 79.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.397 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -59.96 -49.61 76.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 156' ' ' HIS . 39.1 tp -57.12 -35.49 69.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.7 tt -62.67 -46.79 86.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.89 71.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 153' ' ' LEU . 3.5 m-70 . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.578 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 43.4 t -131.24 133.95 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -1.138 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.542 ' CD1' HD13 ' A' ' 130' ' ' ILE . 96.3 m-85 -103.15 137.06 41.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.493 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.7 m -113.33 119.8 38.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.575 ' CE2' HG21 ' A' ' 135' ' ' ILE . 31.1 m-85 -115.16 139.87 49.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.4 mt-10 -115.33 147.17 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.81 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.465 ' OD2' ' HB ' ' A' ' 118' ' ' ILE . 42.1 m-20 -119.16 154.6 33.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.233 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 117' ' ' LYS . 95.2 mt-10 -124.12 140.91 52.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.36 120.73 6.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 109.114 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.0 m -114.51 129.03 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.933 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 14' ' ' ILE . 34.0 t -160.5 140.58 11.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.87 . . . . 0.0 109.078 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.521 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 26.1 m -70.93 90.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 0.0 109.4 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.537 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -139.17 145.56 45.37 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 46.2 Cg_endo -68.02 124.49 11.86 Favored 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 122.361 2.041 . . . . 0.0 111.243 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.52 -30.59 43.18 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.742 2.295 . . . . 0.0 112.429 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -52.62 8.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.646 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -72.06 -41.62 67.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 22.7 tp -61.48 -48.98 78.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.828 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.485 ' O ' ' N ' ' A' ' 24' ' ' VAL . 61.9 t80 -56.22 -52.75 63.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.812 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 61.9 mttm -67.34 -49.57 63.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 110.017 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.52 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 86.1 p -69.85 -21.17 63.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 110.219 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.533 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 62.6 t80 -100.22 -49.21 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.963 -1.086 . . . . 0.0 110.194 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 20' ' ' PHE . 53.2 t -84.56 -52.43 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.5 tp -68.7 -35.22 76.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.046 -1.034 . . . . 0.0 110.184 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.47 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 68.9 m-20 -103.47 19.54 19.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.053 . . . . 0.0 109.868 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.54 -36.39 76.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.41 -26.98 65.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.906 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -97.6 -51.69 4.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 22' ' ' SER . 36.4 mt -59.17 -39.36 82.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.025 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.484 ' CG1' ' O ' ' A' ' 27' ' ' ALA . 21.1 mt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.591 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.5 ' CB ' HG12 ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.295 0.569 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.93 156.16 45.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -85.9 107.36 17.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.447 ' HB3' HG21 ' A' ' 54' ' ' ILE . 43.9 tp -62.78 -40.75 98.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 53' ' ' THR . 97.7 mt-10 -153.53 162.58 41.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.493 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 87.1 159.49 33.87 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -87.87 9.48 21.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -1.17 . . . . 0.0 109.561 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.25 13.65 32.77 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 75' ' ' ILE . . . -110.33 -143.68 9.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.77 123.64 10.3 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.651 2.234 . . . . 0.0 111.765 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 54' ' ' ILE . . . 94.44 -4.42 69.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.462 HG21 ' HA2' ' A' ' 49' ' ' GLY . 94.5 m -74.1 138.17 43.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.463 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.563 ' N ' ' CD1' ' A' ' 54' ' ' ILE . 1.7 mp -103.74 126.82 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 25.0 mttm -110.94 145.18 38.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -124.72 127.02 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.522 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.5 HG12 ' CB ' ' A' ' 42' ' ' ALA . 66.8 mt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.411 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -135.05 141.32 46.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 78.6 m80 -130.77 134.59 47.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -127.02 142.49 51.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.504 HG11 ' CG1' ' A' ' 75' ' ' ILE . 51.9 t -105.82 126.9 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -71.35 -48.65 48.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 83.4 tt0 -166.9 146.02 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.576 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.544 HG22 ' CE1' ' A' ' 77' ' ' HIS . 73.4 mt -122.72 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.382 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 86.2 m-20 -133.4 81.07 1.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.544 ' CE1' HG22 ' A' ' 75' ' ' ILE . 78.8 m80 -59.37 -38.57 80.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.26 82.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.433 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 76.9 m-20 -86.16 3.91 40.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 52.73 29.3 7.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -122.45 135.68 54.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.53 ' CE1' HG12 ' A' ' 75' ' ' ILE . 57.0 t80 -130.08 130.46 44.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.24 115.76 16.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.502 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.503 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.4 p90 -136.88 158.48 44.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.623 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.427 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 84.5 p -139.19 169.51 17.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.362 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.0 mt -117.84 129.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.5 mt -77.36 -32.92 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.43 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.52 HG22 ' CB ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 60.1 22.67 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.579 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 130' ' ' ILE . 88.6 mt -104.43 96.55 6.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.096 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 123' ' ' HIS . 72.8 mm-40 -59.66 -33.39 71.48 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.766 -0.584 . . . . 0.0 111.034 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.473 ' O ' HD13 ' A' ' 99' ' ' ILE . 34.3 ttpt -142.44 142.74 32.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.474 -1.391 . . . . 0.0 110.793 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.568 HG22 ' CE1' ' A' ' 122' ' ' TYR . 27.2 mm -130.77 113.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.427 ' OG ' ' HB3' ' A' ' 85' ' ' SER . 38.4 t -121.31 152.05 39.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -131.05 131.9 44.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.031 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.1 mt-10 -118.72 141.77 48.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.801 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.73 127.56 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.839 . . . . 0.0 109.323 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -130.18 131.68 45.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.637 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.418 ' HG2' ' HG ' ' A' ' 116' ' ' LEU . 63.5 mtt -120.56 141.22 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.9 153.68 41.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.62 132.43 42.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.436 179.998 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.3 m -131.25 146.83 52.47 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.413 -1.051 . . . . 0.0 109.378 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.44 HG22 ' CE ' ' A' ' 117' ' ' LYS . 68.8 mt -116.56 135.91 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.5 mp -107.03 140.71 39.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.464 ' O ' HD11 ' A' ' 118' ' ' ILE . 26.7 mmtp -125.3 139.46 53.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.465 ' HB ' ' OD2' ' A' ' 8' ' ' ASP . 10.5 mm -115.0 126.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.687 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 30.8 m -121.23 133.55 55.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.58 157.42 42.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.955 . . . . 0.0 109.93 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -134.03 117.47 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.568 ' CE1' HG22 ' A' ' 99' ' ' ILE . 13.9 m-30 -109.81 118.81 37.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.578 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 2.2 t60 -85.73 127.06 34.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.9 OUTLIER -109.43 146.82 33.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.8 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -71.33 135.61 47.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 55.07 -145.2 30.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 128' ' ' ALA . 48.5 p-10 -87.45 17.16 4.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' A' ' 95' ' ' THR . . . -44.5 144.41 1.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -114.47 157.0 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.542 HD13 ' CD1' ' A' ' 4' ' ' PHE . 64.4 mt -110.12 140.18 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.43 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 10.1 t-20 -79.4 133.43 36.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.412 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 136' ' ' LYS . 96.4 mt-10 -65.33 -34.99 79.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 79.0 tt0 -66.64 -35.31 79.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.52 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.6 mt-10 -67.89 -38.13 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.575 HG21 ' CE2' ' A' ' 6' ' ' TYR . 38.4 pt -78.16 -39.5 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.506 ' N ' HG13 ' A' ' 135' ' ' ILE . 24.1 mttm -59.41 -37.94 79.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.9 73.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.11 -40.81 84.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -60.1 -43.48 95.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.171 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.37 -44.8 76.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.433 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.14 -45.82 89.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.91 79.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -0.952 . . . . 0.0 109.409 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.86 88.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.44 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.96 -45.26 95.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 149' ' ' VAL . 57.7 mt -60.96 -38.97 87.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -1.095 . . . . 0.0 109.375 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.473 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 67.1 t80 -57.22 -45.84 83.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.37 -40.53 91.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.08 -52.07 46.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.473 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.5 p -64.69 -40.59 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.45 -42.34 77.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.35 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.3 99.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.356 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -59.64 -44.59 93.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.432 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 36.4 tp -60.82 -35.31 76.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.893 . . . . 0.0 109.385 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.93 -45.64 92.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.923 . . . . 0.0 109.34 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.14 -32.17 72.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.57 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 24.7 t -132.52 133.85 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.551 ' CD1' HD13 ' A' ' 130' ' ' ILE . 96.7 m-85 -90.38 140.34 29.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.172 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' SER . 26.6 p -125.52 127.04 45.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 119' ' ' THR . 93.5 m-85 -123.78 143.89 50.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.262 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -123.41 147.97 46.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.76 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -132.46 134.0 44.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.204 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -107.76 134.52 50.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.756 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.74 123.22 19.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 109.118 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -109.73 133.22 53.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.937 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.9 m -160.42 139.94 10.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 109.003 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.469 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.6 p -73.79 90.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.965 -1.084 . . . . 0.0 109.217 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 10.3 mt -139.48 144.29 39.13 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.136 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 43.7 Cg_endo -66.42 121.96 9.33 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.369 2.046 . . . . 0.0 111.165 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.79 -29.24 42.53 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.724 2.283 . . . . 0.0 112.241 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.24 -52.93 7.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.418 ' O ' ' OG ' ' A' ' 22' ' ' SER . 60.5 mtt85 -72.03 -39.35 69.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 3.4 tm? -63.06 -51.88 64.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.0 t80 -56.85 -51.3 69.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.781 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.7 tttp -68.36 -50.22 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 18' ' ' ARG . 69.0 p -68.08 -21.26 64.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.04 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CB ' HD12 ' A' ' 19' ' ' LEU . 12.5 t80 -100.06 -50.61 3.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.063 -1.023 . . . . 0.0 110.115 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 61.8 t -84.68 -52.66 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.26 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.4 tp -68.88 -44.83 72.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.888 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -98.99 30.31 3.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.26 -47.27 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.774 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -69.44 -25.82 64.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.992 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.71 -39.12 18.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.687 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 mp -76.02 -29.03 57.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 27' ' ' ALA . 17.6 mt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -127.74 143.09 51.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.858 . . . . 0.0 109.413 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.439 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 81.0 m-20 -87.14 108.61 18.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 56' ' ' LYS . 2.2 mp -68.85 -39.19 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 49.5 tp10 -150.05 153.23 36.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 90.79 157.74 33.95 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -93.47 10.26 33.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.1 27.99 6.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.515 ' CA ' HD11 ' A' ' 75' ' ' ILE . . . -122.16 -145.63 7.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 51.2 Cg_endo -70.23 123.34 9.86 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.744 2.296 . . . . 0.0 111.884 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.01 83.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 56.9 m -72.75 137.6 45.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -1.223 . . . . 0.0 109.44 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 25.2 mm -101.03 129.75 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 17.6 mttt -126.55 145.95 50.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.882 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.524 ' N ' HD13 ' A' ' 45' ' ' LEU . 28.2 ttpt -130.82 138.84 50.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.366 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 57' ' ' ILE . 9.7 tt . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 38.9 mtt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 94.2 mttt -107.8 148.54 29.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.513 ' CE1' ' CD1' ' A' ' 84' ' ' TYR . 47.5 t60 -129.79 131.26 46.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.476 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.6 tttp -131.88 136.17 47.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 39.6 t -99.36 129.17 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.406 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -76.39 -42.29 44.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 85.4 tt0 -175.27 141.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 82' ' ' TYR . 66.7 mt -119.85 131.24 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -129.95 85.69 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.558 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 87.8 m-70 -62.34 -37.24 84.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.92 70.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -88.99 -3.07 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 57.9 34.55 24.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.475 ' HE2' ' CE ' ' A' ' 104' ' ' LYS . 25.5 mttt -128.95 129.56 45.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.529 ' CE2' HG12 ' A' ' 75' ' ' ILE . 62.1 t80 -120.16 124.13 45.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.898 . . . . 0.0 109.531 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.05 115.03 19.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.513 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 38.3 p90 -128.97 152.41 48.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB3' ' HE2' ' A' ' 98' ' ' LYS . 9.7 m -132.02 146.72 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.526 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 86' ' ' ILE . 67.6 mt -93.16 150.2 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' A' ' 69' ' ' LYS . 88.6 mt -104.02 -34.65 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.443 ' OE1' ' HE3' ' A' ' 69' ' ' LYS . 94.8 mt-10 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.23 0.538 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 125' ' ' LYS . 16.0 m 51.87 19.78 1.04 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 130' ' ' ILE . 51.7 mt -91.09 87.87 6.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 0.0 109.043 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.5 mt-10 -39.93 -35.47 0.36 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.761 -0.587 . . . . 0.0 110.401 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.489 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 31.7 tttt -169.08 160.91 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.766 -1.209 . . . . 0.0 110.371 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.621 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 27.2 mt -137.14 117.62 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.453 ' OG ' ' OG ' ' A' ' 85' ' ' SER . 48.4 t -118.35 152.66 35.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.977 . . . . 0.0 109.906 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.571 ' CZ ' HG23 ' A' ' 99' ' ' ILE . 84.1 m-85 -130.76 136.07 48.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.813 . . . . 0.0 109.175 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 86.8 mt-10 -114.62 143.21 45.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.711 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 79.0 mt -118.51 130.79 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.258 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' CE ' ' HE2' ' A' ' 81' ' ' LYS . 19.8 tttt -127.97 131.51 49.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.608 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.413 ' HE1' HD22 ' A' ' 116' ' ' LEU . 63.3 mtt -122.29 146.25 47.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.386 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -141.27 151.32 43.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.56 139.27 39.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.1 p -117.93 151.71 36.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -1.2 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 69.3 mt -119.34 131.6 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.324 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.2 mp -108.32 136.85 47.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.584 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 90.9 mttt -119.01 144.04 46.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.26 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.6 mt -124.1 131.09 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.945 . . . . 0.0 109.571 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 23.5 m -119.48 142.49 48.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . 64.8 m -123.18 146.33 47.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 51.6 mtmt -135.67 127.39 29.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.621 ' CE1' ' CG2' ' A' ' 99' ' ' ILE . 25.7 m-85 -125.89 122.2 35.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 109.853 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.57 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 90.1 m-70 -89.72 116.97 28.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 108.673 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.473 ' OG1' ' N ' ' A' ' 128' ' ' ALA . 0.7 OUTLIER -104.98 142.29 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.618 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.405 ' HB3' ' CG2' ' A' ' 95' ' ' THR . 31.0 ttpt -84.85 128.16 34.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.6 67.28 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 m120 58.95 40.28 22.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.473 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -69.82 140.59 53.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.293 -0.88 . . . . 0.0 109.54 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 55.3 p -80.16 156.6 26.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.551 HD13 ' CD1' ' A' ' 4' ' ' PHE . 40.4 mt -113.82 130.89 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 109.686 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.452 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 46.5 t-20 -60.04 131.81 52.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.87 -33.66 76.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.338 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.26 -36.44 82.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.452 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 75.5 mm-40 -64.62 -43.81 92.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 136' ' ' LYS . 34.8 pt -75.49 -32.85 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.427 ' N ' HG13 ' A' ' 135' ' ' ILE . 16.7 tttp -55.7 -45.33 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.25 -40.73 71.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.258 -0.902 . . . . 0.0 109.339 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.44 -40.16 95.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -60.3 -40.5 90.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -1.18 . . . . 0.0 109.279 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.74 -40.43 97.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.13 -44.76 92.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.275 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.88 93.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.89 -43.25 93.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.874 . . . . 0.0 109.332 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.65 -43.2 96.39 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.3 mt -65.63 -40.45 92.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -1.161 . . . . 0.0 109.272 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.433 ' O ' HG21 ' A' ' 149' ' ' VAL . 65.1 t80 -66.05 -40.54 91.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -68.0 -35.93 79.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.296 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.21 -51.55 52.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.54 ' CG2' ' N ' ' A' ' 150' ' ' GLU . 3.6 m -64.87 -46.6 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.364 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.54 ' N ' ' CG2' ' A' ' 149' ' ' VAL . 83.7 tt0 -56.19 -35.49 67.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.51 -36.03 81.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -62.3 -43.19 99.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.406 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 153' ' ' LEU . 90.3 mt -60.53 -42.9 97.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.324 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 31.0 mt -73.25 -27.33 61.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.8 -21.98 59.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.505 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.585 HG21 ' CG ' ' A' ' 123' ' ' HIS . 29.3 t -128.68 128.56 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -1.116 . . . . 0.0 109.344 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.577 ' CE1' HG12 ' A' ' 130' ' ' ILE . 97.1 m-85 -85.61 136.46 33.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 120' ' ' SER . 36.0 t -122.55 129.17 51.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.96 . . . . 0.0 109.705 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.574 ' CD1' HG23 ' A' ' 135' ' ' ILE . 77.6 m-85 -129.39 147.16 51.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.147 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -119.3 139.74 51.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.712 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 91.2 m-20 -110.36 150.63 28.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.379 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -115.89 137.68 51.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 109.865 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.0 122.66 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.79 . . . . 0.0 109.018 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -127.51 137.41 52.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.975 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.431 ' HB3' HD13 ' A' ' 14' ' ' ILE . 3.2 t -160.49 150.08 17.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 108.992 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 p -74.59 91.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 0.0 109.446 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.8 mt -138.85 143.5 37.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 45.9 Cg_endo -67.62 124.62 12.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.399 2.066 . . . . 0.0 111.44 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.76 -35.74 26.79 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.253 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.78 -49.56 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -72.43 -46.03 56.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.91 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.522 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 19.7 tp -60.33 -42.97 96.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.995 . . . . 0.0 109.719 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.547 ' CE2' HG21 ' A' ' 24' ' ' VAL . 68.9 t80 -62.39 -47.78 82.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.759 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 25' ' ' LEU . 70.6 tttt -68.35 -41.34 80.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.676 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 86.3 p -77.7 -24.62 49.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 13.7 t80 -100.48 -50.74 3.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.404 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.547 HG21 ' CE2' ' A' ' 20' ' ' PHE . 54.1 t -84.8 -52.63 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.527 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.494 ' CG ' ' HA ' ' A' ' 21' ' ' LYS . 59.3 mt -71.63 -32.62 68.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.045 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 92.0 m-20 -106.58 23.05 14.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.66 -41.81 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.598 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 26.1 p-10 -71.03 -34.03 70.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.85 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.413 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.3 m-20 -88.69 -31.71 18.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.801 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.0 tp -73.74 -21.74 60.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 15.5 mt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -138.0 156.37 47.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.399 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 36.2 p-10 -90.19 108.22 19.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.424 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.0 tp -64.35 -37.72 88.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 49.2 tp10 -141.54 155.44 45.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 91.31 161.34 37.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.7 9.17 30.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -1.159 . . . . 0.0 109.486 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 99.53 19.19 21.22 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -114.92 -141.37 7.5 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.49 123.1 9.86 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.708 2.272 . . . . 0.0 111.781 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.83 71.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.461 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.6 m -77.0 136.19 38.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -1.17 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 55' ' ' LYS . 7.8 mt -105.36 139.44 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' N ' HG22 ' A' ' 54' ' ' ILE . 62.1 mttm -116.09 145.76 42.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -129.45 142.59 50.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 70' ' ' HIS . 64.5 mt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -116.85 140.01 49.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.435 ' CE1' HD12 ' A' ' 57' ' ' ILE . 77.7 m80 -127.88 138.63 52.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.433 ' HB2' HD13 ' A' ' 87' ' ' ILE . 51.5 tttm -133.56 151.24 51.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.543 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.503 HG23 ' CG1' ' A' ' 75' ' ' ILE . 11.3 p -110.81 132.3 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.484 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -72.98 -44.12 61.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -176.07 140.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.503 ' CG1' HG23 ' A' ' 72' ' ' VAL . 66.1 mt -118.09 127.02 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.431 ' CB ' ' HB3' ' A' ' 79' ' ' ASN . 89.3 m-20 -122.27 85.09 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 85.5 m-70 -60.26 -38.8 84.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.76 -30.54 65.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.488 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 76' ' ' ASP . 58.2 t30 -90.56 7.23 40.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 46.03 36.99 3.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -128.17 128.42 44.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.319 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 63.1 t80 -120.11 125.58 48.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.4 m -127.45 114.05 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.524 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.8 p90 -129.48 163.03 26.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.509 ' HB2' ' CB ' ' A' ' 100' ' ' SER . 43.5 t -150.54 162.75 40.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.37 141.1 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' A' ' 71' ' ' LYS . 80.6 mt -92.35 -35.42 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.9 . . . . 0.0 109.307 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.543 -179.969 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.448 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 56.5 m170 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.466 HG23 ' CD ' ' A' ' 125' ' ' LYS . 1.1 m 46.23 24.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.541 ' CD2' ' HB3' ' A' ' 122' ' ' TYR . 27.0 mt -101.6 92.98 5.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.084 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.6 mt-10 -45.63 -36.13 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 0.0 110.728 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.514 ' O ' ' CD1' ' A' ' 99' ' ' ILE . 15.2 tttp -163.38 157.94 20.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.656 -1.277 . . . . 0.0 110.503 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.624 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 5.3 mm -133.0 119.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.748 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 85' ' ' SER . 38.4 m -120.14 144.44 47.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 109.74 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.571 ' CZ ' HG22 ' A' ' 99' ' ' ILE . 86.7 m-85 -125.76 128.62 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.342 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 89.5 mt-10 -105.06 143.71 32.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 77.8 mt -128.8 118.67 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -127.41 134.67 49.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.432 ' SD ' HD23 ' A' ' 19' ' ' LEU . 63.4 mtm -118.97 145.79 45.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.464 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.72 157.5 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.02 139.84 30.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.892 . . . . 0.0 109.314 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 109.661 -179.96 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -139.93 145.15 37.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -1.129 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 62.8 mt -111.31 130.62 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.1 mp -105.41 134.13 49.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -126.37 139.18 53.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.075 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 72.7 mt -124.81 140.97 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.828 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 26.9 m -123.56 142.5 50.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 m -121.41 153.3 38.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.776 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 64.3 mttm -142.25 124.97 15.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.185 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.624 ' CE1' ' CG2' ' A' ' 99' ' ' ILE . 9.6 m-85 -123.85 113.97 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.585 ' CG ' HG21 ' A' ' 3' ' ' VAL . 41.3 m-70 -80.49 114.19 19.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 108.86 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.1 p -102.83 142.37 34.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 0.0 109.593 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.466 ' CD ' HG23 ' A' ' 95' ' ' THR . 39.1 mttt -44.66 -43.03 8.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.8 -68.14 0.31 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.24 -30.33 71.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -1.167 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.431 ' CB ' ' HB ' ' A' ' 95' ' ' THR . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.0 m -127.95 154.3 45.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.391 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.577 HG12 ' CE1' ' A' ' 4' ' ' PHE . 29.4 mm -105.38 120.19 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.494 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.454 ' O ' HD13 ' A' ' 135' ' ' ILE . 24.8 t-20 -75.79 142.31 42.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 135' ' ' ILE . 97.1 mt-10 -57.76 -28.08 63.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -66.87 -35.68 80.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 108.864 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.1 mt-10 -61.82 -25.0 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.172 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.574 HG23 ' CD1' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -80.8 -39.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -56.18 -40.36 73.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.04 -48.65 73.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.294 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.02 -37.41 71.03 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -58.62 -43.68 89.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -1.139 . . . . 0.0 109.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -57.19 -48.39 78.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.072 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -59.35 -45.89 90.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.217 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.38 89.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 0.0 109.208 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.32 88.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.39 86.06 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.57 -38.07 74.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -1.117 . . . . 0.0 109.284 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.459 ' O ' HG13 ' A' ' 149' ' ' VAL . 69.5 t80 -62.39 -43.66 98.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -60.23 -39.78 87.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.0 -50.01 67.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 150' ' ' GLU . 5.8 p -63.72 -42.8 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 149' ' ' VAL . 86.2 tt0 -61.21 -42.4 98.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.09 78.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.5 ' CD1' HD12 ' A' ' 30' ' ' LEU . 51.5 t80 -60.96 -52.2 66.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 34.7 mt -53.21 -42.74 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.4 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.9 mt -59.95 -45.67 91.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -59.14 -25.46 63.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.391 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 155' ' ' ALA . 1.3 t-80 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.508 HG23 ' CD2' ' A' ' 123' ' ' HIS . 7.1 p -122.3 143.53 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -1.207 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.502 ' N ' HG21 ' A' ' 3' ' ' VAL . 90.4 m-85 -105.76 143.2 34.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 120' ' ' SER . 4.2 m -128.8 124.54 35.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.583 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.564 ' CE2' ' CD1' ' A' ' 135' ' ' ILE . 81.1 m-85 -119.59 152.07 37.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.7 mt-10 -126.37 154.98 42.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.449 ' OD2' ' HE2' ' A' ' 139' ' ' LYS . 54.5 t0 -126.77 151.42 48.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 93.2 mt-10 -122.38 135.5 54.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' O ' HG21 ' A' ' 115' ' ' ILE . . . -142.46 124.21 15.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.489 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.4 m -116.48 126.69 53.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.915 . . . . 0.0 109.682 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p -160.29 146.64 15.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 109.25 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.458 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 18.9 m -78.54 91.38 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.472 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CG2' ' HB2' ' A' ' 19' ' ' LEU . 8.8 mt -138.79 144.69 42.75 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 47.8 Cg_endo -68.7 123.35 10.35 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.536 2.158 . . . . 0.0 111.259 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.9 -27.76 43.1 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.745 2.296 . . . . 0.0 112.453 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.95 -54.62 6.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 109.527 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -72.62 -31.37 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.86 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.537 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 25.9 tp -71.96 -45.41 61.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.825 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.463 ' O ' HD13 ' A' ' 25' ' ' LEU . 58.1 t80 -64.72 -33.19 75.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 33.7 tttp -83.09 -30.32 28.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.894 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 81.3 p -97.58 -14.68 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.818 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.55 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 76.7 t80 -100.89 -50.03 3.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 47.2 t -84.83 -49.81 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.356 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 20' ' ' PHE . 8.7 mp -76.34 -39.74 53.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.58 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 30' ' ' LEU . 41.2 m-20 -92.78 10.53 30.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.014 . . . . 0.0 110.311 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.74 -34.31 73.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.888 -1.132 . . . . 0.0 109.414 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.26 -30.43 70.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -114.81 -45.49 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.037 . . . . 0.0 109.973 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 26' ' ' ASP . 7.8 tt -57.41 -38.32 74.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.728 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 27' ' ' ALA . 12.0 mm . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 109.453 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.291 0.567 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -145.4 147.66 32.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -93.62 109.0 20.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -38.55 88.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 85.4 tt0 -144.84 159.11 43.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.516 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.98 158.52 29.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -88.6 9.2 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -1.144 . . . . 0.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.44 ' HA2' HG22 ' A' ' 53' ' ' THR . . . 102.47 23.94 8.61 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.49 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.81 -140.62 6.02 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.31 121.92 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.684 2.256 . . . . 0.0 111.793 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.32 -2.87 75.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.49 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 99.8 m -72.69 136.95 45.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -1.217 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.469 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 22.5 mm -94.09 135.17 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -108.65 133.2 53.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -122.13 132.77 54.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.224 -0.923 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.554 HD11 ' CE1' ' A' ' 70' ' ' HIS . 65.7 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.575 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.469 ' HE1' ' CA ' ' A' ' 88' ' ' GLU . 62.4 mmm . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -116.07 150.27 37.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.917 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.554 ' CE1' HD11 ' A' ' 57' ' ' ILE . 60.0 m170 -122.76 153.02 40.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.469 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 21.3 tttt -131.9 147.22 52.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 50' ' ' GLY . 9.8 p -111.54 136.84 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.2 tt0 -80.03 -51.17 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 95.0 mt-10 -158.97 148.18 18.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.55 HG12 ' CE2' ' A' ' 82' ' ' TYR . 72.0 mt -125.08 126.58 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -127.03 94.1 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 77.2 t60 -70.26 -39.76 74.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.55 76.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -88.9 8.86 27.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 45.25 35.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.5 tttm -124.14 137.96 54.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.55 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.1 t80 -136.97 123.59 21.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 74' ' ' GLU . 4.2 p -125.4 120.31 30.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.54 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 40.3 p90 -132.75 156.02 47.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 86' ' ' ILE . 23.0 t -119.05 172.0 7.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.449 HD12 ' O ' ' A' ' 85' ' ' SER . 33.3 mm -125.45 125.03 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.795 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 88' ' ' GLU . 17.7 pt -107.01 -3.96 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.469 ' CA ' ' HE1' ' A' ' 68' ' ' MET . 21.5 mt-10 . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.952 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 92.8 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.232 0.539 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.6 22.76 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 130' ' ' ILE . 33.0 mt -116.13 98.85 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.357 -0.839 . . . . 0.0 109.369 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 89.6 mt-10 -48.52 -48.41 38.31 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.587 -0.695 . . . . 0.0 110.155 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.453 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 47.2 mtmt -155.22 158.57 39.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.867 -1.146 . . . . 0.0 110.47 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.577 HG21 ' CD1' ' A' ' 122' ' ' TYR . 5.6 mm -135.74 114.68 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 25.4 t -125.85 149.6 48.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.005 . . . . 0.0 109.946 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 84' ' ' TYR . 91.8 m-85 -128.05 126.46 41.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 109.164 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.1 mt-10 -105.34 141.71 36.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.874 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.03 122.86 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -0.855 . . . . 0.0 109.173 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -123.48 137.28 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.723 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -116.61 141.84 47.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.451 ' O ' ' OG ' ' A' ' 114' ' ' SER . . . -141.06 155.12 46.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.619 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.88 132.93 40.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 109.301 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 106' ' ' ALA . 26.3 t -148.12 150.18 33.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -1.124 . . . . 0.0 109.508 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 10' ' ' ALA . 67.8 mt -116.8 133.9 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 5.2 mp -111.16 138.53 47.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -123.9 139.29 54.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.265 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 70.8 mt -121.15 138.34 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 33.1 m -125.58 142.61 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 44.3 m -126.92 152.4 47.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -133.98 133.25 41.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 108.946 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.578 ' CB ' ' CD1' ' A' ' 130' ' ' ILE . 37.9 m-85 -133.32 104.52 6.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.949 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 15.1 m-70 -83.41 122.47 28.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.58 150.03 23.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.963 -1.086 . . . . 0.0 109.876 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -79.92 131.41 35.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 68.76 -144.05 41.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -94.36 17.39 13.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.4 146.91 14.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.499 ' HA ' ' CE2' ' A' ' 4' ' ' PHE . 38.2 m -127.21 154.79 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.578 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 22.6 mt -108.41 130.37 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -72.88 142.87 47.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.456 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.9 mt-10 -65.9 -31.47 72.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.538 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -44.74 83.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -43.56 88.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.564 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 38.3 pt -79.85 -29.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.7 tttm -56.26 -41.14 75.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.4 74.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.31 -38.53 78.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HE2' ' OD2' ' A' ' 8' ' ' ASP . 19.1 tttm -59.83 -43.61 94.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -1.126 . . . . 0.0 109.352 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -58.95 -41.62 87.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 23.3 tttp -60.74 -41.46 95.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.354 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.48 86.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.24 96.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.53 98.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.466 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 57.8 mt -66.09 -38.86 89.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -1.199 . . . . 0.0 109.393 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.78 -44.5 89.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.44 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.59 -35.53 80.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.471 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.32 -50.46 26.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.539 ' CG2' ' N ' ' A' ' 150' ' ' GLU . 3.3 m -64.46 -46.71 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.539 ' N ' ' CG2' ' A' ' 149' ' ' VAL . 83.8 tt0 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.11 72.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.277 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -62.78 -41.28 99.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.35 -41.8 90.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 37.4 mt -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.476 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.95 62.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.572 ' HB ' ' CG ' ' A' ' 123' ' ' HIS . 7.2 p -108.48 135.52 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.14 . . . . 0.0 109.588 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.481 ' CD1' HD11 ' A' ' 130' ' ' ILE . 82.8 m-85 -92.07 139.64 30.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 28.0 p -122.68 119.91 32.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.393 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.557 ' CE2' HD11 ' A' ' 135' ' ' ILE . 47.3 m-85 -116.24 145.54 43.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -121.12 143.14 49.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.558 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.449 ' OD1' ' HE2' ' A' ' 139' ' ' LYS . 60.5 t0 -116.07 135.78 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -113.07 125.08 53.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.685 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.96 7.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.047 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 t -129.48 150.75 50.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -160.29 146.39 15.42 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 13' ' ' VAL . 13.0 m -62.3 90.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.033 . . . . 0.0 109.29 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt -139.81 145.48 43.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.354 -0.841 . . . . 0.0 109.322 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 45.9 Cg_endo -68.44 112.79 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.332 2.021 . . . . 0.0 110.995 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.54 -32.02 40.2 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.851 2.367 . . . . 0.0 112.34 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.03 -56.23 7.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.134 -0.979 . . . . 0.0 109.442 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 mtt85 -72.4 -38.95 68.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.732 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 22.0 tp -62.0 -47.64 83.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 109.654 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.9 t80 -58.59 -46.62 86.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.413 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' ASP . 22.4 mttm -72.84 -44.66 61.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.957 . . . . 0.0 109.522 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 33.9 t -70.83 -21.33 62.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.076 -1.015 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 2.6 t80 -100.13 -50.74 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.089 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 55.5 t -85.04 -52.44 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.095 -1.003 . . . . 0.0 110.12 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.1 tp -70.41 -36.27 73.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.135 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 74.4 m-20 -103.82 23.78 12.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.039 -1.038 . . . . 0.0 109.723 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.5 -46.53 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.62 -33.22 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 109.96 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -90.76 -40.17 11.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.64 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 19.5 tp -66.32 -28.25 68.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.955 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 27' ' ' ALA . 24.6 mt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.164 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.456 ' HB1' HG12 ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -133.72 157.0 46.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -97.87 110.12 22.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.525 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 7.6 mt -63.25 -37.83 88.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 83.9 tt0 -149.14 157.09 43.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.484 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 86.46 155.99 27.69 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -89.9 10.52 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.451 ' HA2' HG23 ' A' ' 53' ' ' THR . . . 104.73 23.41 7.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.45 ' HA2' HD13 ' A' ' 75' ' ' ILE . . . -121.19 -143.91 6.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 50.4 Cg_endo -70.17 121.89 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.678 2.252 . . . . 0.0 111.843 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.74 -2.82 70.33 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.451 HG23 ' HA2' ' A' ' 49' ' ' GLY . 94.3 m -78.59 140.83 38.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -1.196 . . . . 0.0 109.496 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.423 ' N ' HG22 ' A' ' 53' ' ' THR . 23.4 mm -100.67 129.55 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 31.1 tttm -106.71 130.7 54.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . 20.0 tttt -122.86 134.93 54.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.498 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.456 HG12 ' HB1' ' A' ' 42' ' ' ALA . 64.8 mt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.95 146.6 30.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 79.5 m80 -126.8 140.11 52.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -124.62 133.25 53.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.9 t -98.68 130.62 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 82.0 tt0 -81.09 -53.92 5.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.7 mt-10 -156.96 143.35 18.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.539 HG22 ' CE1' ' A' ' 77' ' ' HIS . 71.8 mt -124.31 123.65 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.448 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 73.2 m-20 -130.5 86.25 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.57 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 75.6 m80 -62.38 -38.05 88.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.67 -30.68 68.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 56.8 m-20 -89.49 9.39 26.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.508 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.552 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 56.5 m-85 44.21 39.65 3.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.354 -0.841 . . . . 0.0 109.536 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.482 ' CE ' ' OE2' ' A' ' 102' ' ' GLU . 82.9 tttt -135.39 128.59 31.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.538 ' CE2' HG12 ' A' ' 75' ' ' ILE . 77.5 t80 -125.97 127.9 46.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 109.561 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -128.09 123.38 34.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.7 p90 -139.35 166.06 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.7 t -143.64 167.39 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 130.34 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.4 -47.18 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.557 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 109.503 -179.978 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.527 ' O ' ' CB ' ' A' ' 95' ' ' THR . 57.2 t-80 . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 94' ' ' HIS . 0.2 OUTLIER 78.54 5.31 2.53 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB3' ' CD1' ' A' ' 99' ' ' ILE . 67.2 mt -100.71 93.11 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 108.957 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.7 mt-10 -40.43 -37.63 0.71 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.693 -0.63 . . . . 0.0 110.42 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 15.9 tttt -164.81 155.44 14.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 110.419 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.543 ' CD1' ' HB3' ' A' ' 96' ' ' LEU . 6.5 mm -131.85 124.24 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.4 t -128.43 159.62 34.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.049 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 84' ' ' TYR . 85.0 m-85 -135.68 128.54 31.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.482 ' OE2' ' CE ' ' A' ' 81' ' ' LYS . 78.4 tt0 -112.05 140.66 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' LYS . 68.7 mt -131.81 126.34 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.153 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 11.2 mtpp -123.43 137.77 54.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.612 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.93 151.06 39.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.329 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.27 158.91 43.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.14 146.25 31.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.473 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.364 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 14' ' ' ILE . 95.0 p -146.5 152.71 39.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 69.3 mt -122.61 128.04 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 5.4 mp -110.32 134.59 52.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 29.9 mttp -128.51 128.88 45.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.476 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -118.11 129.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 75.7 m -126.2 134.42 51.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.577 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.4 m -116.4 161.82 18.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.563 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -145.67 127.03 14.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.845 . . . . 0.0 109.37 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.531 ' CD1' HG22 ' A' ' 99' ' ' ILE . 11.0 m-85 -126.63 107.94 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.572 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 22.2 m-70 -80.23 113.98 18.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.089 -1.007 . . . . 0.0 108.336 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.449 ' CG2' HD12 ' A' ' 130' ' ' ILE . 1.3 p -104.45 141.82 35.68 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.029 . . . . 0.0 109.511 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 92.2 mttt -41.83 -42.48 2.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.479 -0.763 . . . . 0.0 109.615 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.73 -70.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -59.67 -31.71 69.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -1.164 . . . . 0.0 109.56 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.502 ' CB ' ' CG2' ' A' ' 95' ' ' THR . . . -61.18 147.47 44.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -128.56 145.76 51.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.509 HG21 ' CG2' ' A' ' 135' ' ' ILE . 17.8 mt -108.78 126.49 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -88.41 152.51 21.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 136' ' ' LYS . 75.6 mm-40 -64.9 -36.79 85.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.02 -44.59 95.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.81 -43.65 90.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.557 HD11 ' CE2' ' A' ' 6' ' ' TYR . 42.2 pt -82.13 -30.69 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 132' ' ' GLU . 47.4 tttt -55.78 -37.51 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.48 74.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.288 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.16 95.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HE2' ' OD1' ' A' ' 8' ' ' ASP . 22.7 tttt -60.01 -42.92 95.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 109.317 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.39 -41.8 94.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.379 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.08 -45.96 86.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.14 -42.56 75.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.1 99.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.371 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.62 -45.06 90.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.82 -38.25 78.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -1.154 . . . . 0.0 109.301 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.468 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 70.0 t80 -62.9 -41.83 99.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.0 -37.39 87.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.46 -47.42 70.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.389 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.515 HG11 ' N ' ' A' ' 150' ' ' GLU . 6.6 p -62.39 -40.45 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.301 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.515 ' N ' HG11 ' A' ' 149' ' ' VAL . 85.7 tt0 -59.74 -43.24 94.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.426 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.6 81.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.919 . . . . 0.0 109.353 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.38 -44.83 96.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.51 -39.64 91.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.1 tt -64.56 -44.59 90.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.502 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.65 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.2 m80 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.94 . . . . 0.0 109.447 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.588 HG23 ' CE1' ' A' ' 123' ' ' HIS . 38.6 t -134.28 141.74 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.523 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 99.1 m-85 -101.59 122.99 44.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 t -111.03 120.97 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.602 ' CZ ' ' CD1' ' A' ' 135' ' ' ILE . 28.2 m-85 -115.49 147.33 40.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -118.16 133.67 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.654 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -109.54 134.2 52.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.86 124.21 52.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.28 124.19 15.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.292 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -110.6 132.3 54.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 m -157.06 147.48 21.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.045 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.492 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 31.0 m -78.44 90.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 8.6 mt -139.37 144.93 42.06 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.224 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.98 113.33 3.21 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.501 2.134 . . . . 0.0 111.228 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.52 -31.13 42.35 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.799 2.333 . . . . 0.0 112.204 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.11 -52.74 8.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -72.01 -45.95 59.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.954 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.523 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 6.7 tp -59.04 -45.13 91.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.959 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' A' ' 24' ' ' VAL . 79.0 t80 -60.73 -55.38 33.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.902 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 23.8 tttp -67.85 -38.39 83.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 29.5 t -72.78 -27.2 61.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.805 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.47 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 34.3 t80 -100.82 -50.11 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' ' 20' ' ' PHE . 54.8 t -78.14 -52.45 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.082 -1.011 . . . . 0.0 110.284 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -65.13 -35.91 82.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.103 -0.998 . . . . 0.0 109.808 -179.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 22' ' ' SER . 89.8 m-20 -108.71 28.36 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.581 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.4 -45.04 70.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HA ' HD12 ' A' ' 31' ' ' ILE . 65.0 m-20 -73.72 -29.65 62.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.98 . . . . 0.0 109.773 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -79.66 -37.79 35.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.965 . . . . 0.0 109.616 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 26' ' ' ASP . 42.1 mt -72.44 -31.47 65.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.72 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 28' ' ' ASP . 16.0 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -134.21 149.71 51.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 33.2 p-10 -84.0 114.56 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.517 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 52.0 mt -65.95 -28.69 69.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 109.404 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 45' ' ' LEU . 14.7 mm-40 -159.44 -173.41 4.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 63.39 164.36 0.57 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -94.51 -3.14 50.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -1.087 . . . . 0.0 109.553 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.72 13.82 5.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.516 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -112.17 -142.12 8.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.63 125.95 13.42 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.42 5.49 79.13 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 53.9 m -73.02 140.78 47.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -1.219 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.524 HG21 HD12 ' A' ' 54' ' ' ILE . 27.0 mm -99.13 133.74 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 79.7 tttt -122.77 134.84 54.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.403 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HD2' HD13 ' A' ' 45' ' ' LEU . 21.8 tttt -130.85 131.46 44.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 57' ' ' ILE . 69.5 mt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.499 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' O ' HG22 ' A' ' 86' ' ' ILE . 53.4 mttm -126.88 136.79 52.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 34.0 m-70 -131.96 133.51 44.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -127.19 141.51 51.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 109.612 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 62.0 t -100.8 129.65 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.335 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.8 -43.96 43.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -173.1 137.26 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 109.583 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.568 ' CG2' ' CE1' ' A' ' 77' ' ' HIS . 60.3 mt -116.77 123.55 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -132.94 72.59 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.511 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.568 ' CE1' ' CG2' ' A' ' 75' ' ' ILE . 60.4 m80 -55.9 -37.14 68.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.44 78.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.363 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 23.9 m120 -87.45 -0.28 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 79' ' ' ASN . 79.5 m-85 60.93 31.78 19.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.425 ' HG2' ' HG3' ' A' ' 104' ' ' LYS . 4.5 mtmp? -130.87 125.14 32.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.4 t80 -117.16 129.25 55.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 0.0 109.42 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.3 t -129.02 114.06 15.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.557 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.3 p90 -129.5 170.44 13.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.311 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 87.5 p -151.93 162.86 40.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.708 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 69' ' ' LYS . 15.6 mm -111.85 122.43 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.447 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 99.7 mt -70.2 -39.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.604 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 0.0 109.626 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.325 0.583 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.492 ' CG2' ' CB ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 56.47 16.85 2.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 109.856 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.515 ' CD2' ' HB3' ' A' ' 122' ' ' TYR . 37.1 mt -90.63 89.67 7.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.029 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.528 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 79.3 mt-10 -48.35 -32.53 7.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.456 ' O ' HD13 ' A' ' 99' ' ' ILE . 21.7 tttp -152.34 152.52 32.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.596 -1.315 . . . . 0.0 110.691 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 96' ' ' LEU . 10.0 mm -132.47 113.62 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 37.3 t -131.36 152.23 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.921 -1.112 . . . . 0.0 110.128 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -130.84 143.66 50.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 82.1 tt0 -120.93 143.73 48.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 109.78 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.29 121.9 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 56.8 tttt -121.04 129.73 53.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.893 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mtt -116.18 132.75 56.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.366 -0.834 . . . . 0.0 109.196 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.56 151.44 41.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.86 124.26 34.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.31 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.946 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -138.09 164.73 28.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -1.162 . . . . 0.0 109.674 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.24 137.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.18 137.1 44.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 47.8 mttp -130.77 135.89 48.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 68.1 mt -127.12 127.68 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.134 -0.979 . . . . 0.0 109.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 32.5 m -116.22 142.51 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.372 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.3 m -122.02 147.83 45.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 109.703 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -129.25 116.67 19.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.227 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.52 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 72.0 m-85 -115.7 124.79 51.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.588 ' CE1' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -91.05 129.19 37.07 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.204 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 125' ' ' LYS . 4.2 t -114.85 136.01 53.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.953 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 21.0 tttm -43.63 -46.86 7.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.75 -85.87 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -58.32 -25.29 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.492 ' CB ' ' CG2' ' A' ' 95' ' ' THR . . . -68.95 142.96 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.53 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 86.6 p -130.33 163.35 27.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 51.4 mt -108.48 126.4 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.24 132.51 47.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.538 ' HA ' HG13 ' A' ' 135' ' ' ILE . 94.7 mt-10 -61.92 -32.63 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.91 -43.82 98.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.3 -26.04 62.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 108.986 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 1.8 mt -69.9 -49.56 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 108.839 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -55.49 -44.54 76.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.209 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.46 -47.37 86.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.64 -31.61 57.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -70.57 -36.79 73.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -1.118 . . . . 0.0 109.306 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.04 -45.02 96.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.14 -45.95 91.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.361 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.52 94.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.267 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.02 82.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.233 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.61 -44.56 95.52 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 38.0 tp -56.77 -41.99 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -1.109 . . . . 0.0 109.311 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.446 ' CE2' HD13 ' A' ' 118' ' ' ILE . 63.9 m-85 -62.09 -41.12 97.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.252 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -56.85 -42.88 80.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.58 77.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 75.3 t -67.21 -50.08 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.435 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 82.7 mt-10 -50.23 -34.02 21.52 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.01 81.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.717 . . . . 0.0 109.458 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.45 -45.06 92.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.1 -42.64 90.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.963 . . . . 0.0 109.303 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 30.0 mt -69.08 -33.0 72.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.26 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 0.0 109.399 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.578 HG23 ' CG ' ' A' ' 123' ' ' HIS . 23.7 t -116.57 140.82 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.153 . . . . 0.0 109.499 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 99.3 m-85 -107.49 129.71 54.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.132 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -117.28 125.94 51.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.552 ' CZ ' ' CD1' ' A' ' 135' ' ' ILE . 46.8 m-85 -124.29 142.75 51.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -116.3 131.78 56.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 56.8 t0 -99.98 133.08 44.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -108.52 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.4 129.55 22.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.7 m -112.66 137.44 50.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.792 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -160.6 147.98 15.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.828 . . . . 0.0 109.047 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 4.0 p -81.84 91.07 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.567 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 13.2 mt -139.17 144.77 41.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.28 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 44.5 Cg_endo -67.69 116.17 4.13 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.41 2.073 . . . . 0.0 111.217 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.9 Cg_endo -66.8 -35.61 26.93 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.884 2.39 . . . . 0.0 112.387 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.09 -52.04 18.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.479 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 22' ' ' SER . 55.9 mtp180 -72.11 -50.32 29.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 13.4 tp -55.01 -45.28 75.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.803 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.592 ' CE2' HG23 ' A' ' 24' ' ' VAL . 47.5 t80 -64.39 -55.59 20.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 109.425 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 27.9 mttt -67.92 -13.73 62.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.648 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 49.7 m -100.33 -21.46 15.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.011 -1.056 . . . . 0.0 109.925 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 35.0 t80 -101.2 -52.5 3.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.996 -1.065 . . . . 0.0 110.722 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.592 HG23 ' CE2' ' A' ' 20' ' ' PHE . 12.6 m -86.22 -40.79 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.961 -1.087 . . . . 0.0 110.63 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 4.1 tt -79.29 -43.16 24.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.574 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 22' ' ' SER . 95.1 m-20 -89.54 10.74 21.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.42 -31.49 69.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -71.56 -14.76 62.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -114.75 -36.92 4.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.0 . . . . 0.0 109.817 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 26' ' ' ASP . 33.4 mt -72.53 -31.12 65.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 31' ' ' ILE . 1.1 mp . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.124 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.427 ' O ' ' CG ' ' A' ' 43' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 42' ' ' ALA . 92.0 mt-10 -155.53 156.42 35.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -88.53 118.49 28.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 28.5 tp -72.95 -35.97 67.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 49.5 tp10 -159.24 153.98 24.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.455 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 93.37 150.29 26.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -83.52 6.91 18.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.602 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.08 20.2 10.01 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -113.58 -146.32 9.47 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.01 124.94 11.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.751 2.301 . . . . 0.0 111.891 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.16 78.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.519 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 61.2 m -72.73 137.79 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -1.193 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.412 ' N ' HG22 ' A' ' 53' ' ' THR . 17.3 mm -103.81 133.44 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 46.6 mtpt -111.73 144.33 41.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 45' ' ' LEU . 16.1 tttp -122.13 133.4 54.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.557 HG12 ' CE1' ' A' ' 70' ' ' HIS . 23.0 mm . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.6 mtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.67 140.48 40.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.826 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.557 ' CE1' HG12 ' A' ' 57' ' ' ILE . 79.8 m80 -126.0 135.36 51.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -130.32 142.15 50.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.6 t -101.65 132.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 89.9 mt-10 -73.59 -58.64 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.426 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 93.9 mt-10 -158.79 144.25 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.564 HG12 ' CE1' ' A' ' 82' ' ' TYR . 91.3 mt -122.79 120.32 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.502 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.463 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 86.8 m-20 -122.78 92.42 3.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.507 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 76.5 m80 -64.95 -37.52 87.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.16 -33.31 71.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.902 . . . . 0.0 109.374 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 76' ' ' ASP . 23.2 m120 -84.98 -2.33 57.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 53.61 41.24 32.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -137.32 122.45 19.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 81.7 t80 -113.18 128.11 56.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 m -127.78 119.13 25.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.579 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.2 p90 -134.32 164.28 27.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.468 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 17.0 t -145.51 158.99 43.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.584 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.0 mt -108.58 137.42 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 96.4 mt -86.24 -27.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.699 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 85.0 tt0 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.514 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.251 0.548 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.402 HG23 ' CB ' ' A' ' 128' ' ' ALA . 2.0 m 48.8 22.94 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.648 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 122' ' ' TYR . 36.4 mt -94.02 89.14 5.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.301 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 83.6 mt-10 -40.75 -28.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.633 -0.667 . . . . 0.0 110.218 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 71.3 tttt -165.87 155.2 11.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 0.0 110.153 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.49 HG22 ' CE1' ' A' ' 122' ' ' TYR . 45.9 mt -141.32 113.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 108.975 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 32.1 t -126.08 150.45 48.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.985 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 84' ' ' TYR . 98.2 m-85 -127.24 126.42 42.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 0.0 109.145 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 51.9 mp0 -112.83 142.1 45.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.803 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.6 mt -117.37 131.72 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.252 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 16.0 tttp -124.83 132.24 53.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.0 mtt -115.58 146.16 42.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.08 40.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.95 41.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.2 p -106.13 163.63 12.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -1.174 . . . . 0.0 109.599 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.81 128.08 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.388 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.11 136.15 47.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 94.1 mttt -131.32 136.92 48.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.48 127.43 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 26.7 m -113.81 142.42 46.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.48 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 51.5 m -127.89 150.58 49.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.445 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 34.7 mttt -138.43 120.68 15.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.399 -0.813 . . . . 0.0 109.079 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.526 ' HB3' ' CD2' ' A' ' 96' ' ' LEU . 28.5 m-85 -120.6 115.75 24.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.122 -0.986 . . . . 0.0 109.889 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.578 ' CG ' HG23 ' A' ' 3' ' ' VAL . 52.1 m-70 -83.15 132.18 35.09 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.515 ' OG1' ' CB ' ' A' ' 128' ' ' ALA . 10.3 t -113.95 138.29 50.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.521 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 75.9 mttt -76.38 144.29 40.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.384 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 54.66 -148.2 22.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 46.2 p-10 -88.06 10.95 17.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -1.139 . . . . 0.0 109.48 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.515 ' CB ' ' OG1' ' A' ' 124' ' ' THR . . . -45.24 144.0 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.458 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.4 p -123.1 167.15 14.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 23.1 mt -116.11 127.67 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.401 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 45.8 t30 -57.1 127.35 31.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.551 ' HA ' HG13 ' A' ' 135' ' ' ILE . 96.1 mt-10 -61.96 -33.72 74.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -55.28 -44.25 75.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.401 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 92.5 mt-10 -58.09 -25.25 61.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.552 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 4.3 mt -70.33 -50.86 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.822 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -55.59 -43.92 76.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.94 84.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.76 -38.09 71.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -61.42 -44.16 97.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -1.058 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.51 -42.19 82.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.436 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -58.48 -45.23 89.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.62 -38.5 75.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.98 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.73 94.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.9 -46.88 90.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.48 -37.99 82.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.497 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.433 ' O ' HG12 ' A' ' 149' ' ' VAL . 67.2 t80 -61.69 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.23 -36.26 79.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.59 -48.72 68.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.512 HG11 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -66.97 -42.55 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.92 . . . . 0.0 109.395 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.512 ' N ' HG11 ' A' ' 149' ' ' VAL . 84.1 tt0 -60.78 -38.63 85.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.421 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.2 -36.96 80.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.436 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 71.4 t80 -63.43 -47.82 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.333 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.9 mt -59.02 -40.84 86.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.24 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 154' ' ' LEU . 2.7 tm? -67.88 -40.03 83.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.09 66.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 124' ' ' THR . . . 87.77 10.03 70.51 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.508 HG22 ' ND1' ' A' ' 123' ' ' HIS . 43.5 t -128.46 131.92 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -1.204 . . . . 0.0 109.666 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.528 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 99.3 m-85 -89.21 129.33 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.883 . . . . 0.0 109.122 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 120' ' ' SER . 93.4 m -116.09 121.72 43.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.528 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 97.8 m-85 -121.19 147.72 45.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 85.1 tt0 -124.08 134.44 53.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.42 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 92.4 m-20 -104.75 148.6 26.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.276 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -116.57 138.09 51.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.69 123.28 13.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.5 m -110.7 127.33 55.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.996 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 p -160.57 147.37 15.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 p -83.82 91.15 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 94.0 mt -139.02 144.78 42.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 45.5 Cg_endo -67.91 121.48 8.52 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 111.235 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.76 -31.85 38.52 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.848 2.365 . . . . 0.0 112.451 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.87 -54.23 8.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 109.654 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.503 ' CZ ' ' O ' ' A' ' 159' ' ' ALA . 33.8 mtp-105 -72.25 -39.19 68.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 109.762 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 60.4 tp -61.26 -45.15 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 77' ' ' HIS . 58.4 t80 -67.4 -46.94 71.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.861 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.504 ' HA ' ' CG ' ' A' ' 25' ' ' LEU . 15.9 tttp -72.72 -22.23 60.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.833 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.459 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 83.8 p -97.72 -29.19 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.072 -1.017 . . . . 0.0 109.826 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.528 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 14.2 t80 -100.27 -46.46 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.493 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.8 t -84.34 -52.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.504 ' CG ' ' HA ' ' A' ' 21' ' ' LYS . 42.5 mt -71.86 -41.89 67.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.024 -1.047 . . . . 0.0 109.681 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.457 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.9 m-20 -97.43 26.35 4.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.546 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.55 -44.51 70.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.512 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 37.2 p-10 -74.19 -18.4 60.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.01 -38.81 14.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.621 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 34' ' ' VAL . 48.5 mt -71.88 -30.89 65.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.624 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.51 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 34.4 mt -55.7 -56.96 24.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.7 Cg_endo -68.29 -35.37 18.95 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.456 2.104 . . . . 0.0 111.824 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 36.6 tttp -54.99 -42.8 72.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.915 . . . . 0.0 109.34 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 30' ' ' LEU . 68.9 t -59.89 -41.02 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.414 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.498 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . 66.49 51.07 0.68 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 0.0 109.368 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 48.6 Cg_endo -69.52 -49.93 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.75 2.3 . . . . 0.0 111.876 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -137.66 141.14 41.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -107.79 11.82 27.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -97.73 -9.51 26.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.5 p -110.54 165.99 11.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.377 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.8 t -157.76 143.26 17.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.527 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.454 ' HB2' HG12 ' A' ' 57' ' ' ILE . . . -112.42 147.24 36.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -141.19 138.91 33.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 47' ' ' GLY . 37.4 t30 -87.89 115.42 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.53 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 54' ' ' ILE . 20.8 tp -73.35 -32.91 64.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.396 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.496 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 81.6 tt0 -166.98 160.18 13.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.505 ' O ' ' ND2' ' A' ' 44' ' ' ASN . . . 92.76 161.45 36.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -98.91 10.48 41.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.99 20.93 9.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 75' ' ' ILE . . . -118.75 -146.02 7.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.2 Cg_endo -68.82 125.08 12.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.826 2.351 . . . . 0.0 111.777 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.14 3.44 75.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 99.6 m -72.91 140.21 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -1.185 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.504 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 18.5 mm -110.91 118.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 70' ' ' HIS . 46.8 mttt -120.52 143.26 48.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' CB ' ' HD2' ' A' ' 66' ' ' LYS . 16.4 mtmt -127.51 135.41 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.454 HG12 ' HB2' ' A' ' 42' ' ' ALA . 71.4 mt -123.88 131.08 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.376 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.462 ' OG1' ' CG ' ' A' ' 66' ' ' LYS . 46.7 m -129.27 138.78 51.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.0 109.586 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -71.36 -30.38 66.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 58' ' ' THR . . . -104.45 147.16 27.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -111.43 160.88 16.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.387 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.11 9.67 47.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -106.59 126.92 52.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 109.512 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.58 -36.99 77.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.923 . . . . 0.0 109.544 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -117.16 150.13 39.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.507 ' HD2' ' CB ' ' A' ' 56' ' ' LYS . 77.8 mttt -104.1 132.57 50.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -67.34 -32.66 73.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 85.8 mtp -95.98 138.47 33.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 87.2 mttt -132.38 141.11 48.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 55' ' ' LYS . 97.9 m-70 -121.86 135.55 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.504 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 61.5 tttt -131.51 131.73 43.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.423 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.56 HG22 ' CE1' ' A' ' 84' ' ' TYR . 21.9 t -89.07 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 86.2 tt0 -71.79 -43.51 65.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.96 . . . . 0.0 109.61 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.4 tt0 -178.36 146.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.525 ' CD1' ' HA2' ' A' ' 50' ' ' GLY . 30.0 mt -126.31 120.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 20.6 t70 -128.74 93.29 3.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.554 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 55.7 p-80 -69.75 -26.46 64.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.0 -43.13 99.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 23.4 m120 -91.25 3.56 54.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.93 . . . . 0.0 109.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 59.29 27.17 16.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 79' ' ' ASN . 36.6 mttt -116.14 141.45 48.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.482 ' CE2' HD11 ' A' ' 75' ' ' ILE . 17.8 t80 -130.23 137.28 49.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 13.2 m -117.32 122.49 44.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.56 ' CE1' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -120.7 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.468 ' HB3' ' HE2' ' A' ' 98' ' ' LYS . 73.3 m -127.74 149.25 50.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.533 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 99' ' ' ILE . 26.9 mm -116.96 129.69 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.415 ' C ' ' HG3' ' A' ' 88' ' ' GLU . 84.9 mt -87.0 -49.75 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.256 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.415 ' HG3' ' C ' ' A' ' 87' ' ' ILE . 97.5 mt-10 -152.86 143.48 22.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -152.67 105.63 0.28 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 46.44 -120.09 4.63 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.7 Cg_endo -70.8 -20.54 29.81 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.572 2.181 . . . . 0.0 111.468 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 9.6 tp 62.51 -74.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.405 -0.81 . . . . 0.0 109.62 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 166.45 167.56 27.29 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -90.59 130.1 36.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -1.118 . . . . 0.0 109.339 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 55.73 17.71 2.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.383 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 130' ' ' ILE . 42.8 mt -97.98 91.01 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.152 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' HIS . 91.4 mt-10 -51.37 -43.01 61.74 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.276 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.506 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 16.7 tttt -155.96 158.18 37.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 0.0 110.315 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 101' ' ' TYR . 35.6 mt -134.41 117.11 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 84' ' ' TYR . 32.5 t -120.87 150.89 40.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.003 -1.061 . . . . 0.0 110.237 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 99' ' ' ILE . 93.4 m-85 -131.38 133.49 45.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 93.5 mt-10 -121.22 139.65 53.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.25 125.86 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 109.392 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -125.04 146.94 49.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.1 mtt -122.82 150.44 42.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.43 153.48 40.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.37 39.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.19 162.56 58.72 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.93 -26.01 32.0 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.731 2.287 . . . . 0.0 111.75 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -58.31 -35.89 72.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.332 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.5 9.31 61.68 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.72 49.42 0.61 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.45 123.54 0.89 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.5 t -112.78 143.99 43.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -1.166 . . . . 0.0 109.55 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 70.1 mt -115.48 135.81 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.6 mp -105.91 138.35 42.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.59 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.406 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 70.7 mttt -127.56 139.66 52.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 76.0 mt -123.31 138.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.618 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 29.7 m -120.33 142.4 49.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.342 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 54.1 m -125.44 148.81 48.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.615 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -134.94 122.5 22.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.888 . . . . 0.0 109.256 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.565 ' CE1' HG22 ' A' ' 99' ' ' ILE . 50.9 m-85 -119.2 119.75 35.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 97' ' ' GLU . 0.9 OUTLIER -84.7 114.01 21.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 108.722 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' THR . 9.6 t -103.38 144.38 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.022 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 124' ' ' THR . 16.0 tttt -43.84 -45.44 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 149.68 -54.06 0.5 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -85.93 8.94 18.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -107.0 145.33 32.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 m -124.16 145.61 49.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.519 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 52.6 mt -101.82 134.07 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -86.14 142.48 28.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.433 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.3 mt-10 -58.88 -35.89 73.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -63.31 -46.26 87.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.843 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -57.22 -44.3 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.351 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.476 ' CG2' HG21 ' A' ' 130' ' ' ILE . 39.7 pt -75.37 -30.64 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.282 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -56.09 -40.55 73.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.19 -47.18 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.9 . . . . 0.0 109.31 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.66 67.87 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.98 -42.6 99.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -1.08 . . . . 0.0 109.214 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -54.95 -45.48 74.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.173 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -59.44 -45.12 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.95 93.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.72 95.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.168 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.69 -46.98 88.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.9 -38.76 76.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.238 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.479 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.6 t80 -62.83 -41.04 99.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -0.895 . . . . 0.0 109.277 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -59.21 -40.99 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.75 -51.94 65.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 146' ' ' PHE . 4.3 p -61.83 -41.2 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 149' ' ' VAL . 84.3 tt0 -63.54 -38.47 91.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.348 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.41 91.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.433 ' OH ' ' HE2' ' A' ' 33' ' ' LYS . 72.1 t80 -61.15 -48.28 82.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.26 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.31 -35.82 78.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.329 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' A' ' 154' ' ' LEU . 2.0 tm? -63.06 -39.87 96.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.853 . . . . 0.0 109.293 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.78 64.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.37 70.13 14.1 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 49.4 Cg_endo -70.46 -9.47 25.93 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.705 2.27 . . . . 0.0 111.591 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -101.7 9.94 40.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.489 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' O ' ' CZ ' ' A' ' 18' ' ' ARG . . . -57.78 144.22 39.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -128.99 139.43 52.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -0.979 . . . . 0.0 109.494 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.507 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.5 mtm . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.317 0.58 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . 91.97 9.06 62.74 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.57 HG23 ' CG ' ' A' ' 123' ' ' HIS . 29.1 t -129.39 133.63 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -1.115 . . . . 0.0 109.313 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.48 ' CD1' ' CD1' ' A' ' 130' ' ' ILE . 97.2 m-85 -92.86 132.09 37.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 109.302 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 120' ' ' SER . 28.5 p -117.89 121.33 40.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 119' ' ' THR . 33.5 m-85 -115.27 143.69 44.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.75 152.51 37.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -135.14 137.66 42.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.37 137.77 45.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.626 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.6 123.31 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.6 m -107.52 127.25 53.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.774 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.4 p -160.39 140.2 11.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.312 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' CG1' ' HA3' ' A' ' 113' ' ' GLY . 3.1 t -88.24 91.61 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 31.3 mm -138.5 144.49 42.67 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.1 Cg_endo -67.94 123.56 10.81 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.44 2.093 . . . . 0.0 111.463 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 43.7 Cg_endo -66.87 -40.01 13.3 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.75 2.3 . . . . 0.0 112.1 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.94 -53.82 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 0.0 109.433 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -72.14 -46.66 55.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.517 ' HB2' ' CG2' ' A' ' 14' ' ' ILE . 27.8 tp -61.11 -41.02 95.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.583 ' CE2' HG23 ' A' ' 24' ' ' VAL . 44.1 t80 -68.19 -55.8 10.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 92.9 mttt -65.58 -13.67 59.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 109.888 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 52.9 p -109.16 -17.58 13.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.953 -1.092 . . . . 0.0 110.231 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 85.5 t80 -100.37 -51.57 3.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 110.109 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.583 HG23 ' CE2' ' A' ' 20' ' ' PHE . 6.6 m -85.67 -39.4 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.984 . . . . 0.0 110.092 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.473 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -81.63 -53.95 5.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.161 -0.962 . . . . 0.0 110.13 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' SER . 84.7 m-20 -76.81 4.87 8.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -65.61 -38.93 90.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.788 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -58.43 -26.66 63.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -106.04 -39.42 5.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.6 mt -69.25 -31.75 70.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 52.2 mt -61.65 -56.09 36.16 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.3 Cg_endo -68.39 -32.7 25.15 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.506 2.137 . . . . 0.0 111.624 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -59.48 -42.06 91.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.475 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.08 -33.84 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.502 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 32' ' ' PRO . . . -47.89 165.64 0.22 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.35 -162.61 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.664 2.242 . . . . 0.0 111.719 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 96.3 mt-30 -52.67 -31.61 38.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -65.86 131.05 45.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 109.456 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.517 ' CE2' ' O ' ' A' ' 37' ' ' GLN . 99.4 m-85 -114.39 156.12 25.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 109.508 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.0 p -127.85 163.46 24.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.534 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -129.94 151.47 50.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -138.81 142.31 38.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.463 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -124.15 145.43 49.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 82.3 m-20 -82.36 114.99 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.41 ' HB3' HG22 ' A' ' 54' ' ' ILE . 19.2 tp -56.63 -49.07 76.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -152.02 -171.35 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 70.74 163.33 4.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -98.37 7.97 45.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.167 . . . . 0.0 109.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 107.68 8.33 30.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' HD12 ' A' ' 75' ' ' ILE . . . -105.31 -145.08 13.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.69 122.71 9.4 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.654 2.236 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.521 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . 95.63 -1.12 63.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.459 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 92.6 m -72.96 141.25 47.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -1.191 . . . . 0.0 109.481 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.557 ' N ' ' CD1' ' A' ' 54' ' ' ILE . 1.6 mp -111.45 131.35 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 27.0 mttm -109.7 140.16 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 109.337 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -129.23 136.3 49.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.585 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 64.8 mt -111.31 134.23 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.39 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.8 m -120.92 138.44 54.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.444 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 45.9 p90 -140.83 -39.83 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.91 . . . . 0.0 109.542 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 59' ' ' PHE . . . -104.42 149.1 25.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.532 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -97.74 140.19 32.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.64 175.59 44.42 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -91.42 10.03 29.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -1.123 . . . . 0.0 109.541 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.61 -32.58 70.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.466 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -116.77 156.88 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.507 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -88.51 152.53 21.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.407 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -112.51 149.97 31.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.441 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.461 ' HE1' ' HA2' ' A' ' 89' ' ' GLY . 87.4 mtp -99.21 138.95 35.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.514 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -111.12 144.81 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.925 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 77.9 m80 -127.04 134.64 50.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HB2' HD11 ' A' ' 87' ' ' ILE . 28.9 tttp -133.5 143.96 49.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG22 ' CG1' ' A' ' 75' ' ' ILE . 9.8 p -108.57 135.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.44 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 97.0 mt-10 -81.72 -43.49 18.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 92.5 mt-10 -158.84 142.37 15.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.606 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.555 HG12 ' CE2' ' A' ' 82' ' ' TYR . 77.5 mt -125.4 123.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 79' ' ' ASN . 25.9 t0 -125.69 91.72 3.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.623 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.437 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 87.8 m-70 -65.2 -41.09 94.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.504 ' O ' ' CE2' ' A' ' 80' ' ' PHE . . . -65.26 -40.43 93.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.436 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 56.3 t30 -79.33 -10.69 59.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' A' ' 78' ' ' ALA . 66.3 m-85 62.16 35.77 15.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.512 ' NZ ' ' OE1' ' A' ' 102' ' ' GLU . 73.0 tttt -128.87 122.53 30.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.294 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.555 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.4 t80 -117.66 116.7 27.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.441 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 51.1 t -117.64 123.66 46.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.209 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.499 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.2 p90 -140.31 167.35 22.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 47.3 t -137.06 169.84 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.421 HD11 HG23 ' A' ' 86' ' ' ILE . 10.6 mt -112.28 122.73 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 71' ' ' LYS . 73.9 mt -79.2 -38.39 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.301 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -139.81 135.46 33.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA2' ' HE1' ' A' ' 68' ' ' MET . . . -141.24 63.7 0.52 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 43.1 -100.97 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 93' ' ' GLY . 49.0 Cg_endo -70.07 -34.02 14.33 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.76 2.306 . . . . 0.0 111.864 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.77 -89.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.91 . . . . 0.0 109.479 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 178.19 -179.76 48.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -103.73 133.29 48.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -1.196 . . . . 0.0 109.523 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 59.47 22.99 11.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.699 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.416 HD23 ' CD1' ' A' ' 130' ' ' ILE . 49.0 mt -110.65 95.95 5.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.949 . . . . 0.0 109.296 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 123' ' ' HIS . 90.0 mt-10 -48.02 -49.71 30.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.619 -0.675 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 23.9 mttp -156.47 169.77 23.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.634 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 55.9 mt -144.66 115.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 42.7 t -116.33 153.33 32.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 110.058 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -125.22 133.49 52.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 108.994 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' OE1' ' NZ ' ' A' ' 81' ' ' LYS . 80.2 tt0 -111.94 136.9 50.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.813 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.01 127.87 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -126.27 130.92 51.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.3 mtt -115.18 130.77 57.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.884 . . . . 0.0 109.162 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.63 154.26 42.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.71 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -97.97 139.51 33.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 0.0 109.345 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . -116.25 116.78 39.43 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.0 -14.31 35.15 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.725 2.283 . . . . 0.0 111.802 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -57.3 -20.68 29.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.61 6.06 9.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 114' ' ' SER . . . -90.39 20.79 35.5 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.523 ' HA3' ' CG1' ' A' ' 13' ' ' VAL . . . 58.56 -80.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 112' ' ' GLY . 55.8 m -143.05 165.16 28.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -1.117 . . . . 0.0 109.418 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.443 HG13 ' HB2' ' A' ' 108' ' ' ALA . 76.7 mt -128.61 133.43 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 50.0 mt -113.56 135.52 53.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -129.75 141.57 50.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.2 mt -125.07 133.37 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 24.7 m -125.3 141.76 51.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 22.4 m -128.31 151.8 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.3 mttp -139.17 126.42 21.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE1' ' CG2' ' A' ' 99' ' ' ILE . 3.2 m-85 -121.21 112.74 19.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.388 -0.82 . . . . 0.0 109.536 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.57 ' CG ' HG23 ' A' ' 3' ' ' VAL . 50.1 m-70 -84.64 121.3 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.467 ' OG1' ' CA ' ' A' ' 127' ' ' ASN . 1.0 OUTLIER -100.93 151.74 21.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.028 -1.045 . . . . 0.0 109.986 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -56.91 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.9 57.97 0.6 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.467 ' CA ' ' OG1' ' A' ' 124' ' ' THR . 67.6 m-20 51.5 45.58 27.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.438 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -72.52 135.02 45.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.4 m -67.32 146.51 54.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.654 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.48 ' CD1' ' CD1' ' A' ' 4' ' ' PHE . 30.8 mt -111.28 130.37 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.69 139.76 55.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.191 -0.943 . . . . 0.0 109.609 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.0 mt-10 -67.8 -31.57 71.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.58 -41.89 95.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.97 -43.16 99.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 136' ' ' LYS . 42.4 pt -82.81 -31.87 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.345 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 58.6 tttm -56.24 -41.15 75.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.38 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.72 -45.42 74.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.392 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.69 -39.26 86.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -62.05 -42.15 98.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -1.139 . . . . 0.0 109.38 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -58.32 -43.71 88.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 109.325 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 145' ' ' LEU . . . -62.06 -40.19 94.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.7 84.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.463 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.65 -37.94 95.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 142' ' ' ALA . 3.6 mt -61.97 -40.9 97.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -1.133 . . . . 0.0 109.414 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.525 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.2 m-85 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.239 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.75 -37.73 87.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.94 -47.43 52.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.385 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.525 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 8.1 p -63.31 -47.18 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.494 ' N ' HG11 ' A' ' 149' ' ' VAL . 96.2 mt-10 -61.13 -42.69 98.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.28 76.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.561 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 54.8 t80 -61.15 -53.4 57.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 64.0 mt -57.62 -38.87 75.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 154' ' ' LEU . 7.1 mp -66.11 -47.14 75.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.18 -0.95 . . . . 0.0 109.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -55.06 -29.24 57.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.963 . . . . 0.0 109.277 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 49.18 66.18 6.06 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.561 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 50.1 Cg_endo -70.13 -1.75 9.31 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.579 2.186 . . . . 0.0 111.716 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -74.2 -28.36 61.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.35 149.94 46.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 109.418 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.446 ' O ' ' OXT' ' A' ' 161' ' ' CYS . 88.3 m-85 -63.34 -28.6 70.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.446 ' OXT' ' O ' ' A' ' 160' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.8 mmm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.274 0.559 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.04 9.9 59.09 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.595 HG23 ' CG ' ' A' ' 123' ' ' HIS . 17.9 t -123.25 134.98 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.166 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.643 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 96.5 m-85 -95.75 135.48 37.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -121.9 129.38 52.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 0.0 109.572 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.539 ' CZ ' ' CD1' ' A' ' 135' ' ' ILE . 97.9 m-85 -125.97 146.82 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.41 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.4 tt0 -116.78 137.38 52.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.585 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 67.7 t0 -115.25 130.38 56.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.342 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -105.06 131.16 52.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.728 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.02 125.56 22.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 109.069 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -112.77 135.09 53.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.814 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -160.25 152.3 20.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.156 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 13' ' ' VAL . 2.2 p -91.74 90.79 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 0.3 OUTLIER -139.45 149.4 60.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 108.837 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 45.5 Cg_endo -67.81 126.41 14.6 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.266 1.977 . . . . 0.0 111.182 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.2 Cg_endo -66.44 -29.76 44.85 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.754 2.303 . . . . 0.0 112.333 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.01 7.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.552 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -72.26 -47.24 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.724 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.525 ' O ' ' CB ' ' A' ' 23' ' ' PHE . 15.0 tp -59.29 -46.96 87.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.761 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.531 ' CZ ' ' HA ' ' A' ' 77' ' ' HIS . 61.5 t80 -56.04 -48.04 76.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 0.0 109.668 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 30.8 mttm -69.15 -55.73 9.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -64.49 -19.1 65.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 109.983 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 78.1 t80 -100.2 -51.44 3.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.055 -1.028 . . . . 0.0 110.07 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 54.4 t -85.22 -52.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -62.26 -42.95 99.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.811 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.9 m-20 -97.67 18.61 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.71 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.78 -34.19 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' A' ' 32' ' ' PRO . 85.1 m-20 -72.2 -27.22 62.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 20.5 m120 -105.76 -42.32 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.945 . . . . 0.0 109.752 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 15.8 tp -63.93 -32.15 73.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.746 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 39.5 mt -63.71 -57.34 19.73 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.085 -1.01 . . . . 0.0 109.408 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.5 Cg_endo -68.36 -42.3 5.64 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.604 2.202 . . . . 0.0 111.852 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -59.4 -41.3 89.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.58 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.436 HG21 HD12 ' A' ' 30' ' ' LEU . 91.4 t -67.67 -39.2 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 109.489 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.86 157.91 56.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.398 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.572 ' O ' ' CE1' ' A' ' 38' ' ' HIS . 50.8 Cg_endo -69.87 -11.03 29.89 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.737 2.291 . . . . 0.0 111.81 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -61.8 144.98 53.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.5 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 36' ' ' PRO . 74.6 m80 -129.76 159.89 35.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.86 . . . . 0.0 109.502 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' A' ' 38' ' ' HIS . 97.5 m-85 61.81 57.82 2.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 109.589 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.4 m -118.98 137.48 53.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.447 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.6 m -132.25 148.18 52.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.178 -0.951 . . . . 0.0 109.509 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.81 145.4 51.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -141.02 145.46 35.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.5 ' OD1' ' CD ' ' A' ' 55' ' ' LYS . 67.2 m-20 -82.33 112.55 19.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.3 tp -70.8 -35.48 72.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 85.9 tt0 -149.54 157.58 43.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.454 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.51 161.59 33.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -91.62 7.64 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.164 . . . . 0.0 109.479 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.03 18.75 11.69 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.463 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -115.24 -142.52 7.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.86 125.21 11.83 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.698 2.265 . . . . 0.0 111.74 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.37 -1.53 82.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 54' ' ' ILE . 67.5 m -72.64 141.11 48.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.517 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 24.8 mm -106.67 130.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.5 ' CD ' ' OD1' ' A' ' 44' ' ' ASN . 34.3 mmtp -102.35 147.86 26.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HE3' ' CD ' ' A' ' 66' ' ' LYS . 18.3 tttm -123.9 137.62 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.517 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.561 HG12 ' CE1' ' A' ' 70' ' ' HIS . 22.7 mm -105.92 136.55 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.4 p -124.36 149.6 46.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.396 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -155.41 -70.02 0.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.983 . . . . 0.0 109.595 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.53 -164.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.34 -0.85 . . . . 0.0 109.613 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -97.3 136.91 37.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.44 41.42 0.02 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -55.73 -29.15 59.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -1.12 . . . . 0.0 109.428 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -48.5 -35.65 13.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -127.22 162.93 25.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' CD ' ' HE3' ' A' ' 56' ' ' LYS . 15.3 mmtt -97.27 121.56 39.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.44 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.517 ' CD1' ' HG3' ' A' ' 68' ' ' MET . 58.9 t80 -63.19 -40.52 97.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 109.469 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.517 ' HG3' ' CD1' ' A' ' 67' ' ' TYR . 62.1 mtt -152.06 154.28 35.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.68 133.27 54.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.561 ' CE1' HG12 ' A' ' 57' ' ' ILE . 76.2 m80 -118.45 139.24 51.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.517 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 34.7 tttt -135.72 137.06 41.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 11.8 p -104.73 130.09 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.49 -41.49 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 84.8 tt0 -176.36 139.79 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.452 HD11 ' HA2' ' A' ' 50' ' ' GLY . 68.5 mt -116.52 124.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -131.82 73.34 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 64.8 m170 -56.35 -37.48 70.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.48 70.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -92.32 8.3 38.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.492 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 74.7 m-85 51.74 28.32 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 0.0 109.477 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -123.92 136.81 54.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 71.4 t80 -133.78 133.6 41.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.448 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.6 m -135.58 120.04 18.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.493 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.2 p90 -135.97 166.25 23.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 92.8 p -148.07 164.11 34.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.2 mm -116.1 120.1 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.2 mt -77.65 -36.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -146.38 132.78 19.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.533 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.438 ' O ' ' HD2' ' A' ' 91' ' ' PRO . . . -144.48 85.39 0.18 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.74 -103.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.3 Cg_endo -70.2 -34.7 12.63 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.624 2.216 . . . . 0.0 111.524 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.457 HD11 HG12 ' A' ' 99' ' ' ILE . 9.6 tp 63.16 -71.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 164.14 166.45 23.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -90.78 124.75 35.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -1.105 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 57.57 16.14 3.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.643 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 99' ' ' ILE . 32.4 mt -96.25 90.78 5.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.007 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 123' ' ' HIS . 79.6 mt-10 -47.05 -36.87 8.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.644 . . . . 0.0 110.529 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 15.4 tttt -164.68 156.99 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.75 -1.219 . . . . 0.0 110.356 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.592 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 6.3 mm -134.43 113.22 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.466 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 17.5 m -115.77 152.88 32.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.061 . . . . 0.0 110.087 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 119' ' ' THR . 84.3 m-85 -132.24 128.93 38.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 84.5 tt0 -104.89 139.82 39.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.841 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.81 122.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.113 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -130.24 136.33 49.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.967 . . . . 0.0 109.724 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.513 ' HE1' ' CD1' ' A' ' 23' ' ' PHE . 64.0 mtt -117.75 143.84 45.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -140.83 152.35 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 109.566 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.21 135.19 47.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.48 148.11 48.54 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.27 -31.09 23.42 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.666 2.244 . . . . 0.0 111.709 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -62.31 -28.32 69.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.51 -4.17 72.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -44.91 -49.25 9.21 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 175.3 -118.6 0.67 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -151.61 154.23 36.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -1.153 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.5 mt -118.24 133.04 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.33 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.9 mp -111.15 135.78 51.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.41 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 18.6 mttt -122.61 135.76 54.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.271 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -119.75 136.8 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 109.627 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 26.2 m -117.98 142.56 47.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.31 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 73.4 m -120.65 151.73 39.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 28.2 mttp -139.78 129.1 24.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.05 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.592 ' CE1' ' CG2' ' A' ' 99' ' ' ILE . 15.4 m-85 -129.34 110.63 12.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.823 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.595 ' CG ' HG23 ' A' ' 3' ' ' VAL . 49.1 m-70 -81.06 113.38 19.21 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.0 OUTLIER -105.71 139.37 40.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.362 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.41 ' CD ' HG21 ' A' ' 95' ' ' THR . 31.3 mttt -42.2 -47.93 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.421 -0.799 . . . . 0.0 109.631 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.42 -64.83 0.27 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.43 -30.34 71.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.0 148.24 48.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.471 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.5 m -132.43 150.36 52.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.643 ' CG1' ' CD1' ' A' ' 4' ' ' PHE . 22.4 mm -102.54 122.63 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -92.53 136.24 33.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.494 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 136' ' ' LYS . 84.8 tt0 -55.62 -41.28 73.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.411 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.63 -40.39 95.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.38 -46.4 86.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.456 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.562 ' CG2' ' CG2' ' A' ' 130' ' ' ILE . 11.5 pt -80.1 -33.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 132' ' ' GLU . 46.7 tttm -56.8 -33.9 67.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.855 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.55 74.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.325 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.09 92.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -56.98 -46.79 81.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.213 -1.169 . . . . 0.0 109.371 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.38 -46.1 87.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 145' ' ' LEU . 39.6 ttpt -58.87 -45.98 88.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.327 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.72 77.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . -60.16 -41.92 93.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.97 89.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.473 ' CD1' ' O ' ' A' ' 141' ' ' LYS . 6.6 mp -64.22 -38.37 90.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -1.13 . . . . 0.0 109.369 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.502 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.8 t80 -63.8 -44.52 93.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.384 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 143' ' ' ALA . 20.3 mmtt -62.41 -38.26 89.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.419 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.39 76.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.337 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 146' ' ' PHE . 4.7 p -65.23 -40.37 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.32 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.7 tt0 -60.22 -40.89 91.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.365 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.43 98.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.606 ' CZ ' ' CG ' ' A' ' 157' ' ' PRO . 54.6 t80 -62.28 -44.72 95.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.892 . . . . 0.0 109.343 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 25.8 tp -57.77 -38.76 76.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.4 mt -71.02 -43.17 68.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -56.72 -27.16 58.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.978 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.5 OUTLIER 43.49 55.97 11.99 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.529 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.606 ' CG ' ' CZ ' ' A' ' 152' ' ' TYR . 49.6 Cg_endo -70.35 -17.91 34.56 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.736 2.291 . . . . 0.0 111.813 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -93.7 11.06 30.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.57 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.23 143.83 57.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 0.0 109.416 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -125.58 136.54 53.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.442 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.276 0.56 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.03 -24.56 60.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.553 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 29.7 t -130.44 136.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -1.168 . . . . 0.0 109.417 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 93.6 m-85 -104.15 136.09 44.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.0 m -113.72 114.65 26.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 4' ' ' PHE . 33.1 m-85 -112.75 138.48 49.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 94.3 mt-10 -112.37 156.5 22.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.674 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -124.05 143.4 50.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.356 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -109.96 135.81 50.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.39 123.86 7.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.156 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.5 m -117.9 131.53 56.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -160.32 144.69 14.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.268 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.451 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 33.4 m -78.08 91.25 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.436 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.533 HG22 ' CD2' ' A' ' 19' ' ' LEU . 24.5 mt -139.0 144.29 40.58 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.443 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 45.4 Cg_endo -67.93 120.41 7.41 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.499 2.132 . . . . 0.0 111.368 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.0 -27.31 42.76 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.818 2.345 . . . . 0.0 112.263 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -54.34 6.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 22' ' ' SER . 62.8 mtt85 -72.15 -42.89 65.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.533 ' CD2' HG22 ' A' ' 14' ' ' ILE . 32.9 tp -59.98 -47.45 85.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.694 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 24' ' ' VAL . 47.1 t80 -59.23 -52.0 67.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' HA ' ' CB ' ' A' ' 25' ' ' LEU . 46.2 mttp -69.14 -29.36 67.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.773 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 83.5 p -84.16 -28.12 27.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.694 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' LEU . 84.7 t80 -100.76 -48.45 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.89 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 20' ' ' PHE . 54.7 t -84.42 -52.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.424 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.486 ' CB ' ' HA ' ' A' ' 21' ' ' LYS . 12.5 tp -74.95 -26.03 59.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 110.024 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' SER . 85.5 m-20 -113.74 27.11 9.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 109.585 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.68 -42.13 74.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HA ' HD12 ' A' ' 31' ' ' ILE . 56.0 t0 -62.63 -32.52 73.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -93.69 -31.38 14.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.857 . . . . 0.0 109.389 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 26' ' ' ASP . 15.9 tp -75.35 -25.8 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.517 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 12.3 mt -59.62 -56.53 34.89 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.45 -31.38 27.68 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.466 2.111 . . . . 0.0 111.661 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -59.13 -41.5 88.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.432 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.429 HG23 ' HA ' ' A' ' 149' ' ' VAL . 78.7 t -58.97 -39.53 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -123.62 82.54 53.97 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.173 -0.954 . . . . 0.0 109.592 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.67 -15.86 33.7 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.683 2.255 . . . . 0.0 111.752 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -59.94 -31.24 69.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.507 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -126.8 133.83 50.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.32 133.34 51.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.7 p -127.81 160.95 30.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.315 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 m -129.74 149.91 51.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.601 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.19 145.27 51.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -132.02 144.5 50.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.446 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 89.9 m-20 -88.29 112.1 22.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.519 HD12 ' CG2' ' A' ' 54' ' ' ILE . 2.0 mp -66.86 -37.79 85.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 82.4 tt0 -149.64 155.55 40.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.515 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 89.55 159.68 35.69 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -92.35 6.77 45.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.517 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' HA2' HG22 ' A' ' 53' ' ' THR . . . 107.25 18.44 10.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 75' ' ' ILE . . . -113.25 -145.97 9.49 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.4 Cg_endo -70.03 121.42 8.05 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.706 2.271 . . . . 0.0 111.725 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.69 67.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.457 HG22 ' HA2' ' A' ' 49' ' ' GLY . 52.4 m -79.47 135.07 36.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.18 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.519 ' CG2' HD12 ' A' ' 45' ' ' LEU . 19.4 mm -95.29 136.28 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.207 -0.933 . . . . 0.0 109.513 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 45.3 mttm -119.9 133.51 55.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . 30.5 tttm -107.36 142.1 37.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.503 HG12 ' ND1' ' A' ' 70' ' ' HIS . 26.3 mm -110.62 138.01 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.0 m -131.02 142.84 50.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.398 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -112.99 149.56 33.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.96 -33.18 72.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.195 -0.941 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.7 -30.77 69.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.441 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.37 -95.03 1.05 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 59.23 43.49 16.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -1.094 . . . . 0.0 109.501 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.459 ' O ' ' CZ ' ' A' ' 67' ' ' TYR . 86.7 tt0 -54.71 -37.56 65.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -49.47 -44.25 45.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -87.36 136.45 32.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.488 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CZ ' ' O ' ' A' ' 64' ' ' GLU . 87.1 m-85 -123.43 138.55 54.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.609 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.48 ' CE ' ' HA2' ' A' ' 89' ' ' GLY . 94.3 mmm -113.9 141.94 46.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 109.334 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.98 129.5 48.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.955 . . . . 0.0 109.677 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.503 ' ND1' HG12 ' A' ' 57' ' ' ILE . 80.8 m80 -128.32 126.67 41.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.359 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.466 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 18.0 tttm -123.6 145.42 48.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.45 HG13 ' CG1' ' A' ' 75' ' ' ILE . 46.9 t -90.39 129.58 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.499 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 83.9 tt0 -79.88 -37.46 34.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.492 ' N ' ' HB2' ' A' ' 83' ' ' CYS . 80.8 tt0 -179.12 144.31 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.534 HG12 ' CE1' ' A' ' 82' ' ' TYR . 27.5 mt -127.39 119.16 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' CG ' ' HB2' ' A' ' 79' ' ' ASN . 29.4 t0 -127.11 86.88 2.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -66.88 -32.31 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.84 81.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.428 ' HB2' ' CG ' ' A' ' 76' ' ' ASP . 1.4 m120 -96.04 2.25 53.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 59.07 22.33 10.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 109.454 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.445 ' HG2' ' HB2' ' A' ' 104' ' ' LYS . 33.9 mttt -110.97 130.46 55.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.534 ' CE1' HG12 ' A' ' 75' ' ' ILE . 25.8 t80 -125.13 129.14 49.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.952 . . . . 0.0 109.673 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.499 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 35.9 m -109.39 131.92 54.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.228 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -120.89 139.53 53.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.668 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 20.2 t -127.2 142.81 51.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 99' ' ' ILE . 24.1 mt -117.97 127.45 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.68 -36.66 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -154.65 130.75 10.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.461 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.48 ' HA2' ' CE ' ' A' ' 68' ' ' MET . . . -145.89 106.07 0.36 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 44.33 -119.3 2.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.8 Cg_endo -70.13 -25.08 27.25 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.644 2.229 . . . . 0.0 111.671 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 14.2 tp 62.39 -75.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.61 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 165.94 171.04 31.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -95.33 123.6 38.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -1.159 . . . . 0.0 109.53 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 124' ' ' THR . 1.4 m 64.08 11.25 6.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.488 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.463 HD21 ' CD1' ' A' ' 130' ' ' ILE . 93.9 mt -94.81 92.11 6.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.311 -0.868 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' HIS . 46.3 mt-10 -49.1 -40.27 31.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.751 -0.593 . . . . 0.0 110.963 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 95.0 mttt -158.12 156.57 31.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.585 HG21 ' CZ ' ' A' ' 122' ' ' TYR . 33.3 mm -133.18 113.0 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 29.7 t -113.68 150.08 33.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.575 ' CZ ' HG23 ' A' ' 99' ' ' ILE . 91.2 m-85 -129.08 130.69 46.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 85.1 tt0 -108.76 137.98 45.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.758 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.0 mt -124.12 124.54 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.299 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HE3' ' HD2' ' A' ' 117' ' ' LYS . 41.3 pttt -134.86 149.52 50.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.422 ' HG2' HD22 ' A' ' 116' ' ' LEU . 64.4 mtt -115.42 145.22 42.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.454 ' O ' ' OG ' ' A' ' 114' ' ' SER . . . -142.44 155.47 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.79 148.09 38.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' A' ' 115' ' ' ILE . . . -111.23 106.81 57.38 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.47 -48.19 0.84 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.709 2.273 . . . . 0.0 111.787 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -77.63 -47.3 19.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 109.517 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.58 -27.68 72.2 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.21 -28.17 6.97 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . -100.88 -133.64 8.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 106' ' ' ALA . 33.0 t -125.22 157.96 35.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.467 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.416 HG13 ' CB ' ' A' ' 108' ' ' ALA . 66.6 mt -117.03 136.99 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.422 HD22 ' HG2' ' A' ' 105' ' ' MET . 36.8 mt -106.24 136.2 46.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.649 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.457 ' HD2' ' HE3' ' A' ' 104' ' ' LYS . 77.1 mttt -130.66 144.58 51.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.122 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.5 mt -132.64 140.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 0.0 109.999 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 20.6 m -120.54 142.31 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' SER . 0.1 OUTLIER -118.98 146.62 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.499 ' CG ' HG13 ' A' ' 3' ' ' VAL . 37.3 ttpt -126.02 112.2 15.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 109.32 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.586 ' CB ' ' CD1' ' A' ' 130' ' ' ILE . 3.5 m-85 -109.74 108.51 18.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.553 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 4.9 t60 -83.79 121.79 27.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.3 p -113.08 143.93 43.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.991 -1.068 . . . . 0.0 109.765 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -70.19 153.33 43.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.59 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 47.59 -131.43 16.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -114.45 41.53 2.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.183 . . . . 0.0 109.385 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.05 150.08 48.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.448 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 96.6 p -114.65 155.48 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.586 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 58.3 mt -113.04 141.5 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -89.13 141.24 28.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.3 mt-10 -65.48 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.463 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 23.1 pt-20 -65.7 -41.74 92.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.457 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 133' ' ' GLU . 83.9 tt0 -61.3 -41.54 97.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 132' ' ' GLU . 47.8 pt -85.05 -29.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 34.0 tttt -55.76 -45.56 78.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.05 78.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.217 -0.927 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.99 -35.08 90.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.09 -44.16 95.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.29 -39.9 94.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.865 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -63.25 -41.05 99.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.939 . . . . 0.0 109.434 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.521 ' HB1' ' CE2' ' A' ' 146' ' ' PHE . . . -71.0 -36.67 72.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.446 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.61 95.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.42 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.45 -38.93 95.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 149' ' ' VAL . 25.1 tp -65.53 -41.2 93.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -1.154 . . . . 0.0 109.442 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.521 ' CE2' ' HB1' ' A' ' 142' ' ' ALA . 16.6 m-85 -65.13 -45.95 82.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -62.83 -37.57 87.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.67 -51.45 56.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.415 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -64.43 -47.53 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 154' ' ' LEU . 87.8 mt-10 -58.66 -38.84 79.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.4 -41.25 89.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.376 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -62.87 -38.59 91.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.09 -43.95 87.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.474 ' CD1' ' O ' ' A' ' 150' ' ' GLU . 6.6 mp -73.64 -40.83 63.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.23 -15.95 63.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.1 74.65 30.39 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.38 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.7 -4.11 13.99 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.707 2.271 . . . . 0.0 111.943 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -106.0 8.46 32.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.483 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.68 146.09 37.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.396 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.71 -38.09 86.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.414 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.419 179.983 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.59 87.33 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.578 HG23 ' CD2' ' A' ' 123' ' ' HIS . 7.2 p -120.19 138.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -1.077 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.575 ' CE2' HG12 ' A' ' 130' ' ' ILE . 96.4 m-85 -98.6 146.03 26.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 5' ' ' CYS . 25.7 p -132.09 128.13 37.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -122.21 151.99 40.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.437 ' HG2' HG21 ' A' ' 119' ' ' THR . 95.9 mt-10 -118.48 145.61 45.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -123.01 145.82 48.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -121.81 137.34 54.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.59 122.97 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.092 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.427 HG23 HG12 ' A' ' 115' ' ' ILE . 59.4 p -123.82 143.21 50.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.534 ' OG ' ' CD1' ' A' ' 14' ' ' ILE . 98.9 p -160.28 149.36 17.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 108.933 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 33.6 m -66.2 90.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.021 . . . . 0.0 109.341 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 5.5 mt -139.36 142.29 31.88 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.32 -0.862 . . . . 0.0 109.341 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.3 Cg_endo -67.92 122.33 9.44 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 122.356 2.037 . . . . 0.0 111.197 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.79 -34.02 32.36 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.702 2.268 . . . . 0.0 112.209 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.64 11.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.994 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -72.15 -37.94 69.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 110.126 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.534 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 32.0 tp -67.0 -51.06 59.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.929 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.575 ' CE2' ' HA ' ' A' ' 80' ' ' PHE . 67.7 t80 -56.25 -46.89 79.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 25.3 mttt -67.99 -49.56 60.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.139 -0.975 . . . . 0.0 109.879 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 88.7 p -71.49 -20.1 62.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.936 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 24.0 t80 -100.48 -51.12 3.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.16 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.562 HG23 ' CE2' ' A' ' 20' ' ' PHE . 54.9 t -85.11 -52.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -0.939 . . . . 0.0 110.128 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 0.7 OUTLIER -67.08 -49.3 65.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.0 m-20 -89.52 20.23 4.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -68.18 -50.63 53.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.062 -1.024 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -63.43 -32.07 73.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.955 . . . . 0.0 109.798 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.423 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 94.5 m-20 -88.91 -34.69 16.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.526 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.1 tp -74.89 -26.54 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.662 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 12.9 mt -56.02 -57.14 23.86 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.6 Cg_endo -68.38 -35.19 18.87 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.548 2.166 . . . . 0.0 111.672 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 21.7 mttm -62.7 -31.85 72.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.417 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 77.2 t -68.66 -33.47 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.494 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 34' ' ' VAL . . . 75.98 51.19 0.2 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.2 Cg_endo -70.13 152.14 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.718 2.279 . . . . 0.0 111.766 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -56.7 -35.72 68.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.372 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -122.52 176.18 6.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 109.352 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.456 ' CD1' HG22 ' A' ' 57' ' ' ILE . 67.9 m-85 55.17 53.07 10.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.393 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.0 m -63.46 -41.85 98.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 82.3 p -151.9 155.37 37.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.572 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.58 148.12 32.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.925 . . . . 0.0 109.446 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 56' ' ' LYS . 93.6 mt-10 -134.21 157.05 47.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 35.7 p-10 -87.96 112.11 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.466 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.1 tp -73.64 -36.24 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 85.9 tt0 -143.1 154.96 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 91.12 159.26 35.47 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.9 8.26 38.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.49 20.39 13.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.446 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -117.67 -145.39 7.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.42 125.31 12.16 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.89 -1.51 80.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.461 HG21 ' HA2' ' A' ' 49' ' ' GLY . 96.2 m -73.59 139.98 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 109.471 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.485 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.8 mm -103.39 134.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 4.0 mtmp? -110.45 156.53 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' GLU . 52.5 tttt -130.91 128.66 40.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 109.353 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.459 HG13 ' CD2' ' A' ' 70' ' ' HIS . 70.5 mt -111.87 137.5 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.527 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.2 m -119.16 141.63 48.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -112.21 149.48 32.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 109.513 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.41 -26.21 68.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.496 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.33 163.21 13.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.453 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.63 -170.78 37.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.415 ' OD1' ' HB3' ' A' ' 65' ' ' PHE . 52.6 p-10 -141.52 -176.8 4.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 109.414 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -62.54 -29.49 70.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.15 -0.969 . . . . 0.0 109.393 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.574 ' O ' ' CE1' ' A' ' 67' ' ' TYR . 62.7 t80 -46.97 -47.51 21.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 109.349 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -69.47 132.41 46.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.93 . . . . 0.0 109.439 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 65' ' ' PHE . 88.4 m-85 -125.63 135.43 52.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.58 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.8 mtp -116.12 152.79 32.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.402 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -134.65 129.01 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.459 ' CD2' HG13 ' A' ' 57' ' ' ILE . 93.9 m-70 -127.34 129.12 47.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.401 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.485 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 14.9 tttp -127.5 146.01 50.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 50' ' ' GLY . 14.8 p -108.43 138.72 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -75.71 -44.16 43.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -173.59 143.49 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 75' ' ' ILE . 70.4 mt -119.36 118.68 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.9 m-20 -125.04 78.36 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 98.1 m-70 -59.18 -34.62 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.63 66.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 80.7 m-20 -94.27 9.49 37.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.575 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 68.5 m-85 48.34 36.36 6.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -131.29 129.72 41.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.955 . . . . 0.0 109.346 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.487 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 61.3 t80 -126.12 122.81 36.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.989 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.6 117.77 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.487 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 35.1 p90 -134.84 167.25 21.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.6 p -145.99 175.23 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.337 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 mt -129.34 126.44 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.451 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.8 mt -78.81 -42.66 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -143.48 137.12 28.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -162.68 105.4 0.26 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 44.69 -130.74 7.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 51.3 Cg_endo -69.9 -22.36 31.57 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.615 2.21 . . . . 0.0 111.804 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 0.3 OUTLIER 70.35 -81.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.86 -160.77 17.67 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -110.74 115.23 29.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -1.145 . . . . 0.0 109.465 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 58.17 16.65 4.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.535 ' CD2' HD13 ' A' ' 130' ' ' ILE . 28.0 mt -96.94 90.49 5.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.315 -0.865 . . . . 0.0 109.509 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 123' ' ' HIS . 89.8 mt-10 -43.59 -37.97 2.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.599 -0.688 . . . . 0.0 110.523 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' O ' HD11 ' A' ' 99' ' ' ILE . 68.2 mttm -145.67 158.06 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.818 -1.176 . . . . 0.0 110.466 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.561 HG21 ' CD1' ' A' ' 122' ' ' TYR . 20.5 mm -135.21 119.29 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -122.52 154.55 37.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 0.0 109.808 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.429 ' OH ' HG23 ' A' ' 99' ' ' ILE . 72.1 m-85 -132.99 137.46 46.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 119' ' ' THR . 80.0 tt0 -113.47 141.83 46.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.494 HD11 HG21 ' A' ' 103' ' ' ILE . 61.3 mt -128.79 118.7 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.302 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -131.53 126.39 34.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.483 ' CE ' ' HA ' ' A' ' 20' ' ' PHE . 75.9 mtm -120.21 150.95 39.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.05 150.82 26.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 138.43 53.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.18 146.04 86.52 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.85 -30.6 21.58 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.621 2.214 . . . . 0.0 111.961 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -128.72 138.04 51.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.65 -23.52 34.92 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.46 33.15 61.43 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . -102.59 -133.14 7.92 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 32.2 t -151.73 149.65 29.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -1.179 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.427 HG12 HG23 ' A' ' 11' ' ' THR . 64.5 mt -111.77 133.98 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 6.6 mp -106.37 130.9 54.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.731 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.6 tttm -124.62 135.71 53.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.115 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 69.4 mt -129.04 123.55 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.838 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 102' ' ' GLU . 46.8 m -122.52 131.24 53.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.375 -0.828 . . . . 0.0 109.032 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.469 ' CB ' ' OH ' ' A' ' 122' ' ' TYR . 1.8 m -114.34 160.76 18.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 109.969 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 44.8 mttp -143.08 123.9 14.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.561 ' CD1' HG21 ' A' ' 99' ' ' ILE . 5.6 m-85 -122.34 122.76 39.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.578 ' CD2' HG23 ' A' ' 3' ' ' VAL . 9.6 m-70 -85.31 113.9 21.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 108.82 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.509 HG21 ' CD1' ' A' ' 130' ' ' ILE . 1.3 p -94.42 148.39 22.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.679 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.444 ' HG2' ' OE2' ' A' ' 97' ' ' GLU . 32.8 mttm -67.27 145.3 55.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.02 -129.63 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -110.32 31.16 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.556 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.87 144.82 26.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 83.9 p -95.61 171.63 8.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.575 HG12 ' CE2' ' A' ' 4' ' ' PHE . 38.5 mm -118.72 121.89 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -59.18 119.69 7.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.477 ' HA ' HG13 ' A' ' 135' ' ' ILE . 97.0 mt-10 -54.27 -36.73 63.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.3 -35.95 82.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.215 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.44 -25.93 67.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.639 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.477 HG13 ' HA ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -87.9 -35.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.208 -0.932 . . . . 0.0 109.049 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -57.45 -44.27 84.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.688 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.83 -43.24 72.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.452 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.86 92.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -57.99 -47.11 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -1.087 . . . . 0.0 109.343 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.43 -40.11 93.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -58.56 -45.45 88.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -38.64 85.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.86 99.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.26 -45.98 92.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.01 -38.39 79.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -1.197 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.461 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 70.2 t80 -61.65 -41.57 97.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -60.42 -40.06 89.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.328 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.12 80.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 150' ' ' GLU . 5.7 p -67.32 -39.98 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.49 ' N ' HG11 ' A' ' 149' ' ' VAL . 85.2 tt0 -63.73 -38.61 91.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.73 97.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.351 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.57 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 71.1 t80 -59.55 -48.89 79.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.454 HD11 HD11 ' A' ' 19' ' ' LEU . 18.3 mt -61.68 -38.8 89.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 109.38 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.6 tp -63.76 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.67 68.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.548 ' CD2' ' OD2' ' A' ' 158' ' ' ASP . 6.7 t60 49.74 61.6 13.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.883 . . . . 0.0 109.415 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.57 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 49.8 Cg_endo -69.69 -13.79 35.36 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.712 2.275 . . . . 0.0 111.736 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.548 ' OD2' ' CD2' ' A' ' 156' ' ' HIS . 55.6 p30 -88.84 12.46 15.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.396 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.76 147.37 53.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -62.71 -33.92 76.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.516 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.248 0.546 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.442 ' O ' HG21 ' A' ' 124' ' ' THR . . . -133.2 167.4 23.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.549 HG22 ' CE1' ' A' ' 123' ' ' HIS . 38.6 t -125.21 132.68 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.17 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.578 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 97.3 m-85 -95.44 130.52 42.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.181 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 t -110.59 125.04 52.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.474 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 93.7 m-85 -125.41 144.51 50.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.315 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 91.5 mt-10 -125.15 160.98 27.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.737 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 60.4 t0 -134.42 142.45 47.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.162 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.33 138.89 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.903 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.69 121.56 8.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.151 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.9 m -112.5 133.07 54.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.004 . . . . 0.0 109.971 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 14' ' ' ILE . 4.8 t -160.41 139.59 10.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.786 . . . . 0.0 109.026 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.511 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 28.2 m -68.59 91.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.04 . . . . 0.0 109.36 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.6 mt -138.89 143.84 39.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.216 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.3 Cg_endo -68.24 127.86 16.53 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.409 2.073 . . . . 0.0 111.259 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.88 -34.64 29.57 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.723 2.282 . . . . 0.0 112.199 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.12 -50.96 11.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.634 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.445 ' HB3' ' SG ' ' A' ' 161' ' ' CYS . 42.0 mtt-85 -70.42 -45.98 64.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.853 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.528 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 40.5 tp -59.91 -48.44 81.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.538 ' CE2' ' HA ' ' A' ' 80' ' ' PHE . 65.9 t80 -52.41 -51.77 57.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.592 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 33.3 mttt -67.45 -57.57 6.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.881 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 46.6 m -62.03 -20.43 63.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CD1' ' CE ' ' A' ' 105' ' ' MET . 56.3 t80 -100.11 -51.27 3.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.993 -1.067 . . . . 0.0 110.095 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 51.7 t -84.93 -51.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 17.8 tp -66.42 -40.48 89.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.835 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.6 m-20 -99.8 20.44 14.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.722 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.63 -34.55 74.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 32' ' ' PRO . 89.3 m-20 -68.17 -32.38 72.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.857 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 89.3 m-20 -101.6 -42.07 6.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.129 -0.982 . . . . 0.0 109.76 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 17.6 tp -56.3 -36.8 69.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.753 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.493 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 17.8 mt -63.65 -58.84 13.48 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.492 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.26 -30.22 31.08 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.539 2.159 . . . . 0.0 111.777 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.52 -37.77 87.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.516 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -61.23 -46.55 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 32' ' ' PRO . . . -142.41 158.9 59.74 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.552 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.5 142.97 45.95 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.756 2.304 . . . . 0.0 111.8 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.423 ' NE2' HG23 ' A' ' 31' ' ' ILE . 93.5 mt-30 -116.15 154.66 29.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.4 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -56.13 -36.13 67.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.558 ' CD2' HG23 ' A' ' 57' ' ' ILE . 80.5 m-85 -84.75 141.88 30.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.868 . . . . 0.0 109.471 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 81.4 m -68.38 -42.26 79.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.385 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.458 ' O ' ' OG1' ' A' ' 58' ' ' THR . 2.7 p -162.92 166.01 24.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.416 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.2 155.54 24.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.496 ' HG3' ' CG2' ' A' ' 58' ' ' THR . 98.2 mt-10 -125.81 165.26 19.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 109.38 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' ILE . 50.9 t30 -91.33 115.29 27.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.489 ' CD2' HG21 ' A' ' 54' ' ' ILE . 16.6 tp -63.87 -40.26 96.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.167 -0.958 . . . . 0.0 109.422 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 47' ' ' GLY . 53.1 tt0 -170.95 162.4 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.425 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' N ' ' CG ' ' A' ' 46' ' ' GLU . . . 94.74 162.54 34.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -95.03 6.16 49.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.573 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.6 19.28 11.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.52 ' HA2' ' CD1' ' A' ' 75' ' ' ILE . . . -117.4 -145.72 8.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.57 125.49 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.722 2.282 . . . . 0.0 111.826 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.55 -1.83 79.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.485 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 31.9 m -73.68 137.22 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -1.18 . . . . 0.0 109.452 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.492 HG22 HD11 ' A' ' 54' ' ' ILE . 4.7 mt -109.78 139.0 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.517 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' N ' HG23 ' A' ' 54' ' ' ILE . 68.6 mttm -112.01 149.07 32.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 45' ' ' LEU . 22.7 tttt -132.95 147.24 52.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.378 -0.827 . . . . 0.0 109.33 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.558 HG23 ' CD2' ' A' ' 39' ' ' PHE . 41.4 mt -97.61 137.63 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.46 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.496 ' CG2' ' HG3' ' A' ' 43' ' ' GLU . 33.8 p -75.37 150.64 38.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.57 165.79 13.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' GLU . . . -140.57 141.49 35.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.433 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 60' ' ' ALA . 94.5 mt-10 60.75 123.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 63' ' ' ASN . . . 62.05 -95.48 0.11 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 7.8 m-20 68.35 12.69 8.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -1.15 . . . . 0.0 109.498 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' O ' ' OH ' ' A' ' 67' ' ' TYR . 77.0 mm-40 -72.63 -30.91 64.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.93 . . . . 0.0 109.449 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -127.21 -177.15 3.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.87 . . . . 0.0 109.468 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 mttt 64.14 74.57 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.905 . . . . 0.0 109.474 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.433 ' OH ' ' O ' ' A' ' 64' ' ' GLU . 90.1 m-85 -108.78 147.18 32.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.465 ' CE ' ' HA2' ' A' ' 89' ' ' GLY . 81.0 mmm -119.69 147.55 44.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.393 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.461 ' CB ' ' HB ' ' A' ' 87' ' ' ILE . 80.1 mttt -134.25 131.71 38.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.399 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 79.6 m80 -125.99 140.54 52.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.955 . . . . 0.0 109.612 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -138.24 140.75 39.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 109.362 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 50.1 t -100.77 138.57 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.5 tt0 -84.07 -56.85 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.384 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.4 mt-10 -158.78 141.64 14.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.454 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.561 HG22 ' CD2' ' A' ' 77' ' ' HIS . 74.0 mt -118.87 128.61 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 85.7 m-20 -128.79 81.25 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.561 ' CD2' HG22 ' A' ' 75' ' ' ILE . 81.8 m-70 -58.93 -36.5 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.93 74.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -85.53 6.96 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.538 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 92.0 m-85 49.44 33.0 5.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -127.82 139.72 52.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 67.1 t80 -126.46 131.4 51.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.45 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.7 m -128.39 117.05 20.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.439 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.6 p90 -139.84 157.47 45.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.483 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 83.9 p -137.71 174.17 10.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.6 mt -124.62 128.21 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.397 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.461 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 72.9 mt -74.86 -37.61 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.867 . . . . 0.0 109.593 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -143.44 131.04 21.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.555 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.465 ' HA2' ' CE ' ' A' ' 68' ' ' MET . . . -137.42 75.19 0.39 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 44.45 -111.28 0.47 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.5 Cg_endo -69.59 -31.91 20.32 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.745 2.296 . . . . 0.0 111.696 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.519 ' CD2' HG12 ' A' ' 99' ' ' ILE . 0.4 OUTLIER 61.7 -85.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -174.82 -166.85 33.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -104.13 126.15 51.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -1.147 . . . . 0.0 109.491 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.447 HG22 ' CB ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 52.76 20.74 1.67 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' A' ' 122' ' ' TYR . 22.3 mt -94.7 90.49 6.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.3 mt-10 -46.24 -40.19 11.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.591 -0.693 . . . . 0.0 110.595 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 99' ' ' ILE . 55.7 tttp -155.88 154.39 31.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.634 -1.291 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.549 HG22 ' CE1' ' A' ' 122' ' ' TYR . 24.1 mm -129.41 118.51 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 120' ' ' SER . 44.8 m -119.52 148.13 43.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 109.945 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -125.55 140.82 52.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.162 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 119' ' ' THR . 84.5 tt0 -124.4 132.86 53.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.696 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.04 126.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.273 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -130.62 133.22 45.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.724 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.549 ' CE ' ' CD1' ' A' ' 23' ' ' PHE . 64.2 mtt -117.55 146.83 43.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.315 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.87 157.76 44.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.3 136.99 34.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.69 168.66 20.32 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.422 ' O ' ' N ' ' A' ' 111' ' ' GLY . 49.5 Cg_endo -69.4 144.27 55.41 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 122.644 2.229 . . . . 0.0 111.826 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 57.69 -89.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 109' ' ' PRO . . . -155.47 22.48 0.56 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -47.86 -45.28 25.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 153.69 -116.1 0.71 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 22.5 t -155.13 145.38 21.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.475 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.9 mt -116.12 128.7 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 5.1 mp -108.44 135.67 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 68.1 mttm -126.6 135.34 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 77.0 mt -119.61 131.08 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 30.8 m -119.85 142.69 48.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 100' ' ' SER . 1.4 m -128.02 156.62 42.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.826 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -133.59 108.99 8.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.838 . . . . 0.0 108.973 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.549 ' CE1' HG22 ' A' ' 99' ' ' ILE . 8.4 m-30 -105.27 118.91 37.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.549 ' CE1' HG22 ' A' ' 3' ' ' VAL . 2.1 m-70 -84.94 134.13 34.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 108.912 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 128' ' ' ALA . 12.8 t -113.56 144.82 42.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 126' ' ' GLY . 22.9 mttp -72.09 139.77 48.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.51 -142.35 3.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' ALA . 73.0 m-20 -85.9 10.67 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.461 ' HB2' ' OG1' ' A' ' 124' ' ' THR . . . -44.12 146.96 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -115.88 161.89 18.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.571 ' CD1' ' CD2' ' A' ' 4' ' ' PHE . 55.8 mt -104.06 139.08 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.46 118.45 7.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.565 ' HA ' HG13 ' A' ' 135' ' ' ILE . 88.1 tt0 -57.72 -34.57 69.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.46 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -56.33 -42.39 77.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.91 -25.09 67.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.565 HG13 ' HA ' ' A' ' 132' ' ' GLU . 2.9 mt -69.49 -52.34 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 108.947 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -55.65 -41.34 73.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.43 86.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.238 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.2 -36.09 80.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.51 -40.27 95.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -1.177 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.39 -35.23 79.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -63.3 -39.72 95.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 109.567 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.6 76.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.909 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.84 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.595 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.31 -48.2 76.83 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 149' ' ' VAL . 64.7 mt -68.26 -37.92 81.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -1.188 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.434 ' O ' HG12 ' A' ' 149' ' ' VAL . 71.0 t80 -63.5 -45.72 89.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.569 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -63.05 -37.77 88.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.2 38.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.606 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 146' ' ' PHE . 7.5 p -66.13 -40.04 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.97 -39.16 91.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.554 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -65.89 -41.79 91.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.491 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.9 tp -61.53 -38.0 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.14 -0.975 . . . . 0.0 109.374 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 33.8 mt -77.98 -30.89 50.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.08 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.38 67.48 80.32 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.69 -2.77 11.38 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.705 2.27 . . . . 0.0 111.834 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -104.66 9.83 35.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.554 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -46.05 145.41 1.56 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.424 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -62.16 -34.38 76.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 18' ' ' ARG . 1.4 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 124' ' ' THR . . . 68.95 -127.65 22.26 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.602 HG22 ' CG ' ' A' ' 123' ' ' HIS . 52.4 t -126.85 135.5 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.149 . . . . 0.0 109.471 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.584 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 97.9 m-85 -91.71 128.25 37.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.364 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.8 t -113.56 123.86 50.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.63 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' A' ' 4' ' ' PHE . 92.4 m-85 -122.86 146.09 47.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 83.9 tt0 -121.94 131.39 53.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.947 . . . . 0.0 109.645 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.88 124.87 45.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -97.07 134.63 40.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.89 124.81 8.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.8 m -118.39 132.49 56.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -160.51 135.47 7.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.137 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.505 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 24.1 m -64.99 91.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.071 -1.018 . . . . 0.0 109.355 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.524 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 20.0 mt -138.86 144.65 42.39 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.48 119.54 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.563 2.176 . . . . 0.0 111.265 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.4 Cg_endo -66.78 -34.83 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.764 2.31 . . . . 0.0 112.264 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.74 14.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -72.2 -40.96 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 22.3 tp -66.39 -36.71 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.111 -0.993 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.565 ' CE1' ' HA ' ' A' ' 80' ' ' PHE . 56.3 t80 -63.79 -50.48 68.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASP . 29.6 mttt -69.26 -48.07 62.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.466 ' O ' HD22 ' A' ' 30' ' ' LEU . 19.2 m -65.62 -23.48 66.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.895 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.519 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 56.7 t80 -100.54 -51.08 3.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 110.139 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 20' ' ' PHE . 55.9 t -84.83 -52.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 22.2 tp -68.07 -29.44 68.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.864 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.8 m-20 -110.38 20.09 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.114 -0.991 . . . . 0.0 109.565 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -67.96 -34.79 77.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.583 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 90.8 m-20 -66.68 -42.17 86.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.828 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -90.02 -34.07 16.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.718 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.528 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 23.2 tp -66.76 -32.82 74.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 31.9 mt -59.68 -57.62 25.49 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.413 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.7 Cg_endo -68.5 -34.68 19.47 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.618 2.212 . . . . 0.0 111.65 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -59.53 -43.93 93.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.547 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.4 t -60.28 -42.31 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.5 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.68 126.63 82.3 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.942 . . . . 0.0 109.507 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 37' ' ' GLN . 50.1 Cg_endo -70.09 147.93 61.84 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.701 2.267 . . . . 0.0 111.806 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 36' ' ' PRO . 94.8 mt-30 43.73 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.935 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 59.26 76.15 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -82.71 138.12 34.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.6 p -117.53 169.04 9.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 109.384 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 61' ' ' GLU . 11.6 t -130.97 144.18 51.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.609 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 56' ' ' LYS . . . -131.26 145.19 51.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 109.332 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 95.5 mt-10 -143.19 151.51 40.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.459 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.9 m-20 -89.04 111.5 22.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.458 ' HB3' HG23 ' A' ' 54' ' ' ILE . 31.4 tp -77.3 -33.74 55.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 53' ' ' THR . 86.5 tt0 -150.9 155.55 39.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.432 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 76.04 157.8 7.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -81.81 -19.96 40.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -1.127 . . . . 0.0 109.449 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.525 ' HA2' ' CG2' ' A' ' 53' ' ' THR . . . 143.07 -12.6 2.34 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -78.55 -148.12 3.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.0 126.0 13.25 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.858 2.372 . . . . 0.0 111.847 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.09 -6.53 66.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.525 ' CG2' ' HA2' ' A' ' 49' ' ' GLY . 53.7 m -74.22 139.48 44.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.079 -1.248 . . . . 0.0 109.537 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.502 HG22 ' N ' ' A' ' 55' ' ' LYS . 7.3 mt -110.6 139.43 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' N ' HG22 ' A' ' 54' ' ' ILE . 64.9 mttt -130.27 138.44 50.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 109.519 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 17.4 mtmt -112.92 136.46 52.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.322 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -112.37 132.27 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 62.3 p -141.17 149.29 41.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.897 . . . . 0.0 109.341 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -62.6 -44.82 95.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.337 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.33 154.33 35.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.447 ' O ' ' OG ' ' A' ' 41' ' ' SER . 75.7 mm-40 -59.68 -31.72 69.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.1 -178.33 37.5 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 44.1 p-10 -101.71 56.1 0.82 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -1.156 . . . . 0.0 109.504 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.83 -26.01 66.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -103.75 126.97 51.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.292 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.454 ' HG2' ' HE2' ' A' ' 69' ' ' LYS . 24.3 tttt -119.26 14.84 13.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 0.0 109.601 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -69.33 -31.04 69.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.247 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.9 mtp -96.81 134.94 39.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 0.0 109.135 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HE2' ' HG2' ' A' ' 66' ' ' LYS . 89.7 mttt -137.14 133.99 35.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 98.7 m-70 -122.4 131.43 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.2 tttm -128.72 127.66 42.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.502 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.504 ' CG2' HD11 ' A' ' 75' ' ' ILE . 2.3 p -84.0 134.22 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 23.4 mt-10 -82.41 -44.76 15.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.857 . . . . 0.0 109.431 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.3 mt-10 -159.23 150.98 20.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.572 HG12 ' CE2' ' A' ' 82' ' ' TYR . 3.2 mt -135.54 107.12 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 79' ' ' ASN . 31.1 t0 -123.21 90.92 3.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.562 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.8 m170 -70.4 -32.78 70.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.58 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.59 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.447 ' OD1' ' OD1' ' A' ' 76' ' ' ASP . 12.4 m120 -84.34 8.25 16.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.565 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 75.6 m-85 54.72 25.36 6.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.378 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.451 ' HE2' ' OE2' ' A' ' 102' ' ' GLU . 63.6 tttt -108.78 122.21 46.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 109.232 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 84' ' ' TYR . 7.4 t80 -128.75 129.82 46.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 109.695 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.446 ' HA ' ' HG3' ' A' ' 102' ' ' GLU . 1.8 t -109.55 123.63 49.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.013 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.608 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -121.14 138.62 54.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.121 -0.987 . . . . 0.0 109.966 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.476 ' HB3' ' NZ ' ' A' ' 98' ' ' LYS . 48.8 m -137.45 158.71 43.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.054 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 mt -127.65 128.1 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.653 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.472 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 89.1 mt -86.01 -39.16 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.451 ' HA ' HD13 ' A' ' 92' ' ' LEU . 98.1 mt-10 -144.55 143.35 30.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -156.23 93.88 0.14 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 43.93 -126.54 5.95 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.6 Cg_endo -69.59 -22.85 32.27 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.694 2.263 . . . . 0.0 111.637 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER 62.37 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.514 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 179.4 -171.88 43.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' C ' ' OG1' ' A' ' 95' ' ' THR . 81.8 t60 -106.63 128.81 54.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -1.2 . . . . 0.0 109.541 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.49 HG21 ' CB ' ' A' ' 128' ' ' ALA . 0.1 OUTLIER 61.36 13.34 4.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.61 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.529 HD22 ' CD1' ' A' ' 130' ' ' ILE . 32.3 mt -94.87 90.23 5.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' HIS . 86.7 mt-10 -47.19 -42.67 20.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.598 -0.689 . . . . 0.0 110.509 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 99' ' ' ILE . 19.7 tttm -158.96 162.49 36.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.713 -1.242 . . . . 0.0 110.522 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.573 HG22 ' CD1' ' A' ' 122' ' ' TYR . 7.2 mm -136.15 126.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.458 ' OG ' ' OG ' ' A' ' 85' ' ' SER . 23.3 t -132.79 155.8 48.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.112 -0.992 . . . . 0.0 109.996 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.57 ' CZ ' HG23 ' A' ' 99' ' ' ILE . 57.1 m-85 -137.86 129.72 28.56 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.451 ' OE2' ' HE2' ' A' ' 81' ' ' LYS . 83.6 tt0 -106.83 129.09 54.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.807 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -108.32 118.53 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -129.53 143.77 50.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.532 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.451 ' HE2' ' HA ' ' A' ' 20' ' ' PHE . 59.8 mtt -118.81 147.82 43.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.95 163.81 33.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.62 32.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.855 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.42 ' HB3' HD12 ' A' ' 115' ' ' ILE . . . -109.37 112.77 59.03 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.481 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.98 -51.03 0.39 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.717 2.278 . . . . 0.0 111.807 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -68.82 -48.32 63.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.14 -30.23 75.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.82 30.14 52.9 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . -151.86 -135.65 2.31 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 t -135.55 148.77 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -1.159 . . . . 0.0 109.479 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 108' ' ' ALA . 64.7 mt -113.86 134.25 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 24.1 mt -106.66 139.24 41.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 109.569 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -135.34 136.45 41.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.376 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.9 mt -125.02 135.23 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 101' ' ' TYR . 25.3 m -116.16 141.9 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.912 . . . . 0.0 109.442 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 67.8 m -124.48 153.15 42.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -137.28 129.08 28.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.573 ' CD1' HG22 ' A' ' 99' ' ' ILE . 51.4 m-85 -125.77 108.72 11.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.745 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.602 ' CG ' HG22 ' A' ' 3' ' ' VAL . 52.6 m-70 -79.88 130.89 35.67 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' THR . 8.8 t -116.17 147.87 40.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.067 -1.02 . . . . 0.0 109.731 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 124' ' ' THR . 18.2 tttt -42.09 -40.96 2.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.646 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.85 0.52 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -86.41 10.72 14.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -1.171 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.49 ' CB ' HG21 ' A' ' 95' ' ' THR . . . -110.36 151.09 27.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -132.25 149.33 52.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.546 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 29.5 mt -98.56 121.39 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.527 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -54.69 138.86 40.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.481 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.2 mt-10 -66.3 -33.22 75.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 109.502 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -59.04 -33.58 70.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.304 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -65.73 -29.52 70.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.268 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.565 HG13 ' CZ ' ' A' ' 6' ' ' TYR . 1.8 mm -69.83 -48.51 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 108.749 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -55.59 -41.55 73.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.193 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.45 75.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.35 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.11 -34.81 58.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.3 -38.14 87.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.294 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.29 -43.74 96.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.282 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -60.2 -42.76 95.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.922 . . . . 0.0 109.428 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.49 82.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.75 89.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.46 -48.47 83.92 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 149' ' ' VAL . 25.2 tp -64.85 -38.85 92.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.16 . . . . 0.0 109.405 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.507 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 68.5 t80 -60.33 -41.31 93.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.291 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.29 66.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.404 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.507 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.9 p -64.2 -44.29 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.494 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.4 tt0 -54.33 -43.57 71.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.85 99.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.567 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 68.5 t80 -60.55 -47.29 86.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.467 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.42 ' HA ' HD11 ' A' ' 153' ' ' LEU . 30.1 tp -61.68 -36.99 82.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.434 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.24 -46.33 87.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.04 -32.08 70.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 m170 50.24 64.89 7.62 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.567 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 49.4 Cg_endo -69.72 -8.39 23.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.648 2.232 . . . . 0.0 111.776 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -68.16 -30.34 69.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.52 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -107.46 144.52 34.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -60.66 -30.58 69.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.546 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 125' ' ' LYS . 87.4 mtp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.255 0.55 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.98 168.68 23.21 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.629 ' CG2' ' CD2' ' A' ' 123' ' ' HIS . 7.7 p -131.52 136.49 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.557 ' CE2' HG12 ' A' ' 130' ' ' ILE . 87.3 m-85 -95.92 144.38 26.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.409 ' SG ' ' HE3' ' A' ' 121' ' ' LYS . 4.0 m -125.26 119.75 29.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.637 ' CE1' ' CD1' ' A' ' 135' ' ' ILE . 29.3 m-85 -110.75 148.41 32.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.416 ' HG2' HG23 ' A' ' 119' ' ' THR . 96.9 mt-10 -121.53 151.97 39.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -131.8 138.94 48.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -108.98 132.47 54.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.645 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -148.89 125.63 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -114.38 135.56 53.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.84 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -160.36 141.33 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 13' ' ' VAL . 2.3 p -77.1 91.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 0.0 109.37 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.9 mt -138.77 142.62 34.59 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 48.4 Cg_endo -68.96 123.02 9.93 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.578 2.185 . . . . 0.0 111.47 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.78 -30.06 41.54 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.774 2.316 . . . . 0.0 112.278 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.38 6.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.597 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -72.55 -47.48 47.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.811 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 3.0 tm? -53.11 -37.17 61.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.84 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 24' ' ' VAL . 53.8 t80 -71.74 -54.93 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 0.0 109.784 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG3' ' CD1' ' A' ' 25' ' ' LEU . 17.5 tttm -67.67 -30.41 69.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.803 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 36.4 m -81.81 -30.53 32.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.945 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.534 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 88.0 t80 -100.84 -44.22 5.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 110.44 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.06 -52.98 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.964 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' CD1' ' HG3' ' A' ' 21' ' ' LYS . 45.0 mt -70.66 -28.68 64.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.937 -1.102 . . . . 0.0 110.037 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 22' ' ' SER . 87.5 m-20 -108.96 19.84 19.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.049 -1.032 . . . . 0.0 109.657 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.96 -52.24 26.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.992 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 71.3 m-20 -62.54 -32.48 73.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.35 -41.62 18.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.001 . . . . 0.0 109.968 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 26' ' ' ASP . 45.2 mt -72.46 -34.15 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.522 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 18.8 mt -48.08 -61.08 3.4 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.494 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.522 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.16 -39.86 9.72 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.651 2.234 . . . . 0.0 112.013 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -58.76 -40.37 83.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.741 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.39 -40.89 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.643 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.43 123.02 88.73 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' O ' ' ND1' ' A' ' 38' ' ' HIS . 49.8 Cg_endo -70.3 133.95 25.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.748 2.298 . . . . 0.0 111.835 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 59.39 46.15 12.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 36' ' ' PRO . 49.1 m80 -145.07 107.32 4.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -111.43 131.48 55.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.8 p -129.96 158.48 39.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.562 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 t -142.87 141.64 31.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.387 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB1' HD11 ' A' ' 57' ' ' ILE . . . -142.96 155.12 44.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -125.02 163.62 21.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -91.45 108.01 19.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 46.0 mt -61.72 -41.99 98.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -158.27 153.18 25.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.409 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.25 158.04 31.75 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -94.9 9.71 38.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -1.186 . . . . 0.0 109.536 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.77 21.82 8.42 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.524 ' HA2' ' CD1' ' A' ' 75' ' ' ILE . . . -118.46 -144.67 7.6 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.32 123.54 10.35 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.701 2.267 . . . . 0.0 111.874 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.23 1.46 72.25 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.513 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 93.4 m -73.38 134.64 44.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.553 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.517 HG12 ' CD ' ' A' ' 71' ' ' LYS . 3.9 mt -104.6 138.92 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 49.2 mttm -123.57 142.32 51.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . 49.3 tttt -134.15 142.46 47.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' A' ' 67' ' ' TYR . 6.1 tp -82.8 134.23 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.573 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.9 m -80.21 150.85 29.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' A' ' 67' ' ' TYR . 97.0 m-85 -97.54 131.55 44.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.61 148.27 46.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.361 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -55.44 -35.71 65.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.505 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.52 171.17 20.8 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 53.81 51.75 14.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -52.28 142.68 16.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.354 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.423 ' CD2' ' N ' ' A' ' 66' ' ' LYS . 66.7 t80 -126.62 161.65 27.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.945 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 39.6 ttpt -52.62 137.11 31.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.462 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.555 ' HB3' ' CE1' ' A' ' 59' ' ' PHE . 37.1 p90 -118.28 159.54 23.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.404 ' HG2' ' HA2' ' A' ' 89' ' ' GLY . 45.5 mtm -151.79 152.44 32.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.414 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -92.04 156.01 17.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.56 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 78.5 m80 -134.96 135.85 41.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.517 ' CD ' HG12 ' A' ' 54' ' ' ILE . 10.3 tptm -132.12 127.3 35.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.428 HG11 ' CG1' ' A' ' 75' ' ' ILE . 40.3 t -91.61 125.11 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.35 -42.67 58.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.382 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.2 tt0 -174.85 142.32 0.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.548 HG12 ' CE2' ' A' ' 82' ' ' TYR . 69.1 mt -119.12 132.4 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 80.8 m-20 -133.14 83.62 2.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -61.68 -37.57 84.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.76 71.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 75.2 m-20 -91.61 9.91 30.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASN . 86.1 m-85 43.71 45.64 6.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.451 ' HG3' ' HG2' ' A' ' 104' ' ' LYS . 10.3 ttpp -140.35 123.22 16.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.548 ' CE2' HG12 ' A' ' 75' ' ' ILE . 58.5 t80 -111.07 129.2 55.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 22.0 m -123.91 114.81 20.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 109.558 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.544 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 37.1 p90 -137.57 159.91 40.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.462 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 85.6 p -141.3 168.84 18.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.6 mm -114.29 121.45 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 81.2 mt -70.78 -41.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -160.55 133.36 6.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 109.531 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.404 ' HA2' ' HG2' ' A' ' 68' ' ' MET . . . -146.53 103.82 0.28 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 45.41 -111.68 0.63 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.3 Cg_endo -70.71 -31.4 16.38 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.748 2.298 . . . . 0.0 111.75 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 2.5 tp 63.32 -70.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.407 -0.808 . . . . 0.0 109.567 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 169.9 162.29 21.91 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -89.14 121.14 31.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.14 . . . . 0.0 109.539 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 59.51 14.79 4.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.565 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.534 ' CD1' HD12 ' A' ' 99' ' ' ILE . 36.5 mt -93.12 90.7 6.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 108.83 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 94.6 mt-10 -43.23 -44.59 5.34 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.795 -0.566 . . . . 0.0 110.125 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.455 ' O ' HD13 ' A' ' 99' ' ' ILE . 88.0 mttt -153.54 156.17 37.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.961 -1.087 . . . . 0.0 110.032 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.559 HD11 ' CD1' ' A' ' 122' ' ' TYR . 32.3 mm -130.51 112.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 36.8 m -115.76 152.5 33.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.769 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.467 ' OH ' HG21 ' A' ' 99' ' ' ILE . 91.2 m-85 -129.63 133.3 47.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.347 -0.846 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -117.4 139.27 51.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.682 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.6 mt -123.88 121.87 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.345 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.451 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 21.3 mtpt -117.54 127.5 54.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.463 ' HG2' HD22 ' A' ' 116' ' ' LEU . 70.1 mtm -124.48 138.6 54.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.34 37.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.96 135.53 43.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.34 158.5 72.38 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.25 -32.09 21.44 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.67 2.247 . . . . 0.0 111.82 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -65.53 -34.53 78.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.374 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 99.86 146.84 20.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.49 38.61 51.88 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.19 114.59 0.56 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 t -115.05 154.48 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.44 127.37 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.332 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 105' ' ' MET . 55.9 mt -106.59 136.96 45.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 40.3 mttt -131.4 138.1 48.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.243 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.9 mt -125.68 122.71 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.731 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 94.3 m -128.66 138.3 52.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.1 m -123.24 166.56 15.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.409 ' HE3' ' SG ' ' A' ' 5' ' ' CYS . 10.6 mtpt -138.45 112.84 8.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.165 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.559 ' CD1' HD11 ' A' ' 99' ' ' ILE . 8.1 m-30 -108.29 115.13 29.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.629 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 12.7 m-70 -82.56 122.91 28.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 108.693 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.453 HG22 ' CE2' ' A' ' 4' ' ' PHE . 14.2 t -106.78 141.12 38.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.988 -1.07 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 1' ' ' MET . 45.1 mttt -45.39 -40.58 8.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.635 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.22 -68.24 0.37 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -65.18 -27.73 68.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -1.141 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.74 149.52 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.497 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 92.3 p -126.63 159.86 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.581 ' CG2' ' CG2' ' A' ' 135' ' ' ILE . 35.1 mm -108.19 123.37 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.444 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 54.6 t30 -91.6 131.34 37.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 136' ' ' LYS . 75.0 mm-40 -53.96 -40.72 67.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.469 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.93 -42.04 90.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 73.6 mm-40 -63.14 -41.59 99.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 6' ' ' TYR . 20.9 pt -84.42 -30.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.511 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.1 tttp -55.72 -40.87 73.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.247 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.81 75.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.06 -39.4 69.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -60.95 -43.36 98.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -1.143 . . . . 0.0 109.225 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.53 -46.82 70.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -57.71 -45.97 85.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.66 -40.32 96.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.36 83.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.72 -46.79 88.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.95 -39.3 85.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -1.091 . . . . 0.0 109.091 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.514 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 68.9 t80 -60.97 -45.46 94.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 109.248 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -62.74 -34.49 77.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.237 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.83 -51.39 59.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 146' ' ' PHE . 3.5 p -59.57 -39.85 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.481 ' N ' HG11 ' A' ' 149' ' ' VAL . 85.9 tt0 -60.6 -39.89 89.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.38 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.13 90.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.585 ' CZ ' ' CG ' ' A' ' 157' ' ' PRO . 67.6 t80 -59.91 -43.98 94.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.354 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 150' ' ' GLU . 14.7 mt -60.46 -40.45 91.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.299 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.471 ' O ' ' CD2' ' A' ' 156' ' ' HIS . 9.4 tt -60.58 -38.88 86.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.87 . . . . 0.0 109.403 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.574 ' O ' ' CG ' ' A' ' 156' ' ' HIS . . . -69.65 -25.44 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 155' ' ' ALA . 18.7 p80 40.43 59.8 7.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.731 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.585 ' CG ' ' CZ ' ' A' ' 152' ' ' TYR . 50.0 Cg_endo -70.53 -6.77 19.73 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.732 2.288 . . . . 0.0 111.712 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -61.5 -33.35 73.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.47 147.23 48.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.388 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -113.02 134.61 54.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.508 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.468 ' O ' HG21 ' A' ' 124' ' ' THR . . . -57.01 -27.47 57.17 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.567 HG22 ' CD2' ' A' ' 123' ' ' HIS . 7.3 p -119.96 143.39 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.539 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' N ' HG23 ' A' ' 3' ' ' VAL . 86.7 m-85 -104.42 137.29 42.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.0 t -117.44 125.67 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.536 ' CZ ' HD12 ' A' ' 135' ' ' ILE . 26.5 m-85 -118.14 147.96 42.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -119.94 149.8 41.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -130.32 139.46 50.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -115.69 139.13 50.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.95 122.42 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -113.19 133.11 55.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.767 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 t -160.26 137.98 9.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 109.2 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' ' CA ' ' A' ' 113' ' ' GLY . 2.7 p -73.02 91.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.541 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.521 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 16.6 mt -138.83 144.2 40.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.521 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.2 Cg_endo -68.62 118.13 5.45 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.384 2.056 . . . . 0.0 111.374 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 20' ' ' PHE . 45.1 Cg_endo -66.96 -43.13 7.12 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.769 2.313 . . . . 0.0 112.223 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -49.61 67.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.573 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HD3' ' HA ' ' A' ' 161' ' ' CYS . 98.5 mtt180 -72.12 -43.98 63.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 7.1 tp -67.2 -41.01 86.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 109.72 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.561 ' CE1' HG23 ' A' ' 24' ' ' VAL . 52.3 t80 -65.42 -47.51 75.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.517 ' HA ' ' CG ' ' A' ' 25' ' ' LEU . 39.4 tttt -68.98 -36.57 78.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.81 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 35.3 t -80.81 -25.74 37.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.526 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 77.5 t80 -100.68 -50.11 3.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.356 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.561 HG23 ' CE1' ' A' ' 20' ' ' PHE . 54.7 t -84.46 -52.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.056 -1.028 . . . . 0.0 110.513 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.517 ' CG ' ' HA ' ' A' ' 21' ' ' LYS . 56.0 mt -72.48 -28.13 62.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.942 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.455 ' HB2' ' HA ' ' A' ' 22' ' ' SER . 87.9 m-20 -113.79 28.38 8.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.461 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.52 -39.62 77.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.645 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 29' ' ' ASN . 26.9 p-10 -69.81 -32.63 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 24.9 m120 -88.71 -32.32 18.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.42 ' O ' HG12 ' A' ' 34' ' ' VAL . 8.1 tt -73.86 -30.25 62.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 17.2 mt -56.57 -56.65 29.97 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 46.9 Cg_endo -68.16 -33.55 24.53 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.535 2.157 . . . . 0.0 111.677 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -62.65 -37.22 85.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.433 HG22 ' HB1' ' A' ' 148' ' ' ALA . 10.0 p -110.54 9.67 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.586 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' A' ' 32' ' ' PRO . . . -68.01 156.06 90.49 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.941 . . . . 0.0 109.423 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.58 -163.45 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.751 2.301 . . . . 0.0 111.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -47.1 -31.28 3.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.9 . . . . 0.0 109.475 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -96.94 134.1 40.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -110.05 143.2 40.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.2 m -124.89 141.08 52.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.7 p -132.38 156.23 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.462 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.494 ' HB2' ' CE ' ' A' ' 55' ' ' LYS . . . -143.74 152.65 41.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.932 . . . . 0.0 109.574 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.19 159.61 37.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.476 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -88.16 108.08 19.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.8 tp -67.88 -37.27 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 86.1 tt0 -139.94 155.71 47.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 87.09 160.82 35.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -91.9 8.88 35.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.554 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.453 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.97 13.36 25.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.509 ' O ' ' CG1' ' A' ' 72' ' ' VAL . . . -110.84 -143.85 9.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.5 Cg_endo -69.43 125.12 11.93 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -2.66 74.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 62.6 m -73.04 139.78 46.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -1.136 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.501 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.1 mm -101.41 128.48 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' CE ' ' HB2' ' A' ' 42' ' ' ALA . 63.1 tttt -105.95 133.86 49.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -122.7 143.32 49.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.408 HG12 ' HB1' ' A' ' 42' ' ' ALA . 73.0 mt -109.17 137.98 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.443 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.2 m -122.13 143.71 49.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.563 ' HB3' ' CD1' ' A' ' 65' ' ' PHE . 98.9 m-85 -105.21 139.05 40.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.49 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.65 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -98.22 141.84 30.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.505 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.29 -120.14 1.0 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.547 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 21.9 m120 -84.29 150.22 25.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.165 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.25 136.13 57.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' CD1' ' HB3' ' A' ' 59' ' ' PHE . 93.5 m-85 -120.44 153.38 36.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -89.05 126.58 35.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -61.44 144.35 54.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.4 mtp -132.5 152.93 51.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' O ' ' CG2' ' A' ' 86' ' ' ILE . 23.6 mttm -118.31 136.82 53.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.618 ' NE2' ' CD2' ' A' ' 84' ' ' TYR . 11.1 t-80 -132.4 128.79 38.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.501 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 75.3 tttt -126.69 150.24 49.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.389 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 50' ' ' GLY . 7.4 p -108.34 134.61 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -82.49 -56.77 3.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 44.3 mt-10 -150.81 140.88 22.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.476 HG23 HD13 ' A' ' 75' ' ' ILE . 73.0 mt -125.59 126.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.482 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 84.3 m-20 -131.55 94.72 3.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.94 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -66.08 -37.88 86.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.47 66.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 18.7 m120 -85.0 2.48 42.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.606 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 49.78 34.36 7.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -130.83 128.49 40.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.447 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.543 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.7 t80 -122.74 130.17 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.5 m -132.48 118.56 19.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.618 ' CD2' ' NE2' ' A' ' 70' ' ' HIS . 36.3 p90 -132.94 162.14 32.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 39.7 t -138.42 150.24 46.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.452 ' CG2' ' O ' ' A' ' 69' ' ' LYS . 22.8 mt -104.04 133.08 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.429 HG21 ' HG3' ' A' ' 88' ' ' GLU . 85.2 mt -77.63 -41.45 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.52 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.51 ' HA ' ' CD1' ' A' ' 92' ' ' LEU . 99.0 mt-10 -145.28 148.49 33.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . 135.4 166.12 10.94 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 43.99 -143.28 2.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 94' ' ' HIS . 49.2 Cg_endo -69.54 -6.96 19.76 Favored 'Trans proline' 0 C--O 1.212 -0.803 0 C-N-CA 122.761 2.308 . . . . 0.0 111.781 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.51 ' CD1' ' HA ' ' A' ' 88' ' ' GLU . 2.9 tm? -40.67 -26.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.942 . . . . 0.0 110.361 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -89.58 -22.72 35.92 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 91' ' ' PRO . 58.7 t-80 -68.86 74.05 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -1.224 . . . . 0.0 109.617 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 45.69 24.31 0.2 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 122' ' ' TYR . 15.1 mt -95.24 90.69 5.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.278 -0.889 . . . . 0.0 109.31 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 123' ' ' HIS . 94.1 mt-10 -41.5 -41.15 2.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.528 -0.733 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 46.6 mttt -158.26 168.18 27.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.922 -1.111 . . . . 0.0 110.139 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.574 HG22 ' CE1' ' A' ' 101' ' ' TYR . 40.3 mt -146.61 117.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 24.1 t -127.41 150.03 49.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.574 ' CE1' HG22 ' A' ' 99' ' ' ILE . 98.6 m-85 -131.1 128.07 39.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.818 . . . . 0.0 109.042 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.7 mt-10 -106.25 141.74 37.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 109.722 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.03 124.18 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.285 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -130.73 129.22 42.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.656 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.509 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 69.0 mtm -126.61 141.0 52.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.82 30.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.53 137.13 52.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.436 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.53 135.92 43.11 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.72 138.76 38.72 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.718 2.279 . . . . 0.0 111.729 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 51.09 22.63 1.31 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.449 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.29 -43.55 0.83 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.82 29.51 47.11 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.515 ' CA ' ' HA ' ' A' ' 13' ' ' VAL . . . -144.0 -135.72 2.99 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 t -152.03 152.12 32.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -1.117 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.81 130.14 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.923 . . . . 0.0 109.377 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.509 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 64.8 mt -109.02 132.51 54.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -130.27 135.62 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.37 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 118' ' ' ILE . 70.8 mt -124.58 133.09 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.586 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 30.4 m -125.58 141.45 52.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.343 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.2 m -126.44 151.95 47.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.66 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -138.32 126.49 22.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 109.221 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.558 ' CE1' HG21 ' A' ' 99' ' ' ILE . 38.0 m-85 -127.0 111.16 13.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.911 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.567 ' CD2' HG22 ' A' ' 3' ' ' VAL . 22.4 m-70 -85.04 135.53 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.526 ' OG1' ' CB ' ' A' ' 128' ' ' ALA . 11.3 t -115.82 141.27 48.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.029 . . . . 0.0 109.852 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.472 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 69.8 mttt -77.82 137.54 38.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.35 -153.76 50.69 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.43 13.81 7.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -1.2 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.526 ' CB ' ' OG1' ' A' ' 124' ' ' THR . . . -52.06 143.77 13.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.7 p -124.01 170.02 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 12.6 mt -115.95 126.82 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -60.78 134.84 57.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.545 ' HA ' HG13 ' A' ' 135' ' ' ILE . 86.6 tt0 -62.88 -29.87 71.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.33 -44.68 95.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 0.0 109.124 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -57.6 -24.92 58.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.842 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 132' ' ' GLU . 2.0 mt -71.69 -51.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.114 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -55.97 -38.29 70.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.93 78.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.364 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.11 -30.21 76.78 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.13 -36.24 72.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -1.214 . . . . 0.0 109.393 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.13 -42.35 93.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -63.05 -40.13 96.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.391 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.12 -35.68 74.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.456 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.79 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.98 -39.33 97.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 18.7 tp -65.47 -40.25 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.457 ' O ' HG11 ' A' ' 149' ' ' VAL . 19.6 m-85 -60.97 -41.54 96.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.522 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -66.92 -34.8 78.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.433 ' HB1' HG22 ' A' ' 34' ' ' VAL . . . -68.99 -50.3 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.386 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 150' ' ' GLU . 3.8 p -57.53 -44.05 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.434 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.466 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.0 mt-10 -59.63 -44.36 93.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 155' ' ' ALA . . . -59.49 -35.61 74.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.9 -47.68 83.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -54.2 -46.98 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.323 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 154' ' ' LEU . 6.7 mp -80.1 -24.85 40.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 151' ' ' ALA . . . -78.81 -17.84 55.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -137.14 63.56 44.0 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 50.1 Cg_endo -71.21 -5.52 17.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.657 2.238 . . . . 0.0 111.702 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -69.56 -36.09 76.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.43 134.4 56.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -57.89 -40.0 79.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.863 . . . . 0.0 109.467 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 27.0 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.43 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.46 55.85 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.577 HG21 ' CG ' ' A' ' 123' ' ' HIS . 38.3 t -128.07 141.13 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -1.115 . . . . 0.0 109.511 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' N ' HG12 ' A' ' 3' ' ' VAL . 98.4 m-85 -99.11 135.2 40.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.338 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.1 p -119.02 125.3 49.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 119' ' ' THR . 77.6 m-85 -126.87 140.9 52.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.2 tt0 -115.95 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 59.9 t0 -101.62 124.7 47.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -99.16 131.48 45.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.963 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.1 124.98 10.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.9 m -105.11 131.96 51.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.786 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.401 ' OG ' HD11 ' A' ' 14' ' ' ILE . 52.8 p -160.34 140.47 11.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.26 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.456 ' O ' HG11 ' A' ' 13' ' ' VAL . 2.4 p -81.64 91.22 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 3.1 mt -138.69 142.52 34.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.231 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 45.3 Cg_endo -68.08 120.47 7.45 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.544 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.0 -28.47 41.7 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.847 2.365 . . . . 0.0 112.224 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.71 -56.5 5.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -72.57 -45.95 56.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.519 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 10.7 tp -56.45 -41.0 75.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.874 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 24' ' ' VAL . 67.6 t80 -64.5 -49.05 72.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.731 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.513 ' HG2' ' CD1' ' A' ' 25' ' ' LEU . 41.7 mttm -69.08 -43.72 73.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 109.628 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 20.3 m -73.39 -22.25 60.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.764 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.527 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 69.7 t80 -100.88 -50.73 3.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.04 -52.83 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.918 . . . . 0.0 110.484 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.513 ' CD1' ' HG2' ' A' ' 21' ' ' LYS . 43.0 mt -71.77 -28.49 63.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 109.974 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 89.9 m-20 -108.4 18.67 20.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 109.555 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -68.29 -33.87 75.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.607 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.52 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 90.0 m-20 -71.04 -37.55 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.703 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -92.29 -41.11 10.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.0 tp -56.98 -41.05 77.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.526 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 33.4 mt -56.93 -60.8 8.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.514 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.526 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -68.11 -33.81 24.15 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.556 2.17 . . . . 0.0 111.86 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -57.7 -38.09 74.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.444 HG13 ' HB1' ' A' ' 148' ' ' ALA . 69.4 t -59.24 -41.25 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.539 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.88 124.1 85.0 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.979 . . . . 0.0 109.519 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.08 137.93 35.65 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.712 2.275 . . . . 0.0 111.754 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 58.35 47.99 13.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -124.55 114.55 19.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -108.72 131.9 54.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 t -137.24 155.97 48.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.455 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -130.47 148.49 52.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.469 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB1' ' HE3' ' A' ' 55' ' ' LYS . . . -142.58 152.55 42.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.438 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -144.56 142.45 30.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 84.8 m-20 -85.89 117.55 24.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.501 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 45.3 tp -69.54 -38.03 77.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.459 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 77.7 tt0 -159.22 157.35 30.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.483 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 91.96 158.02 34.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -93.57 11.37 28.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.163 . . . . 0.0 109.535 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.467 ' HA2' HG23 ' A' ' 53' ' ' THR . . . 101.64 31.08 5.6 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 75' ' ' ILE . . . -127.83 -144.14 5.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.62 125.51 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.701 2.268 . . . . 0.0 111.768 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.13 4.26 86.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.467 HG23 ' HA2' ' A' ' 49' ' ' GLY . 74.8 m -77.68 139.52 39.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.143 -1.21 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 16.8 mm -104.41 137.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 56.1 tttp -126.6 142.27 51.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -124.87 126.92 46.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.319 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.435 HG12 ' HB3' ' A' ' 42' ' ' ALA . 66.3 mt -116.78 138.09 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.607 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.0 m -126.66 124.02 38.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.36 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.425 ' HB3' ' HG3' ' A' ' 61' ' ' GLU . 98.3 m-85 -56.47 -48.86 76.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.586 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 64.79 11.95 7.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.425 ' HG3' ' HB3' ' A' ' 59' ' ' PHE . 98.2 mt-10 -65.43 -33.85 76.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.883 . . . . 0.0 109.444 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.04 -173.32 12.9 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -84.11 0.81 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -1.146 . . . . 0.0 109.692 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 96.2 mt-10 -54.93 -35.25 64.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.434 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 23.5 m-85 61.47 77.5 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.481 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -83.11 145.55 29.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.238 -0.914 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -114.04 134.41 54.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.9 mtp -138.06 157.45 46.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.895 . . . . 0.0 109.318 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' HE3' ' CD1' ' A' ' 87' ' ' ILE . 39.2 tttp -129.26 130.7 46.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 90.0 m-70 -122.94 134.86 54.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.29 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -131.6 132.11 43.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 14.2 m -100.45 128.05 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -70.52 -41.62 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 84.9 tt0 -176.52 144.67 0.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.141 -0.974 . . . . 0.0 109.503 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.558 HG12 ' CE1' ' A' ' 82' ' ' TYR . 62.2 mt -118.79 129.91 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.5 m-20 -130.53 83.8 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.83 -41.24 90.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.11 79.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 22.4 m120 -86.8 5.91 34.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 47.67 33.43 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.945 . . . . 0.0 109.483 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -127.63 132.5 49.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.44 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.558 ' CE1' HG12 ' A' ' 75' ' ' ILE . 71.2 t80 -124.35 126.33 45.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.447 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 12.4 t -124.07 119.59 29.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.556 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 34.5 p90 -140.22 167.11 22.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.384 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 100' ' ' SER . 84.4 p -146.71 168.38 21.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.5 mm -115.39 113.68 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.308 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.466 ' CD1' ' HE3' ' A' ' 69' ' ' LYS . 90.6 mt -68.09 -35.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.305 -0.872 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -156.53 136.65 12.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -155.42 101.28 0.2 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.22 -128.86 8.33 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.2 Cg_endo -70.45 -23.66 27.39 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.623 2.216 . . . . 0.0 111.461 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.515 HD11 ' CG1' ' A' ' 99' ' ' ILE . 6.2 tp 45.47 -92.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.409 -0.807 . . . . 0.0 109.621 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -156.28 172.95 34.16 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.413 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 84.7 t60 -106.74 133.2 51.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.13 . . . . 0.0 109.404 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.507 ' CG2' ' HB3' ' A' ' 128' ' ' ALA . 0.3 OUTLIER 64.08 15.21 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.338 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' A' ' 130' ' ' ILE . 71.5 mt -104.54 93.76 4.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 123' ' ' HIS . 85.5 mt-10 -45.97 -41.53 11.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.638 -0.664 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' O ' ' CD1' ' A' ' 99' ' ' ILE . 89.4 mttt -155.33 160.76 40.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.679 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 98' ' ' LYS . 12.5 mm -135.0 114.36 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.526 ' HA ' ' CB ' ' A' ' 85' ' ' SER . 32.8 m -118.27 150.29 39.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.042 . . . . 0.0 110.405 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -131.95 132.57 43.64 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG3' ' SG ' ' A' ' 83' ' ' CYS . 87.1 tt0 -113.29 141.05 47.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.997 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 103' ' ' ILE . 70.0 mt -121.68 121.61 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -126.26 137.19 53.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.852 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.441 ' SD ' HD22 ' A' ' 19' ' ' LEU . 65.1 mtt -119.94 131.77 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.241 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.86 155.24 43.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 114' ' ' SER . . . -101.33 128.98 47.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.85 150.64 97.7 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.49 -25.33 29.94 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.708 2.272 . . . . 0.0 111.679 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -63.79 -28.93 70.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.34 -3.93 73.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.88 -41.05 58.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 174.62 -126.47 1.19 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 49.5 m -132.88 155.51 48.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 109.531 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.63 134.22 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 49.9 mt -105.86 135.89 46.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.468 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 50.6 mttp -133.46 137.41 45.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 68.8 mt -127.41 135.29 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.4 m -118.38 142.59 47.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.478 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 51.1 m -126.98 152.35 47.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -136.2 126.14 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.561 ' CB ' ' CD1' ' A' ' 130' ' ' ILE . 54.5 m-85 -122.26 116.27 23.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.975 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.577 ' CG ' HG21 ' A' ' 3' ' ' VAL . 72.2 m-70 -85.5 126.01 33.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.5 OUTLIER -109.85 152.65 25.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.106 . . . . 0.0 109.783 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -53.86 -40.86 66.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.01 -84.24 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -61.39 -26.26 67.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.137 . . . . 0.0 109.52 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.507 ' HB3' ' CG2' ' A' ' 95' ' ' THR . . . -62.44 146.25 51.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -137.69 151.15 47.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.561 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 36.4 mt -110.34 124.65 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.554 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -88.6 153.23 21.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.449 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 136' ' ' LYS . 98.2 mt-10 -61.02 -36.7 80.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.528 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.528 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 22.3 pt-20 -60.96 -46.08 92.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.939 . . . . 0.0 109.49 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 133' ' ' GLU . 85.4 tt0 -56.87 -47.61 80.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.489 ' CG2' HG21 ' A' ' 130' ' ' ILE . 41.8 pt -76.68 -29.27 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 132' ' ' GLU . 38.5 tttt -55.53 -41.47 73.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.229 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.36 76.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.072 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.83 -38.34 73.36 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -61.38 -43.74 98.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -1.097 . . . . 0.0 109.075 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.5 -47.68 69.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -57.8 -45.53 85.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.905 . . . . 0.0 109.081 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.53 88.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.302 -0.873 . . . . 0.0 109.127 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.8 66.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.48 -44.37 93.72 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 71.6 mt -55.64 -39.62 71.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.195 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.514 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.6 m-85 -65.91 -39.48 90.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.304 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.8 -38.69 89.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.311 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.444 ' HB1' HG13 ' A' ' 34' ' ' VAL . . . -69.01 -52.11 32.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.514 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.6 p -65.28 -41.53 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -58.83 -40.69 84.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.88 99.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 109.299 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.7 -49.37 78.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 109.352 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.6 -29.6 66.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.3 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.8 tt -65.29 -46.83 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.58 75.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 159' ' ' ALA . 7.7 t-160 45.82 61.62 12.28 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.91 -9.76 26.82 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.66 2.24 . . . . 0.0 111.738 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -69.49 -34.14 73.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 156' ' ' HIS . . . -100.57 142.34 32.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -55.93 -41.12 74.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.447 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.496 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.21 12.62 63.08 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.517 HG22 ' CD2' ' A' ' 123' ' ' HIS . 11.1 p -127.01 137.24 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.473 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.577 ' CE2' HG13 ' A' ' 130' ' ' ILE . 43.0 m-85 -101.99 152.55 20.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.82 111.73 11.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.917 . . . . 0.0 109.412 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 119' ' ' THR . 52.4 m-85 -108.4 151.18 26.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.471 ' HG2' ' CG2' ' A' ' 119' ' ' THR . 95.2 mt-10 -125.93 139.58 53.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.561 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 118' ' ' ILE . 91.6 m-20 -111.66 156.51 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.451 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -127.01 134.26 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.665 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.11 124.21 10.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.22 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.8 m -116.59 139.3 50.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.968 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.418 ' O ' HG12 ' A' ' 14' ' ' ILE . 46.4 m -160.04 144.34 14.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.46 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 31.1 m -70.72 90.67 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.479 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.519 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -139.62 145.03 41.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.054 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 44.1 Cg_endo -67.26 129.92 21.46 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 122.367 2.045 . . . . 0.0 111.084 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.4 Cg_endo -66.62 -39.98 14.57 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.701 2.267 . . . . 0.0 112.502 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -46.52 20.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.062 -1.024 . . . . 0.0 109.794 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . 91.7 mtt-85 -71.99 -49.22 38.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.55 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 28.8 tp -59.51 -47.94 83.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.754 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CE1' ' C ' ' A' ' 80' ' ' PHE . 53.8 t80 -53.73 -55.02 29.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 83.0 tttt -65.84 -54.9 20.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.942 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 31.6 m -62.29 -27.41 69.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.406 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.501 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 86.3 t80 -93.92 -50.88 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.916 -1.115 . . . . 0.0 110.292 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 45.9 t -84.59 -50.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 110.028 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 4.1 tt -68.92 -49.14 60.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 22' ' ' SER . 66.3 m-20 -91.65 24.16 3.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.506 ' O ' ' CG1' ' A' ' 31' ' ' ILE . . . -69.44 -44.54 71.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.46 ' HA ' HD13 ' A' ' 31' ' ' ILE . 76.6 m-20 -64.14 -24.21 67.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -91.27 -38.47 12.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.849 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 22' ' ' SER . 22.1 mt -79.89 -36.64 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.587 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 25.0 mt -44.66 -56.62 8.15 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.8 Cg_endo -68.23 -28.94 33.28 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.485 2.124 . . . . 0.0 111.74 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -72.72 -40.74 65.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.411 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 35' ' ' ALA . 7.2 p -76.66 -24.49 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.327 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' N ' HG11 ' A' ' 34' ' ' VAL . . . -50.5 164.58 0.39 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.348 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.16 -161.74 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.616 2.211 . . . . 0.0 111.777 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -52.84 -30.51 34.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.405 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -80.8 134.45 35.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.403 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.15 149.41 40.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.7 p -126.58 161.94 26.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.126 -0.983 . . . . 0.0 109.454 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -131.46 146.78 52.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.425 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.32 149.34 41.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.32 -0.862 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -133.97 159.11 41.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.454 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.5 m-20 -87.36 108.69 19.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.6 tp -68.59 -36.32 78.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.557 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 86.0 tt0 -140.05 155.29 47.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 85.33 163.81 37.89 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -90.22 8.84 31.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -1.183 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.442 ' HA2' HG23 ' A' ' 53' ' ' THR . . . 99.45 43.18 2.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -145.66 -137.34 3.08 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.1 Cg_endo -69.17 123.0 9.84 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.801 2.334 . . . . 0.0 112.049 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.56 8.73 84.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 54' ' ' ILE . 56.3 m -86.41 139.79 30.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -1.156 . . . . 0.0 109.542 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.52 HD11 HG21 ' A' ' 54' ' ' ILE . 6.0 mt -101.46 139.18 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.526 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 54' ' ' ILE . 93.7 mttt -117.47 150.62 38.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -125.27 137.28 54.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.281 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.9 tt -116.37 137.73 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.656 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -79.17 151.41 31.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.868 . . . . 0.0 109.348 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.573 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 21.6 p90 -131.62 165.27 24.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.469 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.01 -56.87 2.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 84.3 tt0 -81.07 146.39 30.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.486 ' HA3' ' CB ' ' A' ' 66' ' ' LYS . . . 95.97 14.84 44.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -57.15 -26.5 60.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -1.136 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.74 -36.65 84.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.506 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 72.3 t80 -176.31 66.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.448 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.573 ' O ' ' CZ ' ' A' ' 59' ' ' PHE . 16.9 tttt -141.65 128.47 20.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.557 ' CE2' ' HE2' ' A' ' 69' ' ' LYS . 39.5 p90 -146.39 161.99 39.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.1 mtt -132.86 144.73 50.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.557 ' HE2' ' CE2' ' A' ' 67' ' ' TYR . 37.6 mttm -130.69 140.66 50.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 97.4 m-70 -125.47 136.74 53.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.504 ' CD ' HG12 ' A' ' 54' ' ' ILE . 23.8 tptm -130.26 133.83 46.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 45.6 t -100.02 132.86 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.89 -56.48 4.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.662 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.8 tt0 -178.89 138.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.62 ' CG2' ' CD2' ' A' ' 82' ' ' TYR . 15.7 pt -136.29 145.36 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.567 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' OD1' ' A' ' 79' ' ' ASN . 60.7 t0 -132.84 109.14 9.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -60.22 -36.22 77.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.72 99.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.438 ' OD1' ' OD1' ' A' ' 76' ' ' ASP . 15.8 m120 -86.11 -5.74 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.222 -0.923 . . . . 0.0 109.587 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' C ' ' CE1' ' A' ' 20' ' ' PHE . 92.2 m-85 58.74 36.09 24.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.294 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -117.99 131.54 56.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.62 ' CD2' ' CG2' ' A' ' 75' ' ' ILE . 72.6 t80 -128.03 114.85 17.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.885 . . . . 0.0 109.683 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.71 118.17 30.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.217 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.576 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 32.5 p90 -129.33 154.62 46.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 51.1 m -128.9 159.14 36.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.27 129.57 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.414 ' HB ' ' HB2' ' A' ' 69' ' ' LYS . 84.4 mt -77.6 -41.71 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -165.27 138.38 4.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -154.46 103.07 0.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.24 -126.8 7.62 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.1 Cg_endo -70.33 -29.88 20.5 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.652 2.235 . . . . 0.0 111.721 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.462 ' CG ' HG13 ' A' ' 99' ' ' ILE . 4.2 tp 45.72 -93.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.575 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -145.63 -176.12 19.28 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -115.47 125.84 53.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -1.135 . . . . 0.0 109.483 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 58.85 23.59 11.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 130' ' ' ILE . 96.5 mt -101.35 93.62 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.524 ' CG ' ' HG2' ' A' ' 125' ' ' LYS . 96.8 mt-10 -48.49 -32.72 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.764 -0.585 . . . . 0.0 111.287 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.449 ' O ' HD12 ' A' ' 99' ' ' ILE . 78.3 tttt -151.14 143.09 23.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 0.0 110.622 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.58 HD13 ' CD1' ' A' ' 122' ' ' TYR . 23.0 mm -124.81 113.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 28.5 t -116.97 148.68 41.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 120' ' ' SER . 3.7 m-85 -130.87 123.95 30.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.781 . . . . 0.0 109.057 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.457 ' HB2' ' OG1' ' A' ' 119' ' ' THR . 91.1 mt-10 -109.12 135.3 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.752 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.474 HG21 HD11 ' A' ' 103' ' ' ILE . 63.4 mt -131.52 119.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.98 155.11 47.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.698 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -117.35 147.85 42.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.277 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.79 147.18 46.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.23 138.5 38.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -117.16 107.2 45.93 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.05 -29.71 22.09 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.656 2.238 . . . . 0.0 111.712 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -64.41 -44.41 91.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.12 175.9 27.63 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 114' ' ' SER . . . 92.33 20.73 34.43 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 57.62 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 112' ' ' GLY . 87.1 p -144.37 165.48 27.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -1.055 . . . . 0.0 109.41 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 72.4 mt -123.01 133.56 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.429 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.7 mp -106.98 138.91 42.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -124.69 135.49 53.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 8' ' ' ASP . 72.2 mt -123.82 128.79 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.471 ' CG2' ' HG2' ' A' ' 7' ' ' GLU . 8.4 p -126.39 142.69 51.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.468 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.497 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -121.65 152.88 38.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 109.676 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -132.34 115.04 15.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 108.931 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.58 ' CD1' HD13 ' A' ' 99' ' ' ILE . 9.6 m-30 -112.87 121.61 45.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.05 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 97' ' ' GLU . 4.5 m-70 -92.85 115.51 28.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.389 -0.819 . . . . 0.0 108.841 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.1 p -92.7 148.65 21.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.524 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 54.3 mttp -70.09 147.25 50.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 48.19 -143.59 7.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -92.88 15.97 13.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.126 . . . . 0.0 109.418 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 125' ' ' LYS . . . -49.12 146.31 3.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.6 p -113.9 161.75 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.577 HG13 ' CE2' ' A' ' 4' ' ' PHE . 49.4 mt -105.8 139.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.895 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -84.26 123.95 30.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.487 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 96.3 mt-10 -55.65 -35.59 66.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.08 -41.39 90.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -62.88 -45.63 91.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.464 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.519 ' CG2' HG21 ' A' ' 130' ' ' ILE . 38.2 pt -76.86 -31.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 26.4 tttm -55.76 -46.66 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.0 73.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.405 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.01 -39.56 92.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.91 -41.76 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -45.81 91.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -59.94 -45.79 91.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.16 90.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.28 97.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.12 88.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.442 ' O ' HG12 ' A' ' 149' ' ' VAL . 9.4 tt -62.88 -39.34 94.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.319 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.462 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 70.9 t80 -59.54 -46.35 89.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -60.73 -39.22 87.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.376 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.54 -48.74 68.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.507 HG11 ' N ' ' A' ' 150' ' ' GLU . 7.2 p -65.0 -43.65 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.0 109.355 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.507 ' N ' HG11 ' A' ' 149' ' ' VAL . 85.2 tt0 -60.63 -40.17 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.12 96.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.267 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.556 ' CE2' ' HG3' ' A' ' 157' ' ' PRO . 62.5 t80 -67.93 -42.34 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.459 ' CD1' ' C ' ' A' ' 153' ' ' LEU . 3.5 tm? -69.83 -31.49 69.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 154' ' ' LEU . 2.7 tm? -75.38 -40.09 58.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.926 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.48 74.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 51.46 64.61 7.67 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 109.583 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.556 ' HG3' ' CE2' ' A' ' 152' ' ' TYR . 49.2 Cg_endo -70.45 -10.6 28.36 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.686 2.257 . . . . 0.0 111.737 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -60.63 -35.13 75.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.451 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.73 135.26 34.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.491 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.74 140.61 49.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.48 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.33 0.586 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.74 160.69 24.13 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 122' ' ' TYR . 6.7 p -128.44 130.87 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -1.166 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -86.42 144.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.606 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.0 m -130.27 121.22 25.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 119' ' ' THR . 46.2 m-85 -116.72 139.84 50.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.423 ' HG2' HG22 ' A' ' 119' ' ' THR . 93.6 mt-10 -114.82 146.66 40.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 118' ' ' ILE . 90.2 m-20 -122.37 154.83 37.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -115.82 143.1 45.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -154.29 121.73 5.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 0.0 109.182 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.8 m -110.15 133.78 52.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.833 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 m -160.3 146.5 15.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -0.881 . . . . 0.0 109.241 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.455 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.2 p -81.19 91.58 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.9 mt -138.65 142.93 35.95 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.301 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.4 Cg_endo -68.56 116.31 4.34 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.449 2.1 . . . . 0.0 111.244 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.45 -27.73 46.62 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.757 2.304 . . . . 0.0 112.36 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.99 6.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.552 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -72.5 -43.25 63.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 16.2 tp -61.04 -47.97 83.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.887 . . . . 0.0 109.747 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.577 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 70.2 t80 -57.3 -50.44 72.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.8 tttt -68.21 -48.38 65.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 87.0 p -71.79 -20.84 61.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 110.099 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 66.0 t80 -100.42 -50.51 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.286 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 54.7 t -84.62 -52.89 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.06 -1.025 . . . . 0.0 110.349 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 15.9 tp -70.24 -29.67 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 91.4 m-20 -110.42 22.14 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.488 ' OD2' ' NZ ' ' A' ' 55' ' ' LYS . 88.1 m-20 -69.27 -37.05 77.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 22.4 m120 -96.11 -38.04 10.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.685 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.6 tp -56.5 -42.32 78.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.704 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.524 ' O ' ' CG1' ' A' ' 34' ' ' VAL . 31.0 mt -49.85 -61.61 3.43 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.333 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.522 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.61 -25.1 34.8 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.615 2.21 . . . . 0.0 111.632 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -62.25 -48.85 78.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.607 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 31' ' ' ILE . 4.6 p -59.27 -26.23 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.878 . . . . 0.0 109.666 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.427 ' N ' HG11 ' A' ' 34' ' ' VAL . . . -118.06 103.93 49.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.52 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.1 -12.92 33.15 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.715 2.276 . . . . 0.0 111.726 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -63.29 -28.84 70.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.66 42.03 24.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.88 . . . . 0.0 109.465 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.03 -40.4 89.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 58' ' ' THR . 14.2 t -138.33 158.5 44.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.85 . . . . 0.0 109.484 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 t -136.19 142.84 44.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.945 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -112.17 138.77 48.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.935 . . . . 0.0 109.463 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.89 153.14 45.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 35.5 p-10 -89.03 108.6 19.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.411 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.64 -35.32 78.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.329 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 48.4 tp10 -137.91 154.28 49.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 85.48 159.33 31.51 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.52 10.62 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.483 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.83 6.58 43.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.518 ' O ' ' CG1' ' A' ' 72' ' ' VAL . . . -102.12 -147.99 20.36 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.7 Cg_endo -68.63 129.84 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.71 2.273 . . . . 0.0 111.756 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.46 -5.21 84.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -75.14 139.23 42.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.506 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.528 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.6 mm -104.05 135.14 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' NZ ' ' OD2' ' A' ' 28' ' ' ASP . 29.0 mttt -118.37 140.3 50.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.626 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -123.59 142.54 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.61 135.3 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.443 ' O ' ' OG1' ' A' ' 40' ' ' THR . 26.8 p -82.37 151.86 26.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 37.9 p90 -139.41 168.75 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -132.88 147.56 52.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 78.8 tt0 48.86 46.84 21.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' PHE . . . -111.95 51.82 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -56.01 -26.33 48.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.16 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -55.17 -43.12 74.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.461 ' HB3' ' HA2' ' A' ' 90' ' ' GLY . 35.0 p90 -127.0 164.49 21.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.505 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' O ' ' CZ ' ' A' ' 59' ' ' PHE . 28.1 mttt -95.78 -74.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -133.55 146.84 51.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.2 mtm -111.45 154.88 24.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.925 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -131.08 144.13 51.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.485 ' CD2' HD12 ' A' ' 86' ' ' ILE . 65.5 m80 -126.56 133.9 50.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.528 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.4 tttm -124.45 144.28 50.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 50' ' ' GLY . 7.5 p -98.99 130.43 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -73.39 -46.83 46.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 50.6 tp10 -173.56 143.35 1.03 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.568 HG12 ' CE1' ' A' ' 82' ' ' TYR . 82.6 mt -126.95 125.23 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 8.3 t70 -128.14 105.44 8.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 109.511 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.577 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 70.2 m80 -70.24 -35.11 73.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.09 88.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.573 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 83.2 m-20 -85.14 5.33 30.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.551 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 45.11 42.31 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -130.44 137.39 49.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.568 ' CE1' HG12 ' A' ' 75' ' ' ILE . 62.0 t80 -126.32 125.03 41.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.467 ' CB ' ' HG3' ' A' ' 102' ' ' GLU . 8.1 t -127.57 115.56 19.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.376 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.5 p90 -129.42 159.57 35.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.501 ' CB ' ' HE3' ' A' ' 98' ' ' LYS . 60.0 p -141.42 167.58 21.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.485 HD12 ' CD2' ' A' ' 70' ' ' HIS . 17.9 mt -122.59 132.33 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.4 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.1 mt -80.16 -37.39 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -147.54 131.89 17.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.626 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -144.99 97.51 0.19 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 65' ' ' PHE . . . 45.61 -111.52 0.62 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 49.8 Cg_endo -70.18 -30.64 20.0 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.703 2.269 . . . . 0.0 111.684 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.507 ' HG ' ' N ' ' A' ' 93' ' ' GLY . 7.9 tp 60.64 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.85 . . . . 0.0 109.464 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.507 ' N ' ' HG ' ' A' ' 92' ' ' LEU . . . 175.18 167.12 33.94 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -97.77 121.7 40.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -1.128 . . . . 0.0 109.399 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 65.81 9.58 6.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.719 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.522 HD21 ' CD1' ' A' ' 130' ' ' ILE . 83.7 mt -90.16 90.7 8.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 108.881 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 123' ' ' HIS . 33.3 mt-10 -48.59 -43.91 36.42 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.753 -0.592 . . . . 0.0 110.831 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.501 ' HE3' ' CB ' ' A' ' 85' ' ' SER . 54.9 tttp -150.65 155.17 38.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.616 -1.302 . . . . 0.0 110.464 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 121' ' ' LYS . 34.1 mt -138.98 116.03 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 87.7 p -125.65 164.51 20.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.451 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 119' ' ' THR . 89.2 m-85 -137.89 120.48 16.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' HG3' ' CB ' ' A' ' 83' ' ' CYS . 83.1 tt0 -101.88 143.33 31.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.118 -0.989 . . . . 0.0 109.917 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.2 mt -128.51 118.36 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 0.0 108.912 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -120.38 139.61 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.615 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.495 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 63.8 mtm -122.35 137.49 54.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.262 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.95 40.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.555 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.85 135.72 40.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.13 151.97 95.87 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.504 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.35 -27.43 28.44 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.714 2.276 . . . . 0.0 111.719 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -78.67 -21.86 47.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.308 -0.87 . . . . 0.0 109.421 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.84 8.96 64.65 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.29 -37.74 93.51 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 171.64 -122.59 0.96 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.0 t -134.69 150.69 50.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.409 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.23 132.02 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.495 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 49.5 mt -98.95 137.21 37.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.897 . . . . 0.0 109.357 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.03 131.44 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' ASP . 68.0 mt -118.47 137.57 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 80.8 m -133.1 137.29 46.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.4 m -113.88 154.71 27.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 32.4 mttm -142.12 122.05 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.524 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 34.7 m-85 -119.43 132.92 55.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.257 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLU . 2.9 m80 -100.31 121.25 41.18 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -112.09 137.89 49.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.341 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 124' ' ' THR . 71.7 mttt -40.96 -35.12 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.546 -0.722 . . . . 0.0 109.862 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.62 -79.55 0.21 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.98 -29.73 67.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -1.093 . . . . 0.0 109.316 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.5 143.26 57.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.1 m -126.4 154.38 43.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 48.6 mt -112.27 132.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 16.0 t-20 -87.04 138.08 31.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.413 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.427 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.2 mt-10 -62.7 -33.04 74.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.414 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 83.0 tt0 -65.62 -46.22 80.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.479 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.18 -45.14 88.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 109.349 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.436 ' CD1' ' CE1' ' A' ' 6' ' ' TYR . 35.8 pt -76.62 -29.19 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.1 tttt -55.63 -45.6 77.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.17 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 109.327 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.06 -38.39 75.86 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.88 -43.75 90.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -1.118 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.28 -43.25 82.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.259 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -57.92 -45.91 85.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.26 -38.6 85.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.127 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.75 96.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -48.21 79.95 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.488 ' C ' ' CD1' ' A' ' 145' ' ' LEU . 3.1 tm? -60.26 -38.44 83.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -1.131 . . . . 0.0 109.237 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.517 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 71.1 t80 -61.98 -41.39 97.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 0.0 109.298 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -61.0 -41.38 96.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.71 65.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.376 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.517 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.4 p -66.72 -41.94 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -60.49 -39.94 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.75 99.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.44 -47.18 87.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 24.7 mt -59.92 -34.18 72.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.465 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.72 -42.09 95.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -65.01 -31.29 72.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.2 OUTLIER 45.55 60.57 13.45 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.09 -9.04 25.09 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.689 2.259 . . . . 0.0 111.723 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -73.32 -20.07 60.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.358 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 161' ' ' CYS . . . -71.14 142.43 50.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 161' ' ' CYS . 90.9 m-85 51.58 -93.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.304 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.446 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . 96.38 11.95 52.7 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.576 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 25.0 t -126.39 142.43 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -1.119 . . . . 0.0 109.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.427 ' CE2' HG13 ' A' ' 130' ' ' ILE . 95.2 m-85 -105.73 129.64 53.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.472 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.0 t -107.76 129.74 55.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 119' ' ' THR . 21.9 m-85 -116.36 143.23 45.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -123.33 142.73 50.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -129.16 134.61 48.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.99 138.47 46.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.593 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -168.53 113.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 111' ' ' GLY . 14.9 t -120.32 147.63 44.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -160.27 143.88 13.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.172 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 24.6 m -65.43 90.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.309 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 32.7 mm -138.87 144.18 40.47 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.464 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 47.6 Cg_endo -69.21 112.43 2.98 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.542 2.161 . . . . 0.0 111.287 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.9 Cg_endo -67.0 -29.55 40.4 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.761 2.308 . . . . 0.0 112.264 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 -56.13 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -72.58 -37.45 68.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.773 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 15.6 tp -67.07 -33.71 76.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.758 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 66.3 t80 -71.56 -47.87 52.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.139 -0.975 . . . . 0.0 109.954 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 20.0 mttt -71.56 -22.67 61.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.789 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 86.6 p -96.84 -23.64 16.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.09 -1.006 . . . . 0.0 109.458 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.517 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 79.9 t80 -100.46 -45.48 5.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.978 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.499 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 57.8 t -84.58 -52.7 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.98 . . . . 0.0 110.25 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 4.0 mm? -69.79 -45.71 67.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 109.618 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 22' ' ' SER . 80.5 m-20 -93.73 25.63 3.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 109.591 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.92 -42.18 73.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.983 . . . . 0.0 109.775 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.57 -20.52 58.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 0.0 109.965 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -94.88 -38.55 10.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.811 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.446 ' O ' HG21 ' A' ' 34' ' ' VAL . 18.1 mt -74.51 -30.03 61.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.564 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.5 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 21.9 mt -55.47 -59.53 10.95 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.302 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.5 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 47.7 Cg_endo -68.56 -30.86 28.06 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.607 2.205 . . . . 0.0 111.77 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 47.3 tttp -59.03 -35.38 73.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.734 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 30' ' ' LEU . 98.9 t -61.07 -41.63 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.575 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.482 ' HB2' ' CB ' ' A' ' 38' ' ' HIS . . . -78.42 125.28 84.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.525 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.8 138.98 35.67 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.636 2.224 . . . . 0.0 111.754 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 55.3 47.11 22.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.482 ' CB ' ' HB2' ' A' ' 35' ' ' ALA . 86.4 t60 -131.45 106.45 8.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.404 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -112.25 129.84 56.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.562 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.0 t -135.04 158.27 44.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.8 p -137.26 149.32 47.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.525 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.6 151.81 40.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -134.23 150.43 51.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -87.51 108.91 19.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.417 HD11 ' HD3' ' A' ' 56' ' ' LYS . 58.5 mt -66.48 -32.12 73.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 78.1 tt0 -147.92 162.7 38.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.516 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 73.88 156.49 4.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -91.42 9.31 32.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.427 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 108.29 30.21 3.95 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.446 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -126.95 -143.71 5.87 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.57 120.47 7.13 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.667 2.245 . . . . 0.0 111.809 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.95 -2.66 72.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 54' ' ' ILE . 52.2 m -76.83 138.16 39.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -1.216 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.479 ' CG2' ' O ' ' A' ' 70' ' ' HIS . 26.1 mm -102.94 134.28 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.898 . . . . 0.0 109.556 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 27.3 mttt -112.08 141.99 45.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.343 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.48 ' HD2' ' CE1' ' A' ' 67' ' ' TYR . 35.3 ttpt -125.32 125.29 43.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.7 mt -111.76 138.14 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 109.516 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 67.6 m -134.62 133.21 39.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.874 . . . . 0.0 109.312 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.557 ' CE1' ' HB2' ' A' ' 61' ' ' GLU . 9.5 t80 -110.12 124.5 51.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.69 78.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.9 . . . . 0.0 109.417 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.557 ' HB2' ' CE1' ' A' ' 59' ' ' PHE . 74.9 mm-40 -96.43 -170.18 2.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.892 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.96 177.96 37.78 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' GLU . 24.9 m120 -89.53 149.36 22.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.198 -1.178 . . . . 0.0 109.455 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 63' ' ' ASN . 82.8 mt-10 43.94 -165.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.507 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -98.94 134.66 41.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.411 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HD2' ' CB ' ' A' ' 59' ' ' PHE . 55.7 mttm -90.52 20.45 4.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.48 ' CE1' ' HD2' ' A' ' 56' ' ' LYS . 63.7 t80 -45.8 114.42 0.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.405 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -137.55 141.31 41.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.629 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -98.45 144.7 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.479 ' O ' ' CG2' ' A' ' 54' ' ' ILE . 76.0 m80 -130.68 147.01 52.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.475 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 16.3 tttp -135.0 134.86 40.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.14 -0.975 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 75' ' ' ILE . 46.0 t -98.75 133.22 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -79.38 -43.01 24.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.1 tt0 -176.65 140.02 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.446 HD12 ' HA2' ' A' ' 50' ' ' GLY . 70.4 mt -119.31 126.52 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 75' ' ' ILE . 78.3 m-20 -134.7 76.76 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.7 m170 -55.86 -37.15 68.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.0 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.365 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 80' ' ' PHE . 58.7 m-20 -91.71 12.66 20.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ASN . 91.9 m-85 43.21 39.99 2.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.598 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.456 ' HE2' ' SG ' ' A' ' 83' ' ' CYS . 87.7 tttt -132.07 122.77 25.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.451 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 50.9 t80 -118.62 127.44 53.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.456 ' SG ' ' HE2' ' A' ' 81' ' ' LYS . 31.8 m -130.22 121.24 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -135.39 163.05 30.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.9 m -126.38 163.85 22.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 mt -119.97 133.63 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 89' ' ' GLY . 87.3 mt -111.91 -2.31 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.568 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.567 ' CB ' HD11 ' A' ' 92' ' ' LEU . 33.5 mt-10 39.23 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.632 -0.668 . . . . 0.0 109.965 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -127.92 -160.98 10.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . -37.82 -72.66 0.17 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 93' ' ' GLY . 53.1 Cg_endo -94.02 2.49 3.05 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.19 2.593 . . . . 0.0 112.381 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.567 HD11 ' CB ' ' A' ' 88' ' ' GLU . 1.8 tt 49.79 -88.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.333 -0.854 . . . . 0.0 109.532 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -98.79 169.98 23.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -85.05 124.61 31.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -1.149 . . . . 0.0 109.654 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 67.85 6.25 4.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 109.779 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 97' ' ' GLU . 95.9 mt -108.34 94.37 5.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.152 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 123' ' ' HIS . 47.4 mt-10 -41.0 -42.45 1.89 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.7 -0.625 . . . . 0.0 109.888 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 31.4 ttpt -177.73 162.17 1.72 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 0.0 109.752 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.596 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 5.7 mm -129.6 118.05 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.505 -0.747 . . . . 0.0 109.154 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 120' ' ' SER . 46.9 t -112.08 141.02 46.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 119' ' ' THR . 97.3 m-85 -120.33 143.6 48.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.054 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.9 mt-10 -121.12 143.69 48.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.74 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 82' ' ' TYR . 75.7 mt -122.86 130.82 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.294 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -132.27 133.39 44.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.565 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -112.95 144.49 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.322 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.24 161.75 38.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.11 143.72 33.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -128.85 152.54 79.17 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.11 -45.41 1.95 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.668 2.245 . . . . 0.0 111.676 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -150.25 159.18 44.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 109.321 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 11' ' ' THR . . . 77.74 35.28 36.38 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 123.24 87.34 0.81 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -46.04 -27.25 2.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 14' ' ' ILE . 74.6 m -135.29 139.75 44.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.14 . . . . 0.0 109.528 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 63.9 mt -107.75 137.67 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 10' ' ' ALA . 33.0 mt -117.21 130.29 56.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 0.0 109.628 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.37 141.38 51.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.52 138.22 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 0.0 109.738 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 28.7 m -126.78 142.57 51.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 100' ' ' SER . 8.9 m -126.58 158.87 35.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.95 . . . . 0.0 109.831 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 86.2 mttt -144.14 118.19 9.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.596 ' CE1' ' CG2' ' A' ' 99' ' ' ILE . 2.9 m-85 -113.18 113.22 25.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.576 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 54.9 m-70 -85.94 116.51 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 128' ' ' ALA . 1.4 p -107.33 146.14 31.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 109.98 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -80.82 140.69 35.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.46 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.54 67.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.446 ' OD1' ' HA2' ' A' ' 2' ' ' GLY . 30.1 t30 56.14 45.45 23.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 0.0 109.447 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -72.78 142.06 48.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.3 p -82.39 155.42 24.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 21.5 mt -111.57 131.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.83 141.56 58.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.48 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.6 mt-10 -67.65 -29.64 68.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -65.01 -37.56 88.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.94 -44.91 83.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 132' ' ' GLU . 46.4 pt -80.76 -31.85 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.431 ' N ' HG13 ' A' ' 135' ' ' ILE . 25.6 tttm -57.01 -39.87 75.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.87 73.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.913 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.3 -38.09 94.08 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -59.81 -43.61 94.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.69 -38.9 92.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -63.05 -40.91 99.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.79 -38.63 86.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.77 92.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.17 -42.88 97.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.3 tp -66.05 -39.53 90.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -1.108 . . . . 0.0 109.334 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.409 ' O ' HG13 ' A' ' 149' ' ' VAL . 65.9 t80 -64.38 -43.11 95.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.867 . . . . 0.0 109.354 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -66.21 -33.85 76.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.74 -49.25 32.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.361 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 146' ' ' PHE . 7.8 p -63.96 -41.51 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.402 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -56.31 -44.39 79.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.397 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.56 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 63.3 t80 -59.96 -49.61 76.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 156' ' ' HIS . 39.1 tp -57.12 -35.49 69.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.7 tt -62.67 -46.79 86.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.89 71.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 153' ' ' LEU . 3.5 m-70 50.78 61.2 13.72 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.56 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 51.3 Cg_endo -70.91 -9.7 26.22 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.7 2.266 . . . . 0.0 111.751 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.541 ' O ' ' CE2' ' A' ' 160' ' ' TYR . 53.5 p30 -106.94 9.74 30.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.508 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.93 146.03 55.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.541 ' CE2' ' O ' ' A' ' 158' ' ' ASP . 95.3 m-85 -122.17 138.19 54.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.443 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.73 -27.06 65.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.578 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 43.4 t -131.24 133.95 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -1.138 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.542 ' CD1' HD13 ' A' ' 130' ' ' ILE . 96.3 m-85 -103.15 137.06 41.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.493 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.7 m -113.33 119.8 38.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.575 ' CE2' HG21 ' A' ' 135' ' ' ILE . 31.1 m-85 -115.16 139.87 49.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.4 mt-10 -115.33 147.17 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.81 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' OD2' ' HB ' ' A' ' 118' ' ' ILE . 42.1 m-20 -119.16 154.6 33.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.233 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 117' ' ' LYS . 95.2 mt-10 -124.12 140.91 52.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.36 120.73 6.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 109.114 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 55.0 m -114.51 129.03 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.933 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 14' ' ' ILE . 34.0 t -160.5 140.58 11.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.87 . . . . 0.0 109.078 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.521 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 26.1 m -70.93 90.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 0.0 109.4 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.537 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -139.17 145.56 45.37 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 46.2 Cg_endo -68.02 124.49 11.86 Favored 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 122.361 2.041 . . . . 0.0 111.243 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.52 -30.59 43.18 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.742 2.295 . . . . 0.0 112.429 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -52.62 8.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.646 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -72.06 -41.62 67.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 22.7 tp -61.48 -48.98 78.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.828 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' O ' ' N ' ' A' ' 24' ' ' VAL . 61.9 t80 -56.22 -52.75 63.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.812 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 61.9 mttm -67.34 -49.57 63.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 110.017 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.52 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 86.1 p -69.85 -21.17 63.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 110.219 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.533 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 62.6 t80 -100.22 -49.21 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.963 -1.086 . . . . 0.0 110.194 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 20' ' ' PHE . 53.2 t -84.56 -52.43 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.5 tp -68.7 -35.22 76.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.046 -1.034 . . . . 0.0 110.184 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.47 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 68.9 m-20 -103.47 19.54 19.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.053 . . . . 0.0 109.868 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.54 -36.39 76.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.443 ' O ' ' HG3' ' A' ' 32' ' ' PRO . 87.6 m-20 -68.41 -26.98 65.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.906 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 24.9 m120 -97.6 -51.69 4.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 22' ' ' SER . 36.4 mt -59.17 -39.36 82.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.025 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.506 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 21.1 mt -52.52 -60.25 6.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.591 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.506 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.43 -32.31 25.74 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.547 2.165 . . . . 0.0 111.797 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 16.1 tttt -62.06 -31.84 72.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.84 . . . . 0.0 109.621 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.6 -40.15 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.37 117.76 68.74 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.04 -20.92 32.9 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.693 2.262 . . . . 0.0 111.837 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' O ' ' CB ' ' A' ' 38' ' ' HIS . 93.8 mt-30 -115.0 154.73 28.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.547 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.465 ' CB ' ' O ' ' A' ' 37' ' ' GLN . 10.1 m80 73.04 104.46 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.868 . . . . 0.0 109.529 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.94 136.25 41.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.933 . . . . 0.0 109.363 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.1 m -119.14 143.14 47.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.484 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -131.01 148.35 52.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.488 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' CB ' HG12 ' A' ' 57' ' ' ILE . . . -141.26 150.06 42.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.565 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.93 156.16 45.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -85.9 107.36 17.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.447 ' HB3' HG21 ' A' ' 54' ' ' ILE . 43.9 tp -62.78 -40.75 98.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 53' ' ' THR . 97.7 mt-10 -153.53 162.58 41.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.493 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 87.1 159.49 33.87 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -87.87 9.48 21.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -1.17 . . . . 0.0 109.561 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.25 13.65 32.77 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 75' ' ' ILE . . . -110.33 -143.68 9.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.77 123.64 10.3 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.651 2.234 . . . . 0.0 111.765 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 54' ' ' ILE . . . 94.44 -4.42 69.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.462 HG21 ' HA2' ' A' ' 49' ' ' GLY . 94.5 m -74.1 138.17 43.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.463 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.563 ' N ' ' CD1' ' A' ' 54' ' ' ILE . 1.7 mp -103.74 126.82 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 25.0 mttm -110.94 145.18 38.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -124.72 127.02 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.522 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.5 HG12 ' CB ' ' A' ' 42' ' ' ALA . 66.8 mt -114.2 137.6 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.411 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.614 ' CG2' ' CZ ' ' A' ' 65' ' ' PHE . 51.7 m -118.4 134.14 55.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.87 . . . . 0.0 109.471 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -160.2 127.89 4.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 109.462 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -152.83 158.41 42.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.489 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -62.14 -31.18 71.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.867 . . . . 0.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.35 -54.28 0.79 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -60.32 -35.94 76.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -1.127 . . . . 0.0 109.44 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -122.55 150.67 42.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.614 ' CZ ' ' CG2' ' A' ' 58' ' ' THR . 51.8 t80 -108.38 131.78 54.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.521 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -112.15 153.12 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' CE2' ' CE2' ' A' ' 65' ' ' PHE . 98.2 m-85 -116.63 135.27 53.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.3 mtp -134.83 156.43 48.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.36 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -135.05 141.32 46.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 78.6 m80 -130.77 134.59 47.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -127.02 142.49 51.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.504 HG11 ' CG1' ' A' ' 75' ' ' ILE . 51.9 t -105.82 126.9 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -71.35 -48.65 48.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 83.4 tt0 -166.9 146.02 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.576 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.544 HG22 ' CE1' ' A' ' 77' ' ' HIS . 73.4 mt -122.72 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.382 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 86.2 m-20 -133.4 81.07 1.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.544 ' CE1' HG22 ' A' ' 75' ' ' ILE . 78.8 m80 -59.37 -38.57 80.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.26 82.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.433 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 76.9 m-20 -86.16 3.91 40.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 52.73 29.3 7.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -122.45 135.68 54.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.53 ' CE1' HG12 ' A' ' 75' ' ' ILE . 57.0 t80 -130.08 130.46 44.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.24 115.76 16.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.502 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.503 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.4 p90 -136.88 158.48 44.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.623 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.427 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 84.5 p -139.19 169.51 17.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.362 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.0 mt -117.84 129.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.5 mt -77.36 -32.92 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.463 ' HA ' HD13 ' A' ' 92' ' ' LEU . 72.0 tt0 -148.52 134.81 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.43 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -145.21 72.42 0.34 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.0 -107.49 0.15 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.9 Cg_endo -69.62 -35.1 13.69 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.732 2.288 . . . . 0.0 111.762 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER 63.82 -82.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.406 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -172.96 -167.44 32.89 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -107.9 118.0 35.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.143 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.52 HG22 ' CB ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 60.1 22.67 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.579 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.523 HD21 ' CD1' ' A' ' 130' ' ' ILE . 88.6 mt -104.43 96.55 6.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.096 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 123' ' ' HIS . 72.8 mm-40 -59.66 -33.39 71.48 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.766 -0.584 . . . . 0.0 111.034 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.473 ' O ' HD13 ' A' ' 99' ' ' ILE . 34.3 ttpt -142.44 142.74 32.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.474 -1.391 . . . . 0.0 110.793 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.568 HG22 ' CE1' ' A' ' 122' ' ' TYR . 27.2 mm -130.77 113.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.427 ' OG ' ' HB3' ' A' ' 85' ' ' SER . 38.4 t -121.31 152.05 39.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -131.05 131.9 44.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.031 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.1 mt-10 -118.72 141.77 48.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.801 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.73 127.56 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.839 . . . . 0.0 109.323 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -130.18 131.68 45.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.637 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.418 ' HG2' ' HG ' ' A' ' 116' ' ' LEU . 63.5 mtt -120.56 141.22 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.9 153.68 41.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.62 132.43 42.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.63 116.64 50.06 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.51 -25.66 29.52 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.743 2.295 . . . . 0.0 111.739 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -64.01 -41.4 97.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.349 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 162.75 174.24 32.42 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 114' ' ' SER . . . 82.76 17.95 66.81 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 47.3 -87.52 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 112' ' ' GLY . 34.3 m -131.25 146.83 52.47 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.413 -1.051 . . . . 0.0 109.378 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.44 HG22 ' CE ' ' A' ' 117' ' ' LYS . 68.8 mt -116.56 135.91 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.5 mp -107.03 140.71 39.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.464 ' O ' HD11 ' A' ' 118' ' ' ILE . 26.7 mmtp -125.3 139.46 53.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.465 ' HB ' ' OD2' ' A' ' 8' ' ' ASP . 10.5 mm -115.0 126.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.687 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 30.8 m -121.23 133.55 55.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.58 157.42 42.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.955 . . . . 0.0 109.93 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -134.03 117.47 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.568 ' CE1' HG22 ' A' ' 99' ' ' ILE . 13.9 m-30 -109.81 118.81 37.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.578 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 2.2 t60 -85.73 127.06 34.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 95' ' ' THR . 0.9 OUTLIER -109.43 146.82 33.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.8 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -71.33 135.61 47.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 55.07 -145.2 30.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 128' ' ' ALA . 48.5 p-10 -87.45 17.16 4.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' A' ' 95' ' ' THR . . . -44.5 144.41 1.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -114.47 157.0 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.542 HD13 ' CD1' ' A' ' 4' ' ' PHE . 64.4 mt -110.12 140.18 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.43 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 10.1 t-20 -79.4 133.43 36.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.412 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 136' ' ' LYS . 96.4 mt-10 -65.33 -34.99 79.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 79.0 tt0 -66.64 -35.31 79.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.52 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.6 mt-10 -67.89 -38.13 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.575 HG21 ' CE2' ' A' ' 6' ' ' TYR . 38.4 pt -78.16 -39.5 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.506 ' N ' HG13 ' A' ' 135' ' ' ILE . 24.1 mttm -59.41 -37.94 79.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.9 73.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.11 -40.81 84.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -60.1 -43.48 95.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.171 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.37 -44.8 76.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.433 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.14 -45.82 89.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.91 79.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -0.952 . . . . 0.0 109.409 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.86 88.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.44 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.96 -45.26 95.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 149' ' ' VAL . 57.7 mt -60.96 -38.97 87.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -1.095 . . . . 0.0 109.375 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.473 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 67.1 t80 -57.22 -45.84 83.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.37 -40.53 91.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.08 -52.07 46.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.473 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.5 p -64.69 -40.59 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -56.45 -42.34 77.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.35 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.3 99.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.356 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.559 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 73.4 t80 -59.64 -44.59 93.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 36.4 tp -60.82 -35.31 76.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.893 . . . . 0.0 109.385 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.1 tt -61.93 -45.64 92.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.923 . . . . 0.0 109.34 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.14 -32.17 72.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 48.54 61.39 14.03 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.559 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 48.8 Cg_endo -69.98 -14.19 35.08 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.696 2.264 . . . . 0.0 111.744 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -66.18 -33.63 76.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.84 145.78 51.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -118.21 138.15 52.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.413 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.401 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.35 146.84 50.63 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.57 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 24.7 t -132.52 133.85 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.551 ' CD1' HD13 ' A' ' 130' ' ' ILE . 96.7 m-85 -90.38 140.34 29.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.172 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 120' ' ' SER . 26.6 p -125.52 127.04 45.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 119' ' ' THR . 93.5 m-85 -123.78 143.89 50.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.262 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -123.41 147.97 46.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.76 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -132.46 134.0 44.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.204 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -107.76 134.52 50.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.756 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.74 123.22 19.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 109.118 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -109.73 133.22 53.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.937 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.9 m -160.42 139.94 10.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 109.003 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.469 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.6 p -73.79 90.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.965 -1.084 . . . . 0.0 109.217 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 10.3 mt -139.48 144.29 39.13 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.136 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 43.7 Cg_endo -66.42 121.96 9.33 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.369 2.046 . . . . 0.0 111.165 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -66.79 -29.24 42.53 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.724 2.283 . . . . 0.0 112.241 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.24 -52.93 7.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' A' ' 161' ' ' CYS . 60.5 mtt85 -72.03 -39.35 69.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 3.4 tm? -63.06 -51.88 64.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.0 t80 -56.85 -51.3 69.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.781 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.7 tttp -68.36 -50.22 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 18' ' ' ARG . 69.0 p -68.08 -21.26 64.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.04 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.522 ' CB ' HD12 ' A' ' 19' ' ' LEU . 12.5 t80 -100.06 -50.61 3.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.063 -1.023 . . . . 0.0 110.115 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 61.8 t -84.68 -52.66 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.26 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.4 tp -68.88 -44.83 72.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.888 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -98.99 30.31 3.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.26 -47.27 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.774 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 50.6 m-20 -69.44 -25.82 64.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.992 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.403 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 88.6 m-20 -84.71 -39.12 18.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.687 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.459 ' O ' HG13 ' A' ' 34' ' ' VAL . 7.0 mp -76.02 -29.03 57.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.526 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 17.6 mt -52.88 -59.28 9.27 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 28' ' ' ASP . 49.0 Cg_endo -68.46 -31.56 27.27 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.574 2.183 . . . . 0.0 111.958 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.562 ' HB3' ' CE2' ' A' ' 152' ' ' TYR . 73.8 mttt -63.1 -36.82 84.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.723 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 31' ' ' ILE . 4.5 m -62.06 -23.4 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.698 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.446 ' N ' HG21 ' A' ' 34' ' ' VAL . . . -106.54 165.85 12.22 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.622 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.67 -29.34 24.46 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.706 2.271 . . . . 0.0 111.81 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -136.6 150.19 48.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.852 . . . . 0.0 109.443 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.484 ' CG ' ' N ' ' A' ' 39' ' ' PHE . 46.4 p-80 -51.89 -41.31 61.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.484 ' N ' ' CG ' ' A' ' 38' ' ' HIS . 9.6 t80 71.13 -58.17 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.88 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 58' ' ' THR . 10.9 p -127.09 160.9 29.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.7 t -130.31 140.97 50.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.434 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.34 138.52 49.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -127.74 143.09 51.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.858 . . . . 0.0 109.413 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.439 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 81.0 m-20 -87.14 108.61 18.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 56' ' ' LYS . 2.2 mp -68.85 -39.19 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 49.5 tp10 -150.05 153.23 36.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 90.79 157.74 33.95 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -93.47 10.26 33.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.462 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.1 27.99 6.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.515 ' CA ' HD11 ' A' ' 75' ' ' ILE . . . -122.16 -145.63 7.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 51.2 Cg_endo -70.23 123.34 9.86 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.744 2.296 . . . . 0.0 111.884 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.01 83.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 56.9 m -72.75 137.6 45.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -1.223 . . . . 0.0 109.44 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 25.2 mm -101.03 129.75 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 17.6 mttt -126.55 145.95 50.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.882 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' N ' HD13 ' A' ' 45' ' ' LEU . 28.2 ttpt -130.82 138.84 50.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.366 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.537 HG22 ' CE2' ' A' ' 59' ' ' PHE . 9.7 tt -117.48 137.31 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.557 HG23 ' CD1' ' A' ' 65' ' ' PHE . 8.7 p -98.28 151.72 20.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.356 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.537 ' CE2' HG22 ' A' ' 57' ' ' ILE . 92.8 m-85 -127.44 165.81 19.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.549 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.81 -11.8 49.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 109.464 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.509 ' HG3' ' CZ ' ' A' ' 67' ' ' TYR . 76.2 mm-40 -50.58 154.15 1.43 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.86 -37.7 15.52 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -84.21 125.45 32.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -1.147 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.568 ' HG2' ' CD2' ' A' ' 65' ' ' PHE . 71.1 tt0 -121.71 150.0 42.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.384 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.568 ' CD2' ' HG2' ' A' ' 64' ' ' GLU . 95.3 m-85 59.41 18.83 7.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.253 -0.904 . . . . 0.0 109.444 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -167.2 28.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.308 -0.87 . . . . 0.0 109.351 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.509 ' CZ ' ' HG3' ' A' ' 61' ' ' GLU . 70.4 t80 -99.4 -24.44 14.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 109.495 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.481 ' CG ' ' O ' ' A' ' 67' ' ' TYR . 38.9 mtt -159.75 139.38 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.943 . . . . 0.0 109.381 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 94.2 mttt -107.8 148.54 29.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.513 ' CE1' ' CD1' ' A' ' 84' ' ' TYR . 47.5 t60 -129.79 131.26 46.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.476 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.6 tttp -131.88 136.17 47.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 39.6 t -99.36 129.17 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.406 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -76.39 -42.29 44.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 85.4 tt0 -175.27 141.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 82' ' ' TYR . 66.7 mt -119.85 131.24 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -129.95 85.69 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.558 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 87.8 m-70 -62.34 -37.24 84.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.92 70.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -88.99 -3.07 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 57.9 34.55 24.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.475 ' HE2' ' CE ' ' A' ' 104' ' ' LYS . 25.5 mttt -128.95 129.56 45.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.529 ' CE2' HG12 ' A' ' 75' ' ' ILE . 62.1 t80 -120.16 124.13 45.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.898 . . . . 0.0 109.531 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.05 115.03 19.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.513 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 38.3 p90 -128.97 152.41 48.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB3' ' HE2' ' A' ' 98' ' ' LYS . 9.7 m -132.02 146.72 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.526 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 86' ' ' ILE . 67.6 mt -93.16 150.2 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' A' ' 69' ' ' LYS . 88.6 mt -104.02 -34.65 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.443 ' OE1' ' HE3' ' A' ' 69' ' ' LYS . 94.8 mt-10 -151.75 143.44 23.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -158.52 136.52 4.78 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . -30.96 -66.52 0.15 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 93' ' ' GLY . 54.7 Cg_endo -74.37 -33.83 5.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.517 2.145 . . . . 0.0 111.488 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' PRO . 5.4 tp 36.87 -92.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.812 -0.555 . . . . 0.0 110.261 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 171.99 156.21 11.94 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -81.26 125.5 30.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 109.644 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.405 ' CG2' ' HB3' ' A' ' 125' ' ' LYS . 16.0 m 51.87 19.78 1.04 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.491 HD21 ' CD1' ' A' ' 130' ' ' ILE . 51.7 mt -91.09 87.87 6.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 0.0 109.043 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.5 mt-10 -39.93 -35.47 0.36 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.761 -0.587 . . . . 0.0 110.401 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.489 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 31.7 tttt -169.08 160.91 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.766 -1.209 . . . . 0.0 110.371 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.621 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 27.2 mt -137.14 117.62 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.453 ' OG ' ' OG ' ' A' ' 85' ' ' SER . 48.4 t -118.35 152.66 35.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.977 . . . . 0.0 109.906 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.571 ' CZ ' HG23 ' A' ' 99' ' ' ILE . 84.1 m-85 -130.76 136.07 48.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.813 . . . . 0.0 109.175 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 86.8 mt-10 -114.62 143.21 45.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.711 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 79.0 mt -118.51 130.79 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.258 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' CE ' ' HE2' ' A' ' 81' ' ' LYS . 19.8 tttt -127.97 131.51 49.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.608 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.413 ' HE1' HD22 ' A' ' 116' ' ' LEU . 63.3 mtt -122.29 146.25 47.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.386 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -141.27 151.32 43.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.56 139.27 39.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -130.85 103.7 15.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.9 142.88 48.5 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.733 2.289 . . . . 0.0 111.706 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 61.53 34.31 17.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.25 -169.94 13.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -51.29 -39.07 42.35 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 148.56 -109.98 0.47 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.1 p -117.93 151.71 36.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -1.2 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 69.3 mt -119.34 131.6 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.324 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.2 mp -108.32 136.85 47.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.584 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 90.9 mttt -119.01 144.04 46.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.26 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.6 mt -124.1 131.09 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.945 . . . . 0.0 109.571 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 23.5 m -119.48 142.49 48.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.464 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . 64.8 m -123.18 146.33 47.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 51.6 mtmt -135.67 127.39 29.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.621 ' CE1' ' CG2' ' A' ' 99' ' ' ILE . 25.7 m-85 -125.89 122.2 35.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 109.853 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.57 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 90.1 m-70 -89.72 116.97 28.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 108.673 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.473 ' OG1' ' N ' ' A' ' 128' ' ' ALA . 0.7 OUTLIER -104.98 142.29 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.618 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.405 ' HB3' ' CG2' ' A' ' 95' ' ' THR . 31.0 ttpt -84.85 128.16 34.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.6 67.28 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 m120 58.95 40.28 22.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.473 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -69.82 140.59 53.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.293 -0.88 . . . . 0.0 109.54 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 55.3 p -80.16 156.6 26.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.551 HD13 ' CD1' ' A' ' 4' ' ' PHE . 40.4 mt -113.82 130.89 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 109.686 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.452 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 46.5 t-20 -60.04 131.81 52.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.87 -33.66 76.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.338 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.26 -36.44 82.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.452 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 75.5 mm-40 -64.62 -43.81 92.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 136' ' ' LYS . 34.8 pt -75.49 -32.85 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.427 ' N ' HG13 ' A' ' 135' ' ' ILE . 16.7 tttp -55.7 -45.33 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.25 -40.73 71.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.258 -0.902 . . . . 0.0 109.339 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.44 -40.16 95.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -60.3 -40.5 90.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -1.18 . . . . 0.0 109.279 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.74 -40.43 97.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -59.13 -44.76 92.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.275 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.88 93.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.89 -43.25 93.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.874 . . . . 0.0 109.332 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.65 -43.2 96.39 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.3 mt -65.63 -40.45 92.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -1.161 . . . . 0.0 109.272 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.433 ' O ' HG21 ' A' ' 149' ' ' VAL . 65.1 t80 -66.05 -40.54 91.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -68.0 -35.93 79.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.296 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.21 -51.55 52.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.54 ' CG2' ' N ' ' A' ' 150' ' ' GLU . 3.6 m -64.87 -46.6 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.364 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.54 ' N ' ' CG2' ' A' ' 149' ' ' VAL . 83.7 tt0 -56.19 -35.49 67.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.51 -36.03 81.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 33' ' ' LYS . 63.6 t80 -62.3 -43.19 99.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.406 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 153' ' ' LEU . 90.3 mt -60.53 -42.9 97.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.324 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.434 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 31.0 mt -73.25 -27.33 61.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.538 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.8 -21.98 59.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.505 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.69 61.31 3.43 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 50.0 Cg_endo -70.3 -16.3 35.24 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.619 2.212 . . . . 0.0 111.914 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.477 ' O ' ' CE2' ' A' ' 160' ' ' TYR . 88.5 m-20 -61.12 -36.48 79.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.514 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.34 139.88 14.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.525 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 158' ' ' ASP . 93.0 m-85 -117.09 144.84 44.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.38 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.442 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.454 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.297 0.57 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.62 15.96 76.71 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.585 HG21 ' CG ' ' A' ' 123' ' ' HIS . 29.3 t -128.68 128.56 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -1.116 . . . . 0.0 109.344 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.577 ' CE1' HG12 ' A' ' 130' ' ' ILE . 97.1 m-85 -85.61 136.46 33.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 120' ' ' SER . 36.0 t -122.55 129.17 51.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.96 . . . . 0.0 109.705 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.574 ' CD1' HG23 ' A' ' 135' ' ' ILE . 77.6 m-85 -129.39 147.16 51.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.147 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -119.3 139.74 51.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.712 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 91.2 m-20 -110.36 150.63 28.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.379 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -115.89 137.68 51.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 109.865 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.0 122.66 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.79 . . . . 0.0 109.018 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -127.51 137.41 52.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.975 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.431 ' HB3' HD13 ' A' ' 14' ' ' ILE . 3.2 t -160.49 150.08 17.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 108.992 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.3 p -74.59 91.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 0.0 109.446 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 1.8 mt -138.85 143.5 37.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 45.9 Cg_endo -67.62 124.62 12.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.399 2.066 . . . . 0.0 111.44 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.76 -35.74 26.79 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.253 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.78 -49.56 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -72.43 -46.03 56.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.91 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.522 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 19.7 tp -60.33 -42.97 96.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.995 . . . . 0.0 109.719 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.547 ' CE2' HG21 ' A' ' 24' ' ' VAL . 68.9 t80 -62.39 -47.78 82.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.759 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 25' ' ' LEU . 70.6 tttt -68.35 -41.34 80.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.676 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 86.3 p -77.7 -24.62 49.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 13.7 t80 -100.48 -50.74 3.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.404 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.547 HG21 ' CE2' ' A' ' 20' ' ' PHE . 54.1 t -84.8 -52.63 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.527 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.494 ' CG ' ' HA ' ' A' ' 21' ' ' LYS . 59.3 mt -71.63 -32.62 68.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.045 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 92.0 m-20 -106.58 23.05 14.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.66 -41.81 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.598 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.432 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 26.1 p-10 -71.03 -34.03 70.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.85 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.413 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.3 m-20 -88.69 -31.71 18.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.801 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.0 tp -73.74 -21.74 60.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 15.5 mt -65.81 -57.24 14.43 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.6 -27.71 32.32 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.472 2.114 . . . . 0.0 111.744 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -67.37 -45.66 75.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 109.459 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.497 HG11 ' N ' ' A' ' 35' ' ' ALA . 7.1 p -69.29 -34.7 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.497 ' N ' HG11 ' A' ' 34' ' ' VAL . . . -68.67 135.48 90.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.407 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.73 -22.94 31.51 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.721 2.281 . . . . 0.0 111.811 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -110.56 135.67 50.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -107.42 10.21 29.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -61.43 -30.91 70.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.394 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.3 m -107.49 137.15 46.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.5 p -147.28 163.59 35.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.552 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.59 139.23 47.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -138.0 156.37 47.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.399 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 44' ' ' ASN . 36.2 p-10 -90.19 108.22 19.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.424 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.0 tp -64.35 -37.72 88.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.495 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 49.2 tp10 -141.54 155.44 45.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 91.31 161.34 37.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.7 9.17 30.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -1.159 . . . . 0.0 109.486 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.461 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 99.53 19.19 21.22 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -114.92 -141.37 7.5 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.49 123.1 9.86 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.708 2.272 . . . . 0.0 111.781 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.84 0.83 71.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.461 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.6 m -77.0 136.19 38.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -1.17 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.498 HG22 ' N ' ' A' ' 55' ' ' LYS . 7.8 mt -105.36 139.44 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' N ' HG22 ' A' ' 54' ' ' ILE . 62.1 mttm -116.09 145.76 42.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -129.45 142.59 50.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.435 HD12 ' CE1' ' A' ' 70' ' ' HIS . 64.5 mt -100.66 137.49 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 59' ' ' PHE . 91.6 m -86.06 141.51 29.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.895 . . . . 0.0 109.453 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.567 ' O ' ' CD2' ' A' ' 59' ' ' PHE . 64.3 t80 45.54 56.83 5.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.03 149.57 23.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 62' ' ' GLY . 96.7 mt-10 -54.44 142.54 26.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . -44.05 118.86 2.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.504 ' ND2' ' HE1' ' A' ' 68' ' ' MET . 8.8 p30 -145.15 -172.54 3.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -1.132 . . . . 0.0 109.407 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HB3' ' HA2' ' A' ' 90' ' ' GLY . 84.5 tt0 -56.45 -41.27 76.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.407 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' CE2' ' OE1' ' A' ' 88' ' ' GLU . 97.2 m-85 -106.15 144.08 33.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -64.85 -36.17 83.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.362 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.52 148.0 49.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.397 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.504 ' HE1' ' ND2' ' A' ' 63' ' ' ASN . 64.8 mtt -110.29 151.16 27.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.957 . . . . 0.0 109.554 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -116.85 140.01 49.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.435 ' CE1' HD12 ' A' ' 57' ' ' ILE . 77.7 m80 -127.88 138.63 52.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.433 ' HB2' HD13 ' A' ' 87' ' ' ILE . 51.5 tttm -133.56 151.24 51.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.543 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.503 HG23 ' CG1' ' A' ' 75' ' ' ILE . 11.3 p -110.81 132.3 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.484 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -72.98 -44.12 61.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -176.07 140.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.503 ' CG1' HG23 ' A' ' 72' ' ' VAL . 66.1 mt -118.09 127.02 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.431 ' CB ' ' HB3' ' A' ' 79' ' ' ASN . 89.3 m-20 -122.27 85.09 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 85.5 m-70 -60.26 -38.8 84.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.76 -30.54 65.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.488 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 76' ' ' ASP . 58.2 t30 -90.56 7.23 40.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 46.03 36.99 3.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -128.17 128.42 44.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.319 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 63.1 t80 -120.11 125.58 48.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 58.4 m -127.45 114.05 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.524 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.8 p90 -129.48 163.03 26.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.509 ' HB2' ' CB ' ' A' ' 100' ' ' SER . 43.5 t -150.54 162.75 40.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.37 141.1 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' A' ' 71' ' ' LYS . 80.6 mt -92.35 -35.42 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.9 . . . . 0.0 109.307 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.547 ' OE1' ' CE2' ' A' ' 65' ' ' PHE . 29.8 tt0 -154.08 124.79 7.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.543 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -136.78 143.96 15.45 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . -32.74 -67.23 0.19 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 93' ' ' GLY . 54.4 Cg_endo -74.27 -31.22 7.73 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.382 2.055 . . . . 0.0 111.28 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 91' ' ' PRO . 6.6 tp 36.5 -91.4 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.153 0.501 . . . . 0.0 110.264 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 176.2 167.84 35.55 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.448 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 56.5 m170 -90.36 129.88 36.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.466 HG23 ' CD ' ' A' ' 125' ' ' LYS . 1.1 m 46.23 24.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.541 ' CD2' ' HB3' ' A' ' 122' ' ' TYR . 27.0 mt -101.6 92.98 5.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.084 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.6 mt-10 -45.63 -36.13 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 0.0 110.728 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' O ' ' CD1' ' A' ' 99' ' ' ILE . 15.2 tttp -163.38 157.94 20.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.656 -1.277 . . . . 0.0 110.503 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.624 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 5.3 mm -133.0 119.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.748 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 85' ' ' SER . 38.4 m -120.14 144.44 47.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 109.74 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.571 ' CZ ' HG22 ' A' ' 99' ' ' ILE . 86.7 m-85 -125.76 128.62 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.342 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 89.5 mt-10 -105.06 143.71 32.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 77.8 mt -128.8 118.67 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -127.41 134.67 49.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.432 ' SD ' HD23 ' A' ' 19' ' ' LEU . 63.4 mtm -118.97 145.79 45.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.464 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.72 157.5 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.02 139.84 30.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.892 . . . . 0.0 109.314 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -104.87 125.2 34.4 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 109.661 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.91 -49.58 0.53 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.694 2.263 . . . . 0.0 111.704 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -76.83 -48.26 18.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.375 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -57.69 -29.11 60.92 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.66 27.42 69.3 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -151.93 -133.13 1.93 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -139.93 145.15 37.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -1.129 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 62.8 mt -111.31 130.62 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 4.1 mp -105.41 134.13 49.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -126.37 139.18 53.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.075 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 72.7 mt -124.81 140.97 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.828 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 26.9 m -123.56 142.5 50.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 m -121.41 153.3 38.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.776 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 64.3 mttm -142.25 124.97 15.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.185 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.624 ' CE1' ' CG2' ' A' ' 99' ' ' ILE . 9.6 m-85 -123.85 113.97 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.585 ' CG ' HG21 ' A' ' 3' ' ' VAL . 41.3 m-70 -80.49 114.19 19.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 108.86 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.1 p -102.83 142.37 34.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 0.0 109.593 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.466 ' CD ' HG23 ' A' ' 95' ' ' THR . 39.1 mttt -44.66 -43.03 8.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.8 -68.14 0.31 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.24 -30.33 71.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -1.167 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.431 ' CB ' ' HB ' ' A' ' 95' ' ' THR . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.0 m -127.95 154.3 45.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.391 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.577 HG12 ' CE1' ' A' ' 4' ' ' PHE . 29.4 mm -105.38 120.19 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.494 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.454 ' O ' HD13 ' A' ' 135' ' ' ILE . 24.8 t-20 -75.79 142.31 42.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.472 ' O ' HG12 ' A' ' 135' ' ' ILE . 97.1 mt-10 -57.76 -28.08 63.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -66.87 -35.68 80.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 108.864 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.1 mt-10 -61.82 -25.0 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.172 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.574 HG23 ' CD1' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -80.8 -39.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -56.18 -40.36 73.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.04 -48.65 73.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.294 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.02 -37.41 71.03 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -58.62 -43.68 89.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -1.139 . . . . 0.0 109.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -57.19 -48.39 78.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.072 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -59.35 -45.89 90.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.217 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.38 89.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 0.0 109.208 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.32 88.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.39 86.06 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.57 -38.07 74.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -1.117 . . . . 0.0 109.284 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.459 ' O ' HG13 ' A' ' 149' ' ' VAL . 69.5 t80 -62.39 -43.66 98.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -60.23 -39.78 87.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.0 -50.01 67.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 150' ' ' GLU . 5.8 p -63.72 -42.8 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 149' ' ' VAL . 86.2 tt0 -61.21 -42.4 98.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.09 78.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.502 ' CZ ' ' CG ' ' A' ' 157' ' ' PRO . 51.5 t80 -60.96 -52.2 66.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 34.7 mt -53.21 -42.74 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.4 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.9 mt -59.95 -45.67 91.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -59.14 -25.46 63.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.391 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.452 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 1.3 t-80 43.84 53.59 10.41 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.502 ' CG ' ' CZ ' ' A' ' 152' ' ' TYR . 50.0 Cg_endo -70.09 -19.06 35.06 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.688 2.259 . . . . 0.0 111.848 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -61.26 -36.21 79.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.1 145.33 28.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.23 141.8 47.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.453 179.949 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.57 4.84 67.48 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.508 HG23 ' CD2' ' A' ' 123' ' ' HIS . 7.1 p -122.3 143.53 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -1.207 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.502 ' N ' HG21 ' A' ' 3' ' ' VAL . 90.4 m-85 -105.76 143.2 34.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 120' ' ' SER . 4.2 m -128.8 124.54 35.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.583 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.564 ' CE2' ' CD1' ' A' ' 135' ' ' ILE . 81.1 m-85 -119.59 152.07 37.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.7 mt-10 -126.37 154.98 42.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.449 ' OD2' ' HE2' ' A' ' 139' ' ' LYS . 54.5 t0 -126.77 151.42 48.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 93.2 mt-10 -122.38 135.5 54.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' O ' HG21 ' A' ' 115' ' ' ILE . . . -142.46 124.21 15.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.489 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.4 m -116.48 126.69 53.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.915 . . . . 0.0 109.682 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p -160.29 146.64 15.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 109.25 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.458 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 18.9 m -78.54 91.38 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.472 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.53 ' CG2' ' HB2' ' A' ' 19' ' ' LEU . 8.8 mt -138.79 144.69 42.75 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.537 ' O ' ' CB ' ' A' ' 19' ' ' LEU . 47.8 Cg_endo -68.7 123.35 10.35 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.536 2.158 . . . . 0.0 111.259 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.9 -27.76 43.1 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.745 2.296 . . . . 0.0 112.453 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.95 -54.62 6.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 109.527 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -72.62 -31.37 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.86 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.537 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 25.9 tp -71.96 -45.41 61.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.825 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.463 ' O ' HD13 ' A' ' 25' ' ' LEU . 58.1 t80 -64.72 -33.19 75.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 33.7 tttp -83.09 -30.32 28.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.894 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 81.3 p -97.58 -14.68 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.818 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.55 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 76.7 t80 -100.89 -50.03 3.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 47.2 t -84.83 -49.81 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.356 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 20' ' ' PHE . 8.7 mp -76.34 -39.74 53.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.58 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 30' ' ' LEU . 41.2 m-20 -92.78 10.53 30.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.014 . . . . 0.0 110.311 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.74 -34.31 73.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.888 -1.132 . . . . 0.0 109.414 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.26 -30.43 70.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 92.6 m-20 -114.81 -45.49 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.037 . . . . 0.0 109.973 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 26' ' ' ASP . 7.8 tt -57.41 -38.32 74.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.728 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.527 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 12.0 mm -50.38 -61.37 3.85 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 109.453 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.527 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.3 Cg_endo -68.53 -30.01 29.65 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.378 2.052 . . . . 0.0 111.632 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -54.94 -51.61 65.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.52 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 31' ' ' ILE . 5.7 p -58.75 -23.97 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.902 . . . . 0.0 109.333 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 32' ' ' PRO . . . -74.81 122.18 86.9 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.9 -23.0 30.64 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.63 2.22 . . . . 0.0 111.784 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 38' ' ' HIS . 96.1 mt-30 -132.98 163.09 29.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 37' ' ' GLN . 47.5 m-70 70.15 92.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.464 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -101.74 131.85 47.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.511 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.429 HG23 ' CD2' ' A' ' 59' ' ' PHE . 7.7 p -126.93 165.11 20.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.9 . . . . 0.0 109.442 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -129.94 144.94 51.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.418 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.9 143.76 42.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -145.4 147.66 32.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -93.62 109.0 20.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -38.55 88.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 85.4 tt0 -144.84 159.11 43.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.516 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.98 158.52 29.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -88.6 9.2 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -1.144 . . . . 0.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.44 ' HA2' HG22 ' A' ' 53' ' ' THR . . . 102.47 23.94 8.61 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.49 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -120.81 -140.62 6.02 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.31 121.92 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.684 2.256 . . . . 0.0 111.793 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.32 -2.87 75.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.49 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 99.8 m -72.69 136.95 45.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -1.217 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.469 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 22.5 mm -94.09 135.17 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -108.65 133.2 53.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -122.13 132.77 54.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.224 -0.923 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.554 HD11 ' CE1' ' A' ' 70' ' ' HIS . 65.7 mt -111.49 134.87 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.575 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.9 p -128.72 151.18 49.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.405 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.56 ' CD1' ' OE2' ' A' ' 64' ' ' GLU . 87.3 m-85 -114.79 140.9 48.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.962 . . . . 0.0 109.555 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.48 90.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.487 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.93 142.45 58.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.73 14.98 57.44 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -86.39 4.58 38.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -1.13 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.56 ' OE2' ' CD1' ' A' ' 59' ' ' PHE . 86.6 tt0 -105.32 142.11 35.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 0.0 109.53 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 96.2 m-85 -124.96 154.81 40.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -0.958 . . . . 0.0 109.437 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 5.4 ttpm? 64.1 74.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.422 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -60.22 170.16 1.38 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.603 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.469 ' HE1' ' CA ' ' A' ' 88' ' ' GLU . 62.4 mmm -123.19 144.46 49.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.846 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -116.07 150.27 37.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.917 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.554 ' CE1' HD11 ' A' ' 57' ' ' ILE . 60.0 m170 -122.76 153.02 40.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.469 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 21.3 tttt -131.9 147.22 52.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 50' ' ' GLY . 9.8 p -111.54 136.84 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.2 tt0 -80.03 -51.17 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 95.0 mt-10 -158.97 148.18 18.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.55 HG12 ' CE2' ' A' ' 82' ' ' TYR . 72.0 mt -125.08 126.58 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -127.03 94.1 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.453 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 77.2 t60 -70.26 -39.76 74.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.55 76.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -88.9 8.86 27.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 45.25 35.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.5 tttm -124.14 137.96 54.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.55 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.1 t80 -136.97 123.59 21.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 74' ' ' GLU . 4.2 p -125.4 120.31 30.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.54 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 40.3 p90 -132.75 156.02 47.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.449 ' O ' HD12 ' A' ' 86' ' ' ILE . 23.0 t -119.05 172.0 7.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.474 ' O ' ' CD1' ' A' ' 92' ' ' LEU . 33.3 mm -125.45 125.03 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.795 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 89' ' ' GLY . 17.7 pt -107.01 -3.96 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.544 ' HB2' ' CG ' ' A' ' 92' ' ' LEU . 21.5 mt-10 41.04 -93.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.952 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -178.41 117.82 0.59 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.63 -119.28 6.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 93' ' ' GLY . 52.4 Cg_endo -72.63 -12.86 27.08 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.524 2.149 . . . . 0.0 111.828 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.544 ' CG ' ' HB2' ' A' ' 88' ' ' GLU . 1.3 tt 53.83 -86.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -103.51 176.9 24.5 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 92.8 m-70 -96.22 134.53 39.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -1.199 . . . . 0.0 109.632 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.6 22.76 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 130' ' ' ILE . 33.0 mt -116.13 98.85 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.357 -0.839 . . . . 0.0 109.369 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 89.6 mt-10 -48.52 -48.41 38.31 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.587 -0.695 . . . . 0.0 110.155 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.453 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 47.2 mtmt -155.22 158.57 39.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.867 -1.146 . . . . 0.0 110.47 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.577 HG21 ' CD1' ' A' ' 122' ' ' TYR . 5.6 mm -135.74 114.68 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 25.4 t -125.85 149.6 48.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.005 . . . . 0.0 109.946 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 84' ' ' TYR . 91.8 m-85 -128.05 126.46 41.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 109.164 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.1 mt-10 -105.34 141.71 36.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.874 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.03 122.86 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -0.855 . . . . 0.0 109.173 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -123.48 137.28 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.723 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -116.61 141.84 47.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.451 ' O ' ' OG ' ' A' ' 114' ' ' SER . . . -141.06 155.12 46.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.619 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.88 132.93 40.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 109.301 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.29 111.67 38.25 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.46 -50.68 0.37 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.713 2.275 . . . . 0.0 111.669 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.05 -49.24 78.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.93 . . . . 0.0 109.403 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.74 -29.68 72.81 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 13' ' ' VAL . . . 80.39 35.4 26.44 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . -170.18 -129.76 1.14 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 106' ' ' ALA . 26.3 t -148.12 150.18 33.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -1.124 . . . . 0.0 109.508 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.432 HG21 ' O ' ' A' ' 10' ' ' ALA . 67.8 mt -116.8 133.9 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 5.2 mp -111.16 138.53 47.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -123.9 139.29 54.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.265 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 70.8 mt -121.15 138.34 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 33.1 m -125.58 142.61 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 44.3 m -126.92 152.4 47.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -133.98 133.25 41.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 108.946 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.578 ' CB ' ' CD1' ' A' ' 130' ' ' ILE . 37.9 m-85 -133.32 104.52 6.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.949 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 15.1 m-70 -83.41 122.47 28.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.58 150.03 23.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.963 -1.086 . . . . 0.0 109.876 -178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -79.92 131.41 35.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 68.76 -144.05 41.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -94.36 17.39 13.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.4 146.91 14.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.499 ' HA ' ' CE2' ' A' ' 4' ' ' PHE . 38.2 m -127.21 154.79 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.578 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 22.6 mt -108.41 130.37 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -72.88 142.87 47.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.456 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.9 mt-10 -65.9 -31.47 72.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.538 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -44.74 83.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -43.56 88.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.564 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 38.3 pt -79.85 -29.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.7 tttm -56.26 -41.14 75.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.4 74.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.31 -38.53 78.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HE2' ' OD2' ' A' ' 8' ' ' ASP . 19.1 tttm -59.83 -43.61 94.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -1.126 . . . . 0.0 109.352 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -58.95 -41.62 87.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 23.3 tttp -60.74 -41.46 95.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.354 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.48 86.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.24 96.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.53 98.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.466 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 57.8 mt -66.09 -38.86 89.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -1.199 . . . . 0.0 109.393 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.78 -44.5 89.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.44 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.59 -35.53 80.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.471 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 34' ' ' VAL . . . -72.32 -50.46 26.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.539 ' CG2' ' N ' ' A' ' 150' ' ' GLU . 3.3 m -64.46 -46.71 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.539 ' N ' ' CG2' ' A' ' 149' ' ' VAL . 83.8 tt0 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.11 72.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.277 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -62.78 -41.28 99.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.527 ' CD1' ' OXT' ' A' ' 161' ' ' CYS . 30.5 tp -59.35 -41.8 90.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.46 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 37.4 mt -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.476 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.95 62.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.24 70.23 13.02 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 50.1 Cg_endo -70.22 -6.1 18.04 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.759 2.306 . . . . 0.0 111.783 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -75.3 -32.54 61.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.13 144.25 35.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.59 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -61.39 -31.53 71.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.853 . . . . 0.0 109.353 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.527 ' OXT' ' CD1' ' A' ' 153' ' ' LEU . 88.0 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.459 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.299 0.571 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.05 -114.86 6.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.572 ' HB ' ' CG ' ' A' ' 123' ' ' HIS . 7.2 p -108.48 135.52 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.14 . . . . 0.0 109.588 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.481 ' CD1' HD11 ' A' ' 130' ' ' ILE . 82.8 m-85 -92.07 139.64 30.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 28.0 p -122.68 119.91 32.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.393 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.557 ' CE2' HD11 ' A' ' 135' ' ' ILE . 47.3 m-85 -116.24 145.54 43.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -121.12 143.14 49.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.558 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.449 ' OD1' ' HE2' ' A' ' 139' ' ' LYS . 60.5 t0 -116.07 135.78 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -113.07 125.08 53.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.685 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.96 7.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.047 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 t -129.48 150.75 50.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -160.29 146.39 15.42 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 13' ' ' VAL . 13.0 m -62.3 90.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.033 . . . . 0.0 109.29 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt -139.81 145.48 43.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.354 -0.841 . . . . 0.0 109.322 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 45.9 Cg_endo -68.44 112.79 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.332 2.021 . . . . 0.0 110.995 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.54 -32.02 40.2 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.851 2.367 . . . . 0.0 112.34 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.03 -56.23 7.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.134 -0.979 . . . . 0.0 109.442 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.437 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 13.1 mtt85 -72.4 -38.95 68.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.732 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 22.0 tp -62.0 -47.64 83.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 109.654 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.9 t80 -58.59 -46.62 86.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.413 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' ASP . 22.4 mttm -72.84 -44.66 61.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.957 . . . . 0.0 109.522 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 33.9 t -70.83 -21.33 62.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.076 -1.015 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.522 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 2.6 t80 -100.13 -50.74 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.089 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 55.5 t -85.04 -52.44 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.095 -1.003 . . . . 0.0 110.12 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.1 tp -70.41 -36.27 73.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.135 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 74.4 m-20 -103.82 23.78 12.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.039 -1.038 . . . . 0.0 109.723 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.5 -46.53 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.463 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 71.9 m-20 -64.62 -33.22 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 109.96 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.416 ' HB3' ' HE3' ' A' ' 33' ' ' LYS . 86.6 m-20 -90.76 -40.17 11.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.64 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 19.5 tp -66.32 -28.25 68.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.955 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.515 ' HB ' ' CD ' ' A' ' 32' ' ' PRO . 24.6 mt -60.31 -60.37 10.85 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.164 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.515 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.6 Cg_endo -68.41 -23.16 38.22 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.603 2.202 . . . . 0.0 111.649 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 29' ' ' ASN . 79.9 mttt -71.97 -46.17 58.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.352 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 31' ' ' ILE . 10.6 p -59.33 -24.12 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.624 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.491 ' N ' HG13 ' A' ' 34' ' ' VAL . . . -130.76 87.21 50.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.635 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.66 -21.07 29.79 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.729 2.286 . . . . 0.0 111.707 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.84 -36.37 69.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.623 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -130.22 135.21 47.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -113.1 146.75 38.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.34 -0.85 . . . . 0.0 109.45 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.0 p -127.9 157.81 39.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.382 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.8 m -129.29 148.76 51.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.526 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.456 ' HB1' HG12 ' A' ' 57' ' ' ILE . . . -143.27 149.16 37.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.515 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -133.72 157.0 46.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -97.87 110.12 22.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.525 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 56' ' ' LYS . 7.6 mt -63.25 -37.83 88.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.484 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 83.9 tt0 -149.14 157.09 43.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.484 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 86.46 155.99 27.69 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -89.9 10.52 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.451 ' HA2' HG23 ' A' ' 53' ' ' THR . . . 104.73 23.41 7.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.45 ' HA2' HD13 ' A' ' 75' ' ' ILE . . . -121.19 -143.91 6.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.426 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 50.4 Cg_endo -70.17 121.89 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.678 2.252 . . . . 0.0 111.843 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.74 -2.82 70.33 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.451 HG23 ' HA2' ' A' ' 49' ' ' GLY . 94.3 m -78.59 140.83 38.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -1.196 . . . . 0.0 109.496 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.423 ' N ' HG22 ' A' ' 53' ' ' THR . 23.4 mm -100.67 129.55 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 31.1 tttm -106.71 130.7 54.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . 20.0 tttt -122.86 134.93 54.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.498 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.456 HG12 ' HB1' ' A' ' 42' ' ' ALA . 64.8 mt -111.73 135.9 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.7 p -125.31 151.91 45.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -104.44 128.42 52.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.27 -42.65 88.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.439 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' CD ' ' OD1' ' A' ' 63' ' ' ASN . 84.9 tt0 -65.88 -30.84 71.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.77 40.13 27.12 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.413 ' OD1' ' CD ' ' A' ' 61' ' ' GLU . 89.9 m-20 -57.52 -36.63 71.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -1.113 . . . . 0.0 109.441 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -127.96 134.77 49.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.354 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.04 -35.32 76.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -78.44 141.32 38.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -0.973 . . . . 0.0 109.419 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -114.0 156.49 23.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.526 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 88.9 mtp -96.08 140.36 30.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.95 146.6 30.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 79.5 m80 -126.8 140.11 52.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -124.62 133.25 53.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.9 t -98.68 130.62 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 82.0 tt0 -81.09 -53.92 5.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.7 mt-10 -156.96 143.35 18.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.539 HG22 ' CE1' ' A' ' 77' ' ' HIS . 71.8 mt -124.31 123.65 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.448 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 73.2 m-20 -130.5 86.25 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.57 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 75.6 m80 -62.38 -38.05 88.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.67 -30.68 68.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 56.8 m-20 -89.49 9.39 26.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.508 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.552 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 56.5 m-85 44.21 39.65 3.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.354 -0.841 . . . . 0.0 109.536 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.482 ' CE ' ' OE2' ' A' ' 102' ' ' GLU . 82.9 tttt -135.39 128.59 31.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.538 ' CE2' HG12 ' A' ' 75' ' ' ILE . 77.5 t80 -125.97 127.9 46.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 109.561 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -128.09 123.38 34.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.7 p90 -139.35 166.06 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.7 t -143.64 167.39 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 130.34 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.4 -47.18 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.557 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -145.7 135.85 23.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 109.503 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.573 ' N ' ' CD2' ' A' ' 92' ' ' LEU . . . -171.09 104.18 0.2 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 56.96 -157.03 11.96 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 94' ' ' HIS . 54.5 Cg_endo -74.15 7.22 2.61 Favored 'Trans proline' 0 C--O 1.212 -0.791 0 C-N-CA 122.625 2.217 . . . . 0.0 112.294 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 89' ' ' GLY . 2.2 pp -40.21 -26.9 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.036 -1.04 . . . . 0.0 110.332 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -87.95 23.55 13.71 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.527 ' O ' ' CB ' ' A' ' 95' ' ' THR . 57.2 t-80 -67.79 73.83 0.18 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.152 -1.205 . . . . 0.0 107.878 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 94' ' ' HIS . 0.2 OUTLIER 78.54 5.31 2.53 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HB3' ' CD1' ' A' ' 99' ' ' ILE . 67.2 mt -100.71 93.11 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 108.957 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.7 mt-10 -40.43 -37.63 0.71 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.693 -0.63 . . . . 0.0 110.42 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 15.9 tttt -164.81 155.44 14.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 110.419 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.543 ' CD1' ' HB3' ' A' ' 96' ' ' LEU . 6.5 mm -131.85 124.24 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.4 t -128.43 159.62 34.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.049 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 84' ' ' TYR . 85.0 m-85 -135.68 128.54 31.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.482 ' OE2' ' CE ' ' A' ' 81' ' ' LYS . 78.4 tt0 -112.05 140.66 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 117' ' ' LYS . 68.7 mt -131.81 126.34 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.153 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 11.2 mtpp -123.43 137.77 54.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.612 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.93 151.06 39.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.329 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.27 158.91 43.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.14 146.25 31.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.473 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 112' ' ' GLY . . . -141.76 147.39 45.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.364 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.61 -48.59 1.02 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.754 2.303 . . . . 0.0 111.748 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -147.68 166.35 27.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 109.354 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 68.4 36.03 83.3 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 108' ' ' ALA . . . 127.62 77.97 0.24 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 112' ' ' GLY . . . -43.59 -34.69 2.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 14' ' ' ILE . 95.0 p -146.5 152.71 39.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 69.3 mt -122.61 128.04 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 5.4 mp -110.32 134.59 52.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 29.9 mttp -128.51 128.88 45.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.476 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -118.11 129.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 75.7 m -126.2 134.42 51.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.577 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.4 m -116.4 161.82 18.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.563 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -145.67 127.03 14.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.845 . . . . 0.0 109.37 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.531 ' CD1' HG22 ' A' ' 99' ' ' ILE . 11.0 m-85 -126.63 107.94 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.572 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 22.2 m-70 -80.23 113.98 18.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.089 -1.007 . . . . 0.0 108.336 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.449 ' CG2' HD12 ' A' ' 130' ' ' ILE . 1.3 p -104.45 141.82 35.68 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.029 . . . . 0.0 109.511 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 92.2 mttt -41.83 -42.48 2.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.479 -0.763 . . . . 0.0 109.615 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.73 -70.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -59.67 -31.71 69.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -1.164 . . . . 0.0 109.56 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.502 ' CB ' ' CG2' ' A' ' 95' ' ' THR . . . -61.18 147.47 44.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -128.56 145.76 51.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.509 HG21 ' CG2' ' A' ' 135' ' ' ILE . 17.8 mt -108.78 126.49 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -88.41 152.51 21.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 136' ' ' LYS . 75.6 mm-40 -64.9 -36.79 85.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.02 -44.59 95.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.81 -43.65 90.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.557 HD11 ' CE2' ' A' ' 6' ' ' TYR . 42.2 pt -82.13 -30.69 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 132' ' ' GLU . 47.4 tttt -55.78 -37.51 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.48 74.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.288 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.16 95.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' HE2' ' OD1' ' A' ' 8' ' ' ASP . 22.7 tttt -60.01 -42.92 95.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 109.317 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.39 -41.8 94.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.379 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.08 -45.96 86.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.14 -42.56 75.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.1 99.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.371 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.62 -45.06 90.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.82 -38.25 78.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -1.154 . . . . 0.0 109.301 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.468 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 70.0 t80 -62.9 -41.83 99.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.0 -37.39 87.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 34' ' ' VAL . . . -67.46 -47.42 70.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.389 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.515 HG11 ' N ' ' A' ' 150' ' ' GLU . 6.6 p -62.39 -40.45 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.301 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.515 ' N ' HG11 ' A' ' 149' ' ' VAL . 85.7 tt0 -59.74 -43.24 94.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.426 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.6 81.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.919 . . . . 0.0 109.353 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.38 -44.83 96.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.51 -39.64 91.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.465 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 9.1 tt -64.56 -44.59 90.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.502 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.65 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -141.9 70.63 24.2 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.94 . . . . 0.0 109.447 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 51.2 Cg_endo -70.79 -4.98 15.81 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.653 2.236 . . . . 0.0 111.85 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -97.99 9.97 41.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.59 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.27 148.02 38.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -115.98 139.99 49.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' A' ' 18' ' ' ARG . 8.7 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.508 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.337 0.589 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.02 152.76 2.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.588 HG23 ' CE1' ' A' ' 123' ' ' HIS . 38.6 t -134.28 141.74 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.523 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.584 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 99.1 m-85 -101.59 122.99 44.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 t -111.03 120.97 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.602 ' CZ ' ' CD1' ' A' ' 135' ' ' ILE . 28.2 m-85 -115.49 147.33 40.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -118.16 133.67 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.654 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -109.54 134.2 52.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.86 124.21 52.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.28 124.19 15.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.292 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -110.6 132.3 54.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 m -157.06 147.48 21.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.045 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.492 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 31.0 m -78.44 90.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 8.6 mt -139.37 144.93 42.06 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.224 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.98 113.33 3.21 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.501 2.134 . . . . 0.0 111.228 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.52 -31.13 42.35 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.799 2.333 . . . . 0.0 112.204 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.11 -52.74 8.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.486 ' NH1' ' OXT' ' A' ' 161' ' ' CYS . 36.3 ttt180 -72.01 -45.95 59.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.954 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.523 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 6.7 tp -59.04 -45.13 91.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.959 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.543 ' CE1' HG21 ' A' ' 24' ' ' VAL . 79.0 t80 -60.73 -55.38 33.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.902 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 23.8 tttp -67.85 -38.39 83.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 29.5 t -72.78 -27.2 61.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.805 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.47 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 34.3 t80 -100.82 -50.11 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' ' 20' ' ' PHE . 54.8 t -78.14 -52.45 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.082 -1.011 . . . . 0.0 110.284 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 0.3 OUTLIER -65.13 -35.91 82.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.103 -0.998 . . . . 0.0 109.808 -179.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 22' ' ' SER . 89.8 m-20 -108.71 28.36 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.581 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.4 -45.04 70.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.527 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 65.0 m-20 -73.72 -29.65 62.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.98 . . . . 0.0 109.773 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 92.5 m-20 -79.66 -37.79 35.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.965 . . . . 0.0 109.616 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 34' ' ' VAL . 42.1 mt -72.44 -31.47 65.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.72 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.524 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 16.0 mt -49.83 -57.41 12.45 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.527 ' CD ' ' O ' ' A' ' 28' ' ' ASP . 47.7 Cg_endo -68.54 -39.16 9.74 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.573 2.182 . . . . 0.0 111.686 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.451 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 77.4 tttt -68.06 -47.31 68.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 31' ' ' ILE . 7.9 p -62.31 -12.66 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.2 -0.938 . . . . 0.0 109.448 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.69 76.08 71.94 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 109.565 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.42 -36.96 10.68 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.689 2.259 . . . . 0.0 111.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -49.97 -43.8 50.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.607 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -113.53 139.11 49.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.65 127.25 53.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 109.358 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.2 p -122.88 158.33 30.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.176 -0.953 . . . . 0.0 109.414 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.8 m -135.01 148.75 50.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.54 143.64 33.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -134.21 149.71 51.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 33.2 p-10 -84.0 114.56 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.517 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 52.0 mt -65.95 -28.69 69.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 109.404 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 45' ' ' LEU . 14.7 mm-40 -159.44 -173.41 4.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 63.39 164.36 0.57 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -94.51 -3.14 50.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -1.087 . . . . 0.0 109.553 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 119.72 13.82 5.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.516 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -112.17 -142.12 8.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.63 125.95 13.42 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.42 5.49 79.13 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 53.9 m -73.02 140.78 47.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -1.219 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.524 HG21 HD12 ' A' ' 54' ' ' ILE . 27.0 mm -99.13 133.74 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 79.7 tttt -122.77 134.84 54.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.403 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HD2' HD13 ' A' ' 45' ' ' LEU . 21.8 tttt -130.85 131.46 44.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.437 HD11 HG21 ' A' ' 57' ' ' ILE . 69.5 mt -107.07 137.61 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.499 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.5 m -119.9 139.43 52.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.357 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 60' ' ' ALA . 45.3 p90 -136.24 178.04 7.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 0.0 109.492 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.563 ' O ' ' CD2' ' A' ' 59' ' ' PHE . . . -48.19 137.8 10.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.398 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -51.44 -39.16 56.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.59 -119.63 19.13 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.42 146.21 36.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.14 . . . . 0.0 109.381 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 46.89 -164.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.166 -0.959 . . . . 0.0 109.344 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -113.83 129.76 56.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 109.562 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -129.73 130.95 46.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -126.4 135.8 51.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.3 mtt -111.31 148.42 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' O ' HG22 ' A' ' 86' ' ' ILE . 53.4 mttm -126.88 136.79 52.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 34.0 m-70 -131.96 133.51 44.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -127.19 141.51 51.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 109.612 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 62.0 t -100.8 129.65 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.335 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.8 -43.96 43.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -173.1 137.26 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 109.583 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.568 ' CG2' ' CE1' ' A' ' 77' ' ' HIS . 60.3 mt -116.77 123.55 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -132.94 72.59 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.511 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.568 ' CE1' ' CG2' ' A' ' 75' ' ' ILE . 60.4 m80 -55.9 -37.14 68.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.44 78.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.363 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 23.9 m120 -87.45 -0.28 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' A' ' 79' ' ' ASN . 79.5 m-85 60.93 31.78 19.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.425 ' HG2' ' HG3' ' A' ' 104' ' ' LYS . 4.5 mtmp? -130.87 125.14 32.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.4 t80 -117.16 129.25 55.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 0.0 109.42 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.3 t -129.02 114.06 15.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.557 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.3 p90 -129.5 170.44 13.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.311 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 87.5 p -151.93 162.86 40.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.708 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 69' ' ' LYS . 15.6 mm -111.85 122.43 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.447 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 99.7 mt -70.2 -39.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.604 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -157.26 139.77 14.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 0.0 109.626 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -155.05 92.67 0.13 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.7 -119.25 3.57 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' GLY . 49.5 Cg_endo -70.5 -35.6 10.2 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.485 2.124 . . . . 0.0 111.514 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.531 ' CD1' HG13 ' A' ' 99' ' ' ILE . 8.1 tp 55.63 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 109.681 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -162.54 179.7 37.66 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -107.09 127.67 53.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -1.121 . . . . 0.0 109.617 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.492 ' CG2' ' CB ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 56.47 16.85 2.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 109.856 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.515 ' CD2' ' HB3' ' A' ' 122' ' ' TYR . 37.1 mt -90.63 89.67 7.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.029 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.528 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 79.3 mt-10 -48.35 -32.53 7.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.456 ' O ' HD13 ' A' ' 99' ' ' ILE . 21.7 tttp -152.34 152.52 32.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.596 -1.315 . . . . 0.0 110.691 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.531 HG13 ' CD1' ' A' ' 92' ' ' LEU . 10.0 mm -132.47 113.62 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 37.3 t -131.36 152.23 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.921 -1.112 . . . . 0.0 110.128 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -130.84 143.66 50.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 82.1 tt0 -120.93 143.73 48.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 109.78 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.29 121.9 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 56.8 tttt -121.04 129.73 53.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.893 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mtt -116.18 132.75 56.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.366 -0.834 . . . . 0.0 109.196 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.56 151.44 41.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.86 124.26 34.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.31 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.09 143.01 98.22 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.89 -32.09 23.2 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.656 2.238 . . . . 0.0 111.705 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -58.32 -28.13 64.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.411 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.38 -8.54 64.5 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -50.98 -40.38 42.89 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 168.87 -118.62 0.79 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -138.09 164.73 28.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -1.162 . . . . 0.0 109.674 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.24 137.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.18 137.1 44.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 47.8 mttp -130.77 135.89 48.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 68.1 mt -127.12 127.68 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.134 -0.979 . . . . 0.0 109.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 32.5 m -116.22 142.51 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.372 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.3 m -122.02 147.83 45.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 109.703 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -129.25 116.67 19.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.227 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.52 ' HB2' ' CD1' ' A' ' 130' ' ' ILE . 72.0 m-85 -115.7 124.79 51.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.588 ' CE1' HG23 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -91.05 129.19 37.07 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.204 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 125' ' ' LYS . 4.2 t -114.85 136.01 53.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.953 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 21.0 tttm -43.63 -46.86 7.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.75 -85.87 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -58.32 -25.29 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.492 ' CB ' ' CG2' ' A' ' 95' ' ' THR . . . -68.95 142.96 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.53 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 86.6 p -130.33 163.35 27.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.52 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 51.4 mt -108.48 126.4 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.24 132.51 47.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.538 ' HA ' HG13 ' A' ' 135' ' ' ILE . 94.7 mt-10 -61.92 -32.63 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.91 -43.82 98.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.3 -26.04 62.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 108.986 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 1.8 mt -69.9 -49.56 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 108.839 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -55.49 -44.54 76.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.209 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.46 -47.37 86.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.64 -31.61 57.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -70.57 -36.79 73.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -1.118 . . . . 0.0 109.306 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.04 -45.02 96.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.14 -45.95 91.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.361 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.52 94.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.267 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.02 82.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.233 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.61 -44.56 95.52 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 38.0 tp -56.77 -41.99 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -1.109 . . . . 0.0 109.311 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.446 ' CE2' HD13 ' A' ' 118' ' ' ILE . 63.9 m-85 -62.09 -41.12 97.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.252 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -56.85 -42.88 80.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.58 77.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 75.3 t -67.21 -50.08 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.435 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 82.7 mt-10 -50.23 -34.02 21.52 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.01 81.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.717 . . . . 0.0 109.458 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.451 ' OH ' ' HE2' ' A' ' 33' ' ' LYS . 58.4 t80 -59.45 -45.06 92.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 157' ' ' PRO . 76.4 mt -59.1 -42.64 90.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.963 . . . . 0.0 109.303 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 30.0 mt -69.08 -33.0 72.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.26 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 0.0 109.399 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.09 61.75 1.28 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' LEU . 49.7 Cg_endo -69.8 -24.15 29.8 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.707 2.271 . . . . 0.0 111.76 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -68.23 -33.31 74.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.07 142.89 58.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -57.66 -40.35 79.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.486 ' OXT' ' NH1' ' A' ' 18' ' ' ARG . 4.0 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.277 0.561 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 124' ' ' THR . . . 94.8 12.34 55.65 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.578 HG23 ' CG ' ' A' ' 123' ' ' HIS . 23.7 t -116.57 140.82 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.153 . . . . 0.0 109.499 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 99.3 m-85 -107.49 129.71 54.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.132 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -117.28 125.94 51.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.552 ' CZ ' ' CD1' ' A' ' 135' ' ' ILE . 46.8 m-85 -124.29 142.75 51.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -116.3 131.78 56.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 56.8 t0 -99.98 133.08 44.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -108.52 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.4 129.55 22.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.7 m -112.66 137.44 50.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.792 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -160.6 147.98 15.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.828 . . . . 0.0 109.047 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 4.0 p -81.84 91.07 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.567 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 15' ' ' PRO . 13.2 mt -139.17 144.77 41.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.28 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 44.5 Cg_endo -67.69 116.17 4.13 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.41 2.073 . . . . 0.0 111.217 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.43 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.9 Cg_endo -66.8 -35.61 26.93 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.884 2.39 . . . . 0.0 112.387 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.09 -52.04 18.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.479 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 22' ' ' SER . 55.9 mtp180 -72.11 -50.32 29.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 13.4 tp -55.01 -45.28 75.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.803 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.592 ' CE2' HG23 ' A' ' 24' ' ' VAL . 47.5 t80 -64.39 -55.59 20.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 109.425 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 27.9 mttt -67.92 -13.73 62.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.648 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 49.7 m -100.33 -21.46 15.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.011 -1.056 . . . . 0.0 109.925 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 35.0 t80 -101.2 -52.5 3.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.996 -1.065 . . . . 0.0 110.722 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.592 HG23 ' CE2' ' A' ' 20' ' ' PHE . 12.6 m -86.22 -40.79 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.961 -1.087 . . . . 0.0 110.63 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 4.1 tt -79.29 -43.16 24.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.574 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 22' ' ' SER . 95.1 m-20 -89.54 10.74 21.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 23' ' ' PHE . . . -69.42 -31.49 69.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -71.56 -14.76 62.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -114.75 -36.92 4.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.0 . . . . 0.0 109.817 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 26' ' ' ASP . 33.4 mt -72.53 -31.12 65.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 1.1 mp -58.6 -57.5 26.14 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.124 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.2 Cg_endo -68.47 -33.55 22.56 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.65 2.233 . . . . 0.0 111.606 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -69.19 -31.55 70.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.358 -0.839 . . . . 0.0 109.38 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 30' ' ' LEU . 73.3 t -74.4 -34.41 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.499 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 34' ' ' VAL . . . 69.13 61.93 0.59 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' PHE . 50.2 Cg_endo -70.26 137.96 35.17 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.684 2.256 . . . . 0.0 111.744 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.38 -31.08 72.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.939 . . . . 0.0 109.444 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -61.19 -49.81 75.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.571 ' CD1' HG22 ' A' ' 57' ' ' ILE . 81.1 m-85 -118.04 139.93 50.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.28 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.3 p -78.54 -35.84 45.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 82.8 p -163.36 167.28 21.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.519 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.427 ' O ' ' CG ' ' A' ' 43' ' ' GLU . . . -138.21 149.43 45.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 42' ' ' ALA . 92.0 mt-10 -155.53 156.42 35.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -88.53 118.49 28.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 28.5 tp -72.95 -35.97 67.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 49.5 tp10 -159.24 153.98 24.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.455 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 93.37 150.29 26.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -83.52 6.91 18.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.602 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.08 20.2 10.01 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 53' ' ' THR . . . -113.58 -146.32 9.47 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.01 124.94 11.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.751 2.301 . . . . 0.0 111.891 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.16 78.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.519 ' OG1' ' N ' ' A' ' 50' ' ' GLY . 61.2 m -72.73 137.79 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -1.193 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.412 ' N ' HG22 ' A' ' 53' ' ' THR . 17.3 mm -103.81 133.44 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 46.6 mtpt -111.73 144.33 41.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 45' ' ' LEU . 16.1 tttp -122.13 133.4 54.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.571 HG22 ' CD1' ' A' ' 39' ' ' PHE . 23.0 mm -111.1 135.05 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 48.2 m -86.56 140.79 29.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.489 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.443 ' CE2' ' O ' ' A' ' 61' ' ' GLU . 22.0 p90 -113.56 153.37 28.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.895 . . . . 0.0 109.511 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.92 -31.12 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.502 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.443 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 96.0 mt-10 -52.97 144.51 14.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.542 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.78 22.0 41.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -93.16 106.85 18.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.139 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' CZ ' ' A' ' 67' ' ' TYR . 84.3 tt0 -65.77 -28.58 69.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.304 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 63.1 t80 -49.62 -40.96 41.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.392 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -70.69 126.98 31.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.373 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 64' ' ' GLU . 88.5 m-85 -128.97 132.25 47.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.007 . . . . 0.0 109.716 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.432 ' HG2' ' HA2' ' A' ' 89' ' ' GLY . 82.6 mtp -116.21 141.24 48.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.862 . . . . 0.0 109.123 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.67 140.48 40.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.826 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.557 ' CE1' HG12 ' A' ' 57' ' ' ILE . 79.8 m80 -126.0 135.36 51.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -130.32 142.15 50.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.6 t -101.65 132.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.464 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 89.9 mt-10 -73.59 -58.64 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.426 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 93.9 mt-10 -158.79 144.25 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.564 HG12 ' CE1' ' A' ' 82' ' ' TYR . 91.3 mt -122.79 120.32 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.502 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.463 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 86.8 m-20 -122.78 92.42 3.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.507 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 76.5 m80 -64.95 -37.52 87.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.16 -33.31 71.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.902 . . . . 0.0 109.374 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 76' ' ' ASP . 23.2 m120 -84.98 -2.33 57.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 53.61 41.24 32.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -137.32 122.45 19.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 81.7 t80 -113.18 128.11 56.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 m -127.78 119.13 25.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.579 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.2 p90 -134.32 164.28 27.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.468 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 17.0 t -145.51 158.99 43.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.584 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.0 mt -108.58 137.42 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 96.4 mt -86.24 -27.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.699 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.525 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 85.0 tt0 176.54 162.3 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.514 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.467 ' N ' ' HG2' ' A' ' 88' ' ' GLU . . . 172.73 113.02 0.29 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.59 -117.45 2.48 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.7 Cg_endo -69.95 -33.66 15.44 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.439 2.093 . . . . 0.0 111.179 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.525 ' CD2' ' HA ' ' A' ' 88' ' ' GLU . 2.4 tm? 60.48 -76.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.729 . . . . 0.0 109.674 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -173.17 160.7 31.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -92.46 121.56 34.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.142 -1.21 . . . . 0.0 109.712 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.402 HG23 ' CB ' ' A' ' 128' ' ' ALA . 2.0 m 48.8 22.94 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.648 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 122' ' ' TYR . 36.4 mt -94.02 89.14 5.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.301 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 83.6 mt-10 -40.75 -28.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.633 -0.667 . . . . 0.0 110.218 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 71.3 tttt -165.87 155.2 11.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 0.0 110.153 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.49 HG22 ' CE1' ' A' ' 122' ' ' TYR . 45.9 mt -141.32 113.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 108.975 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 32.1 t -126.08 150.45 48.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.985 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 84' ' ' TYR . 98.2 m-85 -127.24 126.42 42.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 0.0 109.145 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 51.9 mp0 -112.83 142.1 45.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.803 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.6 mt -117.37 131.72 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.252 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 16.0 tttp -124.83 132.24 53.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.0 mtt -115.58 146.16 42.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.08 40.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.95 41.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.03 160.49 55.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.88 -31.13 20.61 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.709 2.273 . . . . 0.0 111.821 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -98.06 -12.5 21.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.6 175.48 45.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.27 36.86 19.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 13' ' ' VAL . . . 160.66 125.95 0.8 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.2 p -106.13 163.63 12.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -1.174 . . . . 0.0 109.599 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.81 128.08 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.388 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.11 136.15 47.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 94.1 mttt -131.32 136.92 48.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.48 127.43 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 26.7 m -113.81 142.42 46.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.48 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 51.5 m -127.89 150.58 49.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.445 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 34.7 mttt -138.43 120.68 15.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.399 -0.813 . . . . 0.0 109.079 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.526 ' HB3' ' CD2' ' A' ' 96' ' ' LEU . 28.5 m-85 -120.6 115.75 24.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.122 -0.986 . . . . 0.0 109.889 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.578 ' CG ' HG23 ' A' ' 3' ' ' VAL . 52.1 m-70 -83.15 132.18 35.09 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.515 ' OG1' ' CB ' ' A' ' 128' ' ' ALA . 10.3 t -113.95 138.29 50.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.521 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 75.9 mttt -76.38 144.29 40.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.384 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 54.66 -148.2 22.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 46.2 p-10 -88.06 10.95 17.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -1.139 . . . . 0.0 109.48 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.515 ' CB ' ' OG1' ' A' ' 124' ' ' THR . . . -45.24 144.0 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.458 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.4 p -123.1 167.15 14.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 23.1 mt -116.11 127.67 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.401 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 45.8 t30 -57.1 127.35 31.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.551 ' HA ' HG13 ' A' ' 135' ' ' ILE . 96.1 mt-10 -61.96 -33.72 74.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -55.28 -44.25 75.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.401 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 92.5 mt-10 -58.09 -25.25 61.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.552 ' CD1' ' CZ ' ' A' ' 6' ' ' TYR . 4.3 mt -70.33 -50.86 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.822 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -55.59 -43.92 76.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.94 84.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.76 -38.09 71.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -61.42 -44.16 97.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -1.058 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.51 -42.19 82.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.436 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -58.48 -45.23 89.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.62 -38.5 75.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.98 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.73 94.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.9 -46.88 90.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.48 -37.99 82.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.497 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.433 ' O ' HG12 ' A' ' 149' ' ' VAL . 67.2 t80 -61.69 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.23 -36.26 79.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.59 -48.72 68.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.512 HG11 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -66.97 -42.55 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.92 . . . . 0.0 109.395 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.512 ' N ' HG11 ' A' ' 149' ' ' VAL . 84.1 tt0 -60.78 -38.63 85.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.421 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.2 -36.96 80.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.436 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 71.4 t80 -63.43 -47.82 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.333 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.9 mt -59.02 -40.84 86.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.24 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 154' ' ' LEU . 2.7 tm? -67.88 -40.03 83.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.09 66.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 75.15 65.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.99 0.37 6.68 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.826 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -106.26 10.18 31.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.653 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.27 148.02 15.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 51.29 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.478 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.543 HG22 ' ND1' ' A' ' 123' ' ' HIS . 43.5 t -128.46 131.92 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -1.204 . . . . 0.0 109.666 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.633 ' CD1' HD12 ' A' ' 130' ' ' ILE . 99.3 m-85 -89.21 129.33 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.883 . . . . 0.0 109.122 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 120' ' ' SER . 93.4 m -116.09 121.72 43.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 97.8 m-85 -121.19 147.72 45.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 85.1 tt0 -124.08 134.44 53.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 92.4 m-20 -104.75 148.6 26.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.276 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -116.57 138.09 51.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 115' ' ' ILE . . . -143.69 123.28 13.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.5 m -110.7 127.33 55.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.996 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 p -160.57 147.37 15.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.6 p -83.82 91.15 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.739 HG23 ' HD2' ' A' ' 15' ' ' PRO . 94.0 mt -139.02 144.78 42.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.739 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.5 Cg_endo -67.91 121.48 8.52 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 111.235 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 45.5 Cg_endo -66.76 -31.85 38.52 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.848 2.365 . . . . 0.0 112.451 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.87 -54.23 8.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 109.654 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.408 ' O ' ' OG ' ' A' ' 22' ' ' SER . 33.8 mtp-105 -72.25 -39.19 68.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 109.762 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.659 HD22 HG21 ' A' ' 14' ' ' ILE . 60.4 tp -61.26 -45.15 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.666 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 58.4 t80 -67.4 -46.94 71.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.861 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.591 ' HG3' HD12 ' A' ' 25' ' ' LEU . 15.9 tttp -72.72 -22.23 60.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.833 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.459 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 83.8 p -97.72 -29.19 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.072 -1.017 . . . . 0.0 109.826 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.935 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 14.2 t80 -100.27 -46.46 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.666 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.8 t -84.34 -52.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.591 HD12 ' HG3' ' A' ' 21' ' ' LYS . 42.5 mt -71.86 -41.89 67.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.024 -1.047 . . . . 0.0 109.681 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.464 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.9 m-20 -97.43 26.35 4.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.546 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.935 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.55 -44.51 70.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.512 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.568 ' HA ' HD12 ' A' ' 31' ' ' ILE . 37.2 p-10 -74.19 -18.4 60.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.01 -38.81 14.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.621 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 26' ' ' ASP . 48.5 mt -71.88 -30.89 65.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.624 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 28' ' ' ASP . 34.4 mt . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -141.19 138.91 33.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 47' ' ' GLY . 37.4 t30 -87.89 115.42 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.53 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.546 HD13 ' HZ3' ' A' ' 56' ' ' LYS . 20.8 tp -73.35 -32.91 64.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.396 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 81.6 tt0 -166.98 160.18 13.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.512 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 92.76 161.45 36.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -98.91 10.48 41.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.567 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.99 20.93 9.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 1.041 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -118.75 -146.02 7.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.2 Cg_endo -68.82 125.08 12.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.826 2.351 . . . . 0.0 111.777 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.14 3.44 75.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.567 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.6 m -72.91 140.21 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -1.185 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.503 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 18.5 mm -110.91 118.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' HIS . 46.8 mttt -120.52 143.26 48.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' HZ3' HD13 ' A' ' 45' ' ' LEU . 16.4 mtmt -127.51 135.41 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 68' ' ' MET . 71.4 mt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.376 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 85.8 mtp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 87.2 mttt -132.38 141.11 48.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 55' ' ' LYS . 97.9 m-70 -121.86 135.55 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.503 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 61.5 tttt -131.51 131.73 43.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.423 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.534 HG22 ' CE1' ' A' ' 84' ' ' TYR . 21.9 t -89.07 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 86.2 tt0 -71.79 -43.51 65.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.96 . . . . 0.0 109.61 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.4 tt0 -178.36 146.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.041 HD12 ' HA2' ' A' ' 50' ' ' GLY . 30.0 mt -126.31 120.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 20.6 t70 -128.74 93.29 3.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 55.7 p-80 -69.75 -26.46 64.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.0 -43.13 99.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 23.4 m120 -91.25 3.56 54.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.93 . . . . 0.0 109.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 59.29 27.17 16.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 79' ' ' ASN . 36.6 mttt -116.14 141.45 48.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.622 ' CD2' HG23 ' A' ' 75' ' ' ILE . 17.8 t80 -130.23 137.28 49.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 13.2 m -117.32 122.49 44.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.534 ' CE1' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -120.7 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.532 ' O ' HD13 ' A' ' 86' ' ' ILE . 73.3 m -127.74 149.25 50.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.533 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 85' ' ' SER . 26.9 mm -116.96 129.69 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.713 HG22 ' HG3' ' A' ' 88' ' ' GLU . 84.9 mt -87.0 -49.75 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.256 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 87' ' ' ILE . 97.5 mt-10 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.882 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.3 OUTLIER 55.73 17.71 2.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.383 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 122' ' ' TYR . 42.8 mt -97.98 91.01 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.152 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' HIS . 91.4 mt-10 -51.37 -43.01 61.74 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.276 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 16.7 tttt -155.96 158.18 37.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 0.0 110.315 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.879 HG23 ' CE1' ' A' ' 122' ' ' TYR . 35.6 mt -134.41 117.11 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 32.5 t -120.87 150.89 40.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.003 -1.061 . . . . 0.0 110.237 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 84' ' ' TYR . 93.4 m-85 -131.38 133.49 45.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 93.5 mt-10 -121.22 139.65 53.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.25 125.86 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 109.392 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -125.04 146.94 49.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.1 mtt -122.82 150.44 42.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.43 153.48 40.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.37 39.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.5 t -112.78 143.99 43.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -1.166 . . . . 0.0 109.55 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.41 ' C ' HD12 ' A' ' 116' ' ' LEU . 70.1 mt -115.48 135.81 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -105.91 138.35 42.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.59 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 70.7 mttt -127.56 139.66 52.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 76.0 mt -123.31 138.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.618 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 29.7 m -120.33 142.4 49.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.342 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.44 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 54.1 m -125.44 148.81 48.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.615 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -134.94 122.5 22.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.888 . . . . 0.0 109.256 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.879 ' CE1' HG23 ' A' ' 99' ' ' ILE . 50.9 m-85 -119.2 119.75 35.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.543 ' ND1' HG22 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -84.7 114.01 21.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 108.722 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.601 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 9.6 t -103.38 144.38 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.022 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.423 ' CB ' HG22 ' A' ' 95' ' ' THR . 16.0 tttt -43.84 -45.44 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 149.68 -54.06 0.5 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -85.93 8.94 18.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -107.0 145.33 32.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 m -124.16 145.61 49.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.633 HD12 ' CD1' ' A' ' 4' ' ' PHE . 52.6 mt -101.82 134.07 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -86.14 142.48 28.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.3 mt-10 -58.88 -35.89 73.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -63.31 -46.26 87.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.843 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -57.22 -44.3 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.351 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.448 HD13 ' CE2' ' A' ' 6' ' ' TYR . 39.7 pt -75.37 -30.64 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.282 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -56.09 -40.55 73.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.19 -47.18 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.9 . . . . 0.0 109.31 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.66 67.87 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.98 -42.6 99.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -1.08 . . . . 0.0 109.214 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -54.95 -45.48 74.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.173 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -59.44 -45.12 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.95 93.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.72 95.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.168 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.69 -46.98 88.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.9 -38.76 76.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.238 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.479 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.6 t80 -62.83 -41.04 99.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -0.895 . . . . 0.0 109.277 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -59.21 -40.99 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.75 -51.94 65.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 23' ' ' PHE . 4.3 p -61.83 -41.2 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.454 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.3 tt0 -63.54 -38.47 91.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.348 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.41 91.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -61.15 -48.28 82.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.26 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.31 -35.82 78.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.329 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.938 ' O ' HD13 ' A' ' 154' ' ' LEU . 2.0 tm? -63.06 -39.87 96.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.853 . . . . 0.0 109.293 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.78 64.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.482 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 123' ' ' HIS . 29.1 t -129.39 133.63 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -1.115 . . . . 0.0 109.313 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.589 ' HE1' HG21 ' A' ' 124' ' ' THR . 97.2 m-85 -92.86 132.09 37.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 109.302 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' SER . 28.5 p -117.89 121.33 40.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 119' ' ' THR . 33.5 m-85 -115.27 143.69 44.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.75 152.51 37.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' A' ' 118' ' ' ILE . 60.3 t0 -135.14 137.66 42.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.37 137.77 45.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.626 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -146.6 123.31 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.6 m -107.52 127.25 53.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.774 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.4 p -160.39 140.2 11.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.312 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.884 HG13 ' HA3' ' A' ' 113' ' ' GLY . 3.1 t -88.24 91.61 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.907 HG21 HD13 ' A' ' 19' ' ' LEU . 31.3 mm -138.5 144.49 42.67 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.741 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.1 Cg_endo -67.94 123.56 10.81 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.44 2.093 . . . . 0.0 111.463 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 43.7 Cg_endo -66.87 -40.01 13.3 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.75 2.3 . . . . 0.0 112.1 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.94 -53.82 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 0.0 109.433 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -72.14 -46.66 55.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.907 HD13 HG21 ' A' ' 14' ' ' ILE . 27.8 tp -61.11 -41.02 95.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.668 ' O ' HG22 ' A' ' 24' ' ' VAL . 44.1 t80 -68.19 -55.8 10.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 92.9 mttt -65.58 -13.67 59.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 109.888 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.598 ' O ' HD12 ' A' ' 30' ' ' LEU . 52.9 p -109.16 -17.58 13.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.953 -1.092 . . . . 0.0 110.231 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 1.034 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 85.5 t80 -100.37 -51.57 3.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 110.109 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.6 m -85.67 -39.4 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.984 . . . . 0.0 110.092 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -81.63 -53.95 5.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.161 -0.962 . . . . 0.0 110.13 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' SER . 84.7 m-20 -76.81 4.87 8.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.034 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -65.61 -38.93 90.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.788 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -58.43 -26.66 63.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -106.04 -39.42 5.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 22' ' ' SER . 39.6 mt -69.25 -31.75 70.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.2 mt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.905 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -124.15 145.43 49.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 82.3 m-20 -82.36 114.99 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 45' ' ' LEU . 19.2 tp -56.63 -49.07 76.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 53' ' ' THR . 20.5 mm-40 -152.02 -171.35 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 70.74 163.33 4.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -98.37 7.97 45.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.167 . . . . 0.0 109.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.772 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 107.68 8.33 30.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 75' ' ' ILE . . . -105.31 -145.08 13.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.69 122.71 9.4 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.654 2.236 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.521 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . 95.63 -1.12 63.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.779 ' C ' HD12 ' A' ' 54' ' ' ILE . 92.6 m -72.96 141.25 47.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -1.191 . . . . 0.0 109.481 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.779 HD12 ' C ' ' A' ' 53' ' ' THR . 1.6 mp -111.45 131.35 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 27.0 mttm -109.7 140.16 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 109.337 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -129.23 136.3 49.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.585 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 64.8 mt . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.39 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.287 0.565 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -111.12 144.81 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.925 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 91.7 m-70 -127.04 134.64 50.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 87' ' ' ILE . 28.9 tttp -133.5 143.96 49.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.568 HG21 ' CG1' ' A' ' 75' ' ' ILE . 9.8 p -108.57 135.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.44 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 97.0 mt-10 -81.72 -43.49 18.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 92.5 mt-10 -158.84 142.37 15.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.606 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.568 ' CG1' HG21 ' A' ' 72' ' ' VAL . 77.5 mt -125.4 123.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 79' ' ' ASN . 25.9 t0 -125.69 91.72 3.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.623 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.447 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 87.8 m-70 -65.2 -41.09 94.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.504 ' O ' ' CE2' ' A' ' 80' ' ' PHE . . . -65.26 -40.43 93.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.46 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 56.3 t30 -79.33 -10.69 59.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' A' ' 78' ' ' ALA . 66.3 m-85 62.16 35.77 15.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.512 ' NZ ' ' OE1' ' A' ' 102' ' ' GLU . 73.0 tttt -128.87 122.53 30.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.294 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.556 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.4 t80 -117.66 116.7 27.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.434 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 51.1 t -117.64 123.66 46.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.209 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.2 p90 -140.31 167.35 22.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 47.3 t -137.06 169.84 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 mt -112.28 122.73 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.464 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 71' ' ' LYS . 73.9 mt -79.2 -38.39 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.301 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.337 0.589 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.661 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 59.47 22.99 11.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.699 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 122' ' ' TYR . 49.0 mt -110.65 95.95 5.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.949 . . . . 0.0 109.296 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 123' ' ' HIS . 90.0 mt-10 -48.02 -49.71 30.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.619 -0.675 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 23.9 mttp -156.47 169.77 23.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.755 HG23 ' CE1' ' A' ' 122' ' ' TYR . 55.9 mt -144.66 115.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 42.7 t -116.33 153.33 32.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 110.058 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.51 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 84.1 m-85 -125.22 133.49 52.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 108.994 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' OE1' ' NZ ' ' A' ' 81' ' ' LYS . 80.2 tt0 -111.94 136.9 50.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.813 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.01 127.87 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -126.27 130.92 51.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.448 ' HG2' HD22 ' A' ' 116' ' ' LEU . 63.3 mtt -115.18 130.77 57.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.884 . . . . 0.0 109.162 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.63 154.26 42.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.71 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' SER . . . -97.97 139.51 33.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 0.0 109.345 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 115' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.53 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.884 ' HA3' HG13 ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 55.8 m -143.05 165.16 28.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -1.117 . . . . 0.0 109.418 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 108' ' ' ALA . 76.7 mt -128.61 133.43 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 50.0 mt -113.56 135.52 53.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -129.75 141.57 50.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 8' ' ' ASP . 73.2 mt -125.07 133.37 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 24.7 m -125.3 141.76 51.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.51 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 22.4 m -128.31 151.8 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.3 mttp -139.17 126.42 21.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.755 ' CE1' HG23 ' A' ' 99' ' ' ILE . 3.2 m-85 -121.21 112.74 19.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.388 -0.82 . . . . 0.0 109.536 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.606 ' HA ' HG22 ' A' ' 3' ' ' VAL . 50.1 m-70 -84.64 121.3 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.589 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -100.93 151.74 21.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.028 -1.045 . . . . 0.0 109.986 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -56.91 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.9 57.97 0.6 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.482 ' OD1' ' HA2' ' A' ' 2' ' ' GLY . 67.6 m-20 51.5 45.58 27.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -72.52 135.02 45.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.4 m -67.32 146.51 54.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.654 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.549 HG12 HD21 ' A' ' 96' ' ' LEU . 30.8 mt -111.28 130.37 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.69 139.76 55.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.191 -0.943 . . . . 0.0 109.609 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.0 mt-10 -67.8 -31.57 71.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.58 -41.89 95.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.97 -43.16 99.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 132' ' ' GLU . 42.4 pt -82.81 -31.87 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.345 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 58.6 tttm -56.24 -41.15 75.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.38 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.72 -45.42 74.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.392 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.69 -39.26 86.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -62.05 -42.15 98.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -1.139 . . . . 0.0 109.38 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -58.32 -43.71 88.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 109.325 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.929 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.06 -40.19 94.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.7 84.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.463 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.65 -37.94 95.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 142' ' ' ALA . 3.6 mt -61.97 -40.9 97.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -1.133 . . . . 0.0 109.414 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.53 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.2 m-85 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.239 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.75 -37.73 87.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.94 -47.43 52.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.385 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.604 HG13 ' N ' ' A' ' 150' ' ' GLU . 8.1 p -63.31 -47.18 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 149' ' ' VAL . 96.2 mt-10 -61.13 -42.69 98.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.28 76.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -61.15 -53.4 57.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.45 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 64.0 mt -57.62 -38.87 75.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 150' ' ' GLU . 7.1 mp -66.11 -47.14 75.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.18 -0.95 . . . . 0.0 109.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -55.06 -29.24 57.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.963 . . . . 0.0 109.277 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.713 HG21 ' CE1' ' A' ' 123' ' ' HIS . 17.9 t -123.25 134.98 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.166 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.643 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 96.5 m-85 -95.75 135.48 37.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -121.9 129.38 52.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 0.0 109.572 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.539 ' CZ ' ' CD1' ' A' ' 135' ' ' ILE . 97.9 m-85 -125.97 146.82 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.424 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.4 tt0 -116.78 137.38 52.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.585 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' A' ' 118' ' ' ILE . 67.7 t0 -115.25 130.38 56.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.342 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -105.06 131.16 52.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.728 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.02 125.56 22.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 109.069 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -112.77 135.09 53.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.814 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -160.25 152.3 20.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.156 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.2 p -91.74 90.79 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.919 HG21 HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -139.45 149.4 60.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 108.837 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.913 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.5 Cg_endo -67.81 126.41 14.6 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.266 1.977 . . . . 0.0 111.182 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.2 Cg_endo -66.44 -29.76 44.85 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.754 2.303 . . . . 0.0 112.333 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.01 7.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.552 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -72.26 -47.24 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.724 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 14' ' ' ILE . 15.0 tp -59.29 -46.96 87.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.761 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 77' ' ' HIS . 61.5 t80 -56.04 -48.04 76.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 0.0 109.668 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 30.8 mttm -69.15 -55.73 9.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 44.3 t -64.49 -19.1 65.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 109.983 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.936 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 78.1 t80 -100.2 -51.44 3.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.055 -1.028 . . . . 0.0 110.07 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 54.4 t -85.22 -52.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.831 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -62.26 -42.95 99.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.811 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.9 m-20 -97.67 18.61 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.71 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.936 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.78 -34.19 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -72.2 -27.22 62.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -105.76 -42.32 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.945 . . . . 0.0 109.752 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 15.8 tp -63.93 -32.15 73.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.746 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 27' ' ' ALA . 39.5 mt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.085 -1.01 . . . . 0.0 109.408 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.306 0.574 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -141.02 145.46 35.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.5 ' OD1' ' CD ' ' A' ' 55' ' ' LYS . 67.2 m-20 -82.33 112.55 19.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.3 tp -70.8 -35.48 72.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 53' ' ' THR . 85.9 tt0 -149.54 157.58 43.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.51 161.59 33.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -91.62 7.64 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.164 . . . . 0.0 109.479 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.77 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.03 18.75 11.69 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.71 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -115.24 -142.52 7.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.438 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.86 125.21 11.83 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.698 2.265 . . . . 0.0 111.74 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.675 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 89.37 -1.53 82.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.77 HG21 ' HA2' ' A' ' 49' ' ' GLY . 67.5 m -72.64 141.11 48.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 70' ' ' HIS . 24.8 mm -106.67 130.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.5 ' CD ' ' OD1' ' A' ' 44' ' ' ASN . 34.3 mmtp -102.35 147.86 26.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -123.9 137.62 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.517 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.501 HG12 ' CD2' ' A' ' 70' ' ' HIS . 22.7 mm . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.265 0.555 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.68 133.27 54.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.601 ' O ' HG23 ' A' ' 54' ' ' ILE . 75.5 m-70 -118.45 139.24 51.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.521 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 34.7 tttt -135.72 137.06 41.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.675 HG13 ' H ' ' A' ' 52' ' ' GLY . 11.8 p -104.73 130.09 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.49 -41.49 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 84.8 tt0 -176.36 139.79 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.71 HD12 ' HA2' ' A' ' 50' ' ' GLY . 68.5 mt -116.52 124.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -131.82 73.34 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 64.8 m170 -56.35 -37.48 70.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.48 70.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -92.32 8.3 38.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.499 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 74.7 m-85 51.74 28.32 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 0.0 109.477 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -123.92 136.81 54.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 71.4 t80 -133.78 133.6 41.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.6 m -135.58 120.04 18.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.2 p90 -135.97 166.25 23.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.53 ' O ' HD13 ' A' ' 86' ' ' ILE . 92.8 p -148.07 164.11 34.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 85' ' ' SER . 24.2 mm -116.1 120.1 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 71' ' ' LYS . 67.2 mt -77.65 -36.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.533 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 74.1 m80 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 57.57 16.14 3.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.643 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.0 ' HB3' HD11 ' A' ' 99' ' ' ILE . 32.4 mt -96.25 90.78 5.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.007 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 123' ' ' HIS . 79.6 mt-10 -47.05 -36.87 8.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.644 . . . . 0.0 110.529 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 1.042 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.4 tttt -164.68 156.99 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.75 -1.219 . . . . 0.0 110.356 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.042 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.3 mm -134.43 113.22 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.49 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 17.5 m -115.77 152.88 32.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.061 . . . . 0.0 110.087 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 119' ' ' THR . 84.3 m-85 -132.24 128.93 38.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 84.5 tt0 -104.89 139.82 39.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.841 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.81 122.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.113 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -130.24 136.33 49.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.967 . . . . 0.0 109.724 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.51 ' HE3' ' CD1' ' A' ' 23' ' ' PHE . 64.0 mtt -117.75 143.84 45.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -140.83 152.35 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 109.566 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.21 135.19 47.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -151.61 154.23 36.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -1.153 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.447 ' C ' HD12 ' A' ' 116' ' ' LEU . 67.5 mt -118.24 133.04 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.33 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.778 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.9 mp -111.15 135.78 51.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.424 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 18.6 mttt -122.61 135.76 54.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.271 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -119.75 136.8 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 109.627 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 26.2 m -117.98 142.56 47.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.31 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 73.4 m -120.65 151.73 39.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 28.2 mttp -139.78 129.1 24.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.05 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.952 ' CD1' HG23 ' A' ' 99' ' ' ILE . 15.4 m-85 -129.34 110.63 12.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.823 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.713 ' CE1' HG21 ' A' ' 3' ' ' VAL . 49.1 m-70 -81.06 113.38 19.21 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.0 OUTLIER -105.71 139.37 40.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.362 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 124' ' ' THR . 31.3 mttt -42.2 -47.93 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.421 -0.799 . . . . 0.0 109.631 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.42 -64.83 0.27 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.43 -30.34 71.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -63.0 148.24 48.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.5 m -132.43 150.36 52.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.801 HD11 HD21 ' A' ' 96' ' ' LEU . 22.4 mm -102.54 122.63 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -92.53 136.24 33.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.494 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 84.8 tt0 -55.62 -41.28 73.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.411 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.63 -40.39 95.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.38 -46.4 86.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.456 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.597 HG21 ' CG2' ' A' ' 130' ' ' ILE . 11.5 pt -80.1 -33.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 46.7 tttm -56.8 -33.9 67.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.855 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.55 74.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.325 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.09 92.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -56.98 -46.79 81.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.213 -1.169 . . . . 0.0 109.371 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.38 -46.1 87.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 145' ' ' LEU . 39.6 ttpt -58.87 -45.98 88.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.327 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.72 77.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . -60.16 -41.92 93.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.97 89.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.617 HD12 ' H ' ' A' ' 145' ' ' LEU . 6.6 mp -64.22 -38.37 90.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -1.13 . . . . 0.0 109.369 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.502 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.8 t80 -63.8 -44.52 93.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.384 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 143' ' ' ALA . 20.3 mmtt -62.41 -38.26 89.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.419 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.39 76.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.337 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 146' ' ' PHE . 4.7 p -65.23 -40.37 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.32 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 84.7 tt0 -60.22 -40.89 91.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.365 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.43 98.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -62.28 -44.72 95.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.892 . . . . 0.0 109.343 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.488 ' HA ' HD12 ' A' ' 153' ' ' LEU . 25.8 tp -57.77 -38.76 76.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.4 mt -71.02 -43.17 68.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -56.72 -27.16 58.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.978 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.529 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 123' ' ' HIS . 29.7 t -130.44 136.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -1.168 . . . . 0.0 109.417 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.674 ' HE1' HG21 ' A' ' 124' ' ' THR . 93.6 m-85 -104.15 136.09 44.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.0 m -113.72 114.65 26.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 4' ' ' PHE . 33.1 m-85 -112.75 138.48 49.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 94.3 mt-10 -112.37 156.5 22.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.674 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -124.05 143.4 50.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.356 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -109.96 135.81 50.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -152.39 123.86 7.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.156 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.5 m -117.9 131.53 56.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -160.32 144.69 14.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.268 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.677 ' O ' HG23 ' A' ' 13' ' ' VAL . 33.4 m -78.08 91.25 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.436 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.847 HG21 HD13 ' A' ' 19' ' ' LEU . 24.5 mt -139.0 144.29 40.58 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.443 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.717 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.4 Cg_endo -67.93 120.41 7.41 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.499 2.132 . . . . 0.0 111.368 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 45.6 Cg_endo -67.0 -27.31 42.76 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.818 2.345 . . . . 0.0 112.263 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -54.34 6.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 22' ' ' SER . 62.8 mtt85 -72.15 -42.89 65.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.847 HD13 HG21 ' A' ' 14' ' ' ILE . 32.9 tp -59.98 -47.45 85.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.694 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.507 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 47.1 t80 -59.23 -52.0 67.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 25' ' ' LEU . 46.2 mttp -69.14 -29.36 67.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.773 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 83.5 p -84.16 -28.12 27.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.694 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.862 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 84.7 t80 -100.76 -48.45 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.89 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.7 t -84.42 -52.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.424 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 21' ' ' LYS . 12.5 tp -74.95 -26.03 59.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 110.024 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 22' ' ' SER . 85.5 m-20 -113.74 27.11 9.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 109.585 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.862 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.68 -42.13 74.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.512 ' HA ' HD12 ' A' ' 31' ' ' ILE . 56.0 t0 -62.63 -32.52 73.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -93.69 -31.38 14.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.857 . . . . 0.0 109.389 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.401 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 15.9 tp -75.35 -25.8 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 27' ' ' ALA . 12.3 mt . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -132.02 144.5 50.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.451 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 89.9 m-20 -88.29 112.1 22.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 56' ' ' LYS . 2.0 mp -66.86 -37.79 85.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 53' ' ' THR . 82.4 tt0 -149.64 155.55 40.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.515 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 89.55 159.68 35.69 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -92.35 6.77 45.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.517 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.624 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 107.25 18.44 10.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -113.25 -145.97 9.49 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.4 Cg_endo -70.03 121.42 8.05 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.706 2.271 . . . . 0.0 111.725 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.69 67.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.624 HG21 ' HA2' ' A' ' 49' ' ' GLY . 52.4 m -79.47 135.07 36.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.18 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.461 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 19.4 mm -95.29 136.28 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.207 -0.933 . . . . 0.0 109.513 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 45.3 mttm -119.9 133.51 55.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.744 ' HB2' HD11 ' A' ' 45' ' ' LEU . 30.5 tttm -107.36 142.1 37.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.527 HG12 ' ND1' ' A' ' 70' ' ' HIS . 26.3 mm . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.98 129.5 48.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.955 . . . . 0.0 109.677 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.527 ' ND1' HG12 ' A' ' 57' ' ' ILE . 80.8 m80 -128.32 126.67 41.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.359 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 18.0 tttm -123.6 145.42 48.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 HG13 ' A' ' 75' ' ' ILE . 46.9 t -90.39 129.58 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 83.9 tt0 -79.88 -37.46 34.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.506 ' N ' ' HB2' ' A' ' 83' ' ' CYS . 80.8 tt0 -179.12 144.31 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.024 HD12 ' HA2' ' A' ' 50' ' ' GLY . 27.5 mt -127.39 119.16 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 79' ' ' ASN . 29.4 t0 -127.11 86.88 2.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -66.88 -32.31 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.84 81.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 15.8 m-20 -96.04 2.25 53.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 59.07 22.33 10.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 109.454 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.472 ' HG2' ' HB2' ' A' ' 104' ' ' LYS . 33.9 mttt -110.97 130.46 55.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 75' ' ' ILE . 25.8 t80 -125.13 129.14 49.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.952 . . . . 0.0 109.673 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.506 ' HB2' ' N ' ' A' ' 74' ' ' GLU . 35.9 m -109.39 131.92 54.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.228 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -120.89 139.53 53.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.668 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 20.2 t -127.2 142.81 51.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 99' ' ' ILE . 24.1 mt -117.97 127.45 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.68 -36.66 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.461 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 124' ' ' THR . 1.4 m 64.08 11.25 6.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.488 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.665 HD21 HG12 ' A' ' 130' ' ' ILE . 93.9 mt -94.81 92.11 6.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.311 -0.868 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' HIS . 46.3 mt-10 -49.1 -40.27 31.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.751 -0.593 . . . . 0.0 110.963 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.643 ' O ' HD13 ' A' ' 99' ' ' ILE . 95.0 mttt -158.12 156.57 31.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.855 HG23 ' CE1' ' A' ' 122' ' ' TYR . 33.3 mm -133.18 113.0 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 29.7 t -113.68 150.08 33.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 84' ' ' TYR . 91.2 m-85 -129.08 130.69 46.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 85.1 tt0 -108.76 137.98 45.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.758 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.0 mt -124.12 124.54 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.299 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HE3' ' HD2' ' A' ' 117' ' ' LYS . 41.3 pttt -134.86 149.52 50.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.41 ' HG2' HD22 ' A' ' 116' ' ' LEU . 64.4 mtt -115.42 145.22 42.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.44 155.47 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.79 148.09 38.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 108' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.0 t -125.22 157.96 35.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 108' ' ' ALA . 66.6 mt -117.03 136.99 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 36.8 mt -106.24 136.2 46.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.649 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.489 ' HD2' ' HE3' ' A' ' 104' ' ' LYS . 77.1 mttt -130.66 144.58 51.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.122 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.5 mt -132.64 140.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 0.0 109.999 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 20.6 m -120.54 142.31 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 100' ' ' SER . 0.1 OUTLIER -118.98 146.62 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 100' ' ' SER . 37.3 ttpt -126.02 112.2 15.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 109.32 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.855 ' CE1' HG23 ' A' ' 99' ' ' ILE . 3.5 m-85 -109.74 108.51 18.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.7 ' HA ' HG22 ' A' ' 3' ' ' VAL . 4.9 t60 -83.79 121.79 27.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.674 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.3 p -113.08 143.93 43.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.991 -1.068 . . . . 0.0 109.765 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -70.19 153.33 43.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.59 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 47.59 -131.43 16.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -114.45 41.53 2.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.183 . . . . 0.0 109.385 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -65.05 150.08 48.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.448 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 96.6 p -114.65 155.48 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.665 HG12 HD21 ' A' ' 96' ' ' LEU . 58.3 mt -113.04 141.5 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -89.13 141.24 28.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.3 mt-10 -65.48 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 23.1 pt-20 -65.7 -41.74 92.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.457 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 133' ' ' GLU . 83.9 tt0 -61.3 -41.54 97.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 132' ' ' GLU . 47.8 pt -85.05 -29.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 34.0 tttt -55.76 -45.56 78.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.05 78.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.217 -0.927 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.99 -35.08 90.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.09 -44.16 95.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.29 -39.9 94.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.865 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -63.25 -41.05 99.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.939 . . . . 0.0 109.434 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.575 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -71.0 -36.67 72.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.446 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.61 95.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.42 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.45 -38.93 95.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.527 ' O ' HG12 ' A' ' 149' ' ' VAL . 25.1 tp -65.53 -41.2 93.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -1.154 . . . . 0.0 109.442 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.575 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 16.6 m-85 -65.13 -45.95 82.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -62.83 -37.57 87.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.67 -51.45 56.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.415 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -64.43 -47.53 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.597 ' N ' HG13 ' A' ' 149' ' ' VAL . 87.8 mt-10 -58.66 -38.84 79.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.4 -41.25 89.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.376 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -62.87 -38.59 91.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.09 -43.95 87.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 154' ' ' LEU . 6.6 mp -73.64 -40.83 63.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.23 -15.95 63.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.38 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.611 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.2 p -120.19 138.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -1.077 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.817 ' CE2' HG21 ' A' ' 124' ' ' THR . 96.4 m-85 -98.6 146.03 26.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 25.7 p -132.09 128.13 37.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.514 ' O ' HG23 ' A' ' 119' ' ' THR . 90.9 m-85 -122.21 151.99 40.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 117' ' ' LYS . 95.9 mt-10 -118.48 145.61 45.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -123.01 145.82 48.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -121.81 137.34 54.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.59 122.97 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.092 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 1.069 HG22 HG23 ' A' ' 115' ' ' ILE . 59.4 p -123.82 143.21 50.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.534 ' OG ' ' CD1' ' A' ' 14' ' ' ILE . 98.9 p -160.28 149.36 17.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 108.933 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 13' ' ' VAL . 33.6 m -66.2 90.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.021 . . . . 0.0 109.341 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.979 HG21 HD22 ' A' ' 19' ' ' LEU . 5.5 mt -139.36 142.29 31.88 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.32 -0.862 . . . . 0.0 109.341 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.3 Cg_endo -67.92 122.33 9.44 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 122.356 2.037 . . . . 0.0 111.197 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.79 -34.02 32.36 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.702 2.268 . . . . 0.0 112.209 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.64 11.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.994 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -72.15 -37.94 69.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 110.126 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.979 HD22 HG21 ' A' ' 14' ' ' ILE . 32.0 tp -67.0 -51.06 59.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.929 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.638 ' CE2' HG21 ' A' ' 24' ' ' VAL . 67.7 t80 -56.25 -46.89 79.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 25.3 mttt -67.99 -49.56 60.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.139 -0.975 . . . . 0.0 109.879 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 88.7 p -71.49 -20.1 62.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.936 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.966 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 24.0 t80 -100.48 -51.12 3.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.16 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.638 HG21 ' CE2' ' A' ' 20' ' ' PHE . 54.9 t -85.11 -52.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -0.939 . . . . 0.0 110.128 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.704 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -67.08 -49.3 65.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.0 m-20 -89.52 20.23 4.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.18 -50.63 53.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.062 -1.024 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.701 ' HA ' HD12 ' A' ' 31' ' ' ILE . 91.7 m-20 -63.43 -32.07 73.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.955 . . . . 0.0 109.798 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -88.91 -34.69 16.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.526 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.1 tp -74.89 -26.54 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.662 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 28' ' ' ASP . 12.9 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 56' ' ' LYS . 93.6 mt-10 -134.21 157.05 47.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 35.7 p-10 -87.96 112.11 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.466 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 45' ' ' LEU . 24.1 tp -73.64 -36.24 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 53' ' ' THR . 85.9 tt0 -143.1 154.96 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 91.12 159.26 35.47 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.9 8.26 38.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.49 20.39 13.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.594 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -117.67 -145.39 7.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.42 125.31 12.16 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.89 -1.51 80.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.605 HG21 ' HA2' ' A' ' 49' ' ' GLY . 96.2 m -73.59 139.98 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 109.471 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.8 mm -103.39 134.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 4.0 mtmp? -110.45 156.53 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' GLU . 52.5 tttt -130.91 128.66 40.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 109.353 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.504 HD12 ' CE1' ' A' ' 70' ' ' HIS . 70.5 mt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.527 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -134.65 129.01 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.504 ' CE1' HD12 ' A' ' 57' ' ' ILE . 93.9 m-70 -127.34 129.12 47.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.401 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.483 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 14.9 tttp -127.5 146.01 50.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.572 HG11 ' O ' ' A' ' 50' ' ' GLY . 14.8 p -108.43 138.72 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -75.71 -44.16 43.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -173.59 143.49 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.594 HD12 ' HA2' ' A' ' 50' ' ' GLY . 70.4 mt -119.36 118.68 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.9 m-20 -125.04 78.36 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.578 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 98.1 m-70 -59.18 -34.62 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.63 66.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 80.7 m-20 -94.27 9.49 37.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.584 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 68.5 m-85 48.34 36.36 6.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -131.29 129.72 41.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.955 . . . . 0.0 109.346 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 61.3 t80 -126.12 122.81 36.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.989 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.6 117.77 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.49 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 35.1 p90 -134.84 167.25 21.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.6 p -145.99 175.23 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.337 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 mt -129.34 126.44 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.451 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.8 mt -78.81 -42.66 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 179.952 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 m80 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 58.17 16.65 4.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.923 HD22 ' CB ' ' A' ' 122' ' ' TYR . 28.0 mt -96.94 90.49 5.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.315 -0.865 . . . . 0.0 109.509 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 123' ' ' HIS . 89.8 mt-10 -43.59 -37.97 2.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.599 -0.688 . . . . 0.0 110.523 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' O ' HD13 ' A' ' 99' ' ' ILE . 68.2 mttm -145.67 158.06 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.818 -1.176 . . . . 0.0 110.466 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.733 HG23 ' CD1' ' A' ' 122' ' ' TYR . 20.5 mm -135.21 119.29 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -122.52 154.55 37.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 0.0 109.808 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -132.99 137.46 46.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.374 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 119' ' ' THR . 80.0 tt0 -113.47 141.83 46.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 103' ' ' ILE . 61.3 mt -128.79 118.7 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.302 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -131.53 126.39 34.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.487 ' CE ' ' HA ' ' A' ' 20' ' ' PHE . 75.9 mtm -120.21 150.95 39.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.05 150.82 26.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 138.43 53.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 32.2 t -151.73 149.65 29.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -1.179 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.069 HG23 HG22 ' A' ' 11' ' ' THR . 64.5 mt -111.77 133.98 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.6 mp -106.37 130.9 54.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.731 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 7' ' ' GLU . 37.6 tttm -124.62 135.71 53.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.115 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 69.4 mt -129.04 123.55 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.838 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 6' ' ' TYR . 46.8 m -122.52 131.24 53.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.375 -0.828 . . . . 0.0 109.032 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' OH ' ' A' ' 122' ' ' TYR . 1.8 m -114.34 160.76 18.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 109.969 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 44.8 mttp -143.08 123.9 14.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.923 ' CB ' HD22 ' A' ' 96' ' ' LEU . 5.6 m-85 -122.34 122.76 39.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 97' ' ' GLU . 21.4 m80 -85.31 113.9 21.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 108.82 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.817 HG21 ' CE2' ' A' ' 4' ' ' PHE . 1.3 p -94.42 148.39 22.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.679 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.452 ' HG2' ' OE2' ' A' ' 97' ' ' GLU . 32.8 mttm -67.27 145.3 55.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.02 -129.63 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -110.32 31.16 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.556 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.87 144.82 26.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 130' ' ' ILE . 83.9 p -95.61 171.63 8.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.633 HD11 ' CG2' ' A' ' 124' ' ' THR . 38.5 mm -118.72 121.89 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -59.18 119.69 7.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.483 ' HA ' HG13 ' A' ' 135' ' ' ILE . 97.0 mt-10 -54.27 -36.73 63.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.3 -35.95 82.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.215 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.44 -25.93 67.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.639 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.483 HG13 ' HA ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -87.9 -35.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.208 -0.932 . . . . 0.0 109.049 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -57.45 -44.27 84.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.688 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.83 -43.24 72.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.452 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.86 92.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -57.99 -47.11 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -1.087 . . . . 0.0 109.343 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.43 -40.11 93.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -58.56 -45.45 88.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -38.64 85.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.86 99.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.26 -45.98 92.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.01 -38.39 79.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -1.197 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.478 ' O ' HG12 ' A' ' 149' ' ' VAL . 70.2 t80 -61.65 -41.57 97.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -60.42 -40.06 89.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.328 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.12 80.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 146' ' ' PHE . 5.7 p -67.32 -39.98 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.45 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.2 tt0 -63.73 -38.61 91.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.73 97.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.351 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -59.55 -48.89 79.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.3 mt -61.68 -38.8 89.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 109.38 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 154' ' ' LEU . 20.6 tp -63.76 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.67 68.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.7 t60 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.883 . . . . 0.0 109.415 179.93 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.797 HG22 ' ND1' ' A' ' 123' ' ' HIS . 38.6 t -125.21 132.68 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.17 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.605 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 97.3 m-85 -95.44 130.52 42.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.181 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 t -110.59 125.04 52.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.474 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.605 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 93.7 m-85 -125.41 144.51 50.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.315 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 91.5 mt-10 -125.15 160.98 27.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.737 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 60.4 t0 -134.42 142.45 47.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.162 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.33 138.89 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.903 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.69 121.56 8.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.151 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.9 m -112.5 133.07 54.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.004 . . . . 0.0 109.971 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 14' ' ' ILE . 4.8 t -160.41 139.59 10.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.786 . . . . 0.0 109.026 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 13' ' ' VAL . 28.2 m -68.59 91.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.04 . . . . 0.0 109.36 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.852 HG21 HD13 ' A' ' 19' ' ' LEU . 1.6 mt -138.89 143.84 39.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.216 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.686 ' HD2' HG22 ' A' ' 14' ' ' ILE . 46.3 Cg_endo -68.24 127.86 16.53 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.409 2.073 . . . . 0.0 111.259 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.88 -34.64 29.57 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.723 2.282 . . . . 0.0 112.199 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.12 -50.96 11.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.634 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.45 ' HB2' ' HG2' ' A' ' 15' ' ' PRO . 42.0 mtt-85 -70.42 -45.98 64.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.853 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.852 HD13 HG21 ' A' ' 14' ' ' ILE . 40.5 tp -59.91 -48.44 81.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 80' ' ' PHE . 65.9 t80 -52.41 -51.77 57.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.592 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 33.3 mttt -67.45 -57.57 6.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.881 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 46.6 m -62.03 -20.43 63.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.969 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.3 t80 -100.11 -51.27 3.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.993 -1.067 . . . . 0.0 110.095 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 51.7 t -84.93 -51.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 17.8 tp -66.42 -40.48 89.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.835 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.6 m-20 -99.8 20.44 14.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.722 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.63 -34.55 74.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.17 -32.38 72.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.857 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -101.6 -42.07 6.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.129 -0.982 . . . . 0.0 109.76 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 17.6 tp -56.3 -36.8 69.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.753 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.492 -179.71 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -125.81 165.26 19.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 109.38 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' ILE . 50.9 t30 -91.33 115.29 27.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.695 HD23 HG21 ' A' ' 54' ' ' ILE . 16.6 tp -63.87 -40.26 96.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.167 -0.958 . . . . 0.0 109.422 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 47' ' ' GLY . 53.1 tt0 -170.95 162.4 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.425 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 94.74 162.54 34.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -95.03 6.16 49.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.573 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.516 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.6 19.28 11.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.963 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -117.4 -145.72 8.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.57 125.49 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.722 2.282 . . . . 0.0 111.826 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.55 -1.83 79.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.516 HG21 ' HA2' ' A' ' 49' ' ' GLY . 31.9 m -73.68 137.22 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -1.18 . . . . 0.0 109.452 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.787 HG23 ' O ' ' A' ' 70' ' ' HIS . 4.7 mt -109.78 139.0 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.517 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 68.6 mttm -112.01 149.07 32.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HD2' HD13 ' A' ' 45' ' ' LEU . 22.7 tttt -132.95 147.24 52.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.378 -0.827 . . . . 0.0 109.33 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.4 mt . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.46 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 81.0 mmm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.582 ' O ' HG23 ' A' ' 86' ' ' ILE . 80.1 mttt -134.25 131.71 38.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.399 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.787 ' O ' HG23 ' A' ' 54' ' ' ILE . 79.6 m80 -125.99 140.54 52.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.955 . . . . 0.0 109.612 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -138.24 140.75 39.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 109.362 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 50.1 t -100.77 138.57 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.5 tt0 -84.07 -56.85 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.384 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.4 mt-10 -158.78 141.64 14.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.454 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.963 HD12 ' HA2' ' A' ' 50' ' ' GLY . 74.0 mt -118.87 128.61 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 85.7 m-20 -128.79 81.25 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -58.93 -36.5 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.93 74.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -85.53 6.96 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.545 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 92.0 m-85 49.44 33.0 5.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -127.82 139.72 52.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.531 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 67.1 t80 -126.46 131.4 51.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.7 m -128.39 117.05 20.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.439 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.531 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.6 p90 -139.84 157.47 45.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.483 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 83.9 p -137.71 174.17 10.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.582 HG23 ' O ' ' A' ' 69' ' ' LYS . 12.6 mt -124.62 128.21 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.47 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 72.9 mt -74.86 -37.61 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.867 . . . . 0.0 109.593 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.555 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.8 m80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.668 HG21 ' CB ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 52.76 20.74 1.67 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.99 HD22 ' HB3' ' A' ' 122' ' ' TYR . 22.3 mt -94.7 90.49 6.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.3 mt-10 -46.24 -40.19 11.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.591 -0.693 . . . . 0.0 110.595 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.821 ' O ' HD13 ' A' ' 99' ' ' ILE . 55.7 tttp -155.88 154.39 31.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.634 -1.291 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.842 HD11 ' HB3' ' A' ' 96' ' ' LEU . 24.1 mm -129.41 118.51 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 120' ' ' SER . 44.8 m -119.52 148.13 43.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 109.945 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.542 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 73.6 m-85 -125.55 140.82 52.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.162 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 119' ' ' THR . 84.5 tt0 -124.4 132.86 53.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.696 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.503 HG21 ' HE1' ' A' ' 23' ' ' PHE . 11.1 mm -109.04 126.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.273 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -130.62 133.22 45.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.724 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.549 ' CE ' ' CD1' ' A' ' 23' ' ' PHE . 64.2 mtt -117.55 146.83 43.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.315 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.87 157.76 44.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.3 136.99 34.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.447 ' HB3' ' N ' ' A' ' 113' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.447 ' N ' ' HB3' ' A' ' 108' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 22.5 t -155.13 145.38 21.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.475 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.409 ' C ' HD12 ' A' ' 116' ' ' LEU . 67.9 mt -116.12 128.7 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.765 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.1 mp -108.44 135.67 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 68.1 mttm -126.6 135.34 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 77.0 mt -119.61 131.08 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 30.8 m -119.85 142.69 48.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' SER . 1.4 m -128.02 156.62 42.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.826 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -133.59 108.99 8.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.838 . . . . 0.0 108.973 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.99 ' HB3' HD22 ' A' ' 96' ' ' LEU . 8.4 m-30 -105.27 118.91 37.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.797 ' ND1' HG22 ' A' ' 3' ' ' VAL . 2.1 m-70 -84.94 134.13 34.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 108.912 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.656 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 12.8 t -113.56 144.82 42.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 126' ' ' GLY . 22.9 mttp -72.09 139.77 48.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.51 -142.35 3.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' ALA . 73.0 m-20 -85.9 10.67 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.668 ' CB ' HG21 ' A' ' 95' ' ' THR . . . -44.12 146.96 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -115.88 161.89 18.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 96' ' ' LEU . 55.8 mt -104.06 139.08 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.46 118.45 7.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.567 ' HA ' HG13 ' A' ' 135' ' ' ILE . 88.1 tt0 -57.72 -34.57 69.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.46 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -56.33 -42.39 77.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.91 -25.09 67.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.591 HD13 ' CE1' ' A' ' 6' ' ' TYR . 2.9 mt -69.49 -52.34 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 108.947 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -55.65 -41.34 73.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.43 86.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.238 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.2 -36.09 80.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.51 -40.27 95.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -1.177 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.39 -35.23 79.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -63.3 -39.72 95.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 109.567 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.6 76.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.909 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.84 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.595 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.31 -48.2 76.83 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.713 ' O ' HG12 ' A' ' 149' ' ' VAL . 64.7 mt -68.26 -37.92 81.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -1.188 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.427 ' HE2' HD22 ' A' ' 116' ' ' LEU . 71.0 t80 -63.5 -45.72 89.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.569 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -63.05 -37.77 88.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.2 38.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.606 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 145' ' ' LEU . 7.5 p -66.13 -40.04 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.475 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.6 tt0 -61.97 -39.16 91.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.554 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -65.89 -41.79 91.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.491 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 153' ' ' LEU . 32.9 tp -61.53 -38.0 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.14 -0.975 . . . . 0.0 109.374 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 154' ' ' LEU . 33.8 mt -77.98 -30.89 50.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.08 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 109.428 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.679 HG22 ' HA ' ' A' ' 123' ' ' HIS . 52.4 t -126.85 135.5 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.149 . . . . 0.0 109.471 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.611 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 97.9 m-85 -91.71 128.25 37.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.364 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.8 t -113.56 123.86 50.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.63 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.912 ' CG ' HG21 ' A' ' 135' ' ' ILE . 92.4 m-85 -122.86 146.09 47.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 83.9 tt0 -121.94 131.39 53.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.947 . . . . 0.0 109.645 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.88 124.87 45.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -97.07 134.63 40.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.89 124.81 8.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.405 HG23 HG12 ' A' ' 115' ' ' ILE . 34.8 m -118.39 132.49 56.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -160.51 135.47 7.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.137 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 13' ' ' VAL . 24.1 m -64.99 91.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.071 -1.018 . . . . 0.0 109.355 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.745 HG23 ' HD2' ' A' ' 15' ' ' PRO . 20.0 mt -138.86 144.65 42.39 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.745 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.48 119.54 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.563 2.176 . . . . 0.0 111.265 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.4 Cg_endo -66.78 -34.83 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.764 2.31 . . . . 0.0 112.264 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.74 14.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -72.2 -40.96 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 14' ' ' ILE . 22.3 tp -66.39 -36.71 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.111 -0.993 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 80' ' ' PHE . 56.3 t80 -63.79 -50.48 68.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASP . 29.6 mttt -69.26 -48.07 62.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 19.2 m -65.62 -23.48 66.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.895 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.928 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.7 t80 -100.54 -51.08 3.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 110.139 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 20' ' ' PHE . 55.9 t -84.83 -52.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 22.2 tp -68.07 -29.44 68.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.864 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.8 m-20 -110.38 20.09 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.114 -0.991 . . . . 0.0 109.565 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.928 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -67.96 -34.79 77.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.583 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -66.68 -42.17 86.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.828 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -90.02 -34.07 16.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.718 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.673 HD21 HG23 ' A' ' 149' ' ' VAL . 23.2 tp -66.76 -32.82 74.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 27' ' ' ALA . 31.9 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.413 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 95.5 mt-10 -143.19 151.51 40.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.461 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.9 m-20 -89.04 111.5 22.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.529 HD22 ' HD3' ' A' ' 56' ' ' LYS . 31.4 tp -77.3 -33.74 55.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 53' ' ' THR . 86.5 tt0 -150.9 155.55 39.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.432 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 76.04 157.8 7.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -81.81 -19.96 40.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -1.127 . . . . 0.0 109.449 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.91 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 143.07 -12.6 2.34 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.472 ' C ' HD12 ' A' ' 75' ' ' ILE . . . -78.55 -148.12 3.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.0 126.0 13.25 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.858 2.372 . . . . 0.0 111.847 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.09 -6.53 66.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.91 HG21 ' HA2' ' A' ' 49' ' ' GLY . 53.7 m -74.22 139.48 44.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.079 -1.248 . . . . 0.0 109.537 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.401 HG12 ' HG3' ' A' ' 71' ' ' LYS . 7.3 mt -110.6 139.43 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 64.9 mttt -130.27 138.44 50.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 109.519 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HD3' HD22 ' A' ' 45' ' ' LEU . 17.4 mtmt -112.92 136.46 52.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.322 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -137.14 133.99 35.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 98.7 m-70 -122.4 131.43 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HG3' HG12 ' A' ' 54' ' ' ILE . 17.2 tttm -128.72 127.66 42.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.502 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 1.001 HG21 HD11 ' A' ' 75' ' ' ILE . 2.3 p -84.0 134.22 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 23.4 mt-10 -82.41 -44.76 15.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.857 . . . . 0.0 109.431 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.3 mt-10 -159.23 150.98 20.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.001 HD11 HG21 ' A' ' 72' ' ' VAL . 3.2 mt -135.54 107.12 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.598 ' OD1' ' ND2' ' A' ' 79' ' ' ASN . 31.1 t0 -123.21 90.92 3.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.8 m170 -70.4 -32.78 70.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.58 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.59 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.598 ' ND2' ' OD1' ' A' ' 76' ' ' ASP . 70.2 m-20 -84.34 8.25 16.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 75.6 m-85 54.72 25.36 6.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.378 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HE2' ' OE2' ' A' ' 102' ' ' GLU . 63.6 tttt -108.78 122.21 46.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 109.232 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 84' ' ' TYR . 7.4 t80 -128.75 129.82 46.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 109.695 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.463 ' HA ' ' HG3' ' A' ' 102' ' ' GLU . 1.8 t -109.55 123.63 49.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.013 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.608 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -121.14 138.62 54.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.121 -0.987 . . . . 0.0 109.966 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.496 ' HB3' ' NZ ' ' A' ' 98' ' ' LYS . 48.8 m -137.45 158.71 43.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.054 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 mt -127.65 128.1 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.653 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.544 HG22 ' HG3' ' A' ' 88' ' ' GLU . 89.1 mt -86.01 -39.16 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.544 ' HG3' HG22 ' A' ' 87' ' ' ILE . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.4 ' C ' ' OG1' ' A' ' 95' ' ' THR . 31.9 t-80 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.929 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.1 OUTLIER 61.36 13.34 4.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.61 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.785 ' HB3' HD11 ' A' ' 99' ' ' ILE . 32.3 mt -94.87 90.23 5.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' HIS . 86.7 mt-10 -47.19 -42.67 20.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.598 -0.689 . . . . 0.0 110.509 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 1.051 ' O ' HD13 ' A' ' 99' ' ' ILE . 19.7 tttm -158.96 162.49 36.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.713 -1.242 . . . . 0.0 110.522 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.051 HD13 ' O ' ' A' ' 98' ' ' LYS . 7.2 mm -136.15 126.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -132.79 155.8 48.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.112 -0.992 . . . . 0.0 109.996 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.54 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 57.1 m-85 -137.86 129.72 28.56 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 83.6 tt0 -106.83 129.09 54.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.807 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -108.32 118.53 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -129.53 143.77 50.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.532 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.46 ' SD ' ' HA ' ' A' ' 20' ' ' PHE . 59.8 mtt -118.81 147.82 43.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.95 163.81 33.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.62 32.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.855 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.779 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.481 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 28.7 t -135.55 148.77 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -1.159 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.779 HG13 ' HB2' ' A' ' 108' ' ' ALA . 64.7 mt -113.86 134.25 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' CE2' ' A' ' 146' ' ' PHE . 24.1 mt -106.66 139.24 41.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -135.34 136.45 41.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.376 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.9 mt -125.02 135.23 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 25.3 m -116.16 141.9 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.912 . . . . 0.0 109.442 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.54 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 67.8 m -124.48 153.15 42.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -137.28 129.08 28.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.759 ' HD1' HD12 ' A' ' 99' ' ' ILE . 51.4 m-85 -125.77 108.72 11.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.745 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.679 ' HA ' HG22 ' A' ' 3' ' ' VAL . 52.6 m-70 -79.88 130.89 35.67 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 8.8 t -116.17 147.87 40.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.067 -1.02 . . . . 0.0 109.731 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 124' ' ' THR . 18.2 tttt -42.09 -40.96 2.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.646 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.85 0.52 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -86.41 10.72 14.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -1.171 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.929 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -110.36 151.09 27.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -132.25 149.33 52.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 29.5 mt -98.56 121.39 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.527 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -54.69 138.86 40.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.507 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.2 mt-10 -66.3 -33.22 75.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 109.502 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -59.04 -33.58 70.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.304 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -65.73 -29.52 70.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.268 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.912 HG21 ' CG ' ' A' ' 6' ' ' TYR . 1.8 mm -69.83 -48.51 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 108.749 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -55.59 -41.55 73.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.193 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.45 75.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.35 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.11 -34.81 58.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.3 -38.14 87.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.294 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.29 -43.74 96.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.282 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -60.2 -42.76 95.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.922 . . . . 0.0 109.428 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.49 82.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.75 89.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.46 -48.47 83.92 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 149' ' ' VAL . 25.2 tp -64.85 -38.85 92.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.16 . . . . 0.0 109.405 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.512 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 68.5 t80 -60.33 -41.31 93.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.291 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.29 66.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.404 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.673 HG23 HD21 ' A' ' 30' ' ' LEU . 7.9 p -64.2 -44.29 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.562 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.4 tt0 -54.33 -43.57 71.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.85 99.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -60.55 -47.29 86.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.467 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.68 -36.99 82.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.434 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.517 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.2 tt -63.24 -46.33 87.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.04 -32.08 70.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 m170 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.463 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.52 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.7 p -131.52 136.49 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.576 ' CE2' HG12 ' A' ' 130' ' ' ILE . 87.3 m-85 -95.92 144.38 26.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.41 ' SG ' ' HE3' ' A' ' 121' ' ' LYS . 4.0 m -125.26 119.75 29.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.78 ' O ' HG23 ' A' ' 119' ' ' THR . 29.3 m-85 -110.75 148.41 32.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.53 151.97 39.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -131.8 138.94 48.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -108.98 132.47 54.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.645 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -148.89 125.63 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -114.38 135.56 53.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.84 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -160.36 141.33 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.3 p -77.1 91.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 0.0 109.37 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.607 HG22 ' HD2' ' A' ' 15' ' ' PRO . 1.9 mt -138.77 142.62 34.59 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HD2' HG22 ' A' ' 14' ' ' ILE . 48.4 Cg_endo -68.96 123.02 9.93 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.578 2.185 . . . . 0.0 111.47 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.78 -30.06 41.54 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.774 2.316 . . . . 0.0 112.278 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.38 6.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.597 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -72.55 -47.48 47.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.811 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.947 HD13 ' O ' ' A' ' 19' ' ' LEU . 3.0 tm? -53.11 -37.17 61.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.84 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.476 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 53.8 t80 -71.74 -54.93 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 0.0 109.784 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.812 ' HG3' HD12 ' A' ' 25' ' ' LEU . 17.5 tttm -67.67 -30.41 69.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.803 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 36.4 m -81.81 -30.53 32.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.945 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.978 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 88.0 t80 -100.84 -44.22 5.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 110.44 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.06 -52.98 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.964 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.812 HD12 ' HG3' ' A' ' 21' ' ' LYS . 45.0 mt -70.66 -28.68 64.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.937 -1.102 . . . . 0.0 110.037 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.476 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 87.5 m-20 -108.96 19.84 19.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.049 -1.032 . . . . 0.0 109.657 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.978 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.96 -52.24 26.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.992 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.572 ' HA ' HD12 ' A' ' 31' ' ' ILE . 71.3 m-20 -62.54 -32.48 73.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.35 -41.62 18.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.001 . . . . 0.0 109.968 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' A' ' 26' ' ' ASP . 45.2 mt -72.46 -34.15 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 28' ' ' ASP . 18.8 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.494 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' HD12 ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.296 0.57 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -125.02 163.62 21.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -91.45 108.01 19.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 56' ' ' LYS . 46.0 mt -61.72 -41.99 98.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -158.27 153.18 25.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.409 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 96.25 158.04 31.75 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -94.9 9.71 38.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -1.186 . . . . 0.0 109.536 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.77 21.82 8.42 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -118.46 -144.67 7.6 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.32 123.54 10.35 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.701 2.267 . . . . 0.0 111.874 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.23 1.46 72.25 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.666 HG21 ' HA2' ' A' ' 49' ' ' GLY . 93.4 m -73.38 134.64 44.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.553 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.528 HG12 ' CD ' ' A' ' 71' ' ' LYS . 3.9 mt -104.6 138.92 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 49.2 mttm -123.57 142.32 51.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.742 ' HB2' HD11 ' A' ' 45' ' ' LEU . 49.3 tttt -134.15 142.46 47.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 42' ' ' ALA . 6.1 tp . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.573 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 45.5 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -92.04 156.01 17.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.56 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 90.4 m-70 -134.96 135.85 41.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.528 ' CD ' HG12 ' A' ' 54' ' ' ILE . 10.3 tptm -132.12 127.3 35.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.453 HG11 ' CG1' ' A' ' 75' ' ' ILE . 40.3 t -91.61 125.11 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.35 -42.67 58.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.382 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.2 tt0 -174.85 142.32 0.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.024 HD12 ' HA2' ' A' ' 50' ' ' GLY . 69.1 mt -119.12 132.4 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 80.8 m-20 -133.14 83.62 2.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -61.68 -37.57 84.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.76 71.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 75.2 m-20 -91.61 9.91 30.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASN . 86.1 m-85 43.71 45.64 6.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.46 ' HG3' ' HG2' ' A' ' 104' ' ' LYS . 10.3 ttpp -140.35 123.22 16.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 58.5 t80 -111.07 129.2 55.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.405 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 22.0 m -123.91 114.81 20.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 109.558 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.549 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 37.1 p90 -137.57 159.91 40.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.462 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.447 ' O ' HD13 ' A' ' 86' ' ' ILE . 85.6 p -141.3 168.84 18.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 85' ' ' SER . 26.6 mm -114.29 121.45 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 71' ' ' LYS . 81.2 mt -70.78 -41.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 109.531 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.297 0.57 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.948 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 59.51 14.79 4.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.565 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.992 HD22 ' HB3' ' A' ' 122' ' ' TYR . 36.5 mt -93.12 90.7 6.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 108.83 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 94.6 mt-10 -43.23 -44.59 5.34 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.795 -0.566 . . . . 0.0 110.125 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.685 ' O ' HD13 ' A' ' 99' ' ' ILE . 88.0 mttt -153.54 156.17 37.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.961 -1.087 . . . . 0.0 110.032 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.861 HD11 ' HB3' ' A' ' 96' ' ' LEU . 32.3 mm -130.51 112.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 36.8 m -115.76 152.5 33.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.769 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.456 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 91.2 m-85 -129.63 133.3 47.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.347 -0.846 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.405 ' HG3' ' SG ' ' A' ' 83' ' ' CYS . 84.1 tt0 -117.4 139.27 51.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.682 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.6 mt -123.88 121.87 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.345 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 21.3 mtpt -117.54 127.5 54.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.811 ' SD ' HD12 ' A' ' 19' ' ' LEU . 70.1 mtm -124.48 138.6 54.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.34 37.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.96 135.53 43.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 t -115.05 154.48 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.44 127.37 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.332 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.541 HD22 ' HG2' ' A' ' 105' ' ' MET . 55.9 mt -106.59 136.96 45.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 40.3 mttt -131.4 138.1 48.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.243 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.9 mt -125.68 122.71 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.731 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.78 HG23 ' O ' ' A' ' 6' ' ' TYR . 94.3 m -128.66 138.3 52.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.456 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 2.1 m -123.24 166.56 15.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 10.6 mtpt -138.45 112.84 8.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.165 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.992 ' HB3' HD22 ' A' ' 96' ' ' LEU . 8.1 m-30 -108.29 115.13 29.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 16.4 m80 -82.56 122.91 28.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 108.693 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 95' ' ' THR . 14.2 t -106.78 141.12 38.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.988 -1.07 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -45.39 -40.58 8.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.22 -68.24 0.37 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -65.18 -27.73 68.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -1.141 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.948 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -72.74 149.52 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.497 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 92.3 p -126.63 159.86 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.714 HD11 HD21 ' A' ' 96' ' ' LEU . 35.1 mm -108.19 123.37 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.47 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 54.6 t30 -91.6 131.34 37.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 136' ' ' LYS . 75.0 mm-40 -53.96 -40.72 67.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.469 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.93 -42.04 90.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 73.6 mm-40 -63.14 -41.59 99.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.714 HG21 ' CG2' ' A' ' 130' ' ' ILE . 20.9 pt -84.42 -30.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.511 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.1 tttp -55.72 -40.87 73.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.247 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.81 75.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.06 -39.4 69.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -60.95 -43.36 98.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -1.143 . . . . 0.0 109.225 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.53 -46.82 70.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -57.71 -45.97 85.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.66 -40.32 96.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.36 83.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.72 -46.79 88.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.95 -39.3 85.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -1.091 . . . . 0.0 109.091 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.529 ' O ' HG12 ' A' ' 149' ' ' VAL . 68.9 t80 -60.97 -45.46 94.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 109.248 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -62.74 -34.49 77.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.237 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.83 -51.39 59.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 146' ' ' PHE . 3.5 p -59.57 -39.85 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.567 ' HA ' HD12 ' A' ' 153' ' ' LEU . 85.9 tt0 -60.6 -39.89 89.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.38 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.13 90.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -59.91 -43.98 94.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.354 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 150' ' ' GLU . 14.7 mt -60.46 -40.45 91.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.299 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.4 tt -60.58 -38.88 86.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.87 . . . . 0.0 109.403 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.574 ' O ' ' CG ' ' A' ' 156' ' ' HIS . . . -69.65 -25.44 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 155' ' ' ALA . 18.7 p80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.731 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.835 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.65 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.3 p -119.96 143.39 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.539 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -104.42 137.29 42.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.0 t -117.44 125.67 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.492 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 26.5 m-85 -118.14 147.96 42.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -119.94 149.8 41.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -130.32 139.46 50.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -115.69 139.13 50.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.95 122.42 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -113.19 133.11 55.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.767 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 t -160.26 137.98 9.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 109.2 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.7 p -73.02 91.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.541 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.791 HG21 HD13 ' A' ' 19' ' ' LEU . 16.6 mt -138.83 144.2 40.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.744 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.2 Cg_endo -68.62 118.13 5.45 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.384 2.056 . . . . 0.0 111.374 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 20' ' ' PHE . 45.1 Cg_endo -66.96 -43.13 7.12 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.769 2.313 . . . . 0.0 112.223 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -49.61 67.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.573 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.12 -43.98 63.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 14' ' ' ILE . 7.1 tp -67.2 -41.01 86.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 109.72 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 52.3 t80 -65.42 -47.51 75.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.728 ' HG3' HD12 ' A' ' 25' ' ' LEU . 39.4 tttt -68.98 -36.57 78.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.81 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 35.3 t -80.81 -25.74 37.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.921 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 77.5 t80 -100.68 -50.11 3.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.356 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.764 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.7 t -84.46 -52.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.056 -1.028 . . . . 0.0 110.513 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.728 HD12 ' HG3' ' A' ' 21' ' ' LYS . 56.0 mt -72.48 -28.13 62.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.942 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 22' ' ' SER . 87.9 m-20 -113.79 28.38 8.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.461 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.921 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.52 -39.62 77.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.645 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' HD12 ' A' ' 31' ' ' ILE . 26.9 p-10 -69.81 -32.63 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 24.9 m120 -88.71 -32.32 18.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.829 ' O ' HD23 ' A' ' 30' ' ' LEU . 8.1 tt -73.86 -30.25 62.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 27' ' ' ALA . 17.2 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.614 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.283 0.563 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.19 159.61 37.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.476 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -88.16 108.08 19.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 45' ' ' LEU . 21.8 tp -67.88 -37.27 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 53' ' ' THR . 86.1 tt0 -139.94 155.71 47.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 87.09 160.82 35.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -91.9 8.88 35.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.554 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.706 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.97 13.36 25.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.807 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -110.84 -143.85 9.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.5 Cg_endo -69.43 125.12 11.93 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -2.66 74.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.706 HG21 ' HA2' ' A' ' 49' ' ' GLY . 62.6 m -73.04 139.78 46.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -1.136 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.498 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.1 mm -101.41 128.48 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.614 ' HE2' ' HB3' ' A' ' 42' ' ' ALA . 63.1 tttt -105.95 133.86 49.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -122.7 143.32 49.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 42' ' ' ALA . 73.0 mt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.443 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.6 mttm -118.31 136.82 53.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.618 ' NE2' ' CD2' ' A' ' 84' ' ' TYR . 11.1 t-80 -132.4 128.79 38.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 75.3 tttt -126.69 150.24 49.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.389 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.768 HG11 ' O ' ' A' ' 50' ' ' GLY . 7.4 p -108.34 134.61 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -82.49 -56.77 3.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 44.3 mt-10 -150.81 140.88 22.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.807 HD12 ' HA2' ' A' ' 50' ' ' GLY . 73.0 mt -125.59 126.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.478 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 84.3 m-20 -131.55 94.72 3.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.94 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' HD11 ' A' ' 25' ' ' LEU . 86.6 t60 -66.08 -37.88 86.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.47 66.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.478 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 18.7 m120 -85.0 2.48 42.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.606 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 49.78 34.36 7.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -130.83 128.49 40.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.447 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.7 t80 -122.74 130.17 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.5 m -132.48 118.56 19.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.618 ' CD2' ' NE2' ' A' ' 70' ' ' HIS . 36.3 p90 -132.94 162.14 32.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 39.7 t -138.42 150.24 46.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 69' ' ' LYS . 22.8 mt -104.04 133.08 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 88' ' ' GLU . 85.2 mt -77.63 -41.45 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.52 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.523 ' HG3' HG22 ' A' ' 87' ' ' ILE . 99.0 mt-10 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.224 0.535 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 45.69 24.31 0.2 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 122' ' ' TYR . 15.1 mt -95.24 90.69 5.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.278 -0.889 . . . . 0.0 109.31 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 94.1 mt-10 -41.5 -41.15 2.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.528 -0.733 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 46.6 mttt -158.26 168.18 27.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.922 -1.111 . . . . 0.0 110.139 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.789 HG23 ' CE1' ' A' ' 122' ' ' TYR . 40.3 mt -146.61 117.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 24.1 t -127.41 150.03 49.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 98.6 m-85 -131.1 128.07 39.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.818 . . . . 0.0 109.042 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.7 mt-10 -106.25 141.74 37.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 109.722 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.03 124.18 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.285 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -130.73 129.22 42.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.656 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.498 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 69.0 mtm -126.61 141.0 52.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.82 30.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.53 137.13 52.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.436 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 t -152.03 152.12 32.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -1.117 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.81 130.14 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.923 . . . . 0.0 109.377 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.498 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 64.8 mt -109.02 132.51 54.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -130.27 135.62 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.37 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.8 mt -124.58 133.09 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.586 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 30.4 m -125.58 141.45 52.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.343 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.2 m -126.44 151.95 47.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.66 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -138.32 126.49 22.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 109.221 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.812 ' HB3' HD22 ' A' ' 96' ' ' LEU . 38.0 m-85 -127.0 111.16 13.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.911 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.562 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 37.1 m80 -85.04 135.53 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.894 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 11.3 t -115.82 141.27 48.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.029 . . . . 0.0 109.852 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.495 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 69.8 mttt -77.82 137.54 38.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.35 -153.76 50.69 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.43 13.81 7.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -1.2 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.894 ' HB3' ' OG1' ' A' ' 124' ' ' THR . . . -52.06 143.77 13.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.7 p -124.01 170.02 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 12.6 mt -115.95 126.82 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -60.78 134.84 57.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.552 ' HA ' HG13 ' A' ' 135' ' ' ILE . 86.6 tt0 -62.88 -29.87 71.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.33 -44.68 95.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 0.0 109.124 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -57.6 -24.92 58.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.842 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.552 HG13 ' HA ' ' A' ' 132' ' ' GLU . 2.0 mt -71.69 -51.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.114 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -55.97 -38.29 70.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.93 78.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.364 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.11 -30.21 76.78 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' A' ' 135' ' ' ILE . 68.2 mttm -71.13 -36.24 72.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -1.214 . . . . 0.0 109.393 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.13 -42.35 93.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -63.05 -40.13 96.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.391 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.425 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -70.12 -35.68 74.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.456 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.79 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.98 -39.33 97.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.41 ' O ' HG12 ' A' ' 149' ' ' VAL . 18.7 tp -65.47 -40.25 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.43 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 19.6 m-85 -60.97 -41.54 96.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.522 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -66.92 -34.8 78.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.99 -50.3 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.386 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 150' ' ' GLU . 3.8 p -57.53 -44.05 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.434 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.505 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.0 mt-10 -59.63 -44.36 93.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 155' ' ' ALA . . . -59.49 -35.61 74.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.9 -47.68 83.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -54.2 -46.98 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.323 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.671 ' N ' HD12 ' A' ' 154' ' ' LEU . 6.7 mp -80.1 -24.85 40.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 151' ' ' ALA . . . -78.81 -17.84 55.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.381 179.868 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.8 HG21 ' CE1' ' A' ' 123' ' ' HIS . 38.3 t -128.07 141.13 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -1.115 . . . . 0.0 109.511 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.647 ' HE2' HG21 ' A' ' 124' ' ' THR . 98.4 m-85 -99.11 135.2 40.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.338 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.1 p -119.02 125.3 49.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' THR . 77.6 m-85 -126.87 140.9 52.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.2 tt0 -115.95 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 59.9 t0 -101.62 124.7 47.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -99.16 131.48 45.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.963 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.1 124.98 10.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.9 m -105.11 131.96 51.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.786 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.8 p -160.34 140.47 11.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.26 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.4 p -81.64 91.22 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.949 HG21 HD13 ' A' ' 19' ' ' LEU . 3.1 mt -138.69 142.52 34.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.231 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.3 Cg_endo -68.08 120.47 7.45 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.544 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.6 Cg_endo -67.0 -28.47 41.7 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.847 2.365 . . . . 0.0 112.224 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.71 -56.5 5.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -72.57 -45.95 56.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.949 HD13 HG21 ' A' ' 14' ' ' ILE . 10.7 tp -56.45 -41.0 75.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.874 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 24' ' ' VAL . 67.6 t80 -64.5 -49.05 72.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.731 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.712 ' HG2' HD12 ' A' ' 25' ' ' LEU . 41.7 mttm -69.08 -43.72 73.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 109.628 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 20.3 m -73.39 -22.25 60.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.764 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.965 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 69.7 t80 -100.88 -50.73 3.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.04 -52.83 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.918 . . . . 0.0 110.484 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.712 HD12 ' HG2' ' A' ' 21' ' ' LYS . 43.0 mt -71.77 -28.49 63.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 109.974 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 89.9 m-20 -108.4 18.67 20.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 109.555 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.965 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.29 -33.87 75.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.607 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.04 -37.55 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.703 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -92.29 -41.11 10.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.683 HD21 HG23 ' A' ' 149' ' ' VAL . 16.0 tp -56.98 -41.05 77.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 27' ' ' ALA . 33.4 mt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.514 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.625 ' HB1' ' HE3' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -144.56 142.45 30.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 84.8 m-20 -85.89 117.55 24.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.501 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 45.3 tp -69.54 -38.03 77.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.459 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.5 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 77.7 tt0 -159.22 157.35 30.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 91.96 158.02 34.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -93.57 11.37 28.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.163 . . . . 0.0 109.535 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.64 31.08 5.6 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 1.009 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -127.83 -144.14 5.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.62 125.51 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.701 2.268 . . . . 0.0 111.768 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.13 4.26 86.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.602 HG21 ' HA2' ' A' ' 49' ' ' GLY . 74.8 m -77.68 139.52 39.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.143 -1.21 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 16.8 mm -104.41 137.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HE3' ' HB1' ' A' ' 42' ' ' ALA . 56.1 tttp -126.6 142.27 51.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -124.87 126.92 46.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.319 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.607 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.554 ' HG2' HD12 ' A' ' 87' ' ' ILE . 39.2 tttp -129.26 130.7 46.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 90.0 m-70 -122.94 134.86 54.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.29 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -131.6 132.11 43.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 50' ' ' GLY . 14.2 m -100.45 128.05 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -70.52 -41.62 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 84.9 tt0 -176.52 144.67 0.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.141 -0.974 . . . . 0.0 109.503 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.009 HD12 ' HA2' ' A' ' 50' ' ' GLY . 62.2 mt -118.79 129.91 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.5 m-20 -130.53 83.8 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.83 -41.24 90.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.11 79.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 22.4 m120 -86.8 5.91 34.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 47.67 33.43 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.945 . . . . 0.0 109.483 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -127.63 132.5 49.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.44 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 71.2 t80 -124.35 126.33 45.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.433 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 12.4 t -124.07 119.59 29.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.558 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 34.5 p90 -140.22 167.11 22.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.384 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 100' ' ' SER . 84.4 p -146.71 168.38 21.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 85' ' ' SER . 23.5 mm -115.39 113.68 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.308 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 69' ' ' LYS . 90.6 mt -68.09 -35.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.305 -0.872 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 1.069 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.3 OUTLIER 64.08 15.21 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.338 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' A' ' 99' ' ' ILE . 71.5 mt -104.54 93.76 4.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 85.5 mt-10 -45.97 -41.53 11.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.638 -0.664 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 1.046 ' O ' HD13 ' A' ' 99' ' ' ILE . 89.4 mttt -155.33 160.76 40.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.679 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.046 HD13 ' O ' ' A' ' 98' ' ' LYS . 12.5 mm -135.0 114.36 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 85' ' ' SER . 32.8 m -118.27 150.29 39.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.042 . . . . 0.0 110.405 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HE1' ' HH ' ' A' ' 122' ' ' TYR . 74.3 m-85 -131.95 132.57 43.64 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 118' ' ' ILE . 87.1 tt0 -113.29 141.05 47.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.997 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.609 HD13 ' HE1' ' A' ' 23' ' ' PHE . 70.0 mt -121.68 121.61 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -126.26 137.19 53.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.852 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.1 mtt -119.94 131.77 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.241 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.86 155.24 43.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 114' ' ' SER . . . -101.33 128.98 47.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 49.5 m -132.88 155.51 48.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 109.531 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.63 134.22 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 49.9 mt -105.86 135.89 46.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 50.6 mttp -133.46 137.41 45.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 102' ' ' GLU . 68.8 mt -127.41 135.29 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.4 m -118.38 142.59 47.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.478 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.487 ' HG ' ' HD1' ' A' ' 101' ' ' TYR . 51.1 m -126.98 152.35 47.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -136.2 126.14 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.789 ' HD1' HD12 ' A' ' 99' ' ' ILE . 54.5 m-85 -122.26 116.27 23.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.975 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.8 ' CE1' HG21 ' A' ' 3' ' ' VAL . 72.2 m-70 -85.5 126.01 33.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.647 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -109.85 152.65 25.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.106 . . . . 0.0 109.783 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -53.86 -40.86 66.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.01 -84.24 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -61.39 -26.26 67.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.137 . . . . 0.0 109.52 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 1.069 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -62.44 146.25 51.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -137.69 151.15 47.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 96' ' ' LEU . 36.4 mt -110.34 124.65 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.554 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -88.6 153.23 21.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.449 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.2 mt-10 -61.02 -36.7 80.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.528 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.528 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 22.3 pt-20 -60.96 -46.08 92.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.939 . . . . 0.0 109.49 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 133' ' ' GLU . 85.4 tt0 -56.87 -47.61 80.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 132' ' ' GLU . 41.8 pt -76.68 -29.27 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 132' ' ' GLU . 38.5 tttt -55.53 -41.47 73.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.229 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.36 76.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.072 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.83 -38.34 73.36 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -61.38 -43.74 98.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -1.097 . . . . 0.0 109.075 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.5 -47.68 69.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -57.8 -45.53 85.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.905 . . . . 0.0 109.081 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.53 88.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.302 -0.873 . . . . 0.0 109.127 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.8 66.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.48 -44.37 93.72 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 149' ' ' VAL . 71.6 mt -55.64 -39.62 71.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.195 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.519 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.6 m-85 -65.91 -39.48 90.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.304 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.8 -38.69 89.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.311 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.01 -52.11 32.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.683 HG23 HD21 ' A' ' 30' ' ' LEU . 7.6 p -65.28 -41.53 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.505 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.6 tt0 -58.83 -40.69 84.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.88 99.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 109.299 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.7 -49.37 78.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 109.352 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.6 -29.6 66.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.3 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.8 tt -65.29 -46.83 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.58 75.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.726 HG23 ' C ' ' A' ' 122' ' ' TYR . 11.1 p -127.01 137.24 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.473 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.651 ' HE2' HG21 ' A' ' 124' ' ' THR . 43.0 m-85 -101.99 152.55 20.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.82 111.73 11.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.917 . . . . 0.0 109.412 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' THR . 52.4 m-85 -108.4 151.18 26.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HG2' ' CG2' ' A' ' 119' ' ' THR . 95.2 mt-10 -125.93 139.58 53.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.561 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 118' ' ' ILE . 91.6 m-20 -111.66 156.51 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.451 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -127.01 134.26 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.665 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.11 124.21 10.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.22 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.69 HG23 HG12 ' A' ' 115' ' ' ILE . 33.8 m -116.59 139.3 50.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.968 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.428 ' O ' HG12 ' A' ' 14' ' ' ILE . 46.4 m -160.04 144.34 14.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.893 ' O ' HD13 ' A' ' 14' ' ' ILE . 31.1 m -70.72 90.67 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.479 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 1.044 HG21 HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -139.62 145.03 41.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.054 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HD2' HG22 ' A' ' 14' ' ' ILE . 44.1 Cg_endo -67.26 129.92 21.46 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 122.367 2.045 . . . . 0.0 111.084 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.4 Cg_endo -66.62 -39.98 14.57 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.701 2.267 . . . . 0.0 112.502 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -46.52 20.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.062 -1.024 . . . . 0.0 109.794 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . 91.7 mtt-85 -71.99 -49.22 38.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.044 HD13 HG21 ' A' ' 14' ' ' ILE . 28.8 tp -59.51 -47.94 83.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.754 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CE1' ' C ' ' A' ' 80' ' ' PHE . 53.8 t80 -53.73 -55.02 29.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.729 ' HG3' HD13 ' A' ' 25' ' ' LEU . 83.0 tttt -65.84 -54.9 20.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.942 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 31.6 m -62.29 -27.41 69.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.406 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.3 t80 -93.92 -50.88 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.916 -1.115 . . . . 0.0 110.292 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 45.9 t -84.59 -50.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 110.028 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 ' HG3' ' A' ' 21' ' ' LYS . 4.1 tt -68.92 -49.14 60.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' SER . 66.3 m-20 -91.65 24.16 3.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.919 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.44 -44.54 71.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.454 ' HA ' HD12 ' A' ' 31' ' ' ILE . 76.6 m-20 -64.14 -24.21 67.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -91.27 -38.47 12.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.849 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 30' ' ' LEU . 22.1 mt -79.89 -36.64 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.587 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 27' ' ' ALA . 25.0 mt . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.62 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -133.97 159.11 41.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.461 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.5 m-20 -87.36 108.69 19.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 45' ' ' LEU . 23.6 tp -68.59 -36.32 78.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.557 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.795 ' O ' HG23 ' A' ' 53' ' ' THR . 86.0 tt0 -140.05 155.29 47.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 85.33 163.81 37.89 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -90.22 8.84 31.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -1.183 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.732 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 99.45 43.18 2.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.66 -137.34 3.08 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.1 Cg_endo -69.17 123.0 9.84 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.801 2.334 . . . . 0.0 112.049 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.56 8.73 84.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 46' ' ' GLU . 56.3 m -86.41 139.79 30.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -1.156 . . . . 0.0 109.542 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.52 HG12 ' CD ' ' A' ' 71' ' ' LYS . 6.0 mt -101.46 139.18 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.526 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 93.7 mttt -117.47 150.62 38.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -125.27 137.28 54.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.281 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.9 tt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.656 -179.865 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' HB3' HD12 ' A' ' 87' ' ' ILE . 37.6 mttm -130.69 140.66 50.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 97.4 m-70 -125.47 136.74 53.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.52 ' CD ' HG12 ' A' ' 54' ' ' ILE . 23.8 tptm -130.26 133.83 46.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 45.6 t -100.02 132.86 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.89 -56.48 4.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.662 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.8 tt0 -178.89 138.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.845 HG21 ' CE2' ' A' ' 82' ' ' TYR . 15.7 pt -136.29 145.36 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.567 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' OD1' ' A' ' 79' ' ' ASN . 60.7 t0 -132.84 109.14 9.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -60.22 -36.22 77.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.72 99.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.438 ' OD1' ' OD1' ' A' ' 76' ' ' ASP . 15.8 m120 -86.11 -5.74 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.222 -0.923 . . . . 0.0 109.587 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.524 ' C ' ' CE1' ' A' ' 20' ' ' PHE . 92.2 m-85 58.74 36.09 24.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.294 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -117.99 131.54 56.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.845 ' CE2' HG21 ' A' ' 75' ' ' ILE . 72.6 t80 -128.03 114.85 17.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.885 . . . . 0.0 109.683 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.71 118.17 30.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.217 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.579 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 32.5 p90 -129.33 154.62 46.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 51.1 m -128.9 159.14 36.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.27 129.57 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.459 HD12 ' HB3' ' A' ' 69' ' ' LYS . 84.4 mt -77.6 -41.71 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 58.85 23.59 11.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' ' 99' ' ' ILE . 96.5 mt -101.35 93.62 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.548 ' CG ' ' HG2' ' A' ' 125' ' ' LYS . 96.8 mt-10 -48.49 -32.72 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.764 -0.585 . . . . 0.0 111.287 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.787 ' O ' HD13 ' A' ' 99' ' ' ILE . 78.3 tttt -151.14 143.09 23.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 0.0 110.622 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.809 HG23 ' CE1' ' A' ' 122' ' ' TYR . 23.0 mm -124.81 113.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 28.5 t -116.97 148.68 41.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 120' ' ' SER . 3.7 m-85 -130.87 123.95 30.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.781 . . . . 0.0 109.057 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' OG1' ' A' ' 119' ' ' THR . 91.1 mt-10 -109.12 135.3 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.752 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.4 mt -131.52 119.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.98 155.11 47.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.698 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -117.35 147.85 42.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.277 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.79 147.18 46.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.23 138.5 38.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.1 p -144.37 165.48 27.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -1.055 . . . . 0.0 109.41 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 11' ' ' THR . 72.4 mt -123.01 133.56 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.429 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.773 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.7 mp -106.98 138.91 42.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -124.69 135.49 53.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 8' ' ' ASP . 72.2 mt -123.82 128.79 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 8.4 p -126.39 142.69 51.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.468 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.514 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -121.65 152.88 38.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 109.676 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -132.34 115.04 15.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 108.931 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.809 ' CE1' HG23 ' A' ' 99' ' ' ILE . 9.6 m-30 -112.87 121.61 45.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.05 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 97' ' ' GLU . 11.2 m80 -92.85 115.51 28.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.389 -0.819 . . . . 0.0 108.841 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.651 HG21 ' HE2' ' A' ' 4' ' ' PHE . 1.1 p -92.7 148.65 21.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.548 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 54.3 mttp -70.09 147.25 50.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 48.19 -143.59 7.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -92.88 15.97 13.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.126 . . . . 0.0 109.418 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.12 146.31 3.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.6 p -113.9 161.75 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 96' ' ' LEU . 49.4 mt -105.8 139.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.895 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -84.26 123.95 30.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.487 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 96.3 mt-10 -55.65 -35.59 66.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.08 -41.39 90.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -62.88 -45.63 91.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.464 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 132' ' ' GLU . 38.2 pt -76.86 -31.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 26.4 tttm -55.76 -46.66 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.0 73.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.405 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.01 -39.56 92.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.91 -41.76 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -45.81 91.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -59.94 -45.79 91.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.16 90.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.28 97.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.12 88.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.4 tt -62.88 -39.34 94.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.319 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.468 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 70.9 t80 -59.54 -46.35 89.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -60.73 -39.22 87.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.376 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.54 -48.74 68.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.526 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.2 p -65.0 -43.65 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.0 109.355 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.526 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.2 tt0 -60.63 -40.17 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.12 96.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.267 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -67.93 -42.34 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.915 HD13 ' O ' ' A' ' 153' ' ' LEU . 3.5 tm? -69.83 -31.49 69.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.902 ' O ' HD13 ' A' ' 154' ' ' LEU . 2.7 tm? -75.38 -40.09 58.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.926 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.48 74.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 109.583 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 122' ' ' TYR . 6.7 p -128.44 130.87 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -1.166 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.75 ' HE2' HG21 ' A' ' 124' ' ' THR . 96.8 m-85 -86.42 144.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.606 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.0 m -130.27 121.22 25.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' THR . 46.2 m-85 -116.72 139.84 50.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -114.82 146.66 40.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 118' ' ' ILE . 90.2 m-20 -122.37 154.83 37.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -115.82 143.1 45.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -154.29 121.73 5.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 0.0 109.182 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.8 m -110.15 133.78 52.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.833 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 m -160.3 146.5 15.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -0.881 . . . . 0.0 109.241 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.477 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.2 p -81.19 91.58 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.675 HG21 HD13 ' A' ' 19' ' ' LEU . 1.9 mt -138.65 142.93 35.95 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.301 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.647 ' HD2' HG22 ' A' ' 14' ' ' ILE . 47.4 Cg_endo -68.56 116.31 4.34 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.449 2.1 . . . . 0.0 111.244 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 44.2 Cg_endo -66.45 -27.73 46.62 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.757 2.304 . . . . 0.0 112.36 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.99 6.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.552 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -72.5 -43.25 63.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.675 HD13 HG21 ' A' ' 14' ' ' ILE . 16.2 tp -61.04 -47.97 83.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.887 . . . . 0.0 109.747 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 70.2 t80 -57.3 -50.44 72.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.8 tttt -68.21 -48.38 65.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.553 ' O ' HD22 ' A' ' 30' ' ' LEU . 87.0 p -71.79 -20.84 61.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 110.099 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.937 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 66.0 t80 -100.42 -50.51 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.286 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.645 HG13 ' CD1' ' A' ' 82' ' ' TYR . 54.7 t -84.62 -52.89 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.06 -1.025 . . . . 0.0 110.349 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 15.9 tp -70.24 -29.67 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 91.4 m-20 -110.42 22.14 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.937 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.488 ' OD2' ' NZ ' ' A' ' 55' ' ' LYS . 88.1 m-20 -69.27 -37.05 77.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -96.11 -38.04 10.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.685 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.553 HD22 ' O ' ' A' ' 22' ' ' SER . 16.6 tp -56.5 -42.32 78.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.704 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.333 -179.884 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.89 153.14 45.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 35.5 p-10 -89.03 108.6 19.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.411 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.64 -35.32 78.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.329 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 53' ' ' THR . 48.4 tp10 -137.91 154.28 49.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.482 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 85.48 159.33 31.51 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.52 10.62 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.483 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.83 6.58 43.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.998 ' O ' HG11 ' A' ' 72' ' ' VAL . . . -102.12 -147.99 20.36 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.7 Cg_endo -68.63 129.84 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.71 2.273 . . . . 0.0 111.756 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.65 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 89.46 -5.21 84.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -75.14 139.23 42.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.506 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.525 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.6 mm -104.05 135.14 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.488 ' NZ ' ' OD2' ' A' ' 28' ' ' ASP . 29.0 mttt -118.37 140.3 50.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.626 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -123.59 142.54 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.581 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.2 mtm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.9 mttt -131.08 144.13 51.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 65.5 m80 -126.56 133.9 50.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.4 tttm -124.45 144.28 50.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.998 HG11 ' O ' ' A' ' 50' ' ' GLY . 7.5 p -98.99 130.43 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -73.39 -46.83 46.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 50.6 tp10 -173.56 143.35 1.03 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.724 HD12 ' HA2' ' A' ' 50' ' ' GLY . 82.6 mt -126.95 125.23 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 8.3 t70 -128.14 105.44 8.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 109.511 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 70.2 m80 -70.24 -35.11 73.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.09 88.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.573 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 83.2 m-20 -85.14 5.33 30.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.551 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 45.11 42.31 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 53.6 pttt -130.44 137.39 49.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.645 ' CD1' HG13 ' A' ' 24' ' ' VAL . 62.0 t80 -126.32 125.03 41.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.468 ' CB ' ' HG3' ' A' ' 102' ' ' GLU . 8.1 t -127.57 115.56 19.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.376 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.5 p90 -129.42 159.57 35.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.515 ' CB ' ' HE3' ' A' ' 98' ' ' LYS . 60.0 p -141.42 167.58 21.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 69' ' ' LYS . 17.9 mt -122.59 132.33 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.4 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.1 mt -80.16 -37.39 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.626 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.363 0.602 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.802 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 65.81 9.58 6.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.719 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.627 HD21 HG12 ' A' ' 130' ' ' ILE . 83.7 mt -90.16 90.7 8.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 108.881 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 123' ' ' HIS . 33.3 mt-10 -48.59 -43.91 36.42 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.753 -0.592 . . . . 0.0 110.831 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' A' ' 85' ' ' SER . 54.9 tttp -150.65 155.17 38.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.616 -1.302 . . . . 0.0 110.464 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.627 HG23 ' CE1' ' A' ' 122' ' ' TYR . 34.1 mt -138.98 116.03 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 87.7 p -125.65 164.51 20.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.451 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 119' ' ' THR . 89.2 m-85 -137.89 120.48 16.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' HG3' ' CB ' ' A' ' 83' ' ' CYS . 83.1 tt0 -101.88 143.33 31.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.118 -0.989 . . . . 0.0 109.917 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.2 mt -128.51 118.36 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 0.0 108.912 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -120.38 139.61 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.615 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.623 ' SD ' HD23 ' A' ' 19' ' ' LEU . 63.8 mtm -122.35 137.49 54.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.262 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.95 40.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.555 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.85 135.72 40.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.504 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.0 t -134.69 150.69 50.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.409 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.23 132.02 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.487 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 49.5 mt -98.95 137.21 37.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.897 . . . . 0.0 109.357 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.03 131.44 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' ASP . 68.0 mt -118.47 137.57 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 80.8 m -133.1 137.29 46.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.4 m -113.88 154.71 27.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 32.4 mttm -142.12 122.05 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.842 ' O ' HG23 ' A' ' 3' ' ' VAL . 34.7 m-85 -119.43 132.92 55.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.257 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLU . 2.9 m80 -100.31 121.25 41.18 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.75 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -112.09 137.89 49.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.341 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 95' ' ' THR . 71.7 mttt -40.96 -35.12 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.546 -0.722 . . . . 0.0 109.862 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.62 -79.55 0.21 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.98 -29.73 67.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -1.093 . . . . 0.0 109.316 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.802 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -63.5 143.26 57.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.1 m -126.4 154.38 43.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 96' ' ' LEU . 48.6 mt -112.27 132.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 16.0 t-20 -87.04 138.08 31.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.413 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.441 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.2 mt-10 -62.7 -33.04 74.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.433 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 83.0 tt0 -65.62 -46.22 80.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.479 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.18 -45.14 88.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 109.349 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 132' ' ' GLU . 35.8 pt -76.62 -29.19 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.1 tttt -55.63 -45.6 77.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.17 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 109.327 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.06 -38.39 75.86 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.88 -43.75 90.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -1.118 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.28 -43.25 82.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.259 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -57.92 -45.91 85.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.26 -38.6 85.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.127 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.75 96.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -48.21 79.95 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.904 HD13 ' O ' ' A' ' 145' ' ' LEU . 3.1 tm? -60.26 -38.44 83.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -1.131 . . . . 0.0 109.237 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.521 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 71.1 t80 -61.98 -41.39 97.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 0.0 109.298 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -61.0 -41.38 96.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.71 65.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.376 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.4 p -66.72 -41.94 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.491 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.2 tt0 -60.49 -39.94 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.75 99.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.44 -47.18 87.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.608 HD13 ' CD1' ' A' ' 19' ' ' LEU . 24.7 mt -59.92 -34.18 72.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.465 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 154' ' ' LEU . 8.9 tt -64.72 -42.09 95.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -65.01 -31.29 72.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.453 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.876 HG21 ' CE1' ' A' ' 123' ' ' HIS . 25.0 t -126.39 142.43 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -1.119 . . . . 0.0 109.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.785 ' HE2' HG21 ' A' ' 124' ' ' THR . 95.2 m-85 -105.73 129.64 53.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.472 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.0 t -107.76 129.74 55.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' THR . 21.9 m-85 -116.36 143.23 45.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -123.33 142.73 50.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -129.16 134.61 48.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.99 138.47 46.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.593 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -168.53 113.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -120.32 147.63 44.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -160.27 143.88 13.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.172 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.784 ' O ' HG23 ' A' ' 13' ' ' VAL . 24.6 m -65.43 90.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.309 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.737 HG23 ' HD2' ' A' ' 15' ' ' PRO . 32.7 mm -138.87 144.18 40.47 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.464 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.737 ' HD2' HG23 ' A' ' 14' ' ' ILE . 47.6 Cg_endo -69.21 112.43 2.98 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.542 2.161 . . . . 0.0 111.287 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.9 Cg_endo -67.0 -29.55 40.4 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.761 2.308 . . . . 0.0 112.264 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 -56.13 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -72.58 -37.45 68.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.773 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.674 HD22 HG21 ' A' ' 14' ' ' ILE . 15.6 tp -67.07 -33.71 76.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.758 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.757 ' CE1' HG21 ' A' ' 24' ' ' VAL . 66.3 t80 -71.56 -47.87 52.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.139 -0.975 . . . . 0.0 109.954 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' HD23 ' A' ' 25' ' ' LEU . 20.0 mttt -71.56 -22.67 61.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.789 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.779 ' O ' HD12 ' A' ' 30' ' ' LEU . 86.6 p -96.84 -23.64 16.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.09 -1.006 . . . . 0.0 109.458 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.925 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 79.9 t80 -100.46 -45.48 5.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.978 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 20' ' ' PHE . 57.8 t -84.58 -52.7 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.98 . . . . 0.0 110.25 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 21' ' ' LYS . 4.0 mm? -69.79 -45.71 67.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 109.618 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 80.5 m-20 -93.73 25.63 3.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 109.591 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.925 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.92 -42.18 73.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.983 . . . . 0.0 109.775 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.57 -20.52 58.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 0.0 109.965 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -94.88 -38.55 10.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.811 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 22' ' ' SER . 18.1 mt -74.51 -30.03 61.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.564 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 27' ' ' ALA . 21.9 mt . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.302 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -134.23 150.43 51.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -87.51 108.91 19.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.685 HD11 ' HD3' ' A' ' 56' ' ' LYS . 58.5 mt -66.48 -32.12 73.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 53' ' ' THR . 78.1 tt0 -147.92 162.7 38.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.531 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 73.88 156.49 4.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -91.42 9.31 32.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 108.29 30.21 3.95 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.902 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -126.95 -143.71 5.87 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.57 120.47 7.13 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.667 2.245 . . . . 0.0 111.809 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.95 -2.66 72.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 46' ' ' GLU . 52.2 m -76.83 138.16 39.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -1.216 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 70' ' ' HIS . 26.1 mm -102.94 134.28 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.898 . . . . 0.0 109.556 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' NZ ' ' OH ' ' A' ' 82' ' ' TYR . 27.3 mttt -112.08 141.99 45.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.343 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.685 ' HD3' HD11 ' A' ' 45' ' ' LEU . 35.3 ttpt -125.32 125.29 43.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 42' ' ' ALA . 61.7 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 109.516 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.3 0.571 . . . . 0.0 109.629 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -98.45 144.7 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.731 ' O ' HG23 ' A' ' 54' ' ' ILE . 76.0 m80 -130.68 147.01 52.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.479 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 16.3 tttp -135.0 134.86 40.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.14 -0.975 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.405 HG11 ' CG1' ' A' ' 75' ' ' ILE . 46.0 t -98.75 133.22 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -79.38 -43.01 24.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.1 tt0 -176.65 140.02 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.902 HD12 ' HA2' ' A' ' 50' ' ' GLY . 70.4 mt -119.31 126.52 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 75' ' ' ILE . 78.3 m-20 -134.7 76.76 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.7 m170 -55.86 -37.15 68.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.0 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.365 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 80' ' ' PHE . 58.7 m-20 -91.71 12.66 20.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ASN . 91.9 m-85 43.21 39.99 2.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.598 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.466 ' HE2' ' SG ' ' A' ' 83' ' ' CYS . 87.7 tttt -132.07 122.77 25.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.456 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 50.9 t80 -118.62 127.44 53.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' HE2' ' A' ' 81' ' ' LYS . 31.8 m -130.22 121.24 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -135.39 163.05 30.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.458 ' HG ' ' HG ' ' A' ' 100' ' ' SER . 49.9 m -126.38 163.85 22.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 mt -119.97 133.63 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.567 ' O ' HG22 ' A' ' 87' ' ' ILE . 87.3 mt -111.91 -2.31 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.568 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 68' ' ' MET . 33.5 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.632 -0.668 . . . . 0.0 109.965 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.9 m80 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.281 0.563 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 67.85 6.25 4.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 109.779 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 99' ' ' ILE . 95.9 mt -108.34 94.37 5.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.152 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 47.4 mt-10 -41.0 -42.45 1.89 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.7 -0.625 . . . . 0.0 109.888 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.827 ' O ' HD13 ' A' ' 99' ' ' ILE . 31.4 ttpt -177.73 162.17 1.72 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 0.0 109.752 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.985 HD12 ' CD1' ' A' ' 122' ' ' TYR . 5.7 mm -129.6 118.05 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.505 -0.747 . . . . 0.0 109.154 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.458 ' HG ' ' HG ' ' A' ' 85' ' ' SER . 46.9 t -112.08 141.02 46.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 119' ' ' THR . 97.3 m-85 -120.33 143.6 48.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.054 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.9 mt-10 -121.12 143.69 48.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.74 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 82' ' ' TYR . 75.7 mt -122.86 130.82 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.294 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -132.27 133.39 44.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.565 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -112.95 144.49 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.322 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.24 161.75 38.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.11 143.72 33.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.6 m -135.29 139.75 44.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.14 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.477 ' O ' HD23 ' A' ' 116' ' ' LEU . 63.9 mt -107.75 137.67 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 115' ' ' ILE . 33.0 mt -117.21 130.29 56.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 0.0 109.628 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.37 141.38 51.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.52 138.22 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 0.0 109.738 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 28.7 m -126.78 142.57 51.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 100' ' ' SER . 8.9 m -126.58 158.87 35.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.95 . . . . 0.0 109.831 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 86.2 mttt -144.14 118.19 9.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.985 ' CD1' HD12 ' A' ' 99' ' ' ILE . 2.9 m-85 -113.18 113.22 25.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.876 ' CE1' HG21 ' A' ' 3' ' ' VAL . 54.9 m-70 -85.94 116.51 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.785 HG21 ' HE2' ' A' ' 4' ' ' PHE . 1.4 p -107.33 146.14 31.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 109.98 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -80.82 140.69 35.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.46 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.54 67.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.453 ' OD1' ' HA2' ' A' ' 2' ' ' GLY . 30.1 t30 56.14 45.45 23.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 0.0 109.447 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -72.78 142.06 48.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.3 p -82.39 155.42 24.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 21.5 mt -111.57 131.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.83 141.56 58.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.48 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.45 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.6 mt-10 -67.65 -29.64 68.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -65.01 -37.56 88.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.94 -44.91 83.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 132' ' ' GLU . 46.4 pt -80.76 -31.85 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.444 ' N ' HG13 ' A' ' 135' ' ' ILE . 25.6 tttm -57.01 -39.87 75.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.87 73.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.913 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.3 -38.09 94.08 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -59.81 -43.61 94.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.69 -38.9 92.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -63.05 -40.91 99.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.79 -38.63 86.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.77 92.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.17 -42.88 97.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 149' ' ' VAL . 26.3 tp -66.05 -39.53 90.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -1.108 . . . . 0.0 109.334 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.38 -43.11 95.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.867 . . . . 0.0 109.354 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -66.21 -33.85 76.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.74 -49.25 32.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.361 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.794 HG21 ' HD2' ' A' ' 23' ' ' PHE . 7.8 p -63.96 -41.51 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.402 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.515 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.0 tt0 -56.31 -44.39 79.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.397 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -59.96 -49.61 76.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 19' ' ' LEU . 39.1 tp -57.12 -35.49 69.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.522 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.7 tt -62.67 -46.79 86.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.89 71.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.5 m80 . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.998 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.578 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 43.4 t -131.24 133.95 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -1.138 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.729 ' HE1' HG21 ' A' ' 124' ' ' THR . 96.3 m-85 -103.15 137.06 41.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.493 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.7 m -113.33 119.8 38.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.704 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 31.1 m-85 -115.16 139.87 49.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.4 mt-10 -115.33 147.17 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.81 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.473 ' OD2' ' HB ' ' A' ' 118' ' ' ILE . 42.1 m-20 -119.16 154.6 33.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.233 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 117' ' ' LYS . 95.2 mt-10 -124.12 140.91 52.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.36 120.73 6.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 109.114 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.407 HG23 HG12 ' A' ' 115' ' ' ILE . 55.0 m -114.51 129.03 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.933 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 14' ' ' ILE . 34.0 t -160.5 140.58 11.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.87 . . . . 0.0 109.078 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 13' ' ' VAL . 26.1 m -70.93 90.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 0.0 109.4 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.788 HG22 ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -139.17 145.56 45.37 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.788 ' HD2' HG22 ' A' ' 14' ' ' ILE . 46.2 Cg_endo -68.02 124.49 11.86 Favored 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 122.361 2.041 . . . . 0.0 111.243 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.52 -30.59 43.18 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.742 2.295 . . . . 0.0 112.429 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -52.62 8.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.646 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -72.06 -41.62 67.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.748 HD22 ' HB ' ' A' ' 14' ' ' ILE . 22.7 tp -61.48 -48.98 78.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.828 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 61.9 t80 -56.22 -52.75 63.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.812 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 61.9 mttm -67.34 -49.57 63.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 110.017 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.891 ' O ' HD12 ' A' ' 30' ' ' LEU . 86.1 p -69.85 -21.17 63.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 110.219 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.974 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 62.6 t80 -100.22 -49.21 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.963 -1.086 . . . . 0.0 110.194 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 53.2 t -84.56 -52.43 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.5 tp -68.7 -35.22 76.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.046 -1.034 . . . . 0.0 110.184 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.5 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 68.9 m-20 -103.47 19.54 19.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.053 . . . . 0.0 109.868 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.974 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.54 -36.39 76.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.41 -26.98 65.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.906 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -97.6 -51.69 4.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.891 HD12 ' O ' ' A' ' 22' ' ' SER . 36.4 mt -59.17 -39.36 82.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.025 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.484 ' CG1' ' O ' ' A' ' 27' ' ' ALA . 21.1 mt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.591 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.682 ' HB2' HG12 ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.295 0.569 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.93 156.16 45.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -85.9 107.36 17.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.412 ' HG ' ' HG3' ' A' ' 46' ' ' GLU . 43.9 tp -62.78 -40.75 98.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.729 ' O ' HG23 ' A' ' 53' ' ' THR . 97.7 mt-10 -153.53 162.58 41.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.493 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 87.1 159.49 33.87 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -87.87 9.48 21.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -1.17 . . . . 0.0 109.561 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.723 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.25 13.65 32.77 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.904 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -110.33 -143.68 9.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.77 123.64 10.3 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.651 2.234 . . . . 0.0 111.765 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . 94.44 -4.42 69.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 46' ' ' GLU . 94.5 m -74.1 138.17 43.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.463 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.739 ' N ' HD12 ' A' ' 54' ' ' ILE . 1.7 mp -103.74 126.82 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 25.0 mttm -110.94 145.18 38.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -124.72 127.02 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.522 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.682 HG12 ' HB2' ' A' ' 42' ' ' ALA . 66.8 mt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.411 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 86' ' ' ILE . 93.9 mttt -135.05 141.32 46.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.64 ' CE1' HD12 ' A' ' 57' ' ' ILE . 78.6 m80 -130.77 134.59 47.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -127.02 142.49 51.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.474 HG11 ' CG1' ' A' ' 75' ' ' ILE . 51.9 t -105.82 126.9 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -71.35 -48.65 48.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 83.4 tt0 -166.9 146.02 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.576 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.904 HD12 ' HA2' ' A' ' 50' ' ' GLY . 73.4 mt -122.72 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.382 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 86.2 m-20 -133.4 81.07 1.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.48 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 90.4 m-70 -59.37 -38.57 80.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.26 82.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.433 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 76.9 m-20 -86.16 3.91 40.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 52.73 29.3 7.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -122.45 135.68 54.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CE1' HG12 ' A' ' 75' ' ' ILE . 57.0 t80 -130.08 130.46 44.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.24 115.76 16.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.502 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.4 p90 -136.88 158.48 44.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.623 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.444 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 84.5 p -139.19 169.51 17.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.362 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 69' ' ' LYS . 36.0 mt -117.84 129.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.52 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.5 mt -77.36 -32.92 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.43 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 60.1 22.67 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.579 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.881 ' HB3' HD11 ' A' ' 99' ' ' ILE . 88.6 mt -104.43 96.55 6.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.096 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 123' ' ' HIS . 72.8 mm-40 -59.66 -33.39 71.48 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.766 -0.584 . . . . 0.0 111.034 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.654 ' O ' HD13 ' A' ' 99' ' ' ILE . 34.3 ttpt -142.44 142.74 32.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.474 -1.391 . . . . 0.0 110.793 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.881 HD11 ' HB3' ' A' ' 96' ' ' LEU . 27.2 mm -130.77 113.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 85' ' ' SER . 38.4 t -121.31 152.05 39.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.486 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 81.1 m-85 -131.05 131.9 44.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.031 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.1 mt-10 -118.72 141.77 48.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.801 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.73 127.56 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.839 . . . . 0.0 109.323 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -130.18 131.68 45.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.637 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.424 ' HG2' ' HG ' ' A' ' 116' ' ' LEU . 63.5 mtt -120.56 141.22 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.9 153.68 41.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.62 132.43 42.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.436 179.998 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.3 m -131.25 146.83 52.47 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.413 -1.051 . . . . 0.0 109.378 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' C ' HD12 ' A' ' 116' ' ' LEU . 68.8 mt -116.56 135.91 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.5 mp -107.03 140.71 39.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.485 ' O ' HD13 ' A' ' 118' ' ' ILE . 26.7 mmtp -125.3 139.46 53.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 117' ' ' LYS . 10.5 mm -115.0 126.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.687 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 30.8 m -121.23 133.55 55.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.58 157.42 42.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.955 . . . . 0.0 109.93 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -134.03 117.47 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.815 ' HB3' HD22 ' A' ' 96' ' ' LEU . 13.9 m-30 -109.81 118.81 37.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.578 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 2.2 t60 -85.73 127.06 34.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.729 HG21 ' HE1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -109.43 146.82 33.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.8 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -71.33 135.61 47.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 55.07 -145.2 30.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 128' ' ' ALA . 48.5 p-10 -87.45 17.16 4.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 127' ' ' ASN . . . -44.5 144.41 1.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -114.47 157.0 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.677 HD12 ' CD1' ' A' ' 4' ' ' PHE . 64.4 mt -110.12 140.18 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 10.1 t-20 -79.4 133.43 36.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.412 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.454 ' HA ' HG12 ' A' ' 135' ' ' ILE . 96.4 mt-10 -65.33 -34.99 79.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.446 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 79.0 tt0 -66.64 -35.31 79.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.52 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.6 mt-10 -67.89 -38.13 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.704 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 38.4 pt -78.16 -39.5 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.517 ' N ' HG13 ' A' ' 135' ' ' ILE . 24.1 mttm -59.41 -37.94 79.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.9 73.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.11 -40.81 84.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -60.1 -43.48 95.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.171 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.37 -44.8 76.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.433 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.14 -45.82 89.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.91 79.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -0.952 . . . . 0.0 109.409 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.86 88.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.44 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.96 -45.26 95.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.558 ' O ' HG12 ' A' ' 149' ' ' VAL . 57.7 mt -60.96 -38.97 87.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -1.095 . . . . 0.0 109.375 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.478 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 67.1 t80 -57.22 -45.84 83.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.37 -40.53 91.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.08 -52.07 46.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 145' ' ' LEU . 7.5 p -64.69 -40.59 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.487 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.1 tt0 -56.45 -42.34 77.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.35 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.3 99.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.356 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -59.64 -44.59 93.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.432 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 36.4 tp -60.82 -35.31 76.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.893 . . . . 0.0 109.385 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.1 tt -61.93 -45.64 92.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.923 . . . . 0.0 109.34 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.14 -32.17 72.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.72 HG21 ' CE1' ' A' ' 123' ' ' HIS . 24.7 t -132.52 133.85 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.832 ' HE1' HG21 ' A' ' 124' ' ' THR . 96.7 m-85 -90.38 140.34 29.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.172 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' SER . 26.6 p -125.52 127.04 45.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 119' ' ' THR . 93.5 m-85 -123.78 143.89 50.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.262 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -123.41 147.97 46.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.76 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -132.46 134.0 44.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.204 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -107.76 134.52 50.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.756 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.74 123.22 19.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 109.118 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.453 HG23 HG12 ' A' ' 115' ' ' ILE . 28.8 m -109.73 133.22 53.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.937 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.9 m -160.42 139.94 10.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 109.003 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.6 p -73.79 90.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.965 -1.084 . . . . 0.0 109.217 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.688 HG23 ' HD2' ' A' ' 15' ' ' PRO . 10.3 mt -139.48 144.29 39.13 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.136 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.688 ' HD2' HG23 ' A' ' 14' ' ' ILE . 43.7 Cg_endo -66.42 121.96 9.33 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.369 2.046 . . . . 0.0 111.165 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HG3' ' HB2' ' A' ' 107' ' ' ALA . 45.4 Cg_endo -66.79 -29.24 42.53 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.724 2.283 . . . . 0.0 112.241 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.24 -52.93 7.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.417 ' O ' ' OG ' ' A' ' 22' ' ' SER . 60.5 mtt85 -72.03 -39.35 69.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.753 HD13 ' C ' ' A' ' 19' ' ' LEU . 3.4 tm? -63.06 -51.88 64.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.0 t80 -56.85 -51.3 69.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.781 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.7 tttp -68.36 -50.22 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.83 ' O ' HD22 ' A' ' 30' ' ' LEU . 69.0 p -68.08 -21.26 64.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.04 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.907 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 12.5 t80 -100.06 -50.61 3.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.063 -1.023 . . . . 0.0 110.115 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 61.8 t -84.68 -52.66 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.26 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.4 tp -68.88 -44.83 72.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.888 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 30' ' ' LEU . 20.7 m-20 -98.99 30.31 3.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.907 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.26 -47.27 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.774 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.68 ' HA ' HD12 ' A' ' 31' ' ' ILE . 50.6 m-20 -69.44 -25.82 64.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.992 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.71 -39.12 18.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.687 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 22' ' ' SER . 7.0 mp -76.02 -29.03 57.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 28' ' ' ASP . 17.6 mt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -127.74 143.09 51.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.858 . . . . 0.0 109.413 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.432 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 81.0 m-20 -87.14 108.61 18.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.988 HD11 ' HB2' ' A' ' 56' ' ' LYS . 2.2 mp -68.85 -39.19 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 53' ' ' THR . 49.5 tp10 -150.05 153.23 36.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 90.79 157.74 33.95 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -93.47 10.26 33.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.584 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.1 27.99 6.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.895 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -122.16 -145.63 7.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 51.2 Cg_endo -70.23 123.34 9.86 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.744 2.296 . . . . 0.0 111.884 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.01 83.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 ' HA2' ' A' ' 49' ' ' GLY . 56.9 m -72.75 137.6 45.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -1.223 . . . . 0.0 109.44 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.681 HG22 HD13 ' A' ' 45' ' ' LEU . 25.2 mm -101.03 129.75 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 17.6 mttt -126.55 145.95 50.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.882 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.988 ' HB2' HD11 ' A' ' 45' ' ' LEU . 28.2 ttpt -130.82 138.84 50.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.366 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.7 tt . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 38.9 mtt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 94.2 mttt -107.8 148.54 29.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.454 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 35.4 t-80 -129.79 131.26 46.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.6 tttp -131.88 136.17 47.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.497 HG11 ' CG1' ' A' ' 75' ' ' ILE . 39.6 t -99.36 129.17 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.406 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -76.39 -42.29 44.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 85.4 tt0 -175.27 141.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.895 HD12 ' HA2' ' A' ' 50' ' ' GLY . 66.7 mt -119.85 131.24 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -129.95 85.69 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.567 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 87.8 m-70 -62.34 -37.24 84.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.92 70.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -88.99 -3.07 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 57.9 34.55 24.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.495 ' HE2' ' CE ' ' A' ' 104' ' ' LYS . 25.5 mttt -128.95 129.56 45.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CE2' HG12 ' A' ' 75' ' ' ILE . 62.1 t80 -120.16 124.13 45.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.898 . . . . 0.0 109.531 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.05 115.03 19.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.487 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.3 p90 -128.97 152.41 48.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.51 ' HB3' ' HE2' ' A' ' 98' ' ' LYS . 9.7 m -132.02 146.72 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.526 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.16 150.2 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.594 HG22 ' HG3' ' A' ' 88' ' ' GLU . 88.6 mt -104.02 -34.65 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.594 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.8 mt-10 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.23 0.538 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.773 HG22 ' H ' ' A' ' 125' ' ' LYS . 16.0 m 51.87 19.78 1.04 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.811 HD22 ' HB3' ' A' ' 122' ' ' TYR . 51.7 mt -91.09 87.87 6.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 0.0 109.043 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.5 mt-10 -39.93 -35.47 0.36 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.761 -0.587 . . . . 0.0 110.401 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HE2' ' HB3' ' A' ' 85' ' ' SER . 31.7 tttt -169.08 160.91 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.766 -1.209 . . . . 0.0 110.371 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.783 HG23 ' CE1' ' A' ' 122' ' ' TYR . 27.2 mt -137.14 117.62 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 48.4 t -118.35 152.66 35.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.977 . . . . 0.0 109.906 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.533 ' OH ' HG21 ' A' ' 99' ' ' ILE . 84.1 m-85 -130.76 136.07 48.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.813 . . . . 0.0 109.175 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 86.8 mt-10 -114.62 143.21 45.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.711 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 79.0 mt -118.51 130.79 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.258 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.495 ' CE ' ' HE2' ' A' ' 81' ' ' LYS . 19.8 tttt -127.97 131.51 49.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.608 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.496 ' SD ' HD12 ' A' ' 19' ' ' LEU . 63.3 mtt -122.29 146.25 47.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.386 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -141.27 151.32 43.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.487 ' HB2' ' HG3' ' A' ' 16' ' ' PRO . . . -104.56 139.27 39.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.1 p -117.93 151.71 36.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -1.2 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.453 HG12 HG23 ' A' ' 11' ' ' THR . 69.3 mt -119.34 131.6 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.799 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.2 mp -108.32 136.85 47.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.584 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 90.9 mttt -119.01 144.04 46.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.26 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.6 mt -124.1 131.09 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.945 . . . . 0.0 109.571 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 23.5 m -119.48 142.49 48.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . 64.8 m -123.18 146.33 47.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 51.6 mtmt -135.67 127.39 29.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.811 ' HB3' HD22 ' A' ' 96' ' ' LEU . 25.7 m-85 -125.89 122.2 35.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 109.853 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.72 ' CE1' HG21 ' A' ' 3' ' ' VAL . 90.1 m-70 -89.72 116.97 28.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 108.673 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.832 HG21 ' HE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -104.98 142.29 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.618 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.773 ' H ' HG22 ' A' ' 95' ' ' THR . 31.0 ttpt -84.85 128.16 34.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.6 67.28 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 m120 58.95 40.28 22.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.473 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -69.82 140.59 53.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.293 -0.88 . . . . 0.0 109.54 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 55.3 p -80.16 156.6 26.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.719 HG12 HD21 ' A' ' 96' ' ' LEU . 40.4 mt -113.82 130.89 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 109.686 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.479 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 46.5 t-20 -60.04 131.81 52.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.401 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.6 mt-10 -65.87 -33.66 76.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.338 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.26 -36.44 82.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.479 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 75.5 mm-40 -64.62 -43.81 92.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.436 HG13 ' N ' ' A' ' 136' ' ' LYS . 34.8 pt -75.49 -32.85 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.436 ' N ' HG13 ' A' ' 135' ' ' ILE . 16.7 tttp -55.7 -45.33 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.25 -40.73 71.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.258 -0.902 . . . . 0.0 109.339 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.44 -40.16 95.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -60.3 -40.5 90.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -1.18 . . . . 0.0 109.279 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.74 -40.43 97.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 67.5 tttt -59.13 -44.76 92.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.275 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.88 93.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.89 -43.25 93.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.874 . . . . 0.0 109.332 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.65 -43.2 96.39 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.668 ' O ' HG13 ' A' ' 149' ' ' VAL . 40.3 mt -65.63 -40.45 92.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -1.161 . . . . 0.0 109.272 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -66.05 -40.54 91.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -68.0 -35.93 79.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.296 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.21 -51.55 52.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 145' ' ' LEU . 3.6 m -64.87 -46.6 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.364 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.583 ' N ' HG23 ' A' ' 149' ' ' VAL . 83.7 tt0 -56.19 -35.49 67.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.51 -36.03 81.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -62.3 -43.19 99.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.406 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.53 -42.9 97.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.324 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 31.0 mt -73.25 -27.33 61.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.8 -21.98 59.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.505 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' A' ' 123' ' ' HIS . 29.3 t -128.68 128.56 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -1.116 . . . . 0.0 109.344 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.803 ' HE1' HG21 ' A' ' 124' ' ' THR . 97.1 m-85 -85.61 136.46 33.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 120' ' ' SER . 36.0 t -122.55 129.17 51.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.96 . . . . 0.0 109.705 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.51 ' CD1' HG21 ' A' ' 135' ' ' ILE . 77.6 m-85 -129.39 147.16 51.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.147 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -119.3 139.74 51.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.712 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 91.2 m-20 -110.36 150.63 28.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.379 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -115.89 137.68 51.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 109.865 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.0 122.66 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.79 . . . . 0.0 109.018 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -127.51 137.41 52.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.975 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 t -160.49 150.08 17.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 108.992 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 13' ' ' VAL . 6.3 p -74.59 91.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 0.0 109.446 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.924 HG21 HD13 ' A' ' 19' ' ' LEU . 1.8 mt -138.85 143.5 37.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.635 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.9 Cg_endo -67.62 124.62 12.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.399 2.066 . . . . 0.0 111.44 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.76 -35.74 26.79 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.253 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.78 -49.56 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -72.43 -46.03 56.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.91 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.924 HD13 HG21 ' A' ' 14' ' ' ILE . 19.7 tp -60.33 -42.97 96.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.995 . . . . 0.0 109.719 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.686 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 68.9 t80 -62.39 -47.78 82.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.759 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.725 ' HG3' HD12 ' A' ' 25' ' ' LEU . 70.6 tttt -68.35 -41.34 80.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.676 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 86.3 p -77.7 -24.62 49.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.96 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 13.7 t80 -100.48 -50.74 3.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.404 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.686 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.1 t -84.8 -52.63 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.527 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.725 HD12 ' HG3' ' A' ' 21' ' ' LYS . 59.3 mt -71.63 -32.62 68.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.045 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 92.0 m-20 -106.58 23.05 14.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.96 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.66 -41.81 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.598 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 31' ' ' ILE . 26.1 p-10 -71.03 -34.03 70.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.85 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.3 m-20 -88.69 -31.71 18.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.801 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.0 tp -73.74 -21.74 60.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 27' ' ' ALA . 15.5 mt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -138.0 156.37 47.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.399 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 36.2 p-10 -90.19 108.22 19.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.424 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 45' ' ' LEU . 23.0 tp -64.35 -37.72 88.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 49.2 tp10 -141.54 155.44 45.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 91.31 161.34 37.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.7 9.17 30.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -1.159 . . . . 0.0 109.486 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.871 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 99.53 19.19 21.22 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.861 ' O ' HG11 ' A' ' 72' ' ' VAL . . . -114.92 -141.37 7.5 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.49 123.1 9.86 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.708 2.272 . . . . 0.0 111.781 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.678 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 91.84 0.83 71.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.6 m -77.0 136.19 38.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -1.17 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 70' ' ' HIS . 7.8 mt -105.36 139.44 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 62.1 mttm -116.09 145.76 42.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -129.45 142.59 50.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -116.85 140.01 49.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.651 ' O ' HG23 ' A' ' 54' ' ' ILE . 91.7 m-70 -127.88 138.63 52.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.565 ' HD2' HD11 ' A' ' 87' ' ' ILE . 51.5 tttm -133.56 151.24 51.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.543 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 50' ' ' GLY . 11.3 p -110.81 132.3 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.484 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -72.98 -44.12 61.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -176.07 140.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.841 HD12 ' HA2' ' A' ' 50' ' ' GLY . 66.1 mt -118.09 127.02 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 79' ' ' ASN . 89.3 m-20 -122.27 85.09 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.546 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 85.5 m-70 -60.26 -38.8 84.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.76 -30.54 65.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.488 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 76' ' ' ASP . 58.2 t30 -90.56 7.23 40.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 46.03 36.99 3.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -128.17 128.42 44.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.319 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 63.1 t80 -120.11 125.58 48.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 58.4 m -127.45 114.05 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.53 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.8 p90 -129.48 163.03 26.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' A' ' 100' ' ' SER . 43.5 t -150.54 162.75 40.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.37 141.1 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 71' ' ' LYS . 80.6 mt -92.35 -35.42 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.9 . . . . 0.0 109.307 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.543 -179.969 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.455 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 56.5 m170 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 128' ' ' ALA . 1.1 m 46.23 24.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.12 HD21 HD11 ' A' ' 130' ' ' ILE . 27.0 mt -101.6 92.98 5.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.084 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.6 mt-10 -45.63 -36.13 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 0.0 110.728 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 1.072 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.2 tttp -163.38 157.94 20.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.656 -1.277 . . . . 0.0 110.503 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.072 HD13 ' O ' ' A' ' 98' ' ' LYS . 5.3 mm -133.0 119.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.748 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.505 ' CB ' ' HB2' ' A' ' 85' ' ' SER . 38.4 m -120.14 144.44 47.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 109.74 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -125.76 128.62 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.342 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 89.5 mt-10 -105.06 143.71 32.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.459 HD11 ' HE1' ' A' ' 84' ' ' TYR . 77.8 mt -128.8 118.67 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -127.41 134.67 49.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.424 ' HG2' ' HG ' ' A' ' 116' ' ' LEU . 63.4 mtm -118.97 145.79 45.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.464 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.72 157.5 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.02 139.84 30.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.892 . . . . 0.0 109.314 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 109.661 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -139.93 145.15 37.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -1.129 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.477 HG13 ' HB2' ' A' ' 108' ' ' ALA . 62.8 mt -111.31 130.62 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.828 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.1 mp -105.41 134.13 49.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -126.37 139.18 53.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.075 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 72.7 mt -124.81 140.97 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.828 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 26.9 m -123.56 142.5 50.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 m -121.41 153.3 38.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.776 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 64.3 mttm -142.25 124.97 15.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.185 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.984 ' CD1' HG23 ' A' ' 99' ' ' ILE . 9.6 m-85 -123.85 113.97 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.707 ' CE1' HG21 ' A' ' 3' ' ' VAL . 41.3 m-70 -80.49 114.19 19.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 108.86 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.803 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.1 p -102.83 142.37 34.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 0.0 109.593 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.515 ' HD2' HG23 ' A' ' 95' ' ' THR . 39.1 mttt -44.66 -43.03 8.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.8 -68.14 0.31 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.24 -30.33 71.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -1.167 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.0 m -127.95 154.3 45.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.391 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 1.12 HD11 HD21 ' A' ' 96' ' ' LEU . 29.4 mm -105.38 120.19 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.494 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.417 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 24.8 t-20 -75.79 142.31 42.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 135' ' ' ILE . 97.1 mt-10 -57.76 -28.08 63.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -66.87 -35.68 80.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 108.864 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.1 mt-10 -61.82 -25.0 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.172 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.817 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.4 OUTLIER -80.8 -39.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -56.18 -40.36 73.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.04 -48.65 73.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.294 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.02 -37.41 71.03 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -58.62 -43.68 89.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -1.139 . . . . 0.0 109.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -57.19 -48.39 78.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.072 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -59.35 -45.89 90.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.217 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.38 89.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 0.0 109.208 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.32 88.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.39 86.06 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.57 -38.07 74.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -1.117 . . . . 0.0 109.284 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.463 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 69.5 t80 -62.39 -43.66 98.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -60.23 -39.78 87.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.0 -50.01 67.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 150' ' ' GLU . 5.8 p -63.72 -42.8 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.498 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.2 tt0 -61.21 -42.4 98.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.09 78.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 30' ' ' LEU . 51.5 t80 -60.96 -52.2 66.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 34.7 mt -53.21 -42.74 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.4 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.9 mt -59.95 -45.67 91.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -59.14 -25.46 63.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.391 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 155' ' ' ALA . 1.3 t-80 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.793 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.1 p -122.3 143.53 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -1.207 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.687 ' HE2' HG21 ' A' ' 124' ' ' THR . 90.4 m-85 -105.76 143.2 34.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 120' ' ' SER . 4.2 m -128.8 124.54 35.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.583 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.564 ' CE2' ' CD1' ' A' ' 135' ' ' ILE . 81.1 m-85 -119.59 152.07 37.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.7 mt-10 -126.37 154.98 42.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.47 ' OD2' ' HE2' ' A' ' 139' ' ' LYS . 54.5 t0 -126.77 151.42 48.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 93.2 mt-10 -122.38 135.5 54.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.46 124.21 15.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.489 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.412 HG23 HG12 ' A' ' 115' ' ' ILE . 33.4 m -116.48 126.69 53.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.915 . . . . 0.0 109.682 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p -160.29 146.64 15.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 109.25 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 13' ' ' VAL . 18.9 m -78.54 91.38 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.472 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.967 HG21 HD13 ' A' ' 19' ' ' LEU . 8.8 mt -138.79 144.69 42.75 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.734 ' HD2' HG23 ' A' ' 14' ' ' ILE . 47.8 Cg_endo -68.7 123.35 10.35 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.536 2.158 . . . . 0.0 111.259 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.9 -27.76 43.1 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.745 2.296 . . . . 0.0 112.453 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.95 -54.62 6.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 109.527 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -72.62 -31.37 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.86 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.967 HD13 HG21 ' A' ' 14' ' ' ILE . 25.9 tp -71.96 -45.41 61.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.825 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 58.1 t80 -64.72 -33.19 75.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.521 ' HA ' HD13 ' A' ' 25' ' ' LEU . 33.7 tttp -83.09 -30.32 28.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.894 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 81.3 p -97.58 -14.68 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.818 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 1.067 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 76.7 t80 -100.89 -50.03 3.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 47.2 t -84.83 -49.81 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.356 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.7 mp -76.34 -39.74 53.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.58 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 30' ' ' LEU . 41.2 m-20 -92.78 10.53 30.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.014 . . . . 0.0 110.311 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.067 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.74 -34.31 73.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.888 -1.132 . . . . 0.0 109.414 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.26 -30.43 70.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -114.81 -45.49 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.037 . . . . 0.0 109.973 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.746 ' O ' HD23 ' A' ' 30' ' ' LEU . 7.8 tt -57.41 -38.32 74.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.728 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 27' ' ' ALA . 12.0 mm . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 109.453 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.291 0.567 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -145.4 147.66 32.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -93.62 109.0 20.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -38.55 88.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 53' ' ' THR . 85.4 tt0 -144.84 159.11 43.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.528 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.98 158.52 29.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -88.6 9.2 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -1.144 . . . . 0.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.812 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 102.47 23.94 8.61 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.766 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -120.81 -140.62 6.02 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.31 121.92 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.684 2.256 . . . . 0.0 111.793 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.32 -2.87 75.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.812 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.8 m -72.69 136.95 45.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -1.217 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.468 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 22.5 mm -94.09 135.17 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -108.65 133.2 53.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -122.13 132.77 54.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.224 -0.923 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.7 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.575 -179.883 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 88' ' ' GLU . 62.4 mmm . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -116.07 150.27 37.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.917 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -122.76 153.02 40.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 21.3 tttt -131.9 147.22 52.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 53' ' ' THR . 9.8 p -111.54 136.84 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.2 tt0 -80.03 -51.17 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 95.0 mt-10 -158.97 148.18 18.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.766 HD12 ' HA2' ' A' ' 50' ' ' GLY . 72.0 mt -125.08 126.58 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -127.03 94.1 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 77.2 t60 -70.26 -39.76 74.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.55 76.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -88.9 8.86 27.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 45.25 35.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HG3' ' HG2' ' A' ' 104' ' ' LYS . 37.5 tttm -124.14 137.96 54.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.552 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.1 t80 -136.97 123.59 21.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 74' ' ' GLU . 4.2 p -125.4 120.31 30.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.614 ' HE2' HD11 ' A' ' 86' ' ' ILE . 40.3 p90 -132.75 156.02 47.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.712 ' O ' HD13 ' A' ' 86' ' ' ILE . 23.0 t -119.05 172.0 7.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 85' ' ' SER . 33.3 mm -125.45 125.03 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.795 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 88' ' ' GLU . 17.7 pt -107.01 -3.96 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.504 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 21.5 mt-10 . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.952 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 92.8 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.232 0.539 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.6 22.76 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.912 ' HB3' HD11 ' A' ' 99' ' ' ILE . 33.0 mt -116.13 98.85 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.357 -0.839 . . . . 0.0 109.369 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 89.6 mt-10 -48.52 -48.41 38.31 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.587 -0.695 . . . . 0.0 110.155 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.904 ' O ' HD13 ' A' ' 99' ' ' ILE . 47.2 mtmt -155.22 158.57 39.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.867 -1.146 . . . . 0.0 110.47 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.912 HD11 ' HB3' ' A' ' 96' ' ' LEU . 5.6 mm -135.74 114.68 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 25.4 t -125.85 149.6 48.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.005 . . . . 0.0 109.946 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HE1' ' HH ' ' A' ' 122' ' ' TYR . 91.8 m-85 -128.05 126.46 41.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 109.164 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.1 mt-10 -105.34 141.71 36.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.874 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.03 122.86 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -0.855 . . . . 0.0 109.173 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 18.8 mtpp -123.48 137.28 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.723 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -116.61 141.84 47.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -141.06 155.12 46.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.619 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.88 132.93 40.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 109.301 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.3 t -148.12 150.18 33.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -1.124 . . . . 0.0 109.508 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.412 HG12 HG23 ' A' ' 11' ' ' THR . 67.8 mt -116.8 133.9 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.731 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.2 mp -111.16 138.53 47.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -123.9 139.29 54.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.265 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 70.8 mt -121.15 138.34 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 33.1 m -125.58 142.61 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 44.3 m -126.92 152.4 47.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -133.98 133.25 41.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 108.946 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.793 ' C ' HG23 ' A' ' 3' ' ' VAL . 37.9 m-85 -133.32 104.52 6.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.949 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.549 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 28.6 m80 -83.41 122.47 28.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.687 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -102.58 150.03 23.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.963 -1.086 . . . . 0.0 109.876 -178.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -79.92 131.41 35.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 68.76 -144.05 41.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -94.36 17.39 13.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.4 146.91 14.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.509 ' HA ' ' CE2' ' A' ' 4' ' ' PHE . 38.2 m -127.21 154.79 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.578 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 22.6 mt -108.41 130.37 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -72.88 142.87 47.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.456 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.9 mt-10 -65.9 -31.47 72.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.538 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -44.74 83.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -43.56 88.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.564 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 38.3 pt -79.85 -29.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.7 tttm -56.26 -41.14 75.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.4 74.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.31 -38.53 78.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.47 ' HE2' ' OD2' ' A' ' 8' ' ' ASP . 19.1 tttm -59.83 -43.61 94.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -1.126 . . . . 0.0 109.352 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -58.95 -41.62 87.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 23.3 tttp -60.74 -41.46 95.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.354 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.48 86.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.24 96.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.53 98.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.929 ' O ' HG13 ' A' ' 149' ' ' VAL . 57.8 mt -66.09 -38.86 89.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -1.199 . . . . 0.0 109.393 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.78 -44.5 89.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.44 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.59 -35.53 80.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.471 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.32 -50.46 26.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 145' ' ' LEU . 3.3 m -64.46 -46.71 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.651 ' HG3' HD11 ' A' ' 14' ' ' ILE . 83.8 tt0 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.11 72.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.277 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -62.78 -41.28 99.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.35 -41.8 90.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 37.4 mt -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.476 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.95 62.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.707 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.2 p -108.48 135.52 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.14 . . . . 0.0 109.588 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.659 ' CD1' HD12 ' A' ' 130' ' ' ILE . 82.8 m-85 -92.07 139.64 30.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 28.0 p -122.68 119.91 32.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.393 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 119' ' ' THR . 47.3 m-85 -116.24 145.54 43.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -121.12 143.14 49.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.558 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.473 ' OD1' ' HE2' ' A' ' 139' ' ' LYS . 60.5 t0 -116.07 135.78 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -113.07 125.08 53.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.685 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.96 7.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.047 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 t -129.48 150.75 50.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -160.29 146.39 15.42 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 13' ' ' VAL . 13.0 m -62.3 90.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.033 . . . . 0.0 109.29 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.776 HG23 ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt -139.81 145.48 43.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.354 -0.841 . . . . 0.0 109.322 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.776 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.9 Cg_endo -68.44 112.79 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.332 2.021 . . . . 0.0 110.995 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HG3' ' HB2' ' A' ' 107' ' ' ALA . 44.6 Cg_endo -66.54 -32.02 40.2 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.851 2.367 . . . . 0.0 112.34 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.03 -56.23 7.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.134 -0.979 . . . . 0.0 109.442 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 mtt85 -72.4 -38.95 68.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.732 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.668 HD13 HG21 ' A' ' 14' ' ' ILE . 22.0 tp -62.0 -47.64 83.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 109.654 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.58 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.9 t80 -58.59 -46.62 86.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.413 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.4 mttm -72.84 -44.66 61.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.957 . . . . 0.0 109.522 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 33.9 t -70.83 -21.33 62.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.076 -1.015 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.951 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 2.6 t80 -100.13 -50.74 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.089 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 55.5 t -85.04 -52.44 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.095 -1.003 . . . . 0.0 110.12 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.1 tp -70.41 -36.27 73.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.135 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 74.4 m-20 -103.82 23.78 12.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.039 -1.038 . . . . 0.0 109.723 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.5 -46.53 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.62 -33.22 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 109.96 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -90.76 -40.17 11.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.64 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.799 HD21 HG23 ' A' ' 149' ' ' VAL . 19.5 tp -66.32 -28.25 68.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.955 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 27' ' ' ALA . 24.6 mt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.164 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -133.72 157.0 46.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -97.87 110.12 22.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.525 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 56' ' ' LYS . 7.6 mt -63.25 -37.83 88.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 53' ' ' THR . 83.9 tt0 -149.14 157.09 43.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.499 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 86.46 155.99 27.69 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -89.9 10.52 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.563 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.73 23.41 7.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.853 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -121.19 -143.91 6.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 50.4 Cg_endo -70.17 121.89 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.678 2.252 . . . . 0.0 111.843 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.74 -2.82 70.33 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 46' ' ' GLU . 94.3 m -78.59 140.83 38.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -1.196 . . . . 0.0 109.496 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.4 mm -100.67 129.55 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 31.1 tttm -106.71 130.7 54.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' HB2' HD11 ' A' ' 45' ' ' LEU . 20.0 tttt -122.86 134.93 54.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.498 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.95 146.6 30.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 89.4 m-70 -126.8 140.11 52.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -124.62 133.25 53.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.521 HG11 HD11 ' A' ' 75' ' ' ILE . 46.9 t -98.68 130.62 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 82.0 tt0 -81.09 -53.92 5.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.7 mt-10 -156.96 143.35 18.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.853 HD12 ' HA2' ' A' ' 50' ' ' GLY . 71.8 mt -124.31 123.65 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.449 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 73.2 m-20 -130.5 86.25 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.58 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 94.2 m-70 -62.38 -38.05 88.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.67 -30.68 68.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.449 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 56.8 m-20 -89.49 9.39 26.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.508 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.559 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 56.5 m-85 44.21 39.65 3.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.354 -0.841 . . . . 0.0 109.536 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.482 ' CE ' ' OE2' ' A' ' 102' ' ' GLU . 82.9 tttt -135.39 128.59 31.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.536 ' CE2' HG12 ' A' ' 75' ' ' ILE . 77.5 t80 -125.97 127.9 46.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 109.561 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -128.09 123.38 34.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.7 p90 -139.35 166.06 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.7 t -143.64 167.39 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 130.34 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.4 -47.18 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.557 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 109.503 -179.978 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.527 ' O ' ' CB ' ' A' ' 95' ' ' THR . 57.2 t-80 . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 1.052 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 78.54 5.31 2.53 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.936 ' HB3' HD11 ' A' ' 99' ' ' ILE . 67.2 mt -100.71 93.11 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 108.957 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.7 mt-10 -40.43 -37.63 0.71 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.693 -0.63 . . . . 0.0 110.42 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 1.02 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.9 tttt -164.81 155.44 14.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 110.419 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.02 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.5 mm -131.85 124.24 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.4 t -128.43 159.62 34.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.049 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.468 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 85.0 m-85 -135.68 128.54 31.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.482 ' OE2' ' CE ' ' A' ' 81' ' ' LYS . 78.4 tt0 -112.05 140.66 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 117' ' ' LYS . 68.7 mt -131.81 126.34 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.153 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.433 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 11.2 mtpp -123.43 137.77 54.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.612 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.93 151.06 39.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.329 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.27 158.91 43.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 16' ' ' PRO . . . -107.14 146.25 31.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.473 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.364 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 14' ' ' ILE . 95.0 p -146.5 152.71 39.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.402 ' C ' HD12 ' A' ' 116' ' ' LEU . 69.3 mt -122.61 128.04 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.4 mp -110.32 134.59 52.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 29.9 mttp -128.51 128.88 45.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.476 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -118.11 129.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 75.7 m -126.2 134.42 51.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.577 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.468 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 50.4 m -116.4 161.82 18.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.563 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -145.67 127.03 14.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.845 . . . . 0.0 109.37 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.822 ' CD1' HG23 ' A' ' 99' ' ' ILE . 11.0 m-85 -126.63 107.94 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.58 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 30.0 m80 -80.23 113.98 18.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.089 -1.007 . . . . 0.0 108.336 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.3 p -104.45 141.82 35.68 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.029 . . . . 0.0 109.511 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 92.2 mttt -41.83 -42.48 2.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.479 -0.763 . . . . 0.0 109.615 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.73 -70.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -59.67 -31.71 69.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -1.164 . . . . 0.0 109.56 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 1.052 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -61.18 147.47 44.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -128.56 145.76 51.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.659 HD12 ' CD1' ' A' ' 4' ' ' PHE . 17.8 mt -108.78 126.49 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -88.41 152.51 21.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.809 ' OE1' HD11 ' A' ' 135' ' ' ILE . 75.6 mm-40 -64.9 -36.79 85.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.02 -44.59 95.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.81 -43.65 90.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.809 HD11 ' OE1' ' A' ' 132' ' ' GLU . 42.2 pt -82.13 -30.69 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 132' ' ' GLU . 47.4 tttt -55.78 -37.51 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.48 74.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.288 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.16 95.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' A' ' 8' ' ' ASP . 22.7 tttt -60.01 -42.92 95.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 109.317 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.39 -41.8 94.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.379 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.08 -45.96 86.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.14 -42.56 75.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.1 99.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.371 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.62 -45.06 90.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.82 -38.25 78.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -1.154 . . . . 0.0 109.301 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.51 ' O ' HG12 ' A' ' 149' ' ' VAL . 70.0 t80 -62.9 -41.83 99.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.0 -37.39 87.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.46 -47.42 70.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.389 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.799 HG23 HD21 ' A' ' 30' ' ' LEU . 6.6 p -62.39 -40.45 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.301 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.7 tt0 -59.74 -43.24 94.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.426 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.6 81.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.919 . . . . 0.0 109.353 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.38 -44.83 96.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.51 -39.64 91.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.1 tt -64.56 -44.59 90.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.502 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.65 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.2 m80 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.94 . . . . 0.0 109.447 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.28 141.74 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.523 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CD2' HD12 ' A' ' 130' ' ' ILE . 99.1 m-85 -101.59 122.99 44.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 t -111.03 120.97 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.77 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 28.2 m-85 -115.49 147.33 40.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -118.16 133.67 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.654 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -109.54 134.2 52.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.86 124.21 52.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.28 124.19 15.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.292 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -110.6 132.3 54.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 m -157.06 147.48 21.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.045 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.738 ' O ' HG23 ' A' ' 13' ' ' VAL . 31.0 m -78.44 90.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.84 HG21 HD13 ' A' ' 19' ' ' LEU . 8.6 mt -139.37 144.93 42.06 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.224 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.784 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.98 113.33 3.21 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.501 2.134 . . . . 0.0 111.228 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -66.52 -31.13 42.35 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.799 2.333 . . . . 0.0 112.204 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.11 -52.74 8.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -72.01 -45.95 59.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.954 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.84 HD13 HG21 ' A' ' 14' ' ' ILE . 6.7 tp -59.04 -45.13 91.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.959 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.532 ' CE1' HG21 ' A' ' 24' ' ' VAL . 79.0 t80 -60.73 -55.38 33.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.902 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 23.8 tttp -67.85 -38.39 83.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 29.5 t -72.78 -27.2 61.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.805 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.794 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 34.3 t80 -100.82 -50.11 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.532 HG21 ' CE1' ' A' ' 20' ' ' PHE . 54.8 t -78.14 -52.45 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.082 -1.011 . . . . 0.0 110.284 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.773 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.13 -35.91 82.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.103 -0.998 . . . . 0.0 109.808 -179.434 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' SER . 89.8 m-20 -108.71 28.36 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.581 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.794 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.4 -45.04 70.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.917 ' HA ' HD12 ' A' ' 31' ' ' ILE . 65.0 m-20 -73.72 -29.65 62.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.98 . . . . 0.0 109.773 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -79.66 -37.79 35.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.965 . . . . 0.0 109.616 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 30' ' ' LEU . 42.1 mt -72.44 -31.47 65.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.72 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 28' ' ' ASP . 16.0 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -134.21 149.71 51.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 33.2 p-10 -84.0 114.56 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.53 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 52.0 mt -65.95 -28.69 69.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 109.404 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 45' ' ' LEU . 14.7 mm-40 -159.44 -173.41 4.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 63.39 164.36 0.57 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -94.51 -3.14 50.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -1.087 . . . . 0.0 109.553 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.752 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 119.72 13.82 5.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.722 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -112.17 -142.12 8.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.63 125.95 13.42 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.42 5.49 79.13 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.752 HG21 ' HA2' ' A' ' 49' ' ' GLY . 53.9 m -73.02 140.78 47.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -1.219 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.53 ' CG2' ' HB2' ' A' ' 45' ' ' LEU . 27.0 mm -99.13 133.74 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 79.7 tttt -122.77 134.84 54.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.403 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.8 tttt -130.85 131.46 44.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.478 HD12 ' HE2' ' A' ' 70' ' ' HIS . 69.5 mt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.499 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' CB ' ' HB ' ' A' ' 87' ' ' ILE . 53.4 mttm -126.88 136.79 52.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.606 ' ND1' HG23 ' A' ' 86' ' ' ILE . 34.0 m-70 -131.96 133.51 44.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -127.19 141.51 51.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 109.612 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.583 HG11 ' CG1' ' A' ' 75' ' ' ILE . 62.0 t -100.8 129.65 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.335 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.8 -43.96 43.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -173.1 137.26 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 109.583 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.722 HD12 ' HA2' ' A' ' 50' ' ' GLY . 60.3 mt -116.77 123.55 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -132.94 72.59 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.511 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.489 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 96.8 m-70 -55.9 -37.14 68.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.44 78.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.363 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 23.9 m120 -87.45 -0.28 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 60.93 31.78 19.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 79' ' ' ASN . 4.5 mtmp? -130.87 125.14 32.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.4 t80 -117.16 129.25 55.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 0.0 109.42 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.3 t -129.02 114.06 15.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.56 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.3 p90 -129.5 170.44 13.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.311 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 87.5 p -151.93 162.86 40.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.708 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.606 HG23 ' ND1' ' A' ' 70' ' ' HIS . 15.6 mm -111.85 122.43 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.457 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 99.7 mt -70.2 -39.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.604 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 0.0 109.626 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.325 0.583 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.902 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 56.47 16.85 2.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 109.856 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.906 HD22 ' HB3' ' A' ' 122' ' ' TYR . 37.1 mt -90.63 89.67 7.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.029 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 79.3 mt-10 -48.35 -32.53 7.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 21.7 tttp -152.34 152.52 32.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.596 -1.315 . . . . 0.0 110.691 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 96' ' ' LEU . 10.0 mm -132.47 113.62 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 37.3 t -131.36 152.23 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.921 -1.112 . . . . 0.0 110.128 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.517 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 84.8 m-85 -130.84 143.66 50.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 82.1 tt0 -120.93 143.73 48.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 109.78 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.29 121.9 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 56.8 tttt -121.04 129.73 53.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.893 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mtt -116.18 132.75 56.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.366 -0.834 . . . . 0.0 109.196 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.56 151.44 41.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.86 124.26 34.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.31 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.946 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -138.09 164.73 28.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -1.162 . . . . 0.0 109.674 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.24 137.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.18 137.1 44.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 47.8 mttp -130.77 135.89 48.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 68.1 mt -127.12 127.68 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.134 -0.979 . . . . 0.0 109.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 32.5 m -116.22 142.51 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.372 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.429 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 68.3 m -122.02 147.83 45.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 109.703 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -129.25 116.67 19.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.227 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.906 ' HB3' HD22 ' A' ' 96' ' ' LEU . 72.0 m-85 -115.7 124.79 51.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.544 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 0.3 OUTLIER -91.05 129.19 37.07 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.204 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 125' ' ' LYS . 4.2 t -114.85 136.01 53.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.953 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 21.0 tttm -43.63 -46.86 7.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.75 -85.87 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -58.32 -25.29 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -68.95 142.96 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.53 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 86.6 p -130.33 163.35 27.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.705 HD12 ' CD2' ' A' ' 4' ' ' PHE . 51.4 mt -108.48 126.4 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.24 132.51 47.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.546 ' HA ' ' CD1' ' A' ' 135' ' ' ILE . 94.7 mt-10 -61.92 -32.63 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.91 -43.82 98.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.3 -26.04 62.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 108.986 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.77 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 1.8 mt -69.9 -49.56 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 108.839 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -55.49 -44.54 76.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.209 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.46 -47.37 86.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.64 -31.61 57.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -70.57 -36.79 73.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -1.118 . . . . 0.0 109.306 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.04 -45.02 96.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.14 -45.95 91.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.361 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.52 94.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.267 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.02 82.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.233 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.61 -44.56 95.52 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 145' ' ' LEU . 38.0 tp -56.77 -41.99 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -1.109 . . . . 0.0 109.311 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 118' ' ' ILE . 63.9 m-85 -62.09 -41.12 97.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.252 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -56.85 -42.88 80.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.58 77.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.561 HG21 ' CE1' ' A' ' 23' ' ' PHE . 75.3 t -67.21 -50.08 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.445 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 82.7 mt-10 -50.23 -34.02 21.52 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.01 81.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.717 . . . . 0.0 109.458 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.45 -45.06 92.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.442 HD11 HD12 ' A' ' 19' ' ' LEU . 76.4 mt -59.1 -42.64 90.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.963 . . . . 0.0 109.303 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 30.0 mt -69.08 -33.0 72.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.26 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 0.0 109.399 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.879 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.717 HG21 ' CE1' ' A' ' 123' ' ' HIS . 23.7 t -116.57 140.82 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.153 . . . . 0.0 109.499 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 99.3 m-85 -107.49 129.71 54.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.132 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -117.28 125.94 51.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.786 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 46.8 m-85 -124.29 142.75 51.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -116.3 131.78 56.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 56.8 t0 -99.98 133.08 44.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -108.52 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.4 129.55 22.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.7 m -112.66 137.44 50.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.792 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -160.6 147.98 15.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.828 . . . . 0.0 109.047 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.605 ' O ' HG13 ' A' ' 13' ' ' VAL . 4.0 p -81.84 91.07 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.567 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 19' ' ' LEU . 13.2 mt -139.17 144.77 41.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.28 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.76 ' HD2' HG23 ' A' ' 14' ' ' ILE . 44.5 Cg_endo -67.69 116.17 4.13 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.41 2.073 . . . . 0.0 111.217 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.9 Cg_endo -66.8 -35.61 26.93 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.884 2.39 . . . . 0.0 112.387 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.09 -52.04 18.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.479 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 22' ' ' SER . 55.9 mtp180 -72.11 -50.32 29.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 14' ' ' ILE . 13.4 tp -55.01 -45.28 75.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.803 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.701 ' O ' HG22 ' A' ' 24' ' ' VAL . 47.5 t80 -64.39 -55.59 20.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 109.425 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 27.9 mttt -67.92 -13.73 62.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.648 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.692 ' O ' HD12 ' A' ' 30' ' ' LEU . 49.7 m -100.33 -21.46 15.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.011 -1.056 . . . . 0.0 109.925 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 1.025 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 35.0 t80 -101.2 -52.5 3.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.996 -1.065 . . . . 0.0 110.722 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 20' ' ' PHE . 12.6 m -86.22 -40.79 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.961 -1.087 . . . . 0.0 110.63 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.544 HD12 ' CD2' ' A' ' 77' ' ' HIS . 4.1 tt -79.29 -43.16 24.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.574 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.502 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 95.1 m-20 -89.54 10.74 21.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.025 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.42 -31.49 69.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -71.56 -14.76 62.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -114.75 -36.92 4.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.0 . . . . 0.0 109.817 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 22' ' ' SER . 33.4 mt -72.53 -31.12 65.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.124 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' C ' ' HG3' ' A' ' 43' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HG3' ' C ' ' A' ' 42' ' ' ALA . 92.0 mt-10 -155.53 156.42 35.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 84.1 m-20 -88.53 118.49 28.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.524 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 28.5 tp -72.95 -35.97 67.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 53' ' ' THR . 49.5 tp10 -159.24 153.98 24.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 93.37 150.29 26.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -83.52 6.91 18.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.602 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.675 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.08 20.2 10.01 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.692 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -113.58 -146.32 9.47 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.01 124.94 11.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.751 2.301 . . . . 0.0 111.891 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.16 78.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.675 HG21 ' HA2' ' A' ' 49' ' ' GLY . 61.2 m -72.73 137.79 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -1.193 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.3 mm -103.81 133.44 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 46.6 mtpt -111.73 144.33 41.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 45' ' ' LEU . 16.1 tttp -122.13 133.4 54.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 23.0 mm . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 179.955 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.6 mtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.67 140.48 40.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.826 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 81.8 m-70 -126.0 135.36 51.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -130.32 142.15 50.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.432 HG11 ' CG1' ' A' ' 75' ' ' ILE . 68.6 t -101.65 132.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.464 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 89.9 mt-10 -73.59 -58.64 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.426 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 93.9 mt-10 -158.79 144.25 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.692 HD12 ' HA2' ' A' ' 50' ' ' GLY . 91.3 mt -122.79 120.32 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.502 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.471 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 86.8 m-20 -122.78 92.42 3.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.544 ' CD2' HD12 ' A' ' 25' ' ' LEU . 76.5 m80 -64.95 -37.52 87.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.16 -33.31 71.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.902 . . . . 0.0 109.374 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 76' ' ' ASP . 23.2 m120 -84.98 -2.33 57.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 53.61 41.24 32.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -137.32 122.45 19.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 81.7 t80 -113.18 128.11 56.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 m -127.78 119.13 25.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.583 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.2 p90 -134.32 164.28 27.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 17.0 t -145.51 158.99 43.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.584 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 86' ' ' ILE . 54.0 mt -108.58 137.42 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 96.4 mt -86.24 -27.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.699 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 85.0 tt0 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.514 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.251 0.548 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.0 m 48.8 22.94 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.648 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.945 HD22 ' HB3' ' A' ' 122' ' ' TYR . 36.4 mt -94.02 89.14 5.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.301 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.547 ' CG ' ' HG2' ' A' ' 125' ' ' LYS . 83.6 mt-10 -40.75 -28.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.633 -0.667 . . . . 0.0 110.218 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 71.3 tttt -165.87 155.2 11.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 0.0 110.153 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.831 HG23 ' CD1' ' A' ' 122' ' ' TYR . 45.9 mt -141.32 113.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 108.975 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 32.1 t -126.08 150.45 48.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.985 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.607 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 98.2 m-85 -127.24 126.42 42.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 0.0 109.145 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 51.9 mp0 -112.83 142.1 45.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.803 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.6 mt -117.37 131.72 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.252 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 16.0 tttp -124.83 132.24 53.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.0 mtt -115.58 146.16 42.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.08 40.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.95 41.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.2 p -106.13 163.63 12.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -1.174 . . . . 0.0 109.599 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.81 128.08 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.388 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.11 136.15 47.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 94.1 mttt -131.32 136.92 48.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.48 127.43 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 26.7 m -113.81 142.42 46.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.48 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 51.5 m -127.89 150.58 49.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.465 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 34.7 mttt -138.43 120.68 15.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.399 -0.813 . . . . 0.0 109.079 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.945 ' HB3' HD22 ' A' ' 96' ' ' LEU . 28.5 m-85 -120.6 115.75 24.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.122 -0.986 . . . . 0.0 109.889 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.717 ' CE1' HG21 ' A' ' 3' ' ' VAL . 52.1 m-70 -83.15 132.18 35.09 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 2' ' ' GLY . 10.3 t -113.95 138.29 50.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.547 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 75.9 mttt -76.38 144.29 40.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.384 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 54.66 -148.2 22.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 46.2 p-10 -88.06 10.95 17.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -1.139 . . . . 0.0 109.48 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.865 ' HB3' ' OG1' ' A' ' 124' ' ' THR . . . -45.24 144.0 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.458 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.4 p -123.1 167.15 14.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 23.1 mt -116.11 127.67 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.405 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 45.8 t30 -57.1 127.35 31.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.559 ' HA ' HG13 ' A' ' 135' ' ' ILE . 96.1 mt-10 -61.96 -33.72 74.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -55.28 -44.25 75.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.405 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 92.5 mt-10 -58.09 -25.25 61.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.786 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 4.3 mt -70.33 -50.86 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.822 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -55.59 -43.92 76.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.94 84.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.76 -38.09 71.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -61.42 -44.16 97.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -1.058 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.51 -42.19 82.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.436 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -58.48 -45.23 89.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.62 -38.5 75.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.98 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.73 94.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.9 -46.88 90.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.48 -37.99 82.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.497 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.438 ' O ' HG12 ' A' ' 149' ' ' VAL . 67.2 t80 -61.69 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.23 -36.26 79.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.59 -48.72 68.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -66.97 -42.55 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.92 . . . . 0.0 109.395 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.515 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.1 tt0 -60.78 -38.63 85.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.421 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.2 -36.96 80.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.524 ' CZ ' HD22 ' A' ' 30' ' ' LEU . 71.4 t80 -63.43 -47.82 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.333 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.9 mt -59.02 -40.84 86.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.24 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.89 ' O ' HD13 ' A' ' 154' ' ' LEU . 2.7 tm? -67.88 -40.03 83.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.09 66.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 124' ' ' THR . . . 87.77 10.03 70.51 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.543 HG22 ' ND1' ' A' ' 123' ' ' HIS . 43.5 t -128.46 131.92 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -1.204 . . . . 0.0 109.666 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.633 ' CD1' HD12 ' A' ' 130' ' ' ILE . 99.3 m-85 -89.21 129.33 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.883 . . . . 0.0 109.122 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 120' ' ' SER . 93.4 m -116.09 121.72 43.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 97.8 m-85 -121.19 147.72 45.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 85.1 tt0 -124.08 134.44 53.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 92.4 m-20 -104.75 148.6 26.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.276 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -116.57 138.09 51.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 115' ' ' ILE . . . -143.69 123.28 13.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.5 m -110.7 127.33 55.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.996 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 p -160.57 147.37 15.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.6 p -83.82 91.15 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.739 HG23 ' HD2' ' A' ' 15' ' ' PRO . 94.0 mt -139.02 144.78 42.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.739 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.5 Cg_endo -67.91 121.48 8.52 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 111.235 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 45.5 Cg_endo -66.76 -31.85 38.52 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.848 2.365 . . . . 0.0 112.451 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.87 -54.23 8.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 109.654 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.503 ' CZ ' ' O ' ' A' ' 159' ' ' ALA . 33.8 mtp-105 -72.25 -39.19 68.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 109.762 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.659 HD22 HG21 ' A' ' 14' ' ' ILE . 60.4 tp -61.26 -45.15 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.666 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 58.4 t80 -67.4 -46.94 71.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.861 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.591 ' HG3' HD12 ' A' ' 25' ' ' LEU . 15.9 tttp -72.72 -22.23 60.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.833 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.459 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 83.8 p -97.72 -29.19 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.072 -1.017 . . . . 0.0 109.826 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.935 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 14.2 t80 -100.27 -46.46 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.666 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.8 t -84.34 -52.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.591 HD12 ' HG3' ' A' ' 21' ' ' LYS . 42.5 mt -71.86 -41.89 67.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.024 -1.047 . . . . 0.0 109.681 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.464 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.9 m-20 -97.43 26.35 4.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.546 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.935 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.55 -44.51 70.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.512 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.568 ' HA ' HD12 ' A' ' 31' ' ' ILE . 37.2 p-10 -74.19 -18.4 60.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.01 -38.81 14.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.621 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' VAL . 48.5 mt -71.88 -30.89 65.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.624 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 28' ' ' ASP . 34.4 mt -55.7 -56.96 24.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.7 Cg_endo -68.29 -35.37 18.95 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.456 2.104 . . . . 0.0 111.824 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 36.6 tttp -54.99 -42.8 72.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.915 . . . . 0.0 109.34 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.532 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 68.9 t -59.89 -41.02 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.414 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 34' ' ' VAL . . . 66.49 51.07 0.68 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 0.0 109.368 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 48.6 Cg_endo -69.52 -49.93 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.75 2.3 . . . . 0.0 111.876 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -137.66 141.14 41.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -107.79 11.82 27.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -97.73 -9.51 26.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.5 p -110.54 165.99 11.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.377 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.8 t -157.76 143.26 17.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.527 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -112.42 147.24 36.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -141.19 138.91 33.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 47' ' ' GLY . 37.4 t30 -87.89 115.42 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.53 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.546 HD13 ' HZ3' ' A' ' 56' ' ' LYS . 20.8 tp -73.35 -32.91 64.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.396 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 81.6 tt0 -166.98 160.18 13.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.512 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 92.76 161.45 36.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -98.91 10.48 41.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.567 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.99 20.93 9.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 1.041 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -118.75 -146.02 7.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.2 Cg_endo -68.82 125.08 12.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.826 2.351 . . . . 0.0 111.777 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.14 3.44 75.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.567 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.6 m -72.91 140.21 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -1.185 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.503 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 18.5 mm -110.91 118.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' HIS . 46.8 mttt -120.52 143.26 48.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' HZ3' HD13 ' A' ' 45' ' ' LEU . 16.4 mtmt -127.51 135.41 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 68' ' ' MET . 71.4 mt -123.88 131.08 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.376 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 60' ' ' ALA . 46.7 m -129.27 138.78 51.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.0 109.586 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -71.36 -30.38 66.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.578 ' H ' HG22 ' A' ' 58' ' ' THR . . . -104.45 147.16 27.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -111.43 160.88 16.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.387 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.11 9.67 47.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -106.59 126.92 52.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 109.512 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.58 -36.99 77.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.923 . . . . 0.0 109.544 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -117.16 150.13 39.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HD2' ' CB ' ' A' ' 56' ' ' LYS . 77.8 mttt -104.1 132.57 50.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -67.34 -32.66 73.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 85.8 mtp -95.98 138.47 33.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 87.2 mttt -132.38 141.11 48.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 55' ' ' LYS . 97.9 m-70 -121.86 135.55 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.503 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 61.5 tttt -131.51 131.73 43.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.423 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.534 HG22 ' CE1' ' A' ' 84' ' ' TYR . 21.9 t -89.07 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 86.2 tt0 -71.79 -43.51 65.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.96 . . . . 0.0 109.61 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.4 tt0 -178.36 146.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.041 HD12 ' HA2' ' A' ' 50' ' ' GLY . 30.0 mt -126.31 120.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 20.6 t70 -128.74 93.29 3.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 55.7 p-80 -69.75 -26.46 64.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.0 -43.13 99.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 23.4 m120 -91.25 3.56 54.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.93 . . . . 0.0 109.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 59.29 27.17 16.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 79' ' ' ASN . 36.6 mttt -116.14 141.45 48.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.622 ' CD2' HG23 ' A' ' 75' ' ' ILE . 17.8 t80 -130.23 137.28 49.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 13.2 m -117.32 122.49 44.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.534 ' CE1' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -120.7 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.532 ' O ' HD13 ' A' ' 86' ' ' ILE . 73.3 m -127.74 149.25 50.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.533 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 85' ' ' SER . 26.9 mm -116.96 129.69 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.713 HG22 ' HG3' ' A' ' 88' ' ' GLU . 84.9 mt -87.0 -49.75 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.256 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 87' ' ' ILE . 97.5 mt-10 -152.86 143.48 22.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -152.67 105.63 0.28 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 46.44 -120.09 4.63 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.7 Cg_endo -70.8 -20.54 29.81 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.572 2.181 . . . . 0.0 111.468 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 9.6 tp 62.51 -74.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.405 -0.81 . . . . 0.0 109.62 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.775 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . 166.45 167.56 27.29 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -90.59 130.1 36.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -1.118 . . . . 0.0 109.339 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.882 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.3 OUTLIER 55.73 17.71 2.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.383 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.775 HD12 ' HA3' ' A' ' 93' ' ' GLY . 42.8 mt -97.98 91.01 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.152 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' HIS . 91.4 mt-10 -51.37 -43.01 61.74 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.276 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 16.7 tttt -155.96 158.18 37.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 0.0 110.315 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.879 HG23 ' CE1' ' A' ' 122' ' ' TYR . 35.6 mt -134.41 117.11 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 32.5 t -120.87 150.89 40.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.003 -1.061 . . . . 0.0 110.237 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 84' ' ' TYR . 93.4 m-85 -131.38 133.49 45.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 93.5 mt-10 -121.22 139.65 53.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.25 125.86 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 109.392 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -125.04 146.94 49.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.1 mtt -122.82 150.44 42.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.43 153.48 40.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.37 39.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -81.19 162.56 58.72 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 47.9 Cg_endo -68.93 -26.01 32.0 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.731 2.287 . . . . 0.0 111.75 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -58.31 -35.89 72.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.332 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.5 9.31 61.68 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.72 49.42 0.61 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 13' ' ' VAL . . . -177.45 123.54 0.89 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.5 t -112.78 143.99 43.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -1.166 . . . . 0.0 109.55 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.41 ' C ' HD12 ' A' ' 116' ' ' LEU . 70.1 mt -115.48 135.81 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -105.91 138.35 42.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.59 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 70.7 mttt -127.56 139.66 52.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 76.0 mt -123.31 138.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.618 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 29.7 m -120.33 142.4 49.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.342 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.44 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 54.1 m -125.44 148.81 48.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.615 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -134.94 122.5 22.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.888 . . . . 0.0 109.256 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.879 ' CE1' HG23 ' A' ' 99' ' ' ILE . 50.9 m-85 -119.2 119.75 35.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.543 ' ND1' HG22 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -84.7 114.01 21.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 108.722 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.601 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 9.6 t -103.38 144.38 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.022 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.423 ' CB ' HG22 ' A' ' 95' ' ' THR . 16.0 tttt -43.84 -45.44 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 149.68 -54.06 0.5 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -85.93 8.94 18.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -107.0 145.33 32.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 m -124.16 145.61 49.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.633 HD12 ' CD1' ' A' ' 4' ' ' PHE . 52.6 mt -101.82 134.07 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -86.14 142.48 28.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.3 mt-10 -58.88 -35.89 73.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -63.31 -46.26 87.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.843 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -57.22 -44.3 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.351 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.448 HD13 ' CE2' ' A' ' 6' ' ' TYR . 39.7 pt -75.37 -30.64 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.282 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -56.09 -40.55 73.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.19 -47.18 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.9 . . . . 0.0 109.31 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.66 67.87 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.98 -42.6 99.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -1.08 . . . . 0.0 109.214 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -54.95 -45.48 74.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.173 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -59.44 -45.12 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.95 93.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.72 95.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.168 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.69 -46.98 88.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.9 -38.76 76.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.238 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.479 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.6 t80 -62.83 -41.04 99.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -0.895 . . . . 0.0 109.277 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -59.21 -40.99 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.75 -51.94 65.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 23' ' ' PHE . 4.3 p -61.83 -41.2 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.454 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.3 tt0 -63.54 -38.47 91.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.348 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.41 91.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.445 ' OH ' ' HE2' ' A' ' 33' ' ' LYS . 72.1 t80 -61.15 -48.28 82.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.26 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.31 -35.82 78.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.329 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.938 ' O ' HD13 ' A' ' 154' ' ' LEU . 2.0 tm? -63.06 -39.87 96.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.853 . . . . 0.0 109.293 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.78 64.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.37 70.13 14.1 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 49.4 Cg_endo -70.46 -9.47 25.93 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.705 2.27 . . . . 0.0 111.591 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -101.7 9.94 40.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.489 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' O ' ' CZ ' ' A' ' 18' ' ' ARG . . . -57.78 144.22 39.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -128.99 139.43 52.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -0.979 . . . . 0.0 109.494 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.507 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.5 mtm . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.317 0.58 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.482 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . 91.97 9.06 62.74 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.606 HG22 ' HA ' ' A' ' 123' ' ' HIS . 29.1 t -129.39 133.63 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -1.115 . . . . 0.0 109.313 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.589 ' HE1' HG21 ' A' ' 124' ' ' THR . 97.2 m-85 -92.86 132.09 37.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 109.302 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' SER . 28.5 p -117.89 121.33 40.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 119' ' ' THR . 33.5 m-85 -115.27 143.69 44.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.75 152.51 37.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' A' ' 118' ' ' ILE . 60.3 t0 -135.14 137.66 42.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.37 137.77 45.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.626 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -146.6 123.31 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.6 m -107.52 127.25 53.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.774 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.4 p -160.39 140.2 11.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.312 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.884 HG13 ' HA3' ' A' ' 113' ' ' GLY . 3.1 t -88.24 91.61 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.907 HG21 HD13 ' A' ' 19' ' ' LEU . 31.3 mm -138.5 144.49 42.67 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.741 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.1 Cg_endo -67.94 123.56 10.81 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.44 2.093 . . . . 0.0 111.463 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 43.7 Cg_endo -66.87 -40.01 13.3 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.75 2.3 . . . . 0.0 112.1 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.94 -53.82 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 0.0 109.433 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -72.14 -46.66 55.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.907 HD13 HG21 ' A' ' 14' ' ' ILE . 27.8 tp -61.11 -41.02 95.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.668 ' O ' HG22 ' A' ' 24' ' ' VAL . 44.1 t80 -68.19 -55.8 10.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 92.9 mttt -65.58 -13.67 59.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 109.888 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.598 ' O ' HD12 ' A' ' 30' ' ' LEU . 52.9 p -109.16 -17.58 13.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.953 -1.092 . . . . 0.0 110.231 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 1.034 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 85.5 t80 -100.37 -51.57 3.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 110.109 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.6 m -85.67 -39.4 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.984 . . . . 0.0 110.092 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.65 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -81.63 -53.95 5.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.161 -0.962 . . . . 0.0 110.13 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' SER . 84.7 m-20 -76.81 4.87 8.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.034 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -65.61 -38.93 90.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.788 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -58.43 -26.66 63.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -106.04 -39.42 5.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 22' ' ' SER . 39.6 mt -69.25 -31.75 70.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 52.2 mt -61.65 -56.09 36.16 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.3 Cg_endo -68.39 -32.7 25.15 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.506 2.137 . . . . 0.0 111.624 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -59.48 -42.06 91.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.475 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.534 HG21 ' HB1' ' A' ' 148' ' ' ALA . 98.4 t -65.08 -33.84 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.502 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -47.89 165.64 0.22 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 49.4 Cg_endo -70.35 -162.61 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.664 2.242 . . . . 0.0 111.719 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 96.3 mt-30 -52.67 -31.61 38.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -65.86 131.05 45.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 109.456 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.517 ' CE2' ' O ' ' A' ' 37' ' ' GLN . 99.4 m-85 -114.39 156.12 25.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 109.508 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.0 p -127.85 163.46 24.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.534 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -129.94 151.47 50.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -138.81 142.31 38.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.463 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -124.15 145.43 49.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 82.3 m-20 -82.36 114.99 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 45' ' ' LEU . 19.2 tp -56.63 -49.07 76.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 53' ' ' THR . 20.5 mm-40 -152.02 -171.35 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 70.74 163.33 4.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -98.37 7.97 45.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.167 . . . . 0.0 109.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.772 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 107.68 8.33 30.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 75' ' ' ILE . . . -105.31 -145.08 13.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.69 122.71 9.4 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.654 2.236 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.521 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . 95.63 -1.12 63.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.779 ' C ' HD12 ' A' ' 54' ' ' ILE . 92.6 m -72.96 141.25 47.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -1.191 . . . . 0.0 109.481 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.779 HD12 ' C ' ' A' ' 53' ' ' THR . 1.6 mp -111.45 131.35 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 27.0 mttm -109.7 140.16 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 109.337 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -129.23 136.3 49.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.585 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 64.8 mt -111.31 134.23 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.39 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.8 m -120.92 138.44 54.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.444 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 45.9 p90 -140.83 -39.83 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.91 . . . . 0.0 109.542 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 65' ' ' PHE . . . -104.42 149.1 25.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.532 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -97.74 140.19 32.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.64 175.59 44.42 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -91.42 10.03 29.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -1.123 . . . . 0.0 109.541 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.61 -32.58 70.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.466 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CD2' ' HB1' ' A' ' 60' ' ' ALA . 98.4 m-85 -116.77 156.88 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.507 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -88.51 152.53 21.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.407 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -112.51 149.97 31.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.441 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 87.4 mtp -99.21 138.95 35.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.514 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -111.12 144.81 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.925 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 91.7 m-70 -127.04 134.64 50.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 87' ' ' ILE . 28.9 tttp -133.5 143.96 49.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.568 HG21 ' CG1' ' A' ' 75' ' ' ILE . 9.8 p -108.57 135.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.44 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 97.0 mt-10 -81.72 -43.49 18.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 92.5 mt-10 -158.84 142.37 15.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.606 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.568 ' CG1' HG21 ' A' ' 72' ' ' VAL . 77.5 mt -125.4 123.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 79' ' ' ASN . 25.9 t0 -125.69 91.72 3.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.623 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.447 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 87.8 m-70 -65.2 -41.09 94.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.504 ' O ' ' CE2' ' A' ' 80' ' ' PHE . . . -65.26 -40.43 93.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.46 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 56.3 t30 -79.33 -10.69 59.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' A' ' 78' ' ' ALA . 66.3 m-85 62.16 35.77 15.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.512 ' NZ ' ' OE1' ' A' ' 102' ' ' GLU . 73.0 tttt -128.87 122.53 30.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.294 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.556 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.4 t80 -117.66 116.7 27.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.434 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 51.1 t -117.64 123.66 46.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.209 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.2 p90 -140.31 167.35 22.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 47.3 t -137.06 169.84 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 mt -112.28 122.73 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.464 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 71' ' ' LYS . 73.9 mt -79.2 -38.39 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.301 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HA ' HD11 ' A' ' 92' ' ' LEU . 64.1 tt0 -139.81 135.46 33.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 91' ' ' PRO . . . -141.24 63.7 0.52 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 43.1 -100.97 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 93' ' ' GLY . 49.0 Cg_endo -70.07 -34.02 14.33 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.76 2.306 . . . . 0.0 111.864 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.405 HD11 ' HA ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER 54.77 -89.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.91 . . . . 0.0 109.479 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 178.19 -179.76 48.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -103.73 133.29 48.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -1.196 . . . . 0.0 109.523 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.661 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 59.47 22.99 11.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.699 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 122' ' ' TYR . 49.0 mt -110.65 95.95 5.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.949 . . . . 0.0 109.296 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 123' ' ' HIS . 90.0 mt-10 -48.02 -49.71 30.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.619 -0.675 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 23.9 mttp -156.47 169.77 23.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.755 HG23 ' CE1' ' A' ' 122' ' ' TYR . 55.9 mt -144.66 115.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 42.7 t -116.33 153.33 32.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 110.058 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.51 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 84.1 m-85 -125.22 133.49 52.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 108.994 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' OE1' ' NZ ' ' A' ' 81' ' ' LYS . 80.2 tt0 -111.94 136.9 50.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.813 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.01 127.87 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -126.27 130.92 51.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.448 ' HG2' HD22 ' A' ' 116' ' ' LEU . 63.3 mtt -115.18 130.77 57.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.884 . . . . 0.0 109.162 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.63 154.26 42.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.71 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' SER . . . -97.97 139.51 33.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 0.0 109.345 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 115' ' ' ILE . . . -116.25 116.78 39.43 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.0 -14.31 35.15 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.725 2.283 . . . . 0.0 111.802 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -57.3 -20.68 29.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.61 6.06 9.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 114' ' ' SER . . . -90.39 20.79 35.5 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.884 ' HA3' HG13 ' A' ' 13' ' ' VAL . . . 58.56 -80.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 112' ' ' GLY . 55.8 m -143.05 165.16 28.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -1.117 . . . . 0.0 109.418 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 108' ' ' ALA . 76.7 mt -128.61 133.43 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 50.0 mt -113.56 135.52 53.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -129.75 141.57 50.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 8' ' ' ASP . 73.2 mt -125.07 133.37 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 24.7 m -125.3 141.76 51.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.51 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 22.4 m -128.31 151.8 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.3 mttp -139.17 126.42 21.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.755 ' CE1' HG23 ' A' ' 99' ' ' ILE . 3.2 m-85 -121.21 112.74 19.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.388 -0.82 . . . . 0.0 109.536 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.606 ' HA ' HG22 ' A' ' 3' ' ' VAL . 50.1 m-70 -84.64 121.3 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.589 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -100.93 151.74 21.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.028 -1.045 . . . . 0.0 109.986 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -56.91 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.9 57.97 0.6 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.482 ' OD1' ' HA2' ' A' ' 2' ' ' GLY . 67.6 m-20 51.5 45.58 27.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -72.52 135.02 45.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.4 m -67.32 146.51 54.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.654 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.549 HG12 HD21 ' A' ' 96' ' ' LEU . 30.8 mt -111.28 130.37 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.69 139.76 55.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.191 -0.943 . . . . 0.0 109.609 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.0 mt-10 -67.8 -31.57 71.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.58 -41.89 95.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.97 -43.16 99.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 132' ' ' GLU . 42.4 pt -82.81 -31.87 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.345 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 58.6 tttm -56.24 -41.15 75.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.38 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.72 -45.42 74.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.392 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.69 -39.26 86.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -62.05 -42.15 98.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -1.139 . . . . 0.0 109.38 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -58.32 -43.71 88.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 109.325 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.929 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.06 -40.19 94.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.7 84.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.463 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.65 -37.94 95.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 142' ' ' ALA . 3.6 mt -61.97 -40.9 97.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -1.133 . . . . 0.0 109.414 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.53 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.2 m-85 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.239 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.75 -37.73 87.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.534 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -71.94 -47.43 52.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.385 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.604 HG13 ' N ' ' A' ' 150' ' ' GLU . 8.1 p -63.31 -47.18 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 149' ' ' VAL . 96.2 mt-10 -61.13 -42.69 98.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.28 76.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 54.8 t80 -61.15 -53.4 57.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 64.0 mt -57.62 -38.87 75.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 150' ' ' GLU . 7.1 mp -66.11 -47.14 75.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.18 -0.95 . . . . 0.0 109.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -55.06 -29.24 57.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.963 . . . . 0.0 109.277 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 49.18 66.18 6.06 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.588 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 50.1 Cg_endo -70.13 -1.75 9.31 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.579 2.186 . . . . 0.0 111.716 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -74.2 -28.36 61.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.35 149.94 46.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 109.418 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.446 ' O ' ' OXT' ' A' ' 161' ' ' CYS . 88.3 m-85 -63.34 -28.6 70.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.446 ' OXT' ' O ' ' A' ' 160' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.8 mmm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.274 0.559 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.04 9.9 59.09 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.713 HG21 ' CE1' ' A' ' 123' ' ' HIS . 17.9 t -123.25 134.98 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.166 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.643 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 96.5 m-85 -95.75 135.48 37.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -121.9 129.38 52.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 0.0 109.572 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.539 ' CZ ' ' CD1' ' A' ' 135' ' ' ILE . 97.9 m-85 -125.97 146.82 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.4 tt0 -116.78 137.38 52.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.585 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' A' ' 118' ' ' ILE . 67.7 t0 -115.25 130.38 56.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.342 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -105.06 131.16 52.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.728 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.02 125.56 22.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 109.069 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -112.77 135.09 53.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.814 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -160.25 152.3 20.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.156 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.2 p -91.74 90.79 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.919 HG21 HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -139.45 149.4 60.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 108.837 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.913 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.5 Cg_endo -67.81 126.41 14.6 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.266 1.977 . . . . 0.0 111.182 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.2 Cg_endo -66.44 -29.76 44.85 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.754 2.303 . . . . 0.0 112.333 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.01 7.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.552 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -72.26 -47.24 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.724 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 14' ' ' ILE . 15.0 tp -59.29 -46.96 87.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.761 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 77' ' ' HIS . 61.5 t80 -56.04 -48.04 76.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 0.0 109.668 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 30.8 mttm -69.15 -55.73 9.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 44.3 t -64.49 -19.1 65.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 109.983 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.936 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 78.1 t80 -100.2 -51.44 3.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.055 -1.028 . . . . 0.0 110.07 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 54.4 t -85.22 -52.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.831 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -62.26 -42.95 99.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.811 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.9 m-20 -97.67 18.61 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.71 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.936 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.78 -34.19 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 32' ' ' PRO . 85.1 m-20 -72.2 -27.22 62.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.417 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 84.2 m-20 -105.76 -42.32 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.945 . . . . 0.0 109.752 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 34' ' ' VAL . 15.8 tp -63.93 -32.15 73.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.746 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 39.5 mt -63.71 -57.34 19.73 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.085 -1.01 . . . . 0.0 109.408 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.5 Cg_endo -68.36 -42.3 5.64 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.604 2.202 . . . . 0.0 111.852 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -59.4 -41.3 89.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.58 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 30' ' ' LEU . 91.4 t -67.67 -39.2 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 109.489 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.86 157.91 56.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.398 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.572 ' O ' ' CE1' ' A' ' 38' ' ' HIS . 50.8 Cg_endo -69.87 -11.03 29.89 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.737 2.291 . . . . 0.0 111.81 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -61.8 144.98 53.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.5 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 36' ' ' PRO . 74.6 m80 -129.76 159.89 35.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.86 . . . . 0.0 109.502 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 38' ' ' HIS . 97.5 m-85 61.81 57.82 2.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 109.589 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.4 m -118.98 137.48 53.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.447 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.6 m -132.25 148.18 52.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.178 -0.951 . . . . 0.0 109.509 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.81 145.4 51.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -141.02 145.46 35.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.5 ' OD1' ' CD ' ' A' ' 55' ' ' LYS . 67.2 m-20 -82.33 112.55 19.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.3 tp -70.8 -35.48 72.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 53' ' ' THR . 85.9 tt0 -149.54 157.58 43.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.51 161.59 33.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -91.62 7.64 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.164 . . . . 0.0 109.479 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.77 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.03 18.75 11.69 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.71 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -115.24 -142.52 7.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.438 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.86 125.21 11.83 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.698 2.265 . . . . 0.0 111.74 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.675 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 89.37 -1.53 82.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.77 HG21 ' HA2' ' A' ' 49' ' ' GLY . 67.5 m -72.64 141.11 48.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 70' ' ' HIS . 24.8 mm -106.67 130.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.5 ' CD ' ' OD1' ' A' ' 44' ' ' ASN . 34.3 mmtp -102.35 147.86 26.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' HE3' ' CD ' ' A' ' 66' ' ' LYS . 18.3 tttm -123.9 137.62 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.517 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.501 HG12 ' CD2' ' A' ' 70' ' ' HIS . 22.7 mm -105.92 136.55 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.4 p -124.36 149.6 46.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.396 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -155.41 -70.02 0.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.983 . . . . 0.0 109.595 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.53 -164.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.34 -0.85 . . . . 0.0 109.613 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -97.3 136.91 37.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.44 41.42 0.02 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -55.73 -29.15 59.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -1.12 . . . . 0.0 109.428 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -48.5 -35.65 13.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -127.22 162.93 25.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.514 ' CD ' ' HE3' ' A' ' 56' ' ' LYS . 15.3 mmtt -97.27 121.56 39.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.44 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CD1' ' HG3' ' A' ' 68' ' ' MET . 58.9 t80 -63.19 -40.52 97.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 109.469 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.521 ' HG3' ' CD1' ' A' ' 67' ' ' TYR . 62.1 mtt -152.06 154.28 35.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.68 133.27 54.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.601 ' O ' HG23 ' A' ' 54' ' ' ILE . 75.5 m-70 -118.45 139.24 51.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.521 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 34.7 tttt -135.72 137.06 41.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.675 HG13 ' H ' ' A' ' 52' ' ' GLY . 11.8 p -104.73 130.09 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.49 -41.49 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 84.8 tt0 -176.36 139.79 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.71 HD12 ' HA2' ' A' ' 50' ' ' GLY . 68.5 mt -116.52 124.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -131.82 73.34 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 64.8 m170 -56.35 -37.48 70.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.48 70.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -92.32 8.3 38.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.499 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 74.7 m-85 51.74 28.32 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 0.0 109.477 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -123.92 136.81 54.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 71.4 t80 -133.78 133.6 41.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.6 m -135.58 120.04 18.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.2 p90 -135.97 166.25 23.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.53 ' O ' HD13 ' A' ' 86' ' ' ILE . 92.8 p -148.07 164.11 34.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 85' ' ' SER . 24.2 mm -116.1 120.1 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 71' ' ' LYS . 67.2 mt -77.65 -36.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -146.38 132.78 19.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.533 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 91' ' ' PRO . . . -144.48 85.39 0.18 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.74 -103.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.3 Cg_endo -70.2 -34.7 12.63 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.624 2.216 . . . . 0.0 111.524 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.611 HD11 HG12 ' A' ' 99' ' ' ILE . 9.6 tp 63.16 -71.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 164.14 166.45 23.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -90.78 124.75 35.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -1.105 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 57.57 16.14 3.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.643 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.0 ' HB3' HD11 ' A' ' 99' ' ' ILE . 32.4 mt -96.25 90.78 5.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.007 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 123' ' ' HIS . 79.6 mt-10 -47.05 -36.87 8.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.644 . . . . 0.0 110.529 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 1.042 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.4 tttt -164.68 156.99 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.75 -1.219 . . . . 0.0 110.356 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.042 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.3 mm -134.43 113.22 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.49 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 17.5 m -115.77 152.88 32.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.061 . . . . 0.0 110.087 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 119' ' ' THR . 84.3 m-85 -132.24 128.93 38.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 84.5 tt0 -104.89 139.82 39.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.841 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.81 122.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.113 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -130.24 136.33 49.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.967 . . . . 0.0 109.724 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.51 ' HE3' ' CD1' ' A' ' 23' ' ' PHE . 64.0 mtt -117.75 143.84 45.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -140.83 152.35 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 109.566 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.21 135.19 47.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.48 148.11 48.54 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.27 -31.09 23.42 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.666 2.244 . . . . 0.0 111.709 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -62.31 -28.32 69.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.51 -4.17 72.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -44.91 -49.25 9.21 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 175.3 -118.6 0.67 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -151.61 154.23 36.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -1.153 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.447 ' C ' HD12 ' A' ' 116' ' ' LEU . 67.5 mt -118.24 133.04 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.33 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.778 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.9 mp -111.15 135.78 51.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.424 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 18.6 mttt -122.61 135.76 54.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.271 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -119.75 136.8 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 109.627 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 26.2 m -117.98 142.56 47.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.31 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 73.4 m -120.65 151.73 39.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 28.2 mttp -139.78 129.1 24.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.05 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.952 ' CD1' HG23 ' A' ' 99' ' ' ILE . 15.4 m-85 -129.34 110.63 12.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.823 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.713 ' CE1' HG21 ' A' ' 3' ' ' VAL . 49.1 m-70 -81.06 113.38 19.21 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.0 OUTLIER -105.71 139.37 40.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.362 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 124' ' ' THR . 31.3 mttt -42.2 -47.93 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.421 -0.799 . . . . 0.0 109.631 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.42 -64.83 0.27 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.43 -30.34 71.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -63.0 148.24 48.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.5 m -132.43 150.36 52.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.801 HD11 HD21 ' A' ' 96' ' ' LEU . 22.4 mm -102.54 122.63 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -92.53 136.24 33.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.494 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 84.8 tt0 -55.62 -41.28 73.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.411 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.63 -40.39 95.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.38 -46.4 86.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.456 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.597 HG21 ' CG2' ' A' ' 130' ' ' ILE . 11.5 pt -80.1 -33.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 46.7 tttm -56.8 -33.9 67.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.855 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.55 74.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.325 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.09 92.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -56.98 -46.79 81.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.213 -1.169 . . . . 0.0 109.371 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.38 -46.1 87.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 145' ' ' LEU . 39.6 ttpt -58.87 -45.98 88.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.327 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.72 77.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . -60.16 -41.92 93.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.97 89.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.617 HD12 ' H ' ' A' ' 145' ' ' LEU . 6.6 mp -64.22 -38.37 90.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -1.13 . . . . 0.0 109.369 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.502 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.8 t80 -63.8 -44.52 93.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.384 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 143' ' ' ALA . 20.3 mmtt -62.41 -38.26 89.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.419 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.39 76.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.337 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 146' ' ' PHE . 4.7 p -65.23 -40.37 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.32 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 84.7 tt0 -60.22 -40.89 91.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.365 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.43 98.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.606 ' CZ ' ' CG ' ' A' ' 157' ' ' PRO . 54.6 t80 -62.28 -44.72 95.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.892 . . . . 0.0 109.343 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.488 ' HA ' HD12 ' A' ' 153' ' ' LEU . 25.8 tp -57.77 -38.76 76.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.4 mt -71.02 -43.17 68.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -56.72 -27.16 58.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.978 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.5 OUTLIER 43.49 55.97 11.99 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.529 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.606 ' CG ' ' CZ ' ' A' ' 152' ' ' TYR . 49.6 Cg_endo -70.35 -17.91 34.56 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.736 2.291 . . . . 0.0 111.813 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -93.7 11.06 30.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.57 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.23 143.83 57.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 0.0 109.416 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -125.58 136.54 53.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.442 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.276 0.56 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.03 -24.56 60.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 123' ' ' HIS . 29.7 t -130.44 136.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -1.168 . . . . 0.0 109.417 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.674 ' HE1' HG21 ' A' ' 124' ' ' THR . 93.6 m-85 -104.15 136.09 44.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.0 m -113.72 114.65 26.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 4' ' ' PHE . 33.1 m-85 -112.75 138.48 49.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 94.3 mt-10 -112.37 156.5 22.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.674 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -124.05 143.4 50.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.356 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -109.96 135.81 50.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -152.39 123.86 7.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.156 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.5 m -117.9 131.53 56.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -160.32 144.69 14.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.268 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.677 ' O ' HG23 ' A' ' 13' ' ' VAL . 33.4 m -78.08 91.25 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.436 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.847 HG21 HD13 ' A' ' 19' ' ' LEU . 24.5 mt -139.0 144.29 40.58 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.443 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.717 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.4 Cg_endo -67.93 120.41 7.41 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.499 2.132 . . . . 0.0 111.368 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 45.6 Cg_endo -67.0 -27.31 42.76 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.818 2.345 . . . . 0.0 112.263 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -54.34 6.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 22' ' ' SER . 62.8 mtt85 -72.15 -42.89 65.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.847 HD13 HG21 ' A' ' 14' ' ' ILE . 32.9 tp -59.98 -47.45 85.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.694 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.507 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 47.1 t80 -59.23 -52.0 67.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 25' ' ' LEU . 46.2 mttp -69.14 -29.36 67.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.773 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 83.5 p -84.16 -28.12 27.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.694 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.862 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 84.7 t80 -100.76 -48.45 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.89 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.7 t -84.42 -52.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.424 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 21' ' ' LYS . 12.5 tp -74.95 -26.03 59.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 110.024 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 22' ' ' SER . 85.5 m-20 -113.74 27.11 9.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 109.585 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.862 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.68 -42.13 74.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.512 ' HA ' HD12 ' A' ' 31' ' ' ILE . 56.0 t0 -62.63 -32.52 73.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -93.69 -31.38 14.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.857 . . . . 0.0 109.389 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 15.9 tp -75.35 -25.8 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 27' ' ' ALA . 12.3 mt -59.62 -56.53 34.89 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.45 -31.38 27.68 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.466 2.111 . . . . 0.0 111.661 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -59.13 -41.5 88.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.432 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.7 t -58.97 -39.53 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -123.62 82.54 53.97 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.173 -0.954 . . . . 0.0 109.592 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.67 -15.86 33.7 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.683 2.255 . . . . 0.0 111.752 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -59.94 -31.24 69.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.507 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -126.8 133.83 50.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.32 133.34 51.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.7 p -127.81 160.95 30.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.315 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 m -129.74 149.91 51.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.601 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.19 145.27 51.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -132.02 144.5 50.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.451 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 89.9 m-20 -88.29 112.1 22.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 56' ' ' LYS . 2.0 mp -66.86 -37.79 85.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 53' ' ' THR . 82.4 tt0 -149.64 155.55 40.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.515 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 89.55 159.68 35.69 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -92.35 6.77 45.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.517 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.624 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 107.25 18.44 10.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -113.25 -145.97 9.49 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.4 Cg_endo -70.03 121.42 8.05 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.706 2.271 . . . . 0.0 111.725 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.69 67.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.624 HG21 ' HA2' ' A' ' 49' ' ' GLY . 52.4 m -79.47 135.07 36.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.18 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.461 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 19.4 mm -95.29 136.28 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.207 -0.933 . . . . 0.0 109.513 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 45.3 mttm -119.9 133.51 55.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.744 ' HB2' HD11 ' A' ' 45' ' ' LEU . 30.5 tttm -107.36 142.1 37.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.527 HG12 ' ND1' ' A' ' 70' ' ' HIS . 26.3 mm -110.62 138.01 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.0 m -131.02 142.84 50.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.398 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.487 ' CE2' HG22 ' A' ' 57' ' ' ILE . 15.5 m-85 -112.99 149.56 33.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.96 -33.18 72.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.195 -0.941 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.7 -30.77 69.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.441 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.37 -95.03 1.05 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 59.23 43.49 16.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -1.094 . . . . 0.0 109.501 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.459 ' O ' ' CZ ' ' A' ' 67' ' ' TYR . 86.7 tt0 -54.71 -37.56 65.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -49.47 -44.25 45.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -87.36 136.45 32.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.488 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CZ ' ' O ' ' A' ' 64' ' ' GLU . 87.1 m-85 -123.43 138.55 54.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.609 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.497 ' CE ' ' HA2' ' A' ' 89' ' ' GLY . 94.3 mmm -113.9 141.94 46.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 109.334 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.98 129.5 48.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.955 . . . . 0.0 109.677 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.527 ' ND1' HG12 ' A' ' 57' ' ' ILE . 80.8 m80 -128.32 126.67 41.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.359 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 18.0 tttm -123.6 145.42 48.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 HG13 ' A' ' 75' ' ' ILE . 46.9 t -90.39 129.58 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 83.9 tt0 -79.88 -37.46 34.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.506 ' N ' ' HB2' ' A' ' 83' ' ' CYS . 80.8 tt0 -179.12 144.31 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.024 HD12 ' HA2' ' A' ' 50' ' ' GLY . 27.5 mt -127.39 119.16 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 79' ' ' ASN . 29.4 t0 -127.11 86.88 2.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -66.88 -32.31 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.84 81.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 15.8 m-20 -96.04 2.25 53.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 59.07 22.33 10.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 109.454 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.472 ' HG2' ' HB2' ' A' ' 104' ' ' LYS . 33.9 mttt -110.97 130.46 55.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 75' ' ' ILE . 25.8 t80 -125.13 129.14 49.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.952 . . . . 0.0 109.673 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.506 ' HB2' ' N ' ' A' ' 74' ' ' GLU . 35.9 m -109.39 131.92 54.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.228 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -120.89 139.53 53.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.668 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 20.2 t -127.2 142.81 51.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 99' ' ' ILE . 24.1 mt -117.97 127.45 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.68 -36.66 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -154.65 130.75 10.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.461 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.497 ' HA2' ' CE ' ' A' ' 68' ' ' MET . . . -145.89 106.07 0.36 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 44.33 -119.3 2.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.8 Cg_endo -70.13 -25.08 27.25 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.644 2.229 . . . . 0.0 111.671 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.767 HD11 HG12 ' A' ' 99' ' ' ILE . 14.2 tp 62.39 -75.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.61 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.788 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . 165.94 171.04 31.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -95.33 123.6 38.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -1.159 . . . . 0.0 109.53 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 124' ' ' THR . 1.4 m 64.08 11.25 6.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.488 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.788 HD12 ' HA3' ' A' ' 93' ' ' GLY . 93.9 mt -94.81 92.11 6.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.311 -0.868 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' HIS . 46.3 mt-10 -49.1 -40.27 31.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.751 -0.593 . . . . 0.0 110.963 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.643 ' O ' HD13 ' A' ' 99' ' ' ILE . 95.0 mttt -158.12 156.57 31.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.855 HG23 ' CE1' ' A' ' 122' ' ' TYR . 33.3 mm -133.18 113.0 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 29.7 t -113.68 150.08 33.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 84' ' ' TYR . 91.2 m-85 -129.08 130.69 46.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 85.1 tt0 -108.76 137.98 45.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.758 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.0 mt -124.12 124.54 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.299 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HE3' ' HD2' ' A' ' 117' ' ' LYS . 41.3 pttt -134.86 149.52 50.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.41 ' HG2' HD22 ' A' ' 116' ' ' LEU . 64.4 mtt -115.42 145.22 42.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.44 155.47 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.79 148.09 38.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . -111.23 106.81 57.38 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.47 -48.19 0.84 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.709 2.273 . . . . 0.0 111.787 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -77.63 -47.3 19.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 109.517 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.58 -27.68 72.2 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.21 -28.17 6.97 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 108' ' ' ALA . . . -100.88 -133.64 8.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.0 t -125.22 157.96 35.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 108' ' ' ALA . 66.6 mt -117.03 136.99 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 36.8 mt -106.24 136.2 46.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.649 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.489 ' HD2' ' HE3' ' A' ' 104' ' ' LYS . 77.1 mttt -130.66 144.58 51.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.122 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.5 mt -132.64 140.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 0.0 109.999 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 20.6 m -120.54 142.31 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 100' ' ' SER . 0.1 OUTLIER -118.98 146.62 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 100' ' ' SER . 37.3 ttpt -126.02 112.2 15.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 109.32 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.855 ' CE1' HG23 ' A' ' 99' ' ' ILE . 3.5 m-85 -109.74 108.51 18.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.7 ' HA ' HG22 ' A' ' 3' ' ' VAL . 4.9 t60 -83.79 121.79 27.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.674 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.3 p -113.08 143.93 43.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.991 -1.068 . . . . 0.0 109.765 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -70.19 153.33 43.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.59 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 47.59 -131.43 16.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -114.45 41.53 2.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.183 . . . . 0.0 109.385 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -65.05 150.08 48.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.448 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 96.6 p -114.65 155.48 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.665 HG12 HD21 ' A' ' 96' ' ' LEU . 58.3 mt -113.04 141.5 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -89.13 141.24 28.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.3 mt-10 -65.48 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 23.1 pt-20 -65.7 -41.74 92.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.457 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 133' ' ' GLU . 83.9 tt0 -61.3 -41.54 97.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 132' ' ' GLU . 47.8 pt -85.05 -29.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 34.0 tttt -55.76 -45.56 78.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.05 78.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.217 -0.927 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.99 -35.08 90.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.09 -44.16 95.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.29 -39.9 94.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.865 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -63.25 -41.05 99.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.939 . . . . 0.0 109.434 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.575 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -71.0 -36.67 72.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.446 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.61 95.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.42 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.45 -38.93 95.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.527 ' O ' HG12 ' A' ' 149' ' ' VAL . 25.1 tp -65.53 -41.2 93.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -1.154 . . . . 0.0 109.442 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.575 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 16.6 m-85 -65.13 -45.95 82.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -62.83 -37.57 87.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.67 -51.45 56.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.415 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -64.43 -47.53 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.597 ' N ' HG13 ' A' ' 149' ' ' VAL . 87.8 mt-10 -58.66 -38.84 79.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.4 -41.25 89.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.376 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -62.87 -38.59 91.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.09 -43.95 87.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 154' ' ' LEU . 6.6 mp -73.64 -40.83 63.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.23 -15.95 63.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.1 74.65 30.39 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.38 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.7 -4.11 13.99 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.707 2.271 . . . . 0.0 111.943 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -106.0 8.46 32.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.483 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.68 146.09 37.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.396 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.71 -38.09 86.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.414 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.419 179.983 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.59 87.33 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.611 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.2 p -120.19 138.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -1.077 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.817 ' CE2' HG21 ' A' ' 124' ' ' THR . 96.4 m-85 -98.6 146.03 26.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 25.7 p -132.09 128.13 37.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.514 ' O ' HG23 ' A' ' 119' ' ' THR . 90.9 m-85 -122.21 151.99 40.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 117' ' ' LYS . 95.9 mt-10 -118.48 145.61 45.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -123.01 145.82 48.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -121.81 137.34 54.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.59 122.97 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.092 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 1.069 HG22 HG23 ' A' ' 115' ' ' ILE . 59.4 p -123.82 143.21 50.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.534 ' OG ' ' CD1' ' A' ' 14' ' ' ILE . 98.9 p -160.28 149.36 17.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 108.933 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 13' ' ' VAL . 33.6 m -66.2 90.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.021 . . . . 0.0 109.341 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.979 HG21 HD22 ' A' ' 19' ' ' LEU . 5.5 mt -139.36 142.29 31.88 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.32 -0.862 . . . . 0.0 109.341 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.3 Cg_endo -67.92 122.33 9.44 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 122.356 2.037 . . . . 0.0 111.197 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.79 -34.02 32.36 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.702 2.268 . . . . 0.0 112.209 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.64 11.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.994 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -72.15 -37.94 69.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 110.126 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.979 HD22 HG21 ' A' ' 14' ' ' ILE . 32.0 tp -67.0 -51.06 59.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.929 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.638 ' CE2' HG21 ' A' ' 24' ' ' VAL . 67.7 t80 -56.25 -46.89 79.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 25.3 mttt -67.99 -49.56 60.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.139 -0.975 . . . . 0.0 109.879 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 88.7 p -71.49 -20.1 62.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.936 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.966 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 24.0 t80 -100.48 -51.12 3.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.16 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.638 HG21 ' CE2' ' A' ' 20' ' ' PHE . 54.9 t -85.11 -52.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -0.939 . . . . 0.0 110.128 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.704 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -67.08 -49.3 65.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.0 m-20 -89.52 20.23 4.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.18 -50.63 53.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.062 -1.024 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.701 ' HA ' HD12 ' A' ' 31' ' ' ILE . 91.7 m-20 -63.43 -32.07 73.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.955 . . . . 0.0 109.798 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.414 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 94.5 m-20 -88.91 -34.69 16.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 34' ' ' VAL . 16.1 tp -74.89 -26.54 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.662 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 28' ' ' ASP . 12.9 mt -56.02 -57.14 23.86 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.6 Cg_endo -68.38 -35.19 18.87 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.548 2.166 . . . . 0.0 111.672 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 21.7 mttm -62.7 -31.85 72.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.417 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.686 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 77.2 t -68.66 -33.47 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.494 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 34' ' ' VAL . . . 75.98 51.19 0.2 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.2 Cg_endo -70.13 152.14 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.718 2.279 . . . . 0.0 111.766 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -56.7 -35.72 68.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.372 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -122.52 176.18 6.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 109.352 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.855 ' HD1' HD13 ' A' ' 57' ' ' ILE . 67.9 m-85 55.17 53.07 10.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.393 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.0 m -63.46 -41.85 98.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 82.3 p -151.9 155.37 37.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.572 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.58 148.12 32.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.925 . . . . 0.0 109.446 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 56' ' ' LYS . 93.6 mt-10 -134.21 157.05 47.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 35.7 p-10 -87.96 112.11 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.466 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 45' ' ' LEU . 24.1 tp -73.64 -36.24 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 53' ' ' THR . 85.9 tt0 -143.1 154.96 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 91.12 159.26 35.47 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.9 8.26 38.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.49 20.39 13.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.594 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -117.67 -145.39 7.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.42 125.31 12.16 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.89 -1.51 80.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.605 HG21 ' HA2' ' A' ' 49' ' ' GLY . 96.2 m -73.59 139.98 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 109.471 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.8 mm -103.39 134.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 4.0 mtmp? -110.45 156.53 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' GLU . 52.5 tttt -130.91 128.66 40.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 109.353 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.855 HD13 ' HD1' ' A' ' 39' ' ' PHE . 70.5 mt -111.87 137.5 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.527 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.2 m -119.16 141.63 48.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CE1' HG22 ' A' ' 57' ' ' ILE . 19.6 m-85 -112.21 149.48 32.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 109.513 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.41 -26.21 68.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.496 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.33 163.21 13.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.453 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.63 -170.78 37.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 65' ' ' PHE . 52.6 p-10 -141.52 -176.8 4.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 109.414 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -62.54 -29.49 70.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.15 -0.969 . . . . 0.0 109.393 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.574 ' O ' ' CE1' ' A' ' 67' ' ' TYR . 62.7 t80 -46.97 -47.51 21.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 109.349 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -69.47 132.41 46.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.93 . . . . 0.0 109.439 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 65' ' ' PHE . 88.4 m-85 -125.63 135.43 52.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.58 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.8 mtp -116.12 152.79 32.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.402 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -134.65 129.01 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.504 ' CE1' HD12 ' A' ' 57' ' ' ILE . 93.9 m-70 -127.34 129.12 47.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.401 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.483 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 14.9 tttp -127.5 146.01 50.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.572 HG11 ' O ' ' A' ' 50' ' ' GLY . 14.8 p -108.43 138.72 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -75.71 -44.16 43.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -173.59 143.49 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.594 HD12 ' HA2' ' A' ' 50' ' ' GLY . 70.4 mt -119.36 118.68 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.9 m-20 -125.04 78.36 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.578 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 98.1 m-70 -59.18 -34.62 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.63 66.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 80.7 m-20 -94.27 9.49 37.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.584 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 68.5 m-85 48.34 36.36 6.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -131.29 129.72 41.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.955 . . . . 0.0 109.346 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 61.3 t80 -126.12 122.81 36.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.989 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.6 117.77 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.49 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 35.1 p90 -134.84 167.25 21.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.6 p -145.99 175.23 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.337 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 mt -129.34 126.44 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.451 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.8 mt -78.81 -42.66 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.536 ' HA ' HD11 ' A' ' 92' ' ' LEU . 76.0 tt0 -143.48 137.12 28.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -162.68 105.4 0.26 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 44.69 -130.74 7.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 51.3 Cg_endo -69.9 -22.36 31.57 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.615 2.21 . . . . 0.0 111.804 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.552 HD23 HG13 ' A' ' 99' ' ' ILE . 0.3 OUTLIER 70.35 -81.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.86 -160.77 17.67 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -110.74 115.23 29.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -1.145 . . . . 0.0 109.465 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 58.17 16.65 4.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.923 HD22 ' CB ' ' A' ' 122' ' ' TYR . 28.0 mt -96.94 90.49 5.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.315 -0.865 . . . . 0.0 109.509 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 123' ' ' HIS . 89.8 mt-10 -43.59 -37.97 2.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.599 -0.688 . . . . 0.0 110.523 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' O ' HD13 ' A' ' 99' ' ' ILE . 68.2 mttm -145.67 158.06 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.818 -1.176 . . . . 0.0 110.466 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.733 HG23 ' CD1' ' A' ' 122' ' ' TYR . 20.5 mm -135.21 119.29 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -122.52 154.55 37.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 0.0 109.808 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -132.99 137.46 46.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.374 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 119' ' ' THR . 80.0 tt0 -113.47 141.83 46.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 103' ' ' ILE . 61.3 mt -128.79 118.7 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.302 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -131.53 126.39 34.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.487 ' CE ' ' HA ' ' A' ' 20' ' ' PHE . 75.9 mtm -120.21 150.95 39.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.05 150.82 26.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 138.43 53.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.18 146.04 86.52 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.85 -30.6 21.58 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.621 2.214 . . . . 0.0 111.961 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -128.72 138.04 51.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.65 -23.52 34.92 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.46 33.15 61.43 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . -102.59 -133.14 7.92 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 32.2 t -151.73 149.65 29.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -1.179 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.069 HG23 HG22 ' A' ' 11' ' ' THR . 64.5 mt -111.77 133.98 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.6 mp -106.37 130.9 54.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.731 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 7' ' ' GLU . 37.6 tttm -124.62 135.71 53.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.115 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 69.4 mt -129.04 123.55 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.838 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 6' ' ' TYR . 46.8 m -122.52 131.24 53.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.375 -0.828 . . . . 0.0 109.032 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' OH ' ' A' ' 122' ' ' TYR . 1.8 m -114.34 160.76 18.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 109.969 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 44.8 mttp -143.08 123.9 14.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.923 ' CB ' HD22 ' A' ' 96' ' ' LEU . 5.6 m-85 -122.34 122.76 39.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 97' ' ' GLU . 21.4 m80 -85.31 113.9 21.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 108.82 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.817 HG21 ' CE2' ' A' ' 4' ' ' PHE . 1.3 p -94.42 148.39 22.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.679 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.452 ' HG2' ' OE2' ' A' ' 97' ' ' GLU . 32.8 mttm -67.27 145.3 55.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.02 -129.63 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -110.32 31.16 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.556 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.87 144.82 26.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 130' ' ' ILE . 83.9 p -95.61 171.63 8.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.633 HD11 ' CG2' ' A' ' 124' ' ' THR . 38.5 mm -118.72 121.89 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -59.18 119.69 7.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.483 ' HA ' HG13 ' A' ' 135' ' ' ILE . 97.0 mt-10 -54.27 -36.73 63.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.3 -35.95 82.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.215 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.44 -25.93 67.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.639 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.483 HG13 ' HA ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -87.9 -35.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.208 -0.932 . . . . 0.0 109.049 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -57.45 -44.27 84.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.688 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.83 -43.24 72.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.452 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.86 92.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -57.99 -47.11 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -1.087 . . . . 0.0 109.343 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.43 -40.11 93.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -58.56 -45.45 88.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -38.64 85.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.86 99.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.26 -45.98 92.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.01 -38.39 79.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -1.197 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.478 ' O ' HG12 ' A' ' 149' ' ' VAL . 70.2 t80 -61.65 -41.57 97.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -60.42 -40.06 89.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.328 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.12 80.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 146' ' ' PHE . 5.7 p -67.32 -39.98 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.45 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.2 tt0 -63.73 -38.61 91.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.73 97.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.351 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.6 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 71.1 t80 -59.55 -48.89 79.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.3 mt -61.68 -38.8 89.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 109.38 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 154' ' ' LEU . 20.6 tp -63.76 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.67 68.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.547 ' CE1' ' OD2' ' A' ' 158' ' ' ASP . 46.9 t-80 49.74 61.6 13.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.883 . . . . 0.0 109.415 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.6 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 49.8 Cg_endo -69.69 -13.79 35.36 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.712 2.275 . . . . 0.0 111.736 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.547 ' OD2' ' CE1' ' A' ' 156' ' ' HIS . 55.6 p30 -88.84 12.46 15.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.396 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.76 147.37 53.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -62.71 -33.92 76.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.516 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.248 0.546 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 124' ' ' THR . . . -133.2 167.4 23.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.797 HG22 ' ND1' ' A' ' 123' ' ' HIS . 38.6 t -125.21 132.68 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.17 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.605 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 97.3 m-85 -95.44 130.52 42.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.181 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 t -110.59 125.04 52.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.474 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.605 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 93.7 m-85 -125.41 144.51 50.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.315 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 91.5 mt-10 -125.15 160.98 27.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.737 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 60.4 t0 -134.42 142.45 47.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.162 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.33 138.89 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.903 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.69 121.56 8.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.151 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.9 m -112.5 133.07 54.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.004 . . . . 0.0 109.971 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 14' ' ' ILE . 4.8 t -160.41 139.59 10.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.786 . . . . 0.0 109.026 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 13' ' ' VAL . 28.2 m -68.59 91.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.04 . . . . 0.0 109.36 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.852 HG21 HD13 ' A' ' 19' ' ' LEU . 1.6 mt -138.89 143.84 39.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.216 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.686 ' HD2' HG22 ' A' ' 14' ' ' ILE . 46.3 Cg_endo -68.24 127.86 16.53 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.409 2.073 . . . . 0.0 111.259 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.88 -34.64 29.57 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.723 2.282 . . . . 0.0 112.199 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.12 -50.96 11.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.634 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.45 ' HB2' ' HG2' ' A' ' 15' ' ' PRO . 42.0 mtt-85 -70.42 -45.98 64.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.853 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.852 HD13 HG21 ' A' ' 14' ' ' ILE . 40.5 tp -59.91 -48.44 81.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 80' ' ' PHE . 65.9 t80 -52.41 -51.77 57.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.592 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 33.3 mttt -67.45 -57.57 6.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.881 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 46.6 m -62.03 -20.43 63.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.969 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.3 t80 -100.11 -51.27 3.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.993 -1.067 . . . . 0.0 110.095 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 51.7 t -84.93 -51.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 17.8 tp -66.42 -40.48 89.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.835 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.6 m-20 -99.8 20.44 14.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.722 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.63 -34.55 74.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 32' ' ' PRO . 89.3 m-20 -68.17 -32.38 72.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.857 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.415 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 89.3 m-20 -101.6 -42.07 6.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.129 -0.982 . . . . 0.0 109.76 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.644 ' O ' HG23 ' A' ' 34' ' ' VAL . 17.6 tp -56.3 -36.8 69.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.753 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.527 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 17.8 mt -63.65 -58.84 13.48 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.492 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.527 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.26 -30.22 31.08 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.539 2.159 . . . . 0.0 111.777 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.52 -37.77 87.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.516 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 30' ' ' LEU . 79.0 t -61.23 -46.55 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -142.41 158.9 59.74 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.552 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 50.4 Cg_endo -70.5 142.97 45.95 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.756 2.304 . . . . 0.0 111.8 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.446 ' NE2' HG22 ' A' ' 31' ' ' ILE . 93.5 mt-30 -116.15 154.66 29.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.4 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -56.13 -36.13 67.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.668 ' CD1' HG21 ' A' ' 57' ' ' ILE . 80.5 m-85 -84.75 141.88 30.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.868 . . . . 0.0 109.471 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 81.4 m -68.38 -42.26 79.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.385 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 p -162.92 166.01 24.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.2 155.54 24.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HG3' ' CG2' ' A' ' 58' ' ' THR . 98.2 mt-10 -125.81 165.26 19.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 109.38 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' ILE . 50.9 t30 -91.33 115.29 27.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.695 HD23 HG21 ' A' ' 54' ' ' ILE . 16.6 tp -63.87 -40.26 96.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.167 -0.958 . . . . 0.0 109.422 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 47' ' ' GLY . 53.1 tt0 -170.95 162.4 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.425 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 94.74 162.54 34.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -95.03 6.16 49.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.573 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.516 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.6 19.28 11.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.963 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -117.4 -145.72 8.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.57 125.49 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.722 2.282 . . . . 0.0 111.826 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.55 -1.83 79.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.516 HG21 ' HA2' ' A' ' 49' ' ' GLY . 31.9 m -73.68 137.22 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -1.18 . . . . 0.0 109.452 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.787 HG23 ' O ' ' A' ' 70' ' ' HIS . 4.7 mt -109.78 139.0 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.517 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 68.6 mttm -112.01 149.07 32.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HD2' HD13 ' A' ' 45' ' ' LEU . 22.7 tttt -132.95 147.24 52.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.378 -0.827 . . . . 0.0 109.33 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.668 HG21 ' CD1' ' A' ' 39' ' ' PHE . 41.4 mt -97.61 137.63 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.46 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.492 ' CG2' ' HG3' ' A' ' 43' ' ' GLU . 33.8 p -75.37 150.64 38.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.57 165.79 13.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' GLU . . . -140.57 141.49 35.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.433 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 60' ' ' ALA . 94.5 mt-10 60.75 123.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 63' ' ' ASN . . . 62.05 -95.48 0.11 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 7.8 m-20 68.35 12.69 8.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -1.15 . . . . 0.0 109.498 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.415 ' O ' ' CE2' ' A' ' 67' ' ' TYR . 77.0 mm-40 -72.63 -30.91 64.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.93 . . . . 0.0 109.449 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -127.21 -177.15 3.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.87 . . . . 0.0 109.468 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 mttt 64.14 74.57 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.905 . . . . 0.0 109.474 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 64' ' ' GLU . 90.1 m-85 -108.78 147.18 32.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.469 ' CE ' ' HA2' ' A' ' 89' ' ' GLY . 81.0 mmm -119.69 147.55 44.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.393 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.582 ' O ' HG23 ' A' ' 86' ' ' ILE . 80.1 mttt -134.25 131.71 38.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.399 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.787 ' O ' HG23 ' A' ' 54' ' ' ILE . 79.6 m80 -125.99 140.54 52.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.955 . . . . 0.0 109.612 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -138.24 140.75 39.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 109.362 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 50.1 t -100.77 138.57 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.5 tt0 -84.07 -56.85 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.384 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.4 mt-10 -158.78 141.64 14.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.454 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.963 HD12 ' HA2' ' A' ' 50' ' ' GLY . 74.0 mt -118.87 128.61 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 85.7 m-20 -128.79 81.25 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -58.93 -36.5 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.93 74.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -85.53 6.96 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.545 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 92.0 m-85 49.44 33.0 5.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -127.82 139.72 52.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.531 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 67.1 t80 -126.46 131.4 51.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.7 m -128.39 117.05 20.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.439 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.531 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.6 p90 -139.84 157.47 45.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.483 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 83.9 p -137.71 174.17 10.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.582 HG23 ' O ' ' A' ' 69' ' ' LYS . 12.6 mt -124.62 128.21 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.47 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 72.9 mt -74.86 -37.61 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.867 . . . . 0.0 109.593 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.443 ' HA ' HD11 ' A' ' 92' ' ' LEU . 94.9 mt-10 -143.44 131.04 21.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.555 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.469 ' HA2' ' CE ' ' A' ' 68' ' ' MET . . . -137.42 75.19 0.39 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 44.45 -111.28 0.47 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.5 Cg_endo -69.59 -31.91 20.32 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.745 2.296 . . . . 0.0 111.696 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.543 ' CD2' HG12 ' A' ' 99' ' ' ILE . 0.4 OUTLIER 61.7 -85.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.59 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . -174.82 -166.85 33.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -104.13 126.15 51.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -1.147 . . . . 0.0 109.491 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.668 HG21 ' CB ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 52.76 20.74 1.67 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.99 HD22 ' HB3' ' A' ' 122' ' ' TYR . 22.3 mt -94.7 90.49 6.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.3 mt-10 -46.24 -40.19 11.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.591 -0.693 . . . . 0.0 110.595 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.821 ' O ' HD13 ' A' ' 99' ' ' ILE . 55.7 tttp -155.88 154.39 31.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.634 -1.291 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.842 HD11 ' HB3' ' A' ' 96' ' ' LEU . 24.1 mm -129.41 118.51 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 120' ' ' SER . 44.8 m -119.52 148.13 43.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 109.945 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.542 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 73.6 m-85 -125.55 140.82 52.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.162 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 119' ' ' THR . 84.5 tt0 -124.4 132.86 53.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.696 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.503 HG21 ' HE1' ' A' ' 23' ' ' PHE . 11.1 mm -109.04 126.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.273 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -130.62 133.22 45.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.724 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.549 ' CE ' ' CD1' ' A' ' 23' ' ' PHE . 64.2 mtt -117.55 146.83 43.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.315 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.87 157.76 44.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.3 136.99 34.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.76 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -71.69 168.66 20.32 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.5 Cg_endo -69.4 144.27 55.41 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 122.644 2.229 . . . . 0.0 111.826 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 57.69 -89.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 109' ' ' PRO . . . -155.47 22.48 0.56 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -47.86 -45.28 25.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.73 ' H ' ' HB3' ' A' ' 108' ' ' ALA . . . 153.69 -116.1 0.71 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 22.5 t -155.13 145.38 21.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.475 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.409 ' C ' HD12 ' A' ' 116' ' ' LEU . 67.9 mt -116.12 128.7 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.765 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.1 mp -108.44 135.67 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 68.1 mttm -126.6 135.34 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 77.0 mt -119.61 131.08 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 30.8 m -119.85 142.69 48.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' SER . 1.4 m -128.02 156.62 42.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.826 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -133.59 108.99 8.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.838 . . . . 0.0 108.973 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.99 ' HB3' HD22 ' A' ' 96' ' ' LEU . 8.4 m-30 -105.27 118.91 37.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.797 ' ND1' HG22 ' A' ' 3' ' ' VAL . 2.1 m-70 -84.94 134.13 34.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 108.912 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.656 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 12.8 t -113.56 144.82 42.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 126' ' ' GLY . 22.9 mttp -72.09 139.77 48.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.51 -142.35 3.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' ALA . 73.0 m-20 -85.9 10.67 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.668 ' CB ' HG21 ' A' ' 95' ' ' THR . . . -44.12 146.96 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -115.88 161.89 18.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 96' ' ' LEU . 55.8 mt -104.06 139.08 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.46 118.45 7.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.567 ' HA ' HG13 ' A' ' 135' ' ' ILE . 88.1 tt0 -57.72 -34.57 69.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.46 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -56.33 -42.39 77.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.91 -25.09 67.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.591 HD13 ' CE1' ' A' ' 6' ' ' TYR . 2.9 mt -69.49 -52.34 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 108.947 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -55.65 -41.34 73.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.43 86.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.238 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.2 -36.09 80.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.51 -40.27 95.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -1.177 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.39 -35.23 79.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -63.3 -39.72 95.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 109.567 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.6 76.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.909 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.84 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.595 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.31 -48.2 76.83 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.713 ' O ' HG12 ' A' ' 149' ' ' VAL . 64.7 mt -68.26 -37.92 81.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -1.188 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.427 ' HE2' HD22 ' A' ' 116' ' ' LEU . 71.0 t80 -63.5 -45.72 89.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.569 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -63.05 -37.77 88.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.2 38.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.606 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 145' ' ' LEU . 7.5 p -66.13 -40.04 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.475 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.6 tt0 -61.97 -39.16 91.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.554 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -65.89 -41.79 91.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.491 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 153' ' ' LEU . 32.9 tp -61.53 -38.0 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.14 -0.975 . . . . 0.0 109.374 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 154' ' ' LEU . 33.8 mt -77.98 -30.89 50.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.08 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.38 67.48 80.32 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.69 -2.77 11.38 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.705 2.27 . . . . 0.0 111.834 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -104.66 9.83 35.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.554 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -46.05 145.41 1.56 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.424 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -62.16 -34.38 76.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 18' ' ' ARG . 1.4 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 124' ' ' THR . . . 68.95 -127.65 22.26 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.679 HG22 ' HA ' ' A' ' 123' ' ' HIS . 52.4 t -126.85 135.5 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.149 . . . . 0.0 109.471 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.611 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 97.9 m-85 -91.71 128.25 37.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.364 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.8 t -113.56 123.86 50.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.63 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.912 ' CG ' HG21 ' A' ' 135' ' ' ILE . 92.4 m-85 -122.86 146.09 47.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 83.9 tt0 -121.94 131.39 53.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.947 . . . . 0.0 109.645 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.88 124.87 45.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -97.07 134.63 40.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.89 124.81 8.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.405 HG23 HG12 ' A' ' 115' ' ' ILE . 34.8 m -118.39 132.49 56.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -160.51 135.47 7.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.137 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 13' ' ' VAL . 24.1 m -64.99 91.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.071 -1.018 . . . . 0.0 109.355 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.745 HG23 ' HD2' ' A' ' 15' ' ' PRO . 20.0 mt -138.86 144.65 42.39 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.745 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.48 119.54 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.563 2.176 . . . . 0.0 111.265 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.4 Cg_endo -66.78 -34.83 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.764 2.31 . . . . 0.0 112.264 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.74 14.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -72.2 -40.96 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 14' ' ' ILE . 22.3 tp -66.39 -36.71 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.111 -0.993 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 80' ' ' PHE . 56.3 t80 -63.79 -50.48 68.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASP . 29.6 mttt -69.26 -48.07 62.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 19.2 m -65.62 -23.48 66.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.895 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.928 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.7 t80 -100.54 -51.08 3.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 110.139 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 20' ' ' PHE . 55.9 t -84.83 -52.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 22.2 tp -68.07 -29.44 68.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.864 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.8 m-20 -110.38 20.09 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.114 -0.991 . . . . 0.0 109.565 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.928 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -67.96 -34.79 77.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.583 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 90.8 m-20 -66.68 -42.17 86.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.828 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -90.02 -34.07 16.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.718 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.673 HD21 HG23 ' A' ' 149' ' ' VAL . 23.2 tp -66.76 -32.82 74.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.548 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 31.9 mt -59.68 -57.62 25.49 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.413 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 47.7 Cg_endo -68.5 -34.68 19.47 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.618 2.212 . . . . 0.0 111.65 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -59.53 -43.93 93.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.547 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 30' ' ' LEU . 86.4 t -60.28 -42.31 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.68 126.63 82.3 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.942 . . . . 0.0 109.507 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 37' ' ' GLN . 50.1 Cg_endo -70.09 147.93 61.84 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.701 2.267 . . . . 0.0 111.806 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 36' ' ' PRO . 94.8 mt-30 43.73 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.935 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 59.26 76.15 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -82.71 138.12 34.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.6 p -117.53 169.04 9.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 109.384 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 11.6 t -130.97 144.18 51.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.609 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' LYS . . . -131.26 145.19 51.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 109.332 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 95.5 mt-10 -143.19 151.51 40.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.461 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.9 m-20 -89.04 111.5 22.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.529 HD22 ' HD3' ' A' ' 56' ' ' LYS . 31.4 tp -77.3 -33.74 55.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 53' ' ' THR . 86.5 tt0 -150.9 155.55 39.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.432 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 76.04 157.8 7.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -81.81 -19.96 40.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -1.127 . . . . 0.0 109.449 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.91 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 143.07 -12.6 2.34 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.472 ' C ' HD12 ' A' ' 75' ' ' ILE . . . -78.55 -148.12 3.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.0 126.0 13.25 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.858 2.372 . . . . 0.0 111.847 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.09 -6.53 66.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.91 HG21 ' HA2' ' A' ' 49' ' ' GLY . 53.7 m -74.22 139.48 44.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.079 -1.248 . . . . 0.0 109.537 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.401 HG12 ' HG3' ' A' ' 71' ' ' LYS . 7.3 mt -110.6 139.43 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 64.9 mttt -130.27 138.44 50.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 109.519 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HD3' HD22 ' A' ' 45' ' ' LEU . 17.4 mtmt -112.92 136.46 52.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.322 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 41' ' ' SER . 62.9 mt -112.37 132.27 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 62.3 p -141.17 149.29 41.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.897 . . . . 0.0 109.341 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -62.6 -44.82 95.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.337 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.33 154.33 35.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.68 -31.72 69.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.1 -178.33 37.5 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 44.1 p-10 -101.71 56.1 0.82 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -1.156 . . . . 0.0 109.504 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.83 -26.01 66.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -103.75 126.97 51.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.292 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HG2' ' HE2' ' A' ' 69' ' ' LYS . 24.3 tttt -119.26 14.84 13.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 0.0 109.601 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -69.33 -31.04 69.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.247 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.9 mtp -96.81 134.94 39.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 0.0 109.135 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' HE2' ' HG2' ' A' ' 66' ' ' LYS . 89.7 mttt -137.14 133.99 35.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 98.7 m-70 -122.4 131.43 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HG3' HG12 ' A' ' 54' ' ' ILE . 17.2 tttm -128.72 127.66 42.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.502 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.001 HG21 HD11 ' A' ' 75' ' ' ILE . 2.3 p -84.0 134.22 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 23.4 mt-10 -82.41 -44.76 15.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.857 . . . . 0.0 109.431 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.3 mt-10 -159.23 150.98 20.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.001 HD11 HG21 ' A' ' 72' ' ' VAL . 3.2 mt -135.54 107.12 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.598 ' OD1' ' ND2' ' A' ' 79' ' ' ASN . 31.1 t0 -123.21 90.92 3.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.8 m170 -70.4 -32.78 70.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.58 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.59 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.598 ' ND2' ' OD1' ' A' ' 76' ' ' ASP . 70.2 m-20 -84.34 8.25 16.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 75.6 m-85 54.72 25.36 6.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.378 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HE2' ' OE2' ' A' ' 102' ' ' GLU . 63.6 tttt -108.78 122.21 46.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 109.232 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 84' ' ' TYR . 7.4 t80 -128.75 129.82 46.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 109.695 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.463 ' HA ' ' HG3' ' A' ' 102' ' ' GLU . 1.8 t -109.55 123.63 49.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.013 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.608 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -121.14 138.62 54.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.121 -0.987 . . . . 0.0 109.966 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.496 ' HB3' ' NZ ' ' A' ' 98' ' ' LYS . 48.8 m -137.45 158.71 43.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.054 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 mt -127.65 128.1 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.653 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.544 HG22 ' HG3' ' A' ' 88' ' ' GLU . 89.1 mt -86.01 -39.16 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.685 ' HA ' HD11 ' A' ' 92' ' ' LEU . 98.1 mt-10 -144.55 143.35 30.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -156.23 93.88 0.14 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 43.93 -126.54 5.95 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.6 Cg_endo -69.59 -22.85 32.27 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.694 2.263 . . . . 0.0 111.637 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.685 HD11 ' HA ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER 62.37 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.514 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.577 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . 179.4 -171.88 43.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' C ' ' OG1' ' A' ' 95' ' ' THR . 31.9 t-80 -106.63 128.81 54.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -1.2 . . . . 0.0 109.541 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.929 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.1 OUTLIER 61.36 13.34 4.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.61 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.785 ' HB3' HD11 ' A' ' 99' ' ' ILE . 32.3 mt -94.87 90.23 5.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' HIS . 86.7 mt-10 -47.19 -42.67 20.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.598 -0.689 . . . . 0.0 110.509 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 1.051 ' O ' HD13 ' A' ' 99' ' ' ILE . 19.7 tttm -158.96 162.49 36.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.713 -1.242 . . . . 0.0 110.522 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.051 HD13 ' O ' ' A' ' 98' ' ' LYS . 7.2 mm -136.15 126.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -132.79 155.8 48.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.112 -0.992 . . . . 0.0 109.996 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.54 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 57.1 m-85 -137.86 129.72 28.56 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 83.6 tt0 -106.83 129.09 54.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.807 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -108.32 118.53 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -129.53 143.77 50.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.532 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.46 ' SD ' ' HA ' ' A' ' 20' ' ' PHE . 59.8 mtt -118.81 147.82 43.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.95 163.81 33.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.62 32.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.855 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.779 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . -109.37 112.77 59.03 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.481 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.98 -51.03 0.39 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.717 2.278 . . . . 0.0 111.807 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -68.82 -48.32 63.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.14 -30.23 75.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.82 30.14 52.9 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . -151.86 -135.65 2.31 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 28.7 t -135.55 148.77 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -1.159 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.779 HG13 ' HB2' ' A' ' 108' ' ' ALA . 64.7 mt -113.86 134.25 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' CE2' ' A' ' 146' ' ' PHE . 24.1 mt -106.66 139.24 41.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -135.34 136.45 41.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.376 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.9 mt -125.02 135.23 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 25.3 m -116.16 141.9 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.912 . . . . 0.0 109.442 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.54 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 67.8 m -124.48 153.15 42.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -137.28 129.08 28.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.759 ' HD1' HD12 ' A' ' 99' ' ' ILE . 51.4 m-85 -125.77 108.72 11.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.745 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.679 ' HA ' HG22 ' A' ' 3' ' ' VAL . 52.6 m-70 -79.88 130.89 35.67 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 8.8 t -116.17 147.87 40.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.067 -1.02 . . . . 0.0 109.731 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 124' ' ' THR . 18.2 tttt -42.09 -40.96 2.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.646 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.85 0.52 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -86.41 10.72 14.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -1.171 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.929 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -110.36 151.09 27.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -132.25 149.33 52.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 29.5 mt -98.56 121.39 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.527 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -54.69 138.86 40.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.507 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.2 mt-10 -66.3 -33.22 75.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 109.502 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -59.04 -33.58 70.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.304 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -65.73 -29.52 70.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.268 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.912 HG21 ' CG ' ' A' ' 6' ' ' TYR . 1.8 mm -69.83 -48.51 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 108.749 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -55.59 -41.55 73.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.193 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.45 75.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.35 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.11 -34.81 58.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.3 -38.14 87.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.294 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.29 -43.74 96.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.282 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -60.2 -42.76 95.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.922 . . . . 0.0 109.428 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.49 82.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.75 89.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.46 -48.47 83.92 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 149' ' ' VAL . 25.2 tp -64.85 -38.85 92.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.16 . . . . 0.0 109.405 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.512 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 68.5 t80 -60.33 -41.31 93.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.291 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.29 66.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.404 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.673 HG23 HD21 ' A' ' 30' ' ' LEU . 7.9 p -64.2 -44.29 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.562 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.4 tt0 -54.33 -43.57 71.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.85 99.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 68.5 t80 -60.55 -47.29 86.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.467 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.68 -36.99 82.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.434 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.517 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.2 tt -63.24 -46.33 87.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.04 -32.08 70.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 m170 50.24 64.89 7.62 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 49.4 Cg_endo -69.72 -8.39 23.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.648 2.232 . . . . 0.0 111.776 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -68.16 -30.34 69.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.52 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -107.46 144.52 34.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -60.66 -30.58 69.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.546 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.255 0.55 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.98 168.68 23.21 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.52 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.7 p -131.52 136.49 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.576 ' CE2' HG12 ' A' ' 130' ' ' ILE . 87.3 m-85 -95.92 144.38 26.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.41 ' SG ' ' HE3' ' A' ' 121' ' ' LYS . 4.0 m -125.26 119.75 29.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.78 ' O ' HG23 ' A' ' 119' ' ' THR . 29.3 m-85 -110.75 148.41 32.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.53 151.97 39.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -131.8 138.94 48.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -108.98 132.47 54.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.645 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -148.89 125.63 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -114.38 135.56 53.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.84 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -160.36 141.33 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.3 p -77.1 91.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 0.0 109.37 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.607 HG22 ' HD2' ' A' ' 15' ' ' PRO . 1.9 mt -138.77 142.62 34.59 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HD2' HG22 ' A' ' 14' ' ' ILE . 48.4 Cg_endo -68.96 123.02 9.93 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.578 2.185 . . . . 0.0 111.47 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.78 -30.06 41.54 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.774 2.316 . . . . 0.0 112.278 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.38 6.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.597 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -72.55 -47.48 47.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.811 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.947 HD13 ' O ' ' A' ' 19' ' ' LEU . 3.0 tm? -53.11 -37.17 61.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.84 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 53.8 t80 -71.74 -54.93 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 0.0 109.784 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.812 ' HG3' HD12 ' A' ' 25' ' ' LEU . 17.5 tttm -67.67 -30.41 69.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.803 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 36.4 m -81.81 -30.53 32.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.945 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.978 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 88.0 t80 -100.84 -44.22 5.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 110.44 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.06 -52.98 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.964 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.812 HD12 ' HG3' ' A' ' 21' ' ' LYS . 45.0 mt -70.66 -28.68 64.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.937 -1.102 . . . . 0.0 110.037 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 87.5 m-20 -108.96 19.84 19.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.049 -1.032 . . . . 0.0 109.657 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.978 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.96 -52.24 26.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.992 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.572 ' HA ' HD12 ' A' ' 31' ' ' ILE . 71.3 m-20 -62.54 -32.48 73.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.35 -41.62 18.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.001 . . . . 0.0 109.968 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 34' ' ' VAL . 45.2 mt -72.46 -34.15 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 28' ' ' ASP . 18.8 mt -48.08 -61.08 3.4 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.494 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.537 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.16 -39.86 9.72 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.651 2.234 . . . . 0.0 112.013 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -58.76 -40.37 83.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.741 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 30' ' ' LEU . 57.4 t -59.39 -40.89 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.643 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.43 123.02 88.73 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' O ' ' ND1' ' A' ' 38' ' ' HIS . 49.8 Cg_endo -70.3 133.95 25.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.748 2.298 . . . . 0.0 111.835 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 59.39 46.15 12.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 36' ' ' PRO . 49.1 m80 -145.07 107.32 4.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -111.43 131.48 55.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.8 p -129.96 158.48 39.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.562 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 t -142.87 141.64 31.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.387 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' HD12 ' A' ' 57' ' ' ILE . . . -142.96 155.12 44.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -125.02 163.62 21.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -91.45 108.01 19.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 56' ' ' LYS . 46.0 mt -61.72 -41.99 98.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -158.27 153.18 25.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.409 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 96.25 158.04 31.75 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -94.9 9.71 38.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -1.186 . . . . 0.0 109.536 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.77 21.82 8.42 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -118.46 -144.67 7.6 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.32 123.54 10.35 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.701 2.267 . . . . 0.0 111.874 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.23 1.46 72.25 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.666 HG21 ' HA2' ' A' ' 49' ' ' GLY . 93.4 m -73.38 134.64 44.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.553 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.528 HG12 ' CD ' ' A' ' 71' ' ' LYS . 3.9 mt -104.6 138.92 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 49.2 mttm -123.57 142.32 51.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.742 ' HB2' HD11 ' A' ' 45' ' ' LEU . 49.3 tttt -134.15 142.46 47.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.529 ' CG2' ' HB2' ' A' ' 67' ' ' TYR . 6.1 tp -82.8 134.23 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.573 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.9 m -80.21 150.85 29.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.566 ' CE1' ' HB3' ' A' ' 67' ' ' TYR . 97.0 m-85 -97.54 131.55 44.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.61 148.27 46.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.361 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -55.44 -35.71 65.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.505 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.52 171.17 20.8 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 53.81 51.75 14.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -52.28 142.68 16.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.354 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.423 ' CD2' ' N ' ' A' ' 66' ' ' LYS . 66.7 t80 -126.62 161.65 27.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.945 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 39.6 ttpt -52.62 137.11 31.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.462 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.566 ' HB3' ' CE1' ' A' ' 59' ' ' PHE . 37.1 p90 -118.28 159.54 23.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 45.5 mtm -151.79 152.44 32.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.414 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -92.04 156.01 17.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.56 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 90.4 m-70 -134.96 135.85 41.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.528 ' CD ' HG12 ' A' ' 54' ' ' ILE . 10.3 tptm -132.12 127.3 35.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.453 HG11 ' CG1' ' A' ' 75' ' ' ILE . 40.3 t -91.61 125.11 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.35 -42.67 58.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.382 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.2 tt0 -174.85 142.32 0.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.024 HD12 ' HA2' ' A' ' 50' ' ' GLY . 69.1 mt -119.12 132.4 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 80.8 m-20 -133.14 83.62 2.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -61.68 -37.57 84.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.76 71.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 75.2 m-20 -91.61 9.91 30.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASN . 86.1 m-85 43.71 45.64 6.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.46 ' HG3' ' HG2' ' A' ' 104' ' ' LYS . 10.3 ttpp -140.35 123.22 16.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 58.5 t80 -111.07 129.2 55.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.405 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 22.0 m -123.91 114.81 20.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 109.558 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.549 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 37.1 p90 -137.57 159.91 40.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.462 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.447 ' O ' HD13 ' A' ' 86' ' ' ILE . 85.6 p -141.3 168.84 18.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 85' ' ' SER . 26.6 mm -114.29 121.45 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 71' ' ' LYS . 81.2 mt -70.78 -41.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -160.55 133.36 6.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 109.531 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.53 103.82 0.28 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 45.41 -111.68 0.63 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.3 Cg_endo -70.71 -31.4 16.38 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.748 2.298 . . . . 0.0 111.75 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.831 HD11 HG12 ' A' ' 99' ' ' ILE . 2.5 tp 63.32 -70.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.407 -0.808 . . . . 0.0 109.567 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 169.9 162.29 21.91 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -89.14 121.14 31.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.14 . . . . 0.0 109.539 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.948 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 59.51 14.79 4.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.565 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.992 HD22 ' HB3' ' A' ' 122' ' ' TYR . 36.5 mt -93.12 90.7 6.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 108.83 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 94.6 mt-10 -43.23 -44.59 5.34 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.795 -0.566 . . . . 0.0 110.125 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.685 ' O ' HD13 ' A' ' 99' ' ' ILE . 88.0 mttt -153.54 156.17 37.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.961 -1.087 . . . . 0.0 110.032 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.861 HD11 ' HB3' ' A' ' 96' ' ' LEU . 32.3 mm -130.51 112.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 36.8 m -115.76 152.5 33.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.769 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.456 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 91.2 m-85 -129.63 133.3 47.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.347 -0.846 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.405 ' HG3' ' SG ' ' A' ' 83' ' ' CYS . 84.1 tt0 -117.4 139.27 51.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.682 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.6 mt -123.88 121.87 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.345 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 21.3 mtpt -117.54 127.5 54.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.811 ' SD ' HD12 ' A' ' 19' ' ' LEU . 70.1 mtm -124.48 138.6 54.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.34 37.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.96 135.53 43.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -65.34 158.5 72.38 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.25 -32.09 21.44 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.67 2.247 . . . . 0.0 111.82 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -65.53 -34.53 78.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.374 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 99.86 146.84 20.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.49 38.61 51.88 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.19 114.59 0.56 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 t -115.05 154.48 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.44 127.37 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.332 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.541 HD22 ' HG2' ' A' ' 105' ' ' MET . 55.9 mt -106.59 136.96 45.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 40.3 mttt -131.4 138.1 48.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.243 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.9 mt -125.68 122.71 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.731 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.78 HG23 ' O ' ' A' ' 6' ' ' TYR . 94.3 m -128.66 138.3 52.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.456 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 2.1 m -123.24 166.56 15.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 10.6 mtpt -138.45 112.84 8.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.165 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.992 ' HB3' HD22 ' A' ' 96' ' ' LEU . 8.1 m-30 -108.29 115.13 29.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 16.4 m80 -82.56 122.91 28.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 108.693 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 95' ' ' THR . 14.2 t -106.78 141.12 38.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.988 -1.07 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -45.39 -40.58 8.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.22 -68.24 0.37 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -65.18 -27.73 68.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -1.141 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.948 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -72.74 149.52 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.497 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 92.3 p -126.63 159.86 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.714 HD11 HD21 ' A' ' 96' ' ' LEU . 35.1 mm -108.19 123.37 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.47 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 54.6 t30 -91.6 131.34 37.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 136' ' ' LYS . 75.0 mm-40 -53.96 -40.72 67.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.469 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.93 -42.04 90.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 73.6 mm-40 -63.14 -41.59 99.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.714 HG21 ' CG2' ' A' ' 130' ' ' ILE . 20.9 pt -84.42 -30.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.511 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.1 tttp -55.72 -40.87 73.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.247 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.81 75.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.06 -39.4 69.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -60.95 -43.36 98.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -1.143 . . . . 0.0 109.225 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.53 -46.82 70.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -57.71 -45.97 85.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.66 -40.32 96.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.36 83.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.72 -46.79 88.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.95 -39.3 85.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -1.091 . . . . 0.0 109.091 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.529 ' O ' HG12 ' A' ' 149' ' ' VAL . 68.9 t80 -60.97 -45.46 94.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 109.248 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -62.74 -34.49 77.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.237 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.83 -51.39 59.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 146' ' ' PHE . 3.5 p -59.57 -39.85 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.567 ' HA ' HD12 ' A' ' 153' ' ' LEU . 85.9 tt0 -60.6 -39.89 89.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.38 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.13 90.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.585 ' CZ ' ' CG ' ' A' ' 157' ' ' PRO . 67.6 t80 -59.91 -43.98 94.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.354 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 150' ' ' GLU . 14.7 mt -60.46 -40.45 91.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.299 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.4 tt -60.58 -38.88 86.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.87 . . . . 0.0 109.403 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.574 ' O ' ' CG ' ' A' ' 156' ' ' HIS . . . -69.65 -25.44 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 155' ' ' ALA . 18.7 p80 40.43 59.8 7.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.731 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.585 ' CG ' ' CZ ' ' A' ' 152' ' ' TYR . 50.0 Cg_endo -70.53 -6.77 19.73 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.732 2.288 . . . . 0.0 111.712 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -61.5 -33.35 73.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.47 147.23 48.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.388 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -113.02 134.61 54.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.508 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.835 ' O ' HG22 ' A' ' 124' ' ' THR . . . -57.01 -27.47 57.17 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.65 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.3 p -119.96 143.39 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.539 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -104.42 137.29 42.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.0 t -117.44 125.67 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.492 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 26.5 m-85 -118.14 147.96 42.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -119.94 149.8 41.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -130.32 139.46 50.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -115.69 139.13 50.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.95 122.42 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -113.19 133.11 55.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.767 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 t -160.26 137.98 9.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 109.2 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.54 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.7 p -73.02 91.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.541 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.791 HG21 HD13 ' A' ' 19' ' ' LEU . 16.6 mt -138.83 144.2 40.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.744 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.2 Cg_endo -68.62 118.13 5.45 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.384 2.056 . . . . 0.0 111.374 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 20' ' ' PHE . 45.1 Cg_endo -66.96 -43.13 7.12 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.769 2.313 . . . . 0.0 112.223 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -49.61 67.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.573 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 161' ' ' CYS . 98.5 mtt180 -72.12 -43.98 63.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 14' ' ' ILE . 7.1 tp -67.2 -41.01 86.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 109.72 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 52.3 t80 -65.42 -47.51 75.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.728 ' HG3' HD12 ' A' ' 25' ' ' LEU . 39.4 tttt -68.98 -36.57 78.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.81 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 35.3 t -80.81 -25.74 37.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.921 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 77.5 t80 -100.68 -50.11 3.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.356 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.764 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.7 t -84.46 -52.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.056 -1.028 . . . . 0.0 110.513 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.728 HD12 ' HG3' ' A' ' 21' ' ' LYS . 56.0 mt -72.48 -28.13 62.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.942 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 22' ' ' SER . 87.9 m-20 -113.79 28.38 8.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.461 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.921 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.52 -39.62 77.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.645 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' HD12 ' A' ' 31' ' ' ILE . 26.9 p-10 -69.81 -32.63 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 24.9 m120 -88.71 -32.32 18.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.829 ' O ' HD23 ' A' ' 30' ' ' LEU . 8.1 tt -73.86 -30.25 62.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 27' ' ' ALA . 17.2 mt -56.57 -56.65 29.97 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 46.9 Cg_endo -68.16 -33.55 24.53 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.535 2.157 . . . . 0.0 111.677 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 29' ' ' ASN . 79.4 mttt -62.65 -37.22 85.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 30' ' ' LEU . 10.0 p -110.54 9.67 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.586 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 31' ' ' ILE . . . -68.01 156.06 90.49 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.941 . . . . 0.0 109.423 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.58 -163.45 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.751 2.301 . . . . 0.0 111.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -47.1 -31.28 3.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.9 . . . . 0.0 109.475 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -96.94 134.1 40.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -110.05 143.2 40.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.2 m -124.89 141.08 52.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.7 p -132.38 156.23 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.462 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.614 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . . . -143.74 152.65 41.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.932 . . . . 0.0 109.574 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.19 159.61 37.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.476 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -88.16 108.08 19.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 45' ' ' LEU . 21.8 tp -67.88 -37.27 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 53' ' ' THR . 86.1 tt0 -139.94 155.71 47.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 87.09 160.82 35.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -91.9 8.88 35.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.554 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.706 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.97 13.36 25.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.807 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -110.84 -143.85 9.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.5 Cg_endo -69.43 125.12 11.93 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -2.66 74.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.706 HG21 ' HA2' ' A' ' 49' ' ' GLY . 62.6 m -73.04 139.78 46.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -1.136 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.498 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.1 mm -101.41 128.48 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.614 ' HE2' ' HB3' ' A' ' 42' ' ' ALA . 63.1 tttt -105.95 133.86 49.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -122.7 143.32 49.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 42' ' ' ALA . 73.0 mt -109.17 137.98 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.443 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.2 m -122.13 143.71 49.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.582 ' HB3' ' CD1' ' A' ' 65' ' ' PHE . 98.9 m-85 -105.21 139.05 40.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.49 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.65 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -98.22 141.84 30.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.505 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.29 -120.14 1.0 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.547 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 21.9 m120 -84.29 150.22 25.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.165 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.25 136.13 57.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 59' ' ' PHE . 93.5 m-85 -120.44 153.38 36.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -89.05 126.58 35.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -61.44 144.35 54.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.4 mtp -132.5 152.93 51.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.6 mttm -118.31 136.82 53.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.618 ' NE2' ' CD2' ' A' ' 84' ' ' TYR . 11.1 t-80 -132.4 128.79 38.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 75.3 tttt -126.69 150.24 49.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.389 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.768 HG11 ' O ' ' A' ' 50' ' ' GLY . 7.4 p -108.34 134.61 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -82.49 -56.77 3.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 44.3 mt-10 -150.81 140.88 22.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.807 HD12 ' HA2' ' A' ' 50' ' ' GLY . 73.0 mt -125.59 126.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.478 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 84.3 m-20 -131.55 94.72 3.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.94 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' HD11 ' A' ' 25' ' ' LEU . 86.6 t60 -66.08 -37.88 86.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.47 66.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.478 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 18.7 m120 -85.0 2.48 42.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.606 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 49.78 34.36 7.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -130.83 128.49 40.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.447 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.7 t80 -122.74 130.17 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.5 m -132.48 118.56 19.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.618 ' CD2' ' NE2' ' A' ' 70' ' ' HIS . 36.3 p90 -132.94 162.14 32.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 39.7 t -138.42 150.24 46.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 69' ' ' LYS . 22.8 mt -104.04 133.08 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 88' ' ' GLU . 85.2 mt -77.63 -41.45 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.52 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.523 ' HG3' HG22 ' A' ' 87' ' ' ILE . 99.0 mt-10 -145.28 148.49 33.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . 135.4 166.12 10.94 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 43.99 -143.28 2.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.67 ' HB2' HD12 ' A' ' 96' ' ' LEU . 49.2 Cg_endo -69.54 -6.96 19.76 Favored 'Trans proline' 0 C--O 1.212 -0.803 0 C-N-CA 122.761 2.308 . . . . 0.0 111.781 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.871 HD13 ' O ' ' A' ' 92' ' ' LEU . 2.9 tm? -40.67 -26.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.942 . . . . 0.0 110.361 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -89.58 -22.72 35.92 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 91' ' ' PRO . 58.7 t-80 -68.86 74.05 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -1.224 . . . . 0.0 109.617 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 45.69 24.31 0.2 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 122' ' ' TYR . 15.1 mt -95.24 90.69 5.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.278 -0.889 . . . . 0.0 109.31 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 94.1 mt-10 -41.5 -41.15 2.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.528 -0.733 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 46.6 mttt -158.26 168.18 27.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.922 -1.111 . . . . 0.0 110.139 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.789 HG23 ' CE1' ' A' ' 122' ' ' TYR . 40.3 mt -146.61 117.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 24.1 t -127.41 150.03 49.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 98.6 m-85 -131.1 128.07 39.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.818 . . . . 0.0 109.042 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.7 mt-10 -106.25 141.74 37.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 109.722 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.03 124.18 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.285 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -130.73 129.22 42.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.656 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.498 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 69.0 mtm -126.61 141.0 52.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.82 30.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.53 137.13 52.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.436 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.53 135.92 43.11 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.72 138.76 38.72 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.718 2.279 . . . . 0.0 111.729 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 51.09 22.63 1.31 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.449 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.29 -43.55 0.83 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.82 29.51 47.11 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 13' ' ' VAL . . . -144.0 -135.72 2.99 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 t -152.03 152.12 32.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -1.117 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.81 130.14 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.923 . . . . 0.0 109.377 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.498 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 64.8 mt -109.02 132.51 54.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -130.27 135.62 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.37 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.8 mt -124.58 133.09 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.586 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 30.4 m -125.58 141.45 52.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.343 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.2 m -126.44 151.95 47.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.66 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -138.32 126.49 22.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 109.221 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.812 ' HB3' HD22 ' A' ' 96' ' ' LEU . 38.0 m-85 -127.0 111.16 13.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.911 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.562 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 37.1 m80 -85.04 135.53 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.894 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 11.3 t -115.82 141.27 48.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.029 . . . . 0.0 109.852 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.495 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 69.8 mttt -77.82 137.54 38.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.35 -153.76 50.69 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.43 13.81 7.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -1.2 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.894 ' HB3' ' OG1' ' A' ' 124' ' ' THR . . . -52.06 143.77 13.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.7 p -124.01 170.02 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 12.6 mt -115.95 126.82 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -60.78 134.84 57.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.552 ' HA ' HG13 ' A' ' 135' ' ' ILE . 86.6 tt0 -62.88 -29.87 71.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.33 -44.68 95.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 0.0 109.124 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -57.6 -24.92 58.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.842 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.552 HG13 ' HA ' ' A' ' 132' ' ' GLU . 2.0 mt -71.69 -51.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.114 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -55.97 -38.29 70.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.93 78.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.364 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.11 -30.21 76.78 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' A' ' 135' ' ' ILE . 68.2 mttm -71.13 -36.24 72.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -1.214 . . . . 0.0 109.393 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.13 -42.35 93.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -63.05 -40.13 96.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.391 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.425 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -70.12 -35.68 74.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.456 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.79 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.98 -39.33 97.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.41 ' O ' HG12 ' A' ' 149' ' ' VAL . 18.7 tp -65.47 -40.25 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.43 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 19.6 m-85 -60.97 -41.54 96.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.522 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -66.92 -34.8 78.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.99 -50.3 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.386 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 150' ' ' GLU . 3.8 p -57.53 -44.05 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.434 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.505 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.0 mt-10 -59.63 -44.36 93.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 155' ' ' ALA . . . -59.49 -35.61 74.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.9 -47.68 83.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -54.2 -46.98 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.323 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.671 ' N ' HD12 ' A' ' 154' ' ' LEU . 6.7 mp -80.1 -24.85 40.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 151' ' ' ALA . . . -78.81 -17.84 55.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -137.14 63.56 44.0 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 50.1 Cg_endo -71.21 -5.52 17.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.657 2.238 . . . . 0.0 111.702 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -69.56 -36.09 76.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.43 134.4 56.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -57.89 -40.0 79.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.863 . . . . 0.0 109.467 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 27.0 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.43 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.46 55.85 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.8 HG21 ' CE1' ' A' ' 123' ' ' HIS . 38.3 t -128.07 141.13 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -1.115 . . . . 0.0 109.511 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.647 ' HE2' HG21 ' A' ' 124' ' ' THR . 98.4 m-85 -99.11 135.2 40.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.338 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.1 p -119.02 125.3 49.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' THR . 77.6 m-85 -126.87 140.9 52.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.2 tt0 -115.95 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 59.9 t0 -101.62 124.7 47.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -99.16 131.48 45.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.963 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.1 124.98 10.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.9 m -105.11 131.96 51.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.786 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.8 p -160.34 140.47 11.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.26 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.4 p -81.64 91.22 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.949 HG21 HD13 ' A' ' 19' ' ' LEU . 3.1 mt -138.69 142.52 34.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.231 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.3 Cg_endo -68.08 120.47 7.45 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.544 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.6 Cg_endo -67.0 -28.47 41.7 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.847 2.365 . . . . 0.0 112.224 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.71 -56.5 5.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -72.57 -45.95 56.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.949 HD13 HG21 ' A' ' 14' ' ' ILE . 10.7 tp -56.45 -41.0 75.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.874 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 24' ' ' VAL . 67.6 t80 -64.5 -49.05 72.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.731 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.712 ' HG2' HD12 ' A' ' 25' ' ' LEU . 41.7 mttm -69.08 -43.72 73.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 109.628 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 20.3 m -73.39 -22.25 60.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.764 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.965 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 69.7 t80 -100.88 -50.73 3.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.04 -52.83 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.918 . . . . 0.0 110.484 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.712 HD12 ' HG2' ' A' ' 21' ' ' LYS . 43.0 mt -71.77 -28.49 63.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 109.974 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 89.9 m-20 -108.4 18.67 20.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 109.555 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.965 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.29 -33.87 75.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.607 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.52 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 90.0 m-20 -71.04 -37.55 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.703 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -92.29 -41.11 10.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.683 HD21 HG23 ' A' ' 149' ' ' VAL . 16.0 tp -56.98 -41.05 77.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.542 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 33.4 mt -56.93 -60.8 8.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.514 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -68.11 -33.81 24.15 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.556 2.17 . . . . 0.0 111.86 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -57.7 -38.09 74.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.571 HG11 ' HB1' ' A' ' 148' ' ' ALA . 69.4 t -59.24 -41.25 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.539 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.88 124.1 85.0 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.979 . . . . 0.0 109.519 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.08 137.93 35.65 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.712 2.275 . . . . 0.0 111.754 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 58.35 47.99 13.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -124.55 114.55 19.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -108.72 131.9 54.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 t -137.24 155.97 48.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.455 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -130.47 148.49 52.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.469 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.625 ' HB1' ' HE3' ' A' ' 55' ' ' LYS . . . -142.58 152.55 42.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.438 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -144.56 142.45 30.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 84.8 m-20 -85.89 117.55 24.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.501 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 45.3 tp -69.54 -38.03 77.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.459 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.5 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 77.7 tt0 -159.22 157.35 30.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 91.96 158.02 34.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -93.57 11.37 28.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.163 . . . . 0.0 109.535 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.64 31.08 5.6 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 1.009 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -127.83 -144.14 5.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.62 125.51 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.701 2.268 . . . . 0.0 111.768 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.13 4.26 86.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.602 HG21 ' HA2' ' A' ' 49' ' ' GLY . 74.8 m -77.68 139.52 39.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.143 -1.21 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 16.8 mm -104.41 137.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HE3' ' HB1' ' A' ' 42' ' ' ALA . 56.1 tttp -126.6 142.27 51.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -124.87 126.92 46.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.319 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt -116.78 138.09 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.607 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.0 m -126.66 124.02 38.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.36 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 98.3 m-85 -56.47 -48.86 76.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.586 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 59' ' ' PHE . . . 64.79 11.95 7.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' HG3' ' HB3' ' A' ' 59' ' ' PHE . 98.2 mt-10 -65.43 -33.85 76.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.883 . . . . 0.0 109.444 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.04 -173.32 12.9 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -84.11 0.81 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -1.146 . . . . 0.0 109.692 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 96.2 mt-10 -54.93 -35.25 64.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.434 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 23.5 m-85 61.47 77.5 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.481 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -83.11 145.55 29.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.238 -0.914 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -114.04 134.41 54.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.9 mtp -138.06 157.45 46.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.895 . . . . 0.0 109.318 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.554 ' HG2' HD12 ' A' ' 87' ' ' ILE . 39.2 tttp -129.26 130.7 46.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 90.0 m-70 -122.94 134.86 54.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.29 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -131.6 132.11 43.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 50' ' ' GLY . 14.2 m -100.45 128.05 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -70.52 -41.62 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 84.9 tt0 -176.52 144.67 0.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.141 -0.974 . . . . 0.0 109.503 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.009 HD12 ' HA2' ' A' ' 50' ' ' GLY . 62.2 mt -118.79 129.91 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.5 m-20 -130.53 83.8 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.83 -41.24 90.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.11 79.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 22.4 m120 -86.8 5.91 34.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 47.67 33.43 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.945 . . . . 0.0 109.483 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -127.63 132.5 49.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.44 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 71.2 t80 -124.35 126.33 45.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.433 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 12.4 t -124.07 119.59 29.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.558 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 34.5 p90 -140.22 167.11 22.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.384 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 100' ' ' SER . 84.4 p -146.71 168.38 21.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 85' ' ' SER . 23.5 mm -115.39 113.68 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.308 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 69' ' ' LYS . 90.6 mt -68.09 -35.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.305 -0.872 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -156.53 136.65 12.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -155.42 101.28 0.2 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.22 -128.86 8.33 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.2 Cg_endo -70.45 -23.66 27.39 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.623 2.216 . . . . 0.0 111.461 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.565 HD11 ' CG1' ' A' ' 99' ' ' ILE . 6.2 tp 45.47 -92.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.409 -0.807 . . . . 0.0 109.621 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.592 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . -156.28 172.95 34.16 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -106.74 133.2 51.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.13 . . . . 0.0 109.404 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 1.069 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.3 OUTLIER 64.08 15.21 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.338 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' A' ' 99' ' ' ILE . 71.5 mt -104.54 93.76 4.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 85.5 mt-10 -45.97 -41.53 11.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.638 -0.664 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 1.046 ' O ' HD13 ' A' ' 99' ' ' ILE . 89.4 mttt -155.33 160.76 40.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.679 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.046 HD13 ' O ' ' A' ' 98' ' ' LYS . 12.5 mm -135.0 114.36 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 85' ' ' SER . 32.8 m -118.27 150.29 39.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.042 . . . . 0.0 110.405 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HE1' ' HH ' ' A' ' 122' ' ' TYR . 74.3 m-85 -131.95 132.57 43.64 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 118' ' ' ILE . 87.1 tt0 -113.29 141.05 47.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.997 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.609 HD13 ' HE1' ' A' ' 23' ' ' PHE . 70.0 mt -121.68 121.61 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -126.26 137.19 53.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.852 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.1 mtt -119.94 131.77 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.241 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.86 155.24 43.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 114' ' ' SER . . . -101.33 128.98 47.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.85 150.64 97.7 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.49 -25.33 29.94 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.708 2.272 . . . . 0.0 111.679 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -63.79 -28.93 70.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.34 -3.93 73.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.88 -41.05 58.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 174.62 -126.47 1.19 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 49.5 m -132.88 155.51 48.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 109.531 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.63 134.22 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 49.9 mt -105.86 135.89 46.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 50.6 mttp -133.46 137.41 45.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 102' ' ' GLU . 68.8 mt -127.41 135.29 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.4 m -118.38 142.59 47.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.478 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.487 ' HG ' ' HD1' ' A' ' 101' ' ' TYR . 51.1 m -126.98 152.35 47.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -136.2 126.14 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.789 ' HD1' HD12 ' A' ' 99' ' ' ILE . 54.5 m-85 -122.26 116.27 23.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.975 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.8 ' CE1' HG21 ' A' ' 3' ' ' VAL . 72.2 m-70 -85.5 126.01 33.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.647 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -109.85 152.65 25.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.106 . . . . 0.0 109.783 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -53.86 -40.86 66.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.01 -84.24 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -61.39 -26.26 67.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.137 . . . . 0.0 109.52 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 1.069 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -62.44 146.25 51.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -137.69 151.15 47.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 96' ' ' LEU . 36.4 mt -110.34 124.65 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.554 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -88.6 153.23 21.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.449 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.2 mt-10 -61.02 -36.7 80.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.528 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.528 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 22.3 pt-20 -60.96 -46.08 92.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.939 . . . . 0.0 109.49 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 133' ' ' GLU . 85.4 tt0 -56.87 -47.61 80.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 132' ' ' GLU . 41.8 pt -76.68 -29.27 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 132' ' ' GLU . 38.5 tttt -55.53 -41.47 73.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.229 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.36 76.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.072 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.83 -38.34 73.36 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -61.38 -43.74 98.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -1.097 . . . . 0.0 109.075 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.5 -47.68 69.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -57.8 -45.53 85.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.905 . . . . 0.0 109.081 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.53 88.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.302 -0.873 . . . . 0.0 109.127 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.8 66.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.48 -44.37 93.72 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 149' ' ' VAL . 71.6 mt -55.64 -39.62 71.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.195 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.519 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.6 m-85 -65.91 -39.48 90.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.304 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.8 -38.69 89.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.311 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.571 ' HB1' HG11 ' A' ' 34' ' ' VAL . . . -69.01 -52.11 32.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.683 HG23 HD21 ' A' ' 30' ' ' LEU . 7.6 p -65.28 -41.53 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.505 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.6 tt0 -58.83 -40.69 84.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.88 99.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 109.299 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.7 -49.37 78.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 109.352 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.6 -29.6 66.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.3 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.8 tt -65.29 -46.83 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.58 75.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 45.82 61.62 12.28 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.91 -9.76 26.82 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.66 2.24 . . . . 0.0 111.738 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -69.49 -34.14 73.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.57 142.34 32.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -55.93 -41.12 74.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.447 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.496 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' HB3' HG12 ' A' ' 3' ' ' VAL . 64.9 mtt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.21 12.62 63.08 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.726 HG23 ' C ' ' A' ' 122' ' ' TYR . 11.1 p -127.01 137.24 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.473 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.651 ' HE2' HG21 ' A' ' 124' ' ' THR . 43.0 m-85 -101.99 152.55 20.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.82 111.73 11.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.917 . . . . 0.0 109.412 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' THR . 52.4 m-85 -108.4 151.18 26.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HG2' ' CG2' ' A' ' 119' ' ' THR . 95.2 mt-10 -125.93 139.58 53.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.561 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 118' ' ' ILE . 91.6 m-20 -111.66 156.51 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.451 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -127.01 134.26 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.665 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.11 124.21 10.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.22 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.69 HG23 HG12 ' A' ' 115' ' ' ILE . 33.8 m -116.59 139.3 50.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.968 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.428 ' O ' HG12 ' A' ' 14' ' ' ILE . 46.4 m -160.04 144.34 14.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.893 ' O ' HD13 ' A' ' 14' ' ' ILE . 31.1 m -70.72 90.67 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.479 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 1.044 HG21 HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -139.62 145.03 41.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.054 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HD2' HG22 ' A' ' 14' ' ' ILE . 44.1 Cg_endo -67.26 129.92 21.46 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 122.367 2.045 . . . . 0.0 111.084 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.4 Cg_endo -66.62 -39.98 14.57 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.701 2.267 . . . . 0.0 112.502 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -46.52 20.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.062 -1.024 . . . . 0.0 109.794 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . 91.7 mtt-85 -71.99 -49.22 38.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.044 HD13 HG21 ' A' ' 14' ' ' ILE . 28.8 tp -59.51 -47.94 83.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.754 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CE1' ' C ' ' A' ' 80' ' ' PHE . 53.8 t80 -53.73 -55.02 29.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.729 ' HG3' HD13 ' A' ' 25' ' ' LEU . 83.0 tttt -65.84 -54.9 20.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.942 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 31.6 m -62.29 -27.41 69.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.406 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.3 t80 -93.92 -50.88 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.916 -1.115 . . . . 0.0 110.292 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 45.9 t -84.59 -50.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 110.028 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 ' HG3' ' A' ' 21' ' ' LYS . 4.1 tt -68.92 -49.14 60.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' SER . 66.3 m-20 -91.65 24.16 3.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.919 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.44 -44.54 71.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' HA ' HD12 ' A' ' 31' ' ' ILE . 76.6 m-20 -64.14 -24.21 67.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -91.27 -38.47 12.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.849 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.567 ' O ' HG12 ' A' ' 34' ' ' VAL . 22.1 mt -79.89 -36.64 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.587 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 25.0 mt -44.66 -56.62 8.15 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.8 Cg_endo -68.23 -28.94 33.28 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.485 2.124 . . . . 0.0 111.74 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -72.72 -40.74 65.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.411 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.2 p -76.66 -24.49 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.327 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.618 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -50.5 164.58 0.39 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.348 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.618 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 49.7 Cg_endo -70.16 -161.74 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.616 2.211 . . . . 0.0 111.777 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -52.84 -30.51 34.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.405 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -80.8 134.45 35.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.403 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.15 149.41 40.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.7 p -126.58 161.94 26.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.126 -0.983 . . . . 0.0 109.454 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -131.46 146.78 52.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.425 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.32 149.34 41.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.32 -0.862 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -133.97 159.11 41.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.461 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.5 m-20 -87.36 108.69 19.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 45' ' ' LEU . 23.6 tp -68.59 -36.32 78.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.557 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.795 ' O ' HG23 ' A' ' 53' ' ' THR . 86.0 tt0 -140.05 155.29 47.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 85.33 163.81 37.89 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -90.22 8.84 31.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -1.183 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.732 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 99.45 43.18 2.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.66 -137.34 3.08 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.1 Cg_endo -69.17 123.0 9.84 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.801 2.334 . . . . 0.0 112.049 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.56 8.73 84.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 46' ' ' GLU . 56.3 m -86.41 139.79 30.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -1.156 . . . . 0.0 109.542 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.52 HG12 ' CD ' ' A' ' 71' ' ' LYS . 6.0 mt -101.46 139.18 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.526 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 93.7 mttt -117.47 150.62 38.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -125.27 137.28 54.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.281 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.9 tt -116.37 137.73 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.656 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -79.17 151.41 31.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.868 . . . . 0.0 109.348 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.573 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 21.6 p90 -131.62 165.27 24.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.469 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.01 -56.87 2.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 84.3 tt0 -81.07 146.39 30.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 66' ' ' LYS . . . 95.97 14.84 44.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -57.15 -26.5 60.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -1.136 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.74 -36.65 84.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.506 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 72.3 t80 -176.31 66.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.448 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.573 ' O ' ' CZ ' ' A' ' 59' ' ' PHE . 16.9 tttt -141.65 128.47 20.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.575 ' CE2' ' HE2' ' A' ' 69' ' ' LYS . 39.5 p90 -146.39 161.99 39.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.1 mtt -132.86 144.73 50.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.575 ' HE2' ' CE2' ' A' ' 67' ' ' TYR . 37.6 mttm -130.69 140.66 50.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 97.4 m-70 -125.47 136.74 53.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' CD ' HG12 ' A' ' 54' ' ' ILE . 23.8 tptm -130.26 133.83 46.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 45.6 t -100.02 132.86 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.89 -56.48 4.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.662 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.8 tt0 -178.89 138.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.845 HG21 ' CE2' ' A' ' 82' ' ' TYR . 15.7 pt -136.29 145.36 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.567 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' OD1' ' A' ' 79' ' ' ASN . 60.7 t0 -132.84 109.14 9.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -60.22 -36.22 77.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.72 99.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.438 ' OD1' ' OD1' ' A' ' 76' ' ' ASP . 15.8 m120 -86.11 -5.74 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.222 -0.923 . . . . 0.0 109.587 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' C ' ' CE1' ' A' ' 20' ' ' PHE . 92.2 m-85 58.74 36.09 24.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.294 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -117.99 131.54 56.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.845 ' CE2' HG21 ' A' ' 75' ' ' ILE . 72.6 t80 -128.03 114.85 17.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.885 . . . . 0.0 109.683 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.71 118.17 30.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.217 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.579 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 32.5 p90 -129.33 154.62 46.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 51.1 m -128.9 159.14 36.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.27 129.57 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.459 HD12 ' HB3' ' A' ' 69' ' ' LYS . 84.4 mt -77.6 -41.71 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -165.27 138.38 4.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -154.46 103.07 0.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.24 -126.8 7.62 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.1 Cg_endo -70.33 -29.88 20.5 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.652 2.235 . . . . 0.0 111.721 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.86 HD21 HG12 ' A' ' 99' ' ' ILE . 4.2 tp 45.72 -93.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.575 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.799 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . -145.63 -176.12 19.28 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -115.47 125.84 53.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -1.135 . . . . 0.0 109.483 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 58.85 23.59 11.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' ' 99' ' ' ILE . 96.5 mt -101.35 93.62 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.548 ' CG ' ' HG2' ' A' ' 125' ' ' LYS . 96.8 mt-10 -48.49 -32.72 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.764 -0.585 . . . . 0.0 111.287 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.787 ' O ' HD13 ' A' ' 99' ' ' ILE . 78.3 tttt -151.14 143.09 23.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 0.0 110.622 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.86 HG12 HD21 ' A' ' 92' ' ' LEU . 23.0 mm -124.81 113.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 28.5 t -116.97 148.68 41.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 120' ' ' SER . 3.7 m-85 -130.87 123.95 30.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.781 . . . . 0.0 109.057 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' OG1' ' A' ' 119' ' ' THR . 91.1 mt-10 -109.12 135.3 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.752 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.4 mt -131.52 119.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.98 155.11 47.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.698 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -117.35 147.85 42.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.277 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.79 147.18 46.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.23 138.5 38.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 109' ' ' PRO . . . -117.16 107.2 45.93 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 108' ' ' ALA . 49.9 Cg_endo -70.05 -29.71 22.09 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.656 2.238 . . . . 0.0 111.712 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -64.41 -44.41 91.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.12 175.9 27.63 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 114' ' ' SER . . . 92.33 20.73 34.43 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 57.62 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 112' ' ' GLY . 87.1 p -144.37 165.48 27.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -1.055 . . . . 0.0 109.41 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 11' ' ' THR . 72.4 mt -123.01 133.56 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.429 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.773 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.7 mp -106.98 138.91 42.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -124.69 135.49 53.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 8' ' ' ASP . 72.2 mt -123.82 128.79 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 8.4 p -126.39 142.69 51.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.468 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.514 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -121.65 152.88 38.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 109.676 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -132.34 115.04 15.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 108.931 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.809 ' CE1' HG23 ' A' ' 99' ' ' ILE . 9.6 m-30 -112.87 121.61 45.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.05 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 97' ' ' GLU . 11.2 m80 -92.85 115.51 28.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.389 -0.819 . . . . 0.0 108.841 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.651 HG21 ' HE2' ' A' ' 4' ' ' PHE . 1.1 p -92.7 148.65 21.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.548 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 54.3 mttp -70.09 147.25 50.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 48.19 -143.59 7.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -92.88 15.97 13.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.126 . . . . 0.0 109.418 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.12 146.31 3.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.6 p -113.9 161.75 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 96' ' ' LEU . 49.4 mt -105.8 139.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.895 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -84.26 123.95 30.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.487 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 96.3 mt-10 -55.65 -35.59 66.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.08 -41.39 90.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -62.88 -45.63 91.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.464 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 132' ' ' GLU . 38.2 pt -76.86 -31.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 26.4 tttm -55.76 -46.66 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.0 73.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.405 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.01 -39.56 92.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.91 -41.76 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -45.81 91.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -59.94 -45.79 91.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.16 90.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.28 97.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.12 88.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.4 tt -62.88 -39.34 94.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.319 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.468 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 70.9 t80 -59.54 -46.35 89.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -60.73 -39.22 87.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.376 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.54 -48.74 68.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.526 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.2 p -65.0 -43.65 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.0 109.355 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.526 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.2 tt0 -60.63 -40.17 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.12 96.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.267 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.581 ' CE2' ' HG3' ' A' ' 157' ' ' PRO . 62.5 t80 -67.93 -42.34 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.915 HD13 ' O ' ' A' ' 153' ' ' LEU . 3.5 tm? -69.83 -31.49 69.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.902 ' O ' HD13 ' A' ' 154' ' ' LEU . 2.7 tm? -75.38 -40.09 58.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.926 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.48 74.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 51.46 64.61 7.67 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 109.583 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.581 ' HG3' ' CE2' ' A' ' 152' ' ' TYR . 49.2 Cg_endo -70.45 -10.6 28.36 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.686 2.257 . . . . 0.0 111.737 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -60.63 -35.13 75.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.451 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.73 135.26 34.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.491 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.74 140.61 49.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.48 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.33 0.586 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.74 160.69 24.13 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 122' ' ' TYR . 6.7 p -128.44 130.87 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -1.166 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.75 ' HE2' HG21 ' A' ' 124' ' ' THR . 96.8 m-85 -86.42 144.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.606 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.0 m -130.27 121.22 25.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' THR . 46.2 m-85 -116.72 139.84 50.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -114.82 146.66 40.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 118' ' ' ILE . 90.2 m-20 -122.37 154.83 37.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -115.82 143.1 45.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -154.29 121.73 5.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 0.0 109.182 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.8 m -110.15 133.78 52.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.833 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 m -160.3 146.5 15.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -0.881 . . . . 0.0 109.241 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.477 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.2 p -81.19 91.58 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.675 HG21 HD13 ' A' ' 19' ' ' LEU . 1.9 mt -138.65 142.93 35.95 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.301 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.647 ' HD2' HG22 ' A' ' 14' ' ' ILE . 47.4 Cg_endo -68.56 116.31 4.34 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.449 2.1 . . . . 0.0 111.244 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 44.2 Cg_endo -66.45 -27.73 46.62 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.757 2.304 . . . . 0.0 112.36 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.99 6.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.552 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -72.5 -43.25 63.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.675 HD13 HG21 ' A' ' 14' ' ' ILE . 16.2 tp -61.04 -47.97 83.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.887 . . . . 0.0 109.747 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 70.2 t80 -57.3 -50.44 72.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.8 tttt -68.21 -48.38 65.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.553 ' O ' HD22 ' A' ' 30' ' ' LEU . 87.0 p -71.79 -20.84 61.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 110.099 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.937 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 66.0 t80 -100.42 -50.51 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.286 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.645 HG13 ' CD1' ' A' ' 82' ' ' TYR . 54.7 t -84.62 -52.89 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.06 -1.025 . . . . 0.0 110.349 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 15.9 tp -70.24 -29.67 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 91.4 m-20 -110.42 22.14 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.937 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.488 ' OD2' ' NZ ' ' A' ' 55' ' ' LYS . 88.1 m-20 -69.27 -37.05 77.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 87.6 m-20 -96.11 -38.04 10.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.685 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.553 HD22 ' O ' ' A' ' 22' ' ' SER . 16.6 tp -56.5 -42.32 78.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.704 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 34' ' ' VAL . 31.0 mt -49.85 -61.61 3.43 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.333 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.61 -25.1 34.8 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.615 2.21 . . . . 0.0 111.632 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -62.25 -48.85 78.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.607 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 31' ' ' ILE . 4.6 p -59.27 -26.23 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.878 . . . . 0.0 109.666 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.06 103.93 49.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.52 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.1 -12.92 33.15 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.715 2.276 . . . . 0.0 111.726 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -63.29 -28.84 70.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.66 42.03 24.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.88 . . . . 0.0 109.465 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.03 -40.4 89.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.2 t -138.33 158.5 44.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.85 . . . . 0.0 109.484 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 t -136.19 142.84 44.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.945 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -112.17 138.77 48.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.935 . . . . 0.0 109.463 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.89 153.14 45.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 35.5 p-10 -89.03 108.6 19.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.411 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.64 -35.32 78.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.329 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 53' ' ' THR . 48.4 tp10 -137.91 154.28 49.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.482 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 85.48 159.33 31.51 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.52 10.62 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.483 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.83 6.58 43.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.998 ' O ' HG11 ' A' ' 72' ' ' VAL . . . -102.12 -147.99 20.36 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.7 Cg_endo -68.63 129.84 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.71 2.273 . . . . 0.0 111.756 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.65 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 89.46 -5.21 84.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -75.14 139.23 42.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.506 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.525 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.6 mm -104.05 135.14 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' NZ ' ' OD2' ' A' ' 28' ' ' ASP . 29.0 mttt -118.37 140.3 50.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.626 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -123.59 142.54 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.61 135.3 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.8 p -82.37 151.86 26.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 37.9 p90 -139.41 168.75 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -132.88 147.56 52.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 78.8 tt0 48.86 46.84 21.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' PHE . . . -111.95 51.82 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -56.01 -26.33 48.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.16 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -55.17 -43.12 74.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.498 ' HB3' ' HA2' ' A' ' 90' ' ' GLY . 35.0 p90 -127.0 164.49 21.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.505 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' O ' ' CZ ' ' A' ' 59' ' ' PHE . 28.1 mttt -95.78 -74.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -133.55 146.84 51.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.2 mtm -111.45 154.88 24.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.925 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.9 mttt -131.08 144.13 51.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 65.5 m80 -126.56 133.9 50.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.4 tttm -124.45 144.28 50.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.998 HG11 ' O ' ' A' ' 50' ' ' GLY . 7.5 p -98.99 130.43 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -73.39 -46.83 46.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 50.6 tp10 -173.56 143.35 1.03 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.724 HD12 ' HA2' ' A' ' 50' ' ' GLY . 82.6 mt -126.95 125.23 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 8.3 t70 -128.14 105.44 8.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 109.511 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 70.2 m80 -70.24 -35.11 73.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.09 88.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.573 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 83.2 m-20 -85.14 5.33 30.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.551 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 45.11 42.31 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 53.6 pttt -130.44 137.39 49.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.645 ' CD1' HG13 ' A' ' 24' ' ' VAL . 62.0 t80 -126.32 125.03 41.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.468 ' CB ' ' HG3' ' A' ' 102' ' ' GLU . 8.1 t -127.57 115.56 19.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.376 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.5 p90 -129.42 159.57 35.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.515 ' CB ' ' HE3' ' A' ' 98' ' ' LYS . 60.0 p -141.42 167.58 21.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 69' ' ' LYS . 17.9 mt -122.59 132.33 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.4 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.1 mt -80.16 -37.39 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -147.54 131.89 17.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.626 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -144.99 97.51 0.19 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 65' ' ' PHE . . . 45.61 -111.52 0.62 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.443 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 49.8 Cg_endo -70.18 -30.64 20.0 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.703 2.269 . . . . 0.0 111.684 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.555 HD12 HD12 ' A' ' 99' ' ' ILE . 7.9 tp 60.64 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.85 . . . . 0.0 109.464 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.774 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . 175.18 167.12 33.94 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -97.77 121.7 40.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -1.128 . . . . 0.0 109.399 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.802 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 65.81 9.58 6.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.719 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.774 HD12 ' HA3' ' A' ' 93' ' ' GLY . 83.7 mt -90.16 90.7 8.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 108.881 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 123' ' ' HIS . 33.3 mt-10 -48.59 -43.91 36.42 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.753 -0.592 . . . . 0.0 110.831 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' A' ' 85' ' ' SER . 54.9 tttp -150.65 155.17 38.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.616 -1.302 . . . . 0.0 110.464 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.627 HG23 ' CE1' ' A' ' 122' ' ' TYR . 34.1 mt -138.98 116.03 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 87.7 p -125.65 164.51 20.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.451 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 119' ' ' THR . 89.2 m-85 -137.89 120.48 16.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' HG3' ' CB ' ' A' ' 83' ' ' CYS . 83.1 tt0 -101.88 143.33 31.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.118 -0.989 . . . . 0.0 109.917 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.2 mt -128.51 118.36 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 0.0 108.912 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -120.38 139.61 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.615 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.623 ' SD ' HD23 ' A' ' 19' ' ' LEU . 63.8 mtm -122.35 137.49 54.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.262 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.95 40.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.555 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.85 135.72 40.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.13 151.97 95.87 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.504 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.35 -27.43 28.44 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.714 2.276 . . . . 0.0 111.719 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -78.67 -21.86 47.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.308 -0.87 . . . . 0.0 109.421 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.84 8.96 64.65 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.29 -37.74 93.51 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 171.64 -122.59 0.96 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.0 t -134.69 150.69 50.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.409 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.23 132.02 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.487 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 49.5 mt -98.95 137.21 37.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.897 . . . . 0.0 109.357 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.03 131.44 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' ASP . 68.0 mt -118.47 137.57 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 80.8 m -133.1 137.29 46.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.4 m -113.88 154.71 27.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 32.4 mttm -142.12 122.05 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.842 ' O ' HG23 ' A' ' 3' ' ' VAL . 34.7 m-85 -119.43 132.92 55.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.257 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLU . 2.9 m80 -100.31 121.25 41.18 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.75 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -112.09 137.89 49.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.341 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 95' ' ' THR . 71.7 mttt -40.96 -35.12 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.546 -0.722 . . . . 0.0 109.862 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.62 -79.55 0.21 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.98 -29.73 67.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -1.093 . . . . 0.0 109.316 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.802 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -63.5 143.26 57.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.1 m -126.4 154.38 43.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 96' ' ' LEU . 48.6 mt -112.27 132.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 16.0 t-20 -87.04 138.08 31.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.413 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.441 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.2 mt-10 -62.7 -33.04 74.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.433 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 83.0 tt0 -65.62 -46.22 80.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.479 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.18 -45.14 88.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 109.349 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 132' ' ' GLU . 35.8 pt -76.62 -29.19 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.1 tttt -55.63 -45.6 77.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.17 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 109.327 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.06 -38.39 75.86 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.88 -43.75 90.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -1.118 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.28 -43.25 82.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.259 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -57.92 -45.91 85.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.26 -38.6 85.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.127 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.75 96.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -48.21 79.95 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.904 HD13 ' O ' ' A' ' 145' ' ' LEU . 3.1 tm? -60.26 -38.44 83.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -1.131 . . . . 0.0 109.237 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.521 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 71.1 t80 -61.98 -41.39 97.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 0.0 109.298 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -61.0 -41.38 96.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.71 65.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.376 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.4 p -66.72 -41.94 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.491 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.2 tt0 -60.49 -39.94 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.75 99.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.44 -47.18 87.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.608 HD13 ' CD1' ' A' ' 19' ' ' LEU . 24.7 mt -59.92 -34.18 72.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.465 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.484 ' C ' HD23 ' A' ' 154' ' ' LEU . 8.9 tt -64.72 -42.09 95.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -65.01 -31.29 72.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.2 OUTLIER 45.55 60.57 13.45 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.09 -9.04 25.09 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.689 2.259 . . . . 0.0 111.723 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -73.32 -20.07 60.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.358 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 161' ' ' CYS . . . -71.14 142.43 50.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 161' ' ' CYS . 90.9 m-85 51.58 -93.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.304 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.453 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . 96.38 11.95 52.7 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.876 HG21 ' CE1' ' A' ' 123' ' ' HIS . 25.0 t -126.39 142.43 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -1.119 . . . . 0.0 109.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.785 ' HE2' HG21 ' A' ' 124' ' ' THR . 95.2 m-85 -105.73 129.64 53.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.472 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.0 t -107.76 129.74 55.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' THR . 21.9 m-85 -116.36 143.23 45.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -123.33 142.73 50.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -129.16 134.61 48.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.99 138.47 46.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.593 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -168.53 113.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -120.32 147.63 44.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -160.27 143.88 13.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.172 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.784 ' O ' HG23 ' A' ' 13' ' ' VAL . 24.6 m -65.43 90.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.309 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.737 HG23 ' HD2' ' A' ' 15' ' ' PRO . 32.7 mm -138.87 144.18 40.47 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.464 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.737 ' HD2' HG23 ' A' ' 14' ' ' ILE . 47.6 Cg_endo -69.21 112.43 2.98 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.542 2.161 . . . . 0.0 111.287 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.9 Cg_endo -67.0 -29.55 40.4 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.761 2.308 . . . . 0.0 112.264 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 -56.13 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -72.58 -37.45 68.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.773 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.674 HD22 HG21 ' A' ' 14' ' ' ILE . 15.6 tp -67.07 -33.71 76.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.758 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.757 ' CE1' HG21 ' A' ' 24' ' ' VAL . 66.3 t80 -71.56 -47.87 52.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.139 -0.975 . . . . 0.0 109.954 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' HD23 ' A' ' 25' ' ' LEU . 20.0 mttt -71.56 -22.67 61.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.789 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.779 ' O ' HD12 ' A' ' 30' ' ' LEU . 86.6 p -96.84 -23.64 16.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.09 -1.006 . . . . 0.0 109.458 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.925 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 79.9 t80 -100.46 -45.48 5.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.978 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 20' ' ' PHE . 57.8 t -84.58 -52.7 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.98 . . . . 0.0 110.25 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 21' ' ' LYS . 4.0 mm? -69.79 -45.71 67.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 109.618 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 80.5 m-20 -93.73 25.63 3.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 109.591 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.925 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.92 -42.18 73.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.983 . . . . 0.0 109.775 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.57 -20.52 58.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 0.0 109.965 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -94.88 -38.55 10.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.811 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 22' ' ' SER . 18.1 mt -74.51 -30.03 61.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.564 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 27' ' ' ALA . 21.9 mt -55.47 -59.53 10.95 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.302 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 47.7 Cg_endo -68.56 -30.86 28.06 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.607 2.205 . . . . 0.0 111.77 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.464 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 47.3 tttp -59.03 -35.38 73.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.734 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 30' ' ' LEU . 98.9 t -61.07 -41.63 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.575 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.42 125.28 84.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.525 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.8 138.98 35.67 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.636 2.224 . . . . 0.0 111.754 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 55.3 47.11 22.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -131.45 106.45 8.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.404 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -112.25 129.84 56.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.562 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.0 t -135.04 158.27 44.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.8 p -137.26 149.32 47.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.525 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 57' ' ' ILE . . . -143.6 151.81 40.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -134.23 150.43 51.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -87.51 108.91 19.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.685 HD11 ' HD3' ' A' ' 56' ' ' LYS . 58.5 mt -66.48 -32.12 73.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 53' ' ' THR . 78.1 tt0 -147.92 162.7 38.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.531 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 73.88 156.49 4.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -91.42 9.31 32.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 108.29 30.21 3.95 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.902 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -126.95 -143.71 5.87 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.57 120.47 7.13 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.667 2.245 . . . . 0.0 111.809 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.95 -2.66 72.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 46' ' ' GLU . 52.2 m -76.83 138.16 39.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -1.216 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 70' ' ' HIS . 26.1 mm -102.94 134.28 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.898 . . . . 0.0 109.556 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' NZ ' ' OH ' ' A' ' 82' ' ' TYR . 27.3 mttt -112.08 141.99 45.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.343 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.685 ' HD3' HD11 ' A' ' 45' ' ' LEU . 35.3 ttpt -125.32 125.29 43.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 42' ' ' ALA . 61.7 mt -111.76 138.14 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 109.516 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 67.6 m -134.62 133.21 39.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.874 . . . . 0.0 109.312 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' A' ' 61' ' ' GLU . 9.5 t80 -110.12 124.5 51.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.69 78.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.9 . . . . 0.0 109.417 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.571 ' HB2' ' CE1' ' A' ' 59' ' ' PHE . 74.9 mm-40 -96.43 -170.18 2.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.892 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.96 177.96 37.78 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' GLU . 24.9 m120 -89.53 149.36 22.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.198 -1.178 . . . . 0.0 109.455 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 63' ' ' ASN . 82.8 mt-10 43.94 -165.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.507 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -98.94 134.66 41.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.411 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD2' ' CB ' ' A' ' 59' ' ' PHE . 55.7 mttm -90.52 20.45 4.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CE1' ' HD2' ' A' ' 56' ' ' LYS . 63.7 t80 -45.8 114.42 0.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.405 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -137.55 141.31 41.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.629 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -98.45 144.7 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.731 ' O ' HG23 ' A' ' 54' ' ' ILE . 76.0 m80 -130.68 147.01 52.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.479 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 16.3 tttp -135.0 134.86 40.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.14 -0.975 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.405 HG11 ' CG1' ' A' ' 75' ' ' ILE . 46.0 t -98.75 133.22 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -79.38 -43.01 24.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.1 tt0 -176.65 140.02 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.902 HD12 ' HA2' ' A' ' 50' ' ' GLY . 70.4 mt -119.31 126.52 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 75' ' ' ILE . 78.3 m-20 -134.7 76.76 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.7 m170 -55.86 -37.15 68.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.0 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.365 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 80' ' ' PHE . 58.7 m-20 -91.71 12.66 20.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ASN . 91.9 m-85 43.21 39.99 2.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.598 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.466 ' HE2' ' SG ' ' A' ' 83' ' ' CYS . 87.7 tttt -132.07 122.77 25.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.456 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 50.9 t80 -118.62 127.44 53.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' HE2' ' A' ' 81' ' ' LYS . 31.8 m -130.22 121.24 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -135.39 163.05 30.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.458 ' HG ' ' HG ' ' A' ' 100' ' ' SER . 49.9 m -126.38 163.85 22.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.647 ' O ' HD13 ' A' ' 92' ' ' LEU . 12.7 mt -119.97 133.63 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.723 ' C ' HD12 ' A' ' 92' ' ' LEU . 87.3 mt -111.91 -2.31 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.568 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.825 ' N ' HD12 ' A' ' 92' ' ' LEU . 33.5 mt-10 39.23 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.632 -0.668 . . . . 0.0 109.965 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -127.92 -160.98 10.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . -37.82 -72.66 0.17 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 93' ' ' GLY . 53.1 Cg_endo -94.02 2.49 3.05 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.19 2.593 . . . . 0.0 112.381 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 88' ' ' GLU . 1.8 tt 49.79 -88.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.333 -0.854 . . . . 0.0 109.532 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.72 ' N ' HD23 ' A' ' 92' ' ' LEU . . . -98.79 169.98 23.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -85.05 124.61 31.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -1.149 . . . . 0.0 109.654 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 67.85 6.25 4.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 109.779 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 99' ' ' ILE . 95.9 mt -108.34 94.37 5.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.152 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 47.4 mt-10 -41.0 -42.45 1.89 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.7 -0.625 . . . . 0.0 109.888 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.827 ' O ' HD13 ' A' ' 99' ' ' ILE . 31.4 ttpt -177.73 162.17 1.72 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 0.0 109.752 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.985 HD12 ' CD1' ' A' ' 122' ' ' TYR . 5.7 mm -129.6 118.05 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.505 -0.747 . . . . 0.0 109.154 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.458 ' HG ' ' HG ' ' A' ' 85' ' ' SER . 46.9 t -112.08 141.02 46.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 119' ' ' THR . 97.3 m-85 -120.33 143.6 48.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.054 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.9 mt-10 -121.12 143.69 48.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.74 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 82' ' ' TYR . 75.7 mt -122.86 130.82 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.294 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -132.27 133.39 44.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.565 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -112.95 144.49 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.322 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.24 161.75 38.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.11 143.72 33.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 112' ' ' GLY . . . -128.85 152.54 79.17 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.11 -45.41 1.95 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.668 2.245 . . . . 0.0 111.676 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -150.25 159.18 44.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 109.321 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.74 35.28 36.38 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 108' ' ' ALA . . . 123.24 87.34 0.81 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.71 ' H ' HG12 ' A' ' 13' ' ' VAL . . . -46.04 -27.25 2.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.6 m -135.29 139.75 44.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.14 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.477 ' O ' HD23 ' A' ' 116' ' ' LEU . 63.9 mt -107.75 137.67 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 115' ' ' ILE . 33.0 mt -117.21 130.29 56.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 0.0 109.628 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.37 141.38 51.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.52 138.22 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 0.0 109.738 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 28.7 m -126.78 142.57 51.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 100' ' ' SER . 8.9 m -126.58 158.87 35.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.95 . . . . 0.0 109.831 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 86.2 mttt -144.14 118.19 9.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.985 ' CD1' HD12 ' A' ' 99' ' ' ILE . 2.9 m-85 -113.18 113.22 25.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.876 ' CE1' HG21 ' A' ' 3' ' ' VAL . 54.9 m-70 -85.94 116.51 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.785 HG21 ' HE2' ' A' ' 4' ' ' PHE . 1.4 p -107.33 146.14 31.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 109.98 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -80.82 140.69 35.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.46 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.54 67.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.453 ' OD1' ' HA2' ' A' ' 2' ' ' GLY . 30.1 t30 56.14 45.45 23.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 0.0 109.447 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -72.78 142.06 48.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.3 p -82.39 155.42 24.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 21.5 mt -111.57 131.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.83 141.56 58.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.48 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.45 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.6 mt-10 -67.65 -29.64 68.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -65.01 -37.56 88.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.94 -44.91 83.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 132' ' ' GLU . 46.4 pt -80.76 -31.85 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.444 ' N ' HG13 ' A' ' 135' ' ' ILE . 25.6 tttm -57.01 -39.87 75.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.87 73.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.913 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.3 -38.09 94.08 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -59.81 -43.61 94.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.69 -38.9 92.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -63.05 -40.91 99.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.79 -38.63 86.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.77 92.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.17 -42.88 97.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 149' ' ' VAL . 26.3 tp -66.05 -39.53 90.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -1.108 . . . . 0.0 109.334 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.38 -43.11 95.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.867 . . . . 0.0 109.354 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -66.21 -33.85 76.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 34' ' ' VAL . . . -72.74 -49.25 32.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.361 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.794 HG21 ' HD2' ' A' ' 23' ' ' PHE . 7.8 p -63.96 -41.51 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.402 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.515 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.0 tt0 -56.31 -44.39 79.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.397 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.59 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 63.3 t80 -59.96 -49.61 76.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 19' ' ' LEU . 39.1 tp -57.12 -35.49 69.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.522 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.7 tt -62.67 -46.79 86.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.89 71.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.5 m80 50.78 61.2 13.72 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.59 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 51.3 Cg_endo -70.91 -9.7 26.22 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.7 2.266 . . . . 0.0 111.751 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.541 ' O ' ' CE2' ' A' ' 160' ' ' TYR . 53.5 p30 -106.94 9.74 30.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.508 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.93 146.03 55.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.541 ' CE2' ' O ' ' A' ' 158' ' ' ASP . 95.3 m-85 -122.17 138.19 54.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.443 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.73 -27.06 65.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.578 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 43.4 t -131.24 133.95 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -1.138 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.729 ' HE1' HG21 ' A' ' 124' ' ' THR . 96.3 m-85 -103.15 137.06 41.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.493 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.7 m -113.33 119.8 38.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.704 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 31.1 m-85 -115.16 139.87 49.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.4 mt-10 -115.33 147.17 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.81 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' OD2' ' HB ' ' A' ' 118' ' ' ILE . 42.1 m-20 -119.16 154.6 33.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.233 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 117' ' ' LYS . 95.2 mt-10 -124.12 140.91 52.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.36 120.73 6.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 109.114 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.407 HG23 HG12 ' A' ' 115' ' ' ILE . 55.0 m -114.51 129.03 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.933 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 14' ' ' ILE . 34.0 t -160.5 140.58 11.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.87 . . . . 0.0 109.078 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 13' ' ' VAL . 26.1 m -70.93 90.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 0.0 109.4 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.788 HG22 ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -139.17 145.56 45.37 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.788 ' HD2' HG22 ' A' ' 14' ' ' ILE . 46.2 Cg_endo -68.02 124.49 11.86 Favored 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 122.361 2.041 . . . . 0.0 111.243 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.52 -30.59 43.18 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.742 2.295 . . . . 0.0 112.429 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -52.62 8.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.646 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -72.06 -41.62 67.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.748 HD22 ' HB ' ' A' ' 14' ' ' ILE . 22.7 tp -61.48 -48.98 78.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.828 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 61.9 t80 -56.22 -52.75 63.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.812 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 61.9 mttm -67.34 -49.57 63.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 110.017 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.891 ' O ' HD12 ' A' ' 30' ' ' LEU . 86.1 p -69.85 -21.17 63.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 110.219 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.974 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 62.6 t80 -100.22 -49.21 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.963 -1.086 . . . . 0.0 110.194 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 53.2 t -84.56 -52.43 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.5 tp -68.7 -35.22 76.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.046 -1.034 . . . . 0.0 110.184 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.5 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 68.9 m-20 -103.47 19.54 19.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.053 . . . . 0.0 109.868 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.974 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.54 -36.39 76.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 32' ' ' PRO . 87.6 m-20 -68.41 -26.98 65.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.906 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 24.9 m120 -97.6 -51.69 4.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.891 HD12 ' O ' ' A' ' 22' ' ' SER . 36.4 mt -59.17 -39.36 82.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.025 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.546 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 21.1 mt -52.52 -60.25 6.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.591 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.43 -32.31 25.74 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.547 2.165 . . . . 0.0 111.797 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 16.1 tttt -62.06 -31.84 72.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.84 . . . . 0.0 109.621 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 30' ' ' LEU . 61.1 t -59.6 -40.15 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.37 117.76 68.74 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.04 -20.92 32.9 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.693 2.262 . . . . 0.0 111.837 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' O ' ' CB ' ' A' ' 38' ' ' HIS . 93.8 mt-30 -115.0 154.73 28.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.547 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.465 ' CB ' ' O ' ' A' ' 37' ' ' GLN . 10.1 m80 73.04 104.46 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.868 . . . . 0.0 109.529 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.94 136.25 41.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.933 . . . . 0.0 109.363 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.1 m -119.14 143.14 47.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.484 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -131.01 148.35 52.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.488 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.682 ' HB2' HG12 ' A' ' 57' ' ' ILE . . . -141.26 150.06 42.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.565 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.93 156.16 45.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -85.9 107.36 17.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.412 ' HG ' ' HG3' ' A' ' 46' ' ' GLU . 43.9 tp -62.78 -40.75 98.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.729 ' O ' HG23 ' A' ' 53' ' ' THR . 97.7 mt-10 -153.53 162.58 41.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.493 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 87.1 159.49 33.87 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -87.87 9.48 21.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -1.17 . . . . 0.0 109.561 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.723 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.25 13.65 32.77 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.904 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -110.33 -143.68 9.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.77 123.64 10.3 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.651 2.234 . . . . 0.0 111.765 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . 94.44 -4.42 69.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 46' ' ' GLU . 94.5 m -74.1 138.17 43.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.463 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.739 ' N ' HD12 ' A' ' 54' ' ' ILE . 1.7 mp -103.74 126.82 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 25.0 mttm -110.94 145.18 38.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -124.72 127.02 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.522 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.682 HG12 ' HB2' ' A' ' 42' ' ' ALA . 66.8 mt -114.2 137.6 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.411 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.625 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 51.7 m -118.4 134.14 55.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.87 . . . . 0.0 109.471 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -160.2 127.89 4.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 109.462 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 64' ' ' GLU . . . -152.83 158.41 42.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.489 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -62.14 -31.18 71.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.867 . . . . 0.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.35 -54.28 0.79 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -60.32 -35.94 76.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -1.127 . . . . 0.0 109.44 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 95.1 mt-10 -122.55 150.67 42.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.625 ' CZ ' HG21 ' A' ' 58' ' ' THR . 51.8 t80 -108.38 131.78 54.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.521 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -112.15 153.12 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' CE2' ' CE2' ' A' ' 65' ' ' PHE . 98.2 m-85 -116.63 135.27 53.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.3 mtp -134.83 156.43 48.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.36 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 86' ' ' ILE . 93.9 mttt -135.05 141.32 46.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.64 ' CE1' HD12 ' A' ' 57' ' ' ILE . 78.6 m80 -130.77 134.59 47.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -127.02 142.49 51.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.474 HG11 ' CG1' ' A' ' 75' ' ' ILE . 51.9 t -105.82 126.9 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -71.35 -48.65 48.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 83.4 tt0 -166.9 146.02 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.576 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.904 HD12 ' HA2' ' A' ' 50' ' ' GLY . 73.4 mt -122.72 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.382 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 86.2 m-20 -133.4 81.07 1.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.48 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 90.4 m-70 -59.37 -38.57 80.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.26 82.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.433 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 76.9 m-20 -86.16 3.91 40.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 52.73 29.3 7.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -122.45 135.68 54.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CE1' HG12 ' A' ' 75' ' ' ILE . 57.0 t80 -130.08 130.46 44.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.24 115.76 16.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.502 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.4 p90 -136.88 158.48 44.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.623 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.444 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 84.5 p -139.19 169.51 17.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.362 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 69' ' ' LYS . 36.0 mt -117.84 129.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.52 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.5 mt -77.36 -32.92 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -148.52 134.81 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.43 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -145.21 72.42 0.34 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.0 -107.49 0.15 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.9 Cg_endo -69.62 -35.1 13.69 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.732 2.288 . . . . 0.0 111.762 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.485 HD23 HG13 ' A' ' 99' ' ' ILE . 0.4 OUTLIER 63.82 -82.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.406 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -172.96 -167.44 32.89 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -107.9 118.0 35.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.143 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 60.1 22.67 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.579 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.881 ' HB3' HD11 ' A' ' 99' ' ' ILE . 88.6 mt -104.43 96.55 6.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.096 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 123' ' ' HIS . 72.8 mm-40 -59.66 -33.39 71.48 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.766 -0.584 . . . . 0.0 111.034 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.654 ' O ' HD13 ' A' ' 99' ' ' ILE . 34.3 ttpt -142.44 142.74 32.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.474 -1.391 . . . . 0.0 110.793 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.881 HD11 ' HB3' ' A' ' 96' ' ' LEU . 27.2 mm -130.77 113.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 85' ' ' SER . 38.4 t -121.31 152.05 39.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.486 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 81.1 m-85 -131.05 131.9 44.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.031 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.1 mt-10 -118.72 141.77 48.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.801 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.73 127.56 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.839 . . . . 0.0 109.323 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -130.18 131.68 45.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.637 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.424 ' HG2' ' HG ' ' A' ' 116' ' ' LEU . 63.5 mtt -120.56 141.22 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.9 153.68 41.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.62 132.43 42.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.63 116.64 50.06 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.51 -25.66 29.52 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.743 2.295 . . . . 0.0 111.739 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -64.01 -41.4 97.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.349 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 162.75 174.24 32.42 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 114' ' ' SER . . . 82.76 17.95 66.81 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 47.3 -87.52 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 112' ' ' GLY . 34.3 m -131.25 146.83 52.47 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.413 -1.051 . . . . 0.0 109.378 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' C ' HD12 ' A' ' 116' ' ' LEU . 68.8 mt -116.56 135.91 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.5 mp -107.03 140.71 39.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.485 ' O ' HD13 ' A' ' 118' ' ' ILE . 26.7 mmtp -125.3 139.46 53.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 117' ' ' LYS . 10.5 mm -115.0 126.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.687 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 30.8 m -121.23 133.55 55.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.58 157.42 42.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.955 . . . . 0.0 109.93 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -134.03 117.47 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.815 ' HB3' HD22 ' A' ' 96' ' ' LEU . 13.9 m-30 -109.81 118.81 37.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.578 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 2.2 t60 -85.73 127.06 34.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.729 HG21 ' HE1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -109.43 146.82 33.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.8 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -71.33 135.61 47.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 55.07 -145.2 30.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 128' ' ' ALA . 48.5 p-10 -87.45 17.16 4.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 127' ' ' ASN . . . -44.5 144.41 1.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -114.47 157.0 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.677 HD12 ' CD1' ' A' ' 4' ' ' PHE . 64.4 mt -110.12 140.18 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 10.1 t-20 -79.4 133.43 36.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.412 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.454 ' HA ' HG12 ' A' ' 135' ' ' ILE . 96.4 mt-10 -65.33 -34.99 79.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.446 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 79.0 tt0 -66.64 -35.31 79.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.52 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.6 mt-10 -67.89 -38.13 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.704 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 38.4 pt -78.16 -39.5 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.517 ' N ' HG13 ' A' ' 135' ' ' ILE . 24.1 mttm -59.41 -37.94 79.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.9 73.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.11 -40.81 84.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -60.1 -43.48 95.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.171 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.37 -44.8 76.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.433 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.14 -45.82 89.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.91 79.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -0.952 . . . . 0.0 109.409 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.86 88.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.44 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.96 -45.26 95.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.558 ' O ' HG12 ' A' ' 149' ' ' VAL . 57.7 mt -60.96 -38.97 87.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -1.095 . . . . 0.0 109.375 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.478 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 67.1 t80 -57.22 -45.84 83.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.37 -40.53 91.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.08 -52.07 46.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 145' ' ' LEU . 7.5 p -64.69 -40.59 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.487 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.1 tt0 -56.45 -42.34 77.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.35 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.3 99.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.356 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.586 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 73.4 t80 -59.64 -44.59 93.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 36.4 tp -60.82 -35.31 76.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.893 . . . . 0.0 109.385 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.1 tt -61.93 -45.64 92.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.923 . . . . 0.0 109.34 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.14 -32.17 72.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 48.54 61.39 14.03 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 48.8 Cg_endo -69.98 -14.19 35.08 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.696 2.264 . . . . 0.0 111.744 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -66.18 -33.63 76.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.84 145.78 51.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -118.21 138.15 52.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.413 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.401 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.35 146.84 50.63 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.72 HG21 ' CE1' ' A' ' 123' ' ' HIS . 24.7 t -132.52 133.85 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.832 ' HE1' HG21 ' A' ' 124' ' ' THR . 96.7 m-85 -90.38 140.34 29.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.172 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' SER . 26.6 p -125.52 127.04 45.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 119' ' ' THR . 93.5 m-85 -123.78 143.89 50.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.262 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -123.41 147.97 46.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.76 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -132.46 134.0 44.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.204 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -107.76 134.52 50.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.756 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.74 123.22 19.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 109.118 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.453 HG23 HG12 ' A' ' 115' ' ' ILE . 28.8 m -109.73 133.22 53.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.937 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.9 m -160.42 139.94 10.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 109.003 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.532 ' O ' HG13 ' A' ' 13' ' ' VAL . 2.6 p -73.79 90.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.965 -1.084 . . . . 0.0 109.217 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.688 HG23 ' HD2' ' A' ' 15' ' ' PRO . 10.3 mt -139.48 144.29 39.13 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.136 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.688 ' HD2' HG23 ' A' ' 14' ' ' ILE . 43.7 Cg_endo -66.42 121.96 9.33 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.369 2.046 . . . . 0.0 111.165 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HG3' ' HB2' ' A' ' 107' ' ' ALA . 45.4 Cg_endo -66.79 -29.24 42.53 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.724 2.283 . . . . 0.0 112.241 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.24 -52.93 7.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.443 ' HG2' ' HB2' ' A' ' 161' ' ' CYS . 60.5 mtt85 -72.03 -39.35 69.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.753 HD13 ' C ' ' A' ' 19' ' ' LEU . 3.4 tm? -63.06 -51.88 64.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.0 t80 -56.85 -51.3 69.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.781 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.7 tttp -68.36 -50.22 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.83 ' O ' HD22 ' A' ' 30' ' ' LEU . 69.0 p -68.08 -21.26 64.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.04 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.907 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 12.5 t80 -100.06 -50.61 3.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.063 -1.023 . . . . 0.0 110.115 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 61.8 t -84.68 -52.66 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.26 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.4 tp -68.88 -44.83 72.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.888 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 30' ' ' LEU . 20.7 m-20 -98.99 30.31 3.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.907 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.26 -47.27 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.774 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.68 ' HA ' HD12 ' A' ' 31' ' ' ILE . 50.6 m-20 -69.44 -25.82 64.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.992 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.71 -39.12 18.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.687 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.938 ' O ' HG13 ' A' ' 34' ' ' VAL . 7.0 mp -76.02 -29.03 57.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 1.041 ' O ' HG22 ' A' ' 34' ' ' VAL . 17.6 mt -52.88 -59.28 9.27 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.527 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -68.46 -31.56 27.27 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.574 2.183 . . . . 0.0 111.958 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.579 ' HB3' ' CE2' ' A' ' 152' ' ' TYR . 73.8 mttt -63.1 -36.82 84.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.723 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.041 HG22 ' O ' ' A' ' 31' ' ' ILE . 4.5 m -62.06 -23.4 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.698 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -106.54 165.85 12.22 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.622 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.667 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 49.4 Cg_endo -69.67 -29.34 24.46 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.706 2.271 . . . . 0.0 111.81 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -136.6 150.19 48.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.852 . . . . 0.0 109.443 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.484 ' CG ' ' N ' ' A' ' 39' ' ' PHE . 46.4 p-80 -51.89 -41.31 61.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.484 ' N ' ' CG ' ' A' ' 38' ' ' HIS . 9.6 t80 71.13 -58.17 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.88 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 58' ' ' THR . 10.9 p -127.09 160.9 29.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.7 t -130.31 140.97 50.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.434 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.34 138.52 49.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -127.74 143.09 51.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.858 . . . . 0.0 109.413 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.432 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 81.0 m-20 -87.14 108.61 18.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.988 HD11 ' HB2' ' A' ' 56' ' ' LYS . 2.2 mp -68.85 -39.19 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 53' ' ' THR . 49.5 tp10 -150.05 153.23 36.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 90.79 157.74 33.95 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -93.47 10.26 33.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.584 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.1 27.99 6.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.895 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -122.16 -145.63 7.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 51.2 Cg_endo -70.23 123.34 9.86 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.744 2.296 . . . . 0.0 111.884 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.01 83.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 ' HA2' ' A' ' 49' ' ' GLY . 56.9 m -72.75 137.6 45.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -1.223 . . . . 0.0 109.44 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.681 HG22 HD13 ' A' ' 45' ' ' LEU . 25.2 mm -101.03 129.75 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 17.6 mttt -126.55 145.95 50.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.882 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.988 ' HB2' HD11 ' A' ' 45' ' ' LEU . 28.2 ttpt -130.82 138.84 50.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.366 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.659 HG23 ' CE2' ' A' ' 59' ' ' PHE . 9.7 tt -117.48 137.31 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.536 HG21 ' CE1' ' A' ' 65' ' ' PHE . 8.7 p -98.28 151.72 20.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.356 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.659 ' CE2' HG23 ' A' ' 57' ' ' ILE . 92.8 m-85 -127.44 165.81 19.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.549 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.81 -11.8 49.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 109.464 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 67' ' ' TYR . 76.2 mm-40 -50.58 154.15 1.43 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.86 -37.7 15.52 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -84.21 125.45 32.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -1.147 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.553 ' HG2' ' CD2' ' A' ' 65' ' ' PHE . 71.1 tt0 -121.71 150.0 42.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.384 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.553 ' CD2' ' HG2' ' A' ' 64' ' ' GLU . 95.3 m-85 59.41 18.83 7.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.253 -0.904 . . . . 0.0 109.444 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -167.2 28.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.308 -0.87 . . . . 0.0 109.351 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.517 ' CZ ' ' HG3' ' A' ' 61' ' ' GLU . 70.4 t80 -99.4 -24.44 14.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 109.495 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.486 ' HG3' ' CD2' ' A' ' 67' ' ' TYR . 38.9 mtt -159.75 139.38 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.943 . . . . 0.0 109.381 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 94.2 mttt -107.8 148.54 29.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.454 ' HB3' ' O ' ' A' ' 55' ' ' LYS . 35.4 t-80 -129.79 131.26 46.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.6 tttp -131.88 136.17 47.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.497 HG11 ' CG1' ' A' ' 75' ' ' ILE . 39.6 t -99.36 129.17 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.406 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -76.39 -42.29 44.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 85.4 tt0 -175.27 141.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.895 HD12 ' HA2' ' A' ' 50' ' ' GLY . 66.7 mt -119.85 131.24 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -129.95 85.69 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.567 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 87.8 m-70 -62.34 -37.24 84.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.92 70.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -88.99 -3.07 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 57.9 34.55 24.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.495 ' HE2' ' CE ' ' A' ' 104' ' ' LYS . 25.5 mttt -128.95 129.56 45.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CE2' HG12 ' A' ' 75' ' ' ILE . 62.1 t80 -120.16 124.13 45.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.898 . . . . 0.0 109.531 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.05 115.03 19.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.487 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.3 p90 -128.97 152.41 48.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.51 ' HB3' ' HE2' ' A' ' 98' ' ' LYS . 9.7 m -132.02 146.72 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.526 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.16 150.2 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.594 HG22 ' HG3' ' A' ' 88' ' ' GLU . 88.6 mt -104.02 -34.65 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.594 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.8 mt-10 -151.75 143.44 23.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -158.52 136.52 4.78 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . -30.96 -66.52 0.15 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 93' ' ' GLY . 54.7 Cg_endo -74.37 -33.83 5.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.517 2.145 . . . . 0.0 111.488 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' PRO . 5.4 tp 36.87 -92.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.812 -0.555 . . . . 0.0 110.261 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.9 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . 171.99 156.21 11.94 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -81.26 125.5 30.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 109.644 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.773 HG22 ' H ' ' A' ' 125' ' ' LYS . 16.0 m 51.87 19.78 1.04 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.9 HD12 ' HA3' ' A' ' 93' ' ' GLY . 51.7 mt -91.09 87.87 6.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 0.0 109.043 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.5 mt-10 -39.93 -35.47 0.36 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.761 -0.587 . . . . 0.0 110.401 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HE2' ' HB3' ' A' ' 85' ' ' SER . 31.7 tttt -169.08 160.91 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.766 -1.209 . . . . 0.0 110.371 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.783 HG23 ' CE1' ' A' ' 122' ' ' TYR . 27.2 mt -137.14 117.62 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 48.4 t -118.35 152.66 35.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.977 . . . . 0.0 109.906 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.533 ' OH ' HG21 ' A' ' 99' ' ' ILE . 84.1 m-85 -130.76 136.07 48.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.813 . . . . 0.0 109.175 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 86.8 mt-10 -114.62 143.21 45.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.711 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 79.0 mt -118.51 130.79 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.258 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.495 ' CE ' ' HE2' ' A' ' 81' ' ' LYS . 19.8 tttt -127.97 131.51 49.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.608 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.496 ' SD ' HD12 ' A' ' 19' ' ' LEU . 63.3 mtt -122.29 146.25 47.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.386 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -141.27 151.32 43.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.487 ' HB2' ' HG3' ' A' ' 16' ' ' PRO . . . -104.56 139.27 39.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -130.85 103.7 15.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.9 142.88 48.5 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.733 2.289 . . . . 0.0 111.706 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 61.53 34.31 17.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.25 -169.94 13.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -51.29 -39.07 42.35 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 148.56 -109.98 0.47 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.1 p -117.93 151.71 36.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -1.2 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.453 HG12 HG23 ' A' ' 11' ' ' THR . 69.3 mt -119.34 131.6 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.799 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.2 mp -108.32 136.85 47.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.584 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 90.9 mttt -119.01 144.04 46.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.26 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.6 mt -124.1 131.09 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.945 . . . . 0.0 109.571 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 23.5 m -119.48 142.49 48.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . 64.8 m -123.18 146.33 47.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 51.6 mtmt -135.67 127.39 29.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.811 ' HB3' HD22 ' A' ' 96' ' ' LEU . 25.7 m-85 -125.89 122.2 35.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 109.853 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.72 ' CE1' HG21 ' A' ' 3' ' ' VAL . 90.1 m-70 -89.72 116.97 28.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 108.673 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.832 HG21 ' HE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -104.98 142.29 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.618 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.773 ' H ' HG22 ' A' ' 95' ' ' THR . 31.0 ttpt -84.85 128.16 34.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.6 67.28 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 m120 58.95 40.28 22.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.473 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -69.82 140.59 53.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.293 -0.88 . . . . 0.0 109.54 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 55.3 p -80.16 156.6 26.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.719 HG12 HD21 ' A' ' 96' ' ' LEU . 40.4 mt -113.82 130.89 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 109.686 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.479 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 46.5 t-20 -60.04 131.81 52.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.401 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.6 mt-10 -65.87 -33.66 76.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.338 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.26 -36.44 82.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.479 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 75.5 mm-40 -64.62 -43.81 92.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.436 HG13 ' N ' ' A' ' 136' ' ' LYS . 34.8 pt -75.49 -32.85 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.436 ' N ' HG13 ' A' ' 135' ' ' ILE . 16.7 tttp -55.7 -45.33 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.25 -40.73 71.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.258 -0.902 . . . . 0.0 109.339 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.44 -40.16 95.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -60.3 -40.5 90.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -1.18 . . . . 0.0 109.279 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.74 -40.43 97.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 67.5 tttt -59.13 -44.76 92.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.275 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.88 93.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.89 -43.25 93.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.874 . . . . 0.0 109.332 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.65 -43.2 96.39 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.668 ' O ' HG13 ' A' ' 149' ' ' VAL . 40.3 mt -65.63 -40.45 92.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -1.161 . . . . 0.0 109.272 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -66.05 -40.54 91.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -68.0 -35.93 79.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.296 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.21 -51.55 52.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 145' ' ' LEU . 3.6 m -64.87 -46.6 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.364 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.583 ' N ' HG23 ' A' ' 149' ' ' VAL . 83.7 tt0 -56.19 -35.49 67.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.51 -36.03 81.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 33' ' ' LYS . 63.6 t80 -62.3 -43.19 99.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.406 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.53 -42.9 97.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.324 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.449 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 31.0 mt -73.25 -27.33 61.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.538 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.8 -21.98 59.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.505 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.69 61.31 3.43 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 50.0 Cg_endo -70.3 -16.3 35.24 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.619 2.212 . . . . 0.0 111.914 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.477 ' O ' ' CE2' ' A' ' 160' ' ' TYR . 88.5 m-20 -61.12 -36.48 79.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.514 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.34 139.88 14.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.525 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 158' ' ' ASP . 93.0 m-85 -117.09 144.84 44.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.38 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.443 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.454 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.297 0.57 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.62 15.96 76.71 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' A' ' 123' ' ' HIS . 29.3 t -128.68 128.56 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -1.116 . . . . 0.0 109.344 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.803 ' HE1' HG21 ' A' ' 124' ' ' THR . 97.1 m-85 -85.61 136.46 33.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 120' ' ' SER . 36.0 t -122.55 129.17 51.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.96 . . . . 0.0 109.705 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.51 ' CD1' HG21 ' A' ' 135' ' ' ILE . 77.6 m-85 -129.39 147.16 51.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.147 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -119.3 139.74 51.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.712 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 91.2 m-20 -110.36 150.63 28.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.379 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -115.89 137.68 51.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 109.865 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.0 122.66 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.79 . . . . 0.0 109.018 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -127.51 137.41 52.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.975 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 t -160.49 150.08 17.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 108.992 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 13' ' ' VAL . 6.3 p -74.59 91.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 0.0 109.446 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.924 HG21 HD13 ' A' ' 19' ' ' LEU . 1.8 mt -138.85 143.5 37.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.635 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.9 Cg_endo -67.62 124.62 12.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.399 2.066 . . . . 0.0 111.44 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.76 -35.74 26.79 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.253 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.78 -49.56 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -72.43 -46.03 56.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.91 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.924 HD13 HG21 ' A' ' 14' ' ' ILE . 19.7 tp -60.33 -42.97 96.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.995 . . . . 0.0 109.719 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.686 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 68.9 t80 -62.39 -47.78 82.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.759 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.725 ' HG3' HD12 ' A' ' 25' ' ' LEU . 70.6 tttt -68.35 -41.34 80.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.676 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 86.3 p -77.7 -24.62 49.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.96 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 13.7 t80 -100.48 -50.74 3.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.404 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.686 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.1 t -84.8 -52.63 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.527 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.725 HD12 ' HG3' ' A' ' 21' ' ' LYS . 59.3 mt -71.63 -32.62 68.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.045 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 92.0 m-20 -106.58 23.05 14.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.96 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.66 -41.81 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.598 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 31' ' ' ILE . 26.1 p-10 -71.03 -34.03 70.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.85 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.3 m-20 -88.69 -31.71 18.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.801 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.0 tp -73.74 -21.74 60.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 27' ' ' ALA . 15.5 mt -65.81 -57.24 14.43 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.6 -27.71 32.32 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.472 2.114 . . . . 0.0 111.744 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -67.37 -45.66 75.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 109.459 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.565 HG21 ' HB1' ' A' ' 148' ' ' ALA . 7.1 p -69.29 -34.7 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.67 135.48 90.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.407 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.73 -22.94 31.51 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.721 2.281 . . . . 0.0 111.811 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -110.56 135.67 50.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -107.42 10.21 29.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -61.43 -30.91 70.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.394 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 58' ' ' THR . 58.3 m -107.49 137.15 46.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.5 p -147.28 163.59 35.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.552 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.59 139.23 47.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -138.0 156.37 47.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.399 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 36.2 p-10 -90.19 108.22 19.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.424 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 45' ' ' LEU . 23.0 tp -64.35 -37.72 88.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 49.2 tp10 -141.54 155.44 45.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 91.31 161.34 37.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.7 9.17 30.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -1.159 . . . . 0.0 109.486 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.871 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 99.53 19.19 21.22 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.861 ' O ' HG11 ' A' ' 72' ' ' VAL . . . -114.92 -141.37 7.5 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.49 123.1 9.86 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.708 2.272 . . . . 0.0 111.781 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.678 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 91.84 0.83 71.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.6 m -77.0 136.19 38.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -1.17 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 70' ' ' HIS . 7.8 mt -105.36 139.44 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 62.1 mttm -116.09 145.76 42.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -129.45 142.59 50.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -100.66 137.49 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 40' ' ' THR . 91.6 m -86.06 141.51 29.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.895 . . . . 0.0 109.453 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.567 ' O ' ' CD2' ' A' ' 59' ' ' PHE . 64.3 t80 45.54 56.83 5.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.03 149.57 23.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 62' ' ' GLY . 96.7 mt-10 -54.44 142.54 26.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . -44.05 118.86 2.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 65' ' ' PHE . 8.8 p30 -145.15 -172.54 3.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -1.132 . . . . 0.0 109.407 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.474 ' HB3' ' HA2' ' A' ' 90' ' ' GLY . 84.5 tt0 -56.45 -41.27 76.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.407 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' CE2' ' OE1' ' A' ' 88' ' ' GLU . 97.2 m-85 -106.15 144.08 33.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -64.85 -36.17 83.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.362 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.52 148.0 49.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.397 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.415 ' HE2' ' CG ' ' A' ' 63' ' ' ASN . 64.8 mtt -110.29 151.16 27.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.957 . . . . 0.0 109.554 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -116.85 140.01 49.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.651 ' O ' HG23 ' A' ' 54' ' ' ILE . 91.7 m-70 -127.88 138.63 52.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.565 ' HD2' HD11 ' A' ' 87' ' ' ILE . 51.5 tttm -133.56 151.24 51.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.543 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 50' ' ' GLY . 11.3 p -110.81 132.3 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.484 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -72.98 -44.12 61.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -176.07 140.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.841 HD12 ' HA2' ' A' ' 50' ' ' GLY . 66.1 mt -118.09 127.02 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 79' ' ' ASN . 89.3 m-20 -122.27 85.09 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.546 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 85.5 m-70 -60.26 -38.8 84.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.76 -30.54 65.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.488 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 76' ' ' ASP . 58.2 t30 -90.56 7.23 40.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 46.03 36.99 3.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -128.17 128.42 44.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.319 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 63.1 t80 -120.11 125.58 48.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 58.4 m -127.45 114.05 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.53 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.8 p90 -129.48 163.03 26.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' A' ' 100' ' ' SER . 43.5 t -150.54 162.75 40.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.37 141.1 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 71' ' ' LYS . 80.6 mt -92.35 -35.42 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.9 . . . . 0.0 109.307 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.547 ' OE1' ' CE2' ' A' ' 65' ' ' PHE . 29.8 tt0 -154.08 124.79 7.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.543 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -136.78 143.96 15.45 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . -32.74 -67.23 0.19 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 93' ' ' GLY . 54.4 Cg_endo -74.27 -31.22 7.73 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.382 2.055 . . . . 0.0 111.28 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 91' ' ' PRO . 6.6 tp 36.5 -91.4 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.153 0.501 . . . . 0.0 110.264 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 176.2 167.84 35.55 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.455 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 56.5 m170 -90.36 129.88 36.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 128' ' ' ALA . 1.1 m 46.23 24.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.12 HD21 HD11 ' A' ' 130' ' ' ILE . 27.0 mt -101.6 92.98 5.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.084 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.6 mt-10 -45.63 -36.13 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 0.0 110.728 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 1.072 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.2 tttp -163.38 157.94 20.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.656 -1.277 . . . . 0.0 110.503 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.072 HD13 ' O ' ' A' ' 98' ' ' LYS . 5.3 mm -133.0 119.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.748 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.505 ' CB ' ' HB2' ' A' ' 85' ' ' SER . 38.4 m -120.14 144.44 47.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 109.74 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -125.76 128.62 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.342 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 89.5 mt-10 -105.06 143.71 32.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.459 HD11 ' HE1' ' A' ' 84' ' ' TYR . 77.8 mt -128.8 118.67 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -127.41 134.67 49.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.424 ' HG2' ' HG ' ' A' ' 116' ' ' LEU . 63.4 mtm -118.97 145.79 45.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.464 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.72 157.5 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.02 139.84 30.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.892 . . . . 0.0 109.314 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . -104.87 125.2 34.4 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 109.661 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.91 -49.58 0.53 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.694 2.263 . . . . 0.0 111.704 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -76.83 -48.26 18.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.375 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -57.69 -29.11 60.92 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.66 27.42 69.3 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -151.93 -133.13 1.93 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -139.93 145.15 37.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -1.129 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.477 HG13 ' HB2' ' A' ' 108' ' ' ALA . 62.8 mt -111.31 130.62 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.828 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.1 mp -105.41 134.13 49.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -126.37 139.18 53.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.075 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 72.7 mt -124.81 140.97 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.828 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 26.9 m -123.56 142.5 50.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 m -121.41 153.3 38.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.776 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 64.3 mttm -142.25 124.97 15.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.185 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.984 ' CD1' HG23 ' A' ' 99' ' ' ILE . 9.6 m-85 -123.85 113.97 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.707 ' CE1' HG21 ' A' ' 3' ' ' VAL . 41.3 m-70 -80.49 114.19 19.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 108.86 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.803 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.1 p -102.83 142.37 34.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 0.0 109.593 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.515 ' HD2' HG23 ' A' ' 95' ' ' THR . 39.1 mttt -44.66 -43.03 8.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.8 -68.14 0.31 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.24 -30.33 71.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -1.167 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.0 m -127.95 154.3 45.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.391 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 1.12 HD11 HD21 ' A' ' 96' ' ' LEU . 29.4 mm -105.38 120.19 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.494 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.417 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 24.8 t-20 -75.79 142.31 42.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 135' ' ' ILE . 97.1 mt-10 -57.76 -28.08 63.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -66.87 -35.68 80.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 108.864 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.1 mt-10 -61.82 -25.0 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.172 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.817 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.4 OUTLIER -80.8 -39.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -56.18 -40.36 73.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.04 -48.65 73.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.294 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.02 -37.41 71.03 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -58.62 -43.68 89.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -1.139 . . . . 0.0 109.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -57.19 -48.39 78.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.072 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -59.35 -45.89 90.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.217 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.38 89.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 0.0 109.208 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.32 88.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.39 86.06 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.57 -38.07 74.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -1.117 . . . . 0.0 109.284 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.463 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 69.5 t80 -62.39 -43.66 98.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -60.23 -39.78 87.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.565 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -65.0 -50.01 67.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 150' ' ' GLU . 5.8 p -63.72 -42.8 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.498 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.2 tt0 -61.21 -42.4 98.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.09 78.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 30' ' ' LEU . 51.5 t80 -60.96 -52.2 66.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 34.7 mt -53.21 -42.74 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.4 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.9 mt -59.95 -45.67 91.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB3' ' HD3' ' A' ' 157' ' ' PRO . . . -59.14 -25.46 63.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.391 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.452 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 1.3 t-80 43.84 53.59 10.41 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 152' ' ' TYR . 50.0 Cg_endo -70.09 -19.06 35.06 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.688 2.259 . . . . 0.0 111.848 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -61.26 -36.21 79.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.1 145.33 28.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.23 141.8 47.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.453 179.949 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 124' ' ' THR . . . 91.57 4.84 67.48 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.793 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.1 p -122.3 143.53 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -1.207 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.687 ' HE2' HG21 ' A' ' 124' ' ' THR . 90.4 m-85 -105.76 143.2 34.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 120' ' ' SER . 4.2 m -128.8 124.54 35.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.583 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.564 ' CE2' ' CD1' ' A' ' 135' ' ' ILE . 81.1 m-85 -119.59 152.07 37.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.7 mt-10 -126.37 154.98 42.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.47 ' OD2' ' HE2' ' A' ' 139' ' ' LYS . 54.5 t0 -126.77 151.42 48.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 93.2 mt-10 -122.38 135.5 54.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.46 124.21 15.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.489 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.412 HG23 HG12 ' A' ' 115' ' ' ILE . 33.4 m -116.48 126.69 53.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.915 . . . . 0.0 109.682 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p -160.29 146.64 15.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 109.25 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 13' ' ' VAL . 18.9 m -78.54 91.38 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.472 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.967 HG21 HD13 ' A' ' 19' ' ' LEU . 8.8 mt -138.79 144.69 42.75 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.734 ' HD2' HG23 ' A' ' 14' ' ' ILE . 47.8 Cg_endo -68.7 123.35 10.35 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.536 2.158 . . . . 0.0 111.259 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.9 -27.76 43.1 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.745 2.296 . . . . 0.0 112.453 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.95 -54.62 6.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 109.527 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -72.62 -31.37 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.86 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.967 HD13 HG21 ' A' ' 14' ' ' ILE . 25.9 tp -71.96 -45.41 61.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.825 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 58.1 t80 -64.72 -33.19 75.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.521 ' HA ' HD13 ' A' ' 25' ' ' LEU . 33.7 tttp -83.09 -30.32 28.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.894 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 81.3 p -97.58 -14.68 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.818 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 1.067 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 76.7 t80 -100.89 -50.03 3.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 47.2 t -84.83 -49.81 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.356 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.7 mp -76.34 -39.74 53.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.58 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 30' ' ' LEU . 41.2 m-20 -92.78 10.53 30.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.014 . . . . 0.0 110.311 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.067 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.74 -34.31 73.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.888 -1.132 . . . . 0.0 109.414 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.26 -30.43 70.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 92.6 m-20 -114.81 -45.49 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.037 . . . . 0.0 109.973 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.746 ' O ' HD23 ' A' ' 30' ' ' LEU . 7.8 tt -57.41 -38.32 74.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.728 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.752 ' O ' HG12 ' A' ' 34' ' ' VAL . 12.0 mm -50.38 -61.37 3.85 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 109.453 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.544 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.3 Cg_endo -68.53 -30.01 29.65 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.378 2.052 . . . . 0.0 111.632 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -54.94 -51.61 65.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.52 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 31' ' ' ILE . 5.7 p -58.75 -23.97 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.902 . . . . 0.0 109.333 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 32' ' ' PRO . . . -74.81 122.18 86.9 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.9 -23.0 30.64 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.63 2.22 . . . . 0.0 111.784 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 38' ' ' HIS . 96.1 mt-30 -132.98 163.09 29.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' GLN . 17.9 m80 70.15 92.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.464 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -101.74 131.85 47.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.511 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 59' ' ' PHE . 7.7 p -126.93 165.11 20.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.9 . . . . 0.0 109.442 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -129.94 144.94 51.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.418 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.9 143.76 42.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -145.4 147.66 32.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -93.62 109.0 20.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -38.55 88.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 53' ' ' THR . 85.4 tt0 -144.84 159.11 43.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.528 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.98 158.52 29.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -88.6 9.2 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -1.144 . . . . 0.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.812 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 102.47 23.94 8.61 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.766 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -120.81 -140.62 6.02 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.31 121.92 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.684 2.256 . . . . 0.0 111.793 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.32 -2.87 75.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.812 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.8 m -72.69 136.95 45.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -1.217 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.468 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 22.5 mm -94.09 135.17 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -108.65 133.2 53.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -122.13 132.77 54.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.224 -0.923 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.7 mt -111.49 134.87 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.575 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.9 p -128.72 151.18 49.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.405 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.56 ' CD1' ' OE2' ' A' ' 64' ' ' GLU . 87.3 m-85 -114.79 140.9 48.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.962 . . . . 0.0 109.555 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.48 90.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.487 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.93 142.45 58.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.73 14.98 57.44 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -86.39 4.58 38.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -1.13 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.56 ' OE2' ' CD1' ' A' ' 59' ' ' PHE . 86.6 tt0 -105.32 142.11 35.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 0.0 109.53 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 96.2 m-85 -124.96 154.81 40.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -0.958 . . . . 0.0 109.437 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 5.4 ttpm? 64.1 74.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.422 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -60.22 170.16 1.38 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.603 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 88' ' ' GLU . 62.4 mmm -123.19 144.46 49.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.846 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -116.07 150.27 37.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.917 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -122.76 153.02 40.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 21.3 tttt -131.9 147.22 52.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 53' ' ' THR . 9.8 p -111.54 136.84 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.2 tt0 -80.03 -51.17 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 95.0 mt-10 -158.97 148.18 18.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.766 HD12 ' HA2' ' A' ' 50' ' ' GLY . 72.0 mt -125.08 126.58 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -127.03 94.1 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 77.2 t60 -70.26 -39.76 74.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.55 76.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -88.9 8.86 27.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 45.25 35.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HG3' ' HG2' ' A' ' 104' ' ' LYS . 37.5 tttm -124.14 137.96 54.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.552 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.1 t80 -136.97 123.59 21.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 74' ' ' GLU . 4.2 p -125.4 120.31 30.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.614 ' HE2' HD11 ' A' ' 86' ' ' ILE . 40.3 p90 -132.75 156.02 47.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.712 ' O ' HD13 ' A' ' 86' ' ' ILE . 23.0 t -119.05 172.0 7.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 85' ' ' SER . 33.3 mm -125.45 125.03 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.795 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.687 ' C ' HD12 ' A' ' 92' ' ' LEU . 17.7 pt -107.01 -3.96 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.775 ' N ' HD12 ' A' ' 92' ' ' LEU . 21.5 mt-10 41.04 -93.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.952 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -178.41 117.82 0.59 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.63 -119.28 6.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 93' ' ' GLY . 52.4 Cg_endo -72.63 -12.86 27.08 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.524 2.149 . . . . 0.0 111.828 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 93' ' ' GLY . 1.3 tt 53.83 -86.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.859 ' N ' HD23 ' A' ' 92' ' ' LEU . . . -103.51 176.9 24.5 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 92.8 m-70 -96.22 134.53 39.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -1.199 . . . . 0.0 109.632 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.6 22.76 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.912 ' HB3' HD11 ' A' ' 99' ' ' ILE . 33.0 mt -116.13 98.85 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.357 -0.839 . . . . 0.0 109.369 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 89.6 mt-10 -48.52 -48.41 38.31 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.587 -0.695 . . . . 0.0 110.155 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.904 ' O ' HD13 ' A' ' 99' ' ' ILE . 47.2 mtmt -155.22 158.57 39.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.867 -1.146 . . . . 0.0 110.47 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.912 HD11 ' HB3' ' A' ' 96' ' ' LEU . 5.6 mm -135.74 114.68 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 25.4 t -125.85 149.6 48.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.005 . . . . 0.0 109.946 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HE1' ' HH ' ' A' ' 122' ' ' TYR . 91.8 m-85 -128.05 126.46 41.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 109.164 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.1 mt-10 -105.34 141.71 36.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.874 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.03 122.86 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -0.855 . . . . 0.0 109.173 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 18.8 mtpp -123.48 137.28 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.723 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -116.61 141.84 47.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -141.06 155.12 46.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.619 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.88 132.93 40.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 109.301 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.29 111.67 38.25 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.46 -50.68 0.37 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.713 2.275 . . . . 0.0 111.669 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.05 -49.24 78.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.93 . . . . 0.0 109.403 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.74 -29.68 72.81 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.39 35.4 26.44 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . -170.18 -129.76 1.14 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.3 t -148.12 150.18 33.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -1.124 . . . . 0.0 109.508 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.412 HG12 HG23 ' A' ' 11' ' ' THR . 67.8 mt -116.8 133.9 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.731 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.2 mp -111.16 138.53 47.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -123.9 139.29 54.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.265 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 70.8 mt -121.15 138.34 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 33.1 m -125.58 142.61 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 44.3 m -126.92 152.4 47.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -133.98 133.25 41.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 108.946 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.793 ' C ' HG23 ' A' ' 3' ' ' VAL . 37.9 m-85 -133.32 104.52 6.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.949 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.549 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 28.6 m80 -83.41 122.47 28.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.687 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -102.58 150.03 23.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.963 -1.086 . . . . 0.0 109.876 -178.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -79.92 131.41 35.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 68.76 -144.05 41.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -94.36 17.39 13.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.4 146.91 14.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.509 ' HA ' ' CE2' ' A' ' 4' ' ' PHE . 38.2 m -127.21 154.79 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.578 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 22.6 mt -108.41 130.37 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -72.88 142.87 47.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.456 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.9 mt-10 -65.9 -31.47 72.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.538 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -44.74 83.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -43.56 88.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.564 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 38.3 pt -79.85 -29.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.7 tttm -56.26 -41.14 75.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.4 74.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.31 -38.53 78.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.47 ' HE2' ' OD2' ' A' ' 8' ' ' ASP . 19.1 tttm -59.83 -43.61 94.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -1.126 . . . . 0.0 109.352 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -58.95 -41.62 87.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 23.3 tttp -60.74 -41.46 95.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.354 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.48 86.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.24 96.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.53 98.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.929 ' O ' HG13 ' A' ' 149' ' ' VAL . 57.8 mt -66.09 -38.86 89.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -1.199 . . . . 0.0 109.393 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.78 -44.5 89.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.44 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.59 -35.53 80.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.471 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.421 ' O ' HG21 ' A' ' 34' ' ' VAL . . . -72.32 -50.46 26.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 145' ' ' LEU . 3.3 m -64.46 -46.71 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.651 ' HG3' HD11 ' A' ' 14' ' ' ILE . 83.8 tt0 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.11 72.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.277 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -62.78 -41.28 99.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.527 ' CD1' ' OXT' ' A' ' 161' ' ' CYS . 30.5 tp -59.35 -41.8 90.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.47 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 37.4 mt -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.476 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.95 62.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.24 70.23 13.02 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 50.1 Cg_endo -70.22 -6.1 18.04 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.759 2.306 . . . . 0.0 111.783 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -75.3 -32.54 61.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.13 144.25 35.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.59 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -61.39 -31.53 71.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.853 . . . . 0.0 109.353 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.527 ' OXT' ' CD1' ' A' ' 153' ' ' LEU . 88.0 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.459 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.299 0.571 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.05 -114.86 6.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.707 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.2 p -108.48 135.52 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.14 . . . . 0.0 109.588 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.659 ' CD1' HD12 ' A' ' 130' ' ' ILE . 82.8 m-85 -92.07 139.64 30.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 28.0 p -122.68 119.91 32.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.393 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 119' ' ' THR . 47.3 m-85 -116.24 145.54 43.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -121.12 143.14 49.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.558 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' OD1' ' HE2' ' A' ' 139' ' ' LYS . 60.5 t0 -116.07 135.78 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -113.07 125.08 53.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.685 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.96 7.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.047 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 t -129.48 150.75 50.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -160.29 146.39 15.42 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 13' ' ' VAL . 13.0 m -62.3 90.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.033 . . . . 0.0 109.29 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.776 HG23 ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt -139.81 145.48 43.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.354 -0.841 . . . . 0.0 109.322 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.776 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.9 Cg_endo -68.44 112.79 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.332 2.021 . . . . 0.0 110.995 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HG3' ' HB2' ' A' ' 107' ' ' ALA . 44.6 Cg_endo -66.54 -32.02 40.2 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.851 2.367 . . . . 0.0 112.34 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.03 -56.23 7.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.134 -0.979 . . . . 0.0 109.442 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.445 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 13.1 mtt85 -72.4 -38.95 68.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.732 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.668 HD13 HG21 ' A' ' 14' ' ' ILE . 22.0 tp -62.0 -47.64 83.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 109.654 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.58 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.9 t80 -58.59 -46.62 86.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.413 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.4 mttm -72.84 -44.66 61.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.957 . . . . 0.0 109.522 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 33.9 t -70.83 -21.33 62.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.076 -1.015 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.951 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 2.6 t80 -100.13 -50.74 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.089 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 55.5 t -85.04 -52.44 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.095 -1.003 . . . . 0.0 110.12 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.1 tp -70.41 -36.27 73.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.135 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 74.4 m-20 -103.82 23.78 12.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.039 -1.038 . . . . 0.0 109.723 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.5 -46.53 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.463 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 71.9 m-20 -64.62 -33.22 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 109.96 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.421 ' HB3' ' HE3' ' A' ' 33' ' ' LYS . 86.6 m-20 -90.76 -40.17 11.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.64 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.799 HD21 HG23 ' A' ' 149' ' ' VAL . 19.5 tp -66.32 -28.25 68.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.955 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.84 ' O ' HG12 ' A' ' 34' ' ' VAL . 24.6 mt -60.31 -60.37 10.85 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.164 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.6 Cg_endo -68.41 -23.16 38.22 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.603 2.202 . . . . 0.0 111.649 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 29' ' ' ASN . 79.9 mttt -71.97 -46.17 58.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.352 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.046 HG21 ' HB1' ' A' ' 148' ' ' ALA . 10.6 p -59.33 -24.12 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.624 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.76 87.21 50.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.635 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.66 -21.07 29.79 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.729 2.286 . . . . 0.0 111.707 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.84 -36.37 69.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.623 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -130.22 135.21 47.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -113.1 146.75 38.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.34 -0.85 . . . . 0.0 109.45 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.0 p -127.9 157.81 39.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.382 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.8 m -129.29 148.76 51.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.526 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.27 149.16 37.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.515 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -133.72 157.0 46.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -97.87 110.12 22.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.525 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 56' ' ' LYS . 7.6 mt -63.25 -37.83 88.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 53' ' ' THR . 83.9 tt0 -149.14 157.09 43.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.499 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 86.46 155.99 27.69 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -89.9 10.52 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.563 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.73 23.41 7.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.853 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -121.19 -143.91 6.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 50.4 Cg_endo -70.17 121.89 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.678 2.252 . . . . 0.0 111.843 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.74 -2.82 70.33 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 46' ' ' GLU . 94.3 m -78.59 140.83 38.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -1.196 . . . . 0.0 109.496 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.4 mm -100.67 129.55 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 31.1 tttm -106.71 130.7 54.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' HB2' HD11 ' A' ' 45' ' ' LEU . 20.0 tttt -122.86 134.93 54.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.498 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.8 mt -111.73 135.9 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.7 p -125.31 151.91 45.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -104.44 128.42 52.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.27 -42.65 88.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.439 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' CD ' ' OD1' ' A' ' 63' ' ' ASN . 84.9 tt0 -65.88 -30.84 71.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.77 40.13 27.12 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.413 ' OD1' ' CD ' ' A' ' 61' ' ' GLU . 89.9 m-20 -57.52 -36.63 71.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -1.113 . . . . 0.0 109.441 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -127.96 134.77 49.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.354 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.04 -35.32 76.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -78.44 141.32 38.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -0.973 . . . . 0.0 109.419 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -114.0 156.49 23.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.547 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 88.9 mtp -96.08 140.36 30.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.95 146.6 30.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 89.4 m-70 -126.8 140.11 52.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -124.62 133.25 53.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.521 HG11 HD11 ' A' ' 75' ' ' ILE . 46.9 t -98.68 130.62 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 82.0 tt0 -81.09 -53.92 5.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.7 mt-10 -156.96 143.35 18.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.853 HD12 ' HA2' ' A' ' 50' ' ' GLY . 71.8 mt -124.31 123.65 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 73.2 m-20 -130.5 86.25 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.58 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 94.2 m-70 -62.38 -38.05 88.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.67 -30.68 68.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.449 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 56.8 m-20 -89.49 9.39 26.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.508 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.559 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 56.5 m-85 44.21 39.65 3.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.354 -0.841 . . . . 0.0 109.536 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.482 ' CE ' ' OE2' ' A' ' 102' ' ' GLU . 82.9 tttt -135.39 128.59 31.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.536 ' CE2' HG12 ' A' ' 75' ' ' ILE . 77.5 t80 -125.97 127.9 46.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 109.561 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -128.09 123.38 34.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.7 p90 -139.35 166.06 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.7 t -143.64 167.39 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 130.34 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.4 -47.18 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.557 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -145.7 135.85 23.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 109.503 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.579 ' CA ' HD23 ' A' ' 92' ' ' LEU . . . -171.09 104.18 0.2 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 56.96 -157.03 11.96 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 94' ' ' HIS . 54.5 Cg_endo -74.15 7.22 2.61 Favored 'Trans proline' 0 C--O 1.212 -0.791 0 C-N-CA 122.625 2.217 . . . . 0.0 112.294 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.757 ' C ' HD12 ' A' ' 92' ' ' LEU . 2.2 pp -40.21 -26.9 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.036 -1.04 . . . . 0.0 110.332 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -87.95 23.55 13.71 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.527 ' O ' ' CB ' ' A' ' 95' ' ' THR . 57.2 t-80 -67.79 73.83 0.18 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.152 -1.205 . . . . 0.0 107.878 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 1.052 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 78.54 5.31 2.53 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.936 ' HB3' HD11 ' A' ' 99' ' ' ILE . 67.2 mt -100.71 93.11 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 108.957 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.7 mt-10 -40.43 -37.63 0.71 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.693 -0.63 . . . . 0.0 110.42 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 1.02 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.9 tttt -164.81 155.44 14.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 110.419 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.02 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.5 mm -131.85 124.24 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.4 t -128.43 159.62 34.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.049 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.468 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 85.0 m-85 -135.68 128.54 31.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.482 ' OE2' ' CE ' ' A' ' 81' ' ' LYS . 78.4 tt0 -112.05 140.66 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 117' ' ' LYS . 68.7 mt -131.81 126.34 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.153 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.433 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 11.2 mtpp -123.43 137.77 54.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.612 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.93 151.06 39.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.329 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.27 158.91 43.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 16' ' ' PRO . . . -107.14 146.25 31.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.473 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 112' ' ' GLY . . . -141.76 147.39 45.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.364 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.61 -48.59 1.02 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.754 2.303 . . . . 0.0 111.748 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -147.68 166.35 27.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 109.354 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 68.4 36.03 83.3 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.806 ' O ' ' HB3' ' A' ' 108' ' ' ALA . . . 127.62 77.97 0.24 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 112' ' ' GLY . . . -43.59 -34.69 2.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 14' ' ' ILE . 95.0 p -146.5 152.71 39.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.402 ' C ' HD12 ' A' ' 116' ' ' LEU . 69.3 mt -122.61 128.04 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.4 mp -110.32 134.59 52.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 29.9 mttp -128.51 128.88 45.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.476 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -118.11 129.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 75.7 m -126.2 134.42 51.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.577 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.468 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 50.4 m -116.4 161.82 18.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.563 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -145.67 127.03 14.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.845 . . . . 0.0 109.37 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.822 ' CD1' HG23 ' A' ' 99' ' ' ILE . 11.0 m-85 -126.63 107.94 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.58 ' CG ' ' HB ' ' A' ' 3' ' ' VAL . 30.0 m80 -80.23 113.98 18.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.089 -1.007 . . . . 0.0 108.336 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.3 p -104.45 141.82 35.68 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.029 . . . . 0.0 109.511 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 92.2 mttt -41.83 -42.48 2.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.479 -0.763 . . . . 0.0 109.615 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.73 -70.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -59.67 -31.71 69.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -1.164 . . . . 0.0 109.56 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 1.052 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -61.18 147.47 44.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -128.56 145.76 51.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.659 HD12 ' CD1' ' A' ' 4' ' ' PHE . 17.8 mt -108.78 126.49 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -88.41 152.51 21.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.809 ' OE1' HD11 ' A' ' 135' ' ' ILE . 75.6 mm-40 -64.9 -36.79 85.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.02 -44.59 95.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.81 -43.65 90.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.809 HD11 ' OE1' ' A' ' 132' ' ' GLU . 42.2 pt -82.13 -30.69 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 132' ' ' GLU . 47.4 tttt -55.78 -37.51 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.48 74.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.288 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.16 95.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' A' ' 8' ' ' ASP . 22.7 tttt -60.01 -42.92 95.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 109.317 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.39 -41.8 94.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.379 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.08 -45.96 86.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.14 -42.56 75.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.1 99.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.371 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.62 -45.06 90.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.82 -38.25 78.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -1.154 . . . . 0.0 109.301 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.51 ' O ' HG12 ' A' ' 149' ' ' VAL . 70.0 t80 -62.9 -41.83 99.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.0 -37.39 87.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 1.046 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -67.46 -47.42 70.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.389 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.799 HG23 HD21 ' A' ' 30' ' ' LEU . 6.6 p -62.39 -40.45 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.301 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.7 tt0 -59.74 -43.24 94.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.426 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.6 81.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.919 . . . . 0.0 109.353 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.38 -44.83 96.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.51 -39.64 91.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 154' ' ' LEU . 9.1 tt -64.56 -44.59 90.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.502 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.65 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -141.9 70.63 24.2 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.94 . . . . 0.0 109.447 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 51.2 Cg_endo -70.79 -4.98 15.81 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.653 2.236 . . . . 0.0 111.85 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -97.99 9.97 41.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.59 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.27 148.02 38.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -115.98 139.99 49.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 18' ' ' ARG . 8.7 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.508 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.337 0.589 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.02 152.76 2.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.28 141.74 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.523 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CD2' HD12 ' A' ' 130' ' ' ILE . 99.1 m-85 -101.59 122.99 44.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 t -111.03 120.97 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.77 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 28.2 m-85 -115.49 147.33 40.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -118.16 133.67 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.654 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -109.54 134.2 52.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.86 124.21 52.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.28 124.19 15.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.292 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -110.6 132.3 54.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 m -157.06 147.48 21.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.045 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.738 ' O ' HG23 ' A' ' 13' ' ' VAL . 31.0 m -78.44 90.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.84 HG21 HD13 ' A' ' 19' ' ' LEU . 8.6 mt -139.37 144.93 42.06 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.224 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.784 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.98 113.33 3.21 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.501 2.134 . . . . 0.0 111.228 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -66.52 -31.13 42.35 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.799 2.333 . . . . 0.0 112.204 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.11 -52.74 8.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.486 ' NH1' ' OXT' ' A' ' 161' ' ' CYS . 36.3 ttt180 -72.01 -45.95 59.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.954 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.84 HD13 HG21 ' A' ' 14' ' ' ILE . 6.7 tp -59.04 -45.13 91.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.959 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.532 ' CE1' HG21 ' A' ' 24' ' ' VAL . 79.0 t80 -60.73 -55.38 33.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.902 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 23.8 tttp -67.85 -38.39 83.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 29.5 t -72.78 -27.2 61.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.805 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.794 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 34.3 t80 -100.82 -50.11 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.532 HG21 ' CE1' ' A' ' 20' ' ' PHE . 54.8 t -78.14 -52.45 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.082 -1.011 . . . . 0.0 110.284 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.773 HD13 ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.13 -35.91 82.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.103 -0.998 . . . . 0.0 109.808 -179.434 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' SER . 89.8 m-20 -108.71 28.36 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.581 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.794 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.4 -45.04 70.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.917 ' HA ' HD12 ' A' ' 31' ' ' ILE . 65.0 m-20 -73.72 -29.65 62.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.98 . . . . 0.0 109.773 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 92.5 m-20 -79.66 -37.79 35.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.965 . . . . 0.0 109.616 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.612 ' O ' HG12 ' A' ' 34' ' ' VAL . 42.1 mt -72.44 -31.47 65.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.72 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 28' ' ' ASP . 16.0 mt -49.83 -57.41 12.45 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.7 Cg_endo -68.54 -39.16 9.74 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.573 2.182 . . . . 0.0 111.686 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 77.4 tttt -68.06 -47.31 68.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.9 p -62.31 -12.66 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.2 -0.938 . . . . 0.0 109.448 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.69 76.08 71.94 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 109.565 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.42 -36.96 10.68 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.689 2.259 . . . . 0.0 111.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -49.97 -43.8 50.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.607 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -113.53 139.11 49.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.65 127.25 53.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 109.358 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.2 p -122.88 158.33 30.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.176 -0.953 . . . . 0.0 109.414 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.8 m -135.01 148.75 50.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' A' ' 55' ' ' LYS . . . -141.54 143.64 33.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -134.21 149.71 51.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 33.2 p-10 -84.0 114.56 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.53 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 52.0 mt -65.95 -28.69 69.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 109.404 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 45' ' ' LEU . 14.7 mm-40 -159.44 -173.41 4.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 63.39 164.36 0.57 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -94.51 -3.14 50.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -1.087 . . . . 0.0 109.553 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.752 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 119.72 13.82 5.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.722 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -112.17 -142.12 8.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.63 125.95 13.42 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.42 5.49 79.13 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.752 HG21 ' HA2' ' A' ' 49' ' ' GLY . 53.9 m -73.02 140.78 47.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -1.219 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.53 ' CG2' ' HB2' ' A' ' 45' ' ' LEU . 27.0 mm -99.13 133.74 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 79.7 tttt -122.77 134.84 54.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.403 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.8 tttt -130.85 131.46 44.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.478 HD12 ' HE2' ' A' ' 70' ' ' HIS . 69.5 mt -107.07 137.61 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.499 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.5 m -119.9 139.43 52.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.357 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 60' ' ' ALA . 45.3 p90 -136.24 178.04 7.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 0.0 109.492 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.563 ' O ' ' CD2' ' A' ' 59' ' ' PHE . . . -48.19 137.8 10.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.398 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -51.44 -39.16 56.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.59 -119.63 19.13 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -110.42 146.21 36.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.14 . . . . 0.0 109.381 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 46.89 -164.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.166 -0.959 . . . . 0.0 109.344 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -113.83 129.76 56.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 109.562 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -129.73 130.95 46.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -126.4 135.8 51.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.3 mtt -111.31 148.42 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' CB ' ' HB ' ' A' ' 87' ' ' ILE . 53.4 mttm -126.88 136.79 52.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.606 ' ND1' HG23 ' A' ' 86' ' ' ILE . 34.0 m-70 -131.96 133.51 44.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -127.19 141.51 51.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 109.612 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.583 HG11 ' CG1' ' A' ' 75' ' ' ILE . 62.0 t -100.8 129.65 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.335 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.8 -43.96 43.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -173.1 137.26 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 109.583 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.722 HD12 ' HA2' ' A' ' 50' ' ' GLY . 60.3 mt -116.77 123.55 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -132.94 72.59 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.511 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.489 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 96.8 m-70 -55.9 -37.14 68.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.44 78.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.363 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 23.9 m120 -87.45 -0.28 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 60.93 31.78 19.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 79' ' ' ASN . 4.5 mtmp? -130.87 125.14 32.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.4 t80 -117.16 129.25 55.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 0.0 109.42 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.3 t -129.02 114.06 15.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.56 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.3 p90 -129.5 170.44 13.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.311 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 87.5 p -151.93 162.86 40.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.708 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.606 HG23 ' ND1' ' A' ' 70' ' ' HIS . 15.6 mm -111.85 122.43 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.457 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 99.7 mt -70.2 -39.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.604 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -157.26 139.77 14.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 0.0 109.626 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -155.05 92.67 0.13 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.7 -119.25 3.57 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' GLY . 49.5 Cg_endo -70.5 -35.6 10.2 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.485 2.124 . . . . 0.0 111.514 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD11 HG13 ' A' ' 99' ' ' ILE . 8.1 tp 55.63 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 109.681 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.701 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . -162.54 179.7 37.66 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -107.09 127.67 53.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -1.121 . . . . 0.0 109.617 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.902 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 56.47 16.85 2.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 109.856 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.906 HD22 ' HB3' ' A' ' 122' ' ' TYR . 37.1 mt -90.63 89.67 7.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.029 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 79.3 mt-10 -48.35 -32.53 7.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 21.7 tttp -152.34 152.52 32.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.596 -1.315 . . . . 0.0 110.691 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 96' ' ' LEU . 10.0 mm -132.47 113.62 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 37.3 t -131.36 152.23 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.921 -1.112 . . . . 0.0 110.128 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.517 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 84.8 m-85 -130.84 143.66 50.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 82.1 tt0 -120.93 143.73 48.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 109.78 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.29 121.9 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 56.8 tttt -121.04 129.73 53.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.893 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mtt -116.18 132.75 56.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.366 -0.834 . . . . 0.0 109.196 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.56 151.44 41.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.86 124.26 34.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.31 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.09 143.01 98.22 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.89 -32.09 23.2 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.656 2.238 . . . . 0.0 111.705 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -58.32 -28.13 64.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.411 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.38 -8.54 64.5 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 13' ' ' VAL . . . -50.98 -40.38 42.89 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 168.87 -118.62 0.79 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -138.09 164.73 28.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -1.162 . . . . 0.0 109.674 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.24 137.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.18 137.1 44.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 47.8 mttp -130.77 135.89 48.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 68.1 mt -127.12 127.68 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.134 -0.979 . . . . 0.0 109.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 32.5 m -116.22 142.51 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.372 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.429 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 68.3 m -122.02 147.83 45.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 109.703 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -129.25 116.67 19.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.227 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.906 ' HB3' HD22 ' A' ' 96' ' ' LEU . 72.0 m-85 -115.7 124.79 51.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.544 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 0.3 OUTLIER -91.05 129.19 37.07 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.204 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 125' ' ' LYS . 4.2 t -114.85 136.01 53.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.953 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 21.0 tttm -43.63 -46.86 7.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.75 -85.87 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -58.32 -25.29 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -68.95 142.96 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.53 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 86.6 p -130.33 163.35 27.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.705 HD12 ' CD2' ' A' ' 4' ' ' PHE . 51.4 mt -108.48 126.4 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.24 132.51 47.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.546 ' HA ' ' CD1' ' A' ' 135' ' ' ILE . 94.7 mt-10 -61.92 -32.63 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.91 -43.82 98.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.3 -26.04 62.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 108.986 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.77 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 1.8 mt -69.9 -49.56 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 108.839 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -55.49 -44.54 76.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.209 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.46 -47.37 86.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.64 -31.61 57.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -70.57 -36.79 73.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -1.118 . . . . 0.0 109.306 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.04 -45.02 96.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.14 -45.95 91.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.361 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.52 94.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.267 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.02 82.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.233 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.61 -44.56 95.52 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 145' ' ' LEU . 38.0 tp -56.77 -41.99 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -1.109 . . . . 0.0 109.311 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 118' ' ' ILE . 63.9 m-85 -62.09 -41.12 97.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.252 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -56.85 -42.88 80.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.58 77.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.561 HG21 ' CE1' ' A' ' 23' ' ' PHE . 75.3 t -67.21 -50.08 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.445 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 82.7 mt-10 -50.23 -34.02 21.52 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.01 81.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.717 . . . . 0.0 109.458 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.438 ' OH ' ' HE2' ' A' ' 33' ' ' LYS . 58.4 t80 -59.45 -45.06 92.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 157' ' ' PRO . 76.4 mt -59.1 -42.64 90.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.963 . . . . 0.0 109.303 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.45 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 30.0 mt -69.08 -33.0 72.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.26 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 0.0 109.399 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.09 61.75 1.28 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' LEU . 49.7 Cg_endo -69.8 -24.15 29.8 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.707 2.271 . . . . 0.0 111.76 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -68.23 -33.31 74.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.07 142.89 58.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -57.66 -40.35 79.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.486 ' OXT' ' NH1' ' A' ' 18' ' ' ARG . 4.0 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.277 0.561 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.879 ' O ' HG22 ' A' ' 124' ' ' THR . . . 94.8 12.34 55.65 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.717 HG21 ' CE1' ' A' ' 123' ' ' HIS . 23.7 t -116.57 140.82 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.153 . . . . 0.0 109.499 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 99.3 m-85 -107.49 129.71 54.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.132 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -117.28 125.94 51.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.786 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 46.8 m-85 -124.29 142.75 51.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -116.3 131.78 56.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 56.8 t0 -99.98 133.08 44.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -108.52 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.4 129.55 22.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.7 m -112.66 137.44 50.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.792 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -160.6 147.98 15.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.828 . . . . 0.0 109.047 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.605 ' O ' HG13 ' A' ' 13' ' ' VAL . 4.0 p -81.84 91.07 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.567 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 19' ' ' LEU . 13.2 mt -139.17 144.77 41.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.28 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.76 ' HD2' HG23 ' A' ' 14' ' ' ILE . 44.5 Cg_endo -67.69 116.17 4.13 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.41 2.073 . . . . 0.0 111.217 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.9 Cg_endo -66.8 -35.61 26.93 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.884 2.39 . . . . 0.0 112.387 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.09 -52.04 18.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.479 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 22' ' ' SER . 55.9 mtp180 -72.11 -50.32 29.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 14' ' ' ILE . 13.4 tp -55.01 -45.28 75.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.803 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.701 ' O ' HG22 ' A' ' 24' ' ' VAL . 47.5 t80 -64.39 -55.59 20.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 109.425 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 27.9 mttt -67.92 -13.73 62.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.648 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.692 ' O ' HD12 ' A' ' 30' ' ' LEU . 49.7 m -100.33 -21.46 15.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.011 -1.056 . . . . 0.0 109.925 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 1.025 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 35.0 t80 -101.2 -52.5 3.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.996 -1.065 . . . . 0.0 110.722 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 20' ' ' PHE . 12.6 m -86.22 -40.79 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.961 -1.087 . . . . 0.0 110.63 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.544 HD12 ' CD2' ' A' ' 77' ' ' HIS . 4.1 tt -79.29 -43.16 24.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.574 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.502 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 95.1 m-20 -89.54 10.74 21.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.025 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.42 -31.49 69.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -71.56 -14.76 62.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -114.75 -36.92 4.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.0 . . . . 0.0 109.817 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 22' ' ' SER . 33.4 mt -72.53 -31.12 65.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -58.6 -57.5 26.14 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.124 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.2 Cg_endo -68.47 -33.55 22.56 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.65 2.233 . . . . 0.0 111.606 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -69.19 -31.55 70.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.358 -0.839 . . . . 0.0 109.38 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 30' ' ' LEU . 73.3 t -74.4 -34.41 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.499 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 34' ' ' VAL . . . 69.13 61.93 0.59 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' PHE . 50.2 Cg_endo -70.26 137.96 35.17 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.684 2.256 . . . . 0.0 111.744 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.38 -31.08 72.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.939 . . . . 0.0 109.444 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -61.19 -49.81 75.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.88 ' CD1' HG21 ' A' ' 57' ' ' ILE . 81.1 m-85 -118.04 139.93 50.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.28 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.3 p -78.54 -35.84 45.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 82.8 p -163.36 167.28 21.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.519 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' C ' ' HG3' ' A' ' 43' ' ' GLU . . . -138.21 149.43 45.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HG3' ' C ' ' A' ' 42' ' ' ALA . 92.0 mt-10 -155.53 156.42 35.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 84.1 m-20 -88.53 118.49 28.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.524 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 28.5 tp -72.95 -35.97 67.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 53' ' ' THR . 49.5 tp10 -159.24 153.98 24.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 93.37 150.29 26.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -83.52 6.91 18.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.602 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.675 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.08 20.2 10.01 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.692 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -113.58 -146.32 9.47 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.01 124.94 11.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.751 2.301 . . . . 0.0 111.891 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.16 78.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.675 HG21 ' HA2' ' A' ' 49' ' ' GLY . 61.2 m -72.73 137.79 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -1.193 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.3 mm -103.81 133.44 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 46.6 mtpt -111.73 144.33 41.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 45' ' ' LEU . 16.1 tttp -122.13 133.4 54.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.88 HG21 ' CD1' ' A' ' 39' ' ' PHE . 23.0 mm -111.1 135.05 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 48.2 m -86.56 140.79 29.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.489 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.443 ' CE2' ' O ' ' A' ' 61' ' ' GLU . 22.0 p90 -113.56 153.37 28.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.895 . . . . 0.0 109.511 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.92 -31.12 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.502 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.443 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 96.0 mt-10 -52.97 144.51 14.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.542 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.78 22.0 41.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -93.16 106.85 18.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.139 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' CZ ' ' A' ' 67' ' ' TYR . 84.3 tt0 -65.77 -28.58 69.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.304 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 63.1 t80 -49.62 -40.96 41.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.392 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -70.69 126.98 31.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.373 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 64' ' ' GLU . 88.5 m-85 -128.97 132.25 47.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.007 . . . . 0.0 109.716 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.454 ' HG2' ' HA2' ' A' ' 89' ' ' GLY . 82.6 mtp -116.21 141.24 48.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.862 . . . . 0.0 109.123 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.67 140.48 40.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.826 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 81.8 m-70 -126.0 135.36 51.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -130.32 142.15 50.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG11 ' CG1' ' A' ' 75' ' ' ILE . 68.6 t -101.65 132.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.464 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 89.9 mt-10 -73.59 -58.64 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.426 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 93.9 mt-10 -158.79 144.25 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.692 HD12 ' HA2' ' A' ' 50' ' ' GLY . 91.3 mt -122.79 120.32 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.502 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.471 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 86.8 m-20 -122.78 92.42 3.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.544 ' CD2' HD12 ' A' ' 25' ' ' LEU . 76.5 m80 -64.95 -37.52 87.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.16 -33.31 71.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.902 . . . . 0.0 109.374 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 76' ' ' ASP . 23.2 m120 -84.98 -2.33 57.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 53.61 41.24 32.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -137.32 122.45 19.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 81.7 t80 -113.18 128.11 56.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 m -127.78 119.13 25.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.583 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.2 p90 -134.32 164.28 27.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 17.0 t -145.51 158.99 43.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.584 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 86' ' ' ILE . 54.0 mt -108.58 137.42 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 96.4 mt -86.24 -27.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.699 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.53 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 85.0 tt0 176.54 162.3 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.514 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 88' ' ' GLU . . . 172.73 113.02 0.29 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.59 -117.45 2.48 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.7 Cg_endo -69.95 -33.66 15.44 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.439 2.093 . . . . 0.0 111.179 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.639 HD13 ' C ' ' A' ' 92' ' ' LEU . 2.4 tm? 60.48 -76.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.729 . . . . 0.0 109.674 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.561 ' HA3' HD11 ' A' ' 99' ' ' ILE . . . -173.17 160.7 31.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -92.46 121.56 34.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.142 -1.21 . . . . 0.0 109.712 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.0 m 48.8 22.94 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.648 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.945 HD22 ' HB3' ' A' ' 122' ' ' TYR . 36.4 mt -94.02 89.14 5.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.301 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.547 ' CG ' ' HG2' ' A' ' 125' ' ' LYS . 83.6 mt-10 -40.75 -28.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.633 -0.667 . . . . 0.0 110.218 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 71.3 tttt -165.87 155.2 11.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 0.0 110.153 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.831 HG23 ' CD1' ' A' ' 122' ' ' TYR . 45.9 mt -141.32 113.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 108.975 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 32.1 t -126.08 150.45 48.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.985 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.607 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 98.2 m-85 -127.24 126.42 42.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 0.0 109.145 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 51.9 mp0 -112.83 142.1 45.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.803 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.6 mt -117.37 131.72 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.252 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 16.0 tttp -124.83 132.24 53.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.0 mtt -115.58 146.16 42.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.08 40.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.95 41.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -65.03 160.49 55.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.4 Cg_endo -69.88 -31.13 20.61 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.709 2.273 . . . . 0.0 111.821 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -98.06 -12.5 21.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.6 175.48 45.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.27 36.86 19.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 13' ' ' VAL . . . 160.66 125.95 0.8 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.2 p -106.13 163.63 12.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -1.174 . . . . 0.0 109.599 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.81 128.08 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.388 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.11 136.15 47.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 94.1 mttt -131.32 136.92 48.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.48 127.43 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 26.7 m -113.81 142.42 46.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.48 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 51.5 m -127.89 150.58 49.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.465 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 34.7 mttt -138.43 120.68 15.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.399 -0.813 . . . . 0.0 109.079 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.945 ' HB3' HD22 ' A' ' 96' ' ' LEU . 28.5 m-85 -120.6 115.75 24.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.122 -0.986 . . . . 0.0 109.889 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.717 ' CE1' HG21 ' A' ' 3' ' ' VAL . 52.1 m-70 -83.15 132.18 35.09 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 2' ' ' GLY . 10.3 t -113.95 138.29 50.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.547 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 75.9 mttt -76.38 144.29 40.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.384 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 54.66 -148.2 22.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 46.2 p-10 -88.06 10.95 17.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -1.139 . . . . 0.0 109.48 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.865 ' HB3' ' OG1' ' A' ' 124' ' ' THR . . . -45.24 144.0 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.458 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.4 p -123.1 167.15 14.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 23.1 mt -116.11 127.67 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.405 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 45.8 t30 -57.1 127.35 31.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.559 ' HA ' HG13 ' A' ' 135' ' ' ILE . 96.1 mt-10 -61.96 -33.72 74.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -55.28 -44.25 75.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.405 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 92.5 mt-10 -58.09 -25.25 61.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.786 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 4.3 mt -70.33 -50.86 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.822 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -55.59 -43.92 76.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.94 84.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.76 -38.09 71.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -61.42 -44.16 97.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -1.058 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.51 -42.19 82.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.436 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -58.48 -45.23 89.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.62 -38.5 75.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.98 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.73 94.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.9 -46.88 90.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.48 -37.99 82.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.497 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.438 ' O ' HG12 ' A' ' 149' ' ' VAL . 67.2 t80 -61.69 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.23 -36.26 79.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.59 -48.72 68.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -66.97 -42.55 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.92 . . . . 0.0 109.395 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.515 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.1 tt0 -60.78 -38.63 85.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.421 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.2 -36.96 80.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.524 ' CZ ' HD22 ' A' ' 30' ' ' LEU . 71.4 t80 -63.43 -47.82 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.333 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.9 mt -59.02 -40.84 86.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.24 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.89 ' O ' HD13 ' A' ' 154' ' ' LEU . 2.7 tm? -67.88 -40.03 83.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.09 66.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 75.15 65.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.99 0.37 6.68 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.826 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -106.26 10.18 31.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.653 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.27 148.02 15.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 51.29 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.478 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.543 HG22 ' ND1' ' A' ' 123' ' ' HIS . 43.5 t -128.46 131.92 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -1.204 . . . . 0.0 109.666 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.633 ' CD1' HD12 ' A' ' 130' ' ' ILE . 99.3 m-85 -89.21 129.33 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.883 . . . . 0.0 109.122 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 120' ' ' SER . 93.4 m -116.09 121.72 43.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 97.8 m-85 -121.19 147.72 45.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 85.1 tt0 -124.08 134.44 53.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 92.4 m-20 -104.75 148.6 26.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.276 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -116.57 138.09 51.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 115' ' ' ILE . . . -143.69 123.28 13.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.5 m -110.7 127.33 55.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.996 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 p -160.57 147.37 15.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 13' ' ' VAL . 2.6 p -83.82 91.15 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.739 HG23 ' HD2' ' A' ' 15' ' ' PRO . 94.0 mt -139.02 144.78 42.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.739 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.5 Cg_endo -67.91 121.48 8.52 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 111.235 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 45.5 Cg_endo -66.76 -31.85 38.52 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.848 2.365 . . . . 0.0 112.451 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.87 -54.23 8.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 109.654 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.408 ' O ' ' OG ' ' A' ' 22' ' ' SER . 33.8 mtp-105 -72.25 -39.19 68.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 109.762 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.659 HD22 HG21 ' A' ' 14' ' ' ILE . 60.4 tp -61.26 -45.15 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.666 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 58.4 t80 -67.4 -46.94 71.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.861 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.591 ' HG3' HD12 ' A' ' 25' ' ' LEU . 15.9 tttp -72.72 -22.23 60.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.833 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.459 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 83.8 p -97.72 -29.19 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.072 -1.017 . . . . 0.0 109.826 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.935 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 14.2 t80 -100.27 -46.46 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.666 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.8 t -84.34 -52.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.591 HD12 ' HG3' ' A' ' 21' ' ' LYS . 42.5 mt -71.86 -41.89 67.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.024 -1.047 . . . . 0.0 109.681 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.464 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.9 m-20 -97.43 26.35 4.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.546 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.935 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.55 -44.51 70.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.512 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.568 ' HA ' HD12 ' A' ' 31' ' ' ILE . 37.2 p-10 -74.19 -18.4 60.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.01 -38.81 14.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.621 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 26' ' ' ASP . 48.5 mt -71.88 -30.89 65.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.624 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 28' ' ' ASP . 34.4 mt . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -141.19 138.91 33.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 47' ' ' GLY . 37.4 t30 -87.89 115.42 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.53 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.546 HD13 ' HZ3' ' A' ' 56' ' ' LYS . 20.8 tp -73.35 -32.91 64.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.396 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 81.6 tt0 -166.98 160.18 13.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.512 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 92.76 161.45 36.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -98.91 10.48 41.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.567 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.99 20.93 9.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 1.041 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -118.75 -146.02 7.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.2 Cg_endo -68.82 125.08 12.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.826 2.351 . . . . 0.0 111.777 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.14 3.44 75.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.567 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.6 m -72.91 140.21 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -1.185 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.503 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 18.5 mm -110.91 118.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' HIS . 46.8 mttt -120.52 143.26 48.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' HZ3' HD13 ' A' ' 45' ' ' LEU . 16.4 mtmt -127.51 135.41 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 68' ' ' MET . 71.4 mt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.376 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 85.8 mtp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 87.2 mttt -132.38 141.11 48.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 55' ' ' LYS . 97.9 m-70 -121.86 135.55 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.503 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 61.5 tttt -131.51 131.73 43.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.423 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.534 HG22 ' CE1' ' A' ' 84' ' ' TYR . 21.9 t -89.07 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 86.2 tt0 -71.79 -43.51 65.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.96 . . . . 0.0 109.61 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.4 tt0 -178.36 146.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.041 HD12 ' HA2' ' A' ' 50' ' ' GLY . 30.0 mt -126.31 120.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 20.6 t70 -128.74 93.29 3.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 55.7 p-80 -69.75 -26.46 64.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.0 -43.13 99.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 23.4 m120 -91.25 3.56 54.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.93 . . . . 0.0 109.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 59.29 27.17 16.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 79' ' ' ASN . 36.6 mttt -116.14 141.45 48.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.622 ' CD2' HG23 ' A' ' 75' ' ' ILE . 17.8 t80 -130.23 137.28 49.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 13.2 m -117.32 122.49 44.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.534 ' CE1' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -120.7 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.532 ' O ' HD13 ' A' ' 86' ' ' ILE . 73.3 m -127.74 149.25 50.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.533 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 85' ' ' SER . 26.9 mm -116.96 129.69 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.713 HG22 ' HG3' ' A' ' 88' ' ' GLU . 84.9 mt -87.0 -49.75 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.256 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 87' ' ' ILE . 97.5 mt-10 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.882 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.3 OUTLIER 55.73 17.71 2.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.383 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 122' ' ' TYR . 42.8 mt -97.98 91.01 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.152 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' HIS . 91.4 mt-10 -51.37 -43.01 61.74 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.276 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 16.7 tttt -155.96 158.18 37.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 0.0 110.315 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.879 HG23 ' CE1' ' A' ' 122' ' ' TYR . 35.6 mt -134.41 117.11 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 32.5 t -120.87 150.89 40.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.003 -1.061 . . . . 0.0 110.237 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 84' ' ' TYR . 93.4 m-85 -131.38 133.49 45.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 93.5 mt-10 -121.22 139.65 53.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.25 125.86 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 109.392 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -125.04 146.94 49.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.1 mtt -122.82 150.44 42.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.43 153.48 40.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.37 39.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.5 t -112.78 143.99 43.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -1.166 . . . . 0.0 109.55 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.41 ' C ' HD12 ' A' ' 116' ' ' LEU . 70.1 mt -115.48 135.81 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -105.91 138.35 42.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.59 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 70.7 mttt -127.56 139.66 52.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 76.0 mt -123.31 138.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.618 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 29.7 m -120.33 142.4 49.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.342 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.44 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 54.1 m -125.44 148.81 48.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.615 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -134.94 122.5 22.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.888 . . . . 0.0 109.256 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.879 ' CE1' HG23 ' A' ' 99' ' ' ILE . 50.9 m-85 -119.2 119.75 35.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.543 ' ND1' HG22 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -84.7 114.01 21.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 108.722 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.601 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 9.6 t -103.38 144.38 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.022 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.423 ' CB ' HG22 ' A' ' 95' ' ' THR . 16.0 tttt -43.84 -45.44 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 149.68 -54.06 0.5 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -85.93 8.94 18.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -107.0 145.33 32.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 m -124.16 145.61 49.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.633 HD12 ' CD1' ' A' ' 4' ' ' PHE . 52.6 mt -101.82 134.07 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -86.14 142.48 28.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.3 mt-10 -58.88 -35.89 73.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -63.31 -46.26 87.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.843 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -57.22 -44.3 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.351 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.448 HD13 ' CE2' ' A' ' 6' ' ' TYR . 39.7 pt -75.37 -30.64 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.282 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -56.09 -40.55 73.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.19 -47.18 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.9 . . . . 0.0 109.31 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.66 67.87 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.98 -42.6 99.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -1.08 . . . . 0.0 109.214 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -54.95 -45.48 74.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.173 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -59.44 -45.12 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.95 93.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.72 95.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.168 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.69 -46.98 88.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.9 -38.76 76.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.238 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.479 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.6 t80 -62.83 -41.04 99.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -0.895 . . . . 0.0 109.277 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -59.21 -40.99 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.75 -51.94 65.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 23' ' ' PHE . 4.3 p -61.83 -41.2 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.454 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.3 tt0 -63.54 -38.47 91.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.348 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.41 91.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -61.15 -48.28 82.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.26 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.31 -35.82 78.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.329 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.938 HD13 ' O ' ' A' ' 154' ' ' LEU . 2.0 tm? -63.06 -39.87 96.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.853 . . . . 0.0 109.293 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.78 64.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.482 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.606 HG21 ' CE1' ' A' ' 123' ' ' HIS . 29.1 t -129.39 133.63 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -1.115 . . . . 0.0 109.313 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.589 ' HE1' HG21 ' A' ' 124' ' ' THR . 97.2 m-85 -92.86 132.09 37.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 109.302 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' SER . 28.5 p -117.89 121.33 40.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 119' ' ' THR . 33.5 m-85 -115.27 143.69 44.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.75 152.51 37.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' A' ' 118' ' ' ILE . 60.3 t0 -135.14 137.66 42.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.37 137.77 45.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.626 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -146.6 123.31 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.6 m -107.52 127.25 53.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.774 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.4 p -160.39 140.2 11.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.312 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.884 HG13 ' HA3' ' A' ' 113' ' ' GLY . 3.1 t -88.24 91.61 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.907 HG21 HD13 ' A' ' 19' ' ' LEU . 31.3 mm -138.5 144.49 42.67 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.741 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.1 Cg_endo -67.94 123.56 10.81 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.44 2.093 . . . . 0.0 111.463 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 43.7 Cg_endo -66.87 -40.01 13.3 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.75 2.3 . . . . 0.0 112.1 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.94 -53.82 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 0.0 109.433 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -72.14 -46.66 55.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.907 HD13 HG21 ' A' ' 14' ' ' ILE . 27.8 tp -61.11 -41.02 95.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.668 ' O ' HG22 ' A' ' 24' ' ' VAL . 44.1 t80 -68.19 -55.8 10.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 92.9 mttt -65.58 -13.67 59.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 109.888 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.598 ' O ' HD12 ' A' ' 30' ' ' LEU . 52.9 p -109.16 -17.58 13.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.953 -1.092 . . . . 0.0 110.231 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 1.034 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 85.5 t80 -100.37 -51.57 3.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 110.109 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.6 m -85.67 -39.4 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.984 . . . . 0.0 110.092 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.65 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -81.63 -53.95 5.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.161 -0.962 . . . . 0.0 110.13 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' SER . 84.7 m-20 -76.81 4.87 8.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.034 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -65.61 -38.93 90.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.788 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -58.43 -26.66 63.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -106.04 -39.42 5.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 22' ' ' SER . 39.6 mt -69.25 -31.75 70.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.2 mt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.905 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -124.15 145.43 49.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 82.3 m-20 -82.36 114.99 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 45' ' ' LEU . 19.2 tp -56.63 -49.07 76.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 53' ' ' THR . 20.5 mm-40 -152.02 -171.35 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 70.74 163.33 4.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -98.37 7.97 45.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.167 . . . . 0.0 109.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.772 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 107.68 8.33 30.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 75' ' ' ILE . . . -105.31 -145.08 13.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.69 122.71 9.4 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.654 2.236 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.521 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . 95.63 -1.12 63.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.779 ' C ' HD12 ' A' ' 54' ' ' ILE . 92.6 m -72.96 141.25 47.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -1.191 . . . . 0.0 109.481 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.779 HD12 ' C ' ' A' ' 53' ' ' THR . 1.6 mp -111.45 131.35 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 27.0 mttm -109.7 140.16 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 109.337 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -129.23 136.3 49.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.585 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 64.8 mt . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.39 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.287 0.565 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -111.12 144.81 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.925 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 77.9 m80 -127.04 134.64 50.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 87' ' ' ILE . 28.9 tttp -133.5 143.96 49.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.568 HG21 ' CG1' ' A' ' 75' ' ' ILE . 9.8 p -108.57 135.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.44 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 97.0 mt-10 -81.72 -43.49 18.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 92.5 mt-10 -158.84 142.37 15.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.606 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.568 ' CG1' HG21 ' A' ' 72' ' ' VAL . 77.5 mt -125.4 123.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 79' ' ' ASN . 25.9 t0 -125.69 91.72 3.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.623 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.447 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 87.8 m-70 -65.2 -41.09 94.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.504 ' O ' ' CE2' ' A' ' 80' ' ' PHE . . . -65.26 -40.43 93.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.46 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 56.3 t30 -79.33 -10.69 59.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' A' ' 78' ' ' ALA . 66.3 m-85 62.16 35.77 15.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.512 ' NZ ' ' OE1' ' A' ' 102' ' ' GLU . 73.0 tttt -128.87 122.53 30.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.294 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.556 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.4 t80 -117.66 116.7 27.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.434 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 51.1 t -117.64 123.66 46.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.209 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.2 p90 -140.31 167.35 22.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 47.3 t -137.06 169.84 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 mt -112.28 122.73 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.464 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 71' ' ' LYS . 73.9 mt -79.2 -38.39 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.301 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.337 0.589 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.661 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 59.47 22.99 11.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.699 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 122' ' ' TYR . 49.0 mt -110.65 95.95 5.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.949 . . . . 0.0 109.296 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 123' ' ' HIS . 90.0 mt-10 -48.02 -49.71 30.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.619 -0.675 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 23.9 mttp -156.47 169.77 23.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.755 HG23 ' CE1' ' A' ' 122' ' ' TYR . 55.9 mt -144.66 115.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 42.7 t -116.33 153.33 32.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 110.058 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.51 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 84.1 m-85 -125.22 133.49 52.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 108.994 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.512 ' OE1' ' NZ ' ' A' ' 81' ' ' LYS . 80.2 tt0 -111.94 136.9 50.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.813 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.01 127.87 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -126.27 130.92 51.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.448 ' HG2' HD22 ' A' ' 116' ' ' LEU . 63.3 mtt -115.18 130.77 57.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.884 . . . . 0.0 109.162 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.63 154.26 42.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.71 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' SER . . . -97.97 139.51 33.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 0.0 109.345 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 115' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.53 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.884 ' HA3' HG13 ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 55.8 m -143.05 165.16 28.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -1.117 . . . . 0.0 109.418 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 108' ' ' ALA . 76.7 mt -128.61 133.43 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 50.0 mt -113.56 135.52 53.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -129.75 141.57 50.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 8' ' ' ASP . 73.2 mt -125.07 133.37 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 24.7 m -125.3 141.76 51.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.51 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 22.4 m -128.31 151.8 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.3 mttp -139.17 126.42 21.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.755 ' CE1' HG23 ' A' ' 99' ' ' ILE . 3.2 m-85 -121.21 112.74 19.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.388 -0.82 . . . . 0.0 109.536 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.606 ' CE1' HG21 ' A' ' 3' ' ' VAL . 50.1 m-70 -84.64 121.3 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.589 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -100.93 151.74 21.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.028 -1.045 . . . . 0.0 109.986 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -56.91 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.9 57.97 0.6 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.482 ' OD1' ' HA2' ' A' ' 2' ' ' GLY . 67.6 m-20 51.5 45.58 27.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -72.52 135.02 45.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.4 m -67.32 146.51 54.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.654 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.549 HG12 HD21 ' A' ' 96' ' ' LEU . 30.8 mt -111.28 130.37 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.69 139.76 55.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.191 -0.943 . . . . 0.0 109.609 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.0 mt-10 -67.8 -31.57 71.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.58 -41.89 95.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.97 -43.16 99.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 132' ' ' GLU . 42.4 pt -82.81 -31.87 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.345 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 58.6 tttm -56.24 -41.15 75.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.38 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.72 -45.42 74.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.392 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.69 -39.26 86.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -62.05 -42.15 98.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -1.139 . . . . 0.0 109.38 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -58.32 -43.71 88.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 109.325 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.929 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.06 -40.19 94.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.7 84.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.463 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.65 -37.94 95.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 142' ' ' ALA . 3.6 mt -61.97 -40.9 97.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -1.133 . . . . 0.0 109.414 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.53 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.2 m-85 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.239 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.75 -37.73 87.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.94 -47.43 52.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.385 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.604 HG13 ' N ' ' A' ' 150' ' ' GLU . 8.1 p -63.31 -47.18 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 149' ' ' VAL . 96.2 mt-10 -61.13 -42.69 98.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.28 76.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -61.15 -53.4 57.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.45 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 64.0 mt -57.62 -38.87 75.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 150' ' ' GLU . 7.1 mp -66.11 -47.14 75.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.18 -0.95 . . . . 0.0 109.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -55.06 -29.24 57.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.963 . . . . 0.0 109.277 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 . . . . . 0 N--CA 1.488 1.444 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.713 HG21 ' CE1' ' A' ' 123' ' ' HIS . 17.9 t -123.25 134.98 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.166 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.643 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 96.5 m-85 -95.75 135.48 37.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -121.9 129.38 52.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 0.0 109.572 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.539 ' CZ ' ' CD1' ' A' ' 135' ' ' ILE . 97.9 m-85 -125.97 146.82 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.424 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.4 tt0 -116.78 137.38 52.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.585 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' A' ' 118' ' ' ILE . 67.7 t0 -115.25 130.38 56.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.342 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -105.06 131.16 52.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.728 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.02 125.56 22.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 109.069 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -112.77 135.09 53.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.814 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -160.25 152.3 20.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.156 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.2 p -91.74 90.79 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.919 HG21 HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -139.45 149.4 60.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 108.837 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.913 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.5 Cg_endo -67.81 126.41 14.6 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.266 1.977 . . . . 0.0 111.182 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.2 Cg_endo -66.44 -29.76 44.85 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.754 2.303 . . . . 0.0 112.333 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.01 7.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.552 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -72.26 -47.24 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.724 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 14' ' ' ILE . 15.0 tp -59.29 -46.96 87.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.761 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 77' ' ' HIS . 61.5 t80 -56.04 -48.04 76.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 0.0 109.668 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 30.8 mttm -69.15 -55.73 9.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 44.3 t -64.49 -19.1 65.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 109.983 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.936 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 78.1 t80 -100.2 -51.44 3.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.055 -1.028 . . . . 0.0 110.07 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 54.4 t -85.22 -52.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.831 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -62.26 -42.95 99.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.811 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.9 m-20 -97.67 18.61 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.71 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.936 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.78 -34.19 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -72.2 -27.22 62.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -105.76 -42.32 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.945 . . . . 0.0 109.752 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 15.8 tp -63.93 -32.15 73.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.746 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.53 HD12 ' O ' ' A' ' 27' ' ' ALA . 39.5 mt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.085 -1.01 . . . . 0.0 109.408 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.306 0.574 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -141.02 145.46 35.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.5 ' OD1' ' CD ' ' A' ' 55' ' ' LYS . 67.2 m-20 -82.33 112.55 19.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.3 tp -70.8 -35.48 72.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 53' ' ' THR . 85.9 tt0 -149.54 157.58 43.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.51 161.59 33.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -91.62 7.64 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.164 . . . . 0.0 109.479 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.77 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.03 18.75 11.69 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.71 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -115.24 -142.52 7.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.438 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.86 125.21 11.83 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.698 2.265 . . . . 0.0 111.74 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.675 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 89.37 -1.53 82.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.77 HG21 ' HA2' ' A' ' 49' ' ' GLY . 67.5 m -72.64 141.11 48.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 70' ' ' HIS . 24.8 mm -106.67 130.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.5 ' CD ' ' OD1' ' A' ' 44' ' ' ASN . 34.3 mmtp -102.35 147.86 26.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -123.9 137.62 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.517 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.587 HG12 ' CE1' ' A' ' 70' ' ' HIS . 22.7 mm . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.265 0.555 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.68 133.27 54.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.633 ' CD2' HD12 ' A' ' 86' ' ' ILE . 76.2 m80 -118.45 139.24 51.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.521 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 34.7 tttt -135.72 137.06 41.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.675 HG13 ' H ' ' A' ' 52' ' ' GLY . 11.8 p -104.73 130.09 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.49 -41.49 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 84.8 tt0 -176.36 139.79 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.71 HD12 ' HA2' ' A' ' 50' ' ' GLY . 68.5 mt -116.52 124.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -131.82 73.34 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 64.8 m170 -56.35 -37.48 70.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.48 70.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -92.32 8.3 38.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.499 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 74.7 m-85 51.74 28.32 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 0.0 109.477 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -123.92 136.81 54.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 71.4 t80 -133.78 133.6 41.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.6 m -135.58 120.04 18.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.2 p90 -135.97 166.25 23.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.53 ' O ' HD13 ' A' ' 86' ' ' ILE . 92.8 p -148.07 164.11 34.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.633 HD12 ' CD2' ' A' ' 70' ' ' HIS . 24.2 mm -116.1 120.1 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 71' ' ' LYS . 67.2 mt -77.65 -36.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.533 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 74.1 m80 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 57.57 16.14 3.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.643 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.0 ' HB3' HD11 ' A' ' 99' ' ' ILE . 32.4 mt -96.25 90.78 5.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.007 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 123' ' ' HIS . 79.6 mt-10 -47.05 -36.87 8.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.644 . . . . 0.0 110.529 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 1.042 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.4 tttt -164.68 156.99 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.75 -1.219 . . . . 0.0 110.356 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.042 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.3 mm -134.43 113.22 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.49 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 17.5 m -115.77 152.88 32.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.061 . . . . 0.0 110.087 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 119' ' ' THR . 84.3 m-85 -132.24 128.93 38.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 84.5 tt0 -104.89 139.82 39.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.841 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.81 122.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.113 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -130.24 136.33 49.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.967 . . . . 0.0 109.724 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.51 ' HE3' ' CD1' ' A' ' 23' ' ' PHE . 64.0 mtt -117.75 143.84 45.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -140.83 152.35 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 109.566 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.21 135.19 47.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -151.61 154.23 36.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -1.153 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.447 ' C ' HD12 ' A' ' 116' ' ' LEU . 67.5 mt -118.24 133.04 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.33 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.778 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.9 mp -111.15 135.78 51.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.424 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 18.6 mttt -122.61 135.76 54.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.271 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -119.75 136.8 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 109.627 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 26.2 m -117.98 142.56 47.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.31 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 73.4 m -120.65 151.73 39.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 28.2 mttp -139.78 129.1 24.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.05 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.952 ' CD1' HG23 ' A' ' 99' ' ' ILE . 15.4 m-85 -129.34 110.63 12.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.823 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.713 ' CE1' HG21 ' A' ' 3' ' ' VAL . 49.1 m-70 -81.06 113.38 19.21 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.0 OUTLIER -105.71 139.37 40.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.362 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 124' ' ' THR . 31.3 mttt -42.2 -47.93 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.421 -0.799 . . . . 0.0 109.631 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.42 -64.83 0.27 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.43 -30.34 71.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -63.0 148.24 48.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.5 m -132.43 150.36 52.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.801 HD11 HD21 ' A' ' 96' ' ' LEU . 22.4 mm -102.54 122.63 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -92.53 136.24 33.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.494 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 84.8 tt0 -55.62 -41.28 73.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.411 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.63 -40.39 95.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.38 -46.4 86.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.456 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.597 HG21 ' CG2' ' A' ' 130' ' ' ILE . 11.5 pt -80.1 -33.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 46.7 tttm -56.8 -33.9 67.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.855 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.55 74.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.325 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.09 92.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -56.98 -46.79 81.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.213 -1.169 . . . . 0.0 109.371 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.38 -46.1 87.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 145' ' ' LEU . 39.6 ttpt -58.87 -45.98 88.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.327 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.72 77.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . -60.16 -41.92 93.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.97 89.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.617 ' H ' HD12 ' A' ' 145' ' ' LEU . 6.6 mp -64.22 -38.37 90.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -1.13 . . . . 0.0 109.369 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.502 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.8 t80 -63.8 -44.52 93.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.384 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 143' ' ' ALA . 20.3 mmtt -62.41 -38.26 89.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.419 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.39 76.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.337 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 146' ' ' PHE . 4.7 p -65.23 -40.37 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.32 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 84.7 tt0 -60.22 -40.89 91.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.365 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.43 98.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -62.28 -44.72 95.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.892 . . . . 0.0 109.343 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 153' ' ' LEU . 25.8 tp -57.77 -38.76 76.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.4 mt -71.02 -43.17 68.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -56.72 -27.16 58.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.978 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.529 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 123' ' ' HIS . 29.7 t -130.44 136.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -1.168 . . . . 0.0 109.417 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.674 ' HE1' HG21 ' A' ' 124' ' ' THR . 93.6 m-85 -104.15 136.09 44.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.0 m -113.72 114.65 26.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 4' ' ' PHE . 33.1 m-85 -112.75 138.48 49.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 94.3 mt-10 -112.37 156.5 22.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.674 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -124.05 143.4 50.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.356 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -109.96 135.81 50.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -152.39 123.86 7.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.156 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.5 m -117.9 131.53 56.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -160.32 144.69 14.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.268 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.677 ' O ' HG23 ' A' ' 13' ' ' VAL . 33.4 m -78.08 91.25 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.436 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.847 HG21 HD13 ' A' ' 19' ' ' LEU . 24.5 mt -139.0 144.29 40.58 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.443 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.717 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.4 Cg_endo -67.93 120.41 7.41 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.499 2.132 . . . . 0.0 111.368 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 45.6 Cg_endo -67.0 -27.31 42.76 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.818 2.345 . . . . 0.0 112.263 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -54.34 6.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 22' ' ' SER . 62.8 mtt85 -72.15 -42.89 65.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.847 HD13 HG21 ' A' ' 14' ' ' ILE . 32.9 tp -59.98 -47.45 85.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.694 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.507 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 47.1 t80 -59.23 -52.0 67.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 25' ' ' LEU . 46.2 mttp -69.14 -29.36 67.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.773 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 83.5 p -84.16 -28.12 27.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.694 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.862 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 84.7 t80 -100.76 -48.45 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.89 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.7 t -84.42 -52.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.424 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 21' ' ' LYS . 12.5 tp -74.95 -26.03 59.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 110.024 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 22' ' ' SER . 85.5 m-20 -113.74 27.11 9.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 109.585 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.862 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.68 -42.13 74.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.512 ' HA ' HD12 ' A' ' 31' ' ' ILE . 56.0 t0 -62.63 -32.52 73.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -93.69 -31.38 14.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.857 . . . . 0.0 109.389 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.401 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 15.9 tp -75.35 -25.8 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 27' ' ' ALA . 12.3 mt . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -132.02 144.5 50.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.451 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 89.9 m-20 -88.29 112.1 22.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 56' ' ' LYS . 2.0 mp -66.86 -37.79 85.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 53' ' ' THR . 82.4 tt0 -149.64 155.55 40.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.515 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 89.55 159.68 35.69 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -92.35 6.77 45.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.517 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.624 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 107.25 18.44 10.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -113.25 -145.97 9.49 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.4 Cg_endo -70.03 121.42 8.05 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.706 2.271 . . . . 0.0 111.725 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.69 67.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.624 HG21 ' HA2' ' A' ' 49' ' ' GLY . 52.4 m -79.47 135.07 36.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.18 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.461 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 19.4 mm -95.29 136.28 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.207 -0.933 . . . . 0.0 109.513 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 45.3 mttm -119.9 133.51 55.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.744 ' HB2' HD11 ' A' ' 45' ' ' LEU . 30.5 tttm -107.36 142.1 37.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.527 HG12 ' ND1' ' A' ' 70' ' ' HIS . 26.3 mm . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.98 129.5 48.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.955 . . . . 0.0 109.677 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.527 ' ND1' HG12 ' A' ' 57' ' ' ILE . 80.8 m80 -128.32 126.67 41.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.359 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 18.0 tttm -123.6 145.42 48.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 HG13 ' A' ' 75' ' ' ILE . 46.9 t -90.39 129.58 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 83.9 tt0 -79.88 -37.46 34.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.506 ' N ' ' HB2' ' A' ' 83' ' ' CYS . 80.8 tt0 -179.12 144.31 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.024 HD12 ' HA2' ' A' ' 50' ' ' GLY . 27.5 mt -127.39 119.16 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 79' ' ' ASN . 29.4 t0 -127.11 86.88 2.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -66.88 -32.31 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.84 81.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 1.4 m120 -96.04 2.25 53.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 59.07 22.33 10.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 109.454 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.472 ' HG2' ' HB2' ' A' ' 104' ' ' LYS . 33.9 mttt -110.97 130.46 55.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 75' ' ' ILE . 25.8 t80 -125.13 129.14 49.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.952 . . . . 0.0 109.673 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.506 ' HB2' ' N ' ' A' ' 74' ' ' GLU . 35.9 m -109.39 131.92 54.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.228 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -120.89 139.53 53.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.668 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 20.2 t -127.2 142.81 51.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 99' ' ' ILE . 24.1 mt -117.97 127.45 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.68 -36.66 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.461 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 81.6 t60 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 124' ' ' THR . 1.4 m 64.08 11.25 6.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.488 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.665 HD21 HG12 ' A' ' 130' ' ' ILE . 93.9 mt -94.81 92.11 6.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.311 -0.868 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' HIS . 46.3 mt-10 -49.1 -40.27 31.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.751 -0.593 . . . . 0.0 110.963 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.643 ' O ' HD13 ' A' ' 99' ' ' ILE . 95.0 mttt -158.12 156.57 31.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.855 HG23 ' CE1' ' A' ' 122' ' ' TYR . 33.3 mm -133.18 113.0 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 29.7 t -113.68 150.08 33.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 84' ' ' TYR . 91.2 m-85 -129.08 130.69 46.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 85.1 tt0 -108.76 137.98 45.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.758 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.0 mt -124.12 124.54 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.299 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HE3' ' HD2' ' A' ' 117' ' ' LYS . 41.3 pttt -134.86 149.52 50.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.41 ' HG2' HD22 ' A' ' 116' ' ' LEU . 64.4 mtt -115.42 145.22 42.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.44 155.47 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.79 148.09 38.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 108' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.0 t -125.22 157.96 35.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 108' ' ' ALA . 66.6 mt -117.03 136.99 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 36.8 mt -106.24 136.2 46.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.649 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.489 ' HD2' ' HE3' ' A' ' 104' ' ' LYS . 77.1 mttt -130.66 144.58 51.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.122 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.5 mt -132.64 140.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 0.0 109.999 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 20.6 m -120.54 142.31 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 100' ' ' SER . 0.1 OUTLIER -118.98 146.62 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 100' ' ' SER . 37.3 ttpt -126.02 112.2 15.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 109.32 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.855 ' CE1' HG23 ' A' ' 99' ' ' ILE . 3.5 m-85 -109.74 108.51 18.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.7 ' HA ' HG22 ' A' ' 3' ' ' VAL . 4.9 t60 -83.79 121.79 27.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.674 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.3 p -113.08 143.93 43.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.991 -1.068 . . . . 0.0 109.765 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -70.19 153.33 43.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.59 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 47.59 -131.43 16.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -114.45 41.53 2.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.183 . . . . 0.0 109.385 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -65.05 150.08 48.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.448 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 96.6 p -114.65 155.48 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.665 HG12 HD21 ' A' ' 96' ' ' LEU . 58.3 mt -113.04 141.5 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -89.13 141.24 28.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.3 mt-10 -65.48 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 23.1 pt-20 -65.7 -41.74 92.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.457 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 133' ' ' GLU . 83.9 tt0 -61.3 -41.54 97.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 132' ' ' GLU . 47.8 pt -85.05 -29.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 34.0 tttt -55.76 -45.56 78.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.05 78.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.217 -0.927 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.99 -35.08 90.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.09 -44.16 95.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.29 -39.9 94.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.865 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -63.25 -41.05 99.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.939 . . . . 0.0 109.434 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.575 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -71.0 -36.67 72.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.446 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.61 95.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.42 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.45 -38.93 95.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.527 ' O ' HG12 ' A' ' 149' ' ' VAL . 25.1 tp -65.53 -41.2 93.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -1.154 . . . . 0.0 109.442 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.575 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 16.6 m-85 -65.13 -45.95 82.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -62.83 -37.57 87.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.67 -51.45 56.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.415 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -64.43 -47.53 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.597 ' N ' HG13 ' A' ' 149' ' ' VAL . 87.8 mt-10 -58.66 -38.84 79.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.4 -41.25 89.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.376 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -62.87 -38.59 91.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.09 -43.95 87.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 154' ' ' LEU . 6.6 mp -73.64 -40.83 63.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.23 -15.95 63.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.38 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.611 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.2 p -120.19 138.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -1.077 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.817 ' CE2' HG21 ' A' ' 124' ' ' THR . 96.4 m-85 -98.6 146.03 26.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 25.7 p -132.09 128.13 37.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.514 ' O ' HG23 ' A' ' 119' ' ' THR . 90.9 m-85 -122.21 151.99 40.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 117' ' ' LYS . 95.9 mt-10 -118.48 145.61 45.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -123.01 145.82 48.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -121.81 137.34 54.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.59 122.97 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.092 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 1.069 HG22 HG23 ' A' ' 115' ' ' ILE . 59.4 p -123.82 143.21 50.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.534 ' OG ' ' CD1' ' A' ' 14' ' ' ILE . 98.9 p -160.28 149.36 17.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 108.933 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 13' ' ' VAL . 33.6 m -66.2 90.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.021 . . . . 0.0 109.341 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.979 HG21 HD22 ' A' ' 19' ' ' LEU . 5.5 mt -139.36 142.29 31.88 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.32 -0.862 . . . . 0.0 109.341 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.3 Cg_endo -67.92 122.33 9.44 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 122.356 2.037 . . . . 0.0 111.197 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.79 -34.02 32.36 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.702 2.268 . . . . 0.0 112.209 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.64 11.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.994 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -72.15 -37.94 69.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 110.126 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.979 HD22 HG21 ' A' ' 14' ' ' ILE . 32.0 tp -67.0 -51.06 59.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.929 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.638 ' CE2' HG21 ' A' ' 24' ' ' VAL . 67.7 t80 -56.25 -46.89 79.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 25.3 mttt -67.99 -49.56 60.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.139 -0.975 . . . . 0.0 109.879 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 88.7 p -71.49 -20.1 62.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.936 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.966 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 24.0 t80 -100.48 -51.12 3.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.16 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.638 HG21 ' CE2' ' A' ' 20' ' ' PHE . 54.9 t -85.11 -52.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -0.939 . . . . 0.0 110.128 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.704 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -67.08 -49.3 65.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.0 m-20 -89.52 20.23 4.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.18 -50.63 53.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.062 -1.024 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.701 ' HA ' HD12 ' A' ' 31' ' ' ILE . 91.7 m-20 -63.43 -32.07 73.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.955 . . . . 0.0 109.798 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -88.91 -34.69 16.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.526 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.1 tp -74.89 -26.54 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.662 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 28' ' ' ASP . 12.9 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 56' ' ' LYS . 93.6 mt-10 -134.21 157.05 47.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 35.7 p-10 -87.96 112.11 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.466 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 45' ' ' LEU . 24.1 tp -73.64 -36.24 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 53' ' ' THR . 85.9 tt0 -143.1 154.96 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 91.12 159.26 35.47 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.9 8.26 38.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.49 20.39 13.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.594 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -117.67 -145.39 7.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.42 125.31 12.16 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.89 -1.51 80.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.605 HG21 ' HA2' ' A' ' 49' ' ' GLY . 96.2 m -73.59 139.98 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 109.471 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.8 mm -103.39 134.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 4.0 mtmp? -110.45 156.53 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' GLU . 52.5 tttt -130.91 128.66 40.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 109.353 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.504 HD12 ' CE1' ' A' ' 70' ' ' HIS . 70.5 mt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.527 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -134.65 129.01 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.504 ' CE1' HD12 ' A' ' 57' ' ' ILE . 93.9 m-70 -127.34 129.12 47.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.401 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.483 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 14.9 tttp -127.5 146.01 50.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.572 HG11 ' O ' ' A' ' 50' ' ' GLY . 14.8 p -108.43 138.72 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -75.71 -44.16 43.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -173.59 143.49 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.594 HD12 ' HA2' ' A' ' 50' ' ' GLY . 70.4 mt -119.36 118.68 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.9 m-20 -125.04 78.36 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.578 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 98.1 m-70 -59.18 -34.62 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.63 66.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 80.7 m-20 -94.27 9.49 37.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.584 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 68.5 m-85 48.34 36.36 6.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -131.29 129.72 41.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.955 . . . . 0.0 109.346 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 61.3 t80 -126.12 122.81 36.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.989 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.6 117.77 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.49 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 35.1 p90 -134.84 167.25 21.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.6 p -145.99 175.23 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.337 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 mt -129.34 126.44 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.451 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.8 mt -78.81 -42.66 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 179.952 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 m80 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 58.17 16.65 4.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.923 HD22 ' CB ' ' A' ' 122' ' ' TYR . 28.0 mt -96.94 90.49 5.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.315 -0.865 . . . . 0.0 109.509 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 123' ' ' HIS . 89.8 mt-10 -43.59 -37.97 2.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.599 -0.688 . . . . 0.0 110.523 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' O ' HD13 ' A' ' 99' ' ' ILE . 68.2 mttm -145.67 158.06 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.818 -1.176 . . . . 0.0 110.466 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.733 HG23 ' CD1' ' A' ' 122' ' ' TYR . 20.5 mm -135.21 119.29 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -122.52 154.55 37.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 0.0 109.808 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -132.99 137.46 46.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.374 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 119' ' ' THR . 80.0 tt0 -113.47 141.83 46.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 103' ' ' ILE . 61.3 mt -128.79 118.7 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.302 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -131.53 126.39 34.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.487 ' CE ' ' HA ' ' A' ' 20' ' ' PHE . 75.9 mtm -120.21 150.95 39.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.05 150.82 26.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 138.43 53.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 32.2 t -151.73 149.65 29.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -1.179 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.069 HG23 HG22 ' A' ' 11' ' ' THR . 64.5 mt -111.77 133.98 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.6 mp -106.37 130.9 54.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.731 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 7' ' ' GLU . 37.6 tttm -124.62 135.71 53.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.115 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 69.4 mt -129.04 123.55 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.838 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 6' ' ' TYR . 46.8 m -122.52 131.24 53.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.375 -0.828 . . . . 0.0 109.032 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' OH ' ' A' ' 122' ' ' TYR . 1.8 m -114.34 160.76 18.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 109.969 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 44.8 mttp -143.08 123.9 14.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.923 ' CB ' HD22 ' A' ' 96' ' ' LEU . 5.6 m-85 -122.34 122.76 39.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 97' ' ' GLU . 9.6 m-70 -85.31 113.9 21.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 108.82 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.817 HG21 ' CE2' ' A' ' 4' ' ' PHE . 1.3 p -94.42 148.39 22.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.679 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.452 ' HG2' ' OE2' ' A' ' 97' ' ' GLU . 32.8 mttm -67.27 145.3 55.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.02 -129.63 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -110.32 31.16 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.556 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.87 144.82 26.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 130' ' ' ILE . 83.9 p -95.61 171.63 8.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.633 HD11 ' CG2' ' A' ' 124' ' ' THR . 38.5 mm -118.72 121.89 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -59.18 119.69 7.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.483 ' HA ' HG13 ' A' ' 135' ' ' ILE . 97.0 mt-10 -54.27 -36.73 63.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.3 -35.95 82.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.215 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.44 -25.93 67.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.639 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.483 HG13 ' HA ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -87.9 -35.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.208 -0.932 . . . . 0.0 109.049 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -57.45 -44.27 84.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.688 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.83 -43.24 72.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.452 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.86 92.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -57.99 -47.11 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -1.087 . . . . 0.0 109.343 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.43 -40.11 93.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -58.56 -45.45 88.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -38.64 85.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.86 99.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.26 -45.98 92.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.01 -38.39 79.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -1.197 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.478 ' O ' HG12 ' A' ' 149' ' ' VAL . 70.2 t80 -61.65 -41.57 97.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -60.42 -40.06 89.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.328 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.12 80.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 146' ' ' PHE . 5.7 p -67.32 -39.98 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.45 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.2 tt0 -63.73 -38.61 91.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.73 97.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.351 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -59.55 -48.89 79.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.3 mt -61.68 -38.8 89.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 109.38 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 154' ' ' LEU . 20.6 tp -63.76 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.67 68.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 6.7 t60 . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.883 . . . . 0.0 109.415 179.93 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.797 HG22 ' ND1' ' A' ' 123' ' ' HIS . 38.6 t -125.21 132.68 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.17 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.605 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 97.3 m-85 -95.44 130.52 42.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.181 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 t -110.59 125.04 52.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.474 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.605 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 93.7 m-85 -125.41 144.51 50.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.315 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 91.5 mt-10 -125.15 160.98 27.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.737 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 60.4 t0 -134.42 142.45 47.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.162 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.33 138.89 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.903 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.69 121.56 8.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.151 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.9 m -112.5 133.07 54.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.004 . . . . 0.0 109.971 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 14' ' ' ILE . 4.8 t -160.41 139.59 10.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.786 . . . . 0.0 109.026 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 13' ' ' VAL . 28.2 m -68.59 91.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.04 . . . . 0.0 109.36 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.852 HG21 HD13 ' A' ' 19' ' ' LEU . 1.6 mt -138.89 143.84 39.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.216 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.686 ' HD2' HG22 ' A' ' 14' ' ' ILE . 46.3 Cg_endo -68.24 127.86 16.53 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.409 2.073 . . . . 0.0 111.259 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.88 -34.64 29.57 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.723 2.282 . . . . 0.0 112.199 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.12 -50.96 11.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.634 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.45 ' HB2' ' HG2' ' A' ' 15' ' ' PRO . 42.0 mtt-85 -70.42 -45.98 64.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.853 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.852 HD13 HG21 ' A' ' 14' ' ' ILE . 40.5 tp -59.91 -48.44 81.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 80' ' ' PHE . 65.9 t80 -52.41 -51.77 57.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.592 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 33.3 mttt -67.45 -57.57 6.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.881 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 46.6 m -62.03 -20.43 63.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.969 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.3 t80 -100.11 -51.27 3.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.993 -1.067 . . . . 0.0 110.095 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 51.7 t -84.93 -51.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 17.8 tp -66.42 -40.48 89.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.835 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.6 m-20 -99.8 20.44 14.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.722 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.63 -34.55 74.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -68.17 -32.38 72.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.857 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -101.6 -42.07 6.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.129 -0.982 . . . . 0.0 109.76 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 17.6 tp -56.3 -36.8 69.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.753 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.492 -179.71 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -125.81 165.26 19.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 109.38 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' ILE . 50.9 t30 -91.33 115.29 27.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.695 HD23 HG21 ' A' ' 54' ' ' ILE . 16.6 tp -63.87 -40.26 96.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.167 -0.958 . . . . 0.0 109.422 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 47' ' ' GLY . 53.1 tt0 -170.95 162.4 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.425 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 94.74 162.54 34.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -95.03 6.16 49.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.573 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.516 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.6 19.28 11.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.963 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -117.4 -145.72 8.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.57 125.49 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.722 2.282 . . . . 0.0 111.826 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.55 -1.83 79.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.516 HG21 ' HA2' ' A' ' 49' ' ' GLY . 31.9 m -73.68 137.22 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -1.18 . . . . 0.0 109.452 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.787 HG23 ' O ' ' A' ' 70' ' ' HIS . 4.7 mt -109.78 139.0 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.517 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 68.6 mttm -112.01 149.07 32.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HD2' HD13 ' A' ' 45' ' ' LEU . 22.7 tttt -132.95 147.24 52.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.378 -0.827 . . . . 0.0 109.33 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.4 mt . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.46 -179.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 81.0 mmm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.582 ' O ' HG23 ' A' ' 86' ' ' ILE . 80.1 mttt -134.25 131.71 38.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.399 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.787 ' O ' HG23 ' A' ' 54' ' ' ILE . 79.6 m80 -125.99 140.54 52.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.955 . . . . 0.0 109.612 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -138.24 140.75 39.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 109.362 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 50.1 t -100.77 138.57 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.5 tt0 -84.07 -56.85 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.384 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.4 mt-10 -158.78 141.64 14.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.454 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.963 HD12 ' HA2' ' A' ' 50' ' ' GLY . 74.0 mt -118.87 128.61 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 85.7 m-20 -128.79 81.25 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -58.93 -36.5 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.93 74.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -85.53 6.96 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.545 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 92.0 m-85 49.44 33.0 5.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -127.82 139.72 52.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.531 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 67.1 t80 -126.46 131.4 51.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.7 m -128.39 117.05 20.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.439 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.531 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.6 p90 -139.84 157.47 45.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.483 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 83.9 p -137.71 174.17 10.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.582 HG23 ' O ' ' A' ' 69' ' ' LYS . 12.6 mt -124.62 128.21 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.47 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 72.9 mt -74.86 -37.61 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.867 . . . . 0.0 109.593 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.555 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.8 m80 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.668 HG21 ' CB ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 52.76 20.74 1.67 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.99 HD22 ' HB3' ' A' ' 122' ' ' TYR . 22.3 mt -94.7 90.49 6.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.3 mt-10 -46.24 -40.19 11.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.591 -0.693 . . . . 0.0 110.595 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.821 ' O ' HD13 ' A' ' 99' ' ' ILE . 55.7 tttp -155.88 154.39 31.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.634 -1.291 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.842 HD11 ' HB3' ' A' ' 96' ' ' LEU . 24.1 mm -129.41 118.51 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 120' ' ' SER . 44.8 m -119.52 148.13 43.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 109.945 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.542 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 73.6 m-85 -125.55 140.82 52.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.162 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 119' ' ' THR . 84.5 tt0 -124.4 132.86 53.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.696 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.503 HG21 ' HE1' ' A' ' 23' ' ' PHE . 11.1 mm -109.04 126.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.273 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -130.62 133.22 45.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.724 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.549 ' CE ' ' CD1' ' A' ' 23' ' ' PHE . 64.2 mtt -117.55 146.83 43.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.315 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.87 157.76 44.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.3 136.99 34.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.447 ' HB3' ' N ' ' A' ' 113' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.447 ' N ' ' HB3' ' A' ' 108' ' ' ALA . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 22.5 t -155.13 145.38 21.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.475 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.409 ' C ' HD12 ' A' ' 116' ' ' LEU . 67.9 mt -116.12 128.7 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.765 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.1 mp -108.44 135.67 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 68.1 mttm -126.6 135.34 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 77.0 mt -119.61 131.08 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 30.8 m -119.85 142.69 48.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' SER . 1.4 m -128.02 156.62 42.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.826 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -133.59 108.99 8.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.838 . . . . 0.0 108.973 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.99 ' HB3' HD22 ' A' ' 96' ' ' LEU . 8.4 m-30 -105.27 118.91 37.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.797 ' ND1' HG22 ' A' ' 3' ' ' VAL . 2.1 m-70 -84.94 134.13 34.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 108.912 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.656 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 12.8 t -113.56 144.82 42.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 126' ' ' GLY . 22.9 mttp -72.09 139.77 48.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.51 -142.35 3.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' ALA . 73.0 m-20 -85.9 10.67 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.668 ' CB ' HG21 ' A' ' 95' ' ' THR . . . -44.12 146.96 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -115.88 161.89 18.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 96' ' ' LEU . 55.8 mt -104.06 139.08 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.46 118.45 7.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.567 ' HA ' HG13 ' A' ' 135' ' ' ILE . 88.1 tt0 -57.72 -34.57 69.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.46 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -56.33 -42.39 77.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.91 -25.09 67.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.591 HD13 ' CE1' ' A' ' 6' ' ' TYR . 2.9 mt -69.49 -52.34 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 108.947 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -55.65 -41.34 73.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.43 86.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.238 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.2 -36.09 80.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.51 -40.27 95.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -1.177 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.39 -35.23 79.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -63.3 -39.72 95.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 109.567 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.6 76.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.909 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.84 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.595 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.31 -48.2 76.83 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.713 ' O ' HG12 ' A' ' 149' ' ' VAL . 64.7 mt -68.26 -37.92 81.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -1.188 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.427 ' HE2' HD22 ' A' ' 116' ' ' LEU . 71.0 t80 -63.5 -45.72 89.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.569 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -63.05 -37.77 88.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.2 38.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.606 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 145' ' ' LEU . 7.5 p -66.13 -40.04 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.475 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.6 tt0 -61.97 -39.16 91.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.554 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -65.89 -41.79 91.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.491 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 153' ' ' LEU . 32.9 tp -61.53 -38.0 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.14 -0.975 . . . . 0.0 109.374 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 154' ' ' LEU . 33.8 mt -77.98 -30.89 50.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.08 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 109.428 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.679 HG22 ' HA ' ' A' ' 123' ' ' HIS . 52.4 t -126.85 135.5 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.149 . . . . 0.0 109.471 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.611 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 97.9 m-85 -91.71 128.25 37.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.364 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.8 t -113.56 123.86 50.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.63 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.912 ' CG ' HG21 ' A' ' 135' ' ' ILE . 92.4 m-85 -122.86 146.09 47.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 83.9 tt0 -121.94 131.39 53.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.947 . . . . 0.0 109.645 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.88 124.87 45.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -97.07 134.63 40.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.89 124.81 8.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.405 HG23 HG12 ' A' ' 115' ' ' ILE . 34.8 m -118.39 132.49 56.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -160.51 135.47 7.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.137 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 13' ' ' VAL . 24.1 m -64.99 91.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.071 -1.018 . . . . 0.0 109.355 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.745 HG23 ' HD2' ' A' ' 15' ' ' PRO . 20.0 mt -138.86 144.65 42.39 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.745 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.48 119.54 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.563 2.176 . . . . 0.0 111.265 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.4 Cg_endo -66.78 -34.83 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.764 2.31 . . . . 0.0 112.264 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.74 14.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -72.2 -40.96 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 14' ' ' ILE . 22.3 tp -66.39 -36.71 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.111 -0.993 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 77' ' ' HIS . 56.3 t80 -63.79 -50.48 68.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASP . 29.6 mttt -69.26 -48.07 62.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 19.2 m -65.62 -23.48 66.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.895 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.928 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.7 t80 -100.54 -51.08 3.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 110.139 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 20' ' ' PHE . 55.9 t -84.83 -52.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 22.2 tp -68.07 -29.44 68.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.864 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.8 m-20 -110.38 20.09 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.114 -0.991 . . . . 0.0 109.565 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.928 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -67.96 -34.79 77.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.583 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -66.68 -42.17 86.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.828 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -90.02 -34.07 16.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.718 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.673 HD21 HG23 ' A' ' 149' ' ' VAL . 23.2 tp -66.76 -32.82 74.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 27' ' ' ALA . 31.9 mt . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.413 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 95.5 mt-10 -143.19 151.51 40.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.461 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.9 m-20 -89.04 111.5 22.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.529 HD22 ' HD3' ' A' ' 56' ' ' LYS . 31.4 tp -77.3 -33.74 55.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 53' ' ' THR . 86.5 tt0 -150.9 155.55 39.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.432 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 76.04 157.8 7.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -81.81 -19.96 40.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -1.127 . . . . 0.0 109.449 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.91 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 143.07 -12.6 2.34 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.472 ' C ' HD12 ' A' ' 75' ' ' ILE . . . -78.55 -148.12 3.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.0 126.0 13.25 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.858 2.372 . . . . 0.0 111.847 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.09 -6.53 66.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.91 HG21 ' HA2' ' A' ' 49' ' ' GLY . 53.7 m -74.22 139.48 44.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.079 -1.248 . . . . 0.0 109.537 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.401 HG12 ' HG3' ' A' ' 71' ' ' LYS . 7.3 mt -110.6 139.43 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 64.9 mttt -130.27 138.44 50.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 109.519 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HD3' HD22 ' A' ' 45' ' ' LEU . 17.4 mtmt -112.92 136.46 52.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.322 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -137.14 133.99 35.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 98.7 m-70 -122.4 131.43 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HG3' HG12 ' A' ' 54' ' ' ILE . 17.2 tttm -128.72 127.66 42.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.502 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 1.001 HG21 HD11 ' A' ' 75' ' ' ILE . 2.3 p -84.0 134.22 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 23.4 mt-10 -82.41 -44.76 15.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.857 . . . . 0.0 109.431 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.3 mt-10 -159.23 150.98 20.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.001 HD11 HG21 ' A' ' 72' ' ' VAL . 3.2 mt -135.54 107.12 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 79' ' ' ASN . 31.1 t0 -123.21 90.92 3.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.8 m170 -70.4 -32.78 70.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.58 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.59 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.447 ' OD1' ' OD1' ' A' ' 76' ' ' ASP . 12.4 m120 -84.34 8.25 16.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 75.6 m-85 54.72 25.36 6.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.378 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HE2' ' OE2' ' A' ' 102' ' ' GLU . 63.6 tttt -108.78 122.21 46.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 109.232 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 84' ' ' TYR . 7.4 t80 -128.75 129.82 46.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 109.695 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.463 ' HA ' ' HG3' ' A' ' 102' ' ' GLU . 1.8 t -109.55 123.63 49.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.013 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.608 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -121.14 138.62 54.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.121 -0.987 . . . . 0.0 109.966 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.496 ' HB3' ' NZ ' ' A' ' 98' ' ' LYS . 48.8 m -137.45 158.71 43.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.054 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 mt -127.65 128.1 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.653 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.544 HG22 ' HG3' ' A' ' 88' ' ' GLU . 89.1 mt -86.01 -39.16 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.544 ' HG3' HG22 ' A' ' 87' ' ' ILE . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.4 ' C ' ' OG1' ' A' ' 95' ' ' THR . 81.8 t60 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.267 0.556 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.929 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.1 OUTLIER 61.36 13.34 4.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.61 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.785 ' HB3' HD11 ' A' ' 99' ' ' ILE . 32.3 mt -94.87 90.23 5.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' HIS . 86.7 mt-10 -47.19 -42.67 20.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.598 -0.689 . . . . 0.0 110.509 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 1.051 ' O ' HD13 ' A' ' 99' ' ' ILE . 19.7 tttm -158.96 162.49 36.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.713 -1.242 . . . . 0.0 110.522 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.051 HD13 ' O ' ' A' ' 98' ' ' LYS . 7.2 mm -136.15 126.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -132.79 155.8 48.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.112 -0.992 . . . . 0.0 109.996 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.54 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 57.1 m-85 -137.86 129.72 28.56 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 83.6 tt0 -106.83 129.09 54.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.807 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -108.32 118.53 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -129.53 143.77 50.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.532 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.46 ' SD ' ' HA ' ' A' ' 20' ' ' PHE . 59.8 mtt -118.81 147.82 43.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.95 163.81 33.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.62 32.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.855 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.779 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.481 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 28.7 t -135.55 148.77 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -1.159 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.779 HG13 ' HB2' ' A' ' 108' ' ' ALA . 64.7 mt -113.86 134.25 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' CE2' ' A' ' 146' ' ' PHE . 24.1 mt -106.66 139.24 41.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -135.34 136.45 41.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.376 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.9 mt -125.02 135.23 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 25.3 m -116.16 141.9 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.912 . . . . 0.0 109.442 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.54 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 67.8 m -124.48 153.15 42.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -137.28 129.08 28.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.759 ' HD1' HD12 ' A' ' 99' ' ' ILE . 51.4 m-85 -125.77 108.72 11.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.745 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.679 ' HA ' HG22 ' A' ' 3' ' ' VAL . 52.6 m-70 -79.88 130.89 35.67 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 8.8 t -116.17 147.87 40.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.067 -1.02 . . . . 0.0 109.731 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 124' ' ' THR . 18.2 tttt -42.09 -40.96 2.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.646 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.85 0.52 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -86.41 10.72 14.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -1.171 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.929 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -110.36 151.09 27.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -132.25 149.33 52.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 29.5 mt -98.56 121.39 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.527 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -54.69 138.86 40.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.507 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.2 mt-10 -66.3 -33.22 75.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 109.502 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -59.04 -33.58 70.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.304 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -65.73 -29.52 70.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.268 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.912 HG21 ' CG ' ' A' ' 6' ' ' TYR . 1.8 mm -69.83 -48.51 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 108.749 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -55.59 -41.55 73.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.193 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.45 75.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.35 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.11 -34.81 58.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.3 -38.14 87.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.294 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.29 -43.74 96.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.282 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -60.2 -42.76 95.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.922 . . . . 0.0 109.428 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.49 82.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.75 89.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.46 -48.47 83.92 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 149' ' ' VAL . 25.2 tp -64.85 -38.85 92.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.16 . . . . 0.0 109.405 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.512 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 68.5 t80 -60.33 -41.31 93.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.291 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.29 66.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.404 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.673 HG23 HD21 ' A' ' 30' ' ' LEU . 7.9 p -64.2 -44.29 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.562 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.4 tt0 -54.33 -43.57 71.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.85 99.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -60.55 -47.29 86.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.467 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.68 -36.99 82.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.434 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.2 tt -63.24 -46.33 87.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.04 -32.08 70.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 m170 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.463 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.629 ' CG2' ' CD2' ' A' ' 123' ' ' HIS . 7.7 p -131.52 136.49 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.576 ' CE2' HG12 ' A' ' 130' ' ' ILE . 87.3 m-85 -95.92 144.38 26.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.41 ' SG ' ' HE3' ' A' ' 121' ' ' LYS . 4.0 m -125.26 119.75 29.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.78 ' O ' HG23 ' A' ' 119' ' ' THR . 29.3 m-85 -110.75 148.41 32.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.53 151.97 39.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -131.8 138.94 48.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -108.98 132.47 54.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.645 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -148.89 125.63 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -114.38 135.56 53.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.84 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -160.36 141.33 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 13' ' ' VAL . 2.3 p -77.1 91.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 0.0 109.37 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.607 HG22 ' HD2' ' A' ' 15' ' ' PRO . 1.9 mt -138.77 142.62 34.59 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HD2' HG22 ' A' ' 14' ' ' ILE . 48.4 Cg_endo -68.96 123.02 9.93 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.578 2.185 . . . . 0.0 111.47 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.78 -30.06 41.54 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.774 2.316 . . . . 0.0 112.278 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.38 6.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.597 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -72.55 -47.48 47.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.811 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.947 HD13 ' O ' ' A' ' 19' ' ' LEU . 3.0 tm? -53.11 -37.17 61.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.84 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.476 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 53.8 t80 -71.74 -54.93 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 0.0 109.784 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.812 ' HG3' HD12 ' A' ' 25' ' ' LEU . 17.5 tttm -67.67 -30.41 69.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.803 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 36.4 m -81.81 -30.53 32.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.945 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.978 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 88.0 t80 -100.84 -44.22 5.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 110.44 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.06 -52.98 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.964 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.812 HD12 ' HG3' ' A' ' 21' ' ' LYS . 45.0 mt -70.66 -28.68 64.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.937 -1.102 . . . . 0.0 110.037 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.476 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 87.5 m-20 -108.96 19.84 19.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.049 -1.032 . . . . 0.0 109.657 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.978 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.96 -52.24 26.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.992 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.572 ' HA ' HD12 ' A' ' 31' ' ' ILE . 71.3 m-20 -62.54 -32.48 73.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.35 -41.62 18.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.001 . . . . 0.0 109.968 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' A' ' 26' ' ' ASP . 45.2 mt -72.46 -34.15 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 28' ' ' ASP . 18.8 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.494 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' HD12 ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.296 0.57 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -125.02 163.62 21.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -91.45 108.01 19.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 56' ' ' LYS . 46.0 mt -61.72 -41.99 98.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -158.27 153.18 25.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.409 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 96.25 158.04 31.75 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -94.9 9.71 38.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -1.186 . . . . 0.0 109.536 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.77 21.82 8.42 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -118.46 -144.67 7.6 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.32 123.54 10.35 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.701 2.267 . . . . 0.0 111.874 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.23 1.46 72.25 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.666 HG21 ' HA2' ' A' ' 49' ' ' GLY . 93.4 m -73.38 134.64 44.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.553 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.528 HG12 ' CD ' ' A' ' 71' ' ' LYS . 3.9 mt -104.6 138.92 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 49.2 mttm -123.57 142.32 51.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.742 ' HB2' HD11 ' A' ' 45' ' ' LEU . 49.3 tttt -134.15 142.46 47.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 42' ' ' ALA . 6.1 tp . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.573 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 45.5 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -92.04 156.01 17.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.56 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 78.5 m80 -134.96 135.85 41.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.528 ' CD ' HG12 ' A' ' 54' ' ' ILE . 10.3 tptm -132.12 127.3 35.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.453 HG11 ' CG1' ' A' ' 75' ' ' ILE . 40.3 t -91.61 125.11 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.35 -42.67 58.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.382 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.2 tt0 -174.85 142.32 0.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.024 HD12 ' HA2' ' A' ' 50' ' ' GLY . 69.1 mt -119.12 132.4 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 80.8 m-20 -133.14 83.62 2.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -61.68 -37.57 84.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.76 71.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 75.2 m-20 -91.61 9.91 30.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASN . 86.1 m-85 43.71 45.64 6.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.46 ' HG3' ' HG2' ' A' ' 104' ' ' LYS . 10.3 ttpp -140.35 123.22 16.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 58.5 t80 -111.07 129.2 55.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.405 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 22.0 m -123.91 114.81 20.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 109.558 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.549 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 37.1 p90 -137.57 159.91 40.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.462 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.447 ' O ' HD13 ' A' ' 86' ' ' ILE . 85.6 p -141.3 168.84 18.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 85' ' ' SER . 26.6 mm -114.29 121.45 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 71' ' ' LYS . 81.2 mt -70.78 -41.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 109.531 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.297 0.57 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.948 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 59.51 14.79 4.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.565 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.992 HD22 ' HB3' ' A' ' 122' ' ' TYR . 36.5 mt -93.12 90.7 6.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 108.83 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 94.6 mt-10 -43.23 -44.59 5.34 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.795 -0.566 . . . . 0.0 110.125 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.685 ' O ' HD13 ' A' ' 99' ' ' ILE . 88.0 mttt -153.54 156.17 37.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.961 -1.087 . . . . 0.0 110.032 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.861 HD11 ' HB3' ' A' ' 96' ' ' LEU . 32.3 mm -130.51 112.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 36.8 m -115.76 152.5 33.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.769 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.456 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 91.2 m-85 -129.63 133.3 47.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.347 -0.846 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.405 ' HG3' ' SG ' ' A' ' 83' ' ' CYS . 84.1 tt0 -117.4 139.27 51.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.682 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.6 mt -123.88 121.87 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.345 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 21.3 mtpt -117.54 127.5 54.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.811 ' SD ' HD12 ' A' ' 19' ' ' LEU . 70.1 mtm -124.48 138.6 54.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.34 37.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.96 135.53 43.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 t -115.05 154.48 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.44 127.37 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.332 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.541 HD22 ' HG2' ' A' ' 105' ' ' MET . 55.9 mt -106.59 136.96 45.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 40.3 mttt -131.4 138.1 48.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.243 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.9 mt -125.68 122.71 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.731 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.78 HG23 ' O ' ' A' ' 6' ' ' TYR . 94.3 m -128.66 138.3 52.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.456 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 2.1 m -123.24 166.56 15.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 10.6 mtpt -138.45 112.84 8.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.165 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.992 ' HB3' HD22 ' A' ' 96' ' ' LEU . 8.1 m-30 -108.29 115.13 29.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.629 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 12.7 m-70 -82.56 122.91 28.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 108.693 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 95' ' ' THR . 14.2 t -106.78 141.12 38.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.988 -1.07 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -45.39 -40.58 8.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.22 -68.24 0.37 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -65.18 -27.73 68.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -1.141 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.948 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -72.74 149.52 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.497 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 92.3 p -126.63 159.86 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.714 HD11 HD21 ' A' ' 96' ' ' LEU . 35.1 mm -108.19 123.37 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.47 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 54.6 t30 -91.6 131.34 37.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 136' ' ' LYS . 75.0 mm-40 -53.96 -40.72 67.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.469 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.93 -42.04 90.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 73.6 mm-40 -63.14 -41.59 99.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.714 HG21 ' CG2' ' A' ' 130' ' ' ILE . 20.9 pt -84.42 -30.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.511 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.1 tttp -55.72 -40.87 73.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.247 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.81 75.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.06 -39.4 69.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -60.95 -43.36 98.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -1.143 . . . . 0.0 109.225 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.53 -46.82 70.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -57.71 -45.97 85.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.66 -40.32 96.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.36 83.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.72 -46.79 88.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.95 -39.3 85.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -1.091 . . . . 0.0 109.091 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.529 ' O ' HG12 ' A' ' 149' ' ' VAL . 68.9 t80 -60.97 -45.46 94.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 109.248 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -62.74 -34.49 77.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.237 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.83 -51.39 59.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 146' ' ' PHE . 3.5 p -59.57 -39.85 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.567 ' HA ' HD12 ' A' ' 153' ' ' LEU . 85.9 tt0 -60.6 -39.89 89.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.38 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.13 90.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -59.91 -43.98 94.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.354 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 150' ' ' GLU . 14.7 mt -60.46 -40.45 91.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.299 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.4 tt -60.58 -38.88 86.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.87 . . . . 0.0 109.403 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.574 ' O ' ' CG ' ' A' ' 156' ' ' HIS . . . -69.65 -25.44 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 155' ' ' ALA . 18.7 p80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.731 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.835 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.65 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.3 p -119.96 143.39 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.539 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -104.42 137.29 42.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.0 t -117.44 125.67 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.492 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 26.5 m-85 -118.14 147.96 42.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -119.94 149.8 41.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -130.32 139.46 50.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -115.69 139.13 50.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.95 122.42 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -113.19 133.11 55.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.767 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 t -160.26 137.98 9.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 109.2 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 13' ' ' VAL . 2.7 p -73.02 91.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.541 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.791 HG21 HD13 ' A' ' 19' ' ' LEU . 16.6 mt -138.83 144.2 40.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.744 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.2 Cg_endo -68.62 118.13 5.45 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.384 2.056 . . . . 0.0 111.374 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 20' ' ' PHE . 45.1 Cg_endo -66.96 -43.13 7.12 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.769 2.313 . . . . 0.0 112.223 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -49.61 67.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.573 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -72.12 -43.98 63.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 14' ' ' ILE . 7.1 tp -67.2 -41.01 86.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 109.72 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 52.3 t80 -65.42 -47.51 75.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.728 ' HG3' HD12 ' A' ' 25' ' ' LEU . 39.4 tttt -68.98 -36.57 78.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.81 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 35.3 t -80.81 -25.74 37.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.921 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 77.5 t80 -100.68 -50.11 3.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.356 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.764 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.7 t -84.46 -52.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.056 -1.028 . . . . 0.0 110.513 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.728 HD12 ' HG3' ' A' ' 21' ' ' LYS . 56.0 mt -72.48 -28.13 62.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.942 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 22' ' ' SER . 87.9 m-20 -113.79 28.38 8.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.461 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.921 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.52 -39.62 77.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.645 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' HD12 ' A' ' 31' ' ' ILE . 26.9 p-10 -69.81 -32.63 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 24.9 m120 -88.71 -32.32 18.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.829 HD23 ' O ' ' A' ' 30' ' ' LEU . 8.1 tt -73.86 -30.25 62.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 27' ' ' ALA . 17.2 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.614 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.283 0.563 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.19 159.61 37.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.476 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -88.16 108.08 19.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 45' ' ' LEU . 21.8 tp -67.88 -37.27 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 53' ' ' THR . 86.1 tt0 -139.94 155.71 47.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 87.09 160.82 35.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -91.9 8.88 35.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.554 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.706 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.97 13.36 25.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.807 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -110.84 -143.85 9.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.5 Cg_endo -69.43 125.12 11.93 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -2.66 74.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.706 HG21 ' HA2' ' A' ' 49' ' ' GLY . 62.6 m -73.04 139.78 46.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -1.136 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.498 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.1 mm -101.41 128.48 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.614 ' HE2' ' HB3' ' A' ' 42' ' ' ALA . 63.1 tttt -105.95 133.86 49.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -122.7 143.32 49.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 42' ' ' ALA . 73.0 mt . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.443 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.4 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.6 mttm -118.31 136.82 53.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.618 ' NE2' ' CD2' ' A' ' 84' ' ' TYR . 11.1 t-80 -132.4 128.79 38.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 75.3 tttt -126.69 150.24 49.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.389 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.768 HG11 ' O ' ' A' ' 50' ' ' GLY . 7.4 p -108.34 134.61 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -82.49 -56.77 3.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 44.3 mt-10 -150.81 140.88 22.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.807 HD12 ' HA2' ' A' ' 50' ' ' GLY . 73.0 mt -125.59 126.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.478 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 84.3 m-20 -131.55 94.72 3.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.94 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' HD11 ' A' ' 25' ' ' LEU . 86.6 t60 -66.08 -37.88 86.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.47 66.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.478 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 18.7 m120 -85.0 2.48 42.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.606 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 49.78 34.36 7.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -130.83 128.49 40.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.447 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.7 t80 -122.74 130.17 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.5 m -132.48 118.56 19.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.618 ' CD2' ' NE2' ' A' ' 70' ' ' HIS . 36.3 p90 -132.94 162.14 32.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 39.7 t -138.42 150.24 46.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 69' ' ' LYS . 22.8 mt -104.04 133.08 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 88' ' ' GLU . 85.2 mt -77.63 -41.45 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.52 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.523 ' HG3' HG22 ' A' ' 87' ' ' ILE . 99.0 mt-10 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.224 0.535 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 45.69 24.31 0.2 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 122' ' ' TYR . 15.1 mt -95.24 90.69 5.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.278 -0.889 . . . . 0.0 109.31 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 94.1 mt-10 -41.5 -41.15 2.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.528 -0.733 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 46.6 mttt -158.26 168.18 27.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.922 -1.111 . . . . 0.0 110.139 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.789 HG23 ' CE1' ' A' ' 122' ' ' TYR . 40.3 mt -146.61 117.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 24.1 t -127.41 150.03 49.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 98.6 m-85 -131.1 128.07 39.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.818 . . . . 0.0 109.042 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.7 mt-10 -106.25 141.74 37.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 109.722 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.03 124.18 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.285 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -130.73 129.22 42.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.656 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.498 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 69.0 mtm -126.61 141.0 52.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.82 30.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.53 137.13 52.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.436 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 t -152.03 152.12 32.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -1.117 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.81 130.14 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.923 . . . . 0.0 109.377 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.498 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 64.8 mt -109.02 132.51 54.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -130.27 135.62 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.37 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.8 mt -124.58 133.09 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.586 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 30.4 m -125.58 141.45 52.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.343 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.2 m -126.44 151.95 47.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.66 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -138.32 126.49 22.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 109.221 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.812 ' HB3' HD22 ' A' ' 96' ' ' LEU . 38.0 m-85 -127.0 111.16 13.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.911 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.578 ' CD2' HG21 ' A' ' 3' ' ' VAL . 22.4 m-70 -85.04 135.53 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.894 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 11.3 t -115.82 141.27 48.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.029 . . . . 0.0 109.852 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.495 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 69.8 mttt -77.82 137.54 38.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.35 -153.76 50.69 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.43 13.81 7.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -1.2 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.894 ' HB3' ' OG1' ' A' ' 124' ' ' THR . . . -52.06 143.77 13.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.7 p -124.01 170.02 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 12.6 mt -115.95 126.82 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -60.78 134.84 57.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.552 ' HA ' HG13 ' A' ' 135' ' ' ILE . 86.6 tt0 -62.88 -29.87 71.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.33 -44.68 95.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 0.0 109.124 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -57.6 -24.92 58.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.842 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.552 HG13 ' HA ' ' A' ' 132' ' ' GLU . 2.0 mt -71.69 -51.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.114 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -55.97 -38.29 70.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.93 78.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.364 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.11 -30.21 76.78 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' A' ' 135' ' ' ILE . 68.2 mttm -71.13 -36.24 72.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -1.214 . . . . 0.0 109.393 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.13 -42.35 93.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -63.05 -40.13 96.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.391 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.425 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -70.12 -35.68 74.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.456 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.79 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.98 -39.33 97.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.41 ' O ' HG12 ' A' ' 149' ' ' VAL . 18.7 tp -65.47 -40.25 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.43 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 19.6 m-85 -60.97 -41.54 96.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.522 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -66.92 -34.8 78.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.99 -50.3 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.386 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 150' ' ' GLU . 3.8 p -57.53 -44.05 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.434 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.505 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.0 mt-10 -59.63 -44.36 93.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 155' ' ' ALA . . . -59.49 -35.61 74.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.9 -47.68 83.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -54.2 -46.98 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.323 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.671 ' N ' HD12 ' A' ' 154' ' ' LEU . 6.7 mp -80.1 -24.85 40.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 151' ' ' ALA . . . -78.81 -17.84 55.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.381 179.868 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.8 HG21 ' CE1' ' A' ' 123' ' ' HIS . 38.3 t -128.07 141.13 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -1.115 . . . . 0.0 109.511 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.647 ' HE2' HG21 ' A' ' 124' ' ' THR . 98.4 m-85 -99.11 135.2 40.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.338 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.1 p -119.02 125.3 49.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' THR . 77.6 m-85 -126.87 140.9 52.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.2 tt0 -115.95 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 59.9 t0 -101.62 124.7 47.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -99.16 131.48 45.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.963 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.1 124.98 10.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.9 m -105.11 131.96 51.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.786 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.8 p -160.34 140.47 11.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.26 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 13' ' ' VAL . 2.4 p -81.64 91.22 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.949 HG21 HD13 ' A' ' 19' ' ' LEU . 3.1 mt -138.69 142.52 34.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.231 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.3 Cg_endo -68.08 120.47 7.45 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.544 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.6 Cg_endo -67.0 -28.47 41.7 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.847 2.365 . . . . 0.0 112.224 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.71 -56.5 5.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -72.57 -45.95 56.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.949 HD13 HG21 ' A' ' 14' ' ' ILE . 10.7 tp -56.45 -41.0 75.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.874 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 24' ' ' VAL . 67.6 t80 -64.5 -49.05 72.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.731 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.712 ' HG2' HD12 ' A' ' 25' ' ' LEU . 41.7 mttm -69.08 -43.72 73.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 109.628 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 20.3 m -73.39 -22.25 60.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.764 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.965 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 69.7 t80 -100.88 -50.73 3.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.04 -52.83 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.918 . . . . 0.0 110.484 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.712 HD12 ' HG2' ' A' ' 21' ' ' LYS . 43.0 mt -71.77 -28.49 63.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 109.974 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 89.9 m-20 -108.4 18.67 20.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 109.555 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.965 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.29 -33.87 75.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.607 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.04 -37.55 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.703 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -92.29 -41.11 10.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.683 HD21 HG23 ' A' ' 149' ' ' VAL . 16.0 tp -56.98 -41.05 77.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 27' ' ' ALA . 33.4 mt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.514 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.625 ' HB1' ' HE3' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -144.56 142.45 30.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 84.8 m-20 -85.89 117.55 24.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.501 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 45.3 tp -69.54 -38.03 77.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.459 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.5 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 77.7 tt0 -159.22 157.35 30.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.5 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 91.96 158.02 34.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -93.57 11.37 28.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.163 . . . . 0.0 109.535 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.64 31.08 5.6 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 1.009 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -127.83 -144.14 5.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.62 125.51 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.701 2.268 . . . . 0.0 111.768 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.13 4.26 86.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.602 HG21 ' HA2' ' A' ' 49' ' ' GLY . 74.8 m -77.68 139.52 39.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.143 -1.21 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 16.8 mm -104.41 137.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HE3' ' HB1' ' A' ' 42' ' ' ALA . 56.1 tttp -126.6 142.27 51.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -124.87 126.92 46.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.319 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.607 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.554 ' HG2' HD12 ' A' ' 87' ' ' ILE . 39.2 tttp -129.26 130.7 46.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 90.0 m-70 -122.94 134.86 54.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.29 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -131.6 132.11 43.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 50' ' ' GLY . 14.2 m -100.45 128.05 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -70.52 -41.62 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 84.9 tt0 -176.52 144.67 0.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.141 -0.974 . . . . 0.0 109.503 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.009 HD12 ' HA2' ' A' ' 50' ' ' GLY . 62.2 mt -118.79 129.91 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.5 m-20 -130.53 83.8 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.83 -41.24 90.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.11 79.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 22.4 m120 -86.8 5.91 34.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 47.67 33.43 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.945 . . . . 0.0 109.483 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -127.63 132.5 49.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.44 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 71.2 t80 -124.35 126.33 45.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.433 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 12.4 t -124.07 119.59 29.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.558 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 34.5 p90 -140.22 167.11 22.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.384 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 100' ' ' SER . 84.4 p -146.71 168.38 21.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 85' ' ' SER . 23.5 mm -115.39 113.68 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.308 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 69' ' ' LYS . 90.6 mt -68.09 -35.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.305 -0.872 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.413 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 84.7 t60 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 1.069 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.3 OUTLIER 64.08 15.21 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.338 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' A' ' 99' ' ' ILE . 71.5 mt -104.54 93.76 4.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 85.5 mt-10 -45.97 -41.53 11.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.638 -0.664 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 1.046 ' O ' HD13 ' A' ' 99' ' ' ILE . 89.4 mttt -155.33 160.76 40.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.679 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.046 HD13 ' O ' ' A' ' 98' ' ' LYS . 12.5 mm -135.0 114.36 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 85' ' ' SER . 32.8 m -118.27 150.29 39.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.042 . . . . 0.0 110.405 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HE1' ' HH ' ' A' ' 122' ' ' TYR . 74.3 m-85 -131.95 132.57 43.64 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 118' ' ' ILE . 87.1 tt0 -113.29 141.05 47.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.997 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.609 HD13 ' HE1' ' A' ' 23' ' ' PHE . 70.0 mt -121.68 121.61 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -126.26 137.19 53.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.852 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.1 mtt -119.94 131.77 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.241 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.86 155.24 43.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 114' ' ' SER . . . -101.33 128.98 47.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 49.5 m -132.88 155.51 48.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 109.531 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.63 134.22 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 49.9 mt -105.86 135.89 46.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 50.6 mttp -133.46 137.41 45.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 102' ' ' GLU . 68.8 mt -127.41 135.29 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.4 m -118.38 142.59 47.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.478 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.487 ' HG ' ' HD1' ' A' ' 101' ' ' TYR . 51.1 m -126.98 152.35 47.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -136.2 126.14 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.789 ' HD1' HD12 ' A' ' 99' ' ' ILE . 54.5 m-85 -122.26 116.27 23.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.975 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.8 ' CE1' HG21 ' A' ' 3' ' ' VAL . 72.2 m-70 -85.5 126.01 33.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.647 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -109.85 152.65 25.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.106 . . . . 0.0 109.783 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -53.86 -40.86 66.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.01 -84.24 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -61.39 -26.26 67.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.137 . . . . 0.0 109.52 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 1.069 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -62.44 146.25 51.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -137.69 151.15 47.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 96' ' ' LEU . 36.4 mt -110.34 124.65 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.554 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -88.6 153.23 21.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.449 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.2 mt-10 -61.02 -36.7 80.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.528 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.528 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 22.3 pt-20 -60.96 -46.08 92.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.939 . . . . 0.0 109.49 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 133' ' ' GLU . 85.4 tt0 -56.87 -47.61 80.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 132' ' ' GLU . 41.8 pt -76.68 -29.27 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 132' ' ' GLU . 38.5 tttt -55.53 -41.47 73.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.229 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.36 76.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.072 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.83 -38.34 73.36 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -61.38 -43.74 98.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -1.097 . . . . 0.0 109.075 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.5 -47.68 69.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -57.8 -45.53 85.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.905 . . . . 0.0 109.081 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.53 88.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.302 -0.873 . . . . 0.0 109.127 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.8 66.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.48 -44.37 93.72 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 149' ' ' VAL . 71.6 mt -55.64 -39.62 71.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.195 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.519 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.6 m-85 -65.91 -39.48 90.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.304 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.8 -38.69 89.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.311 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.01 -52.11 32.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.683 HG23 HD21 ' A' ' 30' ' ' LEU . 7.6 p -65.28 -41.53 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.505 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.6 tt0 -58.83 -40.69 84.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.88 99.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 109.299 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.7 -49.37 78.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 109.352 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.6 -29.6 66.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.3 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.5 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.8 tt -65.29 -46.83 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.58 75.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.726 HG23 ' C ' ' A' ' 122' ' ' TYR . 11.1 p -127.01 137.24 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.473 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.651 ' HE2' HG21 ' A' ' 124' ' ' THR . 43.0 m-85 -101.99 152.55 20.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.82 111.73 11.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.917 . . . . 0.0 109.412 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' THR . 52.4 m-85 -108.4 151.18 26.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HG2' ' CG2' ' A' ' 119' ' ' THR . 95.2 mt-10 -125.93 139.58 53.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.561 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 118' ' ' ILE . 91.6 m-20 -111.66 156.51 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.451 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -127.01 134.26 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.665 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.11 124.21 10.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.22 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.69 HG23 HG12 ' A' ' 115' ' ' ILE . 33.8 m -116.59 139.3 50.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.968 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.428 ' O ' HG12 ' A' ' 14' ' ' ILE . 46.4 m -160.04 144.34 14.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.893 ' O ' HD13 ' A' ' 14' ' ' ILE . 31.1 m -70.72 90.67 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.479 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 1.044 HG21 HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -139.62 145.03 41.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.054 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HD2' HG22 ' A' ' 14' ' ' ILE . 44.1 Cg_endo -67.26 129.92 21.46 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 122.367 2.045 . . . . 0.0 111.084 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.4 Cg_endo -66.62 -39.98 14.57 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.701 2.267 . . . . 0.0 112.502 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -46.52 20.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.062 -1.024 . . . . 0.0 109.794 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . 91.7 mtt-85 -71.99 -49.22 38.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.044 HD13 HG21 ' A' ' 14' ' ' ILE . 28.8 tp -59.51 -47.94 83.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.754 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CE1' ' C ' ' A' ' 80' ' ' PHE . 53.8 t80 -53.73 -55.02 29.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.729 ' HG3' HD13 ' A' ' 25' ' ' LEU . 83.0 tttt -65.84 -54.9 20.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.942 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 31.6 m -62.29 -27.41 69.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.406 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.3 t80 -93.92 -50.88 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.916 -1.115 . . . . 0.0 110.292 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 45.9 t -84.59 -50.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 110.028 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 ' HG3' ' A' ' 21' ' ' LYS . 4.1 tt -68.92 -49.14 60.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' SER . 66.3 m-20 -91.65 24.16 3.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.919 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.44 -44.54 71.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.454 ' HA ' HD12 ' A' ' 31' ' ' ILE . 76.6 m-20 -64.14 -24.21 67.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -91.27 -38.47 12.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.849 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 30' ' ' LEU . 22.1 mt -79.89 -36.64 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.587 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 27' ' ' ALA . 25.0 mt . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.62 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -133.97 159.11 41.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.461 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.5 m-20 -87.36 108.69 19.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 45' ' ' LEU . 23.6 tp -68.59 -36.32 78.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.557 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.795 ' O ' HG23 ' A' ' 53' ' ' THR . 86.0 tt0 -140.05 155.29 47.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 85.33 163.81 37.89 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -90.22 8.84 31.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -1.183 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.732 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 99.45 43.18 2.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.66 -137.34 3.08 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.1 Cg_endo -69.17 123.0 9.84 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.801 2.334 . . . . 0.0 112.049 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.56 8.73 84.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 46' ' ' GLU . 56.3 m -86.41 139.79 30.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -1.156 . . . . 0.0 109.542 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.52 HG12 ' CD ' ' A' ' 71' ' ' LYS . 6.0 mt -101.46 139.18 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.526 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 93.7 mttt -117.47 150.62 38.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -125.27 137.28 54.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.281 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.9 tt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.656 -179.865 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' HB3' HD12 ' A' ' 87' ' ' ILE . 37.6 mttm -130.69 140.66 50.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 97.4 m-70 -125.47 136.74 53.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.52 ' CD ' HG12 ' A' ' 54' ' ' ILE . 23.8 tptm -130.26 133.83 46.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 45.6 t -100.02 132.86 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.89 -56.48 4.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.662 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.8 tt0 -178.89 138.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.845 HG21 ' CE2' ' A' ' 82' ' ' TYR . 15.7 pt -136.29 145.36 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.567 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' OD1' ' A' ' 79' ' ' ASN . 60.7 t0 -132.84 109.14 9.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -60.22 -36.22 77.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.72 99.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.438 ' OD1' ' OD1' ' A' ' 76' ' ' ASP . 15.8 m120 -86.11 -5.74 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.222 -0.923 . . . . 0.0 109.587 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.524 ' C ' ' CE1' ' A' ' 20' ' ' PHE . 92.2 m-85 58.74 36.09 24.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.294 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -117.99 131.54 56.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.845 ' CE2' HG21 ' A' ' 75' ' ' ILE . 72.6 t80 -128.03 114.85 17.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.885 . . . . 0.0 109.683 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.71 118.17 30.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.217 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.579 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 32.5 p90 -129.33 154.62 46.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 51.1 m -128.9 159.14 36.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.27 129.57 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.459 HD12 ' HB3' ' A' ' 69' ' ' LYS . 84.4 mt -77.6 -41.71 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 179.961 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 58.85 23.59 11.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' ' 99' ' ' ILE . 96.5 mt -101.35 93.62 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.548 ' CG ' ' HG2' ' A' ' 125' ' ' LYS . 96.8 mt-10 -48.49 -32.72 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.764 -0.585 . . . . 0.0 111.287 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.787 ' O ' HD13 ' A' ' 99' ' ' ILE . 78.3 tttt -151.14 143.09 23.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 0.0 110.622 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.809 HG23 ' CE1' ' A' ' 122' ' ' TYR . 23.0 mm -124.81 113.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 28.5 t -116.97 148.68 41.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 120' ' ' SER . 3.7 m-85 -130.87 123.95 30.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.781 . . . . 0.0 109.057 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' OG1' ' A' ' 119' ' ' THR . 91.1 mt-10 -109.12 135.3 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.752 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.4 mt -131.52 119.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.98 155.11 47.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.698 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -117.35 147.85 42.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.277 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.79 147.18 46.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.23 138.5 38.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.1 p -144.37 165.48 27.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -1.055 . . . . 0.0 109.41 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 11' ' ' THR . 72.4 mt -123.01 133.56 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.429 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.773 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.7 mp -106.98 138.91 42.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -124.69 135.49 53.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 8' ' ' ASP . 72.2 mt -123.82 128.79 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 8.4 p -126.39 142.69 51.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.468 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.514 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -121.65 152.88 38.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 109.676 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -132.34 115.04 15.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 108.931 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.809 ' CE1' HG23 ' A' ' 99' ' ' ILE . 9.6 m-30 -112.87 121.61 45.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.05 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.536 ' CD2' HG21 ' A' ' 3' ' ' VAL . 4.5 m-70 -92.85 115.51 28.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.389 -0.819 . . . . 0.0 108.841 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.651 HG21 ' HE2' ' A' ' 4' ' ' PHE . 1.1 p -92.7 148.65 21.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.548 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 54.3 mttp -70.09 147.25 50.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 48.19 -143.59 7.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -92.88 15.97 13.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.126 . . . . 0.0 109.418 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.12 146.31 3.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.6 p -113.9 161.75 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 96' ' ' LEU . 49.4 mt -105.8 139.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.895 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -84.26 123.95 30.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.487 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 96.3 mt-10 -55.65 -35.59 66.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.08 -41.39 90.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -62.88 -45.63 91.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.464 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 132' ' ' GLU . 38.2 pt -76.86 -31.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 26.4 tttm -55.76 -46.66 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.0 73.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.405 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.01 -39.56 92.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.91 -41.76 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -45.81 91.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -59.94 -45.79 91.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.16 90.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.28 97.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.12 88.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.4 tt -62.88 -39.34 94.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.319 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.468 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 70.9 t80 -59.54 -46.35 89.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -60.73 -39.22 87.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.376 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.54 -48.74 68.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.526 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.2 p -65.0 -43.65 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.0 109.355 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.526 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.2 tt0 -60.63 -40.17 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.12 96.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.267 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -67.93 -42.34 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.915 HD13 ' O ' ' A' ' 153' ' ' LEU . 3.5 tm? -69.83 -31.49 69.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.902 HD13 ' O ' ' A' ' 154' ' ' LEU . 2.7 tm? -75.38 -40.09 58.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.926 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.48 74.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 109.583 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 122' ' ' TYR . 6.7 p -128.44 130.87 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -1.166 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.75 ' HE2' HG21 ' A' ' 124' ' ' THR . 96.8 m-85 -86.42 144.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.606 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.0 m -130.27 121.22 25.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' THR . 46.2 m-85 -116.72 139.84 50.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -114.82 146.66 40.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 118' ' ' ILE . 90.2 m-20 -122.37 154.83 37.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -115.82 143.1 45.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -154.29 121.73 5.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 0.0 109.182 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.8 m -110.15 133.78 52.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.833 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 m -160.3 146.5 15.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -0.881 . . . . 0.0 109.241 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.477 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.2 p -81.19 91.58 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.675 HG21 HD13 ' A' ' 19' ' ' LEU . 1.9 mt -138.65 142.93 35.95 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.301 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.647 ' HD2' HG22 ' A' ' 14' ' ' ILE . 47.4 Cg_endo -68.56 116.31 4.34 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.449 2.1 . . . . 0.0 111.244 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 44.2 Cg_endo -66.45 -27.73 46.62 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.757 2.304 . . . . 0.0 112.36 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.99 6.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.552 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -72.5 -43.25 63.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.675 HD13 HG21 ' A' ' 14' ' ' ILE . 16.2 tp -61.04 -47.97 83.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.887 . . . . 0.0 109.747 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 70.2 t80 -57.3 -50.44 72.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.8 tttt -68.21 -48.38 65.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.553 ' O ' HD22 ' A' ' 30' ' ' LEU . 87.0 p -71.79 -20.84 61.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 110.099 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.937 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 66.0 t80 -100.42 -50.51 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.286 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.645 HG13 ' CD1' ' A' ' 82' ' ' TYR . 54.7 t -84.62 -52.89 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.06 -1.025 . . . . 0.0 110.349 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 15.9 tp -70.24 -29.67 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 91.4 m-20 -110.42 22.14 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.937 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.488 ' OD2' ' NZ ' ' A' ' 55' ' ' LYS . 88.1 m-20 -69.27 -37.05 77.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -96.11 -38.04 10.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.685 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.553 HD22 ' O ' ' A' ' 22' ' ' SER . 16.6 tp -56.5 -42.32 78.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.704 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.0 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.333 -179.884 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.89 153.14 45.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 35.5 p-10 -89.03 108.6 19.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.411 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.64 -35.32 78.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.329 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 53' ' ' THR . 48.4 tp10 -137.91 154.28 49.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.482 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 85.48 159.33 31.51 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.52 10.62 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.483 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.83 6.58 43.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.998 ' O ' HG11 ' A' ' 72' ' ' VAL . . . -102.12 -147.99 20.36 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.7 Cg_endo -68.63 129.84 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.71 2.273 . . . . 0.0 111.756 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.65 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 89.46 -5.21 84.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -75.14 139.23 42.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.506 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.525 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.6 mm -104.05 135.14 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.488 ' NZ ' ' OD2' ' A' ' 28' ' ' ASP . 29.0 mttt -118.37 140.3 50.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.626 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -123.59 142.54 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.581 -179.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.2 mtm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.9 mttt -131.08 144.13 51.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 65.5 m80 -126.56 133.9 50.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.4 tttm -124.45 144.28 50.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.998 HG11 ' O ' ' A' ' 50' ' ' GLY . 7.5 p -98.99 130.43 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -73.39 -46.83 46.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 50.6 tp10 -173.56 143.35 1.03 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.724 HD12 ' HA2' ' A' ' 50' ' ' GLY . 82.6 mt -126.95 125.23 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 8.3 t70 -128.14 105.44 8.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 109.511 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 70.2 m80 -70.24 -35.11 73.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.09 88.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.573 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 83.2 m-20 -85.14 5.33 30.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.551 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 45.11 42.31 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 53.6 pttt -130.44 137.39 49.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.645 ' CD1' HG13 ' A' ' 24' ' ' VAL . 62.0 t80 -126.32 125.03 41.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.468 ' CB ' ' HG3' ' A' ' 102' ' ' GLU . 8.1 t -127.57 115.56 19.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.376 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.5 p90 -129.42 159.57 35.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.515 ' CB ' ' HE3' ' A' ' 98' ' ' LYS . 60.0 p -141.42 167.58 21.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 69' ' ' LYS . 17.9 mt -122.59 132.33 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.4 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.1 mt -80.16 -37.39 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.626 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.363 0.602 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.802 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 65.81 9.58 6.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.719 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.627 HD21 HG12 ' A' ' 130' ' ' ILE . 83.7 mt -90.16 90.7 8.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 108.881 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 123' ' ' HIS . 33.3 mt-10 -48.59 -43.91 36.42 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.753 -0.592 . . . . 0.0 110.831 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' A' ' 85' ' ' SER . 54.9 tttp -150.65 155.17 38.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.616 -1.302 . . . . 0.0 110.464 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.627 HG23 ' CE1' ' A' ' 122' ' ' TYR . 34.1 mt -138.98 116.03 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 87.7 p -125.65 164.51 20.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.451 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 119' ' ' THR . 89.2 m-85 -137.89 120.48 16.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.468 ' HG3' ' CB ' ' A' ' 83' ' ' CYS . 83.1 tt0 -101.88 143.33 31.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.118 -0.989 . . . . 0.0 109.917 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.2 mt -128.51 118.36 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 0.0 108.912 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -120.38 139.61 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.615 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.623 ' SD ' HD23 ' A' ' 19' ' ' LEU . 63.8 mtm -122.35 137.49 54.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.262 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.95 40.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.555 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.85 135.72 40.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.504 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.0 t -134.69 150.69 50.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.409 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.23 132.02 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.487 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 49.5 mt -98.95 137.21 37.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.897 . . . . 0.0 109.357 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.03 131.44 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' ASP . 68.0 mt -118.47 137.57 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 80.8 m -133.1 137.29 46.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.4 m -113.88 154.71 27.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 32.4 mttm -142.12 122.05 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.842 ' O ' HG23 ' A' ' 3' ' ' VAL . 34.7 m-85 -119.43 132.92 55.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.257 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLU . 2.9 m80 -100.31 121.25 41.18 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.75 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -112.09 137.89 49.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.341 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 95' ' ' THR . 71.7 mttt -40.96 -35.12 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.546 -0.722 . . . . 0.0 109.862 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.62 -79.55 0.21 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.98 -29.73 67.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -1.093 . . . . 0.0 109.316 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.802 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -63.5 143.26 57.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.1 m -126.4 154.38 43.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 96' ' ' LEU . 48.6 mt -112.27 132.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 16.0 t-20 -87.04 138.08 31.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.413 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.441 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.2 mt-10 -62.7 -33.04 74.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.433 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 83.0 tt0 -65.62 -46.22 80.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.479 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.18 -45.14 88.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 109.349 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 132' ' ' GLU . 35.8 pt -76.62 -29.19 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.1 tttt -55.63 -45.6 77.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.17 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 109.327 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.06 -38.39 75.86 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.88 -43.75 90.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -1.118 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.28 -43.25 82.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.259 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -57.92 -45.91 85.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.26 -38.6 85.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.127 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.75 96.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -48.21 79.95 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.904 ' O ' HD13 ' A' ' 145' ' ' LEU . 3.1 tm? -60.26 -38.44 83.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -1.131 . . . . 0.0 109.237 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.521 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 71.1 t80 -61.98 -41.39 97.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 0.0 109.298 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -61.0 -41.38 96.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.71 65.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.376 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.4 p -66.72 -41.94 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.491 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.2 tt0 -60.49 -39.94 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.75 99.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.44 -47.18 87.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.608 HD13 ' CD1' ' A' ' 19' ' ' LEU . 24.7 mt -59.92 -34.18 72.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.465 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.484 HD23 ' C ' ' A' ' 154' ' ' LEU . 8.9 tt -64.72 -42.09 95.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -65.01 -31.29 72.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.453 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.876 HG21 ' CE1' ' A' ' 123' ' ' HIS . 25.0 t -126.39 142.43 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -1.119 . . . . 0.0 109.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.785 ' HE2' HG21 ' A' ' 124' ' ' THR . 95.2 m-85 -105.73 129.64 53.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.472 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.0 t -107.76 129.74 55.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' THR . 21.9 m-85 -116.36 143.23 45.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -123.33 142.73 50.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -129.16 134.61 48.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.99 138.47 46.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.593 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -168.53 113.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -120.32 147.63 44.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -160.27 143.88 13.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.172 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.784 ' O ' HG23 ' A' ' 13' ' ' VAL . 24.6 m -65.43 90.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.309 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.737 HG23 ' HD2' ' A' ' 15' ' ' PRO . 32.7 mm -138.87 144.18 40.47 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.464 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.737 ' HD2' HG23 ' A' ' 14' ' ' ILE . 47.6 Cg_endo -69.21 112.43 2.98 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.542 2.161 . . . . 0.0 111.287 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.9 Cg_endo -67.0 -29.55 40.4 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.761 2.308 . . . . 0.0 112.264 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 -56.13 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -72.58 -37.45 68.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.773 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.674 HD22 HG21 ' A' ' 14' ' ' ILE . 15.6 tp -67.07 -33.71 76.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.758 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.757 ' CE1' HG21 ' A' ' 24' ' ' VAL . 66.3 t80 -71.56 -47.87 52.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.139 -0.975 . . . . 0.0 109.954 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' HD23 ' A' ' 25' ' ' LEU . 20.0 mttt -71.56 -22.67 61.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.789 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.779 ' O ' HD12 ' A' ' 30' ' ' LEU . 86.6 p -96.84 -23.64 16.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.09 -1.006 . . . . 0.0 109.458 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.925 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 79.9 t80 -100.46 -45.48 5.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.978 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 20' ' ' PHE . 57.8 t -84.58 -52.7 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.98 . . . . 0.0 110.25 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 21' ' ' LYS . 4.0 mm? -69.79 -45.71 67.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 109.618 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 80.5 m-20 -93.73 25.63 3.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 109.591 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.925 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.92 -42.18 73.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.983 . . . . 0.0 109.775 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.57 -20.52 58.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 0.0 109.965 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -94.88 -38.55 10.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.811 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 22' ' ' SER . 18.1 mt -74.51 -30.03 61.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.564 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 27' ' ' ALA . 21.9 mt . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.302 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -134.23 150.43 51.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -87.51 108.91 19.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.685 HD11 ' HD3' ' A' ' 56' ' ' LYS . 58.5 mt -66.48 -32.12 73.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 53' ' ' THR . 78.1 tt0 -147.92 162.7 38.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.531 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 73.88 156.49 4.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -91.42 9.31 32.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 108.29 30.21 3.95 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.902 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -126.95 -143.71 5.87 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.57 120.47 7.13 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.667 2.245 . . . . 0.0 111.809 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.95 -2.66 72.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 46' ' ' GLU . 52.2 m -76.83 138.16 39.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -1.216 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 70' ' ' HIS . 26.1 mm -102.94 134.28 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.898 . . . . 0.0 109.556 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' NZ ' ' OH ' ' A' ' 82' ' ' TYR . 27.3 mttt -112.08 141.99 45.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.343 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.685 ' HD3' HD11 ' A' ' 45' ' ' LEU . 35.3 ttpt -125.32 125.29 43.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 42' ' ' ALA . 61.7 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 109.516 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.3 0.571 . . . . 0.0 109.629 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -98.45 144.7 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.731 ' O ' HG23 ' A' ' 54' ' ' ILE . 76.0 m80 -130.68 147.01 52.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.479 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 16.3 tttp -135.0 134.86 40.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.14 -0.975 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.405 HG11 ' CG1' ' A' ' 75' ' ' ILE . 46.0 t -98.75 133.22 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -79.38 -43.01 24.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.1 tt0 -176.65 140.02 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.902 HD12 ' HA2' ' A' ' 50' ' ' GLY . 70.4 mt -119.31 126.52 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 75' ' ' ILE . 78.3 m-20 -134.7 76.76 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.7 m170 -55.86 -37.15 68.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.0 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.365 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 80' ' ' PHE . 58.7 m-20 -91.71 12.66 20.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ASN . 91.9 m-85 43.21 39.99 2.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.598 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.466 ' HE2' ' SG ' ' A' ' 83' ' ' CYS . 87.7 tttt -132.07 122.77 25.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.456 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 50.9 t80 -118.62 127.44 53.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' HE2' ' A' ' 81' ' ' LYS . 31.8 m -130.22 121.24 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -135.39 163.05 30.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.458 ' HG ' ' HG ' ' A' ' 100' ' ' SER . 49.9 m -126.38 163.85 22.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.7 mt -119.97 133.63 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 87' ' ' ILE . 87.3 mt -111.91 -2.31 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.568 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 68' ' ' MET . 33.5 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.632 -0.668 . . . . 0.0 109.965 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.9 m80 . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.281 0.563 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 67.85 6.25 4.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 109.779 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 99' ' ' ILE . 95.9 mt -108.34 94.37 5.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.152 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 47.4 mt-10 -41.0 -42.45 1.89 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.7 -0.625 . . . . 0.0 109.888 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.827 ' O ' HD13 ' A' ' 99' ' ' ILE . 31.4 ttpt -177.73 162.17 1.72 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 0.0 109.752 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.985 HD12 ' CD1' ' A' ' 122' ' ' TYR . 5.7 mm -129.6 118.05 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.505 -0.747 . . . . 0.0 109.154 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.458 ' HG ' ' HG ' ' A' ' 85' ' ' SER . 46.9 t -112.08 141.02 46.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 119' ' ' THR . 97.3 m-85 -120.33 143.6 48.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.054 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.9 mt-10 -121.12 143.69 48.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.74 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 82' ' ' TYR . 75.7 mt -122.86 130.82 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.294 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -132.27 133.39 44.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.565 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -112.95 144.49 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.322 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.24 161.75 38.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.11 143.72 33.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.6 m -135.29 139.75 44.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.14 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.477 ' O ' HD23 ' A' ' 116' ' ' LEU . 63.9 mt -107.75 137.67 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 115' ' ' ILE . 33.0 mt -117.21 130.29 56.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 0.0 109.628 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.37 141.38 51.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.52 138.22 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 0.0 109.738 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 28.7 m -126.78 142.57 51.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 100' ' ' SER . 8.9 m -126.58 158.87 35.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.95 . . . . 0.0 109.831 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 86.2 mttt -144.14 118.19 9.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.985 ' CD1' HD12 ' A' ' 99' ' ' ILE . 2.9 m-85 -113.18 113.22 25.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.876 ' CE1' HG21 ' A' ' 3' ' ' VAL . 54.9 m-70 -85.94 116.51 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.785 HG21 ' HE2' ' A' ' 4' ' ' PHE . 1.4 p -107.33 146.14 31.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 109.98 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -80.82 140.69 35.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.46 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.54 67.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.453 ' OD1' ' HA2' ' A' ' 2' ' ' GLY . 30.1 t30 56.14 45.45 23.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 0.0 109.447 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -72.78 142.06 48.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.3 p -82.39 155.42 24.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 21.5 mt -111.57 131.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.83 141.56 58.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.48 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.45 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.6 mt-10 -67.65 -29.64 68.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -65.01 -37.56 88.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.94 -44.91 83.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 132' ' ' GLU . 46.4 pt -80.76 -31.85 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.444 ' N ' HG13 ' A' ' 135' ' ' ILE . 25.6 tttm -57.01 -39.87 75.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.87 73.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.913 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.3 -38.09 94.08 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -59.81 -43.61 94.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.69 -38.9 92.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -63.05 -40.91 99.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.79 -38.63 86.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.77 92.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.17 -42.88 97.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 149' ' ' VAL . 26.3 tp -66.05 -39.53 90.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -1.108 . . . . 0.0 109.334 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.38 -43.11 95.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.867 . . . . 0.0 109.354 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -66.21 -33.85 76.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.74 -49.25 32.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.361 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.794 HG21 ' HD2' ' A' ' 23' ' ' PHE . 7.8 p -63.96 -41.51 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.402 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.515 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.0 tt0 -56.31 -44.39 79.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.397 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -59.96 -49.61 76.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 156' ' ' HIS . 39.1 tp -57.12 -35.49 69.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.522 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.7 tt -62.67 -46.79 86.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.89 71.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 153' ' ' LEU . 3.5 m-70 . . . . . 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.578 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 43.4 t -131.24 133.95 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -1.138 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.729 ' HE1' HG21 ' A' ' 124' ' ' THR . 96.3 m-85 -103.15 137.06 41.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.493 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.7 m -113.33 119.8 38.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.704 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 31.1 m-85 -115.16 139.87 49.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.4 mt-10 -115.33 147.17 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.81 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.473 ' OD2' ' HB ' ' A' ' 118' ' ' ILE . 42.1 m-20 -119.16 154.6 33.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.233 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 117' ' ' LYS . 95.2 mt-10 -124.12 140.91 52.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.36 120.73 6.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 109.114 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.407 HG23 HG12 ' A' ' 115' ' ' ILE . 55.0 m -114.51 129.03 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.933 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 14' ' ' ILE . 34.0 t -160.5 140.58 11.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.87 . . . . 0.0 109.078 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 13' ' ' VAL . 26.1 m -70.93 90.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 0.0 109.4 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.788 HG22 ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -139.17 145.56 45.37 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.788 ' HD2' HG22 ' A' ' 14' ' ' ILE . 46.2 Cg_endo -68.02 124.49 11.86 Favored 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 122.361 2.041 . . . . 0.0 111.243 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.52 -30.59 43.18 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.742 2.295 . . . . 0.0 112.429 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -52.62 8.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.646 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -72.06 -41.62 67.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.748 HD22 ' HB ' ' A' ' 14' ' ' ILE . 22.7 tp -61.48 -48.98 78.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.828 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 61.9 t80 -56.22 -52.75 63.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.812 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 61.9 mttm -67.34 -49.57 63.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 110.017 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.891 ' O ' HD12 ' A' ' 30' ' ' LEU . 86.1 p -69.85 -21.17 63.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 110.219 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.974 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 62.6 t80 -100.22 -49.21 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.963 -1.086 . . . . 0.0 110.194 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 53.2 t -84.56 -52.43 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.5 tp -68.7 -35.22 76.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.046 -1.034 . . . . 0.0 110.184 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.5 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 68.9 m-20 -103.47 19.54 19.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.053 . . . . 0.0 109.868 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.974 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.54 -36.39 76.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.41 -26.98 65.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.906 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -97.6 -51.69 4.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.891 HD12 ' O ' ' A' ' 22' ' ' SER . 36.4 mt -59.17 -39.36 82.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.025 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.484 ' CG1' ' O ' ' A' ' 27' ' ' ALA . 21.1 mt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.591 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.682 ' HB2' HG12 ' A' ' 57' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.295 0.569 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.93 156.16 45.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -85.9 107.36 17.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.412 ' HG ' ' HG3' ' A' ' 46' ' ' GLU . 43.9 tp -62.78 -40.75 98.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.729 ' O ' HG23 ' A' ' 53' ' ' THR . 97.7 mt-10 -153.53 162.58 41.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.493 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 87.1 159.49 33.87 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -87.87 9.48 21.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -1.17 . . . . 0.0 109.561 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.723 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.25 13.65 32.77 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.904 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -110.33 -143.68 9.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.77 123.64 10.3 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.651 2.234 . . . . 0.0 111.765 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . 94.44 -4.42 69.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 46' ' ' GLU . 94.5 m -74.1 138.17 43.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.463 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.739 ' N ' HD12 ' A' ' 54' ' ' ILE . 1.7 mp -103.74 126.82 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 25.0 mttm -110.94 145.18 38.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -124.72 127.02 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.522 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.682 HG12 ' HB2' ' A' ' 42' ' ' ALA . 66.8 mt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.411 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 86' ' ' ILE . 93.9 mttt -135.05 141.32 46.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.64 ' CE1' HD12 ' A' ' 57' ' ' ILE . 78.6 m80 -130.77 134.59 47.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -127.02 142.49 51.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.474 HG11 ' CG1' ' A' ' 75' ' ' ILE . 51.9 t -105.82 126.9 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -71.35 -48.65 48.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 83.4 tt0 -166.9 146.02 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.576 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.904 HD12 ' HA2' ' A' ' 50' ' ' GLY . 73.4 mt -122.72 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.382 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 86.2 m-20 -133.4 81.07 1.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.48 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 78.8 m80 -59.37 -38.57 80.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.26 82.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.433 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 76.9 m-20 -86.16 3.91 40.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 52.73 29.3 7.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -122.45 135.68 54.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CE1' HG12 ' A' ' 75' ' ' ILE . 57.0 t80 -130.08 130.46 44.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.24 115.76 16.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.502 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.4 p90 -136.88 158.48 44.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.623 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.444 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 84.5 p -139.19 169.51 17.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.362 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 69' ' ' LYS . 36.0 mt -117.84 129.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.52 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.5 mt -77.36 -32.92 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.43 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 60.1 22.67 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.579 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.881 ' HB3' HD11 ' A' ' 99' ' ' ILE . 88.6 mt -104.43 96.55 6.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.096 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 123' ' ' HIS . 72.8 mm-40 -59.66 -33.39 71.48 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.766 -0.584 . . . . 0.0 111.034 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.654 ' O ' HD13 ' A' ' 99' ' ' ILE . 34.3 ttpt -142.44 142.74 32.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.474 -1.391 . . . . 0.0 110.793 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.881 HD11 ' HB3' ' A' ' 96' ' ' LEU . 27.2 mm -130.77 113.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 85' ' ' SER . 38.4 t -121.31 152.05 39.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.486 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 81.1 m-85 -131.05 131.9 44.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.031 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.1 mt-10 -118.72 141.77 48.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.801 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.73 127.56 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.839 . . . . 0.0 109.323 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -130.18 131.68 45.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.637 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.424 ' HG2' ' HG ' ' A' ' 116' ' ' LEU . 63.5 mtt -120.56 141.22 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.9 153.68 41.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.62 132.43 42.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.436 179.998 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.3 m -131.25 146.83 52.47 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.413 -1.051 . . . . 0.0 109.378 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' C ' HD12 ' A' ' 116' ' ' LEU . 68.8 mt -116.56 135.91 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.5 mp -107.03 140.71 39.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.485 ' O ' HD13 ' A' ' 118' ' ' ILE . 26.7 mmtp -125.3 139.46 53.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 117' ' ' LYS . 10.5 mm -115.0 126.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.687 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 30.8 m -121.23 133.55 55.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.58 157.42 42.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.955 . . . . 0.0 109.93 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -134.03 117.47 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.815 ' HB3' HD22 ' A' ' 96' ' ' LEU . 13.9 m-30 -109.81 118.81 37.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.578 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 2.2 t60 -85.73 127.06 34.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.729 HG21 ' HE1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -109.43 146.82 33.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.8 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -71.33 135.61 47.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 55.07 -145.2 30.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 128' ' ' ALA . 48.5 p-10 -87.45 17.16 4.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 127' ' ' ASN . . . -44.5 144.41 1.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -114.47 157.0 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.677 HD12 ' CD1' ' A' ' 4' ' ' PHE . 64.4 mt -110.12 140.18 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 10.1 t-20 -79.4 133.43 36.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.412 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.454 ' HA ' HG12 ' A' ' 135' ' ' ILE . 96.4 mt-10 -65.33 -34.99 79.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.446 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 79.0 tt0 -66.64 -35.31 79.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.52 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.6 mt-10 -67.89 -38.13 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.704 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 38.4 pt -78.16 -39.5 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.517 ' N ' HG13 ' A' ' 135' ' ' ILE . 24.1 mttm -59.41 -37.94 79.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.9 73.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.11 -40.81 84.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -60.1 -43.48 95.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.171 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.37 -44.8 76.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.433 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.14 -45.82 89.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.91 79.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -0.952 . . . . 0.0 109.409 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.86 88.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.44 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.96 -45.26 95.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.558 ' O ' HG12 ' A' ' 149' ' ' VAL . 57.7 mt -60.96 -38.97 87.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -1.095 . . . . 0.0 109.375 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.478 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 67.1 t80 -57.22 -45.84 83.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.37 -40.53 91.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.08 -52.07 46.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 145' ' ' LEU . 7.5 p -64.69 -40.59 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.487 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.1 tt0 -56.45 -42.34 77.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.35 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.3 99.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.356 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -59.64 -44.59 93.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.432 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 36.4 tp -60.82 -35.31 76.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.893 . . . . 0.0 109.385 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.1 tt -61.93 -45.64 92.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.923 . . . . 0.0 109.34 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.14 -32.17 72.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.72 HG21 ' CE1' ' A' ' 123' ' ' HIS . 24.7 t -132.52 133.85 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.832 ' HE1' HG21 ' A' ' 124' ' ' THR . 96.7 m-85 -90.38 140.34 29.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.172 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' SER . 26.6 p -125.52 127.04 45.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 119' ' ' THR . 93.5 m-85 -123.78 143.89 50.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.262 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -123.41 147.97 46.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.76 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -132.46 134.0 44.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.204 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -107.76 134.52 50.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.756 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.74 123.22 19.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 109.118 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.453 HG23 HG12 ' A' ' 115' ' ' ILE . 28.8 m -109.73 133.22 53.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.937 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.9 m -160.42 139.94 10.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 109.003 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 13' ' ' VAL . 2.6 p -73.79 90.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.965 -1.084 . . . . 0.0 109.217 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.688 HG23 ' HD2' ' A' ' 15' ' ' PRO . 10.3 mt -139.48 144.29 39.13 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.136 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.688 ' HD2' HG23 ' A' ' 14' ' ' ILE . 43.7 Cg_endo -66.42 121.96 9.33 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.369 2.046 . . . . 0.0 111.165 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HG3' ' HB2' ' A' ' 107' ' ' ALA . 45.4 Cg_endo -66.79 -29.24 42.53 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.724 2.283 . . . . 0.0 112.241 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.24 -52.93 7.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.417 ' O ' ' OG ' ' A' ' 22' ' ' SER . 60.5 mtt85 -72.03 -39.35 69.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.753 ' C ' HD13 ' A' ' 19' ' ' LEU . 3.4 tm? -63.06 -51.88 64.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.0 t80 -56.85 -51.3 69.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.781 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.7 tttp -68.36 -50.22 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.83 ' O ' HD22 ' A' ' 30' ' ' LEU . 69.0 p -68.08 -21.26 64.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.04 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.907 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 12.5 t80 -100.06 -50.61 3.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.063 -1.023 . . . . 0.0 110.115 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 61.8 t -84.68 -52.66 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.26 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.4 tp -68.88 -44.83 72.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.888 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 30' ' ' LEU . 20.7 m-20 -98.99 30.31 3.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.907 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.26 -47.27 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.774 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.68 ' HA ' HD12 ' A' ' 31' ' ' ILE . 50.6 m-20 -69.44 -25.82 64.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.992 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.71 -39.12 18.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.687 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 22' ' ' SER . 7.0 mp -76.02 -29.03 57.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 28' ' ' ASP . 17.6 mt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -127.74 143.09 51.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.858 . . . . 0.0 109.413 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.432 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 81.0 m-20 -87.14 108.61 18.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.988 HD11 ' HB2' ' A' ' 56' ' ' LYS . 2.2 mp -68.85 -39.19 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 53' ' ' THR . 49.5 tp10 -150.05 153.23 36.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 90.79 157.74 33.95 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -93.47 10.26 33.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.584 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.1 27.99 6.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.895 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -122.16 -145.63 7.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 51.2 Cg_endo -70.23 123.34 9.86 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.744 2.296 . . . . 0.0 111.884 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.01 83.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 ' HA2' ' A' ' 49' ' ' GLY . 56.9 m -72.75 137.6 45.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -1.223 . . . . 0.0 109.44 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.681 HG22 HD13 ' A' ' 45' ' ' LEU . 25.2 mm -101.03 129.75 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 17.6 mttt -126.55 145.95 50.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.882 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.988 ' HB2' HD11 ' A' ' 45' ' ' LEU . 28.2 ttpt -130.82 138.84 50.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.366 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.7 tt . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.938 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 38.9 mtt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 94.2 mttt -107.8 148.54 29.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.513 ' CE1' ' CD1' ' A' ' 84' ' ' TYR . 47.5 t60 -129.79 131.26 46.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.6 tttp -131.88 136.17 47.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.497 HG11 ' CG1' ' A' ' 75' ' ' ILE . 39.6 t -99.36 129.17 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.406 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -76.39 -42.29 44.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 85.4 tt0 -175.27 141.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.895 HD12 ' HA2' ' A' ' 50' ' ' GLY . 66.7 mt -119.85 131.24 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -129.95 85.69 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.567 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 87.8 m-70 -62.34 -37.24 84.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.92 70.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -88.99 -3.07 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 57.9 34.55 24.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.495 ' HE2' ' CE ' ' A' ' 104' ' ' LYS . 25.5 mttt -128.95 129.56 45.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CE2' HG12 ' A' ' 75' ' ' ILE . 62.1 t80 -120.16 124.13 45.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.898 . . . . 0.0 109.531 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.05 115.03 19.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.513 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 38.3 p90 -128.97 152.41 48.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.51 ' HB3' ' HE2' ' A' ' 98' ' ' LYS . 9.7 m -132.02 146.72 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.526 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.16 150.2 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.594 HG22 ' HG3' ' A' ' 88' ' ' GLU . 88.6 mt -104.02 -34.65 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.594 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.8 mt-10 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.23 0.538 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.773 HG22 ' H ' ' A' ' 125' ' ' LYS . 16.0 m 51.87 19.78 1.04 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.811 HD22 ' HB3' ' A' ' 122' ' ' TYR . 51.7 mt -91.09 87.87 6.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 0.0 109.043 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.5 mt-10 -39.93 -35.47 0.36 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.761 -0.587 . . . . 0.0 110.401 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HE2' ' HB3' ' A' ' 85' ' ' SER . 31.7 tttt -169.08 160.91 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.766 -1.209 . . . . 0.0 110.371 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.783 HG23 ' CE1' ' A' ' 122' ' ' TYR . 27.2 mt -137.14 117.62 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 48.4 t -118.35 152.66 35.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.977 . . . . 0.0 109.906 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.533 ' OH ' HG21 ' A' ' 99' ' ' ILE . 84.1 m-85 -130.76 136.07 48.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.813 . . . . 0.0 109.175 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 86.8 mt-10 -114.62 143.21 45.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.711 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 79.0 mt -118.51 130.79 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.258 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.495 ' CE ' ' HE2' ' A' ' 81' ' ' LYS . 19.8 tttt -127.97 131.51 49.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.608 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.496 ' SD ' HD12 ' A' ' 19' ' ' LEU . 63.3 mtt -122.29 146.25 47.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.386 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -141.27 151.32 43.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.487 ' HB2' ' HG3' ' A' ' 16' ' ' PRO . . . -104.56 139.27 39.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.1 p -117.93 151.71 36.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -1.2 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.453 HG12 HG23 ' A' ' 11' ' ' THR . 69.3 mt -119.34 131.6 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.799 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.2 mp -108.32 136.85 47.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.584 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 90.9 mttt -119.01 144.04 46.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.26 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.6 mt -124.1 131.09 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.945 . . . . 0.0 109.571 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 23.5 m -119.48 142.49 48.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . 64.8 m -123.18 146.33 47.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 51.6 mtmt -135.67 127.39 29.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.811 ' HB3' HD22 ' A' ' 96' ' ' LEU . 25.7 m-85 -125.89 122.2 35.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 109.853 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.72 ' CE1' HG21 ' A' ' 3' ' ' VAL . 90.1 m-70 -89.72 116.97 28.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 108.673 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.832 HG21 ' HE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -104.98 142.29 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.618 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.773 ' H ' HG22 ' A' ' 95' ' ' THR . 31.0 ttpt -84.85 128.16 34.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.6 67.28 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 m120 58.95 40.28 22.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.473 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -69.82 140.59 53.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.293 -0.88 . . . . 0.0 109.54 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 55.3 p -80.16 156.6 26.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.719 HG12 HD21 ' A' ' 96' ' ' LEU . 40.4 mt -113.82 130.89 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 109.686 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.479 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 46.5 t-20 -60.04 131.81 52.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.401 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.6 mt-10 -65.87 -33.66 76.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.338 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.26 -36.44 82.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.479 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 75.5 mm-40 -64.62 -43.81 92.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.436 HG13 ' N ' ' A' ' 136' ' ' LYS . 34.8 pt -75.49 -32.85 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.436 ' N ' HG13 ' A' ' 135' ' ' ILE . 16.7 tttp -55.7 -45.33 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.25 -40.73 71.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.258 -0.902 . . . . 0.0 109.339 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.44 -40.16 95.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -60.3 -40.5 90.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -1.18 . . . . 0.0 109.279 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.74 -40.43 97.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 67.5 tttt -59.13 -44.76 92.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.275 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.88 93.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.89 -43.25 93.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.874 . . . . 0.0 109.332 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.65 -43.2 96.39 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.668 ' O ' HG13 ' A' ' 149' ' ' VAL . 40.3 mt -65.63 -40.45 92.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -1.161 . . . . 0.0 109.272 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -66.05 -40.54 91.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -68.0 -35.93 79.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.296 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.21 -51.55 52.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 145' ' ' LEU . 3.6 m -64.87 -46.6 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.364 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.583 ' N ' HG23 ' A' ' 149' ' ' VAL . 83.7 tt0 -56.19 -35.49 67.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.51 -36.03 81.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -62.3 -43.19 99.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.406 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.53 -42.9 97.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.324 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 31.0 mt -73.25 -27.33 61.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.8 -21.98 59.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.505 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' A' ' 123' ' ' HIS . 29.3 t -128.68 128.56 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -1.116 . . . . 0.0 109.344 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.803 ' HE1' HG21 ' A' ' 124' ' ' THR . 97.1 m-85 -85.61 136.46 33.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 120' ' ' SER . 36.0 t -122.55 129.17 51.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.96 . . . . 0.0 109.705 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.51 ' CD1' HG21 ' A' ' 135' ' ' ILE . 77.6 m-85 -129.39 147.16 51.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.147 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -119.3 139.74 51.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.712 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 91.2 m-20 -110.36 150.63 28.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.379 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -115.89 137.68 51.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 109.865 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.0 122.66 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.79 . . . . 0.0 109.018 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -127.51 137.41 52.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.975 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 t -160.49 150.08 17.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 108.992 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 13' ' ' VAL . 6.3 p -74.59 91.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 0.0 109.446 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.924 HG21 HD13 ' A' ' 19' ' ' LEU . 1.8 mt -138.85 143.5 37.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.635 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.9 Cg_endo -67.62 124.62 12.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.399 2.066 . . . . 0.0 111.44 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.76 -35.74 26.79 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.253 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.78 -49.56 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -72.43 -46.03 56.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.91 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.924 HD13 HG21 ' A' ' 14' ' ' ILE . 19.7 tp -60.33 -42.97 96.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.995 . . . . 0.0 109.719 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.686 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 68.9 t80 -62.39 -47.78 82.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.759 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.725 ' HG3' HD12 ' A' ' 25' ' ' LEU . 70.6 tttt -68.35 -41.34 80.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.676 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 86.3 p -77.7 -24.62 49.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.96 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 13.7 t80 -100.48 -50.74 3.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.404 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.686 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.1 t -84.8 -52.63 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.527 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.725 HD12 ' HG3' ' A' ' 21' ' ' LYS . 59.3 mt -71.63 -32.62 68.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.045 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 92.0 m-20 -106.58 23.05 14.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.96 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.66 -41.81 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.598 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 31' ' ' ILE . 26.1 p-10 -71.03 -34.03 70.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.85 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.3 m-20 -88.69 -31.71 18.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.801 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.0 tp -73.74 -21.74 60.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 27' ' ' ALA . 15.5 mt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -138.0 156.37 47.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.399 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 36.2 p-10 -90.19 108.22 19.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.424 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 45' ' ' LEU . 23.0 tp -64.35 -37.72 88.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 49.2 tp10 -141.54 155.44 45.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 91.31 161.34 37.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.7 9.17 30.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -1.159 . . . . 0.0 109.486 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.871 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 99.53 19.19 21.22 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.861 ' O ' HG11 ' A' ' 72' ' ' VAL . . . -114.92 -141.37 7.5 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.49 123.1 9.86 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.708 2.272 . . . . 0.0 111.781 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.678 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 91.84 0.83 71.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.6 m -77.0 136.19 38.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -1.17 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 70' ' ' HIS . 7.8 mt -105.36 139.44 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 62.1 mttm -116.09 145.76 42.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -129.45 142.59 50.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -116.85 140.01 49.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.651 ' O ' HG23 ' A' ' 54' ' ' ILE . 77.7 m80 -127.88 138.63 52.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.565 ' HD2' HD11 ' A' ' 87' ' ' ILE . 51.5 tttm -133.56 151.24 51.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.543 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 50' ' ' GLY . 11.3 p -110.81 132.3 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.484 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -72.98 -44.12 61.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -176.07 140.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.841 HD12 ' HA2' ' A' ' 50' ' ' GLY . 66.1 mt -118.09 127.02 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 79' ' ' ASN . 89.3 m-20 -122.27 85.09 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.546 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 85.5 m-70 -60.26 -38.8 84.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.76 -30.54 65.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.488 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 76' ' ' ASP . 58.2 t30 -90.56 7.23 40.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 46.03 36.99 3.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -128.17 128.42 44.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.319 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 63.1 t80 -120.11 125.58 48.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 58.4 m -127.45 114.05 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.53 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.8 p90 -129.48 163.03 26.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' A' ' 100' ' ' SER . 43.5 t -150.54 162.75 40.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.37 141.1 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 71' ' ' LYS . 80.6 mt -92.35 -35.42 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.9 . . . . 0.0 109.307 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.543 -179.969 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.455 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 56.5 m170 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 128' ' ' ALA . 1.1 m 46.23 24.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.12 HD21 HD11 ' A' ' 130' ' ' ILE . 27.0 mt -101.6 92.98 5.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.084 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.6 mt-10 -45.63 -36.13 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 0.0 110.728 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 1.072 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.2 tttp -163.38 157.94 20.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.656 -1.277 . . . . 0.0 110.503 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.072 HD13 ' O ' ' A' ' 98' ' ' LYS . 5.3 mm -133.0 119.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.748 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.505 ' CB ' ' HB2' ' A' ' 85' ' ' SER . 38.4 m -120.14 144.44 47.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 109.74 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -125.76 128.62 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.342 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 89.5 mt-10 -105.06 143.71 32.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.459 HD11 ' HE1' ' A' ' 84' ' ' TYR . 77.8 mt -128.8 118.67 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -127.41 134.67 49.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.424 ' HG2' ' HG ' ' A' ' 116' ' ' LEU . 63.4 mtm -118.97 145.79 45.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.464 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.72 157.5 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.02 139.84 30.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.892 . . . . 0.0 109.314 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 109.661 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -139.93 145.15 37.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -1.129 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.477 HG13 ' HB2' ' A' ' 108' ' ' ALA . 62.8 mt -111.31 130.62 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.828 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.1 mp -105.41 134.13 49.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -126.37 139.18 53.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.075 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 72.7 mt -124.81 140.97 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.828 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 26.9 m -123.56 142.5 50.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 m -121.41 153.3 38.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.776 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 64.3 mttm -142.25 124.97 15.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.185 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.984 ' CD1' HG23 ' A' ' 99' ' ' ILE . 9.6 m-85 -123.85 113.97 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.707 ' CE1' HG21 ' A' ' 3' ' ' VAL . 41.3 m-70 -80.49 114.19 19.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 108.86 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.803 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.1 p -102.83 142.37 34.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 0.0 109.593 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.515 ' HD2' HG23 ' A' ' 95' ' ' THR . 39.1 mttt -44.66 -43.03 8.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.8 -68.14 0.31 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.24 -30.33 71.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -1.167 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.0 m -127.95 154.3 45.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.391 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 1.12 HD11 HD21 ' A' ' 96' ' ' LEU . 29.4 mm -105.38 120.19 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.494 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.417 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 24.8 t-20 -75.79 142.31 42.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 135' ' ' ILE . 97.1 mt-10 -57.76 -28.08 63.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -66.87 -35.68 80.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 108.864 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.1 mt-10 -61.82 -25.0 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.172 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.817 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.4 OUTLIER -80.8 -39.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -56.18 -40.36 73.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.04 -48.65 73.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.294 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.02 -37.41 71.03 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -58.62 -43.68 89.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -1.139 . . . . 0.0 109.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -57.19 -48.39 78.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.072 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -59.35 -45.89 90.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.217 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.38 89.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 0.0 109.208 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.32 88.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.39 86.06 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.57 -38.07 74.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -1.117 . . . . 0.0 109.284 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.463 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 69.5 t80 -62.39 -43.66 98.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -60.23 -39.78 87.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.0 -50.01 67.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 150' ' ' GLU . 5.8 p -63.72 -42.8 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.498 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.2 tt0 -61.21 -42.4 98.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.09 78.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 30' ' ' LEU . 51.5 t80 -60.96 -52.2 66.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 34.7 mt -53.21 -42.74 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.4 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.9 mt -59.95 -45.67 91.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -59.14 -25.46 63.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.391 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 155' ' ' ALA . 1.3 t-80 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.793 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.1 p -122.3 143.53 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -1.207 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.687 ' HE2' HG21 ' A' ' 124' ' ' THR . 90.4 m-85 -105.76 143.2 34.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 120' ' ' SER . 4.2 m -128.8 124.54 35.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.583 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.564 ' CE2' ' CD1' ' A' ' 135' ' ' ILE . 81.1 m-85 -119.59 152.07 37.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.7 mt-10 -126.37 154.98 42.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.47 ' OD2' ' HE2' ' A' ' 139' ' ' LYS . 54.5 t0 -126.77 151.42 48.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 93.2 mt-10 -122.38 135.5 54.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.46 124.21 15.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.489 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.412 HG23 HG12 ' A' ' 115' ' ' ILE . 33.4 m -116.48 126.69 53.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.915 . . . . 0.0 109.682 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p -160.29 146.64 15.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 109.25 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 13' ' ' VAL . 18.9 m -78.54 91.38 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.472 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.967 HG21 HD13 ' A' ' 19' ' ' LEU . 8.8 mt -138.79 144.69 42.75 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.734 ' HD2' HG23 ' A' ' 14' ' ' ILE . 47.8 Cg_endo -68.7 123.35 10.35 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.536 2.158 . . . . 0.0 111.259 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.9 -27.76 43.1 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.745 2.296 . . . . 0.0 112.453 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.95 -54.62 6.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 109.527 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -72.62 -31.37 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.86 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.967 HD13 HG21 ' A' ' 14' ' ' ILE . 25.9 tp -71.96 -45.41 61.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.825 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 58.1 t80 -64.72 -33.19 75.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.521 ' HA ' HD13 ' A' ' 25' ' ' LEU . 33.7 tttp -83.09 -30.32 28.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.894 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 81.3 p -97.58 -14.68 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.818 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 1.067 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 76.7 t80 -100.89 -50.03 3.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 47.2 t -84.83 -49.81 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.356 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.7 mp -76.34 -39.74 53.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.58 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 30' ' ' LEU . 41.2 m-20 -92.78 10.53 30.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.014 . . . . 0.0 110.311 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.067 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.74 -34.31 73.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.888 -1.132 . . . . 0.0 109.414 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.26 -30.43 70.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -114.81 -45.49 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.037 . . . . 0.0 109.973 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 30' ' ' LEU . 7.8 tt -57.41 -38.32 74.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.728 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.463 ' CG1' ' O ' ' A' ' 27' ' ' ALA . 12.0 mm . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 109.453 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.291 0.567 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -145.4 147.66 32.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -93.62 109.0 20.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -38.55 88.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 53' ' ' THR . 85.4 tt0 -144.84 159.11 43.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.528 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.98 158.52 29.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -88.6 9.2 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -1.144 . . . . 0.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.812 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 102.47 23.94 8.61 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.766 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -120.81 -140.62 6.02 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.31 121.92 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.684 2.256 . . . . 0.0 111.793 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.32 -2.87 75.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.812 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.8 m -72.69 136.95 45.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -1.217 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.468 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 22.5 mm -94.09 135.17 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -108.65 133.2 53.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -122.13 132.77 54.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.224 -0.923 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.486 HD12 ' CE1' ' A' ' 70' ' ' HIS . 65.7 mt . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.575 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 88' ' ' GLU . 62.4 mmm . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -116.07 150.27 37.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.917 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.486 ' CE1' HD12 ' A' ' 57' ' ' ILE . 60.0 m170 -122.76 153.02 40.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 21.3 tttt -131.9 147.22 52.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 53' ' ' THR . 9.8 p -111.54 136.84 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.2 tt0 -80.03 -51.17 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 95.0 mt-10 -158.97 148.18 18.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.766 HD12 ' HA2' ' A' ' 50' ' ' GLY . 72.0 mt -125.08 126.58 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -127.03 94.1 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 77.2 t60 -70.26 -39.76 74.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.55 76.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -88.9 8.86 27.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 45.25 35.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HG3' ' HG2' ' A' ' 104' ' ' LYS . 37.5 tttm -124.14 137.96 54.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.552 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.1 t80 -136.97 123.59 21.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 74' ' ' GLU . 4.2 p -125.4 120.31 30.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.614 ' HE2' HD11 ' A' ' 86' ' ' ILE . 40.3 p90 -132.75 156.02 47.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.712 ' O ' HD13 ' A' ' 86' ' ' ILE . 23.0 t -119.05 172.0 7.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 85' ' ' SER . 33.3 mm -125.45 125.03 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.795 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.42 ' O ' ' C ' ' A' ' 88' ' ' GLU . 17.7 pt -107.01 -3.96 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.504 ' HA ' ' HE3' ' A' ' 68' ' ' MET . 21.5 mt-10 . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.952 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 92.8 m-70 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.232 0.539 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.6 22.76 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.912 ' HB3' HD11 ' A' ' 99' ' ' ILE . 33.0 mt -116.13 98.85 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.357 -0.839 . . . . 0.0 109.369 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 89.6 mt-10 -48.52 -48.41 38.31 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.587 -0.695 . . . . 0.0 110.155 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.904 ' O ' HD13 ' A' ' 99' ' ' ILE . 47.2 mtmt -155.22 158.57 39.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.867 -1.146 . . . . 0.0 110.47 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.912 HD11 ' HB3' ' A' ' 96' ' ' LEU . 5.6 mm -135.74 114.68 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 25.4 t -125.85 149.6 48.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.005 . . . . 0.0 109.946 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HE1' ' HH ' ' A' ' 122' ' ' TYR . 91.8 m-85 -128.05 126.46 41.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 109.164 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.1 mt-10 -105.34 141.71 36.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.874 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.03 122.86 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -0.855 . . . . 0.0 109.173 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 18.8 mtpp -123.48 137.28 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.723 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -116.61 141.84 47.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -141.06 155.12 46.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.619 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.88 132.93 40.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 109.301 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.3 t -148.12 150.18 33.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -1.124 . . . . 0.0 109.508 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.412 HG12 HG23 ' A' ' 11' ' ' THR . 67.8 mt -116.8 133.9 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.731 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.2 mp -111.16 138.53 47.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -123.9 139.29 54.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.265 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 70.8 mt -121.15 138.34 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 33.1 m -125.58 142.61 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 44.3 m -126.92 152.4 47.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -133.98 133.25 41.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 108.946 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.793 ' C ' HG23 ' A' ' 3' ' ' VAL . 37.9 m-85 -133.32 104.52 6.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.949 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.549 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 15.1 m-70 -83.41 122.47 28.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.687 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -102.58 150.03 23.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.963 -1.086 . . . . 0.0 109.876 -178.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -79.92 131.41 35.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 68.76 -144.05 41.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -94.36 17.39 13.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.4 146.91 14.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.509 ' HA ' ' CE2' ' A' ' 4' ' ' PHE . 38.2 m -127.21 154.79 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.578 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 22.6 mt -108.41 130.37 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -72.88 142.87 47.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.456 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.9 mt-10 -65.9 -31.47 72.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.538 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -44.74 83.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -43.56 88.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.564 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 38.3 pt -79.85 -29.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.7 tttm -56.26 -41.14 75.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.4 74.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.31 -38.53 78.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.47 ' HE2' ' OD2' ' A' ' 8' ' ' ASP . 19.1 tttm -59.83 -43.61 94.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -1.126 . . . . 0.0 109.352 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -58.95 -41.62 87.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 23.3 tttp -60.74 -41.46 95.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.354 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.48 86.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.24 96.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.53 98.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.929 ' O ' HG13 ' A' ' 149' ' ' VAL . 57.8 mt -66.09 -38.86 89.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -1.199 . . . . 0.0 109.393 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.78 -44.5 89.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.44 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.59 -35.53 80.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.471 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.32 -50.46 26.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 145' ' ' LEU . 3.3 m -64.46 -46.71 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.651 ' HG3' HD11 ' A' ' 14' ' ' ILE . 83.8 tt0 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.11 72.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.277 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -62.78 -41.28 99.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.35 -41.8 90.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 37.4 mt -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.476 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.95 62.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.707 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.2 p -108.48 135.52 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.14 . . . . 0.0 109.588 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.659 ' CD1' HD12 ' A' ' 130' ' ' ILE . 82.8 m-85 -92.07 139.64 30.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 28.0 p -122.68 119.91 32.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.393 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 119' ' ' THR . 47.3 m-85 -116.24 145.54 43.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -121.12 143.14 49.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.558 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.473 ' OD1' ' HE2' ' A' ' 139' ' ' LYS . 60.5 t0 -116.07 135.78 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -113.07 125.08 53.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.685 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.96 7.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.047 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 t -129.48 150.75 50.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -160.29 146.39 15.42 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 13' ' ' VAL . 13.0 m -62.3 90.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.033 . . . . 0.0 109.29 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.776 HG23 ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt -139.81 145.48 43.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.354 -0.841 . . . . 0.0 109.322 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.776 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.9 Cg_endo -68.44 112.79 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.332 2.021 . . . . 0.0 110.995 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HG3' ' HB2' ' A' ' 107' ' ' ALA . 44.6 Cg_endo -66.54 -32.02 40.2 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.851 2.367 . . . . 0.0 112.34 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.03 -56.23 7.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.134 -0.979 . . . . 0.0 109.442 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 mtt85 -72.4 -38.95 68.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.732 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.668 HD13 HG21 ' A' ' 14' ' ' ILE . 22.0 tp -62.0 -47.64 83.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 109.654 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.58 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.9 t80 -58.59 -46.62 86.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.413 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.4 mttm -72.84 -44.66 61.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.957 . . . . 0.0 109.522 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 33.9 t -70.83 -21.33 62.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.076 -1.015 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.951 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 2.6 t80 -100.13 -50.74 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.089 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 55.5 t -85.04 -52.44 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.095 -1.003 . . . . 0.0 110.12 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.1 tp -70.41 -36.27 73.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.135 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 74.4 m-20 -103.82 23.78 12.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.039 -1.038 . . . . 0.0 109.723 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.5 -46.53 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -64.62 -33.22 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 109.96 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -90.76 -40.17 11.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.64 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.799 HD21 HG23 ' A' ' 149' ' ' VAL . 19.5 tp -66.32 -28.25 68.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.955 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 27' ' ' ALA . 24.6 mt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.164 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -133.72 157.0 46.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -97.87 110.12 22.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.525 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 56' ' ' LYS . 7.6 mt -63.25 -37.83 88.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 53' ' ' THR . 83.9 tt0 -149.14 157.09 43.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.499 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 86.46 155.99 27.69 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -89.9 10.52 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.563 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.73 23.41 7.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.853 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -121.19 -143.91 6.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 50.4 Cg_endo -70.17 121.89 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.678 2.252 . . . . 0.0 111.843 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.74 -2.82 70.33 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 46' ' ' GLU . 94.3 m -78.59 140.83 38.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -1.196 . . . . 0.0 109.496 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.4 mm -100.67 129.55 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 31.1 tttm -106.71 130.7 54.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' HB2' HD11 ' A' ' 45' ' ' LEU . 20.0 tttt -122.86 134.93 54.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.498 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.95 146.6 30.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 79.5 m80 -126.8 140.11 52.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -124.62 133.25 53.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.521 HG11 HD11 ' A' ' 75' ' ' ILE . 46.9 t -98.68 130.62 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 82.0 tt0 -81.09 -53.92 5.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.7 mt-10 -156.96 143.35 18.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.853 HD12 ' HA2' ' A' ' 50' ' ' GLY . 71.8 mt -124.31 123.65 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.449 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 73.2 m-20 -130.5 86.25 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.58 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 75.6 m80 -62.38 -38.05 88.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.67 -30.68 68.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.449 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 56.8 m-20 -89.49 9.39 26.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.508 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.559 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 56.5 m-85 44.21 39.65 3.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.354 -0.841 . . . . 0.0 109.536 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.482 ' CE ' ' OE2' ' A' ' 102' ' ' GLU . 82.9 tttt -135.39 128.59 31.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.536 ' CE2' HG12 ' A' ' 75' ' ' ILE . 77.5 t80 -125.97 127.9 46.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 109.561 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -128.09 123.38 34.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.7 p90 -139.35 166.06 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.7 t -143.64 167.39 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 130.34 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.4 -47.18 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.557 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 109.503 -179.978 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.527 ' O ' ' CB ' ' A' ' 95' ' ' THR . 57.2 t-80 . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 1.052 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 78.54 5.31 2.53 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.936 ' HB3' HD11 ' A' ' 99' ' ' ILE . 67.2 mt -100.71 93.11 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 108.957 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.7 mt-10 -40.43 -37.63 0.71 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.693 -0.63 . . . . 0.0 110.42 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 1.02 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.9 tttt -164.81 155.44 14.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 110.419 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.02 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.5 mm -131.85 124.24 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.4 t -128.43 159.62 34.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.049 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.468 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 85.0 m-85 -135.68 128.54 31.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.482 ' OE2' ' CE ' ' A' ' 81' ' ' LYS . 78.4 tt0 -112.05 140.66 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 117' ' ' LYS . 68.7 mt -131.81 126.34 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.153 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.433 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 11.2 mtpp -123.43 137.77 54.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.612 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.93 151.06 39.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.329 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.27 158.91 43.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 16' ' ' PRO . . . -107.14 146.25 31.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.473 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.364 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 14' ' ' ILE . 95.0 p -146.5 152.71 39.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.402 ' C ' HD12 ' A' ' 116' ' ' LEU . 69.3 mt -122.61 128.04 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.4 mp -110.32 134.59 52.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 29.9 mttp -128.51 128.88 45.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.476 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -118.11 129.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 75.7 m -126.2 134.42 51.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.577 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.468 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 50.4 m -116.4 161.82 18.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.563 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -145.67 127.03 14.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.845 . . . . 0.0 109.37 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.822 ' CD1' HG23 ' A' ' 99' ' ' ILE . 11.0 m-85 -126.63 107.94 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.624 ' CD2' HG21 ' A' ' 3' ' ' VAL . 22.2 m-70 -80.23 113.98 18.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.089 -1.007 . . . . 0.0 108.336 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.3 p -104.45 141.82 35.68 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.029 . . . . 0.0 109.511 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 92.2 mttt -41.83 -42.48 2.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.479 -0.763 . . . . 0.0 109.615 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.73 -70.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -59.67 -31.71 69.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -1.164 . . . . 0.0 109.56 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 1.052 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -61.18 147.47 44.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -128.56 145.76 51.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.659 HD12 ' CD1' ' A' ' 4' ' ' PHE . 17.8 mt -108.78 126.49 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -88.41 152.51 21.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.809 ' OE1' HD11 ' A' ' 135' ' ' ILE . 75.6 mm-40 -64.9 -36.79 85.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.02 -44.59 95.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.81 -43.65 90.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.809 HD11 ' OE1' ' A' ' 132' ' ' GLU . 42.2 pt -82.13 -30.69 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 132' ' ' GLU . 47.4 tttt -55.78 -37.51 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.48 74.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.288 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.16 95.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' A' ' 8' ' ' ASP . 22.7 tttt -60.01 -42.92 95.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 109.317 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.39 -41.8 94.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.379 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.08 -45.96 86.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.14 -42.56 75.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.1 99.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.371 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.62 -45.06 90.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.82 -38.25 78.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -1.154 . . . . 0.0 109.301 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.51 ' O ' HG12 ' A' ' 149' ' ' VAL . 70.0 t80 -62.9 -41.83 99.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.0 -37.39 87.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.46 -47.42 70.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.389 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.799 HG23 HD21 ' A' ' 30' ' ' LEU . 6.6 p -62.39 -40.45 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.301 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.7 tt0 -59.74 -43.24 94.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.426 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.6 81.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.919 . . . . 0.0 109.353 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.38 -44.83 96.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.51 -39.64 91.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.527 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.1 tt -64.56 -44.59 90.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.502 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.65 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.2 m80 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.94 . . . . 0.0 109.447 -179.948 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.28 141.74 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.523 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CD2' HD12 ' A' ' 130' ' ' ILE . 99.1 m-85 -101.59 122.99 44.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 t -111.03 120.97 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.77 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 28.2 m-85 -115.49 147.33 40.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -118.16 133.67 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.654 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -109.54 134.2 52.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.86 124.21 52.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.28 124.19 15.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.292 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -110.6 132.3 54.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 m -157.06 147.48 21.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.045 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.738 ' O ' HG23 ' A' ' 13' ' ' VAL . 31.0 m -78.44 90.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.84 HG21 HD13 ' A' ' 19' ' ' LEU . 8.6 mt -139.37 144.93 42.06 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.224 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.784 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.98 113.33 3.21 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.501 2.134 . . . . 0.0 111.228 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -66.52 -31.13 42.35 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.799 2.333 . . . . 0.0 112.204 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.11 -52.74 8.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -72.01 -45.95 59.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.954 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.84 HD13 HG21 ' A' ' 14' ' ' ILE . 6.7 tp -59.04 -45.13 91.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.959 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.532 ' CE1' HG21 ' A' ' 24' ' ' VAL . 79.0 t80 -60.73 -55.38 33.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.902 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 23.8 tttp -67.85 -38.39 83.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 29.5 t -72.78 -27.2 61.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.805 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.794 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 34.3 t80 -100.82 -50.11 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.532 HG21 ' CE1' ' A' ' 20' ' ' PHE . 54.8 t -78.14 -52.45 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.082 -1.011 . . . . 0.0 110.284 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.773 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.13 -35.91 82.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.103 -0.998 . . . . 0.0 109.808 -179.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' SER . 89.8 m-20 -108.71 28.36 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.581 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.794 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.4 -45.04 70.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.917 ' HA ' HD12 ' A' ' 31' ' ' ILE . 65.0 m-20 -73.72 -29.65 62.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.98 . . . . 0.0 109.773 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -79.66 -37.79 35.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.965 . . . . 0.0 109.616 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 30' ' ' LEU . 42.1 mt -72.44 -31.47 65.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.72 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 28' ' ' ASP . 16.0 mt . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' A' ' 55' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -134.21 149.71 51.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 33.2 p-10 -84.0 114.56 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.53 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 52.0 mt -65.95 -28.69 69.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 109.404 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 45' ' ' LEU . 14.7 mm-40 -159.44 -173.41 4.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 63.39 164.36 0.57 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -94.51 -3.14 50.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -1.087 . . . . 0.0 109.553 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.752 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 119.72 13.82 5.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.722 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -112.17 -142.12 8.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.63 125.95 13.42 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.42 5.49 79.13 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.752 HG21 ' HA2' ' A' ' 49' ' ' GLY . 53.9 m -73.02 140.78 47.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -1.219 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.53 ' CG2' ' HB2' ' A' ' 45' ' ' LEU . 27.0 mm -99.13 133.74 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 79.7 tttt -122.77 134.84 54.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.403 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.8 tttt -130.85 131.46 44.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.478 HD12 ' HE2' ' A' ' 70' ' ' HIS . 69.5 mt . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.499 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' CB ' ' HB ' ' A' ' 87' ' ' ILE . 53.4 mttm -126.88 136.79 52.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.606 ' ND1' HG23 ' A' ' 86' ' ' ILE . 34.0 m-70 -131.96 133.51 44.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -127.19 141.51 51.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 109.612 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.583 HG11 ' CG1' ' A' ' 75' ' ' ILE . 62.0 t -100.8 129.65 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.335 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.8 -43.96 43.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -173.1 137.26 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 109.583 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.722 HD12 ' HA2' ' A' ' 50' ' ' GLY . 60.3 mt -116.77 123.55 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -132.94 72.59 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.511 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.568 ' CE1' ' CG2' ' A' ' 75' ' ' ILE . 60.4 m80 -55.9 -37.14 68.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.44 78.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.363 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 23.9 m120 -87.45 -0.28 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 60.93 31.78 19.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 79' ' ' ASN . 4.5 mtmp? -130.87 125.14 32.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.4 t80 -117.16 129.25 55.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 0.0 109.42 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.3 t -129.02 114.06 15.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.56 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.3 p90 -129.5 170.44 13.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.311 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 87.5 p -151.93 162.86 40.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.708 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.606 HG23 ' ND1' ' A' ' 70' ' ' HIS . 15.6 mm -111.85 122.43 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.457 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 99.7 mt -70.2 -39.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.604 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 0.0 109.626 -179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.325 0.583 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.902 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 56.47 16.85 2.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 109.856 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.906 HD22 ' HB3' ' A' ' 122' ' ' TYR . 37.1 mt -90.63 89.67 7.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.029 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 79.3 mt-10 -48.35 -32.53 7.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 21.7 tttp -152.34 152.52 32.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.596 -1.315 . . . . 0.0 110.691 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 96' ' ' LEU . 10.0 mm -132.47 113.62 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 37.3 t -131.36 152.23 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.921 -1.112 . . . . 0.0 110.128 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.517 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 84.8 m-85 -130.84 143.66 50.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 82.1 tt0 -120.93 143.73 48.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 109.78 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.29 121.9 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 56.8 tttt -121.04 129.73 53.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.893 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mtt -116.18 132.75 56.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.366 -0.834 . . . . 0.0 109.196 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.56 151.44 41.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.86 124.26 34.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.31 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.946 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -138.09 164.73 28.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -1.162 . . . . 0.0 109.674 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.24 137.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.18 137.1 44.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 47.8 mttp -130.77 135.89 48.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 68.1 mt -127.12 127.68 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.134 -0.979 . . . . 0.0 109.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 32.5 m -116.22 142.51 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.372 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.429 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 68.3 m -122.02 147.83 45.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 109.703 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -129.25 116.67 19.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.227 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.906 ' HB3' HD22 ' A' ' 96' ' ' LEU . 72.0 m-85 -115.7 124.79 51.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.544 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 0.3 OUTLIER -91.05 129.19 37.07 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.204 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 125' ' ' LYS . 4.2 t -114.85 136.01 53.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.953 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 21.0 tttm -43.63 -46.86 7.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.75 -85.87 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -58.32 -25.29 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -68.95 142.96 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.53 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 86.6 p -130.33 163.35 27.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.705 HD12 ' CD2' ' A' ' 4' ' ' PHE . 51.4 mt -108.48 126.4 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.24 132.51 47.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.546 ' HA ' ' CD1' ' A' ' 135' ' ' ILE . 94.7 mt-10 -61.92 -32.63 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.91 -43.82 98.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.3 -26.04 62.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 108.986 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.77 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 1.8 mt -69.9 -49.56 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 108.839 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -55.49 -44.54 76.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.209 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.46 -47.37 86.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.64 -31.61 57.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -70.57 -36.79 73.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -1.118 . . . . 0.0 109.306 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.04 -45.02 96.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.14 -45.95 91.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.361 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.52 94.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.267 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.02 82.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.233 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.61 -44.56 95.52 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 145' ' ' LEU . 38.0 tp -56.77 -41.99 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -1.109 . . . . 0.0 109.311 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 118' ' ' ILE . 63.9 m-85 -62.09 -41.12 97.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.252 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -56.85 -42.88 80.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.58 77.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.561 HG21 ' CE1' ' A' ' 23' ' ' PHE . 75.3 t -67.21 -50.08 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.445 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 82.7 mt-10 -50.23 -34.02 21.52 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.01 81.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.717 . . . . 0.0 109.458 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -59.45 -45.06 92.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.442 HD11 HD12 ' A' ' 19' ' ' LEU . 76.4 mt -59.1 -42.64 90.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.963 . . . . 0.0 109.303 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 30.0 mt -69.08 -33.0 72.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.26 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 0.0 109.399 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.879 ' O ' HG22 ' A' ' 124' ' ' THR . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.717 HG21 ' CE1' ' A' ' 123' ' ' HIS . 23.7 t -116.57 140.82 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.153 . . . . 0.0 109.499 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 99.3 m-85 -107.49 129.71 54.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.132 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -117.28 125.94 51.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.786 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 46.8 m-85 -124.29 142.75 51.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -116.3 131.78 56.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 56.8 t0 -99.98 133.08 44.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -108.52 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.4 129.55 22.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.7 m -112.66 137.44 50.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.792 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -160.6 147.98 15.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.828 . . . . 0.0 109.047 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 13' ' ' VAL . 4.0 p -81.84 91.07 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.567 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 19' ' ' LEU . 13.2 mt -139.17 144.77 41.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.28 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.76 ' HD2' HG23 ' A' ' 14' ' ' ILE . 44.5 Cg_endo -67.69 116.17 4.13 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.41 2.073 . . . . 0.0 111.217 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.9 Cg_endo -66.8 -35.61 26.93 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.884 2.39 . . . . 0.0 112.387 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.09 -52.04 18.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.479 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 22' ' ' SER . 55.9 mtp180 -72.11 -50.32 29.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 14' ' ' ILE . 13.4 tp -55.01 -45.28 75.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.803 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.701 ' O ' HG22 ' A' ' 24' ' ' VAL . 47.5 t80 -64.39 -55.59 20.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 109.425 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 27.9 mttt -67.92 -13.73 62.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.648 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.692 ' O ' HD12 ' A' ' 30' ' ' LEU . 49.7 m -100.33 -21.46 15.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.011 -1.056 . . . . 0.0 109.925 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 1.025 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 35.0 t80 -101.2 -52.5 3.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.996 -1.065 . . . . 0.0 110.722 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 20' ' ' PHE . 12.6 m -86.22 -40.79 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.961 -1.087 . . . . 0.0 110.63 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.544 HD12 ' CD2' ' A' ' 77' ' ' HIS . 4.1 tt -79.29 -43.16 24.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.574 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.502 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 95.1 m-20 -89.54 10.74 21.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.025 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.42 -31.49 69.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -71.56 -14.76 62.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -114.75 -36.92 4.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.0 . . . . 0.0 109.817 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 22' ' ' SER . 33.4 mt -72.53 -31.12 65.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.124 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' C ' ' HG3' ' A' ' 43' ' ' GLU . . . . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HG3' ' C ' ' A' ' 42' ' ' ALA . 92.0 mt-10 -155.53 156.42 35.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 84.1 m-20 -88.53 118.49 28.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.524 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 28.5 tp -72.95 -35.97 67.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 53' ' ' THR . 49.5 tp10 -159.24 153.98 24.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 93.37 150.29 26.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -83.52 6.91 18.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.602 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.675 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.08 20.2 10.01 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.692 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -113.58 -146.32 9.47 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.01 124.94 11.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.751 2.301 . . . . 0.0 111.891 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.16 78.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.675 HG21 ' HA2' ' A' ' 49' ' ' GLY . 61.2 m -72.73 137.79 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -1.193 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.3 mm -103.81 133.44 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 46.6 mtpt -111.73 144.33 41.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 45' ' ' LEU . 16.1 tttp -122.13 133.4 54.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.581 HG12 ' CE1' ' A' ' 70' ' ' HIS . 23.0 mm . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.6 mtp . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.67 140.48 40.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.826 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.581 ' CE1' HG12 ' A' ' 57' ' ' ILE . 79.8 m80 -126.0 135.36 51.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -130.32 142.15 50.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.432 HG11 ' CG1' ' A' ' 75' ' ' ILE . 68.6 t -101.65 132.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.464 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 89.9 mt-10 -73.59 -58.64 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.426 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 93.9 mt-10 -158.79 144.25 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.692 HD12 ' HA2' ' A' ' 50' ' ' GLY . 91.3 mt -122.79 120.32 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.502 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.471 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 86.8 m-20 -122.78 92.42 3.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.544 ' CD2' HD12 ' A' ' 25' ' ' LEU . 76.5 m80 -64.95 -37.52 87.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.16 -33.31 71.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.902 . . . . 0.0 109.374 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 76' ' ' ASP . 23.2 m120 -84.98 -2.33 57.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 53.61 41.24 32.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -137.32 122.45 19.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 81.7 t80 -113.18 128.11 56.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 m -127.78 119.13 25.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.583 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.2 p90 -134.32 164.28 27.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 17.0 t -145.51 158.99 43.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.584 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 86' ' ' ILE . 54.0 mt -108.58 137.42 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 96.4 mt -86.24 -27.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.699 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 87' ' ' ILE . 85.0 tt0 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.514 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.251 0.548 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.0 m 48.8 22.94 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.648 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.945 HD22 ' HB3' ' A' ' 122' ' ' TYR . 36.4 mt -94.02 89.14 5.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.301 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.547 ' CG ' ' HG2' ' A' ' 125' ' ' LYS . 83.6 mt-10 -40.75 -28.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.633 -0.667 . . . . 0.0 110.218 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 71.3 tttt -165.87 155.2 11.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 0.0 110.153 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.831 HG23 ' CD1' ' A' ' 122' ' ' TYR . 45.9 mt -141.32 113.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 108.975 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 32.1 t -126.08 150.45 48.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.985 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.607 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 98.2 m-85 -127.24 126.42 42.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 0.0 109.145 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 51.9 mp0 -112.83 142.1 45.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.803 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.6 mt -117.37 131.72 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.252 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 16.0 tttp -124.83 132.24 53.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.0 mtt -115.58 146.16 42.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.08 40.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.95 41.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 13' ' ' VAL . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.2 p -106.13 163.63 12.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -1.174 . . . . 0.0 109.599 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.81 128.08 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.388 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.11 136.15 47.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 94.1 mttt -131.32 136.92 48.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.48 127.43 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 26.7 m -113.81 142.42 46.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.48 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 51.5 m -127.89 150.58 49.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.465 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 34.7 mttt -138.43 120.68 15.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.399 -0.813 . . . . 0.0 109.079 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.945 ' HB3' HD22 ' A' ' 96' ' ' LEU . 28.5 m-85 -120.6 115.75 24.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.122 -0.986 . . . . 0.0 109.889 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.717 ' CE1' HG21 ' A' ' 3' ' ' VAL . 52.1 m-70 -83.15 132.18 35.09 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 2' ' ' GLY . 10.3 t -113.95 138.29 50.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.547 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 75.9 mttt -76.38 144.29 40.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.384 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 54.66 -148.2 22.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 46.2 p-10 -88.06 10.95 17.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -1.139 . . . . 0.0 109.48 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.865 ' HB3' ' OG1' ' A' ' 124' ' ' THR . . . -45.24 144.0 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.458 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.4 p -123.1 167.15 14.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 23.1 mt -116.11 127.67 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.405 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 45.8 t30 -57.1 127.35 31.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.559 ' HA ' HG13 ' A' ' 135' ' ' ILE . 96.1 mt-10 -61.96 -33.72 74.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -55.28 -44.25 75.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.405 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 92.5 mt-10 -58.09 -25.25 61.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.786 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 4.3 mt -70.33 -50.86 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.822 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -55.59 -43.92 76.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.94 84.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.76 -38.09 71.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -61.42 -44.16 97.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -1.058 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.51 -42.19 82.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.436 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -58.48 -45.23 89.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.62 -38.5 75.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.98 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.73 94.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.9 -46.88 90.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.48 -37.99 82.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.497 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.438 ' O ' HG12 ' A' ' 149' ' ' VAL . 67.2 t80 -61.69 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.23 -36.26 79.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.59 -48.72 68.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -66.97 -42.55 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.92 . . . . 0.0 109.395 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.515 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.1 tt0 -60.78 -38.63 85.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.421 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.2 -36.96 80.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.524 ' CZ ' HD22 ' A' ' 30' ' ' LEU . 71.4 t80 -63.43 -47.82 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.333 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.9 mt -59.02 -40.84 86.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.24 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.89 HD13 ' O ' ' A' ' 154' ' ' LEU . 2.7 tm? -67.88 -40.03 83.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.09 66.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 124' ' ' THR . . . 87.77 10.03 70.51 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.543 HG22 ' ND1' ' A' ' 123' ' ' HIS . 43.5 t -128.46 131.92 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -1.204 . . . . 0.0 109.666 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.633 ' CD1' HD12 ' A' ' 130' ' ' ILE . 99.3 m-85 -89.21 129.33 35.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.288 -0.883 . . . . 0.0 109.122 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 120' ' ' SER . 93.4 m -116.09 121.72 43.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.645 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.549 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 97.8 m-85 -121.19 147.72 45.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.25 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 85.1 tt0 -124.08 134.44 53.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.0 109.713 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 92.4 m-20 -104.75 148.6 26.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 109.276 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -116.57 138.09 51.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 115' ' ' ILE . . . -143.69 123.28 13.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 109.079 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.5 m -110.7 127.33 55.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.996 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.9 p -160.57 147.37 15.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 13' ' ' VAL . 2.6 p -83.82 91.15 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 0.0 109.515 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.739 HG23 ' HD2' ' A' ' 15' ' ' PRO . 94.0 mt -139.02 144.78 42.53 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.407 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.739 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.5 Cg_endo -67.91 121.48 8.52 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.489 2.126 . . . . 0.0 111.235 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 45.5 Cg_endo -66.76 -31.85 38.52 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.848 2.365 . . . . 0.0 112.451 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.87 -54.23 8.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.143 -0.973 . . . . 0.0 109.654 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.503 ' CZ ' ' O ' ' A' ' 159' ' ' ALA . 33.8 mtp-105 -72.25 -39.19 68.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 109.762 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.659 HD22 HG21 ' A' ' 14' ' ' ILE . 60.4 tp -61.26 -45.15 95.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.865 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.666 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 58.4 t80 -67.4 -46.94 71.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.861 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.591 ' HG3' HD12 ' A' ' 25' ' ' LEU . 15.9 tttp -72.72 -22.23 60.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.132 -0.98 . . . . 0.0 109.833 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.459 ' O ' ' CD1' ' A' ' 30' ' ' LEU . 83.8 p -97.72 -29.19 13.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.072 -1.017 . . . . 0.0 109.826 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.935 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 14.2 t80 -100.27 -46.46 5.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 0.0 110.239 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.666 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.8 t -84.34 -52.43 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.167 -0.958 . . . . 0.0 110.186 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.591 HD12 ' HG3' ' A' ' 21' ' ' LYS . 42.5 mt -71.86 -41.89 67.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.024 -1.047 . . . . 0.0 109.681 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.464 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 94.9 m-20 -97.43 26.35 4.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.546 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.935 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.55 -44.51 70.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.512 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.568 ' HA ' HD12 ' A' ' 31' ' ' ILE . 37.2 p-10 -74.19 -18.4 60.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -89.01 -38.81 14.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.348 -0.845 . . . . 0.0 109.621 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' O ' HG23 ' A' ' 34' ' ' VAL . 48.5 mt -71.88 -30.89 65.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.624 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 28' ' ' ASP . 34.4 mt -55.7 -56.96 24.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 109.727 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.7 Cg_endo -68.29 -35.37 18.95 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.456 2.104 . . . . 0.0 111.824 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 36.6 tttp -54.99 -42.8 72.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.915 . . . . 0.0 109.34 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.532 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 68.9 t -59.89 -41.02 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.414 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 34' ' ' VAL . . . 66.49 51.07 0.68 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 0.0 109.368 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 48.6 Cg_endo -69.52 -49.93 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.75 2.3 . . . . 0.0 111.876 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -137.66 141.14 41.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -107.79 11.82 27.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -97.73 -9.51 26.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.478 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.5 p -110.54 165.99 11.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.883 . . . . 0.0 109.377 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.8 t -157.76 143.26 17.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.527 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -112.42 147.24 36.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -141.19 138.91 33.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 47' ' ' GLY . 37.4 t30 -87.89 115.42 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.254 -0.904 . . . . 0.0 109.53 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.546 HD13 ' HZ3' ' A' ' 56' ' ' LYS . 20.8 tp -73.35 -32.91 64.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.396 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 81.6 tt0 -166.98 160.18 13.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.512 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 92.76 161.45 36.35 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -98.91 10.48 41.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -1.124 . . . . 0.0 109.351 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.567 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.99 20.93 9.98 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 1.041 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -118.75 -146.02 7.87 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.455 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.2 Cg_endo -68.82 125.08 12.17 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.826 2.351 . . . . 0.0 111.777 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.14 3.44 75.98 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.567 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.6 m -72.91 140.21 47.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -1.185 . . . . 0.0 109.375 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.503 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 18.5 mm -110.91 118.49 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.599 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 70' ' ' HIS . 46.8 mttt -120.52 143.26 48.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 109.296 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' HZ3' HD13 ' A' ' 45' ' ' LEU . 16.4 mtmt -127.51 135.41 50.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 68' ' ' MET . 71.4 mt -123.88 131.08 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.355 -0.84 . . . . 0.0 109.376 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 60' ' ' ALA . 46.7 m -129.27 138.78 51.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.168 -0.957 . . . . 0.0 109.586 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -71.36 -30.38 66.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.578 ' H ' HG22 ' A' ' 58' ' ' THR . . . -104.45 147.16 27.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.439 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -111.43 160.88 16.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.233 -0.917 . . . . 0.0 109.387 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 100.11 9.67 47.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -106.59 126.92 52.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 109.512 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.58 -36.99 77.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.923 . . . . 0.0 109.544 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -117.16 150.13 39.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HD2' ' CB ' ' A' ' 56' ' ' LYS . 77.8 mttt -104.1 132.57 50.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 69.5 t80 -67.34 -32.66 73.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 57' ' ' ILE . 85.8 mtp -95.98 138.47 33.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 87.2 mttt -132.38 141.11 48.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.277 -0.889 . . . . 0.0 109.553 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 55' ' ' LYS . 97.9 m-70 -121.86 135.55 54.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.444 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.503 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 61.5 tttt -131.51 131.73 43.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.423 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.534 HG22 ' CE1' ' A' ' 84' ' ' TYR . 21.9 t -89.07 129.33 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 86.2 tt0 -71.79 -43.51 65.56 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.165 -0.96 . . . . 0.0 109.61 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.4 tt0 -178.36 146.4 0.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.164 -0.96 . . . . 0.0 109.51 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.041 HD12 ' HA2' ' A' ' 50' ' ' GLY . 30.0 mt -126.31 120.65 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.901 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 20.6 t70 -128.74 93.29 3.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -0.891 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 55.7 p-80 -69.75 -26.46 64.32 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.0 -43.13 99.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.251 -0.906 . . . . 0.0 109.406 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 23.4 m120 -91.25 3.56 54.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.93 . . . . 0.0 109.535 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 59.29 27.17 16.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 79' ' ' ASN . 36.6 mttt -116.14 141.45 48.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.329 -0.857 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.622 ' CD2' HG23 ' A' ' 75' ' ' ILE . 17.8 t80 -130.23 137.28 49.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.953 . . . . 0.0 109.485 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 73' ' ' GLU . 13.2 m -117.32 122.49 44.04 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.526 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.534 ' CE1' HG22 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -120.7 134.39 55.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.395 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.532 ' O ' HD13 ' A' ' 86' ' ' ILE . 73.3 m -127.74 149.25 50.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.533 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 85' ' ' SER . 26.9 mm -116.96 129.69 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.713 HG22 ' HG3' ' A' ' 88' ' ' GLU . 84.9 mt -87.0 -49.75 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 0.0 109.256 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.713 ' HG3' HG22 ' A' ' 87' ' ' ILE . 97.5 mt-10 -152.86 143.48 22.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.593 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -152.67 105.63 0.28 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 46.44 -120.09 4.63 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.7 Cg_endo -70.8 -20.54 29.81 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.572 2.181 . . . . 0.0 111.468 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 91' ' ' PRO . 9.6 tp 62.51 -74.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.405 -0.81 . . . . 0.0 109.62 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.775 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . 166.45 167.56 27.29 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -90.59 130.1 36.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -1.118 . . . . 0.0 109.339 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.882 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.3 OUTLIER 55.73 17.71 2.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.383 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.775 HD12 ' HA3' ' A' ' 93' ' ' GLY . 42.8 mt -97.98 91.01 5.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.152 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 123' ' ' HIS . 91.4 mt-10 -51.37 -43.01 61.74 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.478 -0.764 . . . . 0.0 110.276 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 16.7 tttt -155.96 158.18 37.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 0.0 110.315 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.879 HG23 ' CE1' ' A' ' 122' ' ' TYR . 35.6 mt -134.41 117.11 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 32.5 t -120.87 150.89 40.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.003 -1.061 . . . . 0.0 110.237 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 84' ' ' TYR . 93.4 m-85 -131.38 133.49 45.31 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 93.5 mt-10 -121.22 139.65 53.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.791 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.25 125.86 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 109.392 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -125.04 146.94 49.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 109.56 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.1 mtt -122.82 150.44 42.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.43 153.48 40.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.333 -0.854 . . . . 0.0 109.467 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -104.09 139.37 39.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.567 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -81.19 162.56 58.72 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.567 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 47.9 Cg_endo -68.93 -26.01 32.0 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.731 2.287 . . . . 0.0 111.75 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -58.31 -35.89 72.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.332 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 92.5 9.31 61.68 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -147.72 49.42 0.61 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 13' ' ' VAL . . . -177.45 123.54 0.89 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.5 t -112.78 143.99 43.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -1.166 . . . . 0.0 109.55 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.41 ' C ' HD12 ' A' ' 116' ' ' LEU . 70.1 mt -115.48 135.81 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.813 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.6 mp -105.91 138.35 42.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.59 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.425 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 70.7 mttt -127.56 139.66 52.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 76.0 mt -123.31 138.16 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -0.953 . . . . 0.0 109.618 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 29.7 m -120.33 142.4 49.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.342 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.44 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 54.1 m -125.44 148.81 48.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.952 . . . . 0.0 109.615 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -134.94 122.5 22.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.888 . . . . 0.0 109.256 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.879 ' CE1' HG23 ' A' ' 99' ' ' ILE . 50.9 m-85 -119.2 119.75 35.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.543 ' ND1' HG22 ' A' ' 3' ' ' VAL . 0.9 OUTLIER -84.7 114.01 21.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 108.722 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.601 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 9.6 t -103.38 144.38 31.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 0.0 110.022 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.423 ' CB ' HG22 ' A' ' 95' ' ' THR . 16.0 tttt -43.84 -45.44 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.367 -0.833 . . . . 0.0 109.422 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 149.68 -54.06 0.5 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -85.93 8.94 18.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.882 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -107.0 145.33 32.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.209 -0.932 . . . . 0.0 109.585 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 m -124.16 145.61 49.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.633 HD12 ' CD1' ' A' ' 4' ' ' PHE . 52.6 mt -101.82 134.07 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.94 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -86.14 142.48 28.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.502 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.3 mt-10 -58.88 -35.89 73.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -63.31 -46.26 87.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.843 . . . . 0.0 109.528 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -57.22 -44.3 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 109.351 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.448 HD13 ' CE2' ' A' ' 6' ' ' TYR . 39.7 pt -75.37 -30.64 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.351 -0.843 . . . . 0.0 109.282 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -56.09 -40.55 73.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -0.884 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.19 -47.18 75.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.9 . . . . 0.0 109.31 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.66 67.87 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -62.98 -42.6 99.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -1.08 . . . . 0.0 109.214 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -54.95 -45.48 74.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.173 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -59.44 -45.12 92.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.95 93.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.58 -41.72 95.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.282 -0.886 . . . . 0.0 109.168 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.69 -46.98 88.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 64.3 mt -57.9 -38.76 76.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -1.118 . . . . 0.0 109.238 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.479 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.6 t80 -62.83 -41.04 99.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -0.895 . . . . 0.0 109.277 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -59.21 -40.99 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.339 -0.851 . . . . 0.0 109.328 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.75 -51.94 65.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 109.321 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.522 HG21 ' CD2' ' A' ' 23' ' ' PHE . 4.3 p -61.83 -41.2 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.454 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.3 tt0 -63.54 -38.47 91.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.884 . . . . 0.0 109.348 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.83 -41.41 91.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.445 ' OH ' ' HE2' ' A' ' 33' ' ' LYS . 72.1 t80 -61.15 -48.28 82.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.26 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 12.8 mt -61.31 -35.82 78.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.329 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.938 HD13 ' O ' ' A' ' 154' ' ' LEU . 2.0 tm? -63.06 -39.87 96.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.336 -0.853 . . . . 0.0 109.293 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.46 -26.78 64.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.37 70.13 14.1 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.232 -0.918 . . . . 0.0 109.399 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 49.4 Cg_endo -70.46 -9.47 25.93 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.705 2.27 . . . . 0.0 111.591 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -101.7 9.94 40.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.489 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.503 ' O ' ' CZ ' ' A' ' 18' ' ' ARG . . . -57.78 144.22 39.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -128.99 139.43 52.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.134 -0.979 . . . . 0.0 109.494 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.507 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.5 mtm . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.317 0.58 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.482 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . 91.97 9.06 62.74 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.606 HG21 ' CE1' ' A' ' 123' ' ' HIS . 29.1 t -129.39 133.63 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -1.115 . . . . 0.0 109.313 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.589 ' HE1' HG21 ' A' ' 124' ' ' THR . 97.2 m-85 -92.86 132.09 37.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.161 -0.962 . . . . 0.0 109.302 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 120' ' ' SER . 28.5 p -117.89 121.33 40.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 119' ' ' THR . 33.5 m-85 -115.27 143.69 44.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -119.75 152.51 37.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' A' ' 118' ' ' ILE . 60.3 t0 -135.14 137.66 42.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.317 -0.865 . . . . 0.0 109.424 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.37 137.77 45.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.626 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -146.6 123.31 11.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.329 -0.857 . . . . 0.0 109.436 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.6 m -107.52 127.25 53.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.774 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 88.4 p -160.39 140.2 11.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.308 -0.87 . . . . 0.0 109.312 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.884 HG13 ' HA3' ' A' ' 113' ' ' GLY . 3.1 t -88.24 91.61 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.131 -0.981 . . . . 0.0 109.55 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.907 HG21 HD13 ' A' ' 19' ' ' LEU . 31.3 mm -138.5 144.49 42.67 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.304 -0.873 . . . . 0.0 109.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.741 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.1 Cg_endo -67.94 123.56 10.81 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.44 2.093 . . . . 0.0 111.463 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 43.7 Cg_endo -66.87 -40.01 13.3 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.75 2.3 . . . . 0.0 112.1 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.94 -53.82 48.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.99 . . . . 0.0 109.433 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 22.1 ttt180 -72.14 -46.66 55.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 0.0 109.767 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.907 HD13 HG21 ' A' ' 14' ' ' ILE . 27.8 tp -61.11 -41.02 95.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.291 -0.88 . . . . 0.0 109.977 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.668 ' O ' HG22 ' A' ' 24' ' ' VAL . 44.1 t80 -68.19 -55.8 10.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 109.489 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 92.9 mttt -65.58 -13.67 59.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.161 -0.962 . . . . 0.0 109.888 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.598 ' O ' HD12 ' A' ' 30' ' ' LEU . 52.9 p -109.16 -17.58 13.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.953 -1.092 . . . . 0.0 110.231 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 1.034 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 85.5 t80 -100.37 -51.57 3.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.879 -1.138 . . . . 0.0 110.109 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 20' ' ' PHE . 6.6 m -85.67 -39.4 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.125 -0.984 . . . . 0.0 110.092 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.65 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -81.63 -53.95 5.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.161 -0.962 . . . . 0.0 110.13 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 22' ' ' SER . 84.7 m-20 -76.81 4.87 8.76 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.124 -0.985 . . . . 0.0 110.187 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.034 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -65.61 -38.93 90.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.998 -1.064 . . . . 0.0 109.788 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -58.43 -26.66 63.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -106.04 -39.42 5.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.225 -0.922 . . . . 0.0 109.65 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 22' ' ' SER . 39.6 mt -69.25 -31.75 70.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.578 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.551 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 52.2 mt -61.65 -56.09 36.16 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.288 -0.882 . . . . 0.0 109.555 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.3 Cg_endo -68.39 -32.7 25.15 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.506 2.137 . . . . 0.0 111.624 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -59.48 -42.06 91.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.475 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.534 HG21 ' HB1' ' A' ' 148' ' ' ALA . 98.4 t -65.08 -33.84 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.502 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -47.89 165.64 0.22 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 49.4 Cg_endo -70.35 -162.61 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.664 2.242 . . . . 0.0 111.719 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.517 ' O ' ' CE2' ' A' ' 39' ' ' PHE . 96.3 mt-30 -52.67 -31.61 38.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -65.86 131.05 45.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.274 -0.891 . . . . 0.0 109.456 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.517 ' CE2' ' O ' ' A' ' 37' ' ' GLN . 99.4 m-85 -114.39 156.12 25.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.907 . . . . 0.0 109.508 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.0 p -127.85 163.46 24.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.886 . . . . 0.0 109.534 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -129.94 151.47 50.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.478 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . . . -138.81 142.31 38.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -0.881 . . . . 0.0 109.463 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -124.15 145.43 49.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 82.3 m-20 -82.36 114.99 21.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 109.432 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 45' ' ' LEU . 19.2 tp -56.63 -49.07 76.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 53' ' ' THR . 20.5 mm-40 -152.02 -171.35 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 70.74 163.33 4.86 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -98.37 7.97 45.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.167 . . . . 0.0 109.445 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.772 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 107.68 8.33 30.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 75' ' ' ILE . . . -105.31 -145.08 13.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.69 122.71 9.4 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.654 2.236 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.521 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . 95.63 -1.12 63.61 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.779 ' C ' HD12 ' A' ' 54' ' ' ILE . 92.6 m -72.96 141.25 47.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -1.191 . . . . 0.0 109.481 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.779 HD12 ' C ' ' A' ' 53' ' ' THR . 1.6 mp -111.45 131.35 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.489 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 27.0 mttm -109.7 140.16 43.89 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.0 109.337 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -129.23 136.3 49.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.585 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 64.8 mt -111.31 134.23 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.39 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.8 m -120.92 138.44 54.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.444 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 60' ' ' ALA . 45.9 p90 -140.83 -39.83 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.91 . . . . 0.0 109.542 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 65' ' ' PHE . . . -104.42 149.1 25.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.532 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -97.74 140.19 32.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.87 . . . . 0.0 109.425 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.64 175.59 44.42 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -91.42 10.03 29.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -1.123 . . . . 0.0 109.541 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.61 -32.58 70.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.9 . . . . 0.0 109.466 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.422 ' CD2' ' HB1' ' A' ' 60' ' ' ALA . 98.4 m-85 -116.77 156.88 26.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.507 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -88.51 152.53 21.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.407 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -112.51 149.97 31.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.441 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 87.4 mtp -99.21 138.95 35.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.514 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -111.12 144.81 39.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.925 . . . . 0.0 109.396 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 77.9 m80 -127.04 134.64 50.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.288 -0.883 . . . . 0.0 109.488 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 87' ' ' ILE . 28.9 tttp -133.5 143.96 49.11 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.453 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.568 HG21 ' CG1' ' A' ' 75' ' ' ILE . 9.8 p -108.57 135.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.44 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 97.0 mt-10 -81.72 -43.49 18.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 92.5 mt-10 -158.84 142.37 15.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -0.883 . . . . 0.0 109.606 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.568 ' CG1' HG21 ' A' ' 72' ' ' VAL . 77.5 mt -125.4 123.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' OD2' ' HB2' ' A' ' 79' ' ' ASN . 25.9 t0 -125.69 91.72 3.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.623 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.447 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 87.8 m-70 -65.2 -41.09 94.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.208 -0.933 . . . . 0.0 109.348 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.504 ' O ' ' CE2' ' A' ' 80' ' ' PHE . . . -65.26 -40.43 93.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.362 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.46 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 56.3 t30 -79.33 -10.69 59.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.504 ' CE2' ' O ' ' A' ' 78' ' ' ALA . 66.3 m-85 62.16 35.77 15.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.273 -0.892 . . . . 0.0 109.343 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.512 ' NZ ' ' OE1' ' A' ' 102' ' ' GLU . 73.0 tttt -128.87 122.53 30.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 109.294 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.556 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.4 t80 -117.66 116.7 27.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.434 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 51.1 t -117.64 123.66 46.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 109.209 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.2 p90 -140.31 167.35 22.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.715 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB2' ' OG ' ' A' ' 100' ' ' SER . 47.3 t -137.06 169.84 17.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 mt -112.28 122.73 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.943 . . . . 0.0 109.464 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 71' ' ' LYS . 73.9 mt -79.2 -38.39 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.301 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HA ' HD11 ' A' ' 92' ' ' LEU . 64.1 tt0 -139.81 135.46 33.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.286 -0.884 . . . . 0.0 109.374 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 91' ' ' PRO . . . -141.24 63.7 0.52 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 43.1 -100.97 0.02 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.487 ' O ' ' N ' ' A' ' 93' ' ' GLY . 49.0 Cg_endo -70.07 -34.02 14.33 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.76 2.306 . . . . 0.0 111.864 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.405 HD11 ' HA ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER 54.77 -89.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.91 . . . . 0.0 109.479 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 178.19 -179.76 48.42 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -103.73 133.29 48.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.167 -1.196 . . . . 0.0 109.523 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.661 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 59.47 22.99 11.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.238 -0.914 . . . . 0.0 109.699 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.641 HD22 ' HB3' ' A' ' 122' ' ' TYR . 49.0 mt -110.65 95.95 5.88 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.181 -0.949 . . . . 0.0 109.296 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 123' ' ' HIS . 90.0 mt-10 -48.02 -49.71 30.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.619 -0.675 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.46 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 23.9 mttp -156.47 169.77 23.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.969 -1.082 . . . . 0.0 110.281 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.755 HG23 ' CE1' ' A' ' 122' ' ' TYR . 55.9 mt -144.66 115.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 42.7 t -116.33 153.33 32.17 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 110.058 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.51 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 84.1 m-85 -125.22 133.49 52.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.35 -0.844 . . . . 0.0 108.994 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.512 ' OE1' ' NZ ' ' A' ' 81' ' ' LYS . 80.2 tt0 -111.94 136.9 50.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.135 -0.978 . . . . 0.0 109.813 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.01 127.87 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.176 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -126.27 130.92 51.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.748 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.448 ' HG2' HD22 ' A' ' 116' ' ' LEU . 63.3 mtt -115.18 130.77 57.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.286 -0.884 . . . . 0.0 109.162 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.63 154.26 42.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.71 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' SER . . . -97.97 139.51 33.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.904 . . . . 0.0 109.345 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' A' ' 115' ' ' ILE . . . -116.25 116.78 39.43 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.53 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.0 -14.31 35.15 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.725 2.283 . . . . 0.0 111.802 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -57.3 -20.68 29.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.61 6.06 9.74 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 114' ' ' SER . . . -90.39 20.79 35.5 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.884 ' HA3' HG13 ' A' ' 13' ' ' VAL . . . 58.56 -80.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 112' ' ' GLY . 55.8 m -143.05 165.16 28.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -1.117 . . . . 0.0 109.418 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 108' ' ' ALA . 76.7 mt -128.61 133.43 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.658 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 50.0 mt -113.56 135.52 53.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -129.75 141.57 50.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 8' ' ' ASP . 73.2 mt -125.07 133.37 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.645 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 24.7 m -125.3 141.76 51.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.311 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.51 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 22.4 m -128.31 151.8 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.576 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 53.3 mttp -139.17 126.42 21.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.755 ' CE1' HG23 ' A' ' 99' ' ' ILE . 3.2 m-85 -121.21 112.74 19.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.388 -0.82 . . . . 0.0 109.536 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.606 ' CE1' HG21 ' A' ' 3' ' ' VAL . 50.1 m-70 -84.64 121.3 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.589 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -100.93 151.74 21.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.028 -1.045 . . . . 0.0 109.986 -179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -56.91 -60.66 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -121.9 57.97 0.6 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.482 ' OD1' ' HA2' ' A' ' 2' ' ' GLY . 67.6 m-20 51.5 45.58 27.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -1.133 . . . . 0.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.661 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -72.52 135.02 45.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.4 m -67.32 146.51 54.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.654 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.549 HG12 HD21 ' A' ' 96' ' ' LEU . 30.8 mt -111.28 130.37 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -68.69 139.76 55.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.191 -0.943 . . . . 0.0 109.609 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.0 mt-10 -67.8 -31.57 71.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 0.0 109.394 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -64.58 -41.89 95.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.48 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.97 -43.16 99.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 132' ' ' GLU . 42.4 pt -82.81 -31.87 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.884 . . . . 0.0 109.345 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 58.6 tttm -56.24 -41.15 75.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 0.0 109.38 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.72 -45.42 74.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.392 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.69 -39.26 86.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -62.05 -42.15 98.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -1.139 . . . . 0.0 109.38 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -56.54 -43.9 80.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -58.32 -43.71 88.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.243 -0.911 . . . . 0.0 109.325 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.929 ' HA ' HD12 ' A' ' 145' ' ' LEU . . . -62.06 -40.19 94.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.7 84.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.463 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -61.65 -37.94 95.05 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 142' ' ' ALA . 3.6 mt -61.97 -40.9 97.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -1.133 . . . . 0.0 109.414 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.53 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.2 m-85 -63.22 -41.47 99.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.0 109.239 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -65.75 -37.73 87.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.283 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.534 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -71.94 -47.43 52.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.385 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.604 HG13 ' N ' ' A' ' 150' ' ' GLU . 8.1 p -63.31 -47.18 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 149' ' ' VAL . 96.2 mt-10 -61.13 -42.69 98.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.28 -0.887 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.28 76.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 54.8 t80 -61.15 -53.4 57.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 64.0 mt -57.62 -38.87 75.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.582 HD13 ' O ' ' A' ' 150' ' ' GLU . 7.1 mp -66.11 -47.14 75.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.18 -0.95 . . . . 0.0 109.433 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -55.06 -29.24 57.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.963 . . . . 0.0 109.277 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 49.18 66.18 6.06 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.22 -0.925 . . . . 0.0 109.554 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.588 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 50.1 Cg_endo -70.13 -1.75 9.31 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.579 2.186 . . . . 0.0 111.716 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -74.2 -28.36 61.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.319 -0.863 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.35 149.94 46.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.905 . . . . 0.0 109.418 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.446 ' O ' ' OXT' ' A' ' 161' ' ' CYS . 88.3 m-85 -63.34 -28.6 70.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.446 ' OXT' ' O ' ' A' ' 160' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.927 -1.035 . . . . 0.0 109.478 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.8 mmm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.274 0.559 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.04 9.9 59.09 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.713 HG21 ' CE1' ' A' ' 123' ' ' HIS . 17.9 t -123.25 134.98 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.166 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.643 ' CD1' ' CG1' ' A' ' 130' ' ' ILE . 96.5 m-85 -95.75 135.48 37.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -121.9 129.38 52.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -0.924 . . . . 0.0 109.572 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.539 ' CZ ' ' CD1' ' A' ' 135' ' ' ILE . 97.9 m-85 -125.97 146.82 49.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.424 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.4 tt0 -116.78 137.38 52.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.585 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' A' ' 118' ' ' ILE . 67.7 t0 -115.25 130.38 56.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.342 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -105.06 131.16 52.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.728 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.02 125.56 22.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.315 -0.866 . . . . 0.0 109.069 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.5 m -112.77 135.09 53.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.196 -0.94 . . . . 0.0 109.814 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -160.25 152.3 20.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.304 -0.873 . . . . 0.0 109.156 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.476 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.2 p -91.74 90.79 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 109.448 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.919 HG21 HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -139.45 149.4 60.11 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 108.837 179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.913 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.5 Cg_endo -67.81 126.41 14.6 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.266 1.977 . . . . 0.0 111.182 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.2 Cg_endo -66.44 -29.76 44.85 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.754 2.303 . . . . 0.0 112.333 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.01 7.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.097 -1.002 . . . . 0.0 109.552 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 -72.26 -47.24 51.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.724 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 14' ' ' ILE . 15.0 tp -59.29 -46.96 87.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.761 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 77' ' ' HIS . 61.5 t80 -56.04 -48.04 76.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.176 -0.952 . . . . 0.0 109.668 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 30.8 mttm -69.15 -55.73 9.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.164 -0.96 . . . . 0.0 109.963 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 44.3 t -64.49 -19.1 65.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 109.983 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.936 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 78.1 t80 -100.2 -51.44 3.66 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.055 -1.028 . . . . 0.0 110.07 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 54.4 t -85.22 -52.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.812 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.831 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -62.26 -42.95 99.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.19 -0.944 . . . . 0.0 109.811 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.9 m-20 -97.67 18.61 15.18 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.71 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.936 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.78 -34.19 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 0.0 109.774 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 32' ' ' PRO . 85.1 m-20 -72.2 -27.22 62.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.295 -0.878 . . . . 0.0 110.015 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.417 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 20.5 m120 -105.76 -42.32 5.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.187 -0.945 . . . . 0.0 109.752 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.693 ' O ' HG23 ' A' ' 34' ' ' VAL . 15.8 tp -63.93 -32.15 73.58 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.746 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 39.5 mt -63.71 -57.34 19.73 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.085 -1.01 . . . . 0.0 109.408 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 49.5 Cg_endo -68.36 -42.3 5.64 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.604 2.202 . . . . 0.0 111.852 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mttm -59.4 -41.3 89.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.58 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 30' ' ' LEU . 91.4 t -67.67 -39.2 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.89 . . . . 0.0 109.489 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.86 157.91 56.67 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 109.398 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.572 ' O ' ' CE1' ' A' ' 38' ' ' HIS . 50.8 Cg_endo -69.87 -11.03 29.89 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.737 2.291 . . . . 0.0 111.81 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -61.8 144.98 53.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.5 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 36' ' ' PRO . 74.6 m80 -129.76 159.89 35.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.86 . . . . 0.0 109.502 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 38' ' ' HIS . 97.5 m-85 61.81 57.82 2.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 109.589 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.4 m -118.98 137.48 53.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.447 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.6 m -132.25 148.18 52.44 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.178 -0.951 . . . . 0.0 109.509 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.81 145.4 51.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -141.02 145.46 35.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.5 ' OD1' ' CD ' ' A' ' 55' ' ' LYS . 67.2 m-20 -82.33 112.55 19.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.3 tp -70.8 -35.48 72.54 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.639 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.611 ' O ' HG23 ' A' ' 53' ' ' THR . 85.9 tt0 -149.54 157.58 43.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.51 161.59 33.46 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -91.62 7.64 40.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.164 . . . . 0.0 109.479 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.77 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.03 18.75 11.69 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.71 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -115.24 -142.52 7.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.438 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.86 125.21 11.83 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.698 2.265 . . . . 0.0 111.74 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.675 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 89.37 -1.53 82.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.77 HG21 ' HA2' ' A' ' 49' ' ' GLY . 67.5 m -72.64 141.11 48.31 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.107 -1.231 . . . . 0.0 109.474 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 70' ' ' HIS . 24.8 mm -106.67 130.05 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.5 ' CD ' ' OD1' ' A' ' 44' ' ' ASN . 34.3 mmtp -102.35 147.86 26.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.514 ' HE3' ' CD ' ' A' ' 66' ' ' LYS . 18.3 tttm -123.9 137.62 54.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.517 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.587 HG12 ' CE1' ' A' ' 70' ' ' HIS . 22.7 mm -105.92 136.55 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.4 p -124.36 149.6 46.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.396 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -155.41 -70.02 0.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.983 . . . . 0.0 109.595 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.53 -164.09 1.13 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.34 -0.85 . . . . 0.0 109.613 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -97.3 136.91 37.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.44 41.42 0.02 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -55.73 -29.15 59.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -1.12 . . . . 0.0 109.428 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -48.5 -35.65 13.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -127.22 162.93 25.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.514 ' CD ' ' HE3' ' A' ' 56' ' ' LYS . 15.3 mmtt -97.27 121.56 39.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.44 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.521 ' CD1' ' HG3' ' A' ' 68' ' ' MET . 58.9 t80 -63.19 -40.52 97.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.956 . . . . 0.0 109.469 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.521 ' HG3' ' CD1' ' A' ' 67' ' ' TYR . 62.1 mtt -152.06 154.28 35.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.541 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -122.68 133.27 54.51 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.382 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.633 ' CD2' HD12 ' A' ' 86' ' ' ILE . 76.2 m80 -118.45 139.24 51.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.531 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.521 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 34.7 tttt -135.72 137.06 41.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.675 HG13 ' H ' ' A' ' 52' ' ' GLY . 11.8 p -104.73 130.09 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.933 . . . . 0.0 109.411 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.49 -41.49 69.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.481 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 84.8 tt0 -176.36 139.79 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.259 -0.901 . . . . 0.0 109.518 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.71 HD12 ' HA2' ' A' ' 50' ' ' GLY . 68.5 mt -116.52 124.54 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.511 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -131.82 73.34 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 109.434 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 64.8 m170 -56.35 -37.48 70.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.57 -30.48 70.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.546 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -92.32 8.3 38.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.583 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.499 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 74.7 m-85 51.74 28.32 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 0.0 109.477 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -123.92 136.81 54.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 71.4 t80 -133.78 133.6 41.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.557 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.459 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.6 m -135.58 120.04 18.06 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.495 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 34.2 p90 -135.97 166.25 23.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.53 ' O ' HD13 ' A' ' 86' ' ' ILE . 92.8 p -148.07 164.11 34.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.633 HD12 ' CD2' ' A' ' 70' ' ' HIS . 24.2 mm -116.1 120.1 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 71' ' ' LYS . 67.2 mt -77.65 -36.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.399 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -146.38 132.78 19.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 109.533 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 91' ' ' PRO . . . -144.48 85.39 0.18 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.74 -103.32 0.05 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.3 Cg_endo -70.2 -34.7 12.63 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.624 2.216 . . . . 0.0 111.524 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.611 HD11 HG12 ' A' ' 99' ' ' ILE . 9.6 tp 63.16 -71.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 109.736 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 164.14 166.45 23.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -90.78 124.75 35.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -1.105 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 57.57 16.14 3.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.643 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.0 ' HB3' HD11 ' A' ' 99' ' ' ILE . 32.4 mt -96.25 90.78 5.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.007 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 123' ' ' HIS . 79.6 mt-10 -47.05 -36.87 8.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.67 -0.644 . . . . 0.0 110.529 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 1.042 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.4 tttt -164.68 156.99 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.75 -1.219 . . . . 0.0 110.356 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.042 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.3 mm -134.43 113.22 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.49 ' OG ' ' HB2' ' A' ' 85' ' ' SER . 17.5 m -115.77 152.88 32.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.061 . . . . 0.0 110.087 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 119' ' ' THR . 84.3 m-85 -132.24 128.93 38.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.356 -0.84 . . . . 0.0 109.044 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.504 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 84.5 tt0 -104.89 139.82 39.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.192 -0.942 . . . . 0.0 109.841 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 66.3 mt -122.81 122.83 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.862 . . . . 0.0 109.113 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -130.24 136.33 49.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.152 -0.967 . . . . 0.0 109.724 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.51 ' HE3' ' CD1' ' A' ' 23' ' ' PHE . 64.0 mtt -117.75 143.84 45.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -140.83 152.35 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 109.566 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -105.21 135.19 47.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.37 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.48 148.11 48.54 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.27 -31.09 23.42 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.666 2.244 . . . . 0.0 111.709 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -62.31 -28.32 69.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.382 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.51 -4.17 72.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -44.91 -49.25 9.21 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 175.3 -118.6 0.67 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -151.61 154.23 36.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -1.153 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.447 ' C ' HD12 ' A' ' 116' ' ' LEU . 67.5 mt -118.24 133.04 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.327 -0.858 . . . . 0.0 109.33 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.778 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.9 mp -111.15 135.78 51.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.424 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 18.6 mttt -122.61 135.76 54.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.271 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -119.75 136.8 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.194 -0.941 . . . . 0.0 109.627 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 26.2 m -117.98 142.56 47.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.31 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 122' ' ' TYR . 73.4 m -120.65 151.73 39.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.646 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 28.2 mttp -139.78 129.1 24.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.277 -0.889 . . . . 0.0 109.05 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.952 ' CD1' HG23 ' A' ' 99' ' ' ILE . 15.4 m-85 -129.34 110.63 12.09 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.823 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.713 ' CE1' HG21 ' A' ' 3' ' ' VAL . 49.1 m-70 -81.06 113.38 19.21 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.0 OUTLIER -105.71 139.37 40.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -0.934 . . . . 0.0 109.362 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 124' ' ' THR . 31.3 mttt -42.2 -47.93 4.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.421 -0.799 . . . . 0.0 109.631 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.42 -64.83 0.27 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.43 -30.34 71.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -63.0 148.24 48.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.5 m -132.43 150.36 52.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.348 -0.845 . . . . 0.0 109.499 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.801 HD11 HD21 ' A' ' 96' ' ' LEU . 22.4 mm -102.54 122.63 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.915 . . . . 0.0 109.508 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -92.53 136.24 33.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 0.0 109.494 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 84.8 tt0 -55.62 -41.28 73.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.411 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -64.63 -40.39 95.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.38 -46.4 86.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.297 -0.877 . . . . 0.0 109.456 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.597 HG21 ' CG2' ' A' ' 130' ' ' ILE . 11.5 pt -80.1 -33.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.442 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 46.7 tttm -56.8 -33.9 67.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.333 -0.855 . . . . 0.0 109.414 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.95 -45.55 74.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 0.0 109.325 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.98 -37.09 92.15 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -56.98 -46.79 81.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.213 -1.169 . . . . 0.0 109.371 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.38 -46.1 87.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.473 ' O ' ' CD1' ' A' ' 145' ' ' LEU . 39.6 ttpt -58.87 -45.98 88.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.327 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.72 77.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.355 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . -60.16 -41.92 93.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.78 -46.97 89.17 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.617 ' H ' HD12 ' A' ' 145' ' ' LEU . 6.6 mp -64.22 -38.37 90.82 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.278 -1.13 . . . . 0.0 109.369 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.502 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 69.8 t80 -63.8 -44.52 93.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.384 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 143' ' ' ALA . 20.3 mmtt -62.41 -38.26 89.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 0.0 109.419 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.39 76.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.337 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 146' ' ' PHE . 4.7 p -65.23 -40.37 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.32 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 84.7 tt0 -60.22 -40.89 91.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -0.899 . . . . 0.0 109.365 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.43 98.18 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.311 -0.868 . . . . 0.0 109.279 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.606 ' CZ ' ' CG ' ' A' ' 157' ' ' PRO . 54.6 t80 -62.28 -44.72 95.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.892 . . . . 0.0 109.343 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 153' ' ' LEU . 25.8 tp -57.77 -38.76 76.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.401 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.4 mt -71.02 -43.17 68.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -56.72 -27.16 58.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.136 -0.978 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.5 OUTLIER 43.49 55.97 11.99 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.859 . . . . 0.0 109.529 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.606 ' CG ' ' CZ ' ' A' ' 152' ' ' TYR . 49.6 Cg_endo -70.35 -17.91 34.56 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.736 2.291 . . . . 0.0 111.813 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 55.4 p30 -93.7 11.06 30.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 0.0 109.57 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.23 143.83 57.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.318 -0.864 . . . . 0.0 109.416 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -125.58 136.54 53.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.177 -0.952 . . . . 0.0 109.505 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.442 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.276 0.56 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.03 -24.56 60.82 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 123' ' ' HIS . 29.7 t -130.44 136.27 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -1.168 . . . . 0.0 109.417 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.674 ' HE1' HG21 ' A' ' 124' ' ' THR . 93.6 m-85 -104.15 136.09 44.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.0 m -113.72 114.65 26.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 4' ' ' PHE . 33.1 m-85 -112.75 138.48 49.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.353 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 94.3 mt-10 -112.37 156.5 22.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.232 -0.917 . . . . 0.0 109.674 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -124.05 143.4 50.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.356 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -109.96 135.81 50.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.696 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -152.39 123.86 7.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.379 -0.826 . . . . 0.0 109.156 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 56.5 m -117.9 131.53 56.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.946 . . . . 0.0 109.797 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -160.32 144.69 14.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.268 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.677 ' O ' HG23 ' A' ' 13' ' ' VAL . 33.4 m -78.08 91.25 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 109.436 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.847 HG21 HD13 ' A' ' 19' ' ' LEU . 24.5 mt -139.0 144.29 40.58 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.298 -0.876 . . . . 0.0 109.443 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.717 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.4 Cg_endo -67.93 120.41 7.41 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.499 2.132 . . . . 0.0 111.368 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 45.6 Cg_endo -67.0 -27.31 42.76 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.818 2.345 . . . . 0.0 112.263 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -54.34 6.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.18 -0.95 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 22' ' ' SER . 62.8 mtt85 -72.15 -42.89 65.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.847 HD13 HG21 ' A' ' 14' ' ' ILE . 32.9 tp -59.98 -47.45 85.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.927 . . . . 0.0 109.694 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.507 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 47.1 t80 -59.23 -52.0 67.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.132 -0.98 . . . . 0.0 109.376 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.495 ' HA ' ' CB ' ' A' ' 25' ' ' LEU . 46.2 mttp -69.14 -29.36 67.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.773 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 83.5 p -84.16 -28.12 27.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.148 -0.97 . . . . 0.0 109.694 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.862 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 84.7 t80 -100.76 -48.45 4.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.0 109.89 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.7 t -84.42 -52.64 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.243 -0.91 . . . . 0.0 110.424 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 21' ' ' LYS . 12.5 tp -74.95 -26.03 59.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.084 -1.01 . . . . 0.0 110.024 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 22' ' ' SER . 85.5 m-20 -113.74 27.11 9.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 109.585 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.862 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.68 -42.13 74.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.512 ' HA ' HD12 ' A' ' 31' ' ' ILE . 56.0 t0 -62.63 -32.52 73.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -93.69 -31.38 14.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.857 . . . . 0.0 109.389 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 15.9 tp -75.35 -25.8 58.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.405 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 27' ' ' ALA . 12.3 mt -59.62 -56.53 34.89 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.519 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.45 -31.38 27.68 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.466 2.111 . . . . 0.0 111.661 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -59.13 -41.5 88.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 109.432 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.7 t -58.97 -39.53 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.0 109.532 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -123.62 82.54 53.97 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.173 -0.954 . . . . 0.0 109.592 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.67 -15.86 33.7 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.683 2.255 . . . . 0.0 111.752 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -59.94 -31.24 69.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 109.507 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -126.8 133.83 50.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -106.32 133.34 51.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.525 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.7 p -127.81 160.95 30.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.354 -0.841 . . . . 0.0 109.315 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.3 m -129.74 149.91 51.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 0.0 109.601 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.19 145.27 51.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -132.02 144.5 50.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.451 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 89.9 m-20 -88.29 112.1 22.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.908 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 56' ' ' LYS . 2.0 mp -66.86 -37.79 85.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.529 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.62 ' O ' HG23 ' A' ' 53' ' ' THR . 82.4 tt0 -149.64 155.55 40.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.515 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 89.55 159.68 35.69 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -92.35 6.77 45.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.517 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.624 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 107.25 18.44 10.38 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -113.25 -145.97 9.49 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.4 Cg_endo -70.03 121.42 8.05 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.706 2.271 . . . . 0.0 111.725 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.95 -0.69 67.2 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.624 HG21 ' HA2' ' A' ' 49' ' ' GLY . 52.4 m -79.47 135.07 36.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -1.18 . . . . 0.0 109.445 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.461 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 19.4 mm -95.29 136.28 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.207 -0.933 . . . . 0.0 109.513 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 45.3 mttm -119.9 133.51 55.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.325 -0.859 . . . . 0.0 109.484 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.744 ' HB2' HD11 ' A' ' 45' ' ' LEU . 30.5 tttm -107.36 142.1 37.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.527 HG12 ' ND1' ' A' ' 70' ' ' HIS . 26.3 mm -110.62 138.01 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.0 m -131.02 142.84 50.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 109.398 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.487 ' CE2' HG22 ' A' ' 57' ' ' ILE . 15.5 m-85 -112.99 149.56 33.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.96 -33.18 72.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.195 -0.941 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.7 -30.77 69.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.441 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 105.37 -95.03 1.05 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 59.23 43.49 16.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -1.094 . . . . 0.0 109.501 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.459 ' O ' ' CZ ' ' A' ' 67' ' ' TYR . 86.7 tt0 -54.71 -37.56 65.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -49.47 -44.25 45.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -87.36 136.45 32.93 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.933 . . . . 0.0 109.488 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.459 ' CZ ' ' O ' ' A' ' 64' ' ' GLU . 87.1 m-85 -123.43 138.55 54.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.894 . . . . 0.0 109.609 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.497 ' CE ' ' HA2' ' A' ' 89' ' ' GLY . 94.3 mmm -113.9 141.94 46.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 109.334 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -126.98 129.5 48.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.955 . . . . 0.0 109.677 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.527 ' ND1' HG12 ' A' ' 57' ' ' ILE . 80.8 m80 -128.32 126.67 41.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.939 . . . . 0.0 109.359 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 18.0 tttm -123.6 145.42 48.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.156 -0.965 . . . . 0.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 HG13 ' A' ' 75' ' ' ILE . 46.9 t -90.39 129.58 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.48 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HB3' ' CB ' ' A' ' 83' ' ' CYS . 83.9 tt0 -79.88 -37.46 34.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.506 ' N ' ' HB2' ' A' ' 83' ' ' CYS . 80.8 tt0 -179.12 144.31 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.024 HD12 ' HA2' ' A' ' 50' ' ' GLY . 27.5 mt -127.39 119.16 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.526 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' CG ' ' HB2' ' A' ' 79' ' ' ASN . 29.4 t0 -127.11 86.88 2.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -66.88 -32.31 73.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.84 81.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 1.4 m120 -96.04 2.25 53.2 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.512 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 59.07 22.33 10.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.926 . . . . 0.0 109.454 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.472 ' HG2' ' HB2' ' A' ' 104' ' ' LYS . 33.9 mttt -110.97 130.46 55.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 75' ' ' ILE . 25.8 t80 -125.13 129.14 49.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.952 . . . . 0.0 109.673 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.506 ' HB2' ' N ' ' A' ' 74' ' ' GLU . 35.9 m -109.39 131.92 54.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.246 -0.909 . . . . 0.0 109.228 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 101' ' ' TYR . 0.1 OUTLIER -120.89 139.53 53.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.668 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 20.2 t -127.2 142.81 51.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.237 -0.914 . . . . 0.0 109.463 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.453 ' HB ' ' O ' ' A' ' 99' ' ' ILE . 24.1 mt -117.97 127.45 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.68 -36.66 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.521 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -154.65 130.75 10.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.461 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.497 ' HA2' ' CE ' ' A' ' 68' ' ' MET . . . -145.89 106.07 0.36 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 44.33 -119.3 2.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.516 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.8 Cg_endo -70.13 -25.08 27.25 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.644 2.229 . . . . 0.0 111.671 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.767 HD11 HG12 ' A' ' 99' ' ' ILE . 14.2 tp 62.39 -75.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.61 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.788 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . 165.94 171.04 31.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -95.33 123.6 38.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -1.159 . . . . 0.0 109.53 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 124' ' ' THR . 1.4 m 64.08 11.25 6.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.488 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.788 HD12 ' HA3' ' A' ' 93' ' ' GLY . 93.9 mt -94.81 92.11 6.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.311 -0.868 . . . . 0.0 108.959 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' HIS . 46.3 mt-10 -49.1 -40.27 31.49 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.751 -0.593 . . . . 0.0 110.963 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.643 ' O ' HD13 ' A' ' 99' ' ' ILE . 95.0 mttt -158.12 156.57 31.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.598 -1.314 . . . . 0.0 110.23 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.855 HG23 ' CE1' ' A' ' 122' ' ' TYR . 33.3 mm -133.18 113.0 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 29.7 t -113.68 150.08 33.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.927 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.496 ' N ' ' O ' ' A' ' 84' ' ' TYR . 91.2 m-85 -129.08 130.69 46.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.335 -0.853 . . . . 0.0 109.121 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 85.1 tt0 -108.76 137.98 45.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.758 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.0 mt -124.12 124.54 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.299 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HE3' ' HD2' ' A' ' 117' ' ' LYS . 41.3 pttt -134.86 149.52 50.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.608 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.41 ' HG2' HD22 ' A' ' 116' ' ' LEU . 64.4 mtt -115.42 145.22 42.77 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.44 155.47 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.79 148.09 38.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . -111.23 106.81 57.38 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.47 -48.19 0.84 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.709 2.273 . . . . 0.0 111.787 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -77.63 -47.3 19.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 109.517 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -64.58 -27.68 72.2 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.21 -28.17 6.97 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 108' ' ' ALA . . . -100.88 -133.64 8.21 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.0 t -125.22 157.96 35.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.857 HG13 ' HB2' ' A' ' 108' ' ' ALA . 66.6 mt -117.03 136.99 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.264 -0.898 . . . . 0.0 109.404 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 36.8 mt -106.24 136.2 46.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.649 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.489 ' HD2' ' HE3' ' A' ' 104' ' ' LYS . 77.1 mttt -130.66 144.58 51.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.122 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.5 mt -132.64 140.82 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.073 -1.017 . . . . 0.0 109.999 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 20.6 m -120.54 142.31 49.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 100' ' ' SER . 0.1 OUTLIER -118.98 146.62 44.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.649 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 100' ' ' SER . 37.3 ttpt -126.02 112.2 15.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 109.32 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.855 ' CE1' HG23 ' A' ' 99' ' ' ILE . 3.5 m-85 -109.74 108.51 18.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.7 ' HA ' HG22 ' A' ' 3' ' ' VAL . 4.9 t60 -83.79 121.79 27.79 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.674 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.3 p -113.08 143.93 43.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.991 -1.068 . . . . 0.0 109.765 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -70.19 153.33 43.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.59 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 47.59 -131.43 16.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -114.45 41.53 2.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -1.183 . . . . 0.0 109.385 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.536 ' HB3' ' HB ' ' A' ' 124' ' ' THR . . . -65.05 150.08 48.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.32 -0.863 . . . . 0.0 109.448 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 96.6 p -114.65 155.48 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.665 HG12 HD21 ' A' ' 96' ' ' LEU . 58.3 mt -113.04 141.5 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -89.13 141.24 28.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.3 mt-10 -65.48 -27.94 68.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 134' ' ' GLU . 23.1 pt-20 -65.7 -41.74 92.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.457 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.466 ' N ' ' HG3' ' A' ' 133' ' ' GLU . 83.9 tt0 -61.3 -41.54 97.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.505 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 132' ' ' GLU . 47.8 pt -85.05 -29.42 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.145 -0.972 . . . . 0.0 109.472 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 34.0 tttt -55.76 -45.56 78.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -0.922 . . . . 0.0 109.421 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.73 -45.05 78.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.217 -0.927 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.99 -35.08 90.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.3 tttt -60.09 -44.16 95.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -1.159 . . . . 0.0 109.428 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.29 -39.9 94.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.315 -0.865 . . . . 0.0 109.455 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -63.25 -41.05 99.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.939 . . . . 0.0 109.434 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.575 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -71.0 -36.67 72.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 0.0 109.446 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.61 95.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.42 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.45 -38.93 95.39 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.527 ' O ' HG12 ' A' ' 149' ' ' VAL . 25.1 tp -65.53 -41.2 93.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -1.154 . . . . 0.0 109.442 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.575 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 16.6 m-85 -65.13 -45.95 82.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.402 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -62.83 -37.57 87.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.67 -51.45 56.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.885 . . . . 0.0 109.415 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -64.43 -47.53 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.231 -0.918 . . . . 0.0 109.365 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.597 ' N ' HG13 ' A' ' 149' ' ' VAL . 87.8 mt-10 -58.66 -38.84 79.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 109.325 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.4 -41.25 89.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.376 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -62.87 -38.59 91.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.09 -43.95 87.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.318 -0.864 . . . . 0.0 109.41 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 154' ' ' LEU . 6.6 mp -73.64 -40.83 63.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 109.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.23 -15.95 63.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.1 74.65 30.39 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.38 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -70.7 -4.11 13.99 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.707 2.271 . . . . 0.0 111.943 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -106.0 8.46 32.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.24 -0.912 . . . . 0.0 109.483 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.68 146.09 37.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.396 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.71 -38.09 86.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.414 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.419 179.983 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.78 -33.59 87.33 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.611 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.2 p -120.19 138.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -1.077 . . . . 0.0 109.341 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.817 ' CE2' HG21 ' A' ' 124' ' ' THR . 96.4 m-85 -98.6 146.03 26.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 25.7 p -132.09 128.13 37.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.603 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.514 ' O ' HG23 ' A' ' 119' ' ' THR . 90.9 m-85 -122.21 151.99 40.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 117' ' ' LYS . 95.9 mt-10 -118.48 145.61 45.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -123.01 145.82 48.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 0.0 109.158 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -121.81 137.34 54.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.776 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.59 122.97 5.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.092 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 1.069 HG22 HG23 ' A' ' 115' ' ' ILE . 59.4 p -123.82 143.21 50.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.946 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.534 ' OG ' ' CD1' ' A' ' 14' ' ' ILE . 98.9 p -160.28 149.36 17.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 108.933 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.74 ' O ' HG23 ' A' ' 13' ' ' VAL . 33.6 m -66.2 90.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.021 . . . . 0.0 109.341 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.979 HG21 HD22 ' A' ' 19' ' ' LEU . 5.5 mt -139.36 142.29 31.88 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.32 -0.862 . . . . 0.0 109.341 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HD2' ' CG2' ' A' ' 14' ' ' ILE . 46.3 Cg_endo -67.92 122.33 9.44 Favored 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 122.356 2.037 . . . . 0.0 111.197 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.79 -34.02 32.36 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.702 2.268 . . . . 0.0 112.209 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.45 -50.64 11.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.994 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -72.15 -37.94 69.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 110.126 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.979 HD22 HG21 ' A' ' 14' ' ' ILE . 32.0 tp -67.0 -51.06 59.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.145 -0.972 . . . . 0.0 109.929 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.638 ' CE2' HG21 ' A' ' 24' ' ' VAL . 67.7 t80 -56.25 -46.89 79.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.947 . . . . 0.0 109.806 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 25.3 mttt -67.99 -49.56 60.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.139 -0.975 . . . . 0.0 109.879 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 88.7 p -71.49 -20.1 62.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 109.936 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.966 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 24.0 t80 -100.48 -51.12 3.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.16 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.638 HG21 ' CE2' ' A' ' 20' ' ' PHE . 54.9 t -85.11 -52.47 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -0.939 . . . . 0.0 110.128 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.704 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -67.08 -49.3 65.48 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.876 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 86.0 m-20 -89.52 20.23 4.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.164 -0.96 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.18 -50.63 53.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.062 -1.024 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.701 ' HA ' HD12 ' A' ' 31' ' ' ILE . 91.7 m-20 -63.43 -32.07 73.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.955 . . . . 0.0 109.798 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.414 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 94.5 m-20 -88.91 -34.69 16.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.086 -1.009 . . . . 0.0 109.693 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 34' ' ' VAL . 16.1 tp -74.89 -26.54 59.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.662 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 28' ' ' ASP . 12.9 mt -56.02 -57.14 23.86 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.96 . . . . 0.0 109.498 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.6 Cg_endo -68.38 -35.19 18.87 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.548 2.166 . . . . 0.0 111.672 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 29' ' ' ASN . 21.7 mttm -62.7 -31.85 72.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.417 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.686 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 77.2 t -68.66 -33.47 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.494 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 34' ' ' VAL . . . 75.98 51.19 0.2 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.321 -0.862 . . . . 0.0 109.5 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.2 Cg_endo -70.13 152.14 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.718 2.279 . . . . 0.0 111.766 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -56.7 -35.72 68.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.372 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -122.52 176.18 6.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.313 -0.867 . . . . 0.0 109.352 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.855 ' HD1' HD13 ' A' ' 57' ' ' ILE . 67.9 m-85 55.17 53.07 10.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.393 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.0 m -63.46 -41.85 98.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 82.3 p -151.9 155.37 37.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.572 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.58 148.12 32.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.925 . . . . 0.0 109.446 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 56' ' ' LYS . 93.6 mt-10 -134.21 157.05 47.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.918 . . . . 0.0 109.535 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 35.7 p-10 -87.96 112.11 22.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.466 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 45' ' ' LEU . 24.1 tp -73.64 -36.24 65.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.547 ' O ' HG23 ' A' ' 53' ' ' THR . 85.9 tt0 -143.1 154.96 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 91.12 159.26 35.47 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -91.9 8.26 38.22 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.162 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.605 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.49 20.39 13.54 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.594 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -117.67 -145.39 7.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.42 125.31 12.16 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.73 2.287 . . . . 0.0 111.837 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.89 -1.51 80.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.605 HG21 ' HA2' ' A' ' 49' ' ' GLY . 96.2 m -73.59 139.98 45.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -1.169 . . . . 0.0 109.471 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.8 mm -103.39 134.83 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 4.0 mtmp? -110.45 156.53 20.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.573 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' GLU . 52.5 tttt -130.91 128.66 40.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.865 . . . . 0.0 109.353 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.855 HD13 ' HD1' ' A' ' 39' ' ' PHE . 70.5 mt -111.87 137.5 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.527 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.2 m -119.16 141.63 48.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CE1' HG22 ' A' ' 57' ' ' ILE . 19.6 m-85 -112.21 149.48 32.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 109.513 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.41 -26.21 68.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.496 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -95.33 163.21 13.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.453 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.63 -170.78 37.18 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 65' ' ' PHE . 52.6 p-10 -141.52 -176.8 4.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -1.159 . . . . 0.0 109.414 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -62.54 -29.49 70.6 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.15 -0.969 . . . . 0.0 109.393 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.574 ' O ' ' CE1' ' A' ' 67' ' ' TYR . 62.7 t80 -46.97 -47.51 21.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -0.928 . . . . 0.0 109.349 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -69.47 132.41 46.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.211 -0.93 . . . . 0.0 109.439 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.574 ' CE1' ' O ' ' A' ' 65' ' ' PHE . 88.4 m-85 -125.63 135.43 52.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.58 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 84.8 mtp -116.12 152.79 32.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.248 -0.907 . . . . 0.0 109.402 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.9 mttt -134.65 129.01 34.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.504 ' CE1' HD12 ' A' ' 57' ' ' ILE . 93.9 m-70 -127.34 129.12 47.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.401 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.483 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 14.9 tttp -127.5 146.01 50.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.931 . . . . 0.0 109.485 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.572 HG11 ' O ' ' A' ' 50' ' ' GLY . 14.8 p -108.43 138.72 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.476 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -75.71 -44.16 43.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -173.59 143.49 1.03 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.505 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.594 HD12 ' HA2' ' A' ' 50' ' ' GLY . 70.4 mt -119.36 118.68 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.9 m-20 -125.04 78.36 1.7 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.578 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 98.1 m-70 -59.18 -34.62 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.64 -28.63 66.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 80.7 m-20 -94.27 9.49 37.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.584 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 68.5 m-85 48.34 36.36 6.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -131.29 129.72 41.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.955 . . . . 0.0 109.346 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 61.3 t80 -126.12 122.81 36.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.989 . . . . 0.0 109.611 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 3.7 m -125.6 117.77 24.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.217 -0.927 . . . . 0.0 109.4 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.49 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 35.1 p90 -134.84 167.25 21.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.6 p -145.99 175.23 10.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -0.864 . . . . 0.0 109.337 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.7 mt -129.34 126.44 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.176 -0.952 . . . . 0.0 109.451 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 71.8 mt -78.81 -42.66 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.489 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.536 ' HA ' HD11 ' A' ' 92' ' ' LEU . 76.0 tt0 -143.48 137.12 28.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.929 . . . . 0.0 109.493 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -162.68 105.4 0.26 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 44.69 -130.74 7.68 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 51.3 Cg_endo -69.9 -22.36 31.57 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.615 2.21 . . . . 0.0 111.804 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.552 HD23 HG13 ' A' ' 99' ' ' ILE . 0.3 OUTLIER 70.35 -81.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.344 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.86 -160.77 17.67 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -110.74 115.23 29.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -1.145 . . . . 0.0 109.465 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 58.17 16.65 4.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.509 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.923 HD22 ' CB ' ' A' ' 122' ' ' TYR . 28.0 mt -96.94 90.49 5.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.315 -0.865 . . . . 0.0 109.509 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 123' ' ' HIS . 89.8 mt-10 -43.59 -37.97 2.78 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.599 -0.688 . . . . 0.0 110.523 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' O ' HD13 ' A' ' 99' ' ' ILE . 68.2 mttm -145.67 158.06 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.818 -1.176 . . . . 0.0 110.466 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.733 HG23 ' CD1' ' A' ' 122' ' ' TYR . 20.5 mm -135.21 119.29 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 t -122.52 154.55 37.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 0.0 109.808 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -132.99 137.46 46.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.374 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 119' ' ' THR . 80.0 tt0 -113.47 141.83 46.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 103' ' ' ILE . 61.3 mt -128.79 118.7 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 0.0 109.302 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 16.6 tttp -131.53 126.39 34.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.133 -0.98 . . . . 0.0 109.601 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.487 ' CE ' ' HA ' ' A' ' 20' ' ' PHE . 75.9 mtm -120.21 150.95 39.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.05 150.82 26.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.46 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 138.43 53.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.18 146.04 86.52 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.329 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.85 -30.6 21.58 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.621 2.214 . . . . 0.0 111.961 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -128.72 138.04 51.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.558 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 96.65 -23.52 34.92 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.46 33.15 61.43 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . -102.59 -133.14 7.92 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 32.2 t -151.73 149.65 29.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -1.179 . . . . 0.0 109.417 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.069 HG23 HG22 ' A' ' 11' ' ' THR . 64.5 mt -111.77 133.98 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.891 . . . . 0.0 109.431 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 116' ' ' LEU . 6.6 mp -106.37 130.9 54.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.731 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.405 ' NZ ' ' HB3' ' A' ' 7' ' ' GLU . 37.6 tttm -124.62 135.71 53.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.115 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 69.4 mt -129.04 123.55 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.838 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 6' ' ' TYR . 46.8 m -122.52 131.24 53.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.375 -0.828 . . . . 0.0 109.032 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.484 ' HB2' ' OH ' ' A' ' 122' ' ' TYR . 1.8 m -114.34 160.76 18.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 109.969 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 44.8 mttp -143.08 123.9 14.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.923 ' CB ' HD22 ' A' ' 96' ' ' LEU . 5.6 m-85 -122.34 122.76 39.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.988 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 97' ' ' GLU . 9.6 m-70 -85.31 113.9 21.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 108.82 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.817 HG21 ' CE2' ' A' ' 4' ' ' PHE . 1.3 p -94.42 148.39 22.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.679 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.452 ' HG2' ' OE2' ' A' ' 97' ' ' GLU . 32.8 mttm -67.27 145.3 55.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -0.869 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.02 -129.63 6.73 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -110.32 31.16 6.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -1.141 . . . . 0.0 109.556 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.87 144.82 26.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.489 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 130' ' ' ILE . 83.9 p -95.61 171.63 8.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.297 -0.877 . . . . 0.0 109.466 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.633 HD11 ' CG2' ' A' ' 124' ' ' THR . 38.5 mm -118.72 121.89 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -59.18 119.69 7.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.483 ' HA ' HG13 ' A' ' 135' ' ' ILE . 97.0 mt-10 -54.27 -36.73 63.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.3 -35.95 82.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.215 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -65.44 -25.93 67.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 0.0 109.639 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.483 HG13 ' HA ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -87.9 -35.58 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.208 -0.932 . . . . 0.0 109.049 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -57.45 -44.27 84.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.688 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.83 -43.24 72.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.452 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.86 92.8 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -57.99 -47.11 83.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -1.087 . . . . 0.0 109.343 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.43 -40.11 93.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -58.56 -45.45 88.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.6 -38.64 85.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.43 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.39 -42.86 99.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.437 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.26 -45.98 92.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 26.1 tp -59.01 -38.39 79.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -1.197 . . . . 0.0 109.395 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.478 ' O ' HG12 ' A' ' 149' ' ' VAL . 70.2 t80 -61.65 -41.57 97.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -60.42 -40.06 89.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.328 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.12 80.34 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.903 . . . . 0.0 109.449 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 146' ' ' PHE . 5.7 p -67.32 -39.98 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.45 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.2 tt0 -63.73 -38.61 91.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.73 97.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.351 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.6 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 71.1 t80 -59.55 -48.89 79.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.3 mt -61.68 -38.8 89.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.9 . . . . 0.0 109.38 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 154' ' ' LEU . 20.6 tp -63.76 -39.1 93.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.33 -28.67 68.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.548 ' CD2' ' OD2' ' A' ' 158' ' ' ASP . 6.7 t60 49.74 61.6 13.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.288 -0.883 . . . . 0.0 109.415 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.6 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 49.8 Cg_endo -69.69 -13.79 35.36 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.712 2.275 . . . . 0.0 111.736 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.548 ' OD2' ' CD2' ' A' ' 156' ' ' HIS . 55.6 p30 -88.84 12.46 15.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.396 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.542 ' HB2' ' HD2' ' A' ' 156' ' ' HIS . . . -64.76 147.37 53.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.491 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -62.71 -33.92 76.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.516 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.248 0.546 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.478 ' O ' HG22 ' A' ' 124' ' ' THR . . . -133.2 167.4 23.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.797 HG22 ' ND1' ' A' ' 123' ' ' HIS . 38.6 t -125.21 132.68 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.17 . . . . 0.0 109.51 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.605 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 97.3 m-85 -95.44 130.52 42.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.212 -0.93 . . . . 0.0 109.181 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 t -110.59 125.04 52.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.474 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.605 ' CE2' ' HB3' ' A' ' 4' ' ' PHE . 93.7 m-85 -125.41 144.51 50.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.266 -0.896 . . . . 0.0 109.315 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 91.5 mt-10 -125.15 160.98 27.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.737 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 60.4 t0 -134.42 142.45 47.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.206 -0.934 . . . . 0.0 109.162 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.33 138.89 46.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.903 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.69 121.56 8.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.333 -0.854 . . . . 0.0 109.151 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.9 m -112.5 133.07 54.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.004 . . . . 0.0 109.971 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.479 ' HB3' HD11 ' A' ' 14' ' ' ILE . 4.8 t -160.41 139.59 10.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.442 -0.786 . . . . 0.0 109.026 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 13' ' ' VAL . 28.2 m -68.59 91.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.04 . . . . 0.0 109.36 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.852 HG21 HD13 ' A' ' 19' ' ' LEU . 1.6 mt -138.89 143.84 39.0 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.426 -0.796 . . . . 0.0 109.216 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.686 ' HD2' HG22 ' A' ' 14' ' ' ILE . 46.3 Cg_endo -68.24 127.86 16.53 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.409 2.073 . . . . 0.0 111.259 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.88 -34.64 29.57 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.723 2.282 . . . . 0.0 112.199 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.12 -50.96 11.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.634 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.45 ' HB2' ' HG2' ' A' ' 15' ' ' PRO . 42.0 mtt-85 -70.42 -45.98 64.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.853 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.852 HD13 HG21 ' A' ' 14' ' ' ILE . 40.5 tp -59.91 -48.44 81.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.983 . . . . 0.0 109.688 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CE2' ' HA ' ' A' ' 80' ' ' PHE . 65.9 t80 -52.41 -51.77 57.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.592 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 33.3 mttt -67.45 -57.57 6.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.073 -1.017 . . . . 0.0 109.881 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 46.6 m -62.03 -20.43 63.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.969 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.3 t80 -100.11 -51.27 3.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.993 -1.067 . . . . 0.0 110.095 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 51.7 t -84.93 -51.36 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.937 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 17.8 tp -66.42 -40.48 89.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.0 109.835 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.6 m-20 -99.8 20.44 14.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 109.722 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.63 -34.55 74.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 32' ' ' PRO . 89.3 m-20 -68.17 -32.38 72.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.857 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.415 ' C ' ' HD2' ' A' ' 32' ' ' PRO . 89.3 m-20 -101.6 -42.07 6.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.129 -0.982 . . . . 0.0 109.76 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.644 ' O ' HG23 ' A' ' 34' ' ' VAL . 17.6 tp -56.3 -36.8 69.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.753 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.527 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 17.8 mt -63.65 -58.84 13.48 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.492 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.527 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.26 -30.22 31.08 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.539 2.159 . . . . 0.0 111.777 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -65.52 -37.77 87.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.516 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 30' ' ' LEU . 79.0 t -61.23 -46.55 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -142.41 158.9 59.74 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 109.552 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 50.4 Cg_endo -70.5 142.97 45.95 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.756 2.304 . . . . 0.0 111.8 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.446 ' NE2' HG22 ' A' ' 31' ' ' ILE . 93.5 mt-30 -116.15 154.66 29.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.4 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -56.13 -36.13 67.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.411 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.668 ' CD1' HG21 ' A' ' 57' ' ' ILE . 80.5 m-85 -84.75 141.88 30.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.868 . . . . 0.0 109.471 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 81.4 m -68.38 -42.26 79.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.385 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 p -162.92 166.01 24.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.2 155.54 24.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HG3' ' CG2' ' A' ' 58' ' ' THR . 98.2 mt-10 -125.81 165.26 19.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 109.38 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.447 ' OD1' ' O ' ' A' ' 54' ' ' ILE . 50.9 t30 -91.33 115.29 27.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 0.0 109.529 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.695 HD23 HG21 ' A' ' 54' ' ' ILE . 16.6 tp -63.87 -40.26 96.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.167 -0.958 . . . . 0.0 109.422 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.467 ' CG ' ' N ' ' A' ' 47' ' ' GLY . 53.1 tt0 -170.95 162.4 7.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 0.0 109.425 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' HA3' HG23 ' A' ' 53' ' ' THR . . . 94.74 162.54 34.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -95.03 6.16 49.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -1.153 . . . . 0.0 109.573 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.516 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.6 19.28 11.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.963 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -117.4 -145.72 8.11 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.57 125.49 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.722 2.282 . . . . 0.0 111.826 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.55 -1.83 79.57 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.516 HG21 ' HA2' ' A' ' 49' ' ' GLY . 31.9 m -73.68 137.22 43.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.194 -1.18 . . . . 0.0 109.452 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.787 HG23 ' O ' ' A' ' 70' ' ' HIS . 4.7 mt -109.78 139.0 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.517 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 68.6 mttm -112.01 149.07 32.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.608 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.459 ' HD2' HD13 ' A' ' 45' ' ' LEU . 22.7 tttt -132.95 147.24 52.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.378 -0.827 . . . . 0.0 109.33 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.668 HG21 ' CD1' ' A' ' 39' ' ' PHE . 41.4 mt -97.61 137.63 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.17 -0.956 . . . . 0.0 109.46 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.492 ' CG2' ' HG3' ' A' ' 43' ' ' GLU . 33.8 p -75.37 150.64 38.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.57 165.79 13.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' GLU . . . -140.57 141.49 35.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.433 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 60' ' ' ALA . 94.5 mt-10 60.75 123.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 63' ' ' ASN . . . 62.05 -95.48 0.11 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 7.8 m-20 68.35 12.69 8.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -1.15 . . . . 0.0 109.498 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.415 ' O ' ' CE2' ' A' ' 67' ' ' TYR . 77.0 mm-40 -72.63 -30.91 64.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.93 . . . . 0.0 109.449 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -127.21 -177.15 3.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.87 . . . . 0.0 109.468 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.5 mttt 64.14 74.57 0.4 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.905 . . . . 0.0 109.474 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 64' ' ' GLU . 90.1 m-85 -108.78 147.18 32.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.204 -0.935 . . . . 0.0 109.471 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.469 ' CE ' ' HA2' ' A' ' 89' ' ' GLY . 81.0 mmm -119.69 147.55 44.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.393 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.582 ' O ' HG23 ' A' ' 86' ' ' ILE . 80.1 mttt -134.25 131.71 38.79 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.399 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.787 ' O ' HG23 ' A' ' 54' ' ' ILE . 79.6 m80 -125.99 140.54 52.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.955 . . . . 0.0 109.612 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -138.24 140.75 39.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.905 . . . . 0.0 109.362 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 50.1 t -100.77 138.57 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.527 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.5 tt0 -84.07 -56.85 3.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.384 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.506 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.4 mt-10 -158.78 141.64 14.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.454 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.963 HD12 ' HA2' ' A' ' 50' ' ' GLY . 74.0 mt -118.87 128.61 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 85.7 m-20 -128.79 81.25 2.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.516 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -58.93 -36.5 74.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.45 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.58 -34.93 74.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -85.53 6.96 24.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.545 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 92.0 m-85 49.44 33.0 5.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -127.82 139.72 52.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.531 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 67.1 t80 -126.46 131.4 51.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 109.56 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 3.7 m -128.39 117.05 20.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.439 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.531 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 33.6 p90 -139.84 157.47 45.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.483 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 83.9 p -137.71 174.17 10.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.582 HG23 ' O ' ' A' ' 69' ' ' LYS . 12.6 mt -124.62 128.21 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.47 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 72.9 mt -74.86 -37.61 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.867 . . . . 0.0 109.593 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.443 ' HA ' HD11 ' A' ' 92' ' ' LEU . 94.9 mt-10 -143.44 131.04 21.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.555 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.469 ' HA2' ' CE ' ' A' ' 68' ' ' MET . . . -137.42 75.19 0.39 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 44.45 -111.28 0.47 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.5 Cg_endo -69.59 -31.91 20.32 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.745 2.296 . . . . 0.0 111.696 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.543 ' CD2' HG12 ' A' ' 99' ' ' ILE . 0.4 OUTLIER 61.7 -85.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.59 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . -174.82 -166.85 33.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -104.13 126.15 51.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -1.147 . . . . 0.0 109.491 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.668 HG21 ' CB ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 52.76 20.74 1.67 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.864 . . . . 0.0 109.467 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.99 HD22 ' HB3' ' A' ' 122' ' ' TYR . 22.3 mt -94.7 90.49 6.12 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.202 -0.936 . . . . 0.0 109.196 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.3 mt-10 -46.24 -40.19 11.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.591 -0.693 . . . . 0.0 110.595 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.821 ' O ' HD13 ' A' ' 99' ' ' ILE . 55.7 tttp -155.88 154.39 31.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.634 -1.291 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.842 HD11 ' HB3' ' A' ' 96' ' ' LEU . 24.1 mm -129.41 118.51 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 120' ' ' SER . 44.8 m -119.52 148.13 43.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.084 -1.01 . . . . 0.0 109.945 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.542 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 73.6 m-85 -125.55 140.82 52.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.806 . . . . 0.0 109.162 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 119' ' ' THR . 84.5 tt0 -124.4 132.86 53.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.197 -0.94 . . . . 0.0 109.696 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.503 HG21 ' HE1' ' A' ' 23' ' ' PHE . 11.1 mm -109.04 126.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.273 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.6 tttm -130.62 133.22 45.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.204 -0.935 . . . . 0.0 109.724 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.549 ' CE ' ' CD1' ' A' ' 23' ' ' PHE . 64.2 mtt -117.55 146.83 43.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.315 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.87 157.76 44.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.542 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.3 136.99 34.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.262 -0.899 . . . . 0.0 109.405 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.76 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -71.69 168.66 20.32 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.431 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.5 Cg_endo -69.4 144.27 55.41 Favored 'Trans proline' 0 C--O 1.217 -0.573 0 C-N-CA 122.644 2.229 . . . . 0.0 111.826 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 57.69 -89.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 109' ' ' PRO . . . -155.47 22.48 0.56 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -47.86 -45.28 25.23 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.73 ' H ' ' HB3' ' A' ' 108' ' ' ALA . . . 153.69 -116.1 0.71 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 22.5 t -155.13 145.38 21.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.475 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.409 ' C ' HD12 ' A' ' 116' ' ' LEU . 67.9 mt -116.12 128.7 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.423 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.765 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.1 mp -108.44 135.67 49.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 8' ' ' ASP . 68.1 mttm -126.6 135.34 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 77.0 mt -119.61 131.08 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 109.53 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 102' ' ' GLU . 30.8 m -119.85 142.69 48.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.261 -0.899 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 100' ' ' SER . 1.4 m -128.02 156.62 42.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 109.826 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -133.59 108.99 8.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.36 -0.838 . . . . 0.0 108.973 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.99 ' HB3' HD22 ' A' ' 96' ' ' LEU . 8.4 m-30 -105.27 118.91 37.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.797 ' ND1' HG22 ' A' ' 3' ' ' VAL . 2.1 m-70 -84.94 134.13 34.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.294 -0.879 . . . . 0.0 108.912 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.656 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 12.8 t -113.56 144.82 42.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 126' ' ' GLY . 22.9 mttp -72.09 139.77 48.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.0 109.463 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 125' ' ' LYS . . . 44.51 -142.35 3.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 128' ' ' ALA . 73.0 m-20 -85.9 10.67 13.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -1.138 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.668 ' CB ' HG21 ' A' ' 95' ' ' THR . . . -44.12 146.96 0.57 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.469 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.2 p -115.88 161.89 18.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.642 ' CD1' HD21 ' A' ' 96' ' ' LEU . 55.8 mt -104.06 139.08 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.898 . . . . 0.0 109.473 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -62.46 118.45 7.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.534 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.567 ' HA ' HG13 ' A' ' 135' ' ' ILE . 88.1 tt0 -57.72 -34.57 69.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.908 . . . . 0.0 109.46 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -56.33 -42.39 77.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.404 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.91 -25.09 67.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.591 HD13 ' CE1' ' A' ' 6' ' ' TYR . 2.9 mt -69.49 -52.34 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.907 . . . . 0.0 108.947 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -55.65 -41.34 73.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.231 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -58.36 -42.43 86.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.272 -0.892 . . . . 0.0 109.238 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.2 -36.09 80.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -64.51 -40.27 95.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.199 -1.177 . . . . 0.0 109.387 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -66.39 -35.23 79.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.49 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -63.3 -39.72 95.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.201 -0.937 . . . . 0.0 109.567 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.6 76.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.245 -0.909 . . . . 0.0 109.638 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.84 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.595 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.31 -48.2 76.83 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.713 ' O ' HG12 ' A' ' 149' ' ' VAL . 64.7 mt -68.26 -37.92 81.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.18 -1.188 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.427 ' HE2' HD22 ' A' ' 116' ' ' LEU . 71.0 t80 -63.5 -45.72 89.39 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.296 -0.877 . . . . 0.0 109.569 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.8 tttp -63.05 -37.77 88.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.39 -51.2 38.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 109.606 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.713 HG12 ' O ' ' A' ' 145' ' ' LEU . 7.5 p -66.13 -40.04 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.475 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.6 tt0 -61.97 -39.16 91.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.554 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.83 -36.51 83.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.315 -0.866 . . . . 0.0 109.545 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -65.89 -41.79 91.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.168 -0.958 . . . . 0.0 109.491 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 153' ' ' LEU . 32.9 tp -61.53 -38.0 85.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.14 -0.975 . . . . 0.0 109.374 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 154' ' ' LEU . 33.8 mt -77.98 -30.89 50.44 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.244 -0.91 . . . . 0.0 109.471 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.08 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.38 67.48 80.32 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.844 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.69 -2.77 11.38 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.705 2.27 . . . . 0.0 111.834 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 47.6 p30 -104.66 9.83 35.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.906 . . . . 0.0 109.554 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -46.05 145.41 1.56 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.424 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -62.16 -34.38 76.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 18' ' ' ARG . 1.4 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.538 ' O ' HG22 ' A' ' 124' ' ' THR . . . 68.95 -127.65 22.26 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.679 HG22 ' HA ' ' A' ' 123' ' ' HIS . 52.4 t -126.85 135.5 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.149 . . . . 0.0 109.471 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.611 ' HB3' ' CE1' ' A' ' 6' ' ' TYR . 97.9 m-85 -91.71 128.25 37.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.364 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.8 t -113.56 123.86 50.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.63 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.912 ' CG ' HG21 ' A' ' 135' ' ' ILE . 92.4 m-85 -122.86 146.09 47.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.372 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 83.9 tt0 -121.94 131.39 53.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.186 -0.947 . . . . 0.0 109.645 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.88 124.87 45.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.302 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -97.07 134.63 40.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.722 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -151.89 124.81 8.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.405 HG23 HG12 ' A' ' 115' ' ' ILE . 34.8 m -118.39 132.49 56.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.925 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -160.51 135.47 7.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.137 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.772 ' O ' HG23 ' A' ' 13' ' ' VAL . 24.1 m -64.99 91.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.071 -1.018 . . . . 0.0 109.355 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.745 HG23 ' HD2' ' A' ' 15' ' ' PRO . 20.0 mt -138.86 144.65 42.39 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.352 -0.842 . . . . 0.0 109.448 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.745 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.48 119.54 6.54 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.563 2.176 . . . . 0.0 111.265 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.4 Cg_endo -66.78 -34.83 29.8 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.764 2.31 . . . . 0.0 112.264 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.7 -53.74 14.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 tpt180 -72.2 -40.96 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.743 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.736 HD13 HG21 ' A' ' 14' ' ' ILE . 22.3 tp -66.39 -36.71 83.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.111 -0.993 . . . . 0.0 109.717 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 77' ' ' HIS . 56.3 t80 -63.79 -50.48 68.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' ASP . 29.6 mttt -69.26 -48.07 62.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 19.2 m -65.62 -23.48 66.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.895 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.928 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 56.7 t80 -100.54 -51.08 3.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.014 . . . . 0.0 110.139 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 20' ' ' PHE . 55.9 t -84.83 -52.82 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.108 -0.995 . . . . 0.0 110.163 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 22.2 tp -68.07 -29.44 68.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.095 -1.003 . . . . 0.0 109.864 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 90.8 m-20 -110.38 20.09 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.114 -0.991 . . . . 0.0 109.565 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.928 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -67.96 -34.79 77.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.583 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 90.8 m-20 -66.68 -42.17 86.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.18 -0.95 . . . . 0.0 109.828 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -90.02 -34.07 16.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.171 -0.955 . . . . 0.0 109.718 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.673 HD21 HG23 ' A' ' 149' ' ' VAL . 23.2 tp -66.76 -32.82 74.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.548 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 31.9 mt -59.68 -57.62 25.49 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.413 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 47.7 Cg_endo -68.5 -34.68 19.47 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.618 2.212 . . . . 0.0 111.65 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -59.53 -43.93 93.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.547 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 30' ' ' LEU . 86.4 t -60.28 -42.31 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.68 126.63 82.3 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.942 . . . . 0.0 109.507 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 37' ' ' GLN . 50.1 Cg_endo -70.09 147.93 61.84 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.701 2.267 . . . . 0.0 111.806 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.423 ' O ' ' O ' ' A' ' 36' ' ' PRO . 94.8 mt-30 43.73 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.935 . . . . 0.0 109.58 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 59.26 76.15 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -82.71 138.12 34.19 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.6 p -117.53 169.04 9.85 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 109.384 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 11.6 t -130.97 144.18 51.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.609 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' LYS . . . -131.26 145.19 51.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.888 . . . . 0.0 109.332 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 95.5 mt-10 -143.19 151.51 40.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.461 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.9 m-20 -89.04 111.5 22.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.378 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.529 HD22 ' HD3' ' A' ' 56' ' ' LYS . 31.4 tp -77.3 -33.74 55.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 53' ' ' THR . 86.5 tt0 -150.9 155.55 39.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.432 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 76.04 157.8 7.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -81.81 -19.96 40.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.284 -1.127 . . . . 0.0 109.449 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.91 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 143.07 -12.6 2.34 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.472 ' C ' HD12 ' A' ' 75' ' ' ILE . . . -78.55 -148.12 3.81 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.0 126.0 13.25 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.858 2.372 . . . . 0.0 111.847 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.09 -6.53 66.55 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.91 HG21 ' HA2' ' A' ' 49' ' ' GLY . 53.7 m -74.22 139.48 44.39 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.079 -1.248 . . . . 0.0 109.537 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.401 HG12 ' HG3' ' A' ' 71' ' ' LYS . 7.3 mt -110.6 139.43 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 64.9 mttt -130.27 138.44 50.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.396 -0.815 . . . . 0.0 109.519 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.529 ' HD3' HD22 ' A' ' 45' ' ' LEU . 17.4 mtmt -112.92 136.46 52.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.905 . . . . 0.0 109.322 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 41' ' ' SER . 62.9 mt -112.37 132.27 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 62.3 p -141.17 149.29 41.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.897 . . . . 0.0 109.341 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -62.6 -44.82 95.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -0.917 . . . . 0.0 109.337 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.33 154.33 35.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.68 -31.72 69.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.1 -178.33 37.5 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ASN . 44.1 p-10 -101.71 56.1 0.82 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -1.156 . . . . 0.0 109.504 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.83 -26.01 66.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -103.75 126.97 51.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.292 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HG2' ' HE2' ' A' ' 69' ' ' LYS . 24.3 tttt -119.26 14.84 13.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.121 -0.987 . . . . 0.0 109.601 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -69.33 -31.04 69.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.247 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 82.9 mtp -96.81 134.94 39.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 0.0 109.135 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' HE2' ' HG2' ' A' ' 66' ' ' LYS . 89.7 mttt -137.14 133.99 35.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 98.7 m-70 -122.4 131.43 53.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.355 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.401 ' HG3' HG12 ' A' ' 54' ' ' ILE . 17.2 tttm -128.72 127.66 42.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.502 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.001 HG21 HD11 ' A' ' 75' ' ' ILE . 2.3 p -84.0 134.22 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.316 -0.865 . . . . 0.0 109.462 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 23.4 mt-10 -82.41 -44.76 15.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.328 -0.857 . . . . 0.0 109.431 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.3 mt-10 -159.23 150.98 20.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.001 HD11 HG21 ' A' ' 72' ' ' VAL . 3.2 mt -135.54 107.12 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.447 ' OD1' ' OD1' ' A' ' 79' ' ' ASN . 31.1 t0 -123.21 90.92 3.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.8 m170 -70.4 -32.78 70.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.86 . . . . 0.0 109.58 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.29 -51.59 67.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 109.375 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.447 ' OD1' ' OD1' ' A' ' 76' ' ' ASP . 12.4 m120 -84.34 8.25 16.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 75.6 m-85 54.72 25.36 6.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.378 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HE2' ' OE2' ' A' ' 102' ' ' GLU . 63.6 tttt -108.78 122.21 46.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 109.232 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 84' ' ' TYR . 7.4 t80 -128.75 129.82 46.24 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 109.695 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.463 ' HA ' ' HG3' ' A' ' 102' ' ' GLU . 1.8 t -109.55 123.63 49.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.315 -0.865 . . . . 0.0 109.013 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.608 ' CD1' ' CE1' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -121.14 138.62 54.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.121 -0.987 . . . . 0.0 109.966 -179.475 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.496 ' HB3' ' NZ ' ' A' ' 98' ' ' LYS . 48.8 m -137.45 158.71 43.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -0.852 . . . . 0.0 109.054 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.1 mt -127.65 128.1 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.653 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.544 HG22 ' HG3' ' A' ' 88' ' ' GLU . 89.1 mt -86.01 -39.16 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.685 ' HA ' HD11 ' A' ' 92' ' ' LEU . 98.1 mt-10 -144.55 143.35 30.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.202 -0.936 . . . . 0.0 109.493 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.42 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -156.23 93.88 0.14 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 43.93 -126.54 5.95 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.423 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.6 Cg_endo -69.59 -22.85 32.27 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.694 2.263 . . . . 0.0 111.637 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.685 HD11 ' HA ' ' A' ' 88' ' ' GLU . 0.4 OUTLIER 62.37 -84.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.514 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.577 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . 179.4 -171.88 43.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' C ' ' OG1' ' A' ' 95' ' ' THR . 81.8 t60 -106.63 128.81 54.46 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -1.2 . . . . 0.0 109.541 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.929 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.1 OUTLIER 61.36 13.34 4.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.61 179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.785 ' HB3' HD11 ' A' ' 99' ' ' ILE . 32.3 mt -94.87 90.23 5.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.529 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' HIS . 86.7 mt-10 -47.19 -42.67 20.39 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.598 -0.689 . . . . 0.0 110.509 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 1.051 ' O ' HD13 ' A' ' 99' ' ' ILE . 19.7 tttm -158.96 162.49 36.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.713 -1.242 . . . . 0.0 110.522 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.051 HD13 ' O ' ' A' ' 98' ' ' LYS . 7.2 mm -136.15 126.96 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -132.79 155.8 48.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.112 -0.992 . . . . 0.0 109.996 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.54 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 57.1 m-85 -137.86 129.72 28.56 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 83.6 tt0 -106.83 129.09 54.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.119 -0.988 . . . . 0.0 109.807 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 67.9 mt -108.32 118.53 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.392 -0.817 . . . . 0.0 109.324 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -129.53 143.77 50.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.532 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.46 ' SD ' ' HA ' ' A' ' 20' ' ' PHE . 59.8 mtt -118.81 147.82 43.51 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.483 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.95 163.81 33.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.305 -0.872 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.93 143.62 32.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.855 . . . . 0.0 109.435 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.779 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . -109.37 112.77 59.03 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.949 . . . . 0.0 109.481 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.98 -51.03 0.39 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.717 2.278 . . . . 0.0 111.807 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -68.82 -48.32 63.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -62.14 -30.23 75.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.82 30.14 52.9 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . -151.86 -135.65 2.31 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' ILE . 28.7 t -135.55 148.77 49.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.23 -1.159 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.779 HG13 ' HB2' ' A' ' 108' ' ' ALA . 64.7 mt -113.86 134.25 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.442 HD12 ' CE2' ' A' ' 146' ' ' PHE . 24.1 mt -106.66 139.24 41.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.893 . . . . 0.0 109.569 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.9 mttp -135.34 136.45 41.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.322 -0.861 . . . . 0.0 109.376 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 69.9 mt -125.02 135.23 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 109.461 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 25.3 m -116.16 141.9 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.912 . . . . 0.0 109.442 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.54 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 67.8 m -124.48 153.15 42.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -137.28 129.08 28.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -0.869 . . . . 0.0 109.202 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.759 ' HD1' HD12 ' A' ' 99' ' ' ILE . 51.4 m-85 -125.77 108.72 11.77 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.745 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.679 ' HA ' HG22 ' A' ' 3' ' ' VAL . 52.6 m-70 -79.88 130.89 35.67 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 8.8 t -116.17 147.87 40.95 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.067 -1.02 . . . . 0.0 109.731 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 124' ' ' THR . 18.2 tttt -42.09 -40.96 2.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.646 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 145.65 -56.85 0.52 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.0 p-10 -86.41 10.72 14.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -1.171 . . . . 0.0 109.588 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.929 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -110.36 151.09 27.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.9 t -132.25 149.33 52.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.552 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 29.5 mt -98.56 121.39 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 109.527 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -54.69 138.86 40.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.353 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.507 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.2 mt-10 -66.3 -33.22 75.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 109.502 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -59.04 -33.58 70.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -0.891 . . . . 0.0 109.304 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -65.73 -29.52 70.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.268 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.912 HG21 ' CG ' ' A' ' 6' ' ' TYR . 1.8 mm -69.83 -48.51 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.288 -0.882 . . . . 0.0 108.749 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -55.59 -41.55 73.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.362 -0.836 . . . . 0.0 109.193 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.81 -49.45 75.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.35 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.11 -34.81 58.8 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.3 -38.14 87.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -1.133 . . . . 0.0 109.294 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.29 -43.74 96.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.257 -0.902 . . . . 0.0 109.282 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -60.2 -42.76 95.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.224 -0.922 . . . . 0.0 109.428 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.66 -37.49 82.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.75 89.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.46 -48.47 83.92 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 149' ' ' VAL . 25.2 tp -64.85 -38.85 92.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.16 . . . . 0.0 109.405 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.512 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 68.5 t80 -60.33 -41.31 93.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 109.291 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -64.79 -40.17 94.81 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.39 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.79 -47.29 66.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.404 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.673 HG23 HD21 ' A' ' 30' ' ' LEU . 7.9 p -64.2 -44.29 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.384 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.562 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.4 tt0 -54.33 -43.57 71.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 0.0 109.391 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.85 99.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.292 -0.88 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.595 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 68.5 t80 -60.55 -47.29 86.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.2 -0.937 . . . . 0.0 109.467 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 30.1 tp -61.68 -36.99 82.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.434 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.2 tt -63.24 -46.33 87.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.04 -32.08 70.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.505 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 m170 50.24 64.89 7.62 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.595 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 49.4 Cg_endo -69.72 -8.39 23.48 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.648 2.232 . . . . 0.0 111.776 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -68.16 -30.34 69.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -0.901 . . . . 0.0 109.52 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -107.46 144.52 34.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.456 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -60.66 -30.58 69.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.546 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.255 0.55 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.98 168.68 23.21 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.629 ' CG2' ' CD2' ' A' ' 123' ' ' HIS . 7.7 p -131.52 136.49 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.524 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.576 ' CE2' HG12 ' A' ' 130' ' ' ILE . 87.3 m-85 -95.92 144.38 26.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.41 ' SG ' ' HE3' ' A' ' 121' ' ' LYS . 4.0 m -125.26 119.75 29.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.307 -0.871 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.78 ' O ' HG23 ' A' ' 119' ' ' THR . 29.3 m-85 -110.75 148.41 32.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 109.4 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -121.53 151.97 39.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.619 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -131.8 138.94 48.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.87 . . . . 0.0 109.463 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -108.98 132.47 54.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.287 -0.883 . . . . 0.0 109.645 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -148.89 125.63 11.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -114.38 135.56 53.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.904 . . . . 0.0 109.84 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.3 m -160.36 141.33 12.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 109.178 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 13' ' ' VAL . 2.3 p -77.1 91.3 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 0.0 109.37 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.607 HG22 ' HD2' ' A' ' 15' ' ' PRO . 1.9 mt -138.77 142.62 34.59 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 0.0 109.459 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HD2' HG22 ' A' ' 14' ' ' ILE . 48.4 Cg_endo -68.96 123.02 9.93 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.578 2.185 . . . . 0.0 111.47 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -66.78 -30.06 41.54 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.774 2.316 . . . . 0.0 112.278 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.04 -56.38 6.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.136 -0.978 . . . . 0.0 109.597 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -72.55 -47.48 47.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.811 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.947 HD13 ' O ' ' A' ' 19' ' ' LEU . 3.0 tm? -53.11 -37.17 61.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.84 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 53.8 t80 -71.74 -54.93 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 0.0 109.784 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.812 ' HG3' HD12 ' A' ' 25' ' ' LEU . 17.5 tttm -67.67 -30.41 69.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.235 -0.916 . . . . 0.0 109.803 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 36.4 m -81.81 -30.53 32.18 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.098 -1.002 . . . . 0.0 109.945 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.978 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 88.0 t80 -100.84 -44.22 5.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.134 -0.979 . . . . 0.0 110.44 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.06 -52.98 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.964 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.812 HD12 ' HG3' ' A' ' 21' ' ' LYS . 45.0 mt -70.66 -28.68 64.97 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.937 -1.102 . . . . 0.0 110.037 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.476 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 87.5 m-20 -108.96 19.84 19.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.049 -1.032 . . . . 0.0 109.657 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.978 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.96 -52.24 26.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 109.992 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.572 ' HA ' HD12 ' A' ' 31' ' ' ILE . 71.3 m-20 -62.54 -32.48 73.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.102 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -83.35 -41.62 18.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.001 . . . . 0.0 109.968 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.822 ' O ' HG23 ' A' ' 34' ' ' VAL . 45.2 mt -72.46 -34.15 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 28' ' ' ASP . 18.8 mt -48.08 -61.08 3.4 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.494 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.537 ' CD ' ' HB ' ' A' ' 31' ' ' ILE . 48.4 Cg_endo -68.16 -39.86 9.72 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.651 2.234 . . . . 0.0 112.013 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -58.76 -40.37 83.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.741 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 30' ' ' LEU . 57.4 t -59.39 -40.89 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.643 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.43 123.02 88.73 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 0.0 109.486 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' O ' ' ND1' ' A' ' 38' ' ' HIS . 49.8 Cg_endo -70.3 133.95 25.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.748 2.298 . . . . 0.0 111.835 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 59.39 46.15 12.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 36' ' ' PRO . 49.1 m80 -145.07 107.32 4.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -111.43 131.48 55.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.361 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 26.8 p -129.96 158.48 39.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 0.0 109.562 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 t -142.87 141.64 31.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.387 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB2' HD12 ' A' ' 57' ' ' ILE . . . -142.96 155.12 44.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -125.02 163.62 21.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.396 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -91.45 108.01 19.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 56' ' ' LYS . 46.0 mt -61.72 -41.99 98.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.44 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -158.27 153.18 25.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.896 . . . . 0.0 109.409 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 96.25 158.04 31.75 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 -94.9 9.71 38.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -1.186 . . . . 0.0 109.536 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.666 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.77 21.82 8.42 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 1.024 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -118.46 -144.67 7.6 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.0 Cg_endo -69.32 123.54 10.35 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.701 2.267 . . . . 0.0 111.874 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.23 1.46 72.25 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.666 HG21 ' HA2' ' A' ' 49' ' ' GLY . 93.4 m -73.38 134.64 44.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -1.192 . . . . 0.0 109.553 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.528 HG12 ' CD ' ' A' ' 71' ' ' LYS . 3.9 mt -104.6 138.92 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 49.2 mttm -123.57 142.32 51.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.462 -0.774 . . . . 0.0 109.559 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.742 ' HB2' HD11 ' A' ' 45' ' ' LEU . 49.3 tttt -134.15 142.46 47.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.529 ' CG2' ' HB2' ' A' ' 67' ' ' TYR . 6.1 tp -82.8 134.23 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.573 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.9 m -80.21 150.85 29.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.406 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.566 ' CE1' ' HB3' ' A' ' 67' ' ' TYR . 97.0 m-85 -97.54 131.55 44.04 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -71.61 148.27 46.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.361 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -55.44 -35.71 65.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.36 -0.837 . . . . 0.0 109.505 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.52 171.17 20.8 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 53.81 51.75 14.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -1.145 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -52.28 142.68 16.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.354 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.423 ' CD2' ' N ' ' A' ' 66' ' ' LYS . 66.7 t80 -126.62 161.65 27.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.945 . . . . 0.0 109.559 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' N ' ' CD2' ' A' ' 65' ' ' PHE . 39.6 ttpt -52.62 137.11 31.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.462 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.566 ' HB3' ' CE1' ' A' ' 59' ' ' PHE . 37.1 p90 -118.28 159.54 23.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 45.5 mtm -151.79 152.44 32.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.414 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -92.04 156.01 17.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.56 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 78.5 m80 -134.96 135.85 41.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.533 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.528 ' CD ' HG12 ' A' ' 54' ' ' ILE . 10.3 tptm -132.12 127.3 35.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.453 HG11 ' CG1' ' A' ' 75' ' ' ILE . 40.3 t -91.61 125.11 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -74.35 -42.67 58.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.91 . . . . 0.0 109.382 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 85.2 tt0 -174.85 142.32 0.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.363 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.024 HD12 ' HA2' ' A' ' 50' ' ' GLY . 69.1 mt -119.12 132.4 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 80.8 m-20 -133.14 83.62 2.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.286 -0.884 . . . . 0.0 109.447 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -61.68 -37.57 84.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.76 71.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 75.2 m-20 -91.61 9.91 30.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.448 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 79' ' ' ASN . 86.1 m-85 43.71 45.64 6.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.38 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.46 ' HG3' ' HG2' ' A' ' 104' ' ' LYS . 10.3 ttpp -140.35 123.22 16.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.222 -0.924 . . . . 0.0 109.398 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 58.5 t80 -111.07 129.2 55.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.405 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 22.0 m -123.91 114.81 20.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.916 . . . . 0.0 109.558 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.549 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 37.1 p90 -137.57 159.91 40.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.462 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.447 ' O ' HD13 ' A' ' 86' ' ' ILE . 85.6 p -141.3 168.84 18.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.447 HD13 ' O ' ' A' ' 85' ' ' SER . 26.6 mm -114.29 121.45 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.408 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 71' ' ' LYS . 81.2 mt -70.78 -41.73 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.321 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -160.55 133.36 6.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 109.531 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.53 103.82 0.28 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 45.41 -111.68 0.63 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.3 Cg_endo -70.71 -31.4 16.38 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.748 2.298 . . . . 0.0 111.75 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.831 HD11 HG12 ' A' ' 99' ' ' ILE . 2.5 tp 63.32 -70.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.407 -0.808 . . . . 0.0 109.567 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 169.9 162.29 21.91 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -89.14 121.14 31.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.14 . . . . 0.0 109.539 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.948 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 59.51 14.79 4.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.871 . . . . 0.0 109.565 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.992 HD22 ' HB3' ' A' ' 122' ' ' TYR . 36.5 mt -93.12 90.7 6.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.239 -0.913 . . . . 0.0 108.83 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 94.6 mt-10 -43.23 -44.59 5.34 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.795 -0.566 . . . . 0.0 110.125 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.685 ' O ' HD13 ' A' ' 99' ' ' ILE . 88.0 mttt -153.54 156.17 37.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.961 -1.087 . . . . 0.0 110.032 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.861 HD11 ' HB3' ' A' ' 96' ' ' LEU . 32.3 mm -130.51 112.91 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.948 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 36.8 m -115.76 152.5 33.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.769 -179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.456 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 91.2 m-85 -129.63 133.3 47.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.347 -0.846 . . . . 0.0 109.113 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.405 ' HG3' ' SG ' ' A' ' 83' ' ' CYS . 84.1 tt0 -117.4 139.27 51.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.682 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.6 mt -123.88 121.87 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 109.345 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 21.3 mtpt -117.54 127.5 54.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.537 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.811 ' SD ' HD12 ' A' ' 19' ' ' LEU . 70.1 mtm -124.48 138.6 54.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.34 37.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -101.96 135.53 43.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -65.34 158.5 72.38 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 48.6 Cg_endo -69.25 -32.09 21.44 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.67 2.247 . . . . 0.0 111.82 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -65.53 -34.53 78.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 0.0 109.374 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 99.86 146.84 20.52 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 73.49 38.61 51.88 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -169.19 114.59 0.56 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.9 t -115.05 154.48 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.525 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 66.6 mt -117.44 127.37 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.332 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.541 HD22 ' HG2' ' A' ' 105' ' ' MET . 55.9 mt -106.59 136.96 45.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.277 -0.89 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.454 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 40.3 mttt -131.4 138.1 48.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.243 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.9 mt -125.68 122.71 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.113 -0.992 . . . . 0.0 109.731 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.78 HG23 ' O ' ' A' ' 6' ' ' TYR . 94.3 m -128.66 138.3 52.1 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.456 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 2.1 m -123.24 166.56 15.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 109.679 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 10.6 mtpt -138.45 112.84 8.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.385 -0.822 . . . . 0.0 109.165 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.992 ' HB3' HD22 ' A' ' 96' ' ' LEU . 8.1 m-30 -108.29 115.13 29.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.629 ' CD2' ' CG2' ' A' ' 3' ' ' VAL . 12.7 m-70 -82.56 122.91 28.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 108.693 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 95' ' ' THR . 14.2 t -106.78 141.12 38.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.988 -1.07 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 45.1 mttt -45.39 -40.58 8.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 109.635 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.22 -68.24 0.37 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -65.18 -27.73 68.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -1.141 . . . . 0.0 109.515 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.948 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -72.74 149.52 43.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.269 -0.894 . . . . 0.0 109.497 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 92.3 p -126.63 159.86 32.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.169 -0.957 . . . . 0.0 109.397 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.714 HD11 HD21 ' A' ' 96' ' ' LEU . 35.1 mm -108.19 123.37 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.969 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.47 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 54.6 t30 -91.6 131.34 37.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 136' ' ' LYS . 75.0 mm-40 -53.96 -40.72 67.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.469 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -65.93 -42.04 90.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 0.0 109.483 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 73.6 mm-40 -63.14 -41.59 99.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.486 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.714 HG21 ' CG2' ' A' ' 130' ' ' ILE . 20.9 pt -84.42 -30.12 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.511 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 132' ' ' GLU . 15.1 tttp -55.72 -40.87 73.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.247 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.81 75.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.0 109.187 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.06 -39.4 69.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -60.95 -43.36 98.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.257 -1.143 . . . . 0.0 109.225 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -53.53 -46.82 70.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -57.71 -45.97 85.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.66 -40.32 96.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.284 -0.885 . . . . 0.0 109.046 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.18 -44.36 83.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.38 -0.825 . . . . 0.0 109.12 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.72 -46.79 88.98 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.014 -1.634 . . . . 0.0 109.014 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 62.2 mt -59.95 -39.3 85.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -1.091 . . . . 0.0 109.091 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.529 ' O ' HG12 ' A' ' 149' ' ' VAL . 68.9 t80 -60.97 -45.46 94.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 0.0 109.248 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -62.74 -34.49 77.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.237 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.83 -51.39 59.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.195 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 146' ' ' PHE . 3.5 p -59.57 -39.85 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.263 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.567 ' HA ' HD12 ' A' ' 153' ' ' LEU . 85.9 tt0 -60.6 -39.89 89.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.299 -0.876 . . . . 0.0 109.38 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.13 90.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.318 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.585 ' CZ ' ' CG ' ' A' ' 157' ' ' PRO . 67.6 t80 -59.91 -43.98 94.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.354 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.567 HD12 ' HA ' ' A' ' 150' ' ' GLU . 14.7 mt -60.46 -40.45 91.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.212 -0.93 . . . . 0.0 109.299 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.4 tt -60.58 -38.88 86.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.87 . . . . 0.0 109.403 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.574 ' O ' ' CG ' ' A' ' 156' ' ' HIS . . . -69.65 -25.44 63.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.574 ' CG ' ' O ' ' A' ' 155' ' ' ALA . 18.7 p80 40.43 59.8 7.43 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.518 -0.739 . . . . 0.0 109.731 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.585 ' CG ' ' CZ ' ' A' ' 152' ' ' TYR . 50.0 Cg_endo -70.53 -6.77 19.73 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.732 2.288 . . . . 0.0 111.712 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -61.5 -33.35 73.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.279 -0.888 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.47 147.23 48.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.388 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -113.02 134.61 54.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.508 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.835 ' O ' HG22 ' A' ' 124' ' ' THR . . . -57.01 -27.47 57.17 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.65 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.3 p -119.96 143.39 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -1.188 . . . . 0.0 109.539 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -104.42 137.29 42.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.175 -0.953 . . . . 0.0 109.418 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.0 t -117.44 125.67 51.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.492 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 26.5 m-85 -118.14 147.96 42.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.438 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -119.94 149.8 41.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -130.32 139.46 50.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -115.69 139.13 50.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.581 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -156.95 122.42 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.347 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -113.19 133.11 55.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.767 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 t -160.26 137.98 9.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.405 -0.809 . . . . 0.0 109.2 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 13' ' ' VAL . 2.7 p -73.02 91.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.168 -0.958 . . . . 0.0 109.541 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.791 HG21 HD13 ' A' ' 19' ' ' LEU . 16.6 mt -138.83 144.2 40.65 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.239 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.744 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.2 Cg_endo -68.62 118.13 5.45 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.384 2.056 . . . . 0.0 111.374 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 20' ' ' PHE . 45.1 Cg_endo -66.96 -43.13 7.12 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.769 2.313 . . . . 0.0 112.223 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.81 -49.61 67.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.573 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' HD3' ' HA ' ' A' ' 161' ' ' CYS . 98.5 mtt180 -72.12 -43.98 63.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 14' ' ' ILE . 7.1 tp -67.2 -41.01 86.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.11 -0.994 . . . . 0.0 109.72 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.764 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 52.3 t80 -65.42 -47.51 75.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.231 -0.918 . . . . 0.0 109.753 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.728 ' HG3' HD12 ' A' ' 25' ' ' LEU . 39.4 tttt -68.98 -36.57 78.02 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.81 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 35.3 t -80.81 -25.74 37.61 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.052 -1.03 . . . . 0.0 109.73 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.921 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 77.5 t80 -100.68 -50.11 3.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 110.356 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.764 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.7 t -84.46 -52.76 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.056 -1.028 . . . . 0.0 110.513 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.728 HD12 ' HG3' ' A' ' 21' ' ' LYS . 56.0 mt -72.48 -28.13 62.71 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.124 -0.985 . . . . 0.0 109.942 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 22' ' ' SER . 87.9 m-20 -113.79 28.38 8.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.461 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.921 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.52 -39.62 77.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.645 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' HD12 ' A' ' 31' ' ' ILE . 26.9 p-10 -69.81 -32.63 71.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.233 -0.917 . . . . 0.0 109.612 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 24.9 m120 -88.71 -32.32 18.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.829 HD23 ' O ' ' A' ' 30' ' ' LEU . 8.1 tt -73.86 -30.25 62.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 27' ' ' ALA . 17.2 mt -56.57 -56.65 29.97 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 46.9 Cg_endo -68.16 -33.55 24.53 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.535 2.157 . . . . 0.0 111.677 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 29' ' ' ASN . 79.4 mttt -62.65 -37.22 85.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.45 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 30' ' ' LEU . 10.0 p -110.54 9.67 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.586 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 31' ' ' ILE . . . -68.01 156.06 90.49 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.941 . . . . 0.0 109.423 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.58 -163.45 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.751 2.301 . . . . 0.0 111.869 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -47.1 -31.28 3.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.9 . . . . 0.0 109.475 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -96.94 134.1 40.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.332 -0.855 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -110.05 143.2 40.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.2 m -124.89 141.08 52.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.194 -0.941 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.7 p -132.38 156.23 47.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.462 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.614 ' HB3' ' HE2' ' A' ' 55' ' ' LYS . . . -143.74 152.65 41.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.21 -0.932 . . . . 0.0 109.574 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.19 159.61 37.24 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.476 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -88.16 108.08 19.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.471 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 45' ' ' LEU . 21.8 tp -67.88 -37.27 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 109.432 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 53' ' ' THR . 86.1 tt0 -139.94 155.71 47.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 87.09 160.82 35.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -91.9 8.88 35.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -1.123 . . . . 0.0 109.554 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.706 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.97 13.36 25.5 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.807 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -110.84 -143.85 9.67 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.5 Cg_endo -69.43 125.12 11.93 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.586 2.191 . . . . 0.0 111.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.44 -2.66 74.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.706 HG21 ' HA2' ' A' ' 49' ' ' GLY . 62.6 m -73.04 139.78 46.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -1.136 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.498 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.1 mm -101.41 128.48 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.397 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.614 ' HE2' ' HB3' ' A' ' 42' ' ' ALA . 63.1 tttt -105.95 133.86 49.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -122.7 143.32 49.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 42' ' ' ALA . 73.0 mt -109.17 137.98 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.443 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.2 m -122.13 143.71 49.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.379 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.582 ' HB3' ' CD1' ' A' ' 65' ' ' PHE . 98.9 m-85 -105.21 139.05 40.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.49 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.65 -149.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -98.22 141.84 30.63 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.505 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.29 -120.14 1.0 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.547 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 21.9 m120 -84.29 150.22 25.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -1.165 . . . . 0.0 109.469 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -59.25 136.13 57.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 59' ' ' PHE . 93.5 m-85 -120.44 153.38 36.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -89.05 126.58 35.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -61.44 144.35 54.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.908 . . . . 0.0 109.484 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 88.4 mtp -132.5 152.93 51.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.478 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.6 mttm -118.31 136.82 53.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.454 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.618 ' NE2' ' CD2' ' A' ' 84' ' ' TYR . 11.1 t-80 -132.4 128.79 38.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 75.3 tttt -126.69 150.24 49.11 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.227 -0.921 . . . . 0.0 109.389 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.768 HG11 ' O ' ' A' ' 50' ' ' GLY . 7.4 p -108.34 134.61 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -82.49 -56.77 3.68 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 44.3 mt-10 -150.81 140.88 22.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.544 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.807 HD12 ' HA2' ' A' ' 50' ' ' GLY . 73.0 mt -125.59 126.39 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.478 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 84.3 m-20 -131.55 94.72 3.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.94 . . . . 0.0 109.397 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' HD11 ' A' ' 25' ' ' LEU . 86.6 t60 -66.08 -37.88 86.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.92 -31.47 66.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.215 -0.928 . . . . 0.0 109.441 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.478 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 18.7 m120 -85.0 2.48 42.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.606 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 49.78 34.36 7.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -130.83 128.49 40.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 109.447 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.7 t80 -122.74 130.17 52.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.948 . . . . 0.0 109.581 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.5 m -132.48 118.56 19.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.349 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.618 ' CD2' ' NE2' ' A' ' 70' ' ' HIS . 36.3 p90 -132.94 162.14 32.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.585 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 39.7 t -138.42 150.24 46.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 109.341 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 69' ' ' LYS . 22.8 mt -104.04 133.08 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.277 -0.889 . . . . 0.0 109.465 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.523 HG22 ' HG3' ' A' ' 88' ' ' GLU . 85.2 mt -77.63 -41.45 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.52 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.523 ' HG3' HG22 ' A' ' 87' ' ' ILE . 99.0 mt-10 -145.28 148.49 33.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.545 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . 135.4 166.12 10.94 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 43.99 -143.28 2.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.67 ' HB2' HD12 ' A' ' 96' ' ' LEU . 49.2 Cg_endo -69.54 -6.96 19.76 Favored 'Trans proline' 0 C--O 1.212 -0.803 0 C-N-CA 122.761 2.308 . . . . 0.0 111.781 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.871 ' O ' HD13 ' A' ' 92' ' ' LEU . 2.9 tm? -40.67 -26.53 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.192 -0.942 . . . . 0.0 110.361 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -89.58 -22.72 35.92 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 91' ' ' PRO . 58.7 t-80 -68.86 74.05 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.119 -1.224 . . . . 0.0 109.617 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 45.69 24.31 0.2 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' A' ' 122' ' ' TYR . 15.1 mt -95.24 90.69 5.95 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.278 -0.889 . . . . 0.0 109.31 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 94.1 mt-10 -41.5 -41.15 2.01 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.528 -0.733 . . . . 0.0 110.139 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 97' ' ' GLU . 46.6 mttt -158.26 168.18 27.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.922 -1.111 . . . . 0.0 110.139 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.789 HG23 ' CE1' ' A' ' 122' ' ' TYR . 40.3 mt -146.61 117.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 24.1 t -127.41 150.03 49.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.553 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 98.6 m-85 -131.1 128.07 39.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.392 -0.818 . . . . 0.0 109.042 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.7 mt-10 -106.25 141.74 37.1 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.1 -1.0 . . . . 0.0 109.722 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 75.9 mt -125.03 124.18 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.369 -0.832 . . . . 0.0 109.285 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -130.73 129.22 42.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.954 . . . . 0.0 109.656 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.498 ' HG2' ' CD2' ' A' ' 116' ' ' LEU . 69.0 mtm -126.61 141.0 52.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 109.321 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.45 150.82 30.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 109.534 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.53 137.13 52.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.193 -0.942 . . . . 0.0 109.436 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -83.53 135.92 43.11 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.384 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.72 138.76 38.72 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.718 2.279 . . . . 0.0 111.729 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 51.09 22.63 1.31 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.449 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.29 -43.55 0.83 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 79.82 29.51 47.11 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.524 ' CA ' ' HA ' ' A' ' 13' ' ' VAL . . . -144.0 -135.72 2.99 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 t -152.03 152.12 32.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -1.117 . . . . 0.0 109.482 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 69.5 mt -110.81 130.14 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.923 . . . . 0.0 109.377 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.498 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 64.8 mt -109.02 132.51 54.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -130.27 135.62 48.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.893 . . . . 0.0 109.37 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.8 mt -124.58 133.09 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.586 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 30.4 m -125.58 141.45 52.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.338 -0.851 . . . . 0.0 109.343 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.2 m -126.44 151.95 47.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.66 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -138.32 126.49 22.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.857 . . . . 0.0 109.221 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.812 ' HB3' HD22 ' A' ' 96' ' ' LEU . 38.0 m-85 -127.0 111.16 13.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.911 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.578 ' CD2' HG21 ' A' ' 3' ' ' VAL . 22.4 m-70 -85.04 135.53 33.97 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.894 ' OG1' ' HB3' ' A' ' 128' ' ' ALA . 11.3 t -115.82 141.27 48.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.053 -1.029 . . . . 0.0 109.852 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.495 ' CG ' ' HG2' ' A' ' 97' ' ' GLU . 69.8 mttt -77.82 137.54 38.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.434 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 65.35 -153.76 50.69 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -86.43 13.81 7.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -1.2 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.894 ' HB3' ' OG1' ' A' ' 124' ' ' THR . . . -52.06 143.77 13.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.7 p -124.01 170.02 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.513 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.546 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 12.6 mt -115.95 126.82 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -60.78 134.84 57.49 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.552 ' HA ' HG13 ' A' ' 135' ' ' ILE . 86.6 tt0 -62.88 -29.87 71.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -60.33 -44.68 95.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 0.0 109.124 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -57.6 -24.92 58.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.352 -0.842 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.552 HG13 ' HA ' ' A' ' 132' ' ' GLU . 2.0 mt -71.69 -51.15 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.876 . . . . 0.0 109.114 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -55.97 -38.29 70.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.93 78.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.364 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.11 -30.21 76.78 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.414 ' HE2' HG22 ' A' ' 135' ' ' ILE . 68.2 mttm -71.13 -36.24 72.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.136 -1.214 . . . . 0.0 109.393 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.13 -42.35 93.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 tttm -63.05 -40.13 96.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.917 . . . . 0.0 109.391 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.425 ' HB1' ' CZ ' ' A' ' 146' ' ' PHE . . . -70.12 -35.68 74.27 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 0.0 109.456 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.79 99.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -63.98 -39.33 97.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.41 ' O ' HG12 ' A' ' 149' ' ' VAL . 18.7 tp -65.47 -40.25 92.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.284 -1.127 . . . . 0.0 109.477 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.43 ' O ' ' CG1' ' A' ' 149' ' ' VAL . 19.6 m-85 -60.97 -41.54 96.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.522 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -66.92 -34.8 78.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.471 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.99 -50.3 50.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.91 . . . . 0.0 109.386 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 150' ' ' GLU . 3.8 p -57.53 -44.05 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.434 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.505 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.0 mt-10 -59.63 -44.36 93.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.405 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 155' ' ' ALA . . . -59.49 -35.61 74.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 109.341 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -61.9 -47.68 83.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 32.6 mt -54.2 -46.98 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.323 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.671 ' N ' HD12 ' A' ' 154' ' ' LEU . 6.7 mp -80.1 -24.85 40.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 151' ' ' ALA . . . -78.81 -17.84 55.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.227 -0.921 . . . . 0.0 109.473 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -137.14 63.56 44.0 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 50.1 Cg_endo -71.21 -5.52 17.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.657 2.238 . . . . 0.0 111.702 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -69.56 -36.09 76.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.43 134.4 56.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -57.89 -40.0 79.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.863 . . . . 0.0 109.467 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 18' ' ' ARG . 27.0 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.43 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.71 24.46 55.85 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.8 HG21 ' CE1' ' A' ' 123' ' ' HIS . 38.3 t -128.07 141.13 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -1.115 . . . . 0.0 109.511 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.647 ' HE2' HG21 ' A' ' 124' ' ' THR . 98.4 m-85 -99.11 135.2 40.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.338 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 120' ' ' SER . 7.1 p -119.02 125.3 49.03 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.465 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 119' ' ' THR . 77.6 m-85 -126.87 140.9 52.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.0 109.393 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' OE1' ' HD3' ' A' ' 117' ' ' LYS . 83.2 tt0 -115.95 134.14 55.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 59.9 t0 -101.62 124.7 47.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.547 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -99.16 131.48 45.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.16 -0.963 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -149.1 124.98 10.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.299 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.9 m -105.11 131.96 51.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.786 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.8 p -160.34 140.47 11.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.308 -0.87 . . . . 0.0 109.26 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 13' ' ' VAL . 2.4 p -81.64 91.22 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.412 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.949 HG21 HD13 ' A' ' 19' ' ' LEU . 3.1 mt -138.69 142.52 34.47 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 109.231 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.3 Cg_endo -68.08 120.47 7.45 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.458 2.105 . . . . 0.0 111.544 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.6 Cg_endo -67.0 -28.47 41.7 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.847 2.365 . . . . 0.0 112.224 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.71 -56.5 5.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -72.57 -45.95 56.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.356 -0.84 . . . . 0.0 109.651 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.949 HD13 HG21 ' A' ' 14' ' ' ILE . 10.7 tp -56.45 -41.0 75.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.874 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 24' ' ' VAL . 67.6 t80 -64.5 -49.05 72.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.731 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.712 ' HG2' HD12 ' A' ' 25' ' ' LEU . 41.7 mttm -69.08 -43.72 73.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 109.628 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 20.3 m -73.39 -22.25 60.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.764 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.965 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 69.7 t80 -100.88 -50.73 3.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 20' ' ' PHE . 52.9 t -85.04 -52.83 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.232 -0.918 . . . . 0.0 110.484 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.712 HD12 ' HG2' ' A' ' 21' ' ' LYS . 43.0 mt -71.77 -28.49 63.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 109.974 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 89.9 m-20 -108.4 18.67 20.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.072 -1.017 . . . . 0.0 109.555 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.965 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -68.29 -33.87 75.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.607 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.52 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 90.0 m-20 -71.04 -37.55 72.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.703 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -92.29 -41.11 10.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.683 HD21 HG23 ' A' ' 149' ' ' VAL . 16.0 tp -56.98 -41.05 77.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.89 . . . . 0.0 109.74 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.542 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 33.4 mt -56.93 -60.8 8.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.514 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -68.11 -33.81 24.15 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 122.556 2.17 . . . . 0.0 111.86 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.9 tttt -57.7 -38.09 74.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.614 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.571 HG11 ' HB1' ' A' ' 148' ' ' ALA . 69.4 t -59.24 -41.25 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.539 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.88 124.1 85.0 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.134 -0.979 . . . . 0.0 109.519 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.08 137.93 35.65 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.712 2.275 . . . . 0.0 111.754 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 58.35 47.99 13.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -124.55 114.55 19.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -108.72 131.9 54.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 t -137.24 155.97 48.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.455 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -130.47 148.49 52.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.469 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.625 ' HB1' ' HE3' ' A' ' 55' ' ' LYS . . . -142.58 152.55 42.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.438 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -144.56 142.45 30.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 84.8 m-20 -85.89 117.55 24.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.922 . . . . 0.0 109.501 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 54' ' ' ILE . 45.3 tp -69.54 -38.03 77.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.459 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.5 ' HG2' ' N ' ' A' ' 47' ' ' GLY . 77.7 tt0 -159.22 157.35 30.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.5 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 91.96 158.02 34.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -93.57 11.37 28.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -1.163 . . . . 0.0 109.535 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.64 31.08 5.6 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 1.009 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -127.83 -144.14 5.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.62 125.51 12.3 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.701 2.268 . . . . 0.0 111.768 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.13 4.26 86.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.602 HG21 ' HA2' ' A' ' 49' ' ' GLY . 74.8 m -77.68 139.52 39.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.143 -1.21 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 45' ' ' LEU . 16.8 mm -104.41 137.97 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.302 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HE3' ' HB1' ' A' ' 42' ' ' ALA . 56.1 tttp -126.6 142.27 51.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -124.87 126.92 46.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.319 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.3 mt -116.78 138.09 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.607 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.0 m -126.66 124.02 38.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.36 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 60' ' ' ALA . 98.3 m-85 -56.47 -48.86 76.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.586 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' A' ' 59' ' ' PHE . . . 64.79 11.95 7.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' HG3' ' HB3' ' A' ' 59' ' ' PHE . 98.2 mt-10 -65.43 -33.85 76.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.883 . . . . 0.0 109.444 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -138.04 -173.32 12.9 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.1 p-10 -84.11 0.81 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -1.146 . . . . 0.0 109.692 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 96.2 mt-10 -54.93 -35.25 64.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.434 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 23.5 m-85 61.47 77.5 0.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.481 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -83.11 145.55 29.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.238 -0.914 . . . . 0.0 109.442 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -114.04 134.41 54.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.606 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.9 mtp -138.06 157.45 46.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.895 . . . . 0.0 109.318 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.554 ' HG2' HD12 ' A' ' 87' ' ' ILE . 39.2 tttp -129.26 130.7 46.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 90.0 m-70 -122.94 134.86 54.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.301 -0.874 . . . . 0.0 109.29 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 tttp -131.6 132.11 43.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.754 HG21 ' O ' ' A' ' 50' ' ' GLY . 14.2 m -100.45 128.05 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.915 . . . . 0.0 109.439 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -70.52 -41.62 72.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -0.9 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 84.9 tt0 -176.52 144.67 0.53 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.141 -0.974 . . . . 0.0 109.503 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.009 HD12 ' HA2' ' A' ' 50' ' ' GLY . 62.2 mt -118.79 129.91 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.903 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 89.5 m-20 -130.53 83.8 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.461 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.83 -41.24 90.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.11 79.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 22.4 m120 -86.8 5.91 34.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.955 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 47.67 33.43 3.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.945 . . . . 0.0 109.483 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -127.63 132.5 49.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.44 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 71.2 t80 -124.35 126.33 45.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.301 -0.874 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.433 ' SG ' ' HG3' ' A' ' 102' ' ' GLU . 12.4 t -124.07 119.59 29.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.598 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.558 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 34.5 p90 -140.22 167.11 22.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.384 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 100' ' ' SER . 84.4 p -146.71 168.38 21.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.654 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 85' ' ' SER . 23.5 mm -115.39 113.68 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.308 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.554 HD12 ' HG2' ' A' ' 69' ' ' LYS . 90.6 mt -68.09 -35.79 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.305 -0.872 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -156.53 136.65 12.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.297 -0.877 . . . . 0.0 109.633 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -155.42 101.28 0.2 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.22 -128.86 8.33 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.2 Cg_endo -70.45 -23.66 27.39 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.623 2.216 . . . . 0.0 111.461 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.565 HD11 ' CG1' ' A' ' 99' ' ' ILE . 6.2 tp 45.47 -92.94 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.409 -0.807 . . . . 0.0 109.621 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.592 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . -156.28 172.95 34.16 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.413 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 84.7 t60 -106.74 133.2 51.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.28 -1.13 . . . . 0.0 109.404 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 1.069 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.3 OUTLIER 64.08 15.21 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.338 -179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.76 ' HB3' HD11 ' A' ' 99' ' ' ILE . 71.5 mt -104.54 93.76 4.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.187 -0.946 . . . . 0.0 109.277 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 85.5 mt-10 -45.97 -41.53 11.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.638 -0.664 . . . . 0.0 110.717 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 1.046 ' O ' HD13 ' A' ' 99' ' ' ILE . 89.4 mttt -155.33 160.76 40.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.679 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.046 HD13 ' O ' ' A' ' 98' ' ' LYS . 12.5 mm -135.0 114.36 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.529 ' CB ' ' HB3' ' A' ' 85' ' ' SER . 32.8 m -118.27 150.29 39.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.032 -1.042 . . . . 0.0 110.405 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.557 ' HE1' ' HH ' ' A' ' 122' ' ' TYR . 74.3 m-85 -131.95 132.57 43.64 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 118' ' ' ILE . 87.1 tt0 -113.29 141.05 47.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.997 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.609 HD13 ' HE1' ' A' ' 23' ' ' PHE . 70.0 mt -121.68 121.61 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.039 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -126.26 137.19 53.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 109.852 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.1 mtt -119.94 131.77 55.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -0.83 . . . . 0.0 109.241 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.86 155.24 43.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.14 -0.975 . . . . 0.0 109.679 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 114' ' ' SER . . . -101.33 128.98 47.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.369 -0.832 . . . . 0.0 109.356 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.85 150.64 97.7 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -69.49 -25.33 29.94 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.708 2.272 . . . . 0.0 111.679 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -63.79 -28.93 70.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 93.34 -3.93 73.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -52.88 -41.05 58.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 174.62 -126.47 1.19 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 107' ' ' ALA . 49.5 m -132.88 155.51 48.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -1.145 . . . . 0.0 109.531 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -112.63 134.22 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 49.9 mt -105.86 135.89 46.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 109.558 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.481 ' HD3' ' OE1' ' A' ' 7' ' ' GLU . 50.6 mttp -133.46 137.41 45.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 102' ' ' GLU . 68.8 mt -127.41 135.29 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.583 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 31.4 m -118.38 142.59 47.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 109.478 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.487 ' HG ' ' HD1' ' A' ' 101' ' ' TYR . 51.1 m -126.98 152.35 47.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -0.94 . . . . 0.0 109.953 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -136.2 126.14 25.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.383 -0.823 . . . . 0.0 109.114 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.789 ' HD1' HD12 ' A' ' 99' ' ' ILE . 54.5 m-85 -122.26 116.27 23.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 109.975 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.8 ' CE1' HG21 ' A' ' 3' ' ' VAL . 72.2 m-70 -85.5 126.01 33.5 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.647 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -109.85 152.65 25.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.931 -1.106 . . . . 0.0 109.783 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -53.86 -40.86 66.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.443 -0.786 . . . . 0.0 109.509 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.01 -84.24 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -61.39 -26.26 67.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -1.137 . . . . 0.0 109.52 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 1.069 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -62.44 146.25 51.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.469 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.5 t -137.69 151.15 47.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.468 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.613 HD11 ' CD2' ' A' ' 96' ' ' LEU . 36.4 mt -110.34 124.65 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.554 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -88.6 153.23 21.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.449 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.2 mt-10 -61.02 -36.7 80.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.528 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.528 ' CG ' ' N ' ' A' ' 134' ' ' GLU . 22.3 pt-20 -60.96 -46.08 92.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.197 -0.939 . . . . 0.0 109.49 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 133' ' ' GLU . 85.4 tt0 -56.87 -47.61 80.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 132' ' ' GLU . 41.8 pt -76.68 -29.27 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 132' ' ' GLU . 38.5 tttt -55.53 -41.47 73.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.911 . . . . 0.0 109.229 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.36 76.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.072 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.83 -38.34 73.36 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -61.38 -43.74 98.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -1.097 . . . . 0.0 109.075 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -53.5 -47.68 69.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -57.8 -45.53 85.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.905 . . . . 0.0 109.081 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.75 -40.53 88.42 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.302 -0.873 . . . . 0.0 109.127 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -52.59 -47.8 66.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 0.0 109.184 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -57.48 -44.37 93.72 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 149' ' ' VAL . 71.6 mt -55.64 -39.62 71.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.195 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.519 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 72.6 m-85 -65.91 -39.48 90.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.304 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -61.8 -38.69 89.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.947 . . . . 0.0 109.311 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.571 ' HB1' HG11 ' A' ' 34' ' ' VAL . . . -69.01 -52.11 32.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.683 HG23 HD21 ' A' ' 30' ' ' LEU . 7.6 p -65.28 -41.53 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.505 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.6 tt0 -58.83 -40.69 84.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 109.306 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.88 99.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.331 -0.856 . . . . 0.0 109.299 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -59.7 -49.37 78.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.885 . . . . 0.0 109.352 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.2 mt -58.6 -29.6 66.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.3 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.5 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.8 tt -65.29 -46.83 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.58 75.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 45.82 61.62 12.28 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.451 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.91 -9.76 26.82 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.66 2.24 . . . . 0.0 111.738 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -69.49 -34.14 73.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 109.487 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.57 142.34 32.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -55.93 -41.12 74.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.289 -0.882 . . . . 0.0 109.447 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.496 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' HB3' HG12 ' A' ' 3' ' ' VAL . 64.9 mtt . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.21 12.62 63.08 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.726 HG23 ' C ' ' A' ' 122' ' ' TYR . 11.1 p -127.01 137.24 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.473 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.651 ' HE2' HG21 ' A' ' 124' ' ' THR . 43.0 m-85 -101.99 152.55 20.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.8 m -131.82 111.73 11.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.917 . . . . 0.0 109.412 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 119' ' ' THR . 52.4 m-85 -108.4 151.18 26.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HG2' ' CG2' ' A' ' 119' ' ' THR . 95.2 mt-10 -125.93 139.58 53.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 109.561 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 118' ' ' ILE . 91.6 m-20 -111.66 156.51 21.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.451 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -127.01 134.26 50.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.665 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -148.11 124.21 10.76 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.22 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.69 HG23 HG12 ' A' ' 115' ' ' ILE . 33.8 m -116.59 139.3 50.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.968 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.428 ' O ' HG12 ' A' ' 14' ' ' ILE . 46.4 m -160.04 144.34 14.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.893 ' O ' HD13 ' A' ' 14' ' ' ILE . 31.1 m -70.72 90.67 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.479 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 1.044 HG21 HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -139.62 145.03 41.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.375 -0.828 . . . . 0.0 109.054 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HD2' HG22 ' A' ' 14' ' ' ILE . 44.1 Cg_endo -67.26 129.92 21.46 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 122.367 2.045 . . . . 0.0 111.084 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.4 Cg_endo -66.62 -39.98 14.57 Favored 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 122.701 2.267 . . . . 0.0 112.502 -179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.01 -46.52 20.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.062 -1.024 . . . . 0.0 109.794 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HB2' ' CG ' ' A' ' 15' ' ' PRO . 91.7 mtt-85 -71.99 -49.22 38.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.169 -0.957 . . . . 0.0 109.959 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.044 HD13 HG21 ' A' ' 14' ' ' ILE . 28.8 tp -59.51 -47.94 83.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.073 -1.017 . . . . 0.0 109.754 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.524 ' CE1' ' C ' ' A' ' 80' ' ' PHE . 53.8 t80 -53.73 -55.02 29.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 109.661 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.729 ' HG3' HD13 ' A' ' 25' ' ' LEU . 83.0 tttt -65.84 -54.9 20.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.942 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 31.6 m -62.29 -27.41 69.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.249 -0.907 . . . . 0.0 110.406 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 86.3 t80 -93.92 -50.88 5.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.916 -1.115 . . . . 0.0 110.292 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 45.9 t -84.59 -50.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 110.028 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD13 ' HG3' ' A' ' 21' ' ' LYS . 4.1 tt -68.92 -49.14 60.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.105 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' SER . 66.3 m-20 -91.65 24.16 3.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.919 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.44 -44.54 71.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.137 -0.977 . . . . 0.0 109.441 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' HA ' HD12 ' A' ' 31' ' ' ILE . 76.6 m-20 -64.14 -24.21 67.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.177 -0.952 . . . . 0.0 109.776 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -91.27 -38.47 12.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.849 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.567 ' O ' HG12 ' A' ' 34' ' ' VAL . 22.1 mt -79.89 -36.64 36.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.587 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.548 ' N ' ' HD2' ' A' ' 32' ' ' PRO . 25.0 mt -44.66 -56.62 8.15 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.8 Cg_endo -68.23 -28.94 33.28 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.485 2.124 . . . . 0.0 111.74 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -72.72 -40.74 65.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.411 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.567 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.2 p -76.66 -24.49 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.327 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.618 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -50.5 164.58 0.39 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.906 . . . . 0.0 109.348 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.618 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 49.7 Cg_endo -70.16 -161.74 0.09 OUTLIER 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.616 2.211 . . . . 0.0 111.777 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -52.84 -30.51 34.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.405 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -80.8 134.45 35.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.403 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -117.15 149.41 40.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.7 p -126.58 161.94 26.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.126 -0.983 . . . . 0.0 109.454 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.0 m -131.46 146.78 52.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.425 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.32 149.34 41.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.32 -0.862 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -133.97 159.11 41.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.33 -0.856 . . . . 0.0 109.491 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.461 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 76.5 m-20 -87.36 108.69 19.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 45' ' ' LEU . 23.6 tp -68.59 -36.32 78.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.37 -0.831 . . . . 0.0 109.557 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.795 ' O ' HG23 ' A' ' 53' ' ' THR . 86.0 tt0 -140.05 155.29 47.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.286 -0.884 . . . . 0.0 109.335 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 85.33 163.81 37.89 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -90.22 8.84 31.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -1.183 . . . . 0.0 109.546 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.732 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 99.45 43.18 2.58 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.66 -137.34 3.08 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.1 Cg_endo -69.17 123.0 9.84 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.801 2.334 . . . . 0.0 112.049 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.56 8.73 84.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 46' ' ' GLU . 56.3 m -86.41 139.79 30.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.234 -1.156 . . . . 0.0 109.542 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.52 HG12 ' CD ' ' A' ' 71' ' ' LYS . 6.0 mt -101.46 139.18 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.526 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 44' ' ' ASN . 93.7 mttt -117.47 150.62 38.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.713 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -125.27 137.28 54.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 0.0 109.281 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.9 tt -116.37 137.73 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.656 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -79.17 151.41 31.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.312 -0.868 . . . . 0.0 109.348 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.573 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 21.6 p90 -131.62 165.27 24.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.469 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.01 -56.87 2.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.329 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' HD3' ' A' ' 66' ' ' LYS . 84.3 tt0 -81.07 146.39 30.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.427 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.495 ' HA3' ' CB ' ' A' ' 66' ' ' LYS . . . 95.97 14.84 44.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -57.15 -26.5 60.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.269 -1.136 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.74 -36.65 84.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 109.506 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 72.3 t80 -176.31 66.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.448 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.573 ' O ' ' CZ ' ' A' ' 59' ' ' PHE . 16.9 tttt -141.65 128.47 20.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.575 ' CE2' ' HE2' ' A' ' 69' ' ' LYS . 39.5 p90 -146.39 161.99 39.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 63.1 mtt -132.86 144.73 50.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.333 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.575 ' HE2' ' CE2' ' A' ' 67' ' ' TYR . 37.6 mttm -130.69 140.66 50.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.615 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.457 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 97.4 m-70 -125.47 136.74 53.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' CD ' HG12 ' A' ' 54' ' ' ILE . 23.8 tptm -130.26 133.83 46.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 45.6 t -100.02 132.86 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.89 -56.48 4.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.857 . . . . 0.0 109.662 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.8 tt0 -178.89 138.66 0.15 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.845 HG21 ' CE2' ' A' ' 82' ' ' TYR . 15.7 pt -136.29 145.36 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.567 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.438 ' OD1' ' OD1' ' A' ' 79' ' ' ASN . 60.7 t0 -132.84 109.14 9.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.335 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -60.22 -36.22 77.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.969 . . . . 0.0 109.485 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.11 -42.72 99.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.438 ' OD1' ' OD1' ' A' ' 76' ' ' ASP . 15.8 m120 -86.11 -5.74 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.222 -0.923 . . . . 0.0 109.587 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' C ' ' CE1' ' A' ' 20' ' ' PHE . 92.2 m-85 58.74 36.09 24.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.935 . . . . 0.0 109.294 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -117.99 131.54 56.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.845 ' CE2' HG21 ' A' ' 75' ' ' ILE . 72.6 t80 -128.03 114.85 17.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.885 . . . . 0.0 109.683 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.5 m -118.71 118.17 30.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.944 . . . . 0.0 109.217 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.579 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 32.5 p90 -129.33 154.62 46.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.218 -0.926 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 51.1 m -128.9 159.14 36.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.366 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.2 mt -116.27 129.57 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 109.543 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.459 HD12 ' HB3' ' A' ' 69' ' ' LYS . 84.4 mt -77.6 -41.71 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.893 . . . . 0.0 109.43 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -165.27 138.38 4.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.512 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -154.46 103.07 0.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.24 -126.8 7.62 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' GLY . 50.1 Cg_endo -70.33 -29.88 20.5 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.652 2.235 . . . . 0.0 111.721 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.86 HD21 HG12 ' A' ' 99' ' ' ILE . 4.2 tp 45.72 -93.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.302 -0.874 . . . . 0.0 109.575 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.799 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . -145.63 -176.12 19.28 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -115.47 125.84 53.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -1.135 . . . . 0.0 109.483 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 58.85 23.59 11.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.804 ' HB3' HD11 ' A' ' 99' ' ' ILE . 96.5 mt -101.35 93.62 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.132 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.548 ' CG ' ' HG2' ' A' ' 125' ' ' LYS . 96.8 mt-10 -48.49 -32.72 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.764 -0.585 . . . . 0.0 111.287 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.787 ' O ' HD13 ' A' ' 99' ' ' ILE . 78.3 tttt -151.14 143.09 23.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.592 -1.317 . . . . 0.0 110.622 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.86 HG12 HD21 ' A' ' 92' ' ' LEU . 23.0 mm -124.81 113.46 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 28.5 t -116.97 148.68 41.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.182 -0.949 . . . . 0.0 110.108 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.476 ' CE2' ' HB3' ' A' ' 120' ' ' SER . 3.7 m-85 -130.87 123.95 30.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.781 . . . . 0.0 109.057 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' OG1' ' A' ' 119' ' ' THR . 91.1 mt-10 -109.12 135.3 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.897 . . . . 0.0 109.752 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 63.4 mt -131.52 119.2 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.272 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.98 155.11 47.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.698 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -117.35 147.85 42.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.277 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -136.79 147.18 46.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.23 138.5 38.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 109' ' ' PRO . . . -117.16 107.2 45.93 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 108' ' ' ALA . 49.9 Cg_endo -70.05 -29.71 22.09 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.656 2.238 . . . . 0.0 111.712 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -64.41 -44.41 91.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.424 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.12 175.9 27.63 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 114' ' ' SER . . . 92.33 20.73 34.43 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 57.62 -81.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 112' ' ' GLY . 87.1 p -144.37 165.48 27.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.406 -1.055 . . . . 0.0 109.41 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.69 HG12 HG23 ' A' ' 11' ' ' THR . 72.4 mt -123.01 133.56 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -0.927 . . . . 0.0 109.429 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.773 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.7 mp -106.98 138.91 42.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.239 -0.913 . . . . 0.0 109.517 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -124.69 135.49 53.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.288 -0.883 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 8' ' ' ASP . 72.2 mt -123.82 128.79 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.561 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 8.4 p -126.39 142.69 51.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.468 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.514 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -121.65 152.88 38.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.059 -1.026 . . . . 0.0 109.676 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -132.34 115.04 15.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.858 . . . . 0.0 108.931 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.809 ' CE1' HG23 ' A' ' 99' ' ' ILE . 9.6 m-30 -112.87 121.61 45.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 110.05 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.536 ' CD2' HG21 ' A' ' 3' ' ' VAL . 4.5 m-70 -92.85 115.51 28.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.389 -0.819 . . . . 0.0 108.841 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.651 HG21 ' HE2' ' A' ' 4' ' ' PHE . 1.1 p -92.7 148.65 21.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.677 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.548 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 54.3 mttp -70.09 147.25 50.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 48.19 -143.59 7.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -92.88 15.97 13.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -1.126 . . . . 0.0 109.418 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.12 146.31 3.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.159 -0.963 . . . . 0.0 109.519 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.6 p -113.9 161.75 17.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 96' ' ' LEU . 49.4 mt -105.8 139.93 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -0.895 . . . . 0.0 109.445 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -84.26 123.95 30.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.487 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 96.3 mt-10 -55.65 -35.59 66.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.08 -41.39 90.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -62.88 -45.63 91.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.464 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 132' ' ' GLU . 38.2 pt -76.86 -31.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.392 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 26.4 tttm -55.76 -46.66 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -0.919 . . . . 0.0 109.357 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.0 73.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.217 -0.927 . . . . 0.0 109.405 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -58.01 -39.56 92.11 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -60.91 -41.76 96.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -1.126 . . . . 0.0 109.454 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.04 -45.81 91.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -59.94 -45.79 91.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.84 -39.16 90.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.28 97.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.385 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -47.12 88.38 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 145' ' ' LEU . 9.4 tt -62.88 -39.34 94.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.256 -1.143 . . . . 0.0 109.319 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.468 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 70.9 t80 -59.54 -46.35 89.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -60.73 -39.22 87.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.376 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.54 -48.74 68.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.526 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.2 p -65.0 -43.65 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 0.0 109.355 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.526 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.2 tt0 -60.63 -40.17 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -0.89 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.01 -44.12 96.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.267 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.581 ' CE2' ' HG3' ' A' ' 157' ' ' PRO . 62.5 t80 -67.93 -42.34 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 109.43 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.915 HD13 ' O ' ' A' ' 153' ' ' LEU . 3.5 tm? -69.83 -31.49 69.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.385 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.902 HD13 ' O ' ' A' ' 154' ' ' LEU . 2.7 tm? -75.38 -40.09 58.44 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.219 -0.926 . . . . 0.0 109.306 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.2 -33.48 74.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.46 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 51.46 64.61 7.67 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.24 -0.913 . . . . 0.0 109.583 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.581 ' HG3' ' CE2' ' A' ' 152' ' ' TYR . 49.2 Cg_endo -70.45 -10.6 28.36 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.686 2.257 . . . . 0.0 111.737 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -60.63 -35.13 75.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.214 -0.929 . . . . 0.0 109.451 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.73 135.26 34.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.491 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.74 140.61 49.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.46 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.48 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.33 0.586 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.74 160.69 24.13 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 122' ' ' TYR . 6.7 p -128.44 130.87 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.219 -1.166 . . . . 0.0 109.475 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.75 ' HE2' HG21 ' A' ' 124' ' ' THR . 96.8 m-85 -86.42 144.46 27.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.193 -0.942 . . . . 0.0 109.606 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.0 m -130.27 121.22 25.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' THR . 46.2 m-85 -116.72 139.84 50.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.478 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -114.82 146.66 40.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 118' ' ' ILE . 90.2 m-20 -122.37 154.83 37.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.469 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -115.82 143.1 45.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.775 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 116' ' ' LEU . . . -154.29 121.73 5.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 0.0 109.182 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.8 m -110.15 133.78 52.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 109.833 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 m -160.3 146.5 15.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.291 -0.881 . . . . 0.0 109.241 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.477 ' HA ' ' HA3' ' A' ' 113' ' ' GLY . 2.2 p -81.19 91.58 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.675 HG21 HD13 ' A' ' 19' ' ' LEU . 1.9 mt -138.65 142.93 35.95 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.301 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.647 ' HD2' HG22 ' A' ' 14' ' ' ILE . 47.4 Cg_endo -68.56 116.31 4.34 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.449 2.1 . . . . 0.0 111.244 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 44.2 Cg_endo -66.45 -27.73 46.62 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.757 2.304 . . . . 0.0 112.36 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.18 -53.99 6.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 109.552 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -72.5 -43.25 63.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.313 -0.867 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.675 HD13 HG21 ' A' ' 14' ' ' ILE . 16.2 tp -61.04 -47.97 83.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.887 . . . . 0.0 109.747 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 70.2 t80 -57.3 -50.44 72.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.168 -0.957 . . . . 0.0 109.769 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.8 tttt -68.21 -48.38 65.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 110.018 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.553 ' O ' HD22 ' A' ' 30' ' ' LEU . 87.0 p -71.79 -20.84 61.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 110.099 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.937 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 66.0 t80 -100.42 -50.51 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.037 -1.039 . . . . 0.0 110.286 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.645 HG13 ' CD1' ' A' ' 82' ' ' TYR . 54.7 t -84.62 -52.89 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.06 -1.025 . . . . 0.0 110.349 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 15.9 tp -70.24 -29.67 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.941 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 91.4 m-20 -110.42 22.14 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.937 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -67.88 -33.53 74.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.648 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.488 ' OD2' ' NZ ' ' A' ' 55' ' ' LYS . 88.1 m-20 -69.27 -37.05 77.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.188 -0.945 . . . . 0.0 109.892 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 22.4 m120 -96.11 -38.04 10.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -0.979 . . . . 0.0 109.685 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.553 HD22 ' O ' ' A' ' 22' ' ' SER . 16.6 tp -56.5 -42.32 78.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.704 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 34' ' ' VAL . 31.0 mt -49.85 -61.61 3.43 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.19 -0.944 . . . . 0.0 109.333 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.559 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.61 -25.1 34.8 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.615 2.21 . . . . 0.0 111.632 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -62.25 -48.85 78.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.898 . . . . 0.0 109.607 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 31' ' ' ILE . 4.6 p -59.27 -26.23 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.878 . . . . 0.0 109.666 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -118.06 103.93 49.22 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 109.52 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.1 -12.92 33.15 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.715 2.276 . . . . 0.0 111.726 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -63.29 -28.84 70.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 57.66 42.03 24.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.88 . . . . 0.0 109.465 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.03 -40.4 89.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.421 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.2 t -138.33 158.5 44.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.341 -0.85 . . . . 0.0 109.484 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.8 t -136.19 142.84 44.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.945 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -112.17 138.77 48.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.203 -0.935 . . . . 0.0 109.463 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.89 153.14 45.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 35.5 p-10 -89.03 108.6 19.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.411 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.64 -35.32 78.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.329 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 53' ' ' THR . 48.4 tp10 -137.91 154.28 49.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.327 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.482 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 85.48 159.33 31.51 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.52 10.62 24.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -1.182 . . . . 0.0 109.483 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.83 6.58 43.08 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.998 ' O ' HG11 ' A' ' 72' ' ' VAL . . . -102.12 -147.99 20.36 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 47.7 Cg_endo -68.63 129.84 19.61 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.71 2.273 . . . . 0.0 111.756 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.65 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 89.46 -5.21 84.07 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 46' ' ' GLU . 92.3 m -75.14 139.23 42.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.506 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.525 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 23.6 mm -104.05 135.14 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 109.352 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.488 ' NZ ' ' OD2' ' A' ' 28' ' ' ASP . 29.0 mttt -118.37 140.3 50.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.626 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -123.59 142.54 50.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -116.61 135.3 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.581 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.8 p -82.37 151.86 26.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' CZ ' ' O ' ' A' ' 66' ' ' LYS . 37.9 p90 -139.41 168.75 19.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -132.88 147.56 52.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 78.8 tt0 48.86 46.84 21.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.431 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' PHE . . . -111.95 51.82 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -56.01 -26.33 48.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -1.16 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -55.17 -43.12 74.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.498 ' HB3' ' HA2' ' A' ' 90' ' ' GLY . 35.0 p90 -127.0 164.49 21.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.505 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' O ' ' CZ ' ' A' ' 59' ' ' PHE . 28.1 mttt -95.78 -74.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -133.55 146.84 51.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 75.2 mtm -111.45 154.88 24.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.925 . . . . 0.0 109.509 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.553 ' O ' HG23 ' A' ' 86' ' ' ILE . 23.9 mttt -131.08 144.13 51.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 55' ' ' LYS . 65.5 m80 -126.56 133.9 50.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.4 tttm -124.45 144.28 50.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -0.926 . . . . 0.0 109.458 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.998 HG11 ' O ' ' A' ' 50' ' ' GLY . 7.5 p -98.99 130.43 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.55 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -73.39 -46.83 46.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 50.6 tp10 -173.56 143.35 1.03 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.724 HD12 ' HA2' ' A' ' 50' ' ' GLY . 82.6 mt -126.95 125.23 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 79' ' ' ASN . 8.3 t70 -128.14 105.44 8.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 109.511 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 70.2 m80 -70.24 -35.11 73.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.47 -39.09 88.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.573 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 83.2 m-20 -85.14 5.33 30.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.916 . . . . 0.0 109.551 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 45.11 42.31 6.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.143 -0.973 . . . . 0.0 109.314 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 76' ' ' ASP . 53.6 pttt -130.44 137.39 49.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.386 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.645 ' CD1' HG13 ' A' ' 24' ' ' VAL . 62.0 t80 -126.32 125.03 41.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.56 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.468 ' CB ' ' HG3' ' A' ' 102' ' ' GLU . 8.1 t -127.57 115.56 19.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -0.878 . . . . 0.0 109.376 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.492 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.5 p90 -129.42 159.57 35.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.515 ' CB ' ' HE3' ' A' ' 98' ' ' LYS . 60.0 p -141.42 167.58 21.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.553 HG23 ' O ' ' A' ' 69' ' ' LYS . 17.9 mt -122.59 132.33 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.4 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 69.1 mt -80.16 -37.39 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -147.54 131.89 17.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.317 -0.864 . . . . 0.0 109.626 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -144.99 97.51 0.19 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 65' ' ' PHE . . . 45.61 -111.52 0.62 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.443 ' O ' ' HB3' ' A' ' 92' ' ' LEU . 49.8 Cg_endo -70.18 -30.64 20.0 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.703 2.269 . . . . 0.0 111.684 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.555 HD12 HD12 ' A' ' 99' ' ' ILE . 7.9 tp 60.64 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.339 -0.85 . . . . 0.0 109.464 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.774 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . 175.18 167.12 33.94 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -97.77 121.7 40.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -1.128 . . . . 0.0 109.399 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.802 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 65.81 9.58 6.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.719 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.774 HD12 ' HA3' ' A' ' 93' ' ' GLY . 83.7 mt -90.16 90.7 8.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.35 -0.844 . . . . 0.0 108.881 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 123' ' ' HIS . 33.3 mt-10 -48.59 -43.91 36.42 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.753 -0.592 . . . . 0.0 110.831 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.515 ' HE3' ' CB ' ' A' ' 85' ' ' SER . 54.9 tttp -150.65 155.17 38.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.616 -1.302 . . . . 0.0 110.464 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.627 HG23 ' CE1' ' A' ' 122' ' ' TYR . 34.1 mt -138.98 116.03 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 87.7 p -125.65 164.51 20.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.451 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 119' ' ' THR . 89.2 m-85 -137.89 120.48 16.15 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.468 ' HG3' ' CB ' ' A' ' 83' ' ' CYS . 83.1 tt0 -101.88 143.33 31.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.118 -0.989 . . . . 0.0 109.917 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 71.2 mt -128.51 118.36 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 0.0 108.912 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -120.38 139.61 52.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.205 -0.934 . . . . 0.0 109.615 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.623 ' SD ' HD23 ' A' ' 19' ' ' LEU . 63.8 mtm -122.35 137.49 54.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.892 . . . . 0.0 109.262 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.95 40.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.555 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.85 135.72 40.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.897 . . . . 0.0 109.365 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.13 151.97 95.87 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.504 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.35 -27.43 28.44 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.714 2.276 . . . . 0.0 111.719 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -78.67 -21.86 47.62 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.308 -0.87 . . . . 0.0 109.421 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 90.84 8.96 64.65 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.29 -37.74 93.51 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 171.64 -122.59 0.96 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.0 t -134.69 150.69 50.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -1.155 . . . . 0.0 109.409 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.4 mt -107.23 132.02 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.513 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.487 ' CD2' ' HG2' ' A' ' 105' ' ' MET . 49.5 mt -98.95 137.21 37.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.897 . . . . 0.0 109.357 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -127.03 131.44 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 8' ' ' ASP . 68.0 mt -118.47 137.57 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 80.8 m -133.1 137.29 46.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.679 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.4 m -113.88 154.71 27.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.266 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 32.4 mttm -142.12 122.05 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.113 -0.992 . . . . 0.0 109.606 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.842 ' O ' HG23 ' A' ' 3' ' ' VAL . 34.7 m-85 -119.43 132.92 55.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -0.882 . . . . 0.0 109.257 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.552 ' O ' ' N ' ' A' ' 97' ' ' GLU . 2.9 m80 -100.31 121.25 41.18 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.75 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -112.09 137.89 49.52 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.933 -1.104 . . . . 0.0 109.341 -179.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.514 ' HG3' HG22 ' A' ' 95' ' ' THR . 71.7 mttt -40.96 -35.12 0.48 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.546 -0.722 . . . . 0.0 109.862 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 148.62 -79.55 0.21 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.98 -29.73 67.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.342 -1.093 . . . . 0.0 109.316 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.802 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -63.5 143.26 57.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 0.0 109.439 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.1 m -126.4 154.38 43.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.627 HG12 HD21 ' A' ' 96' ' ' LEU . 48.6 mt -112.27 132.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.431 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.433 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 16.0 t-20 -87.04 138.08 31.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.895 . . . . 0.0 109.413 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.441 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.2 mt-10 -62.7 -33.04 74.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.433 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 83.0 tt0 -65.62 -46.22 80.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.352 -0.843 . . . . 0.0 109.479 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.18 -45.14 88.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.185 -0.947 . . . . 0.0 109.349 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 132' ' ' GLU . 35.8 pt -76.62 -29.19 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.322 -0.861 . . . . 0.0 109.389 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.1 tttt -55.63 -45.6 77.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.435 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.17 75.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 109.327 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.06 -38.39 75.86 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -58.88 -43.75 90.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -1.118 . . . . 0.0 109.148 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.28 -43.25 82.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.259 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -57.92 -45.91 85.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.26 -38.6 85.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.199 -0.938 . . . . 0.0 109.127 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.75 96.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.267 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.8 -48.21 79.95 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.904 ' O ' HD13 ' A' ' 145' ' ' LEU . 3.1 tm? -60.26 -38.44 83.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -1.131 . . . . 0.0 109.237 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.521 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 71.1 t80 -61.98 -41.39 97.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.904 . . . . 0.0 109.298 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -61.0 -41.38 96.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.71 65.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 109.376 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.521 ' CG1' ' HA ' ' A' ' 146' ' ' PHE . 7.4 p -66.72 -41.94 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.322 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.491 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.2 tt0 -60.49 -39.94 89.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.91 -42.75 99.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -60.44 -47.18 87.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.608 HD13 ' CD1' ' A' ' 19' ' ' LEU . 24.7 mt -59.92 -34.18 72.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 0.0 109.465 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.484 HD23 ' C ' ' A' ' 154' ' ' LEU . 8.9 tt -64.72 -42.09 95.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 156' ' ' HIS . . . -65.01 -31.29 72.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.495 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 155' ' ' ALA . 0.2 OUTLIER 45.55 60.57 13.45 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.214 -0.929 . . . . 0.0 109.455 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.09 -9.04 25.09 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.689 2.259 . . . . 0.0 111.723 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -73.32 -20.07 60.88 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.358 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 161' ' ' CYS . . . -71.14 142.43 50.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.876 . . . . 0.0 109.277 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 161' ' ' CYS . 90.9 m-85 51.58 -93.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.304 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.453 ' HA2' ' OD1' ' A' ' 127' ' ' ASN . . . 96.38 11.95 52.7 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.876 HG21 ' CE1' ' A' ' 123' ' ' HIS . 25.0 t -126.39 142.43 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.298 -1.119 . . . . 0.0 109.298 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.785 ' HE2' HG21 ' A' ' 124' ' ' THR . 95.2 m-85 -105.73 129.64 53.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.179 -0.951 . . . . 0.0 109.472 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.0 t -107.76 129.74 55.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.493 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 119' ' ' THR . 21.9 m-85 -116.36 143.23 45.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.437 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -123.33 142.73 50.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.181 -0.949 . . . . 0.0 109.412 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -129.16 134.61 48.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -109.99 138.47 46.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.593 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -168.53 113.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.9 t -120.32 147.63 44.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.759 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -160.27 143.88 13.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.27 -0.894 . . . . 0.0 109.172 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.784 ' O ' HG23 ' A' ' 13' ' ' VAL . 24.6 m -65.43 90.97 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 0.0 109.309 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.737 HG23 ' HD2' ' A' ' 15' ' ' PRO . 32.7 mm -138.87 144.18 40.47 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.464 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.737 ' HD2' HG23 ' A' ' 14' ' ' ILE . 47.6 Cg_endo -69.21 112.43 2.98 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.542 2.161 . . . . 0.0 111.287 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 45.9 Cg_endo -67.0 -29.55 40.4 Favored 'Trans proline' 0 C--O 1.216 -0.591 0 C-N-CA 122.761 2.308 . . . . 0.0 112.264 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.0 -56.13 5.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 109.723 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -72.58 -37.45 68.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.85 . . . . 0.0 109.773 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.674 HD22 HG21 ' A' ' 14' ' ' ILE . 15.6 tp -67.07 -33.71 76.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.166 -0.959 . . . . 0.0 109.758 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.757 ' CE1' HG21 ' A' ' 24' ' ' VAL . 66.3 t80 -71.56 -47.87 52.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.139 -0.975 . . . . 0.0 109.954 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' HD23 ' A' ' 25' ' ' LEU . 20.0 mttt -71.56 -22.67 61.72 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.139 -0.975 . . . . 0.0 109.789 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.779 ' O ' HD12 ' A' ' 30' ' ' LEU . 86.6 p -96.84 -23.64 16.27 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.09 -1.006 . . . . 0.0 109.458 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.925 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 79.9 t80 -100.46 -45.48 5.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.978 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 20' ' ' PHE . 57.8 t -84.58 -52.7 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.131 -0.98 . . . . 0.0 110.25 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 21' ' ' LYS . 4.0 mm? -69.79 -45.71 67.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 109.618 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 80.5 m-20 -93.73 25.63 3.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.185 -0.947 . . . . 0.0 109.591 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.925 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.92 -42.18 73.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.983 . . . . 0.0 109.775 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.57 -20.52 58.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 0.0 109.965 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -94.88 -38.55 10.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.811 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 22' ' ' SER . 18.1 mt -74.51 -30.03 61.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.564 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 27' ' ' ALA . 21.9 mt -55.47 -59.53 10.95 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 109.302 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 47.7 Cg_endo -68.56 -30.86 28.06 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.607 2.205 . . . . 0.0 111.77 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.464 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 47.3 tttp -59.03 -35.38 73.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.734 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 30' ' ' LEU . 98.9 t -61.07 -41.63 90.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.575 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.42 125.28 84.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.156 -0.965 . . . . 0.0 109.525 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.8 138.98 35.67 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.636 2.224 . . . . 0.0 111.754 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 55.3 47.11 22.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -131.45 106.45 8.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 109.404 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -112.25 129.84 56.13 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.562 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.0 t -135.04 158.27 44.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 88.8 p -137.26 149.32 47.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.245 -0.909 . . . . 0.0 109.525 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 57' ' ' ILE . . . -143.6 151.81 40.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -134.23 150.43 51.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.405 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -87.51 108.91 19.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.644 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.685 HD11 ' HD3' ' A' ' 56' ' ' LYS . 58.5 mt -66.48 -32.12 73.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -0.924 . . . . 0.0 109.274 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.826 ' O ' HG23 ' A' ' 53' ' ' THR . 78.1 tt0 -147.92 162.7 38.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.386 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.531 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 73.88 156.49 4.32 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -91.42 9.31 32.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.59 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 108.29 30.21 3.95 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.902 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -126.95 -143.71 5.87 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.57 120.47 7.13 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.667 2.245 . . . . 0.0 111.809 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.95 -2.66 72.55 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 46' ' ' GLU . 52.2 m -76.83 138.16 39.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.133 -1.216 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 70' ' ' HIS . 26.1 mm -102.94 134.28 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.898 . . . . 0.0 109.556 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' NZ ' ' OH ' ' A' ' 82' ' ' TYR . 27.3 mttt -112.08 141.99 45.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.343 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.685 ' HD3' HD11 ' A' ' 45' ' ' LEU . 35.3 ttpt -125.32 125.29 43.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 42' ' ' ALA . 61.7 mt -111.76 138.14 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.213 -0.929 . . . . 0.0 109.516 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 67.6 m -134.62 133.21 39.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.301 -0.874 . . . . 0.0 109.312 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' A' ' 61' ' ' GLU . 9.5 t80 -110.12 124.5 51.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.223 -0.923 . . . . 0.0 109.559 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.69 78.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.9 . . . . 0.0 109.417 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.571 ' HB2' ' CE1' ' A' ' 59' ' ' PHE . 74.9 mm-40 -96.43 -170.18 2.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.892 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.96 177.96 37.78 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 64' ' ' GLU . 24.9 m120 -89.53 149.36 22.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.198 -1.178 . . . . 0.0 109.455 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 63' ' ' ASN . 82.8 mt-10 43.94 -165.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.507 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -98.94 134.66 41.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.411 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.49 ' HD2' ' CB ' ' A' ' 59' ' ' PHE . 55.7 mttm -90.52 20.45 4.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.623 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' CE1' ' HD2' ' A' ' 56' ' ' LYS . 63.7 t80 -45.8 114.42 0.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.405 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -137.55 141.31 41.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 109.629 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -98.45 144.7 27.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.731 ' O ' HG23 ' A' ' 54' ' ' ILE . 76.0 m80 -130.68 147.01 52.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.479 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 16.3 tttp -135.0 134.86 40.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.14 -0.975 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.405 HG11 ' CG1' ' A' ' 75' ' ' ILE . 46.0 t -98.75 133.22 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.273 -0.892 . . . . 0.0 109.474 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -79.38 -43.01 24.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 51' ' ' PRO . 83.1 tt0 -176.65 140.02 0.33 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.902 HD12 ' HA2' ' A' ' 50' ' ' GLY . 70.4 mt -119.31 126.52 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 75' ' ' ILE . 78.3 m-20 -134.7 76.76 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.276 -0.89 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 48.7 m170 -55.86 -37.15 68.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.0 74.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.365 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 80' ' ' PHE . 58.7 m-20 -91.71 12.66 20.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.383 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ASN . 91.9 m-85 43.21 39.99 2.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.598 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.466 ' HE2' ' SG ' ' A' ' 83' ' ' CYS . 87.7 tttt -132.07 122.77 25.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.334 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.456 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 50.9 t80 -118.62 127.44 53.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -0.959 . . . . 0.0 109.587 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' HE2' ' A' ' 81' ' ' LYS . 31.8 m -130.22 121.24 25.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.363 -0.836 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -135.39 163.05 30.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.535 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.458 ' HG ' ' HG ' ' A' ' 100' ' ' SER . 49.9 m -126.38 163.85 22.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.647 ' O ' HD13 ' A' ' 92' ' ' LEU . 12.7 mt -119.97 133.63 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.723 ' C ' HD12 ' A' ' 92' ' ' LEU . 87.3 mt -111.91 -2.31 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.568 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.825 ' N ' HD12 ' A' ' 92' ' ' LEU . 33.5 mt-10 39.23 -92.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.632 -0.668 . . . . 0.0 109.965 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -127.92 -160.98 10.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . -37.82 -72.66 0.17 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 93' ' ' GLY . 53.1 Cg_endo -94.02 2.49 3.05 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.19 2.593 . . . . 0.0 112.381 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.825 HD12 ' N ' ' A' ' 88' ' ' GLU . 1.8 tt 49.79 -88.23 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.333 -0.854 . . . . 0.0 109.532 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.72 ' N ' HD23 ' A' ' 92' ' ' LEU . . . -98.79 169.98 23.64 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -85.05 124.61 31.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -1.149 . . . . 0.0 109.654 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.3 OUTLIER 67.85 6.25 4.99 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.235 -0.916 . . . . 0.0 109.779 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 99' ' ' ILE . 95.9 mt -108.34 94.37 5.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.152 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 47.4 mt-10 -41.0 -42.45 1.89 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.7 -0.625 . . . . 0.0 109.888 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.827 ' O ' HD13 ' A' ' 99' ' ' ILE . 31.4 ttpt -177.73 162.17 1.72 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.044 -1.035 . . . . 0.0 109.752 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.985 HD12 ' CD1' ' A' ' 122' ' ' TYR . 5.7 mm -129.6 118.05 44.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.505 -0.747 . . . . 0.0 109.154 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.458 ' HG ' ' HG ' ' A' ' 85' ' ' SER . 46.9 t -112.08 141.02 46.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.744 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 119' ' ' THR . 97.3 m-85 -120.33 143.6 48.29 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.054 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.9 mt-10 -121.12 143.69 48.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.203 -0.935 . . . . 0.0 109.74 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 82' ' ' TYR . 75.7 mt -122.86 130.82 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.881 . . . . 0.0 109.294 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -132.27 133.39 44.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.144 -0.972 . . . . 0.0 109.565 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.3 mtt -112.95 144.49 42.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.322 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.24 161.75 38.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -106.11 143.72 33.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 112' ' ' GLY . . . -128.85 152.54 79.17 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 109.471 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.11 -45.41 1.95 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.668 2.245 . . . . 0.0 111.676 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -150.25 159.18 44.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.354 -0.841 . . . . 0.0 109.321 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.74 35.28 36.38 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.648 ' O ' ' HB3' ' A' ' 108' ' ' ALA . . . 123.24 87.34 0.81 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.71 ' H ' HG12 ' A' ' 13' ' ' VAL . . . -46.04 -27.25 2.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.6 m -135.29 139.75 44.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.14 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.477 ' O ' HD23 ' A' ' 116' ' ' LEU . 63.9 mt -107.75 137.67 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.383 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 115' ' ' ILE . 33.0 mt -117.21 130.29 56.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 0.0 109.628 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -128.37 141.38 51.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.326 -0.859 . . . . 0.0 109.199 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.52 138.22 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 0.0 109.738 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 28.7 m -126.78 142.57 51.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 100' ' ' SER . 8.9 m -126.58 158.87 35.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.95 . . . . 0.0 109.831 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 86.2 mttt -144.14 118.19 9.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.33 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.985 ' CD1' HD12 ' A' ' 99' ' ' ILE . 2.9 m-85 -113.18 113.22 25.05 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.493 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.876 ' CE1' HG21 ' A' ' 3' ' ' VAL . 54.9 m-70 -85.94 116.51 24.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.785 HG21 ' HE2' ' A' ' 4' ' ' PHE . 1.4 p -107.33 146.14 31.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.006 -1.059 . . . . 0.0 109.98 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -80.82 140.69 35.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.439 -0.788 . . . . 0.0 109.46 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.54 67.9 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.453 ' OD1' ' HA2' ' A' ' 2' ' ' GLY . 30.1 t30 56.14 45.45 23.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 0.0 109.447 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.503 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -72.78 142.06 48.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.3 p -82.39 155.42 24.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 21.5 mt -111.57 131.01 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 109.547 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -65.83 141.56 58.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.274 -0.891 . . . . 0.0 109.48 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.45 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.6 mt-10 -67.65 -29.64 68.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.903 . . . . 0.0 109.444 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -65.01 -37.56 88.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.256 -0.902 . . . . 0.0 109.426 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.94 -44.91 83.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 132' ' ' GLU . 46.4 pt -80.76 -31.85 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.869 . . . . 0.0 109.383 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.444 ' N ' HG13 ' A' ' 135' ' ' ILE . 25.6 tttm -57.01 -39.87 75.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.87 73.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.913 . . . . 0.0 109.481 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -60.3 -38.09 94.08 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -59.81 -43.61 94.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.222 -1.164 . . . . 0.0 109.46 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.69 -38.9 92.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -63.05 -40.91 99.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.495 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.79 -38.63 86.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.56 -43.77 92.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.17 -42.88 97.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 149' ' ' VAL . 26.3 tp -66.05 -39.53 90.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -1.108 . . . . 0.0 109.334 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -64.38 -43.11 95.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.867 . . . . 0.0 109.354 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -66.21 -33.85 76.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.449 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 34' ' ' VAL . . . -72.74 -49.25 32.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.361 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.794 HG21 ' HD2' ' A' ' 23' ' ' PHE . 7.8 p -63.96 -41.51 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.402 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.515 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.0 tt0 -56.31 -44.39 79.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 109.397 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.58 -43.35 99.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.244 -0.91 . . . . 0.0 109.404 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.59 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 63.3 t80 -59.96 -49.61 76.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.956 . . . . 0.0 109.425 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.575 ' O ' ' CD2' ' A' ' 156' ' ' HIS . 39.1 tp -57.12 -35.49 69.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.337 -0.852 . . . . 0.0 109.421 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.522 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.7 tt -62.67 -46.79 86.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -60.55 -32.89 71.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.575 ' CD2' ' O ' ' A' ' 153' ' ' LEU . 3.5 m-70 50.78 61.2 13.72 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.59 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 51.3 Cg_endo -70.91 -9.7 26.22 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.7 2.266 . . . . 0.0 111.751 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.541 ' O ' ' CE2' ' A' ' 160' ' ' TYR . 53.5 p30 -106.94 9.74 30.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.508 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.93 146.03 55.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -0.897 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.541 ' CE2' ' O ' ' A' ' 158' ' ' ASP . 95.3 m-85 -122.17 138.19 54.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 109.448 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.443 179.966 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 ttm . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.73 -27.06 65.86 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.578 ' CG2' ' ND1' ' A' ' 123' ' ' HIS . 43.4 t -131.24 133.95 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -1.138 . . . . 0.0 109.453 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.729 ' HE1' HG21 ' A' ' 124' ' ' THR . 96.3 m-85 -103.15 137.06 41.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.309 -0.87 . . . . 0.0 109.493 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.7 m -113.33 119.8 38.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.704 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 31.1 m-85 -115.16 139.87 49.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.91 . . . . 0.0 109.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.4 mt-10 -115.33 147.17 40.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.169 -0.957 . . . . 0.0 109.81 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' OD2' ' HB ' ' A' ' 118' ' ' ILE . 42.1 m-20 -119.16 154.6 33.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.233 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 117' ' ' LYS . 95.2 mt-10 -124.12 140.91 52.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.36 120.73 6.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.37 -0.831 . . . . 0.0 109.114 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.407 HG23 HG12 ' A' ' 115' ' ' ILE . 55.0 m -114.51 129.03 56.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.179 -0.951 . . . . 0.0 109.933 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.419 ' O ' HG13 ' A' ' 14' ' ' ILE . 34.0 t -160.5 140.58 11.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.87 . . . . 0.0 109.078 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 13' ' ' VAL . 26.1 m -70.93 90.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 0.0 109.4 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.788 HG22 ' HD2' ' A' ' 15' ' ' PRO . 1.0 OUTLIER -139.17 145.56 45.37 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.788 ' HD2' HG22 ' A' ' 14' ' ' ILE . 46.2 Cg_endo -68.02 124.49 11.86 Favored 'Trans proline' 0 C--O 1.212 -0.79 0 C-N-CA 122.361 2.041 . . . . 0.0 111.243 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.52 -30.59 43.18 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.742 2.295 . . . . 0.0 112.429 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.97 -52.62 8.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.646 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -72.06 -41.62 67.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.748 HD22 ' HB ' ' A' ' 14' ' ' ILE . 22.7 tp -61.48 -48.98 78.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.193 -0.942 . . . . 0.0 109.828 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 61.9 t80 -56.22 -52.75 63.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.124 -0.985 . . . . 0.0 109.812 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 61.9 mttm -67.34 -49.57 63.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 110.017 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.891 ' O ' HD12 ' A' ' 30' ' ' LEU . 86.1 p -69.85 -21.17 63.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.016 . . . . 0.0 110.219 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.974 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 62.6 t80 -100.22 -49.21 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.963 -1.086 . . . . 0.0 110.194 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 53.2 t -84.56 -52.43 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.14 -0.975 . . . . 0.0 110.439 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.5 tp -68.7 -35.22 76.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.046 -1.034 . . . . 0.0 110.184 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.5 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 68.9 m-20 -103.47 19.54 19.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.016 -1.053 . . . . 0.0 109.868 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.974 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.54 -36.39 76.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.46 ' O ' ' HG3' ' A' ' 32' ' ' PRO . 87.6 m-20 -68.41 -26.98 65.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.935 . . . . 0.0 109.906 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 24.9 m120 -97.6 -51.69 4.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.83 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.891 HD12 ' O ' ' A' ' 22' ' ' SER . 36.4 mt -59.17 -39.36 82.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 110.025 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.546 ' HB ' ' HD3' ' A' ' 32' ' ' PRO . 21.1 mt -52.52 -60.25 6.85 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.082 -1.011 . . . . 0.0 109.591 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.546 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.0 Cg_endo -68.43 -32.31 25.74 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.547 2.165 . . . . 0.0 111.797 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 16.1 tttt -62.06 -31.84 72.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.84 . . . . 0.0 109.621 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 30' ' ' LEU . 61.1 t -59.6 -40.15 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.37 117.76 68.74 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.949 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.04 -20.92 32.9 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.693 2.262 . . . . 0.0 111.837 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' O ' ' CB ' ' A' ' 38' ' ' HIS . 93.8 mt-30 -115.0 154.73 28.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.547 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.465 ' CB ' ' O ' ' A' ' 37' ' ' GLN . 10.1 m80 73.04 104.46 0.07 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.868 . . . . 0.0 109.529 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.94 136.25 41.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.933 . . . . 0.0 109.363 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 63.1 m -119.14 143.14 47.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.484 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.7 m -131.01 148.35 52.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.488 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.682 ' HB2' HG12 ' A' ' 57' ' ' ILE . . . -141.26 150.06 42.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -0.894 . . . . 0.0 109.565 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -130.93 156.16 45.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -85.9 107.36 17.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.412 ' HG ' ' HG3' ' A' ' 46' ' ' GLU . 43.9 tp -62.78 -40.75 98.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.451 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.729 ' O ' HG23 ' A' ' 53' ' ' THR . 97.7 mt-10 -153.53 162.58 41.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.917 . . . . 0.0 109.493 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 87.1 159.49 33.87 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -87.87 9.48 21.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.211 -1.17 . . . . 0.0 109.561 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.723 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 101.25 13.65 32.77 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.904 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -110.33 -143.68 9.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 49.2 Cg_endo -69.77 123.64 10.3 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.651 2.234 . . . . 0.0 111.765 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 54' ' ' ILE . . . 94.44 -4.42 69.83 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 46' ' ' GLU . 94.5 m -74.1 138.17 43.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -1.15 . . . . 0.0 109.463 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.739 ' N ' HD12 ' A' ' 54' ' ' ILE . 1.7 mp -103.74 126.82 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.42 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' HIS . 25.0 mttm -110.94 145.18 38.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -124.72 127.02 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.886 . . . . 0.0 109.522 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.682 HG12 ' HB2' ' A' ' 42' ' ' ALA . 66.8 mt -114.2 137.6 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 109.411 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.625 HG21 ' CZ ' ' A' ' 65' ' ' PHE . 51.7 m -118.4 134.14 55.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.307 -0.87 . . . . 0.0 109.471 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -160.2 127.89 4.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 109.462 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 64' ' ' GLU . . . -152.83 158.41 42.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.489 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -62.14 -31.18 71.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.312 -0.867 . . . . 0.0 109.522 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.35 -54.28 0.79 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -60.32 -35.94 76.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -1.127 . . . . 0.0 109.44 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 95.1 mt-10 -122.55 150.67 42.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.28 -0.887 . . . . 0.0 109.465 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.625 ' CZ ' HG21 ' A' ' 58' ' ' THR . 51.8 t80 -108.38 131.78 54.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.521 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -112.15 153.12 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.449 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.415 ' CE2' ' CE2' ' A' ' 65' ' ' PHE . 98.2 m-85 -116.63 135.27 53.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 86.3 mtp -134.83 156.43 48.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.904 . . . . 0.0 109.36 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.672 ' O ' HG23 ' A' ' 86' ' ' ILE . 93.9 mttt -135.05 141.32 46.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.64 ' CE1' HD12 ' A' ' 57' ' ' ILE . 78.6 m80 -130.77 134.59 47.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -127.02 142.49 51.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.41 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.474 HG11 ' CG1' ' A' ' 75' ' ' ILE . 51.9 t -105.82 126.9 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -71.35 -48.65 48.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.525 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.499 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 83.4 tt0 -166.9 146.02 5.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 109.576 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.904 HD12 ' HA2' ' A' ' 50' ' ' GLY . 73.4 mt -122.72 129.14 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 0.0 109.382 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 86.2 m-20 -133.4 81.07 1.91 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.501 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.48 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 78.8 m80 -59.37 -38.57 80.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.866 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.26 82.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.433 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 76.9 m-20 -86.16 3.91 40.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.521 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 52.73 29.3 7.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.503 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -122.45 135.68 54.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.869 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.526 ' CE1' HG12 ' A' ' 75' ' ' ILE . 57.0 t80 -130.08 130.46 44.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.252 -0.905 . . . . 0.0 109.488 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 8.4 m -132.24 115.76 16.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.172 -0.955 . . . . 0.0 109.502 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.507 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.4 p90 -136.88 158.48 44.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.623 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.444 ' HB3' ' OG ' ' A' ' 100' ' ' SER . 84.5 p -139.19 169.51 17.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.362 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 69' ' ' LYS . 36.0 mt -117.84 129.43 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.52 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.5 mt -77.36 -32.92 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.933 . . . . 0.0 109.42 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -148.52 134.81 19.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 0.0 109.43 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -145.21 72.42 0.34 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.0 -107.49 0.15 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.9 Cg_endo -69.62 -35.1 13.69 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.732 2.288 . . . . 0.0 111.762 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.485 HD23 HG13 ' A' ' 99' ' ' ILE . 0.4 OUTLIER 63.82 -82.71 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.406 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -172.96 -167.44 32.89 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -107.9 118.0 35.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.143 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 124' ' ' THR . 0.2 OUTLIER 60.1 22.67 11.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.218 -0.926 . . . . 0.0 109.579 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.881 ' HB3' HD11 ' A' ' 99' ' ' ILE . 88.6 mt -104.43 96.55 6.69 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.096 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 123' ' ' HIS . 72.8 mm-40 -59.66 -33.39 71.48 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.766 -0.584 . . . . 0.0 111.034 -179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.654 ' O ' HD13 ' A' ' 99' ' ' ILE . 34.3 ttpt -142.44 142.74 32.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.474 -1.391 . . . . 0.0 110.793 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.881 HD11 ' HB3' ' A' ' 96' ' ' LEU . 27.2 mm -130.77 113.46 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.444 ' OG ' ' HB3' ' A' ' 85' ' ' SER . 38.4 t -121.31 152.05 39.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.017 -1.052 . . . . 0.0 110.09 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.486 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 81.1 m-85 -131.05 131.9 44.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.461 -0.774 . . . . 0.0 109.031 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 90.1 mt-10 -118.72 141.77 48.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.801 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.73 127.56 75.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.357 -0.839 . . . . 0.0 109.323 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -130.18 131.68 45.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.637 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.424 ' HG2' ' HG ' ' A' ' 116' ' ' LEU . 63.5 mtt -120.56 141.22 50.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.9 153.68 41.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.62 132.43 42.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.464 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -111.63 116.64 50.06 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.51 -25.66 29.52 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.743 2.295 . . . . 0.0 111.739 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -64.01 -41.4 97.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.349 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 162.75 174.24 32.42 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 114' ' ' SER . . . 82.76 17.95 66.81 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 47.3 -87.52 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 112' ' ' GLY . 34.3 m -131.25 146.83 52.47 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.413 -1.051 . . . . 0.0 109.378 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' C ' HD12 ' A' ' 116' ' ' LEU . 68.8 mt -116.56 135.91 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.231 -0.918 . . . . 0.0 109.495 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.818 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.5 mp -107.03 140.71 39.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.555 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.485 ' O ' HD13 ' A' ' 118' ' ' ILE . 26.7 mmtp -125.3 139.46 53.68 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 117' ' ' LYS . 10.5 mm -115.0 126.6 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.247 -0.908 . . . . 0.0 109.687 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 30.8 m -121.23 133.55 55.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 0.0 109.304 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.58 157.42 42.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.171 -0.955 . . . . 0.0 109.93 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 59.9 mttt -134.03 117.47 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.815 ' HB3' HD22 ' A' ' 96' ' ' LEU . 13.9 m-30 -109.81 118.81 37.48 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.9 . . . . 0.0 110.038 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.578 ' ND1' ' CG2' ' A' ' 3' ' ' VAL . 2.2 t60 -85.73 127.06 34.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.729 HG21 ' HE1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -109.43 146.82 33.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 109.8 -179.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -71.33 135.61 47.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 55.07 -145.2 30.63 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 128' ' ' ALA . 48.5 p-10 -87.45 17.16 4.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 127' ' ' ASN . . . -44.5 144.41 1.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.45 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -114.47 157.0 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.677 HD12 ' CD1' ' A' ' 4' ' ' PHE . 64.4 mt -110.12 140.18 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 133' ' ' GLU . 10.1 t-20 -79.4 133.43 36.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.875 . . . . 0.0 109.412 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.454 ' HA ' HG12 ' A' ' 135' ' ' ILE . 96.4 mt-10 -65.33 -34.99 79.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.446 ' HB3' ' OD1' ' A' ' 131' ' ' ASN . 79.0 tt0 -66.64 -35.31 79.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -0.882 . . . . 0.0 109.52 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.6 mt-10 -67.89 -38.13 82.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.881 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.704 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 38.4 pt -78.16 -39.5 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.535 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.517 ' N ' HG13 ' A' ' 135' ' ' ILE . 24.1 mttm -59.41 -37.94 79.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.9 73.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.276 -0.89 . . . . 0.0 109.381 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.11 -40.81 84.31 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -60.1 -43.48 95.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -1.171 . . . . 0.0 109.426 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.37 -44.8 76.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.433 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -59.14 -45.82 89.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.91 79.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.177 -0.952 . . . . 0.0 109.409 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.31 -46.86 88.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.44 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.96 -45.26 95.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.558 ' O ' HG12 ' A' ' 149' ' ' VAL . 57.7 mt -60.96 -38.97 87.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.338 -1.095 . . . . 0.0 109.375 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.478 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 67.1 t80 -57.22 -45.84 83.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.392 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -60.37 -40.53 91.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.08 -52.07 46.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 145' ' ' LEU . 7.5 p -64.69 -40.59 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.402 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.487 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.1 tt0 -56.45 -42.34 77.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.35 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.07 -41.3 99.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.932 . . . . 0.0 109.356 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.586 ' CZ ' ' HG3' ' A' ' 157' ' ' PRO . 73.4 t80 -59.64 -44.59 93.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 36.4 tp -60.82 -35.31 76.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.893 . . . . 0.0 109.385 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.1 tt -61.93 -45.64 92.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.923 . . . . 0.0 109.34 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.14 -32.17 72.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 48.54 61.39 14.03 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.219 -0.926 . . . . 0.0 109.433 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 152' ' ' TYR . 48.8 Cg_endo -69.98 -14.19 35.08 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.696 2.264 . . . . 0.0 111.744 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -66.18 -33.63 76.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.84 145.78 51.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -118.21 138.15 52.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.413 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.401 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.35 146.84 50.63 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.72 HG21 ' CE1' ' A' ' 123' ' ' HIS . 24.7 t -132.52 133.85 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.832 ' HE1' HG21 ' A' ' 124' ' ' THR . 96.7 m-85 -90.38 140.34 29.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.172 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 120' ' ' SER . 26.6 p -125.52 127.04 45.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.636 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 119' ' ' THR . 93.5 m-85 -123.78 143.89 50.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.262 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -123.41 147.97 46.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 109.76 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -132.46 134.0 44.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.204 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -107.76 134.52 50.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.14 -0.975 . . . . 0.0 109.756 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.74 123.22 19.62 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 109.118 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.453 HG23 HG12 ' A' ' 115' ' ' ILE . 28.8 m -109.73 133.22 53.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 109.937 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.9 m -160.42 139.94 10.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 0.0 109.003 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 13' ' ' VAL . 2.6 p -73.79 90.15 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.965 -1.084 . . . . 0.0 109.217 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.688 HG23 ' HD2' ' A' ' 15' ' ' PRO . 10.3 mt -139.48 144.29 39.13 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.431 -0.793 . . . . 0.0 109.136 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.688 ' HD2' HG23 ' A' ' 14' ' ' ILE . 43.7 Cg_endo -66.42 121.96 9.33 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.369 2.046 . . . . 0.0 111.165 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HG3' ' HB2' ' A' ' 107' ' ' ALA . 45.4 Cg_endo -66.79 -29.24 42.53 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.724 2.283 . . . . 0.0 112.241 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.24 -52.93 7.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.613 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.443 ' HG2' ' HB2' ' A' ' 161' ' ' CYS . 60.5 mtt85 -72.03 -39.35 69.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.706 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.753 ' C ' HD13 ' A' ' 19' ' ' LEU . 3.4 tm? -63.06 -51.88 64.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.716 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.0 t80 -56.85 -51.3 69.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.224 -0.923 . . . . 0.0 109.781 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 44.7 tttp -68.36 -50.22 54.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.83 ' O ' HD22 ' A' ' 30' ' ' LEU . 69.0 p -68.08 -21.26 64.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.037 -1.04 . . . . 0.0 110.189 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.907 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 12.5 t80 -100.06 -50.61 3.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.063 -1.023 . . . . 0.0 110.115 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 61.8 t -84.68 -52.66 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 110.26 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 21.4 tp -68.88 -44.83 72.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.006 . . . . 0.0 109.888 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 30' ' ' LEU . 20.7 m-20 -98.99 30.31 3.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.907 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.26 -47.27 65.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.322 -0.861 . . . . 0.0 109.774 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.68 ' HA ' HD12 ' A' ' 31' ' ' ILE . 50.6 m-20 -69.44 -25.82 64.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 109.992 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.71 -39.12 18.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.687 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.938 ' O ' HG13 ' A' ' 34' ' ' VAL . 7.0 mp -76.02 -29.03 57.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 1.041 ' O ' HG22 ' A' ' 34' ' ' VAL . 17.6 mt -52.88 -59.28 9.27 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.527 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 49.0 Cg_endo -68.46 -31.56 27.27 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.574 2.183 . . . . 0.0 111.958 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.579 ' HB3' ' CE2' ' A' ' 152' ' ' TYR . 73.8 mttt -63.1 -36.82 84.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.723 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.041 HG22 ' O ' ' A' ' 31' ' ' ILE . 4.5 m -62.06 -23.4 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.698 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.667 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -106.54 165.85 12.22 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.23 -0.919 . . . . 0.0 109.622 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.667 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 49.4 Cg_endo -69.67 -29.34 24.46 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.706 2.271 . . . . 0.0 111.81 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -136.6 150.19 48.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.852 . . . . 0.0 109.443 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.484 ' CG ' ' N ' ' A' ' 39' ' ' PHE . 46.4 p-80 -51.89 -41.31 61.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.484 ' N ' ' CG ' ' A' ' 38' ' ' HIS . 9.6 t80 71.13 -58.17 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.293 -0.88 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 58' ' ' THR . 10.9 p -127.09 160.9 29.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 0.0 109.513 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.7 t -130.31 140.97 50.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.434 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.34 138.52 49.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -127.74 143.09 51.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.326 -0.858 . . . . 0.0 109.413 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.432 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 81.0 m-20 -87.14 108.61 18.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.988 HD11 ' HB2' ' A' ' 56' ' ' LYS . 2.2 mp -68.85 -39.19 80.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.528 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 53' ' ' THR . 49.5 tp10 -150.05 153.23 36.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 0.0 109.53 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 90.79 157.74 33.95 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -93.47 10.26 33.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -1.116 . . . . 0.0 109.489 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.584 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 103.1 27.99 6.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.895 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -122.16 -145.63 7.09 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HB3' ' HG3' ' A' ' 74' ' ' GLU . 51.2 Cg_endo -70.23 123.34 9.86 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.744 2.296 . . . . 0.0 111.884 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.21 -0.01 83.26 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.584 HG21 ' HA2' ' A' ' 49' ' ' GLY . 56.9 m -72.75 137.6 45.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -1.223 . . . . 0.0 109.44 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.681 HG22 HD13 ' A' ' 45' ' ' LEU . 25.2 mm -101.03 129.75 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' O ' ' HB3' ' A' ' 70' ' ' HIS . 17.6 mttt -126.55 145.95 50.33 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.29 -0.882 . . . . 0.0 109.489 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.988 ' HB2' HD11 ' A' ' 45' ' ' LEU . 28.2 ttpt -130.82 138.84 50.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.366 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.659 HG23 ' CE2' ' A' ' 59' ' ' PHE . 9.7 tt -117.48 137.31 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.536 HG21 ' CE1' ' A' ' 65' ' ' PHE . 8.7 p -98.28 151.72 20.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 0.0 109.356 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.659 ' CE2' HG23 ' A' ' 57' ' ' ILE . 92.8 m-85 -127.44 165.81 19.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.549 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.81 -11.8 49.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.896 . . . . 0.0 109.464 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 67' ' ' TYR . 76.2 mm-40 -50.58 154.15 1.43 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.894 . . . . 0.0 109.508 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -47.86 -37.7 15.52 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -84.21 125.45 32.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -1.147 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.553 ' HG2' ' CD2' ' A' ' 65' ' ' PHE . 71.1 tt0 -121.71 150.0 42.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 0.0 109.384 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.553 ' CD2' ' HG2' ' A' ' 64' ' ' GLU . 95.3 m-85 59.41 18.83 7.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.253 -0.904 . . . . 0.0 109.444 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 tttm -167.2 28.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.308 -0.87 . . . . 0.0 109.351 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.517 ' CZ ' ' HG3' ' A' ' 61' ' ' GLU . 70.4 t80 -99.4 -24.44 14.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 109.495 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.486 ' HG3' ' CD2' ' A' ' 67' ' ' TYR . 38.9 mtt -159.75 139.38 11.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.19 -0.943 . . . . 0.0 109.381 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 87' ' ' ILE . 94.2 mttt -107.8 148.54 29.37 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.513 ' CE1' ' CD1' ' A' ' 84' ' ' TYR . 47.5 t60 -129.79 131.26 46.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.423 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.48 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 26.6 tttp -131.88 136.17 47.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.502 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.497 HG11 ' CG1' ' A' ' 75' ' ' ILE . 39.6 t -99.36 129.17 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.406 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -76.39 -42.29 44.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.396 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 51' ' ' PRO . 85.4 tt0 -175.27 141.21 0.54 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.895 HD12 ' HA2' ' A' ' 50' ' ' GLY . 66.7 mt -119.85 131.24 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.453 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' ASN . 90.7 m-20 -129.95 85.69 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.452 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.567 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 87.8 m-70 -62.34 -37.24 84.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.11 -31.92 70.96 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.267 -0.896 . . . . 0.0 109.566 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 76' ' ' ASP . 24.0 m120 -88.99 -3.07 58.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 57.9 34.55 24.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 0.0 109.346 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.495 ' HE2' ' CE ' ' A' ' 104' ' ' LYS . 25.5 mttt -128.95 129.56 45.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.437 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.524 ' CE2' HG12 ' A' ' 75' ' ' ILE . 62.1 t80 -120.16 124.13 45.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.898 . . . . 0.0 109.531 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 84.3 m -125.05 115.03 19.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.513 ' CD1' ' CE1' ' A' ' 70' ' ' HIS . 38.3 p90 -128.97 152.41 48.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.51 ' HB3' ' HE2' ' A' ' 98' ' ' LYS . 9.7 m -132.02 146.72 52.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.526 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.16 150.2 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -0.905 . . . . 0.0 109.332 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.594 HG22 ' HG3' ' A' ' 88' ' ' GLU . 88.6 mt -104.02 -34.65 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.232 -0.917 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.594 ' HG3' HG22 ' A' ' 87' ' ' ILE . 94.8 mt-10 -151.75 143.44 23.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.309 -0.869 . . . . 0.0 109.438 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -158.52 136.52 4.78 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . -30.96 -66.52 0.15 Allowed Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 93' ' ' GLY . 54.7 Cg_endo -74.37 -33.83 5.18 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.517 2.145 . . . . 0.0 111.488 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' PRO . 5.4 tp 36.87 -92.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.812 -0.555 . . . . 0.0 110.261 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.9 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . 171.99 156.21 11.94 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -81.26 125.5 30.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 109.644 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.773 HG22 ' H ' ' A' ' 125' ' ' LYS . 16.0 m 51.87 19.78 1.04 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.751 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.9 HD12 ' HA3' ' A' ' 93' ' ' GLY . 51.7 mt -91.09 87.87 6.74 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 0.0 109.043 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.535 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.5 mt-10 -39.93 -35.47 0.36 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.761 -0.587 . . . . 0.0 110.401 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HE2' ' HB3' ' A' ' 85' ' ' SER . 31.7 tttt -169.08 160.91 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.766 -1.209 . . . . 0.0 110.371 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.783 HG23 ' CE1' ' A' ' 122' ' ' TYR . 27.2 mt -137.14 117.62 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 48.4 t -118.35 152.66 35.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.138 -0.977 . . . . 0.0 109.906 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.533 ' OH ' HG21 ' A' ' 99' ' ' ILE . 84.1 m-85 -130.76 136.07 48.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.813 . . . . 0.0 109.175 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 86.8 mt-10 -114.62 143.21 45.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.14 -0.975 . . . . 0.0 109.711 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 79.0 mt -118.51 130.79 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.258 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.495 ' CE ' ' HE2' ' A' ' 81' ' ' LYS . 19.8 tttt -127.97 131.51 49.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.608 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.496 ' SD ' HD12 ' A' ' 19' ' ' LEU . 63.3 mtt -122.29 146.25 47.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.255 -0.903 . . . . 0.0 109.386 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -141.27 151.32 43.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.487 ' HB2' ' HG3' ' A' ' 16' ' ' PRO . . . -104.56 139.27 39.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.415 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -130.85 103.7 15.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.9 142.88 48.5 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.733 2.289 . . . . 0.0 111.706 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 61.53 34.31 17.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.25 -169.94 13.34 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -51.29 -39.07 42.35 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 148.56 -109.98 0.47 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 96.1 p -117.93 151.71 36.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -1.2 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.453 HG12 HG23 ' A' ' 11' ' ' THR . 69.3 mt -119.34 131.6 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.799 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.2 mp -108.32 136.85 47.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.882 . . . . 0.0 109.584 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 90.9 mttt -119.01 144.04 46.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.26 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 77.6 mt -124.1 131.09 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.945 . . . . 0.0 109.571 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 23.5 m -119.48 142.49 48.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . 64.8 m -123.18 146.33 47.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.737 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 51.6 mtmt -135.67 127.39 29.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.811 ' HB3' HD22 ' A' ' 96' ' ' LEU . 25.7 m-85 -125.89 122.2 35.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.303 -0.873 . . . . 0.0 109.853 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.72 ' CE1' HG21 ' A' ' 3' ' ' VAL . 90.1 m-70 -89.72 116.97 28.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 108.673 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.832 HG21 ' HE1' ' A' ' 4' ' ' PHE . 0.7 OUTLIER -104.98 142.29 35.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.618 -179.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.773 ' H ' HG22 ' A' ' 95' ' ' THR . 31.0 ttpt -84.85 128.16 34.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.59 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.54 26.6 67.28 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.6 m120 58.95 40.28 22.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 109.53 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.473 ' N ' ' OG1' ' A' ' 124' ' ' THR . . . -69.82 140.59 53.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.293 -0.88 . . . . 0.0 109.54 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 55.3 p -80.16 156.6 26.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.719 HG12 HD21 ' A' ' 96' ' ' LEU . 40.4 mt -113.82 130.89 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.184 -0.947 . . . . 0.0 109.686 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.479 ' HB3' ' HG2' ' A' ' 134' ' ' GLU . 46.5 t-20 -60.04 131.81 52.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.486 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.401 ' HA ' HG12 ' A' ' 135' ' ' ILE . 97.6 mt-10 -65.87 -33.66 76.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.338 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.26 -36.44 82.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.293 -0.879 . . . . 0.0 109.497 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.479 ' HG2' ' HB3' ' A' ' 131' ' ' ASN . 75.5 mm-40 -64.62 -43.81 92.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.436 HG13 ' N ' ' A' ' 136' ' ' LYS . 34.8 pt -75.49 -32.85 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.18 -0.95 . . . . 0.0 109.39 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.436 ' N ' HG13 ' A' ' 135' ' ' ILE . 16.7 tttp -55.7 -45.33 77.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.411 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.25 -40.73 71.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.258 -0.902 . . . . 0.0 109.339 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -59.44 -40.16 95.78 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -60.3 -40.5 90.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -1.18 . . . . 0.0 109.279 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -62.74 -40.43 97.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.313 -0.867 . . . . 0.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.407 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 67.5 tttt -59.13 -44.76 92.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 109.275 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.88 93.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.317 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.89 -43.25 93.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.301 -0.874 . . . . 0.0 109.332 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.65 -43.2 96.39 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.668 ' O ' HG13 ' A' ' 149' ' ' VAL . 40.3 mt -65.63 -40.45 92.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -1.161 . . . . 0.0 109.272 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -66.05 -40.54 91.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 45.1 tttt -68.0 -35.93 79.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.903 . . . . 0.0 109.296 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.21 -51.55 52.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.448 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' ' 145' ' ' LEU . 3.6 m -64.87 -46.6 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.364 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.583 ' N ' HG23 ' A' ' 149' ' ' VAL . 83.7 tt0 -56.19 -35.49 67.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.51 -36.03 81.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.272 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 33' ' ' LYS . 63.6 t80 -62.3 -43.19 99.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.406 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.53 -42.9 97.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.324 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.449 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 31.0 mt -73.25 -27.33 61.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.314 -0.866 . . . . 0.0 109.538 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.8 -21.98 59.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.338 -0.851 . . . . 0.0 109.505 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.69 61.31 3.43 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 50.0 Cg_endo -70.3 -16.3 35.24 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.619 2.212 . . . . 0.0 111.914 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.477 ' O ' ' CE2' ' A' ' 160' ' ' TYR . 88.5 m-20 -61.12 -36.48 79.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.0 109.514 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.34 139.88 14.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.936 . . . . 0.0 109.525 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 158' ' ' ASP . 93.0 m-85 -117.09 144.84 44.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.38 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.443 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.454 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.297 0.57 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.62 15.96 76.71 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' A' ' 123' ' ' HIS . 29.3 t -128.68 128.56 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -1.116 . . . . 0.0 109.344 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.803 ' HE1' HG21 ' A' ' 124' ' ' THR . 97.1 m-85 -85.61 136.46 33.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 120' ' ' SER . 36.0 t -122.55 129.17 51.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.163 -0.96 . . . . 0.0 109.705 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.51 ' CD1' HG21 ' A' ' 135' ' ' ILE . 77.6 m-85 -129.39 147.16 51.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.147 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -119.3 139.74 51.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.712 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' A' ' 118' ' ' ILE . 91.2 m-20 -110.36 150.63 28.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.823 . . . . 0.0 109.379 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -115.89 137.68 51.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.32 -0.863 . . . . 0.0 109.865 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -155.0 122.66 5.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.437 -0.79 . . . . 0.0 109.018 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.2 t -127.51 137.41 52.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 0.0 109.975 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 t -160.49 150.08 17.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 108.992 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 13' ' ' VAL . 6.3 p -74.59 91.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.036 -1.04 . . . . 0.0 109.446 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.924 HG21 HD13 ' A' ' 19' ' ' LEU . 1.8 mt -138.85 143.5 37.69 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.216 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.635 ' HD2' HG22 ' A' ' 14' ' ' ILE . 45.9 Cg_endo -67.62 124.62 12.19 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.399 2.066 . . . . 0.0 111.44 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.76 -35.74 26.79 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.861 2.374 . . . . 0.0 112.253 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.78 -49.56 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.5 mtp85 -72.43 -46.03 56.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.91 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.924 HD13 HG21 ' A' ' 14' ' ' ILE . 19.7 tp -60.33 -42.97 96.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.995 . . . . 0.0 109.719 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.686 ' CZ ' HG11 ' A' ' 24' ' ' VAL . 68.9 t80 -62.39 -47.78 82.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.759 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.725 ' HG3' HD12 ' A' ' 25' ' ' LEU . 70.6 tttt -68.35 -41.34 80.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 109.676 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 86.3 p -77.7 -24.62 49.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.96 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 13.7 t80 -100.48 -50.74 3.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.113 -0.992 . . . . 0.0 110.404 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.686 HG11 ' CZ ' ' A' ' 20' ' ' PHE . 54.1 t -84.8 -52.63 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.078 -1.014 . . . . 0.0 110.527 -179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.725 HD12 ' HG3' ' A' ' 21' ' ' LYS . 59.3 mt -71.63 -32.62 68.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.079 -1.013 . . . . 0.0 110.045 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 92.0 m-20 -106.58 23.05 14.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.96 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.66 -41.81 75.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.598 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 31' ' ' ILE . 26.1 p-10 -71.03 -34.03 70.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.85 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.3 m-20 -88.69 -31.71 18.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.801 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 26' ' ' ASP . 16.0 tp -73.74 -21.74 60.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.162 -0.961 . . . . 0.0 109.543 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 27' ' ' ALA . 15.5 mt -65.81 -57.24 14.43 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.1 Cg_endo -68.6 -27.71 32.32 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.472 2.114 . . . . 0.0 111.744 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -67.37 -45.66 75.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.317 -0.864 . . . . 0.0 109.459 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.565 HG21 ' HB1' ' A' ' 148' ' ' ALA . 7.1 p -69.29 -34.7 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 109.549 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.67 135.48 90.34 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.324 -0.86 . . . . 0.0 109.407 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.73 -22.94 31.51 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.721 2.281 . . . . 0.0 111.811 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -110.56 135.67 50.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -107.42 10.21 29.55 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.261 -0.899 . . . . 0.0 109.575 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -61.43 -30.91 70.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.394 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 58' ' ' THR . 58.3 m -107.49 137.15 46.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.5 p -147.28 163.59 35.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.552 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.59 139.23 47.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.495 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -138.0 156.37 47.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.399 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 36.2 p-10 -90.19 108.22 19.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.303 -0.873 . . . . 0.0 109.424 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 45' ' ' LEU . 23.0 tp -64.35 -37.72 88.51 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -0.885 . . . . 0.0 109.426 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' A' ' 47' ' ' GLY . 49.2 tp10 -141.54 155.44 45.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' A' ' 46' ' ' GLU . . . 91.31 161.34 37.14 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -90.7 9.17 30.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.229 -1.159 . . . . 0.0 109.486 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.871 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 99.53 19.19 21.22 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.861 ' O ' HG11 ' A' ' 72' ' ' VAL . . . -114.92 -141.37 7.5 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.49 123.1 9.86 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.708 2.272 . . . . 0.0 111.781 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.678 ' H ' HG13 ' A' ' 72' ' ' VAL . . . 91.84 0.83 71.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.871 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.6 m -77.0 136.19 38.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -1.17 . . . . 0.0 109.507 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 70' ' ' HIS . 7.8 mt -105.36 139.44 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 44' ' ' ASN . 62.1 mttm -116.09 145.76 42.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 109.596 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -129.45 142.59 50.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.411 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -100.66 137.49 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.287 -0.883 . . . . 0.0 109.424 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 40' ' ' THR . 91.6 m -86.06 141.51 29.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.267 -0.895 . . . . 0.0 109.453 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.567 ' O ' ' CD2' ' A' ' 59' ' ' PHE . 64.3 t80 45.54 56.83 5.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.432 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.03 149.57 23.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.458 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 62' ' ' GLY . 96.7 mt-10 -54.44 142.54 26.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.5 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 61' ' ' GLU . . . -44.05 118.86 2.49 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 8.8 p30 -145.15 -172.54 3.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -1.132 . . . . 0.0 109.407 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.474 ' HB3' ' HA2' ' A' ' 90' ' ' GLY . 84.5 tt0 -56.45 -41.27 76.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.225 -0.922 . . . . 0.0 109.407 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' CE2' ' OE1' ' A' ' 88' ' ' GLU . 97.2 m-85 -106.15 144.08 33.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -64.85 -36.17 83.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 109.362 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -125.52 148.0 49.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 109.397 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.415 ' HE2' ' CG ' ' A' ' 63' ' ' ASN . 64.8 mtt -110.29 151.16 27.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.957 . . . . 0.0 109.554 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.9 mttt -116.85 140.01 49.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.244 -0.91 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.651 ' O ' HG23 ' A' ' 54' ' ' ILE . 77.7 m80 -127.88 138.63 52.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.381 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.565 ' HD2' HD11 ' A' ' 87' ' ' ILE . 51.5 tttm -133.56 151.24 51.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.543 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.861 HG11 ' O ' ' A' ' 50' ' ' GLY . 11.3 p -110.81 132.3 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.484 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -72.98 -44.12 61.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.926 . . . . 0.0 109.463 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -176.07 140.1 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.894 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.841 HD12 ' HA2' ' A' ' 50' ' ' GLY . 66.1 mt -118.09 127.02 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.424 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 79' ' ' ASN . 89.3 m-20 -122.27 85.09 2.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.487 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.546 ' HA ' ' CZ ' ' A' ' 20' ' ' PHE . 85.5 m-70 -60.26 -38.8 84.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.76 -30.54 65.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.275 -0.891 . . . . 0.0 109.488 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 76' ' ' ASP . 58.2 t30 -90.56 7.23 40.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 46.03 36.99 3.36 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.917 . . . . 0.0 109.419 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -128.17 128.42 44.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.847 . . . . 0.0 109.319 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' A' ' 84' ' ' TYR . 63.1 t80 -120.11 125.58 48.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -0.948 . . . . 0.0 109.574 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 58.4 m -127.45 114.05 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.53 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.8 p90 -129.48 163.03 26.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' A' ' 100' ' ' SER . 43.5 t -150.54 162.75 40.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.8 mt -108.37 141.1 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 0.0 109.328 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 71' ' ' LYS . 80.6 mt -92.35 -35.42 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.9 . . . . 0.0 109.307 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.547 ' OE1' ' CE2' ' A' ' 65' ' ' PHE . 29.8 tt0 -154.08 124.79 7.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.543 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.514 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -136.78 143.96 15.45 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . -32.74 -67.23 0.19 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 93' ' ' GLY . 54.4 Cg_endo -74.27 -31.22 7.73 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.382 2.055 . . . . 0.0 111.28 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 91' ' ' PRO . 6.6 tp 36.5 -91.4 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.153 0.501 . . . . 0.0 110.264 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . 176.2 167.84 35.55 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.455 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 56.5 m170 -90.36 129.88 36.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -1.159 . . . . 0.0 109.45 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 128' ' ' ALA . 1.1 m 46.23 24.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.382 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.12 HD21 HD11 ' A' ' 130' ' ' ILE . 27.0 mt -101.6 92.98 5.12 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.084 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' HIS . 92.6 mt-10 -45.63 -36.13 4.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.548 -0.72 . . . . 0.0 110.728 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 1.072 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.2 tttp -163.38 157.94 20.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.656 -1.277 . . . . 0.0 110.503 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.072 HD13 ' O ' ' A' ' 98' ' ' LYS . 5.3 mm -133.0 119.34 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.502 -0.748 . . . . 0.0 109.006 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.505 ' CB ' ' HB2' ' A' ' 85' ' ' SER . 38.4 m -120.14 144.44 47.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.158 -0.964 . . . . 0.0 109.74 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -125.76 128.62 48.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 0.0 109.342 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 89.5 mt-10 -105.06 143.71 32.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.459 HD11 ' HE1' ' A' ' 84' ' ' TYR . 77.8 mt -128.8 118.67 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.382 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -127.41 134.67 49.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.424 ' HG2' ' HG ' ' A' ' 116' ' ' LEU . 63.4 mtm -118.97 145.79 45.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 0.0 109.464 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.72 157.5 43.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.936 . . . . 0.0 109.598 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -88.02 139.84 30.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.892 . . . . 0.0 109.314 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB2' HG13 ' A' ' 115' ' ' ILE . . . -104.87 125.2 34.4 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 109.661 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.91 -49.58 0.53 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.694 2.263 . . . . 0.0 111.704 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -76.83 -48.26 18.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 109.375 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -57.69 -29.11 60.92 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 72.66 27.42 69.3 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -151.93 -133.13 1.93 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -139.93 145.15 37.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -1.129 . . . . 0.0 109.524 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.477 HG13 ' HB2' ' A' ' 108' ' ' ALA . 62.8 mt -111.31 130.62 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.393 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.828 ' N ' HD12 ' A' ' 116' ' ' LEU . 4.1 mp -105.41 134.13 49.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.266 -0.896 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -126.37 139.18 53.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.336 -0.852 . . . . 0.0 109.075 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 72.7 mt -124.81 140.97 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.828 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 26.9 m -123.56 142.5 50.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.313 -0.867 . . . . 0.0 109.315 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 1.5 m -121.41 153.3 38.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.776 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 64.3 mttm -142.25 124.97 15.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.185 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.984 ' CD1' HG23 ' A' ' 99' ' ' ILE . 9.6 m-85 -123.85 113.97 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 0.0 110.037 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.707 ' CE1' HG21 ' A' ' 3' ' ' VAL . 41.3 m-70 -80.49 114.19 19.21 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.234 -0.916 . . . . 0.0 108.86 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.803 HG21 ' HE1' ' A' ' 4' ' ' PHE . 1.1 p -102.83 142.37 34.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 0.0 109.593 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.515 ' HD2' HG23 ' A' ' 95' ' ' THR . 39.1 mttt -44.66 -43.03 8.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 109.541 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 153.8 -68.14 0.31 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -64.24 -30.33 71.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -1.167 . . . . 0.0 109.482 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 109.537 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 39.0 m -127.95 154.3 45.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.391 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 1.12 HD11 HD21 ' A' ' 96' ' ' LEU . 29.4 mm -105.38 120.19 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.894 . . . . 0.0 109.494 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.417 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 24.8 t-20 -75.79 142.31 42.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.491 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.479 ' O ' HG12 ' A' ' 135' ' ' ILE . 97.1 mt-10 -57.76 -28.08 63.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.375 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -66.87 -35.68 80.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.134 -0.978 . . . . 0.0 108.864 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.417 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 97.1 mt-10 -61.82 -25.0 67.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.366 -0.834 . . . . 0.0 109.172 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.817 ' N ' HD13 ' A' ' 135' ' ' ILE . 0.4 OUTLIER -80.8 -39.8 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.942 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.8 mtpm? -56.18 -40.36 73.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.383 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.04 -48.65 73.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.294 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.02 -37.41 71.03 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -58.62 -43.68 89.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -1.139 . . . . 0.0 109.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -57.19 -48.39 78.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.072 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -59.35 -45.89 90.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.217 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.38 89.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.349 -0.845 . . . . 0.0 109.208 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.27 -44.32 88.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.236 -0.915 . . . . 0.0 109.131 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.77 -47.39 86.06 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 66.8 mt -57.57 -38.07 74.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -1.117 . . . . 0.0 109.284 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.463 ' HA ' ' CG1' ' A' ' 149' ' ' VAL . 69.5 t80 -62.39 -43.66 98.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.294 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -60.23 -39.78 87.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.299 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.565 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -65.0 -50.01 67.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.374 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 150' ' ' GLU . 5.8 p -63.72 -42.8 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.498 ' N ' HG13 ' A' ' 149' ' ' VAL . 86.2 tt0 -61.21 -42.4 98.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.96 -37.09 78.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.229 -0.919 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 30' ' ' LEU . 51.5 t80 -60.96 -52.2 66.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.33 -0.856 . . . . 0.0 109.368 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 34.7 mt -53.21 -42.74 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.199 -0.938 . . . . 0.0 109.4 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 150' ' ' GLU . 29.9 mt -59.95 -45.67 91.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB3' ' HD3' ' A' ' 157' ' ' PRO . . . -59.14 -25.46 63.9 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.277 -0.889 . . . . 0.0 109.391 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.452 ' N ' ' CD ' ' A' ' 157' ' ' PRO . 1.3 t-80 43.84 53.59 10.41 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 152' ' ' TYR . 50.0 Cg_endo -70.09 -19.06 35.06 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.688 2.259 . . . . 0.0 111.848 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -61.26 -36.21 79.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -0.92 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.1 145.33 28.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.23 141.8 47.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.476 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.453 179.949 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 124' ' ' THR . . . 91.57 4.84 67.48 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.793 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.1 p -122.3 143.53 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -1.207 . . . . 0.0 109.516 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.687 ' HE2' HG21 ' A' ' 124' ' ' THR . 90.4 m-85 -105.76 143.2 34.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.451 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 120' ' ' SER . 4.2 m -128.8 124.54 35.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.583 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.564 ' CE2' ' CD1' ' A' ' 135' ' ' ILE . 81.1 m-85 -119.59 152.07 37.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.394 -0.816 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 95.7 mt-10 -126.37 154.98 42.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 0.0 109.627 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.47 ' OD2' ' HE2' ' A' ' 139' ' ' LYS . 54.5 t0 -126.77 151.42 48.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 93.2 mt-10 -122.38 135.5 54.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.46 124.21 15.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 0.0 109.489 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.412 HG23 HG12 ' A' ' 115' ' ' ILE . 33.4 m -116.48 126.69 53.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.915 . . . . 0.0 109.682 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 57.7 p -160.29 146.64 15.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.877 . . . . 0.0 109.25 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 13' ' ' VAL . 18.9 m -78.54 91.38 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.183 -0.948 . . . . 0.0 109.472 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.967 HG21 HD13 ' A' ' 19' ' ' LEU . 8.8 mt -138.79 144.69 42.75 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.473 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.734 ' HD2' HG23 ' A' ' 14' ' ' ILE . 47.8 Cg_endo -68.7 123.35 10.35 Favored 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 122.536 2.158 . . . . 0.0 111.259 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.9 -27.76 43.1 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.745 2.296 . . . . 0.0 112.453 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.95 -54.62 6.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 109.527 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.7 mtt85 -72.62 -31.37 65.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.86 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.967 HD13 HG21 ' A' ' 14' ' ' ILE . 25.9 tp -71.96 -45.41 61.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.186 -0.946 . . . . 0.0 109.825 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 58.1 t80 -64.72 -33.19 75.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.105 -0.997 . . . . 0.0 109.641 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.521 ' HA ' HD13 ' A' ' 25' ' ' LEU . 33.7 tttp -83.09 -30.32 28.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 109.894 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 81.3 p -97.58 -14.68 20.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.17 -0.956 . . . . 0.0 109.818 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 1.067 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 76.7 t80 -100.89 -50.03 3.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.932 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 47.2 t -84.83 -49.81 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.356 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.623 ' N ' HD12 ' A' ' 25' ' ' LEU . 8.7 mp -76.34 -39.74 53.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.58 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 30' ' ' LEU . 41.2 m-20 -92.78 10.53 30.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.077 -1.014 . . . . 0.0 110.311 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.067 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.74 -34.31 73.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.888 -1.132 . . . . 0.0 109.414 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -61.26 -30.43 70.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.974 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 92.6 m-20 -114.81 -45.49 2.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.037 . . . . 0.0 109.973 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 30' ' ' LEU . 7.8 tt -57.41 -38.32 74.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.156 -0.965 . . . . 0.0 109.728 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.752 ' O ' HG12 ' A' ' 34' ' ' VAL . 12.0 mm -50.38 -61.37 3.85 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.096 -1.003 . . . . 0.0 109.453 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.544 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.3 Cg_endo -68.53 -30.01 29.65 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.378 2.052 . . . . 0.0 111.632 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -54.94 -51.61 65.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.52 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 31' ' ' ILE . 5.7 p -58.75 -23.97 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.902 . . . . 0.0 109.333 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 32' ' ' PRO . . . -74.81 122.18 86.9 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.899 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.9 -23.0 30.64 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.63 2.22 . . . . 0.0 111.784 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 38' ' ' HIS . 96.1 mt-30 -132.98 163.09 29.98 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.429 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' GLN . 47.5 m-70 70.15 92.13 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.464 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -101.74 131.85 47.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.511 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.511 HG22 ' CD2' ' A' ' 59' ' ' PHE . 7.7 p -126.93 165.11 20.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.9 . . . . 0.0 109.442 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.2 t -129.94 144.94 51.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.418 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.9 143.76 42.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -145.4 147.66 32.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.334 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -93.62 109.0 20.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.97 -38.55 88.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 53' ' ' THR . 85.4 tt0 -144.84 159.11 43.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.391 -0.818 . . . . 0.0 109.306 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.528 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 84.98 158.52 29.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -88.6 9.2 24.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.255 -1.144 . . . . 0.0 109.543 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.812 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 102.47 23.94 8.61 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.766 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -120.81 -140.62 6.02 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 49.8 Cg_endo -70.31 121.92 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.684 2.256 . . . . 0.0 111.793 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.32 -2.87 75.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.812 HG21 ' HA2' ' A' ' 49' ' ' GLY . 99.8 m -72.69 136.95 45.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.131 -1.217 . . . . 0.0 109.536 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.468 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 22.5 mm -94.09 135.17 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -108.65 133.2 53.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -122.13 132.77 54.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.224 -0.923 . . . . 0.0 109.427 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.486 HD12 ' CE1' ' A' ' 70' ' ' HIS . 65.7 mt -111.49 134.87 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.193 -0.942 . . . . 0.0 109.575 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.9 p -128.72 151.18 49.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.405 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.56 ' CD1' ' OE2' ' A' ' 64' ' ' GLU . 87.3 m-85 -114.79 140.9 48.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.16 -0.962 . . . . 0.0 109.555 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.48 90.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.487 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.93 142.45 58.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.73 14.98 57.44 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -86.39 4.58 38.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -1.13 . . . . 0.0 109.586 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.56 ' OE2' ' CD1' ' A' ' 59' ' ' PHE . 86.6 tt0 -105.32 142.11 35.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 0.0 109.53 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 66' ' ' LYS . 96.2 m-85 -124.96 154.81 40.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.167 -0.958 . . . . 0.0 109.437 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 65' ' ' PHE . 5.4 ttpm? 64.1 74.95 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.422 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -60.22 170.16 1.38 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.603 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 88' ' ' GLU . 62.4 mmm -123.19 144.46 49.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.846 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 mttp -116.07 150.27 37.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.917 . . . . 0.0 109.488 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.486 ' CE1' HD12 ' A' ' 57' ' ' ILE . 60.0 m170 -122.76 153.02 40.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.933 . . . . 0.0 109.428 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HG3' ' CD1' ' A' ' 54' ' ' ILE . 21.3 tttt -131.9 147.22 52.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.511 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 53' ' ' THR . 9.8 p -111.54 136.84 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.515 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.498 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 81.2 tt0 -80.03 -51.17 9.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 95.0 mt-10 -158.97 148.18 18.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.887 . . . . 0.0 109.415 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.766 HD12 ' HA2' ' A' ' 50' ' ' GLY . 72.0 mt -125.08 126.58 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.452 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -127.03 94.1 3.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -0.911 . . . . 0.0 109.591 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.463 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 77.2 t60 -70.26 -39.76 74.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.55 76.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -88.9 8.86 27.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.521 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 45.25 35.93 1.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HG3' ' HG2' ' A' ' 104' ' ' LYS . 37.5 tttm -124.14 137.96 54.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -0.892 . . . . 0.0 109.379 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.552 ' CE2' HG12 ' A' ' 75' ' ' ILE . 78.1 t80 -136.97 123.59 21.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.692 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 74' ' ' GLU . 4.2 p -125.4 120.31 30.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.253 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.614 ' HE2' HD11 ' A' ' 86' ' ' ILE . 40.3 p90 -132.75 156.02 47.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.174 -0.954 . . . . 0.0 109.64 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.712 ' O ' HD13 ' A' ' 86' ' ' ILE . 23.0 t -119.05 172.0 7.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.343 -0.848 . . . . 0.0 109.507 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 85' ' ' SER . 33.3 mm -125.45 125.03 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.795 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.687 ' C ' HD12 ' A' ' 92' ' ' LEU . 17.7 pt -107.01 -3.96 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.775 ' N ' HD12 ' A' ' 92' ' ' LEU . 21.5 mt-10 41.04 -93.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.952 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -178.41 117.82 0.59 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.63 -119.28 6.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 93' ' ' GLY . 52.4 Cg_endo -72.63 -12.86 27.08 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.524 2.149 . . . . 0.0 111.828 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.859 HD23 ' N ' ' A' ' 93' ' ' GLY . 1.3 tt 53.83 -86.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.859 ' N ' HD23 ' A' ' 92' ' ' LEU . . . -103.51 176.9 24.5 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.459 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 92.8 m-70 -96.22 134.53 39.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -1.199 . . . . 0.0 109.632 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.6 22.76 0.54 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.912 ' HB3' HD11 ' A' ' 99' ' ' ILE . 33.0 mt -116.13 98.85 6.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.357 -0.839 . . . . 0.0 109.369 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 89.6 mt-10 -48.52 -48.41 38.31 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.587 -0.695 . . . . 0.0 110.155 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.904 ' O ' HD13 ' A' ' 99' ' ' ILE . 47.2 mtmt -155.22 158.57 39.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.867 -1.146 . . . . 0.0 110.47 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.912 HD11 ' HB3' ' A' ' 96' ' ' LEU . 5.6 mm -135.74 114.68 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 25.4 t -125.85 149.6 48.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.093 -1.005 . . . . 0.0 109.946 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.536 ' HE1' ' HH ' ' A' ' 122' ' ' TYR . 91.8 m-85 -128.05 126.46 41.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.416 -0.803 . . . . 0.0 109.164 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 91.1 mt-10 -105.34 141.71 36.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -0.975 . . . . 0.0 109.874 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.03 122.86 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.332 -0.855 . . . . 0.0 109.173 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 18.8 mtpp -123.48 137.28 54.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.182 -0.949 . . . . 0.0 109.723 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -116.61 141.84 47.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.237 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -141.06 155.12 46.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.619 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.88 132.93 40.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.284 -0.885 . . . . 0.0 109.301 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -118.29 111.67 38.25 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.192 -0.942 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.46 -50.68 0.37 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.713 2.275 . . . . 0.0 111.669 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.05 -49.24 78.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.93 . . . . 0.0 109.403 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.74 -29.68 72.81 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.39 35.4 26.44 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . -170.18 -129.76 1.14 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.3 t -148.12 150.18 33.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -1.124 . . . . 0.0 109.508 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.412 HG12 HG23 ' A' ' 11' ' ' THR . 67.8 mt -116.8 133.9 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 0.0 109.502 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.731 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.2 mp -111.16 138.53 47.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -123.9 139.29 54.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.265 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 70.8 mt -121.15 138.34 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 33.1 m -125.58 142.61 51.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 44.3 m -126.92 152.4 47.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.741 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -133.98 133.25 41.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.337 -0.852 . . . . 0.0 108.946 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.793 ' C ' HG23 ' A' ' 3' ' ' VAL . 37.9 m-85 -133.32 104.52 6.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.949 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.549 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 15.1 m-70 -83.41 122.47 28.54 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.687 HG21 ' HE2' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -102.58 150.03 23.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.963 -1.086 . . . . 0.0 109.876 -178.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -79.92 131.41 35.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.461 -0.774 . . . . 0.0 109.541 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 68.76 -144.05 41.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -94.36 17.39 13.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -1.179 . . . . 0.0 109.584 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.4 146.91 14.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.135 -0.978 . . . . 0.0 109.47 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.509 ' HA ' ' CE2' ' A' ' 4' ' ' PHE . 38.2 m -127.21 154.79 44.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.578 ' CD1' ' CB ' ' A' ' 122' ' ' TYR . 22.6 mt -108.41 130.37 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.533 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -72.88 142.87 47.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.456 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HA ' HG12 ' A' ' 135' ' ' ILE . 98.9 mt-10 -65.9 -31.47 72.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.538 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.99 -44.74 83.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.45 -43.56 88.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.564 ' CD1' ' CE2' ' A' ' 6' ' ' TYR . 38.3 pt -79.85 -29.65 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.882 . . . . 0.0 109.428 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 36.7 tttm -56.26 -41.14 75.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.381 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.4 74.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -56.31 -38.53 78.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.47 ' HE2' ' OD2' ' A' ' 8' ' ' ASP . 19.1 tttm -59.83 -43.61 94.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -1.126 . . . . 0.0 109.352 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -58.95 -41.62 87.87 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.453 ' O ' ' HG ' ' A' ' 145' ' ' LEU . 23.3 tttp -60.74 -41.46 95.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.354 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.48 86.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.377 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.24 96.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.877 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.53 98.23 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.929 ' O ' HG13 ' A' ' 149' ' ' VAL . 57.8 mt -66.09 -38.86 89.3 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -1.199 . . . . 0.0 109.393 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -64.78 -44.5 89.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.44 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.59 -35.53 80.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.362 -0.836 . . . . 0.0 109.471 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.421 ' O ' HG21 ' A' ' 34' ' ' VAL . . . -72.32 -50.46 26.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.371 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 145' ' ' LEU . 3.3 m -64.46 -46.71 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.324 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.651 ' HG3' HD11 ' A' ' 14' ' ' ILE . 83.8 tt0 -60.67 -35.56 76.55 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.275 -0.891 . . . . 0.0 108.946 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.89 -43.11 72.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.277 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -62.78 -41.28 99.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.527 ' CD1' ' OXT' ' A' ' 161' ' ' CYS . 30.5 tp -59.35 -41.8 90.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.35 -0.844 . . . . 0.0 109.355 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.47 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 37.4 mt -74.29 -29.47 61.65 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.476 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -70.66 -21.95 62.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.24 70.23 13.02 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 50.1 Cg_endo -70.22 -6.1 18.04 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.759 2.306 . . . . 0.0 111.783 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -75.3 -32.54 61.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.13 144.25 35.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.59 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -61.39 -31.53 71.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.853 . . . . 0.0 109.353 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.527 ' OXT' ' CD1' ' A' ' 153' ' ' LEU . 88.0 m . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.459 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mmm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.299 0.571 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.05 -114.86 6.92 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.707 HG23 ' C ' ' A' ' 122' ' ' TYR . 7.2 p -108.48 135.52 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -1.14 . . . . 0.0 109.588 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.659 ' CD1' HD12 ' A' ' 130' ' ' ILE . 82.8 m-85 -92.07 139.64 30.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.237 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 28.0 p -122.68 119.91 32.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.393 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 119' ' ' THR . 47.3 m-85 -116.24 145.54 43.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.395 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -121.12 143.14 49.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.558 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' OD1' ' HE2' ' A' ' 139' ' ' LYS . 60.5 t0 -116.07 135.78 53.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.358 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -113.07 125.08 53.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.685 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.96 7.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.047 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.8 t -129.48 150.75 50.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.101 -0.999 . . . . 0.0 109.972 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.7 t -160.29 146.39 15.42 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 13' ' ' VAL . 13.0 m -62.3 90.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.033 . . . . 0.0 109.29 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.776 HG23 ' HD2' ' A' ' 15' ' ' PRO . 8.8 mt -139.81 145.48 43.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.354 -0.841 . . . . 0.0 109.322 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.776 ' HD2' HG23 ' A' ' 14' ' ' ILE . 45.9 Cg_endo -68.44 112.79 2.92 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 122.332 2.021 . . . . 0.0 110.995 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HG3' ' HB2' ' A' ' 107' ' ' ALA . 44.6 Cg_endo -66.54 -32.02 40.2 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.851 2.367 . . . . 0.0 112.34 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.03 -56.23 7.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.134 -0.979 . . . . 0.0 109.442 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.445 ' HA ' ' SG ' ' A' ' 161' ' ' CYS . 13.1 mtt85 -72.4 -38.95 68.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.243 -0.911 . . . . 0.0 109.732 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.668 HD13 HG21 ' A' ' 14' ' ' ILE . 22.0 tp -62.0 -47.64 83.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 109.654 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.58 ' CE1' ' HA ' ' A' ' 77' ' ' HIS . 53.9 t80 -58.59 -46.62 86.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.413 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 22.4 mttm -72.84 -44.66 61.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.957 . . . . 0.0 109.522 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 26' ' ' ASP . 33.9 t -70.83 -21.33 62.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.076 -1.015 . . . . 0.0 109.582 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.951 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 2.6 t80 -100.13 -50.74 3.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.089 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 20' ' ' PHE . 55.5 t -85.04 -52.44 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.095 -1.003 . . . . 0.0 110.12 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 21' ' ' LYS . 18.1 tp -70.41 -36.27 73.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.135 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 30' ' ' LEU . 74.4 m-20 -103.82 23.78 12.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.039 -1.038 . . . . 0.0 109.723 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.5 -46.53 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.771 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.463 ' O ' ' CD ' ' A' ' 32' ' ' PRO . 71.9 m-20 -64.62 -33.22 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 109.96 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.421 ' HB3' ' HE3' ' A' ' 33' ' ' LYS . 86.6 m-20 -90.76 -40.17 11.97 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 109.64 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.799 HD21 HG23 ' A' ' 149' ' ' VAL . 19.5 tp -66.32 -28.25 68.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.955 . . . . 0.0 109.57 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.84 ' O ' HG12 ' A' ' 34' ' ' VAL . 24.6 mt -60.31 -60.37 10.85 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.182 -0.949 . . . . 0.0 109.164 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 31' ' ' ILE . 48.6 Cg_endo -68.41 -23.16 38.22 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.603 2.202 . . . . 0.0 111.649 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 29' ' ' ASN . 79.9 mttt -71.97 -46.17 58.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.352 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.046 HG21 ' HB1' ' A' ' 148' ' ' ALA . 10.6 p -59.33 -24.12 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.624 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.76 87.21 50.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.635 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.66 -21.07 29.79 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.729 2.286 . . . . 0.0 111.707 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -56.84 -36.37 69.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.623 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -130.22 135.21 47.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -113.1 146.75 38.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.34 -0.85 . . . . 0.0 109.45 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.0 p -127.9 157.81 39.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.382 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.8 m -129.29 148.76 51.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.526 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.27 149.16 37.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.515 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -133.72 157.0 46.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -97.87 110.12 22.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.525 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.599 HD11 ' HB2' ' A' ' 56' ' ' LYS . 7.6 mt -63.25 -37.83 88.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.432 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.724 ' O ' HG23 ' A' ' 53' ' ' THR . 83.9 tt0 -149.14 157.09 43.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.279 -0.888 . . . . 0.0 109.456 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.499 ' N ' ' HG2' ' A' ' 46' ' ' GLU . . . 86.46 155.99 27.69 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -89.9 10.52 23.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.563 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 104.73 23.41 7.88 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.853 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -121.19 -143.91 6.8 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' ' 74' ' ' GLU . 50.4 Cg_endo -70.17 121.89 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.678 2.252 . . . . 0.0 111.843 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.74 -2.82 70.33 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 46' ' ' GLU . 94.3 m -78.59 140.83 38.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -1.196 . . . . 0.0 109.496 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 23.4 mm -100.67 129.55 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 31.1 tttm -106.71 130.7 54.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' HB2' HD11 ' A' ' 45' ' ' LEU . 20.0 tttt -122.86 134.93 54.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.498 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.8 mt -111.73 135.9 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.534 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.7 p -125.31 151.91 45.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -104.44 128.42 52.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -66.27 -42.65 88.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.219 -0.925 . . . . 0.0 109.439 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' CD ' ' OD1' ' A' ' 63' ' ' ASN . 84.9 tt0 -65.88 -30.84 71.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.368 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.77 40.13 27.12 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.413 ' OD1' ' CD ' ' A' ' 61' ' ' GLU . 89.9 m-20 -57.52 -36.63 71.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.308 -1.113 . . . . 0.0 109.441 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -127.96 134.77 49.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.354 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.04 -35.32 76.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -78.44 141.32 38.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.144 -0.973 . . . . 0.0 109.419 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -114.0 156.49 23.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.456 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.547 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 88.9 mtp -96.08 140.36 30.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.452 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.95 146.6 30.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.583 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 79.5 m80 -126.8 140.11 52.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -124.62 133.25 53.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.5 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.521 HG11 HD11 ' A' ' 75' ' ' ILE . 46.9 t -98.68 130.62 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 82.0 tt0 -81.09 -53.92 5.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.182 -0.949 . . . . 0.0 109.461 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 94.7 mt-10 -156.96 143.35 18.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 0.0 109.438 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.853 HD12 ' HA2' ' A' ' 50' ' ' GLY . 71.8 mt -124.31 123.65 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.296 -0.877 . . . . 0.0 109.498 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.449 ' CB ' ' HB2' ' A' ' 79' ' ' ASN . 73.2 m-20 -130.5 86.25 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.239 -0.913 . . . . 0.0 109.422 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.58 ' HA ' ' CE1' ' A' ' 20' ' ' PHE . 75.6 m80 -62.38 -38.05 88.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.67 -30.68 68.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.424 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.449 ' HB2' ' CB ' ' A' ' 76' ' ' ASP . 56.8 m-20 -89.49 9.39 26.72 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.508 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.559 ' HA ' ' CE2' ' A' ' 20' ' ' PHE . 56.5 m-85 44.21 39.65 3.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.354 -0.841 . . . . 0.0 109.536 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.482 ' CE ' ' OE2' ' A' ' 102' ' ' GLU . 82.9 tttt -135.39 128.59 31.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.536 ' CE2' HG12 ' A' ' 75' ' ' ILE . 77.5 t80 -125.97 127.9 46.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.942 . . . . 0.0 109.561 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 4.3 t -128.09 123.38 34.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.392 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 38.7 p90 -139.35 166.06 25.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.954 . . . . 0.0 109.566 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.7 t -143.64 167.39 22.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.0 mt -115.06 130.34 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.578 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.4 -47.18 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.557 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -145.7 135.85 23.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 109.503 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.579 ' CA ' HD23 ' A' ' 92' ' ' LEU . . . -171.09 104.18 0.2 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 56.96 -157.03 11.96 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' O ' ' N ' ' A' ' 94' ' ' HIS . 54.5 Cg_endo -74.15 7.22 2.61 Favored 'Trans proline' 0 C--O 1.212 -0.791 0 C-N-CA 122.625 2.217 . . . . 0.0 112.294 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.757 ' C ' HD12 ' A' ' 92' ' ' LEU . 2.2 pp -40.21 -26.9 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.036 -1.04 . . . . 0.0 110.332 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -87.95 23.55 13.71 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.527 ' O ' ' CB ' ' A' ' 95' ' ' THR . 57.2 t-80 -67.79 73.83 0.18 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.152 -1.205 . . . . 0.0 107.878 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 1.052 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 78.54 5.31 2.53 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.936 ' HB3' HD11 ' A' ' 99' ' ' ILE . 67.2 mt -100.71 93.11 5.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.275 -0.891 . . . . 0.0 108.957 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 123' ' ' HIS . 87.7 mt-10 -40.43 -37.63 0.71 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.693 -0.63 . . . . 0.0 110.42 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 1.02 ' O ' HD13 ' A' ' 99' ' ' ILE . 15.9 tttt -164.81 155.44 14.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 110.419 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.02 HD13 ' O ' ' A' ' 98' ' ' LYS . 6.5 mm -131.85 124.24 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.4 t -128.43 159.62 34.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.022 -1.049 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.468 ' HD2' ' HG ' ' A' ' 120' ' ' SER . 85.0 m-85 -135.68 128.54 31.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.482 ' OE2' ' CE ' ' A' ' 81' ' ' LYS . 78.4 tt0 -112.05 140.66 46.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 117' ' ' LYS . 68.7 mt -131.81 126.34 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 109.153 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.433 ' HG2' ' HG3' ' A' ' 81' ' ' LYS . 11.2 mtpp -123.43 137.77 54.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.612 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.93 151.06 39.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.375 -0.828 . . . . 0.0 109.329 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.27 158.91 43.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 109.457 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.469 ' HB2' ' HG3' ' A' ' 16' ' ' PRO . . . -107.14 146.25 31.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.861 . . . . 0.0 109.473 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 112' ' ' GLY . . . -141.76 147.39 45.16 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.364 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.61 -48.59 1.02 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.754 2.303 . . . . 0.0 111.748 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -147.68 166.35 27.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.3 -0.875 . . . . 0.0 109.354 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 68.4 36.03 83.3 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.806 ' O ' ' HB3' ' A' ' 108' ' ' ALA . . . 127.62 77.97 0.24 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 112' ' ' GLY . . . -43.59 -34.69 2.7 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 14' ' ' ILE . 95.0 p -146.5 152.71 39.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.384 -1.068 . . . . 0.0 109.385 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.402 ' C ' HD12 ' A' ' 116' ' ' LEU . 69.3 mt -122.61 128.04 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.737 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.4 mp -110.32 134.59 52.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 29.9 mttp -128.51 128.88 45.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 109.476 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 70.9 mt -118.11 129.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.895 . . . . 0.0 109.463 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 75.7 m -126.2 134.42 51.25 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 109.577 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.468 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 50.4 m -116.4 161.82 18.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.563 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -145.67 127.03 14.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -0.845 . . . . 0.0 109.37 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.822 ' CD1' HG23 ' A' ' 99' ' ' ILE . 11.0 m-85 -126.63 107.94 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.301 -0.874 . . . . 0.0 109.484 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.624 ' CD2' HG21 ' A' ' 3' ' ' VAL . 22.2 m-70 -80.23 113.98 18.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.089 -1.007 . . . . 0.0 108.336 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' THR . 1.3 p -104.45 141.82 35.68 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.053 -1.029 . . . . 0.0 109.511 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 92.2 mttt -41.83 -42.48 2.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.479 -0.763 . . . . 0.0 109.615 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 151.73 -70.25 0.3 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -59.67 -31.71 69.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -1.164 . . . . 0.0 109.56 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 1.052 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -61.18 147.47 44.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.2 m -128.56 145.76 51.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.92 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.659 HD12 ' CD1' ' A' ' 4' ' ' PHE . 17.8 mt -108.78 126.49 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -88.41 152.51 21.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.809 ' OE1' HD11 ' A' ' 135' ' ' ILE . 75.6 mm-40 -64.9 -36.79 85.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.02 -44.59 95.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.901 . . . . 0.0 109.521 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.81 -43.65 90.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.571 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.809 HD11 ' OE1' ' A' ' 132' ' ' GLU . 42.2 pt -82.13 -30.69 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 132' ' ' GLU . 47.4 tttt -55.78 -37.51 68.66 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.189 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.4 -42.48 74.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 109.288 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.16 95.07 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.473 ' HE2' ' OD1' ' A' ' 8' ' ' ASP . 22.7 tttt -60.01 -42.92 95.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -1.14 . . . . 0.0 109.317 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.39 -41.8 94.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.379 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -58.08 -45.96 86.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.14 -42.56 75.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.262 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.7 -43.1 99.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.371 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.62 -45.06 90.84 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.82 -38.25 78.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -1.154 . . . . 0.0 109.301 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.51 ' O ' HG12 ' A' ' 149' ' ' VAL . 70.0 t80 -62.9 -41.83 99.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.313 -0.867 . . . . 0.0 109.395 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.0 -37.39 87.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.901 . . . . 0.0 109.309 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 1.046 ' HB1' HG21 ' A' ' 34' ' ' VAL . . . -67.46 -47.42 70.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.935 . . . . 0.0 109.389 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.799 HG23 HD21 ' A' ' 30' ' ' LEU . 6.6 p -62.39 -40.45 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.301 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 149' ' ' VAL . 85.7 tt0 -59.74 -43.24 94.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.426 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.6 81.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.919 . . . . 0.0 109.353 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -61.38 -44.83 96.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.36 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 85.5 mt -61.51 -39.64 91.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.527 HD23 ' C ' ' A' ' 154' ' ' LEU . 9.1 tt -64.56 -44.59 90.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.502 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.02 -29.65 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -141.9 70.63 24.2 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.94 . . . . 0.0 109.447 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 154' ' ' LEU . 51.2 Cg_endo -70.79 -4.98 15.81 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.653 2.236 . . . . 0.0 111.85 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -97.99 9.97 41.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.177 -0.952 . . . . 0.0 109.59 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.27 148.02 38.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -115.98 139.99 49.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.549 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 18' ' ' ARG . 8.7 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.508 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 ttp . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.337 0.589 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.02 152.76 2.02 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 38.6 t -134.28 141.74 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.523 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CD2' HD12 ' A' ' 130' ' ' ILE . 99.1 m-85 -101.59 122.99 44.87 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.7 t -111.03 120.97 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.77 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 28.2 m-85 -115.49 147.33 40.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -118.16 133.67 55.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.925 . . . . 0.0 109.654 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -109.54 134.2 52.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.419 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.86 124.21 52.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.207 -0.933 . . . . 0.0 109.768 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.28 124.19 15.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -0.855 . . . . 0.0 109.292 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.2 m -110.6 132.3 54.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 m -157.06 147.48 21.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 109.045 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.738 ' O ' HG23 ' A' ' 13' ' ' VAL . 31.0 m -78.44 90.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.501 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.84 HG21 HD13 ' A' ' 19' ' ' LEU . 8.6 mt -139.37 144.93 42.06 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.224 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.784 ' HD2' HG23 ' A' ' 14' ' ' ILE . 46.9 Cg_endo -68.98 113.33 3.21 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.501 2.134 . . . . 0.0 111.228 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 15' ' ' PRO . 43.2 Cg_endo -66.52 -31.13 42.35 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.799 2.333 . . . . 0.0 112.204 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.11 -52.74 8.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.486 ' NH1' ' OXT' ' A' ' 161' ' ' CYS . 36.3 ttt180 -72.01 -45.95 59.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 109.954 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.84 HD13 HG21 ' A' ' 14' ' ' ILE . 6.7 tp -59.04 -45.13 91.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.959 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.532 ' CE1' HG21 ' A' ' 24' ' ' VAL . 79.0 t80 -60.73 -55.38 33.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.902 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 23.8 tttp -67.85 -38.39 83.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 26' ' ' ASP . 29.5 t -72.78 -27.2 61.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.92 . . . . 0.0 109.805 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.794 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 34.3 t80 -100.82 -50.11 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.307 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.532 HG21 ' CE1' ' A' ' 20' ' ' PHE . 54.8 t -78.14 -52.45 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.082 -1.011 . . . . 0.0 110.284 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.773 ' O ' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.13 -35.91 82.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.103 -0.998 . . . . 0.0 109.808 -179.434 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 22' ' ' SER . 89.8 m-20 -108.71 28.36 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.0 109.581 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.794 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.4 -45.04 70.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 109.687 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.917 ' HA ' HD12 ' A' ' 31' ' ' ILE . 65.0 m-20 -73.72 -29.65 62.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.98 . . . . 0.0 109.773 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 32' ' ' PRO . 92.5 m-20 -79.66 -37.79 35.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.965 . . . . 0.0 109.616 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.612 ' O ' HG12 ' A' ' 34' ' ' VAL . 42.1 mt -72.44 -31.47 65.49 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.72 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.917 HD12 ' HA ' ' A' ' 28' ' ' ASP . 16.0 mt -49.83 -57.41 12.45 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.7 Cg_endo -68.54 -39.16 9.74 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.573 2.182 . . . . 0.0 111.686 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' HE2' ' OH ' ' A' ' 152' ' ' TYR . 77.4 tttt -68.06 -47.31 68.67 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 30' ' ' LEU . 7.9 p -62.31 -12.66 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.2 -0.938 . . . . 0.0 109.448 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.69 76.08 71.94 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.204 -0.935 . . . . 0.0 109.565 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.42 -36.96 10.68 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.689 2.259 . . . . 0.0 111.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -49.97 -43.8 50.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.607 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -113.53 139.11 49.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -107.65 127.25 53.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 109.358 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.2 p -122.88 158.33 30.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.176 -0.953 . . . . 0.0 109.414 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.8 m -135.01 148.75 50.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.146 -0.972 . . . . 0.0 109.575 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' A' ' 55' ' ' LYS . . . -141.54 143.64 33.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.321 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -134.21 149.71 51.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 54' ' ' ILE . 33.2 p-10 -84.0 114.56 21.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.391 -0.818 . . . . 0.0 109.596 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.53 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . 52.0 mt -65.95 -28.69 69.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.0 109.404 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 45' ' ' LEU . 14.7 mm-40 -159.44 -173.41 4.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 0.0 109.445 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 63.39 164.36 0.57 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -94.51 -3.14 50.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -1.087 . . . . 0.0 109.553 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.752 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 119.72 13.82 5.97 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.722 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -112.17 -142.12 8.55 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.63 125.95 13.42 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.905 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.42 5.49 79.13 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.752 HG21 ' HA2' ' A' ' 49' ' ' GLY . 53.9 m -73.02 140.78 47.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -1.219 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.53 ' CG2' ' HB2' ' A' ' 45' ' ' LEU . 27.0 mm -99.13 133.74 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.417 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 70' ' ' HIS . 79.7 tttt -122.77 134.84 54.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.403 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HB2' HD11 ' A' ' 45' ' ' LEU . 21.8 tttt -130.85 131.46 44.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.507 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.478 HD12 ' HE2' ' A' ' 70' ' ' HIS . 69.5 mt -107.07 137.61 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.499 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.5 m -119.9 139.43 52.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.357 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 60' ' ' ALA . 45.3 p90 -136.24 178.04 7.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 0.0 109.492 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.563 ' O ' ' CD2' ' A' ' 59' ' ' PHE . . . -48.19 137.8 10.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.398 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -51.44 -39.16 56.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.59 -119.63 19.13 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -110.42 146.21 36.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.14 . . . . 0.0 109.381 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 46.89 -164.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.166 -0.959 . . . . 0.0 109.344 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -113.83 129.76 56.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.131 -0.981 . . . . 0.0 109.562 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -129.73 130.95 46.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.265 -0.897 . . . . 0.0 109.345 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -126.4 135.8 51.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 65.3 mtt -111.31 148.42 32.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.367 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' CB ' ' HB ' ' A' ' 87' ' ' ILE . 53.4 mttm -126.88 136.79 52.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.519 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.606 ' ND1' HG23 ' A' ' 86' ' ' ILE . 34.0 m-70 -131.96 133.51 44.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.6 tttm -127.19 141.51 51.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 109.612 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.583 HG11 ' CG1' ' A' ' 75' ' ' ILE . 62.0 t -100.8 129.65 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.367 -0.833 . . . . 0.0 109.335 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -75.8 -43.96 43.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.612 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -173.1 137.26 0.69 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.169 -0.957 . . . . 0.0 109.583 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.722 HD12 ' HA2' ' A' ' 50' ' ' GLY . 60.3 mt -116.77 123.55 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 109.46 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -132.94 72.59 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.511 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.568 ' CE1' ' CG2' ' A' ' 75' ' ' ILE . 60.4 m80 -55.9 -37.14 68.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.455 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.44 78.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.363 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 23.9 m120 -87.45 -0.28 56.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.188 -0.945 . . . . 0.0 109.569 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 60.93 31.78 19.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.335 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 79' ' ' ASN . 4.5 mtmp? -130.87 125.14 32.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 73.4 t80 -117.16 129.25 55.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 0.0 109.42 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 1.3 t -129.02 114.06 15.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.56 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 37.3 p90 -129.5 170.44 13.71 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.311 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 87.5 p -151.93 162.86 40.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.0 109.708 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.606 HG23 ' ND1' ' A' ' 70' ' ' HIS . 15.6 mm -111.85 122.43 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -0.891 . . . . 0.0 109.315 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.457 ' HB ' ' CB ' ' A' ' 69' ' ' LYS . 99.7 mt -70.2 -39.24 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.604 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -157.26 139.77 14.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 0.0 109.626 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 90' ' ' GLY . . . -155.05 92.67 0.13 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.7 -119.25 3.57 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 93' ' ' GLY . 49.5 Cg_endo -70.5 -35.6 10.2 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.485 2.124 . . . . 0.0 111.514 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD11 HG13 ' A' ' 99' ' ' ILE . 8.1 tp 55.63 -85.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 109.681 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.701 ' HA3' HD12 ' A' ' 96' ' ' LEU . . . -162.54 179.7 37.66 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -107.09 127.67 53.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -1.121 . . . . 0.0 109.617 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.902 HG21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER 56.47 16.85 2.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 0.0 109.856 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.906 HD22 ' HB3' ' A' ' 122' ' ' TYR . 37.1 mt -90.63 89.67 7.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.029 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.544 ' HB2' ' CB ' ' A' ' 123' ' ' HIS . 79.3 mt-10 -48.35 -32.53 7.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.551 -0.718 . . . . 0.0 110.608 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 99' ' ' ILE . 21.7 tttp -152.34 152.52 32.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.596 -1.315 . . . . 0.0 110.691 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 96' ' ' LEU . 10.0 mm -132.47 113.62 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 37.3 t -131.36 152.23 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.921 -1.112 . . . . 0.0 110.128 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.517 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 84.8 m-85 -130.84 143.66 50.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.484 ' HB3' ' HB ' ' A' ' 119' ' ' THR . 82.1 tt0 -120.93 143.73 48.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 109.78 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.6 mt -124.29 121.9 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.13 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 56.8 tttt -121.04 129.73 53.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.893 -179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mtt -116.18 132.75 56.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.366 -0.834 . . . . 0.0 109.196 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -142.56 151.44 41.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.2 -0.937 . . . . 0.0 109.6 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.86 124.26 34.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.31 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.09 143.01 98.22 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.529 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.89 -32.09 23.2 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.656 2.238 . . . . 0.0 111.705 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -58.32 -28.13 64.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.411 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.38 -8.54 64.5 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 13' ' ' VAL . . . -50.98 -40.38 42.89 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 13' ' ' VAL . . . 168.87 -118.62 0.79 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -138.09 164.73 28.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -1.162 . . . . 0.0 109.674 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.24 137.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.18 137.1 44.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.563 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 47.8 mttp -130.77 135.89 48.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 102' ' ' GLU . 68.1 mt -127.12 127.68 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.134 -0.979 . . . . 0.0 109.668 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 102' ' ' GLU . 32.5 m -116.22 142.51 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.31 -0.869 . . . . 0.0 109.372 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.429 ' HG ' ' HD2' ' A' ' 101' ' ' TYR . 68.3 m -122.02 147.83 45.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.213 -0.93 . . . . 0.0 109.703 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -129.25 116.67 19.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.442 -0.786 . . . . 0.0 109.227 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.906 ' HB3' HD22 ' A' ' 96' ' ' LEU . 72.0 m-85 -115.7 124.79 51.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.253 -0.904 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.544 ' CB ' ' HB2' ' A' ' 97' ' ' GLU . 0.3 OUTLIER -91.05 129.19 37.07 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.204 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 125' ' ' LYS . 4.2 t -114.85 136.01 53.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.99 -1.069 . . . . 0.0 109.953 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 124' ' ' THR . 21.0 tttm -43.63 -46.86 7.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.452 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 163.75 -85.87 0.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -58.32 -25.29 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 0.0 109.699 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 95' ' ' THR . . . -68.95 142.96 54.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.146 -0.971 . . . . 0.0 109.53 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 86.6 p -130.33 163.35 27.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 0.0 109.383 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.705 HD12 ' CD2' ' A' ' 4' ' ' PHE . 51.4 mt -108.48 126.4 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.458 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -67.24 132.51 47.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.342 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.546 ' HA ' ' CD1' ' A' ' 135' ' ' ILE . 94.7 mt-10 -61.92 -32.63 73.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.226 -0.921 . . . . 0.0 109.192 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -61.91 -43.82 98.06 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.3 -26.04 62.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.882 . . . . 0.0 108.986 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.77 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 1.8 mt -69.9 -49.56 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 108.839 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -55.49 -44.54 76.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.318 -0.864 . . . . 0.0 109.209 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.46 -47.37 86.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.218 -0.926 . . . . 0.0 109.281 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.64 -31.61 57.78 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -70.57 -36.79 73.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.3 -1.118 . . . . 0.0 109.306 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -61.04 -45.02 96.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -60.14 -45.95 91.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.841 . . . . 0.0 109.361 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.52 94.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.228 -0.92 . . . . 0.0 109.267 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.02 82.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.233 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.61 -44.56 95.52 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 145' ' ' LEU . 38.0 tp -56.77 -41.99 78.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -1.109 . . . . 0.0 109.311 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.454 ' CE2' HD11 ' A' ' 118' ' ' ILE . 63.9 m-85 -62.09 -41.12 97.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.252 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -56.85 -42.88 80.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.291 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.58 77.27 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.561 HG21 ' CE1' ' A' ' 23' ' ' PHE . 75.3 t -67.21 -50.08 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.445 ' O ' ' HG ' ' A' ' 154' ' ' LEU . 82.7 mt-10 -50.23 -34.02 21.52 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.01 81.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.717 . . . . 0.0 109.458 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.438 ' OH ' ' HE2' ' A' ' 33' ' ' LYS . 58.4 t80 -59.45 -45.06 92.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 157' ' ' PRO . 76.4 mt -59.1 -42.64 90.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.158 -0.963 . . . . 0.0 109.303 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.45 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 30.0 mt -69.08 -33.0 72.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.442 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.28 -23.26 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 0.0 109.399 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.09 61.75 1.28 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.258 -0.901 . . . . 0.0 109.411 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.471 ' N ' ' O ' ' A' ' 153' ' ' LEU . 49.7 Cg_endo -69.8 -24.15 29.8 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.707 2.271 . . . . 0.0 111.76 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -68.23 -33.31 74.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.929 . . . . 0.0 109.452 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.07 142.89 58.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -57.66 -40.35 79.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.486 ' OXT' ' NH1' ' A' ' 18' ' ' ARG . 4.0 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.277 0.561 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.879 ' O ' HG22 ' A' ' 124' ' ' THR . . . 94.8 12.34 55.65 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.717 HG21 ' CE1' ' A' ' 123' ' ' HIS . 23.7 t -116.57 140.82 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.153 . . . . 0.0 109.499 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 99.3 m-85 -107.49 129.71 54.92 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.306 -0.871 . . . . 0.0 109.132 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 120' ' ' SER . 0.7 OUTLIER -117.28 125.94 51.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.191 -0.943 . . . . 0.0 109.454 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.786 ' CZ ' HD13 ' A' ' 135' ' ' ILE . 46.8 m-85 -124.29 142.75 51.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.405 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -116.3 131.78 56.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.487 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 117' ' ' LYS . 56.8 t0 -99.98 133.08 44.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 109.484 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -108.52 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -141.4 129.55 22.15 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.24 -0.913 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.7 m -112.66 137.44 50.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.792 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.6 m -160.6 147.98 15.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.828 . . . . 0.0 109.047 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 13' ' ' VAL . 4.0 p -81.84 91.07 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.567 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 19' ' ' LEU . 13.2 mt -139.17 144.77 41.99 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 109.28 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.76 ' HD2' HG23 ' A' ' 14' ' ' ILE . 44.5 Cg_endo -67.69 116.17 4.13 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.41 2.073 . . . . 0.0 111.217 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 20' ' ' PHE . 44.9 Cg_endo -66.8 -35.61 26.93 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.884 2.39 . . . . 0.0 112.387 -179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.09 -52.04 18.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.079 -1.013 . . . . 0.0 109.479 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 22' ' ' SER . 55.9 mtp180 -72.11 -50.32 29.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.297 -0.877 . . . . 0.0 109.686 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 14' ' ' ILE . 13.4 tp -55.01 -45.28 75.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 109.803 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.701 ' O ' HG22 ' A' ' 24' ' ' VAL . 47.5 t80 -64.39 -55.59 20.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.085 -1.009 . . . . 0.0 109.425 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 25' ' ' LEU . 27.9 mttt -67.92 -13.73 62.39 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 109.648 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.692 ' O ' HD12 ' A' ' 30' ' ' LEU . 49.7 m -100.33 -21.46 15.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.011 -1.056 . . . . 0.0 109.925 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 1.025 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 35.0 t80 -101.2 -52.5 3.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.996 -1.065 . . . . 0.0 110.722 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 20' ' ' PHE . 12.6 m -86.22 -40.79 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.961 -1.087 . . . . 0.0 110.63 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.544 HD12 ' CD2' ' A' ' 77' ' ' HIS . 4.1 tt -79.29 -43.16 24.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.574 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.502 ' HB3' ' HG ' ' A' ' 30' ' ' LEU . 95.1 m-20 -89.54 10.74 21.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.025 ' HB2' ' O ' ' A' ' 23' ' ' PHE . . . -69.42 -31.49 69.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -0.985 . . . . 0.0 109.689 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -71.56 -14.76 62.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -114.75 -36.92 4.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.0 . . . . 0.0 109.817 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 22' ' ' SER . 33.4 mt -72.53 -31.12 65.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.642 HD13 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -58.6 -57.5 26.14 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.124 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 31' ' ' ILE . 47.2 Cg_endo -68.47 -33.55 22.56 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.65 2.233 . . . . 0.0 111.606 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -69.19 -31.55 70.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.358 -0.839 . . . . 0.0 109.38 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 30' ' ' LEU . 73.3 t -74.4 -34.41 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.887 . . . . 0.0 109.499 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 34' ' ' VAL . . . 69.13 61.93 0.59 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 39' ' ' PHE . 50.2 Cg_endo -70.26 137.96 35.17 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.684 2.256 . . . . 0.0 111.744 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.38 -31.08 72.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.939 . . . . 0.0 109.444 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -61.19 -49.81 75.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.88 ' CD1' HG21 ' A' ' 57' ' ' ILE . 81.1 m-85 -118.04 139.93 50.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.28 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.3 p -78.54 -35.84 45.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 82.8 p -163.36 167.28 21.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.172 -0.955 . . . . 0.0 109.519 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' C ' ' HG3' ' A' ' 43' ' ' GLU . . . -138.21 149.43 45.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.436 ' HG3' ' C ' ' A' ' 42' ' ' ALA . 92.0 mt-10 -155.53 156.42 35.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.211 -0.931 . . . . 0.0 109.477 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' LYS . 84.1 m-20 -88.53 118.49 28.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.524 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 56' ' ' LYS . 28.5 tp -72.95 -35.97 67.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.437 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 53' ' ' THR . 49.5 tp10 -159.24 153.98 24.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.3 -0.875 . . . . 0.0 109.314 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 53' ' ' THR . . . 93.37 150.29 26.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -83.52 6.91 18.78 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.602 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.675 ' HA2' HG21 ' A' ' 53' ' ' THR . . . 105.08 20.2 10.01 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.692 ' HA2' HD12 ' A' ' 75' ' ' ILE . . . -113.58 -146.32 9.47 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.01 124.94 11.91 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.751 2.301 . . . . 0.0 111.891 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.16 78.22 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.675 HG21 ' HA2' ' A' ' 49' ' ' GLY . 61.2 m -72.73 137.79 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -1.193 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.3 mm -103.81 133.44 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.276 -0.89 . . . . 0.0 109.39 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 70' ' ' HIS . 46.6 mtpt -111.73 144.33 41.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 45' ' ' LEU . 16.1 tttp -122.13 133.4 54.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.582 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.88 HG21 ' CD1' ' A' ' 39' ' ' PHE . 23.0 mm -111.1 135.05 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.471 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 48.2 m -86.56 140.79 29.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.182 -0.949 . . . . 0.0 109.489 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.443 ' CE2' ' O ' ' A' ' 61' ' ' GLU . 22.0 p90 -113.56 153.37 28.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.895 . . . . 0.0 109.511 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.92 -31.12 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.502 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.443 ' O ' ' CE2' ' A' ' 59' ' ' PHE . 96.0 mt-10 -52.97 144.51 14.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.542 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.78 22.0 41.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -93.16 106.85 18.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.139 . . . . 0.0 109.516 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' CZ ' ' A' ' 67' ' ' TYR . 84.3 tt0 -65.77 -28.58 69.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.304 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' O ' ' CD1' ' A' ' 67' ' ' TYR . 63.1 t80 -49.62 -40.96 41.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.392 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -70.69 126.98 31.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.373 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 64' ' ' GLU . 88.5 m-85 -128.97 132.25 47.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.089 -1.007 . . . . 0.0 109.716 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.454 ' HG2' ' HA2' ' A' ' 89' ' ' GLY . 82.6 mtp -116.21 141.24 48.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.862 . . . . 0.0 109.123 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -137.67 140.48 40.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.132 -0.98 . . . . 0.0 109.826 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.581 ' CE1' HG12 ' A' ' 57' ' ' ILE . 79.8 m80 -126.0 135.36 51.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -130.32 142.15 50.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG11 ' CG1' ' A' ' 75' ' ' ILE . 68.6 t -101.65 132.61 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.464 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 74' ' ' GLU . 89.9 mt-10 -73.59 -58.64 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.426 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 93.9 mt-10 -158.79 144.25 16.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.692 HD12 ' HA2' ' A' ' 50' ' ' GLY . 91.3 mt -122.79 120.32 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.502 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.471 ' HB3' ' OD1' ' A' ' 79' ' ' ASN . 86.8 m-20 -122.78 92.42 3.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.452 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.544 ' CD2' HD12 ' A' ' 25' ' ' LEU . 76.5 m80 -64.95 -37.52 87.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.16 -33.31 71.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.902 . . . . 0.0 109.374 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' OD1' ' HB3' ' A' ' 76' ' ' ASP . 23.2 m120 -84.98 -2.33 57.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.614 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 53.61 41.24 32.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -137.32 122.45 19.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.913 . . . . 0.0 109.538 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 84' ' ' TYR . 81.7 t80 -113.18 128.11 56.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 m -127.78 119.13 25.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.215 -0.928 . . . . 0.0 109.502 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.583 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 33.2 p90 -134.32 164.28 27.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.202 -0.936 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 17.0 t -145.51 158.99 43.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.239 -0.913 . . . . 0.0 109.584 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 86' ' ' ILE . 54.0 mt -108.58 137.42 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 109.386 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.475 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 96.4 mt -86.24 -27.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.699 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.53 ' HA ' ' CD2' ' A' ' 92' ' ' LEU . 85.0 tt0 176.54 162.3 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.299 -0.876 . . . . 0.0 109.514 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 88' ' ' GLU . . . 172.73 113.02 0.29 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 89' ' ' GLY . . . 45.59 -117.45 2.48 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' GLY . 48.7 Cg_endo -69.95 -33.66 15.44 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.439 2.093 . . . . 0.0 111.179 179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.639 ' C ' HD13 ' A' ' 92' ' ' LEU . 2.4 tm? 60.48 -76.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.534 -0.729 . . . . 0.0 109.674 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.561 ' HA3' HD11 ' A' ' 99' ' ' ILE . . . -173.17 160.7 31.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -92.46 121.56 34.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.142 -1.21 . . . . 0.0 109.712 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.0 m 48.8 22.94 0.6 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 109.648 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.945 HD22 ' HB3' ' A' ' 122' ' ' TYR . 36.4 mt -94.02 89.14 5.93 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 109.301 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.547 ' CG ' ' HG2' ' A' ' 125' ' ' LYS . 83.6 mt-10 -40.75 -28.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.633 -0.667 . . . . 0.0 110.218 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.488 ' HB3' ' CD2' ' A' ' 123' ' ' HIS . 71.3 tttt -165.87 155.2 11.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 0.0 110.153 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.831 HG23 ' CD1' ' A' ' 122' ' ' TYR . 45.9 mt -141.32 113.73 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.422 -0.799 . . . . 0.0 108.975 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 32.1 t -126.08 150.45 48.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.944 . . . . 0.0 109.985 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.607 ' HE2' ' HH ' ' A' ' 122' ' ' TYR . 98.2 m-85 -127.24 126.42 42.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.412 -0.805 . . . . 0.0 109.145 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 51.9 mp0 -112.83 142.1 45.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 109.803 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.6 mt -117.37 131.72 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.338 -0.851 . . . . 0.0 109.252 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 117' ' ' LYS . 16.0 tttp -124.83 132.24 53.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 64.0 mtt -115.58 146.16 42.01 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.303 -0.873 . . . . 0.0 109.409 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -143.88 152.08 40.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.481 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -103.75 137.95 41.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.462 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.497 ' HB1' ' HD2' ' A' ' 109' ' ' PRO . . . -65.03 160.49 55.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.497 ' HD2' ' HB1' ' A' ' 108' ' ' ALA . 49.4 Cg_endo -69.88 -31.13 20.61 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.709 2.273 . . . . 0.0 111.821 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -98.06 -12.5 21.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.6 175.48 45.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.27 36.86 19.72 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 13' ' ' VAL . . . 160.66 125.95 0.8 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.2 p -106.13 163.63 12.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -1.174 . . . . 0.0 109.599 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.81 128.08 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.283 -0.886 . . . . 0.0 109.388 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 78.8 mt -107.11 136.15 47.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 104' ' ' LYS . 94.1 mttt -131.32 136.92 48.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.2 mt -124.48 127.43 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 109.42 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 102' ' ' GLU . 26.7 m -113.81 142.42 46.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.48 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 51.5 m -127.89 150.58 49.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.551 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.465 ' HG2' ' SG ' ' A' ' 5' ' ' CYS . 34.7 mttt -138.43 120.68 15.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.399 -0.813 . . . . 0.0 109.079 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.945 ' HB3' HD22 ' A' ' 96' ' ' LEU . 28.5 m-85 -120.6 115.75 24.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.122 -0.986 . . . . 0.0 109.889 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.717 ' CE1' HG21 ' A' ' 3' ' ' VAL . 52.1 m-70 -83.15 132.18 35.09 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 2' ' ' GLY . 10.3 t -113.95 138.29 50.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.997 -1.064 . . . . 0.0 109.87 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.547 ' HG2' ' CG ' ' A' ' 97' ' ' GLU . 75.9 mttt -76.38 144.29 40.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.31 -0.869 . . . . 0.0 109.384 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 54.66 -148.2 22.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 128' ' ' ALA . 46.2 p-10 -88.06 10.95 17.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -1.139 . . . . 0.0 109.48 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.865 ' HB3' ' OG1' ' A' ' 124' ' ' THR . . . -45.24 144.0 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.458 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.4 p -123.1 167.15 14.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 122' ' ' TYR . 23.1 mt -116.11 127.67 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 109.578 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.405 ' HB3' ' HG3' ' A' ' 134' ' ' GLU . 45.8 t30 -57.1 127.35 31.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.559 ' HA ' HG13 ' A' ' 135' ' ' ILE . 96.1 mt-10 -61.96 -33.72 74.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.321 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -55.28 -44.25 75.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.171 -0.956 . . . . 0.0 108.941 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.405 ' HG3' ' HB3' ' A' ' 131' ' ' ASN . 92.5 mt-10 -58.09 -25.25 61.08 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.786 HD13 ' CZ ' ' A' ' 6' ' ' TYR . 4.3 mt -70.33 -50.86 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.822 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -55.59 -43.92 76.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 109.194 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -57.56 -42.94 84.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.207 -0.933 . . . . 0.0 109.191 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -55.76 -38.09 71.6 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -61.42 -44.16 97.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -1.058 . . . . 0.0 109.118 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -57.51 -42.19 82.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.436 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -58.48 -45.23 89.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.62 -38.5 75.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -0.98 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.94 -44.73 94.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.9 -46.88 90.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 25.0 tp -60.48 -37.99 82.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.199 -1.177 . . . . 0.0 109.497 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.438 ' O ' HG12 ' A' ' 149' ' ' VAL . 67.2 t80 -61.69 -43.3 99.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -0.89 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -61.23 -36.26 79.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.369 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.59 -48.72 68.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 150' ' ' GLU . 7.4 p -66.97 -42.55 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.92 . . . . 0.0 109.395 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.515 ' N ' HG13 ' A' ' 149' ' ' VAL . 84.1 tt0 -60.78 -38.63 85.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.421 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.2 -36.96 80.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.237 -0.915 . . . . 0.0 109.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.524 ' CZ ' HD22 ' A' ' 30' ' ' LEU . 71.4 t80 -63.43 -47.82 80.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.918 . . . . 0.0 109.333 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.9 mt -59.02 -40.84 86.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.24 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.89 HD13 ' O ' ' A' ' 154' ' ' LEU . 2.7 tm? -67.88 -40.03 83.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.867 . . . . 0.0 109.441 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.09 66.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.37 75.15 65.08 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -70.99 0.37 6.68 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.826 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -106.26 10.18 31.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.653 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.27 148.02 15.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 51.29 95.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.282 -0.886 . . . . 0.0 109.43 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.478 179.963 . . . . . . . . 0 0 . 1 stop_ save_